data_2n8j_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n8j _Structure_validation_residue.Date_analyzed 2016-10-15 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.389 0 N-CA-C 111.345 0.128 . . . . 0.0 111.345 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -99.4 -41.35 7.45 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.422 0.451 . . . . 0.0 111.266 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.623 HE21 HE22 ' A' ' 8' ' ' GLN . 54.5 mt-30 -133.83 152.46 51.87 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 123.431 0.457 . . . . 0.0 110.853 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.497 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -109.23 -119.86 0.27 Allowed 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.672 ' CG2' ' H ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -102.82 -173.66 2.37 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.521 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.518 ' N ' HG23 ' A' ' 5' ' ' THR . 10.2 mm-40 -60.84 -13.34 14.88 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.143 0.177 . . . . 0.0 111.08 176.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.672 ' H ' ' CG2' ' A' ' 5' ' ' THR . 7.7 pt-20 -52.37 -38.75 59.62 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.906 0.754 . . . . 0.0 111.112 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.623 HE22 HE21 ' A' ' 3' ' ' GLN . 1.4 pt20 -70.09 -49.66 48.66 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.642 176.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.61 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . 20.1 mm -52.82 -35.1 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.947 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.36 -35.01 73.28 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -119.31 -17.72 8.77 Favored 'General case' 0 C--N 1.346 0.418 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -177.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.61 ' CE1' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -69.75 -16.33 63.29 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.743 0.701 . . . . 0.0 111.012 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.7 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 1.2 pttt -83.35 -41.51 18.12 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.7 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 1.8 mt-10 -80.94 -37.61 29.2 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 114.082 -1.417 . . . . 0.0 112.205 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.56 ' O ' HG13 ' A' ' 35' ' ' VAL . . . -66.56 -19.19 65.72 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.52 0.676 . . . . 0.0 109.182 178.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.543 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 11.2 t80 -86.75 -48.97 7.79 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.773 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.402 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 52.3 m -87.02 -12.9 46.0 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -177.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -69.48 -28.25 65.91 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 118.54 0.609 . . . . 0.0 111.979 -179.551 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.566 ' CD1' HG23 ' A' ' 35' ' ' VAL . 4.6 m-85 -132.73 -3.07 3.29 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 -178.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 14.7 t70 -80.48 55.19 2.22 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 119.087 0.858 . . . . 0.0 112.189 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.479 ' N ' ' HD2' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -87.04 -22.39 25.49 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 178.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.67 -22.43 61.67 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.299 0.571 . . . . 0.0 110.446 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.43 44.3 27.91 Favored Glycine 0 N--CA 1.47 0.933 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.54 23.13 13.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 113.029 -1.586 . . . . 0.0 112.458 -175.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.33 -79.96 1.77 Allowed Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.072 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.509 ' CG2' ' HA ' ' A' ' 64' ' ' ASP . 14.6 p -101.21 177.78 4.84 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 122.862 0.465 . . . . 0.0 110.952 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -83.58 148.34 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.406 ' OG1' ' HB2' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -60.41 161.75 7.02 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -178.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.47 ' HG1' ' H ' ' A' ' 30' ' ' LYS . 1.9 p -79.97 -56.71 4.06 Favored 'General case' 0 C--N 1.345 0.398 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.47 ' H ' ' HG1' ' A' ' 29' ' ' THR . 97.1 mttt -59.2 -13.34 7.17 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.332 177.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.469 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 28.0 mt-10 -110.14 -16.36 13.8 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.746 -177.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.527 ' HA ' HG22 ' A' ' 35' ' ' VAL . 8.6 tp -52.57 -41.06 63.25 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.231 0.612 . . . . 0.0 112.555 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.742 ' O ' ' HD3' ' A' ' 37' ' ' ARG . . . -56.32 -39.65 83.1 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 177.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.2 m -74.28 -29.4 61.63 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.479 -0.861 . . . . 0.0 112.401 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.566 HG23 ' CD1' ' A' ' 19' ' ' PHE . 1.3 t -73.82 -27.94 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 176.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.656 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 11.4 mtm -75.03 -41.94 58.22 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 113.066 -1.879 . . . . 0.0 111.319 176.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.742 ' HD3' ' O ' ' A' ' 33' ' ' GLY . 10.3 mtp180 -79.2 -29.19 42.73 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.1 m -67.78 -8.31 34.76 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.991 0.9 . . . . 0.0 111.877 178.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 35' ' ' VAL . 80.9 mt -95.46 -5.87 42.01 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.229 -1.805 . . . . 0.0 109.535 177.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.85 -0.21 52.06 Favored Glycine 0 CA--C 1.494 -1.248 0 CA-C-O 122.206 0.892 . . . . 0.0 115.163 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.656 ' HB2' ' O ' ' A' ' 36' ' ' MET . 47.2 mt-30 -83.03 139.32 33.33 Favored 'General case' 0 C--N 1.279 -2.457 0 CA-C-N 112.293 -1.954 . . . . 0.0 112.195 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -117.87 76.52 11.12 Favored Pre-proline 0 CA--C 1.55 0.962 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.454 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.93 -179.87 4.32 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 123.063 2.509 . . . . 0.0 112.454 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.5 m -100.72 160.63 14.2 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.565 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 33.5 mt-10 -80.67 -28.08 36.91 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.134 178.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.76 -36.31 67.66 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.884 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.466 ' O ' ' HE2' ' A' ' 51' ' ' MET . 43.5 mt-10 -78.17 -29.12 48.4 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 114.088 -1.415 . . . . 0.0 108.607 176.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.565 ' HB2' ' HA ' ' A' ' 45' ' ' GLU . 0.5 OUTLIER -66.06 -20.54 66.2 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.171 174.561 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.825 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 11.8 mm100 -97.48 -15.46 20.58 Favored 'General case' 0 CA--C 1.481 -1.681 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.128 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.425 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 5.9 t70 -85.58 -34.12 21.54 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 111.996 -2.365 . . . . 0.0 110.167 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.466 ' HE2' ' O ' ' A' ' 47' ' ' GLU . 2.0 mpp? -86.46 -34.16 20.16 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.985 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 48' ' ' LEU . 1.2 mp -70.06 -29.17 38.93 Favored 'Isoleucine or valine' 0 C--N 1.345 0.405 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 175.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.825 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.1 t30 -71.45 -33.85 69.71 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.806 175.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 50' ' ' ASP . 41.3 mt-10 -80.25 -38.99 29.86 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.614 ' C ' ' H ' ' A' ' 57' ' ' ALA . 57.7 t -81.42 -39.36 17.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.64 34.18 0.07 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 122.015 0.912 . . . . 0.0 110.485 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.614 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -86.8 -5.99 58.95 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 114.096 -1.411 . . . . 0.0 111.929 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -110.28 -35.64 6.02 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 111.784 -2.462 . . . . 0.0 110.769 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.36 51.24 3.98 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.971 -0.559 . . . . 0.0 113.293 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -109.92 -21.53 12.3 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.568 0.223 . . . . 0.0 111.337 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.78 26.62 68.89 Favored Glycine 0 N--CA 1.466 0.638 0 CA-C-N 115.824 -0.625 . . . . 0.0 114.316 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.465 ' HB ' ' OG1' ' A' ' 26' ' ' THR . 0.1 OUTLIER -143.74 174.71 10.56 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 123.312 0.645 . . . . 0.0 110.538 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.462 ' O ' ' HB ' ' A' ' 26' ' ' THR . 6.7 mm -136.45 110.59 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -177.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.509 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 9.8 m-20 -55.83 143.34 31.67 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.006 173.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.536 ' CG ' ' HD3' ' A' ' 66' ' ' PRO . 7.9 p90 -91.33 -38.94 0.38 Allowed Pre-proline 0 CA--C 1.546 0.806 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -177.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.536 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 11.9 Cg_exo -71.64 -18.72 28.7 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 121.94 1.76 . . . . 0.0 113.022 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -97.51 -12.4 22.64 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.548 ' O ' ' HB2' ' A' ' 71' ' ' MET . 7.3 t80 -84.35 -36.11 22.75 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 73' ' ' ALA . 1.2 mt -66.91 -33.07 74.79 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 121.734 0.778 . . . . 0.0 110.045 177.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.551 ' O ' ' HD3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -57.28 -34.8 69.04 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 113.346 -1.752 . . . . 0.0 108.644 174.347 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.641 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 50.0 mtt -67.81 -36.62 80.72 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.712 175.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.515 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 83.4 mtp -75.33 -25.58 57.94 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.967 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -71.95 -36.81 69.98 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.585 ' NE ' ' HA ' ' A' ' 71' ' ' MET . 2.1 ptt180 -83.57 -17.79 40.51 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.641 ' HD2' ' O ' ' A' ' 71' ' ' MET . 24.2 mttt -72.84 -13.93 61.39 Favored 'General case' 0 C--N 1.346 0.451 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 176.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.683 ' SD ' HG23 ' B' ' 163' ' ' ILE . 26.0 ptt? -123.45 -34.63 3.05 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -176.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 26.7 mmtt -62.19 -40.33 95.69 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 -178.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -97.0 -29.37 13.69 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.5 t -59.45 -64.86 0.79 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -153.36 115.64 4.38 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.819 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.7 t -83.83 -14.46 51.22 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.215 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.517 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -87.12 -50.89 6.32 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.489 0.661 . . . . 0.0 109.767 -179.41 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.517 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 36.8 mt-10 -69.64 -17.76 63.54 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.295 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.532 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 9.4 tt0 -57.03 -29.85 63.72 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.36 0.664 . . . . 0.0 112.27 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.8 mp -87.97 -51.38 12.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.419 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -58.05 -19.26 30.2 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.93 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.532 ' OE1' ' HA ' ' A' ' 84' ' ' GLU . 3.4 pt-20 -75.39 -20.5 58.91 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 123.484 0.49 . . . . 0.0 110.258 178.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.25 -20.06 62.28 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.56 177.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.536 ' HE2' ' O ' ' A' ' 98' ' ' GLY . 13.9 m-85 -81.1 -21.56 39.82 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 174.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.414 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 10.7 tpt180 -77.68 -20.44 53.68 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.083 -1.417 . . . . 0.0 107.268 174.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.51 HG23 ' OG ' ' B' ' 164' ' ' SER . 77.9 t -88.17 -56.15 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 114.201 -1.363 . . . . 0.0 112.183 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.627 ' CE2' HG11 ' A' ' 108' ' ' VAL . 29.7 m-85 -100.33 -42.98 6.41 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -176.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.718 ' CA ' HG12 ' A' ' 100' ' ' ILE . 2.9 t70 -63.57 95.83 0.11 Allowed 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.697 0.761 . . . . 0.0 113.014 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -87.06 -48.15 8.33 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.225 -1.352 . . . . 0.0 113.423 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.414 ' HB2' ' OE2' ' A' ' 104' ' ' GLU . 5.2 t70 -71.62 0.42 8.71 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 -175.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.95 30.15 3.61 Favored Glycine 0 N--CA 1.475 1.256 0 CA-C-N 114.309 -1.314 . . . . 0.0 114.923 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -98.53 -6.55 29.96 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 122.291 0.236 . . . . 0.0 111.433 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.536 ' O ' ' HE2' ' A' ' 89' ' ' PHE . . . 105.93 -18.33 40.23 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.207 -0.52 . . . . 0.0 112.606 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -119.85 118.36 30.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.595 -0.803 . . . . 0.0 111.124 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.718 HG12 ' CA ' ' A' ' 93' ' ' ASP . 41.4 mt -78.34 89.09 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.3 t -61.74 163.56 7.2 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.892 -177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.584 ' O ' HG13 ' A' ' 121' ' ' VAL . . . -61.78 -14.79 35.85 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.92 -28.97 19.94 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-O 121.905 0.859 . . . . 0.0 109.422 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 1.034 ' O ' HG22 ' A' ' 108' ' ' VAL . 3.1 mm-40 -79.59 -39.9 30.62 Favored 'General case' 0 CA--C 1.484 -1.563 0 CA-C-N 112.595 -2.093 . . . . 0.0 111.253 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.5 ' C ' HD22 ' A' ' 105' ' ' LEU . 8.5 tt -67.31 -30.69 70.61 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 176.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.652 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -73.67 -43.27 59.82 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.754 176.196 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.552 ' O ' HG21 ' A' ' 110' ' ' THR . 8.5 t-80 -69.33 -21.75 63.82 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 114.086 -1.415 . . . . 0.0 108.223 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 1.034 HG22 ' O ' ' A' ' 104' ' ' GLU . 37.2 t -72.4 -58.48 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.297 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 175.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.634 ' O ' ' N ' ' A' ' 114' ' ' GLU . 3.4 mtt -47.82 -41.16 23.13 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 113.021 -1.9 . . . . 0.0 112.258 177.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.552 HG21 ' O ' ' A' ' 107' ' ' HIS . 0.8 OUTLIER -66.77 -39.18 87.76 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.522 0.677 . . . . 0.0 110.633 -178.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.47 -46.5 76.13 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.776 -1.557 . . . . 0.0 109.501 176.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.769 HD13 ' O ' ' A' ' 108' ' ' VAL . 9.2 mp -72.98 -27.92 62.09 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.131 -1.395 . . . . 0.0 112.69 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 109' ' ' MET . . . 147.92 -32.84 1.29 Allowed Glycine 0 CA--C 1.536 1.394 0 N-CA-C 116.685 1.434 . . . . 0.0 116.685 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.634 ' N ' ' O ' ' A' ' 109' ' ' MET . 5.2 mt-10 -102.14 149.88 23.83 Favored 'General case' 0 C--N 1.358 0.971 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -176.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.433 ' H ' ' HG2' ' A' ' 115' ' ' LYS . 2.9 mmtp -105.03 131.99 51.84 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 113.87 -1.514 . . . . 0.0 107.202 173.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.652 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 0.8 OUTLIER -136.26 116.03 13.06 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.726 -1.124 . . . . 0.0 113.383 -175.243 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.786 ' O ' HG21 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -67.6 -175.94 0.57 Allowed 'General case' 0 C--N 1.349 0.581 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.266 179.504 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.524 ' N ' HG23 ' A' ' 117' ' ' THR . 16.4 t70 -69.8 -37.93 76.47 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -177.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -88.75 -16.42 32.23 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.648 ' HG3' ' HG ' ' A' ' 116' ' ' LEU . 13.9 pt-20 -86.66 -15.88 38.3 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 123.184 0.303 . . . . 0.0 111.134 178.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.786 HG21 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -84.23 -26.78 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 123.368 0.417 . . . . 0.0 111.847 177.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -69.41 29.24 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.13 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.537 ' H ' ' C ' ' A' ' 121' ' ' VAL . 11.2 pt-20 -137.68 -34.81 0.67 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.493 177.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.61 ' HA ' ' HG1' ' B' ' 153' ' ' THR . 0.1 OUTLIER -69.77 -29.7 67.1 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.901 176.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.597 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 1.6 mp -89.11 -48.37 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.598 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -56.56 -28.47 60.22 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 124.09 0.869 . . . . 0.0 111.477 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.71 ' OE2' ' HG2' ' A' ' 144' ' ' MET . 0.2 OUTLIER -62.29 -35.08 77.9 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.146 177.722 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.719 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -106.59 -32.9 7.84 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.123 0.487 . . . . 0.0 110.113 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.597 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -59.84 126.93 29.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.47 -1.241 . . . . 0.0 113.212 -178.061 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.405 HG12 ' HG2' ' A' ' 140' ' ' GLU . 30.6 mm -89.54 -48.98 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 113.449 -1.705 . . . . 0.0 110.411 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -88.93 -25.31 22.16 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.25 49.61 5.82 Favored Glycine 0 CA--C 1.525 0.668 0 O-C-N 123.525 0.515 . . . . 0.0 113.886 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -86.48 -19.57 29.37 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.22 12.35 58.8 Favored Glycine 0 CA--C 1.501 -0.792 0 CA-C-N 115.657 -0.702 . . . . 0.0 114.04 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -140.14 105.41 5.04 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.421 ' CG1' ' HB2' ' A' ' 141' ' ' PHE . 2.4 t -64.82 125.53 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -87.84 -163.16 0.9 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.267 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -53.2 7.17 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.268 0.627 . . . . 0.0 109.968 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -62.57 -20.41 64.67 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.719 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 11.2 mt-10 -88.85 -43.91 10.87 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.559 0.695 . . . . 0.0 109.769 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.421 ' HB2' ' CG1' ' A' ' 136' ' ' VAL . 11.9 t80 -67.39 -24.53 65.69 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.916 -1.493 . . . . 0.0 108.847 175.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.549 ' HA ' ' SD ' ' A' ' 145' ' ' MET . 16.1 t -86.7 -51.32 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.344 -177.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.586 ' O ' ' N ' ' A' ' 147' ' ' ALA . 54.1 mt-30 -56.15 -36.14 67.95 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.653 0.596 . . . . 0.0 111.837 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.71 ' HG2' ' OE2' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -66.9 -14.93 63.29 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 123.426 0.453 . . . . 0.0 111.35 179.513 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.549 ' SD ' ' HA ' ' A' ' 142' ' ' VAL . 27.1 mtp -84.72 -13.08 52.42 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 176.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.3 t -122.04 -38.18 2.75 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.048 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -31.04 -43.77 0.05 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 178.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.4 pttt . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.25 180.0 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' THR . . . . . 0.515 ' HB ' ' O ' ' B' ' 152' ' ' LYS . 18.7 p . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.525 0.202 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -131.47 -40.14 1.12 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.342 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 55.3 tttt -94.91 -16.61 22.71 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.455 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . 0.515 ' O ' ' HB ' ' B' ' 149' ' ' THR . 98.1 mttt -123.69 116.47 23.12 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 123.351 0.407 . . . . 0.0 110.56 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.64 ' HG1' ' HG2' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -138.34 -43.45 0.5 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 179.694 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' PHE . . . . . 0.609 ' H ' ' CD ' ' A' ' 127' ' ' GLU . 61.1 t80 -67.95 -31.37 71.06 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 119.144 0.884 . . . . 0.0 109.48 177.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . 0.476 ' HD2' ' OE1' ' A' ' 127' ' ' GLU . 3.6 mptt -56.79 -36.31 69.72 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.461 0.475 . . . . 0.0 110.789 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -77.41 -43.6 32.05 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.444 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' VAL . . . . . 0.44 HG22 ' O ' ' B' ' 154' ' ' PHE . 17.7 m -71.78 -30.13 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . 0.591 ' O ' ' HB2' ' B' ' 162' ' ' LYS . . . -64.19 -40.66 96.56 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.497 0.719 . . . . 0.0 112.606 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -54.94 -36.75 65.61 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.715 0.293 . . . . 0.0 111.068 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -78.04 -47.2 18.92 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.392 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 20.8 t -131.15 66.05 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 21.2 ttmt -90.55 -26.44 19.72 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.464 176.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' ILE . . . . . 0.683 HG23 ' SD ' ' A' ' 76' ' ' MET . 2.1 pp -140.47 132.43 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 O-C-N 123.481 0.488 . . . . 0.0 111.459 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' SER . . . . . 0.617 ' O ' ' HB2' ' B' ' 168' ' ' MET . 28.2 m -128.97 -34.06 1.95 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.001 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.25 -2.43 28.02 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.458 0.474 . . . . 0.0 112.219 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 23.5 m -75.57 -38.48 59.15 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 122.907 0.483 . . . . 0.0 110.892 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.586 HD23 ' SD ' ' A' ' 36' ' ' MET . 10.8 tp -110.81 1.43 17.72 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.82 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' MET . . . . . 0.617 ' HB2' ' O ' ' B' ' 164' ' ' SER . 0.0 OUTLIER -93.11 143.15 26.52 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.946 -179.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -143.1 101.91 0.27 Allowed Glycine 0 C--N 1.337 0.624 0 O-C-N 123.616 0.573 . . . . 0.0 112.611 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.971 179.912 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.492 0.187 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -118.31 117.35 28.86 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.085 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.413 ' HG2' HE22 ' A' ' 8' ' ' GLN . 49.1 mt-30 -97.09 151.02 20.18 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.01 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.55 ' HG ' ' OE1' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -92.65 -115.1 0.09 Allowed 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 123.183 0.593 . . . . 0.0 109.476 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.45 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 19.1 p -101.38 -173.25 2.32 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 124.203 1.001 . . . . 0.0 109.685 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 10' ' ' ALA . 46.2 mt-10 -69.55 -17.03 63.53 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.532 ' OE1' ' HE1' ' A' ' 76' ' ' MET . 13.0 pt-20 -47.1 -36.3 8.1 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 123.903 0.752 . . . . 0.0 112.368 178.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.55 ' OE1' ' HG ' ' A' ' 4' ' ' LEU . 1.8 pt20 -74.49 -49.91 20.3 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.117 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.438 HG13 HE21 ' A' ' 8' ' ' GLN . 5.6 mt -62.57 -28.29 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-N 113.751 -1.568 . . . . 0.0 110.404 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 6' ' ' GLU . . . -65.65 -47.38 75.74 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.753 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 22.1 mt-10 -138.1 -32.93 0.71 Allowed 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -177.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.481 ' CG ' HD22 ' A' ' 69' ' ' LEU . 74.0 m-85 -59.77 -13.12 8.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.968 0.413 . . . . 0.0 111.04 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.73 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 4.5 pttt -74.01 -41.05 62.45 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 176.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.753 ' HG2' ' O ' ' A' ' 11' ' ' GLU . 11.5 pt-20 -70.26 -43.98 69.39 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.811 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.642 ' O ' HG12 ' A' ' 35' ' ' VAL . . . -62.46 -18.09 60.98 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.779 0.8 . . . . 0.0 108.88 175.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.638 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 35.5 t80 -84.31 -49.9 8.33 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 113.886 -1.507 . . . . 0.0 109.461 177.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.445 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 9.2 t -87.35 -12.77 45.41 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -177.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.431 ' N ' ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -68.69 -29.98 68.54 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.356 0.526 . . . . 0.0 112.238 -179.236 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.538 ' CD1' HG22 ' A' ' 35' ' ' VAL . 2.5 m-85 -125.44 -4.51 7.23 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.545 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 16.8 t70 -79.36 55.78 1.98 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 118.723 0.692 . . . . 0.0 112.219 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.473 ' N ' ' HD2' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -86.53 -22.5 26.32 Favored 'General case' 0 C--N 1.344 0.347 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 179.274 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.7 -22.25 61.67 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.33 0.586 . . . . 0.0 110.357 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.8 40.52 30.96 Favored Glycine 0 N--CA 1.47 0.93 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.821 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.0 23.27 9.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 112.925 -1.637 . . . . 0.0 112.753 -176.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.25 -78.46 1.97 Allowed Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.266 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.96 174.76 5.71 Favored 'General case' 0 N--CA 1.436 -1.13 0 O-C-N 123.624 0.249 . . . . 0.0 110.437 178.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -78.81 148.53 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.428 ' OG1' ' HB2' ' A' ' 31' ' ' GLU . 0.6 OUTLIER -61.78 160.08 12.53 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.18 -0.918 . . . . 0.0 113.321 -179.439 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 p -76.63 -56.01 5.0 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.353 -0.839 . . . . 0.0 113.148 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.9 -13.32 6.02 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.482 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.504 ' O ' HG21 ' A' ' 35' ' ' VAL . 32.4 mt-10 -110.53 -16.84 13.57 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -176.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -55.65 -38.86 70.11 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.915 0.486 . . . . 0.0 111.859 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.791 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -57.06 -39.55 89.91 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 110.706 -0.957 . . . . 0.0 110.706 177.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 m -73.84 -31.03 63.0 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 114.434 -0.883 . . . . 0.0 112.534 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.642 HG12 ' O ' ' A' ' 15' ' ' ALA . 1.5 t -73.84 -26.53 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 176.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.624 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 17.9 mmt -76.03 -40.87 52.5 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 113.013 -1.903 . . . . 0.0 111.429 176.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.791 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 10.8 mtt180 -82.38 -27.27 32.19 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 55.9 m -64.69 -7.95 12.71 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.996 0.903 . . . . 0.0 112.249 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.4 mt -95.66 -6.22 40.51 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 113.201 -1.818 . . . . 0.0 109.678 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.63 -0.63 52.77 Favored Glycine 0 CA--C 1.492 -1.364 0 CA-C-O 122.323 0.957 . . . . 0.0 114.719 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.624 ' HB2' ' O ' ' A' ' 36' ' ' MET . 54.3 mt-30 -79.87 139.81 37.0 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 112.11 -2.045 . . . . 0.0 111.981 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -119.44 75.34 17.17 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.821 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.71 -177.78 3.98 Favored 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 123.124 2.55 . . . . 0.0 111.754 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.69 158.3 16.05 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.967 0.413 . . . . 0.0 109.948 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.541 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 30.1 mt-10 -80.91 -28.18 35.94 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.522 177.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.43 -35.25 70.87 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 113.464 -1.698 . . . . 0.0 109.801 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -79.58 -30.3 41.53 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 113.977 -1.465 . . . . 0.0 108.776 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.573 ' O ' HD12 ' A' ' 52' ' ' ILE . 0.4 OUTLIER -67.98 -20.12 65.0 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.166 174.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.817 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 53.4 mt-30 -98.86 -15.74 19.1 Favored 'General case' 0 CA--C 1.482 -1.666 0 CA-C-N 114.46 -1.245 . . . . 0.0 111.07 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 4.6 t70 -85.29 -33.45 22.12 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-N 111.991 -2.368 . . . . 0.0 109.901 176.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 72.1 mtm -86.6 -33.67 20.11 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.9 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.573 HD12 ' O ' ' A' ' 48' ' ' LEU . 1.4 mp -71.23 -28.6 33.02 Favored 'Isoleucine or valine' 0 C--N 1.345 0.389 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 175.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.817 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.0 t30 -72.71 -33.97 66.82 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.882 176.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 50' ' ' ASP . 44.4 mt-10 -84.03 -31.46 25.42 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.587 ' C ' ' H ' ' A' ' 57' ' ' ALA . 58.9 t -87.93 -42.23 14.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -72.55 36.79 0.07 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.979 0.895 . . . . 0.0 110.223 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.587 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -86.4 -5.71 59.1 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 114.056 -1.429 . . . . 0.0 112.056 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -108.26 -33.76 7.03 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 112.01 -2.359 . . . . 0.0 110.784 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.34 51.28 3.97 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-N 116.046 -0.525 . . . . 0.0 113.027 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -109.91 -21.43 12.35 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.53 26.76 70.93 Favored Glycine 0 N--CA 1.467 0.763 0 CA-C-N 116.001 -0.545 . . . . 0.0 114.046 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.42 165.5 30.93 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.275 0.63 . . . . 0.0 110.471 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.9 mm -110.16 85.8 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.641 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -50.23 151.45 2.08 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.877 0.871 . . . . 0.0 111.698 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.567 ' HA ' ' CD1' ' A' ' 68' ' ' PHE . 29.6 p90 -90.74 -38.5 0.4 Allowed Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.55 ' HD3' ' CD1' ' A' ' 65' ' ' PHE . 6.6 Cg_exo -74.2 -18.14 21.13 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 121.983 1.789 . . . . 0.0 113.01 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -102.26 -24.99 13.84 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -178.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.688 ' O ' ' HG2' ' A' ' 71' ' ' MET . 0.1 OUTLIER -84.91 -24.88 28.24 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -177.434 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.637 ' O ' ' N ' ' A' ' 73' ' ' ALA . 4.4 mt -74.38 -33.57 63.1 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.891 0.853 . . . . 0.0 109.38 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.49 -35.47 65.58 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 112.842 -1.981 . . . . 0.0 109.949 174.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.793 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 17.8 ptt? -78.82 -24.15 44.65 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.566 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 0.8 OUTLIER -88.98 -19.43 25.71 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.505 176.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.637 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . -77.2 -29.84 54.46 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.421 ' HD2' ' N ' ' A' ' 75' ' ' LYS . 6.7 ppt_? -82.05 -25.55 34.5 Favored 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 123.713 0.633 . . . . 0.0 110.107 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.793 ' HD2' ' O ' ' A' ' 71' ' ' MET . 24.2 mttt -68.34 -14.39 62.96 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.406 175.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.614 ' O ' HG23 ' A' ' 79' ' ' THR . 12.5 ptt? -122.68 -23.59 5.08 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -176.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.607 ' HG3' ' O ' ' A' ' 73' ' ' ALA . 53.9 mttt -58.82 -12.75 4.73 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -103.76 -29.68 10.88 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 76' ' ' MET . 9.9 t -75.59 104.45 6.15 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.053 0.454 . . . . 0.0 111.271 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.492 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 1.3 t70 -45.57 152.03 0.35 Allowed 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.219 -0.901 . . . . 0.0 112.801 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.419 ' HA ' ' OE2' ' A' ' 84' ' ' GLU . 53.0 m -71.27 -13.6 61.95 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.743 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.623 ' O ' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -74.12 -50.03 21.25 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.683 0.793 . . . . 0.0 110.597 -178.915 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.503 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 9.5 pt-20 -76.46 -18.31 58.85 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.166 -1.379 . . . . 0.0 112.835 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 39.7 mt-10 -67.79 -18.22 64.79 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 122.916 0.486 . . . . 0.0 112.289 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.623 HD13 ' O ' ' A' ' 82' ' ' GLU . 2.2 mt -86.61 -53.52 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.294 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.401 ' HD2' ' H ' ' A' ' 86' ' ' ARG . 3.0 mpt_? -56.58 -20.16 19.49 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.418 ' OE2' ' HA ' ' A' ' 84' ' ' GLU . 3.0 pt-20 -77.54 -20.38 54.26 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 123.362 0.414 . . . . 0.0 110.311 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 85' ' ' ILE . . . -69.79 -22.87 63.29 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.774 177.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.519 ' O ' ' HB3' ' A' ' 93' ' ' ASP . 12.0 m-85 -81.84 -20.94 37.96 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 174.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.416 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 12.4 tpt180 -78.31 -21.64 49.33 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.128 -1.396 . . . . 0.0 107.491 174.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.1 t -88.25 -53.26 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.962 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.464 ' CE2' HG12 ' A' ' 108' ' ' VAL . 11.8 m-85 -100.3 -46.12 5.38 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -176.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.678 ' CA ' HG12 ' A' ' 100' ' ' ILE . 3.9 t70 -60.48 95.01 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.63 0.729 . . . . 0.0 111.309 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.1 mmpm? -87.36 -50.33 6.64 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.424 -1.262 . . . . 0.0 113.16 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -72.17 0.22 10.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -175.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 48.69 32.64 11.2 Favored Glycine 0 N--CA 1.472 1.069 0 CA-C-N 114.37 -1.286 . . . . 0.0 114.574 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -96.6 -5.73 38.43 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 122.374 0.27 . . . . 0.0 111.654 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.496 ' O ' ' HE2' ' A' ' 89' ' ' PHE . . . 104.13 -18.54 45.61 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 121.225 -0.512 . . . . 0.0 112.698 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -122.67 125.01 44.74 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.463 -0.869 . . . . 0.0 110.8 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.678 HG12 ' CA ' ' A' ' 93' ' ' ASP . 48.0 mt -80.44 88.05 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.8 t -67.54 165.38 16.97 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.893 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.415 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -60.59 -14.19 18.68 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.49 -32.45 18.23 Favored 'General case' 0 CA--C 1.49 -1.36 0 CA-C-O 121.982 0.896 . . . . 0.0 109.132 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.977 ' O ' HG23 ' A' ' 108' ' ' VAL . 16.1 mt-10 -77.12 -42.87 36.25 Favored 'General case' 0 CA--C 1.481 -1.675 0 CA-C-N 112.557 -2.111 . . . . 0.0 109.68 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.827 HD11 ' SD ' ' A' ' 124' ' ' MET . 5.3 tt -61.8 -35.57 78.58 Favored 'General case' 0 N--CA 1.441 -0.919 0 O-C-N 124.599 1.187 . . . . 0.0 108.025 177.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.429 ' HG3' ' N ' ' A' ' 107' ' ' HIS . 0.0 OUTLIER -72.22 -43.59 64.19 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 114.253 -1.339 . . . . 0.0 108.912 176.452 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.429 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 8.5 t-80 -69.57 -21.55 63.61 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.834 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.977 HG23 ' O ' ' A' ' 104' ' ' GLU . 42.3 t -73.97 -52.34 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 176.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.734 ' SD ' ' HB2' ' A' ' 116' ' ' LEU . 18.3 mtt -56.69 -31.99 65.01 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 112.302 -2.226 . . . . 0.0 112.476 176.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -76.98 -19.06 57.78 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.516 -0.873 . . . . 0.0 110.261 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.17 -45.57 22.82 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.617 176.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.6 mt -81.49 -27.85 34.34 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.411 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 95.98 41.22 3.85 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 114.209 -1.36 . . . . 0.0 114.296 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.66 ' HB2' ' SD ' ' A' ' 109' ' ' MET . 0.1 OUTLIER -101.36 -23.46 14.37 Favored 'General case' 0 CA--C 1.479 -1.754 0 CA-C-O 123.473 1.606 . . . . 0.0 110.499 179.259 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.55 ' O ' HD11 ' A' ' 116' ' ' LEU . 5.3 mptt 34.9 122.68 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 108.902 -3.772 . . . . 0.0 112.793 -177.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.734 ' HB2' ' SD ' ' A' ' 109' ' ' MET . 0.9 OUTLIER -144.16 120.57 10.97 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 112.746 -2.025 . . . . 0.0 111.909 -175.625 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.911 ' O ' HG21 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -65.74 -176.24 0.35 Allowed 'General case' 0 C--N 1.344 0.361 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.021 179.306 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.524 ' N ' HG23 ' A' ' 117' ' ' THR . 17.3 t70 -65.59 -41.05 93.28 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -177.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -87.27 -18.19 30.79 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.628 ' CD ' ' H ' ' A' ' 117' ' ' THR . 12.7 pt-20 -85.07 -15.67 43.21 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 123.197 0.311 . . . . 0.0 111.245 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.911 HG21 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -82.47 -23.27 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 123.226 0.329 . . . . 0.0 111.005 177.1 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -70.96 31.34 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.769 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.909 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 12.0 pt-20 -132.6 -49.48 0.9 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.927 177.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.827 ' SD ' HD11 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -58.31 -29.84 66.2 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.017 0.927 . . . . 0.0 110.619 178.31 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.833 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 2.8 mt -85.02 -28.67 6.54 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.122 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -75.82 -30.21 58.92 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.369 0.604 . . . . 0.0 111.392 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.909 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 2.9 mm-40 -69.64 -28.21 65.71 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.833 177.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.575 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -99.61 -40.1 7.97 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.003 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.833 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.4 OUTLIER -61.08 122.96 16.3 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -178.123 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.7 mt -90.7 -52.74 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 113.867 -1.515 . . . . 0.0 109.676 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -87.71 -24.76 23.75 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.487 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.11 49.93 3.61 Favored Glycine 0 CA--C 1.523 0.532 0 O-C-N 123.563 0.539 . . . . 0.0 113.915 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -78.9 -20.46 49.35 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.11 26.02 49.99 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 114.766 0.667 . . . . 0.0 114.766 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.66 ' O ' ' HB ' ' A' ' 136' ' ' VAL . 38.7 mt-30 -134.03 -72.15 0.49 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.883 -0.658 . . . . 0.0 110.495 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.66 ' HB ' ' O ' ' A' ' 135' ' ' GLN . 4.1 t 120.78 116.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 125.322 1.449 . . . . 0.0 111.12 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -93.68 -163.57 1.06 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.377 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.481 ' O ' HG21 ' A' ' 142' ' ' VAL . 56.7 m-85 -66.36 -60.61 2.6 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.652 178.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -60.26 -20.51 59.26 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.575 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 9.3 mt-10 -86.58 -40.75 14.89 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 120.254 -0.578 . . . . 0.0 109.681 178.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.432 ' O ' ' HG3' ' A' ' 144' ' ' MET . 46.6 t80 -73.8 -24.02 59.77 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.762 176.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.538 ' O ' ' HG2' ' A' ' 145' ' ' MET . 53.5 t -86.7 -37.73 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-N 114.713 -1.13 . . . . 0.0 112.897 -177.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 140' ' ' GLU . 18.8 pt20 -50.0 -21.52 1.26 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.538 ' HB3' ' CE2' ' B' ' 154' ' ' PHE . 0.0 OUTLIER -68.58 -26.01 65.17 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 118.388 0.54 . . . . 0.0 109.912 177.712 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.538 ' HG2' ' O ' ' A' ' 142' ' ' VAL . 6.2 ptt? -82.25 -7.37 59.62 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.892 177.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.424 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 74.0 p -115.02 -48.39 2.83 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.534 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -55.23 -40.48 70.91 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 117.948 -1.025 . . . . 0.0 112.446 -179.927 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 19.5 p . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 111.303 0.112 . . . . 0.0 111.303 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -127.03 148.07 50.13 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 123.465 0.478 . . . . 0.0 110.842 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -99.96 133.31 44.52 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.893 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . 0.402 ' HG2' ' CD ' ' B' ' 156' ' ' GLU . 98.0 mttt -129.4 130.41 45.95 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.716 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.928 ' HG1' ' H ' ' B' ' 154' ' ' PHE . 11.8 t -110.85 -168.25 1.28 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.824 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' PHE . . . . . 0.928 ' H ' ' HG1' ' B' ' 153' ' ' THR . 0.1 OUTLIER -56.16 -28.17 57.07 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.507 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . 0.608 ' HD2' ' CE1' ' B' ' 154' ' ' PHE . 9.3 mptt -60.06 -49.73 76.52 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . 0.402 ' CD ' ' HG2' ' B' ' 152' ' ' LYS . 42.9 mt-10 -79.67 -56.09 4.54 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 178.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' VAL . . . . . 0.481 HG12 ' O ' ' B' ' 153' ' ' THR . 8.9 p -73.32 -46.71 48.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -176.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . 0.504 ' HB2' ' O ' ' B' ' 154' ' ' PHE . . . -73.04 -34.99 66.64 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -71.6 -21.76 61.81 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.87 -41.65 43.08 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.673 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 9.4 p -92.94 7.15 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 O-C-N 123.405 0.441 . . . . 0.0 111.406 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -60.97 -38.48 86.1 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.545 0.338 . . . . 0.0 111.737 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 3.2 tp -94.39 101.39 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-O 121.14 0.495 . . . . 0.0 110.296 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 53.5 m -128.91 -15.62 4.28 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.798 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . -80.83 3.11 23.64 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' SER . . . . . 0.506 ' O ' ' HD3' ' A' ' 75' ' ' LYS . 69.5 m -96.75 -35.11 11.09 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.56 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 4.8 tp -120.91 -39.37 2.73 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.203 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 7.3 ttt -89.33 151.87 21.84 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.32 0.388 . . . . 0.0 111.075 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . 0.427 ' C ' ' HG1' ' B' ' 170' ' ' THR . . . 174.06 53.84 0.05 OUTLIER Glycine 0 C--N 1.337 0.586 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.43 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' THR . . . . . 0.427 ' HG1' ' C ' ' B' ' 169' ' ' GLY . 40.7 p . . . . . 0 N--CA 1.485 1.288 0 C-N-CA 124.314 1.046 . . . . 0.0 112.797 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.569 0.223 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -97.85 165.73 11.8 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.245 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.575 ' NE2' ' H ' ' A' ' 3' ' ' GLN . 0.4 OUTLIER -59.74 162.74 4.97 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.355 0.662 . . . . 0.0 112.028 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.469 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -107.52 -109.63 0.31 Allowed 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.551 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 16.9 p -101.04 -173.95 2.5 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 123.622 0.769 . . . . 0.0 110.194 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 10' ' ' ALA . 40.6 mt-10 -63.5 -22.61 66.99 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.551 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 12.8 pt-20 -53.07 -30.2 34.68 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.673 0.749 . . . . 0.0 111.816 178.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.465 ' HG3' ' N ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -76.74 -48.67 18.06 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 113.759 -1.564 . . . . 0.0 110.411 178.527 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.478 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 3.5 mp -68.99 -28.06 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.675 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.411 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 6' ' ' GLU . . . -68.64 -45.5 71.66 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -137.14 -37.8 0.63 Allowed 'General case' 0 C--N 1.36 1.05 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -176.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.527 ' CD1' HD21 ' A' ' 69' ' ' LEU . 7.6 m-85 -60.54 -13.43 14.01 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.718 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 3.1 pttt -74.21 -40.87 62.16 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.718 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 6.9 mt-10 -75.32 -42.75 53.8 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-N 113.829 -1.532 . . . . 0.0 110.525 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.742 ' O ' HG12 ' A' ' 27' ' ' ILE . . . -60.74 -18.43 54.58 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.574 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 47.8 t80 -84.11 -50.65 7.75 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.205 -1.361 . . . . 0.0 109.471 177.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.453 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 9.0 t -87.64 -12.74 44.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -177.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -66.29 -30.62 71.08 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.527 ' CD1' HG23 ' A' ' 35' ' ' VAL . 5.9 m-85 -131.94 -2.78 3.63 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 19.0 t70 -80.83 55.97 2.57 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 118.802 0.728 . . . . 0.0 112.653 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.481 ' N ' ' HD2' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -86.45 -21.43 27.07 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 178.751 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.95 -22.45 61.46 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.395 0.617 . . . . 0.0 110.446 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.81 44.52 14.69 Favored Glycine 0 N--CA 1.47 0.963 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.79 23.25 13.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 113.131 -1.535 . . . . 0.0 112.831 -175.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.24 -81.47 1.75 Allowed Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.007 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.508 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -110.53 173.63 6.24 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.123 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.742 HG12 ' O ' ' A' ' 15' ' ' ALA . 2.5 pp -75.51 150.12 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -177.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.533 ' HG1' ' CD ' ' A' ' 31' ' ' GLU . 0.6 OUTLIER -55.18 160.41 2.16 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.306 -1.316 . . . . 0.0 113.687 -179.558 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 p -80.57 -56.24 4.31 Favored 'General case' 0 C--N 1.348 0.516 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -56.31 -13.51 2.22 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.585 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.55 ' O ' HG22 ' A' ' 35' ' ' VAL . 12.5 mt-10 -111.26 -16.27 13.44 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.305 -0.862 . . . . 0.0 112.791 -177.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.423 ' HA ' HG22 ' A' ' 35' ' ' VAL . 6.3 tp -49.68 -41.41 43.05 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.541 0.736 . . . . 0.0 112.534 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.729 ' O ' ' HD3' ' A' ' 37' ' ' ARG . . . -57.75 -40.29 92.61 Favored Glycine 0 C--N 1.339 0.748 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 177.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.4 m -74.58 -29.67 61.41 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 114.452 -0.874 . . . . 0.0 112.226 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 15' ' ' ALA . 1.7 t -73.19 -26.91 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 176.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.653 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 43.5 mtt -77.43 -42.09 37.38 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 113.055 -1.884 . . . . 0.0 111.604 176.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.729 ' HD3' ' O ' ' A' ' 33' ' ' GLY . 11.9 mtp180 -81.43 -28.0 34.45 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 56.4 m -65.12 -8.13 15.4 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 122.003 0.906 . . . . 0.0 112.237 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.5 mt -97.09 -5.39 37.52 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 113.169 -1.832 . . . . 0.0 109.588 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.52 0.98 57.85 Favored Glycine 0 CA--C 1.494 -1.275 0 CA-C-O 122.35 0.972 . . . . 0.0 114.771 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.653 ' HB2' ' O ' ' A' ' 36' ' ' MET . 55.9 mt-30 -83.27 139.74 32.91 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 112.116 -2.042 . . . . 0.0 112.036 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -116.3 78.55 8.21 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.802 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.26 -177.87 4.09 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 123.053 2.502 . . . . 0.0 111.944 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 m -101.92 159.1 15.64 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.974 0.416 . . . . 0.0 109.985 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.541 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 29.9 mt-10 -80.86 -28.16 36.16 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.728 177.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.24 -36.24 69.03 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 113.557 -1.656 . . . . 0.0 109.935 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -78.57 -28.22 45.87 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 114.03 -1.441 . . . . 0.0 108.772 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.541 ' HB2' ' HA ' ' A' ' 45' ' ' GLU . 0.5 OUTLIER -68.6 -20.26 64.49 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.097 174.711 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.908 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 47.1 mt-30 -98.71 -15.68 19.27 Favored 'General case' 0 CA--C 1.481 -1.711 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.11 178.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -86.74 -32.22 20.53 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 111.999 -2.364 . . . . 0.0 109.707 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.619 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 66.8 mtt -86.71 -35.47 19.24 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.036 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.535 HD11 ' O ' ' A' ' 48' ' ' LEU . 1.4 mp -71.83 -25.87 24.82 Favored 'Isoleucine or valine' 0 C--N 1.343 0.313 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 175.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.908 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 2.7 t30 -71.01 -36.22 72.35 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.355 175.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.619 ' HG2' ' O ' ' A' ' 51' ' ' MET . 6.8 pt-20 -79.28 -42.98 24.6 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.589 ' C ' ' H ' ' A' ' 57' ' ' ALA . 75.1 t -70.43 -41.77 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -72.82 36.19 0.07 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.924 0.869 . . . . 0.0 110.515 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -86.51 -6.21 58.95 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 114.242 -1.344 . . . . 0.0 112.351 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -112.93 -33.9 5.92 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 112.029 -2.35 . . . . 0.0 110.815 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.39 48.27 5.12 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 115.865 -0.607 . . . . 0.0 113.358 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -110.07 -21.49 12.27 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.16 26.96 62.93 Favored Glycine 0 N--CA 1.465 0.603 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.808 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.96 163.75 37.97 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.224 0.609 . . . . 0.0 110.808 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.65 HG23 ' N ' ' A' ' 64' ' ' ASP . 2.3 mp -94.27 162.63 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.311 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.65 ' N ' HG23 ' A' ' 63' ' ' ILE . 9.3 m-20 -117.14 148.39 41.61 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.992 0.917 . . . . 0.0 108.877 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.562 ' HA ' ' CE1' ' A' ' 68' ' ' PHE . 24.4 p90 -90.82 -37.25 0.39 Allowed Pre-proline 0 CA--C 1.545 0.775 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -178.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.502 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 6.5 Cg_exo -75.56 -17.75 18.11 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 121.715 1.61 . . . . 0.0 112.639 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -111.3 -7.4 14.41 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.562 ' CE1' ' HA ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -84.59 -43.18 14.7 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -177.822 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 73' ' ' ALA . 1.5 mt -65.38 -31.85 73.18 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 118.827 0.74 . . . . 0.0 110.249 176.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.553 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -55.03 -34.51 63.57 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 113.563 -1.653 . . . . 0.0 108.893 175.078 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.615 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 64.7 mtt -70.46 -37.49 74.31 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.433 176.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.568 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 1.2 mpt? -78.45 -21.58 48.89 Favored 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 124.152 0.908 . . . . 0.0 110.937 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.618 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -75.5 -35.16 60.85 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.553 ' HD2' ' O ' ' A' ' 70' ' ' THR . 2.3 ptm180 -83.03 -18.02 41.23 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 120.469 -0.493 . . . . 0.0 112.276 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.615 ' HD2' ' O ' ' A' ' 71' ' ' MET . 29.0 mttt -73.16 -13.9 61.26 Favored 'General case' 0 C--N 1.348 0.515 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 25.4 ptm -121.76 -34.88 3.31 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -177.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.618 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 16.7 mmtm -71.22 -38.34 72.01 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -178.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -104.84 -17.74 14.47 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.322 1.231 . . . . 0.0 114.322 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.487 HG22 ' O ' ' A' ' 75' ' ' LYS . 4.0 t -58.93 -68.99 0.21 Allowed 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -178.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.511 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 1.4 m-20 -167.99 125.05 1.11 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.67 0.788 . . . . 0.0 110.796 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.413 ' HA ' ' OE1' ' A' ' 84' ' ' GLU . 15.5 t -83.41 -13.63 54.43 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.415 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.576 ' O ' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -77.14 -45.8 25.57 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.775 0.83 . . . . 0.0 110.189 -179.082 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.535 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 38.9 mt-10 -74.86 -18.87 60.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.525 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.532 ' HA ' ' OG ' ' B' ' 164' ' ' SER . 37.7 mt-10 -68.65 -18.51 64.3 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 122.697 0.399 . . . . 0.0 112.008 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.576 HD13 ' O ' ' A' ' 82' ' ' GLU . 2.1 mt -87.87 -57.27 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.059 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.744 ' O ' ' HD1' ' A' ' 89' ' ' PHE . 9.6 mpt_? -55.5 -16.61 4.02 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.557 ' O ' HG23 ' A' ' 91' ' ' VAL . 35.3 mt-10 -79.67 -19.68 48.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.725 0.298 . . . . 0.0 111.175 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.45 -19.35 60.42 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.187 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.744 ' HD1' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -84.46 -21.51 30.65 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 175.399 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 32.3 mmt180 -78.07 -24.93 47.47 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 113.91 -1.495 . . . . 0.0 107.942 175.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 87' ' ' GLU . 85.2 t -88.38 -56.41 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.827 178.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.488 ' CE2' HG12 ' A' ' 108' ' ' VAL . 15.1 m-85 -100.54 -45.6 5.48 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -176.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.707 ' CA ' HG12 ' A' ' 100' ' ' ILE . 12.4 t70 -63.3 94.62 0.08 Allowed 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.761 0.791 . . . . 0.0 111.615 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.7 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 31.6 mttm -87.92 -48.78 7.53 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.374 -1.284 . . . . 0.0 113.892 -178.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.11 0.65 9.07 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -175.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 50.02 29.3 14.27 Favored Glycine 0 N--CA 1.472 1.093 0 CA-C-N 114.357 -1.292 . . . . 0.0 114.724 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -96.23 -7.15 36.37 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.685 0.242 . . . . 0.0 111.441 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.53 -19.09 46.11 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.954 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -120.14 118.49 30.69 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.556 -0.822 . . . . 0.0 110.7 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.707 HG12 ' CA ' ' A' ' 93' ' ' ASP . 30.1 mt -77.28 93.71 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.3 p -71.94 163.37 27.97 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.334 -0.848 . . . . 0.0 113.12 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.51 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -60.13 -14.39 16.77 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -178.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.65 -33.0 17.75 Favored 'General case' 0 CA--C 1.487 -1.449 0 CA-C-O 121.943 0.878 . . . . 0.0 109.425 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 1.013 ' O ' HG22 ' A' ' 108' ' ' VAL . 3.2 mm-40 -80.02 -39.92 28.91 Favored 'General case' 0 CA--C 1.48 -1.728 0 CA-C-N 112.537 -2.12 . . . . 0.0 110.077 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.578 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 5.9 tt -63.75 -35.74 81.58 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 177.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.702 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -71.13 -44.68 65.1 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 113.906 -1.497 . . . . 0.0 108.439 175.11 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.504 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 2.2 t60 -67.14 -21.87 65.81 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.428 177.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 1.013 HG22 ' O ' ' A' ' 104' ' ' GLU . 24.5 t -72.27 -50.5 35.65 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.852 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 176.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.63 ' SD ' HD21 ' A' ' 116' ' ' LEU . 20.8 mtt -56.31 -41.27 75.73 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.589 -2.096 . . . . 0.0 111.966 175.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.68 -19.21 64.38 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.412 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.95 -45.0 19.3 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.517 176.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.1 mt -79.55 -28.25 41.22 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.879 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 139.95 -8.18 3.0 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-O 117.846 -1.53 . . . . 0.0 116.765 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 109' ' ' MET . 5.0 mt-10 -100.88 151.75 21.36 Favored 'General case' 0 C--N 1.358 0.97 0 CA-C-N 120.781 2.29 . . . . 0.0 114.276 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.48 ' O ' HD13 ' A' ' 116' ' ' LEU . 5.1 mptt -110.94 129.22 55.95 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 113.628 -1.624 . . . . 0.0 107.152 175.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.702 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 1.0 OUTLIER -138.67 115.87 11.05 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.968 -175.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.806 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -72.13 -175.7 1.57 Allowed 'General case' 0 C--N 1.347 0.494 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.784 179.372 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.486 ' N ' HG23 ' A' ' 117' ' ' THR . 17.0 t70 -70.17 -38.53 75.42 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -89.34 -16.99 29.77 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.618 ' CD ' ' H ' ' A' ' 117' ' ' THR . 15.0 pt-20 -85.54 -16.0 40.87 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.117 0.261 . . . . 0.0 111.028 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -81.19 -26.64 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.522 177.605 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.86 30.67 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.999 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.584 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 11.6 pt-20 -141.99 -16.77 0.76 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.534 177.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.563 ' SD ' HG21 ' B' ' 153' ' ' THR . 0.0 OUTLIER -88.05 -27.02 22.25 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.091 0.956 . . . . 0.0 108.867 176.085 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.723 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 1.9 mp -86.88 -40.21 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 114.376 -1.284 . . . . 0.0 113.484 -177.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.1 mtt180 -61.41 -27.24 68.4 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 122.153 0.978 . . . . 0.0 110.718 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.672 ' HB3' ' CD1' ' B' ' 154' ' ' PHE . 6.5 mm-40 -56.63 -44.07 80.88 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 112.838 -1.983 . . . . 0.0 111.108 176.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.746 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -106.26 -29.57 9.72 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 114.926 -1.033 . . . . 0.0 111.7 -178.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.723 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -60.75 115.91 4.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.541 1.162 . . . . 0.0 112.902 -178.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.551 HD12 ' CD ' ' A' ' 140' ' ' GLU . 86.2 mt -91.09 -44.61 14.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 112.397 -2.183 . . . . 0.0 110.629 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -86.42 -25.16 25.41 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.83 49.53 6.44 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 116.04 -0.527 . . . . 0.0 113.947 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -99.52 -19.75 16.74 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.99 15.29 52.7 Favored Glycine 0 CA--C 1.502 -0.741 0 CA-C-O 121.5 0.5 . . . . 0.0 113.308 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -138.78 105.34 5.32 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 113.893 -1.154 . . . . 0.0 108.935 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.9 t -75.75 127.69 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.665 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -88.51 -168.15 2.11 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.949 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.446 ' O ' ' N ' ' A' ' 142' ' ' VAL . 1.7 m-85 -74.06 -58.82 3.04 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.321 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -57.35 -22.95 45.81 Favored 'General case' 0 C--N 1.345 0.412 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.746 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 0.2 OUTLIER -87.68 -41.44 13.36 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.656 179.353 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -71.6 -23.37 61.7 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.679 175.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' A' ' 138' ' ' TYR . 34.8 t -85.18 -48.24 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 114.633 -1.167 . . . . 0.0 112.793 -177.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.575 ' O ' ' N ' ' A' ' 147' ' ' ALA . 48.0 mt-30 -61.42 -23.84 66.1 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.384 0.427 . . . . 0.0 111.828 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.572 ' SD ' ' HE2' ' B' ' 154' ' ' PHE . 24.8 mmt -77.13 -14.76 59.75 Favored 'General case' 0 C--N 1.331 -0.201 0 O-C-N 123.502 0.501 . . . . 0.0 110.392 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 61.5 mtt -81.06 -19.08 44.54 Favored 'General case' 0 C--N 1.347 0.493 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.413 HG21 ' O ' ' A' ' 143' ' ' GLN . 1.8 t -110.48 -48.7 3.13 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.707 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.575 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -2.54 -63.0 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 177.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.8 pttm . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.48 -0.771 . . . . 0.0 111.571 -179.928 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.551 0.215 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -128.38 -42.23 1.51 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.228 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt -99.7 130.0 45.88 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 123.372 0.42 . . . . 0.0 110.851 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -103.41 129.61 50.56 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.563 HG21 ' SD ' ' A' ' 124' ' ' MET . 2.4 t -138.16 -53.89 0.63 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.065 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' PHE . . . . . 0.738 ' H ' ' HD1' ' B' ' 154' ' ' PHE . 0.0 OUTLIER -55.56 -45.02 77.33 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.826 0.85 . . . . 0.0 112.941 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . 0.556 ' HD2' ' CZ ' ' B' ' 154' ' ' PHE . 1.3 mppt? -71.79 -32.5 67.69 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 123.389 0.43 . . . . 0.0 109.947 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -77.37 -40.14 44.91 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.297 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' VAL . . . . . 0.445 HG23 ' O ' ' B' ' 154' ' ' PHE . 34.6 m -66.12 -41.96 90.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.069 0.548 . . . . 0.0 110.932 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' B' ' 162' ' ' LYS . . . -73.95 -37.99 64.36 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.933 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . 0.547 ' HB2' ' O ' ' B' ' 155' ' ' LYS . 1.9 t30 -59.78 -30.02 68.6 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.437 0.461 . . . . 0.0 111.773 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.82 -35.86 57.28 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.577 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 8.9 p -111.07 25.5 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.402 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 1.9 ttpm? -85.66 77.15 9.87 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.586 0.707 . . . . 0.0 110.919 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 2.9 tt -143.65 107.67 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.348 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' SER . . . . . 0.532 ' OG ' ' HA ' ' A' ' 84' ' ' GLU . 20.2 t -128.41 122.02 30.41 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.718 -178.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . 64.18 8.93 4.39 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 18.4 t -67.46 -38.83 85.05 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.384 0.273 . . . . 0.0 111.643 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 3.4 tp -131.58 -55.62 1.01 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.738 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 15.2 ttt 48.76 109.87 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.661 1.185 . . . . 0.0 112.68 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -97.0 -94.95 1.87 Allowed Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.559 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 19.6 p . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.442 -0.789 . . . . 0.0 111.039 179.977 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.438 0 N-CA-C 111.4 0.148 . . . . 0.0 111.4 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.566 ' OD2' HD13 ' A' ' 9' ' ' ILE . 1.4 m-20 -118.73 114.7 23.11 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 123.454 0.471 . . . . 0.0 110.735 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -108.72 -51.31 2.9 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.654 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.407 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -122.29 -112.02 0.32 Allowed 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.533 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.507 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 17.3 p -101.31 -173.77 2.45 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 123.796 0.838 . . . . 0.0 110.854 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -61.94 -23.44 66.36 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.507 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 12.7 pt-20 -53.83 -30.57 45.83 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.463 0.649 . . . . 0.0 111.444 178.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.5 ' O ' ' HB3' ' A' ' 12' ' ' PHE . 1.2 tp60 -75.2 -45.95 37.14 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.139 -1.391 . . . . 0.0 109.811 178.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.566 HD13 ' OD2' ' A' ' 2' ' ' ASP . 3.9 mt -65.98 -32.23 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.629 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.56 -35.47 58.18 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -114.11 -18.4 11.68 Favored 'General case' 0 C--N 1.347 0.495 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.642 ' O ' ' HB2' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -74.62 -15.28 60.83 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.939 0.79 . . . . 0.0 110.028 178.536 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.715 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 1.1 pttt -80.99 -41.6 22.5 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.715 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 2.2 mt-10 -82.17 -39.98 22.43 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 114.225 -1.352 . . . . 0.0 112.314 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.408 ' HA ' ' CG1' ' A' ' 35' ' ' VAL . . . -66.21 -18.85 65.6 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 178.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.991 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 10.3 t80 -86.27 -48.85 8.15 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.496 177.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.0 m -86.71 -12.96 46.78 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -176.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -72.74 -29.67 63.53 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.76 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.447 ' CD1' HG22 ' A' ' 35' ' ' VAL . 5.3 m-85 -134.49 -5.86 2.56 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.991 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 0.8 OUTLIER -97.23 79.28 2.8 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 118.833 0.742 . . . . 0.0 111.052 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.474 ' N ' ' HD2' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -81.04 -34.78 32.57 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.29 -21.57 58.39 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.37 178.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.16 51.73 6.66 Favored Glycine 0 N--CA 1.469 0.898 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.84 22.56 7.19 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 113.445 -1.377 . . . . 0.0 113.952 -175.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.29 -67.74 0.52 Allowed Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.438 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.569 ' HG1' ' H ' ' A' ' 63' ' ' ILE . 1.3 t -98.09 174.01 6.75 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.708 0.766 . . . . 0.0 111.625 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.58 HG22 ' OD2' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -132.56 148.23 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.724 0 CA-C-N 113.723 -1.58 . . . . 0.0 109.964 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.469 ' H ' ' HG1' ' A' ' 28' ' ' THR . 0.5 OUTLIER -55.58 150.47 12.16 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -178.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.38 -55.18 11.12 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.909 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -55.0 -13.92 1.3 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.599 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.638 ' O ' HG21 ' A' ' 35' ' ' VAL . 24.7 mt-10 -111.0 -18.41 13.06 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.101 -178.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -58.49 -36.87 74.43 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.874 0.47 . . . . 0.0 111.646 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.794 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -55.82 -39.78 78.56 Favored Glycine 0 C--N 1.34 0.769 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 177.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.7 m -76.51 -29.1 56.64 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.559 -0.82 . . . . 0.0 112.452 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.638 HG21 ' O ' ' A' ' 31' ' ' GLU . 1.6 t -75.71 -26.59 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 177.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.601 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 10.5 mmt -73.92 -44.1 56.19 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 112.941 -1.936 . . . . 0.0 110.982 175.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.794 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 12.1 mtt180 -77.7 -29.75 51.48 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.5 m -69.04 -8.77 48.22 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 122.002 0.906 . . . . 0.0 111.845 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.9 mt -91.87 -6.85 50.83 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 113.255 -1.793 . . . . 0.0 109.917 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.95 -3.03 33.64 Favored Glycine 0 CA--C 1.492 -1.382 0 CA-C-O 122.32 0.956 . . . . 0.0 115.082 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.601 ' HB2' ' O ' ' A' ' 36' ' ' MET . 47.0 mt-30 -80.09 139.85 36.71 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 112.214 -1.993 . . . . 0.0 112.04 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -123.34 68.61 39.18 Favored Pre-proline 0 CA--C 1.55 0.97 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.295 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.422 ' HD3' ' C ' ' A' ' 41' ' ' GLN . 6.9 Cg_endo -88.37 -177.82 1.9 Allowed 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 123.157 2.571 . . . . 0.0 112.384 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.431 ' O ' HD23 ' A' ' 48' ' ' LEU . 1.4 m -100.35 160.57 14.23 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 29.7 mt-10 -80.77 -28.03 36.52 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.613 0.721 . . . . 0.0 109.835 178.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.92 -37.18 67.31 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 113.576 -1.647 . . . . 0.0 110.014 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.57 ' HA ' ' OD2' ' A' ' 50' ' ' ASP . 9.6 mm-40 -75.37 -29.14 59.78 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.724 176.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.473 ' HB2' ' HA ' ' A' ' 45' ' ' GLU . 0.5 OUTLIER -64.53 -20.79 66.43 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.644 174.538 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.781 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 49.1 mt-30 -92.33 -17.18 25.05 Favored 'General case' 0 CA--C 1.48 -1.717 0 CA-C-N 114.031 -1.44 . . . . 0.0 111.478 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.57 ' OD2' ' HA ' ' A' ' 47' ' ' GLU . 26.9 m-20 -80.9 -36.05 31.69 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 111.795 -2.457 . . . . 0.0 109.854 176.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.653 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 13.0 ttt -86.41 -30.89 21.76 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.755 177.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.3 mt -74.81 -23.48 17.68 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 174.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.781 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.0 t30 -66.42 -35.05 79.33 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.974 174.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.653 ' HG2' ' O ' ' A' ' 51' ' ' MET . 7.6 pt-20 -86.7 -40.71 14.8 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 123.475 0.484 . . . . 0.0 111.947 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.575 ' C ' ' H ' ' A' ' 57' ' ' ALA . 75.6 t -69.42 -43.52 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -72.98 38.15 0.08 Allowed 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.917 0.865 . . . . 0.0 110.376 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.575 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -86.24 -5.82 59.11 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 114.277 -1.328 . . . . 0.0 111.977 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -111.56 -33.59 6.33 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 111.982 -2.372 . . . . 0.0 110.63 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.39 48.58 5.0 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-N 115.866 -0.606 . . . . 0.0 113.43 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -110.13 -21.85 12.07 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.85 26.61 72.24 Favored Glycine 0 N--CA 1.468 0.815 0 CA-C-N 115.953 -0.567 . . . . 0.0 114.216 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.412 ' HB ' ' HG1' ' A' ' 26' ' ' THR . 0.0 OUTLIER -135.97 -177.51 4.72 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 123.067 0.547 . . . . 0.0 110.77 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.569 ' H ' ' HG1' ' A' ' 26' ' ' THR . 36.6 mm -138.42 86.6 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -176.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -70.18 149.42 47.54 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.349 -0.219 . . . . 0.0 110.557 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.604 ' HA ' ' CE2' ' A' ' 68' ' ' PHE . 24.9 p90 -70.18 -36.72 6.4 Favored Pre-proline 0 N--CA 1.479 0.977 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -177.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.496 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 17.4 Cg_exo -67.63 -16.78 47.48 Favored 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 122.119 1.879 . . . . 0.0 113.194 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -104.11 -26.03 12.73 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -177.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.604 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 6.5 p90 -85.09 -45.41 12.11 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 116.409 2.004 . . . . 0.0 116.409 -176.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.415 ' HG ' ' CE1' ' A' ' 68' ' ' PHE . 3.0 mt -63.3 -32.41 73.82 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.694 0.759 . . . . 0.0 110.965 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.53 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -57.34 -34.75 69.1 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 113.39 -1.732 . . . . 0.0 108.878 174.278 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.642 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 23.5 mmt -70.41 -27.13 64.04 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.521 175.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.515 ' HA ' ' CD ' ' A' ' 75' ' ' LYS . 28.3 mtm -85.36 -18.53 33.51 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.351 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.527 ' O ' ' HG3' ' A' ' 77' ' ' LYS . . . -81.53 -35.29 30.52 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 176.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.53 ' HD2' ' O ' ' A' ' 70' ' ' THR . 2.3 ptm180 -82.18 -17.9 44.6 Favored 'General case' 0 C--N 1.349 0.585 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.642 ' HD2' ' O ' ' A' ' 71' ' ' MET . 0.0 OUTLIER -86.38 -12.88 48.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 119.358 -0.937 . . . . 0.0 112.398 177.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.566 ' O ' HG22 ' A' ' 79' ' ' THR . 20.6 ptt? -111.2 -28.01 8.45 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.925 0.393 . . . . 0.0 111.969 -178.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.527 ' HG3' ' O ' ' A' ' 73' ' ' ALA . 38.8 mttt -66.92 -13.75 62.07 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.733 0.813 . . . . 0.0 113.089 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -104.22 -23.46 13.25 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.566 HG22 ' O ' ' A' ' 76' ' ' MET . 8.8 t -76.78 10.18 2.38 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.403 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 9.8 m-20 65.12 149.81 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.064 0.946 . . . . 0.0 112.497 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.554 ' HA ' ' OE2' ' A' ' 84' ' ' GLU . 53.8 m -83.11 -13.78 54.96 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.044 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.575 ' O ' HD12 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -77.83 -43.5 30.22 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.74 0.816 . . . . 0.0 109.947 -179.332 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.422 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 9.0 mm-40 -70.92 -18.42 62.65 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.847 -1.524 . . . . 0.0 112.256 178.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.554 ' OE2' ' HA ' ' A' ' 81' ' ' SER . 39.8 mt-10 -66.96 -19.56 65.74 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.575 HD12 ' O ' ' A' ' 82' ' ' GLU . 3.1 mp -87.92 -50.99 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.529 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.583 ' O ' ' HD1' ' A' ' 89' ' ' PHE . 9.4 mpt_? -63.21 -16.84 61.44 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.501 ' OE2' ' HA ' ' A' ' 84' ' ' GLU . 3.4 pt-20 -73.77 -18.78 60.93 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 177.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.507 ' HA ' ' HB ' ' A' ' 91' ' ' VAL . . . -64.67 -23.82 67.38 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.914 178.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.583 ' HD1' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -82.35 -21.0 36.15 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 175.137 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -82.01 -19.86 39.6 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.252 -1.34 . . . . 0.0 107.752 174.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.507 ' HB ' ' HA ' ' A' ' 88' ' ' ALA . 3.1 t -88.09 -56.12 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.181 178.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.643 ' CE1' HG13 ' A' ' 108' ' ' VAL . 1.8 m-85 -100.79 -46.28 5.19 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -177.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.685 ' CA ' HG12 ' A' ' 100' ' ' ILE . 8.3 t70 -62.33 95.56 0.07 Allowed 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.757 0.789 . . . . 0.0 112.734 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.4 ' HB2' ' OE2' ' A' ' 104' ' ' GLU . 70.1 mmtt -86.7 -41.89 13.81 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.757 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -70.68 -19.41 62.79 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 -175.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.66 20.41 75.7 Favored Glycine 0 C--N 1.295 -1.714 0 CA-C-N 112.866 -1.97 . . . . 0.0 114.159 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -94.82 -6.02 43.8 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 122.295 0.238 . . . . 0.0 111.427 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.9 -19.12 44.9 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.725 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.538 ' CB ' HE21 ' A' ' 135' ' ' GLN . 41.1 m-85 -112.1 121.01 43.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.486 -0.857 . . . . 0.0 110.72 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.685 HG12 ' CA ' ' A' ' 93' ' ' ASP . 16.1 mt -85.4 86.84 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-O 121.542 0.687 . . . . 0.0 109.345 178.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.1 m -61.29 162.45 7.66 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.873 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.572 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -60.72 -14.22 19.72 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.56 -30.94 18.92 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-O 122.086 0.946 . . . . 0.0 109.416 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 1.032 ' O ' HG21 ' A' ' 108' ' ' VAL . 2.7 mm-40 -81.32 -40.81 23.04 Favored 'General case' 0 CA--C 1.481 -1.707 0 CA-C-N 112.461 -2.154 . . . . 0.0 110.392 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.675 HD23 ' SD ' ' A' ' 124' ' ' MET . 6.8 tt -65.88 -30.55 71.17 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 176.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.581 ' HA ' HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -73.72 -44.65 55.76 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 113.933 -1.485 . . . . 0.0 108.855 176.043 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.532 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 10.8 t-80 -67.52 -21.53 65.48 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 114.055 -1.43 . . . . 0.0 108.041 176.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 1.032 HG21 ' O ' ' A' ' 104' ' ' GLU . 35.8 t -70.82 -52.84 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 176.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.759 ' SD ' HD13 ' A' ' 116' ' ' LEU . 16.7 mtt -56.85 -42.37 79.59 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 113.587 -1.642 . . . . 0.0 111.965 176.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.21 -18.7 61.22 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 119.524 -0.871 . . . . 0.0 110.256 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 107' ' ' HIS . 0.8 OUTLIER -78.92 -46.0 19.34 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.146 176.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.8 mt -79.72 -28.36 40.56 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.082 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.98 0.75 3.82 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 117.419 -1.767 . . . . 0.0 116.852 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.668 ' N ' ' O ' ' A' ' 109' ' ' MET . 4.6 mt-10 -100.94 147.54 26.04 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 121.482 2.641 . . . . 0.0 113.716 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.2 mptt -111.34 117.03 32.0 Favored 'General case' 0 CA--C 1.485 -1.558 0 CA-C-N 113.598 -1.637 . . . . 0.0 107.353 175.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.759 HD13 ' SD ' ' A' ' 109' ' ' MET . 0.5 OUTLIER -122.26 128.43 51.1 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 112.52 -2.127 . . . . 0.0 112.883 -175.505 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.886 ' H ' ' HG3' ' A' ' 120' ' ' GLU . 0.6 OUTLIER -78.17 -175.18 4.01 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.824 -1.534 . . . . 0.0 111.854 178.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.544 ' N ' HG21 ' A' ' 117' ' ' THR . 18.3 t70 -61.96 -44.43 96.77 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.966 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -78.51 -15.18 58.88 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.745 0.307 . . . . 0.0 111.112 178.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.886 ' HG3' ' H ' ' A' ' 117' ' ' THR . 1.4 mm-40 -74.55 -31.87 62.25 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.36 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -86.38 -34.5 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.79 -178.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -79.01 24.79 0.3 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.668 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.547 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 9.7 pt-20 -138.57 -19.16 1.07 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.052 -1.431 . . . . 0.0 111.134 178.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.693 ' SD ' ' HE2' ' A' ' 109' ' ' MET . 8.7 ttt -88.66 -27.9 20.96 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.733 ' O ' ' N ' ' A' ' 129' ' ' ASP . 1.5 mp -87.89 -45.65 15.96 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 CA-C-N 114.662 -1.154 . . . . 0.0 112.467 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.415 ' HA ' ' CG ' ' A' ' 129' ' ' ASP . 70.9 mtt180 -60.07 -29.66 68.7 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 123.845 0.716 . . . . 0.0 112.85 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.547 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 4.6 mm-40 -74.61 -25.86 59.52 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.834 177.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.594 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -104.88 -27.8 11.51 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.074 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.733 ' N ' ' O ' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -60.03 114.13 2.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.352 -1.295 . . . . 0.0 113.489 -178.358 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 41.2 mt -91.89 -51.83 10.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 113.125 -1.852 . . . . 0.0 110.619 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -89.12 -25.35 21.92 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.598 ' HA2' ' OD2' ' A' ' 129' ' ' ASP . . . 86.5 49.76 4.04 Favored Glycine 0 CA--C 1.522 0.505 0 O-C-N 123.46 0.475 . . . . 0.0 113.783 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.49 ' HB3' ' OE1' ' A' ' 135' ' ' GLN . 6.5 m-20 -96.39 -19.64 19.05 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 100.96 -1.65 55.24 Favored Glycine 0 CA--C 1.504 -0.599 0 CA-C-O 121.688 0.604 . . . . 0.0 113.309 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.538 HE21 ' CB ' ' A' ' 99' ' ' TYR . 1.7 pt20 -119.31 175.97 5.55 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 113.496 -1.352 . . . . 0.0 109.558 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.5 ' HA ' ' OE2' ' A' ' 140' ' ' GLU . 15.1 t -135.02 119.33 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 121.125 0.488 . . . . 0.0 111.622 -178.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -84.67 -169.9 2.85 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.906 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.433 ' O ' HG21 ' A' ' 142' ' ' VAL . 46.5 m-85 -62.03 -48.9 78.21 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.33 177.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 143' ' ' GLN . 9.4 mm-40 -69.21 -22.18 63.89 Favored 'General case' 0 C--N 1.347 0.487 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.594 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 3.4 mt-10 -85.55 -34.65 21.45 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.814 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.458 ' O ' ' HG3' ' A' ' 144' ' ' MET . 85.8 t80 -77.56 -24.35 49.84 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.409 176.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.515 ' O ' ' HG2' ' A' ' 145' ' ' MET . 19.6 t -86.78 -38.27 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.3 -178.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.469 ' HA ' ' OG1' ' A' ' 146' ' ' THR . 10.3 mt-30 -48.76 -29.92 5.06 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.566 ' HB3' ' CD2' ' B' ' 154' ' ' PHE . 0.0 OUTLIER -63.55 -27.12 69.04 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 118.533 0.606 . . . . 0.0 110.8 178.608 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.515 ' HG2' ' O ' ' A' ' 142' ' ' VAL . 9.8 ptm -83.36 -4.37 58.4 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.881 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.469 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 44.5 p -120.23 -44.17 2.5 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.547 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -48.62 -33.5 9.96 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 94.2 mttt . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.113 -0.946 . . . . 0.0 111.302 179.732 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.531 0.205 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -100.54 -39.57 7.85 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.259 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -95.04 140.29 30.19 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.824 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -129.48 145.53 51.43 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.198 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.888 ' HG1' ' H ' ' B' ' 154' ' ' PHE . 8.7 t -137.31 -170.2 2.68 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.433 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' PHE . . . . . 0.888 ' H ' ' HG1' ' B' ' 153' ' ' THR . 0.1 OUTLIER -61.11 -27.89 68.7 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.452 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . 0.479 ' HD2' ' CE1' ' B' ' 154' ' ' PHE . 1.4 mptt -71.93 -44.02 64.33 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.757 0.423 . . . . 0.0 111.319 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -76.73 -38.91 53.44 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' VAL . . . . . . . . . . . . . 23.4 m -71.76 -29.55 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.88 0.472 . . . . 0.0 111.622 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . 0.555 ' O ' ' HB2' ' B' ' 162' ' ' LYS . . . -52.57 -42.66 64.66 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.859 0.864 . . . . 0.0 113.128 -178.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -58.89 -30.64 67.93 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 123.182 0.301 . . . . 0.0 111.506 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.65 -39.98 43.25 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.781 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 9.0 p -119.85 33.77 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.318 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' LYS . . . . . 0.555 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 0.1 OUTLIER -82.63 -45.18 14.87 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 122.252 -0.28 . . . . 0.0 110.712 178.458 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 1.7 tp -101.68 63.06 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-O 121.688 0.756 . . . . 0.0 110.241 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 16.5 t -84.74 -2.14 57.21 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.554 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . -90.39 -10.81 42.52 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.937 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' SER . . . . . 0.424 ' OG ' ' HB3' ' A' ' 72' ' ' MET . 22.8 t -70.36 -34.17 72.31 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.858 0.463 . . . . 0.0 111.929 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.532 HD23 ' OE1' ' A' ' 41' ' ' GLN . 4.5 tp -132.16 -39.02 1.07 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.002 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 67.2 mtt 63.62 127.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.081 0.953 . . . . 0.0 111.848 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -100.2 92.91 1.15 Allowed Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.526 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 19.7 p . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.105 -0.95 . . . . 0.0 111.061 179.994 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.568 0.223 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 62.8 122.75 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.929 0.891 . . . . 0.0 112.227 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.604 ' HA ' ' NE2' ' A' ' 8' ' ' GLN . 1.1 mp0 -89.74 160.53 16.51 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.191 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.466 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -107.27 -109.62 0.31 Allowed 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.773 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.559 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 14.0 p -101.26 -173.69 2.43 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 123.633 0.773 . . . . 0.0 111.015 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -59.39 -25.96 64.72 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.559 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 9.9 pt-20 -56.41 -32.52 64.92 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.29 0.566 . . . . 0.0 111.611 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.604 ' NE2' ' HA ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -78.3 -44.95 23.97 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.034 177.553 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.552 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . 20.8 mm -58.9 -35.97 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.557 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.03 -34.81 64.24 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -111.77 -17.96 12.84 Favored 'General case' 0 C--N 1.345 0.379 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 -177.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.552 ' CE1' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -73.3 -16.13 61.38 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.578 0.626 . . . . 0.0 110.542 179.328 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.688 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 1.2 pttt -83.35 -41.46 18.19 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.615 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.688 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 1.2 mt-10 -81.53 -37.05 28.42 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 114.241 -1.345 . . . . 0.0 112.417 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.535 ' O ' HG11 ' A' ' 35' ' ' VAL . . . -67.28 -23.27 65.65 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.32 0.581 . . . . 0.0 109.504 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.936 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 26.1 t80 -86.91 -43.4 12.44 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.908 176.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.1 m -86.4 -12.81 48.12 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 114.814 1.412 . . . . 0.0 114.814 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -73.0 -29.4 63.0 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.348 179.364 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.561 ' CD1' HG23 ' A' ' 35' ' ' VAL . 7.4 m-85 -131.31 -7.71 3.78 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.936 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 1.4 m-20 -99.38 79.7 2.33 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.845 0.748 . . . . 0.0 110.059 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.441 ' N ' ' HD2' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -76.07 -37.45 58.24 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -178.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.84 -20.33 58.21 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.243 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.5 51.55 5.97 Favored Glycine 0 C--N 1.343 0.918 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.77 22.15 4.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 113.454 -1.373 . . . . 0.0 114.338 -175.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.17 -62.82 0.23 Allowed Glycine 0 CA--C 1.528 0.858 0 CA-C-N 115.367 -0.833 . . . . 0.0 114.362 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.707 HG23 ' N ' ' A' ' 64' ' ' ASP . 10.4 p -97.65 157.77 15.86 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 123.662 0.785 . . . . 0.0 111.791 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.605 HG22 ' OD2' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -120.02 148.33 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.74 -179.463 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.441 ' H ' ' HG1' ' A' ' 28' ' ' THR . 0.7 OUTLIER -55.48 150.24 12.21 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -179.051 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.422 ' C ' ' H ' ' A' ' 31' ' ' GLU . 1.0 OUTLIER -75.24 -55.7 5.46 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.319 -179.152 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -53.66 -14.07 0.81 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 123.856 0.722 . . . . 0.0 111.378 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.485 ' O ' HG22 ' A' ' 35' ' ' VAL . 18.0 mt-10 -114.07 -16.9 12.05 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.692 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.443 ' HA ' HG22 ' A' ' 35' ' ' VAL . 7.8 tp -56.0 -40.42 73.31 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.264 0.626 . . . . 0.0 111.866 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.798 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -55.82 -39.27 76.89 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 177.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.0 m -74.94 -30.85 61.35 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 114.514 -0.843 . . . . 0.0 112.565 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.561 HG23 ' CD1' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -74.48 -27.07 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 176.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.605 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 45.0 mtt -73.52 -42.56 61.61 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 113.001 -1.909 . . . . 0.0 111.064 176.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.798 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 11.8 mtt180 -80.2 -29.12 38.57 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.8 m -66.87 -8.23 27.53 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.987 0.899 . . . . 0.0 112.051 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 35' ' ' VAL . 69.0 mt -92.44 -8.27 45.2 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 113.191 -1.822 . . . . 0.0 109.63 177.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.52 -3.91 30.99 Favored Glycine 0 CA--C 1.492 -1.372 0 CA-C-O 122.25 0.917 . . . . 0.0 114.949 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.605 ' HB2' ' O ' ' A' ' 36' ' ' MET . 55.7 mt-30 -78.45 141.51 38.21 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 112.3 -1.95 . . . . 0.0 112.198 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -125.38 68.09 58.21 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.486 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -84.2 -177.83 3.19 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 123.177 2.584 . . . . 0.0 112.19 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 m -98.97 160.8 14.0 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.517 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 28.6 mt-10 -80.63 -28.32 36.99 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.686 0.755 . . . . 0.0 109.896 178.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.45 -38.23 65.54 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.087 -178.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.585 ' HA ' ' OD2' ' A' ' 50' ' ' ASP . 43.1 mt-10 -76.3 -28.68 57.07 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 114.265 -1.334 . . . . 0.0 108.562 176.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.811 ' O ' HG12 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -63.08 -24.2 67.8 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.882 174.269 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.643 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 57.0 mt-30 -87.72 -18.93 28.37 Favored 'General case' 0 CA--C 1.478 -1.791 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.553 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.585 ' OD2' ' HA ' ' A' ' 47' ' ' GLU . 10.5 m-20 -75.64 -27.96 58.6 Favored 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 112.031 -2.35 . . . . 0.0 108.332 175.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.527 ' HA ' ' OE1' ' A' ' 54' ' ' GLU . 46.9 mtt -86.61 -35.67 19.28 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.663 176.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.811 HG12 ' O ' ' A' ' 48' ' ' LEU . 30.3 mm -68.8 -27.51 36.14 Favored 'Isoleucine or valine' 0 C--N 1.352 0.711 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 175.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.643 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.7 t-20 -72.94 -34.29 66.45 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 114.006 -1.452 . . . . 0.0 111.699 176.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.527 ' OE1' ' HA ' ' A' ' 51' ' ' MET . 5.5 pt-20 -88.24 -49.53 6.93 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.629 ' C ' ' H ' ' A' ' 57' ' ' ALA . 47.8 t -83.79 -49.75 16.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -178.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 5.1 t70 -71.14 37.46 0.05 Allowed 'General case' 0 C--O 1.238 0.484 0 CA-C-O 122.089 0.947 . . . . 0.0 110.289 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.629 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -86.26 -5.77 59.11 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 113.969 -1.469 . . . . 0.0 112.154 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -101.98 -33.36 9.77 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 112.069 -2.332 . . . . 0.0 110.864 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.38 51.09 4.03 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.149 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -109.94 -21.76 12.18 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.632 0.253 . . . . 0.0 111.546 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.93 26.67 72.33 Favored Glycine 0 N--CA 1.468 0.767 0 CA-C-N 115.711 -0.677 . . . . 0.0 114.599 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.67 156.17 42.99 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 123.202 0.601 . . . . 0.0 110.593 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.554 ' O ' HG13 ' A' ' 27' ' ' ILE . 10.9 mm -135.11 126.41 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.707 ' N ' HG23 ' A' ' 26' ' ' THR . 0.3 OUTLIER -73.22 156.83 38.14 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.363 176.587 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.559 ' CG ' ' HD3' ' A' ' 66' ' ' PRO . 10.6 p90 -91.61 -40.12 0.38 Allowed Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -177.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.559 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 7.4 Cg_exo -73.76 -18.17 22.31 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 121.793 1.662 . . . . 0.0 112.821 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -93.5 -19.42 21.25 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.445 ' CD2' ' HA ' ' A' ' 65' ' ' PHE . 2.7 p90 -83.62 -33.29 25.33 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 120.069 1.304 . . . . 0.0 114.283 -178.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.466 ' O ' ' N ' ' A' ' 73' ' ' ALA . 1.3 mt -65.66 -35.64 81.36 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.667 0.746 . . . . 0.0 110.417 178.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.47 -33.49 71.37 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 113.447 -1.706 . . . . 0.0 108.834 174.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.631 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 60.4 mtt -77.26 -23.32 51.23 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.992 175.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.549 ' HA ' ' CD ' ' A' ' 75' ' ' LYS . 66.0 mtt -88.75 -18.59 27.47 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.029 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.765 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -83.27 -24.99 32.01 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.846 177.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.447 ' HD2' ' N ' ' A' ' 75' ' ' LYS . 4.0 ppt_? -89.62 -28.48 19.48 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.631 ' HD2' ' O ' ' A' ' 71' ' ' MET . 8.5 ptmt -75.61 -12.9 60.3 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.546 ' HG2' ' O ' ' A' ' 72' ' ' MET . 14.7 ptm -113.27 -34.27 5.7 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.765 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 32.3 mmtt -76.39 -25.39 54.52 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.88 -1.055 . . . . 0.0 113.844 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -104.01 -22.85 13.39 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -177.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.5 t -61.06 -67.6 0.39 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -162.73 121.14 2.11 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.8 0.84 . . . . 0.0 110.327 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.3 t -83.66 -13.48 54.06 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.451 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.532 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -75.99 -52.11 10.95 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.391 0.677 . . . . 0.0 111.079 -178.049 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.55 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -72.65 -17.76 61.63 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.578 -1.192 . . . . 0.0 113.248 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -53.54 -26.63 21.96 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.225 0.61 . . . . 0.0 112.167 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.7 mp -87.77 -47.47 15.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.272 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.628 ' O ' ' HD1' ' A' ' 89' ' ' PHE . 45.7 mtt180 -51.59 -30.6 21.6 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.111 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.561 ' O ' HG23 ' A' ' 91' ' ' VAL . 43.9 mt-10 -62.63 -20.39 64.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.787 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.79 -19.53 60.74 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.942 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.628 ' HD1' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -84.96 -21.35 29.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 174.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 30.9 mmt180 -78.74 -28.62 44.92 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.131 -1.395 . . . . 0.0 108.333 175.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 87' ' ' GLU . 82.5 t -88.75 -50.92 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 CA-C-N 114.4 -1.273 . . . . 0.0 113.07 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.611 ' CE2' HG12 ' A' ' 108' ' ' VAL . 30.6 m-85 -100.07 -43.05 6.48 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.667 ' CA ' HG12 ' A' ' 100' ' ' ILE . 14.1 t70 -69.02 94.96 0.68 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 122.295 1.045 . . . . 0.0 112.429 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.424 ' HZ3' ' C ' ' A' ' 107' ' ' HIS . 1.2 mptm? -88.59 -48.78 7.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 113.088 -1.869 . . . . 0.0 114.075 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -71.49 2.02 5.63 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 48.19 29.15 6.62 Favored Glycine 0 N--CA 1.474 1.182 0 CA-C-N 114.302 -1.317 . . . . 0.0 115.091 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -98.56 -3.12 37.07 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.703 0.251 . . . . 0.0 111.304 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.03 -19.12 53.3 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.513 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.509 ' HB3' ' HG3' ' A' ' 135' ' ' GLN . 39.0 m-85 -115.1 129.06 56.59 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.379 -0.911 . . . . 0.0 110.852 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.667 HG12 ' CA ' ' A' ' 93' ' ' ASP . 54.9 mt -88.55 83.54 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.4 t -61.06 166.59 3.47 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 114.42 -1.263 . . . . 0.0 113.099 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.57 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -59.21 -14.8 11.94 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.594 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.46 -28.08 21.08 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 121.76 0.791 . . . . 0.0 109.473 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 1.042 ' O ' HG21 ' A' ' 108' ' ' VAL . 19.0 mt-10 -81.28 -42.18 21.04 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-N 112.639 -2.073 . . . . 0.0 111.327 -178.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.64 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 7.0 tt -67.83 -31.41 71.24 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.673 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -72.13 -44.34 63.29 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.014 -1.448 . . . . 0.0 108.724 175.244 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.594 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 2.2 t60 -66.88 -21.95 65.99 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.033 177.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 1.042 HG21 ' O ' ' A' ' 104' ' ' GLU . 27.6 t -71.26 -51.47 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 176.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.642 ' SD ' HD23 ' A' ' 116' ' ' LEU . 18.6 mtt -57.42 -41.95 81.4 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 112.65 -2.068 . . . . 0.0 112.196 175.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.68 -19.07 63.6 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.221 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.91 -44.95 21.59 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.563 176.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.1 mt -80.95 -28.25 35.77 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.084 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 140.65 -8.17 2.8 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 117.691 -1.616 . . . . 0.0 116.902 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 109' ' ' MET . 4.9 mt-10 -100.7 151.55 21.52 Favored 'General case' 0 C--N 1.358 0.947 0 CA-C-N 120.988 2.394 . . . . 0.0 114.39 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -109.46 128.86 55.47 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 113.519 -1.673 . . . . 0.0 107.487 175.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.673 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 1.4 tp -135.58 119.79 17.76 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.394 -1.275 . . . . 0.0 112.425 -175.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.845 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -72.76 -175.97 1.86 Allowed 'General case' 0 C--N 1.347 0.483 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.554 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.532 ' N ' HG21 ' A' ' 117' ' ' THR . 16.7 t70 -73.21 -38.6 66.04 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -177.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -88.85 -16.04 32.98 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.627 ' HG3' ' HG ' ' A' ' 116' ' ' LEU . 14.8 pt-20 -85.11 -15.43 43.91 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 123.118 0.261 . . . . 0.0 110.887 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.845 HG22 ' O ' ' A' ' 117' ' ' THR . 0.1 OUTLIER -83.35 -24.2 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.793 178.285 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -72.87 30.54 0.06 Allowed 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.724 0.773 . . . . 0.0 112.554 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.659 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 11.3 pt-20 -141.43 -17.64 0.8 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.636 177.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.412 ' SD ' ' HE2' ' A' ' 109' ' ' MET . 2.2 ttm -88.05 -22.74 24.03 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.073 0.949 . . . . 0.0 109.136 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.653 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 2.6 mt -87.82 -44.36 15.84 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.804 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -58.48 -28.47 65.4 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 122.028 0.918 . . . . 0.0 111.01 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.696 ' HB3' ' CE1' ' B' ' 154' ' ' PHE . 7.4 mm-40 -55.33 -44.19 75.63 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.111 -1.859 . . . . 0.0 111.161 176.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.834 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -106.08 -29.0 10.17 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.028 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.653 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -59.92 124.52 20.43 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 122.15 0.976 . . . . 0.0 113.109 -178.324 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.5 mm -89.8 -47.54 14.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 112.97 -1.923 . . . . 0.0 110.459 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -90.59 -25.33 20.23 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.53 49.79 5.02 Favored Glycine 0 CA--C 1.525 0.69 0 O-C-N 123.428 0.455 . . . . 0.0 113.95 178.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -87.41 -19.58 27.88 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.438 ' C ' HG23 ' A' ' 125' ' ' ILE . . . 101.39 2.52 53.77 Favored Glycine 0 CA--C 1.507 -0.453 0 CA-C-N 115.846 -0.616 . . . . 0.0 113.468 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.509 ' HG3' ' HB3' ' A' ' 99' ' ' TYR . 5.1 pt20 -133.56 135.83 44.58 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 124.63 1.172 . . . . 0.0 109.389 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.6 t -93.16 135.18 28.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.274 0.559 . . . . 0.0 112.487 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -96.07 -168.67 1.79 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.358 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.416 ' O ' ' N ' ' A' ' 142' ' ' VAL . 9.2 m-85 -73.17 -58.86 3.02 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.875 177.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -59.78 -20.5 57.1 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.834 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 11.9 mt-10 -88.79 -40.49 13.15 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 121.28 0.562 . . . . 0.0 110.192 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -73.46 -23.38 60.07 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.363 -1.289 . . . . 0.0 109.14 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.615 ' O ' ' HG2' ' A' ' 145' ' ' MET . 6.8 t -85.19 -48.62 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.786 -177.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.549 ' O ' ' N ' ' A' ' 147' ' ' ALA . 57.4 mt-30 -64.78 -19.04 65.6 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.419 -0.513 . . . . 0.0 112.322 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.563 ' SD ' ' HE2' ' B' ' 154' ' ' PHE . 24.1 mmt -84.79 -21.17 30.04 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 123.292 0.37 . . . . 0.0 110.717 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.615 ' HG2' ' O ' ' A' ' 142' ' ' VAL . 14.3 ptt? -83.57 -13.78 53.64 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 175.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.46 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 31.8 p -103.7 -58.4 1.88 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.276 177.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . 7.43 -69.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 177.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.54 ' HZ3' ' HZ3' ' B' ' 152' ' ' LYS . 50.4 pttt . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.401 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.498 0.189 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -128.97 129.77 45.84 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -130.6 -44.32 1.1 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.351 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . 0.54 ' HZ3' ' HZ3' ' A' ' 148' ' ' LYS . 97.2 mttt -98.27 138.2 35.88 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.464 0.477 . . . . 0.0 110.753 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 27.2 p -139.43 -56.04 0.58 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.993 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' PHE . . . . . 0.804 ' H ' ' HD1' ' B' ' 154' ' ' PHE . 0.0 OUTLIER -55.1 -43.01 73.63 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.163 0.985 . . . . 0.0 113.008 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . 0.6 ' HD2' ' CE2' ' B' ' 154' ' ' PHE . 1.0 OUTLIER -71.87 -32.83 67.87 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.05 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -77.79 -39.23 44.61 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.564 178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' VAL . . . . . 0.528 HG23 ' O ' ' B' ' 154' ' ' PHE . 32.0 m -62.59 -38.14 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 122.919 0.488 . . . . 0.0 111.067 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.0 -43.61 57.42 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.985 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -59.77 -29.58 68.29 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.947 0.499 . . . . 0.0 112.064 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.91 -33.76 57.75 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.448 0.468 . . . . 0.0 112.112 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 7.6 p -118.77 28.82 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 O-C-N 123.374 0.421 . . . . 0.0 111.741 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -84.63 -13.72 50.73 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 3.4 tp -130.68 29.8 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-O 120.994 0.426 . . . . 0.0 111.168 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 49.8 m -92.97 -41.59 9.93 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.356 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . -92.27 20.31 6.18 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.425 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 50.3 m -86.59 -20.79 27.39 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.022 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.506 HD22 ' NE2' ' A' ' 41' ' ' GLN . 12.8 tp -91.46 88.13 6.69 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.265 0.555 . . . . 0.0 110.654 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 62.8 mtt -137.76 148.49 45.62 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.742 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -177.42 71.3 0.08 OUTLIER Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.549 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.537 -0.744 . . . . 0.0 111.066 179.963 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.546 0.212 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -135.69 125.45 25.52 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.862 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -83.45 157.1 22.58 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.389 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.518 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -105.82 -114.29 0.25 Allowed 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.552 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 18.4 p -101.45 -173.59 2.4 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 123.953 0.901 . . . . 0.0 110.391 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -58.19 -23.96 57.4 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.552 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 12.9 pt-20 -55.89 -29.46 60.02 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.74 0.65 . . . . 0.0 111.078 177.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.508 ' OE1' HD11 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -75.62 -46.8 29.56 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.801 178.068 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.547 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . 3.9 mt -65.09 -32.97 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.706 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.32 -34.3 59.03 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.551 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 44.4 mt-10 -109.6 -18.29 13.52 Favored 'General case' 0 C--N 1.346 0.44 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 -177.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.547 ' CE1' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -72.12 -15.58 61.99 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.773 0.715 . . . . 0.0 110.026 178.715 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.721 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 5.3 pttt -78.4 -41.84 31.92 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 114.55 -1.205 . . . . 0.0 108.385 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.721 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 7.3 pt-20 -80.16 -44.82 19.2 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 113.605 -1.634 . . . . 0.0 113.384 -178.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.509 ' O ' HG11 ' A' ' 35' ' ' VAL . . . -61.4 -18.49 59.05 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.459 0.647 . . . . 0.0 109.346 177.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.411 ' O ' HG21 ' A' ' 27' ' ' ILE . 82.8 t80 -86.01 -52.79 5.48 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.583 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.594 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 50.5 m -87.12 -13.0 45.42 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -176.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -65.66 -28.71 69.29 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.471 0.578 . . . . 0.0 112.216 -178.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.507 ' CD1' HG21 ' A' ' 35' ' ' VAL . 6.6 m-85 -135.88 -0.36 2.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 116.301 1.963 . . . . 0.0 116.301 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.594 ' OD1' ' HA ' ' A' ' 17' ' ' SER . 31.0 p-10 -78.11 54.29 1.32 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 119.348 0.976 . . . . 0.0 112.348 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.484 ' N ' ' HD2' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -87.05 -17.21 33.45 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 179.676 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.73 -22.54 61.61 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.314 0.578 . . . . 0.0 110.438 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.46 43.83 14.6 Favored Glycine 0 N--CA 1.469 0.896 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.26 23.04 14.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.107 -1.547 . . . . 0.0 112.297 -175.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.37 -82.22 1.69 Allowed Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.386 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.515 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 7.2 p -98.61 178.66 4.93 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 122.864 0.466 . . . . 0.0 111.302 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -78.81 148.93 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -179.13 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.01 162.58 27.86 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.436 ' C ' ' H ' ' A' ' 31' ' ' GLU . 1.1 p -78.66 -55.77 4.93 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.061 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -54.63 -14.14 1.23 Allowed 'General case' 0 N--CA 1.475 0.799 0 O-C-N 123.662 0.601 . . . . 0.0 110.85 177.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.492 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 21.5 mt-10 -113.82 -16.48 12.24 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.48 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.603 ' HA ' HG23 ' A' ' 35' ' ' VAL . 14.3 tp -53.49 -43.09 67.93 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.747 0.819 . . . . 0.0 112.326 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.807 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -55.55 -37.97 69.27 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 177.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 m -75.99 -30.48 58.57 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.451 -0.874 . . . . 0.0 112.928 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.603 HG23 ' HA ' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -75.02 -27.8 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 176.342 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.639 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 44.6 mtt -70.18 -43.67 70.33 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 113.061 -1.882 . . . . 0.0 110.413 175.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.807 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 11.9 mtt180 -77.76 -28.3 50.59 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.687 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.4 m -67.47 -8.65 35.12 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.927 0.87 . . . . 0.0 112.055 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 76.8 mt -94.04 -6.08 46.02 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 113.277 -1.783 . . . . 0.0 109.701 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.65 -2.45 39.22 Favored Glycine 0 CA--C 1.493 -1.298 0 CA-C-O 122.333 0.963 . . . . 0.0 114.891 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.639 ' HB2' ' O ' ' A' ' 36' ' ' MET . 46.9 mt-30 -78.25 143.11 37.37 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 112.138 -2.031 . . . . 0.0 112.379 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -124.63 70.31 56.46 Favored Pre-proline 0 CA--C 1.55 0.973 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.92 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -82.66 -179.57 4.64 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 123.26 2.64 . . . . 0.0 112.784 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.9 m -100.57 162.62 12.81 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.708 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.499 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 28.3 mt-10 -80.7 -28.72 36.59 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-O 121.63 0.728 . . . . 0.0 109.983 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.69 -38.03 67.69 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 113.638 -1.619 . . . . 0.0 110.234 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -76.5 -29.25 56.75 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.598 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.789 ' O ' HG12 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -62.49 -26.32 68.47 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.09 174.581 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.608 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 57.2 mt-30 -88.76 -18.44 27.76 Favored 'General case' 0 CA--C 1.48 -1.742 0 CA-C-N 114.188 -1.369 . . . . 0.0 111.164 178.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -76.57 -28.43 56.23 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 111.957 -2.383 . . . . 0.0 107.805 175.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 23.3 mmt -86.92 -31.67 20.57 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.013 176.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.789 HG12 ' O ' ' A' ' 48' ' ' LEU . 24.4 mm -72.99 -27.17 24.12 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.608 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.1 t-20 -79.5 -35.85 39.47 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.065 -1.425 . . . . 0.0 111.765 176.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -89.99 -49.39 6.62 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.602 ' C ' ' H ' ' A' ' 57' ' ' ALA . 67.9 t -84.18 -49.81 15.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.498 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 5.0 t70 -72.43 38.78 0.08 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 122.048 0.927 . . . . 0.0 110.158 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.602 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -86.1 -5.57 59.18 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.647 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -97.33 -33.34 11.47 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 112.408 -2.178 . . . . 0.0 111.009 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.41 45.12 6.28 Favored Glycine 0 C--N 1.342 0.881 0 O-C-N 123.505 0.503 . . . . 0.0 113.702 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -110.05 -21.57 12.24 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.694 0.283 . . . . 0.0 111.432 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.76 26.41 73.83 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 115.607 -0.724 . . . . 0.0 114.181 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.408 ' HB ' ' OG1' ' A' ' 26' ' ' THR . 0.0 OUTLIER -140.43 163.82 31.79 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 123.574 0.75 . . . . 0.0 110.57 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.515 ' O ' ' HB ' ' A' ' 26' ' ' THR . 5.0 mp -133.13 111.61 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.435 ' OD1' ' HB2' ' A' ' 67' ' ' GLU . 2.0 p30 -49.63 146.34 4.32 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.003 -0.998 . . . . 0.0 111.835 174.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.578 ' CG ' ' HD3' ' A' ' 66' ' ' PRO . 5.8 p90 -90.83 -39.91 0.4 Allowed Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -177.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.578 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 17.4 Cg_exo -67.97 -18.52 46.42 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 121.903 1.735 . . . . 0.0 112.691 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.435 ' HB2' ' OD1' ' A' ' 64' ' ' ASP . 35.1 mt-10 -107.95 5.72 26.53 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.726 ' O ' ' HG2' ' A' ' 71' ' ' MET . 57.3 t80 -84.5 -60.76 1.97 Allowed 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.508 HD11 ' OE1' ' A' ' 8' ' ' GLN . 0.8 OUTLIER -59.18 -31.46 69.03 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.673 0.749 . . . . 0.0 110.746 178.392 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.637 ' O ' ' HD3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -57.74 -39.27 76.95 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 113.362 -1.745 . . . . 0.0 109.399 174.338 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.726 ' HG2' ' O ' ' A' ' 68' ' ' PHE . 13.2 ptt? -77.43 -18.84 56.87 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 123.803 0.69 . . . . 0.0 109.195 176.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.537 ' HA ' ' HG3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -88.74 -20.38 24.86 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.193 176.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.598 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -80.18 -33.68 38.13 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.637 ' HD3' ' O ' ' A' ' 70' ' ' THR . 7.7 ptt180 -83.57 -16.99 43.26 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.576 ' HZ2' ' H ' ' B' ' 167' ' ' LEU . 0.0 OUTLIER -82.8 -13.99 55.23 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 118.545 0.611 . . . . 0.0 112.495 179.181 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 22.4 ptt? -113.58 -31.5 6.49 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.114 0.483 . . . . 0.0 112.12 -177.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.598 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 30.9 mmtt -74.67 -22.64 58.77 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.853 -1.067 . . . . 0.0 113.764 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -104.12 -14.99 15.68 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.0 t -75.95 54.77 0.86 Allowed 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.504 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 8.1 m-20 58.87 121.47 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.016 0.926 . . . . 0.0 112.498 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.6 m -83.08 -14.02 54.56 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.484 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.454 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -85.13 -45.62 11.88 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.709 0.766 . . . . 0.0 109.639 -179.532 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 87' ' ' GLU . 35.3 mt-10 -73.09 -17.99 61.35 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.797 -1.547 . . . . 0.0 112.574 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.612 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 15.0 mt-10 -61.35 -22.21 64.72 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.421 HD11 ' O ' ' A' ' 82' ' ' GLU . 3.7 mp -88.01 -52.34 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.712 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.579 ' O ' ' HD1' ' A' ' 89' ' ' PHE . 10.4 mtt180 -68.45 -16.94 64.08 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.612 ' OE1' ' HA ' ' A' ' 84' ' ' GLU . 3.5 pt-20 -75.09 -18.75 60.21 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.556 ' HA ' ' HB ' ' A' ' 91' ' ' VAL . . . -64.37 -24.39 67.62 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.13 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.579 ' HD1' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -83.02 -21.04 33.95 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 175.029 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 31.8 mmt180 -81.59 -20.14 40.45 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.757 174.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.556 ' HB ' ' HA ' ' A' ' 88' ' ' ALA . 2.6 t -88.1 -53.89 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 CA-C-N 114.285 -1.325 . . . . 0.0 112.534 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.6 ' CE1' HG13 ' A' ' 108' ' ' VAL . 1.3 m-85 -100.77 -44.44 5.79 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -176.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.695 ' CA ' HG12 ' A' ' 100' ' ' ILE . 2.7 t70 -59.8 95.11 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.455 0.645 . . . . 0.0 111.967 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.4 mmpt? -87.59 -50.85 6.24 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.785 -1.098 . . . . 0.0 113.069 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -72.31 0.84 8.92 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -175.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 50.89 32.9 27.37 Favored Glycine 0 N--CA 1.471 1.03 0 CA-C-N 114.324 -1.307 . . . . 0.0 114.554 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -98.0 -5.53 33.91 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.44 -19.25 53.44 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 121.439 -0.41 . . . . 0.0 112.811 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -121.37 118.59 29.82 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.452 -0.874 . . . . 0.0 110.302 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.695 HG12 ' CA ' ' A' ' 93' ' ' ASP . 18.9 mt -77.2 97.3 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.222 0.609 . . . . 0.0 109.429 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.1 t -78.66 169.07 18.82 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.32 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.487 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -60.59 -14.92 23.06 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.522 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.94 -29.39 19.61 Favored 'General case' 0 CA--C 1.487 -1.458 0 CA-C-O 121.79 0.805 . . . . 0.0 109.136 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.892 ' O ' HG22 ' A' ' 108' ' ' VAL . 23.0 mt-10 -79.25 -42.92 24.8 Favored 'General case' 0 CA--C 1.482 -1.671 0 CA-C-N 112.74 -2.027 . . . . 0.0 110.883 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.54 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 7.1 tt -65.25 -34.36 78.17 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.581 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -70.87 -43.76 67.74 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.174 176.367 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.522 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 10.3 t-80 -70.06 -21.63 63.14 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.752 177.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.892 HG22 ' O ' ' A' ' 104' ' ' GLU . 4.1 t -71.18 -53.15 22.34 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.413 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.655 ' O ' ' N ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -60.07 -39.18 85.16 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 111.497 -2.592 . . . . 0.0 112.514 178.313 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.6 m -73.86 -18.73 60.89 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 119.172 -1.011 . . . . 0.0 109.831 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.25 -45.75 13.46 Favored 'General case' 0 C--N 1.347 0.467 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 176.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.49 HD22 ' O ' ' A' ' 108' ' ' VAL . 1.3 mm? -76.91 -28.09 55.18 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 114.763 -1.108 . . . . 0.0 113.466 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 140.83 -11.12 2.88 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-O 117.815 -1.547 . . . . 0.0 116.911 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.655 ' N ' ' O ' ' A' ' 109' ' ' MET . 4.8 mt-10 -101.18 152.77 20.25 Favored 'General case' 0 C--N 1.356 0.874 0 CA-C-N 120.763 2.281 . . . . 0.0 114.254 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -108.96 127.0 53.68 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.824 -1.535 . . . . 0.0 107.5 175.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.581 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 1.2 tp -135.57 116.09 13.75 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.167 -175.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.766 ' O ' HG21 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -72.59 -176.01 1.81 Allowed 'General case' 0 C--N 1.346 0.42 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.675 179.4 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.493 ' N ' HG23 ' A' ' 117' ' ' THR . 16.5 t70 -73.87 -37.97 64.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.696 -1.138 . . . . 0.0 113.968 -177.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -86.36 -16.13 38.3 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.622 ' CD ' ' H ' ' A' ' 117' ' ' THR . 13.8 pt-20 -85.64 -16.64 38.53 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 122.985 0.178 . . . . 0.0 111.308 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.766 HG21 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -85.01 -27.26 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.526 178.3 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -75.54 35.3 0.12 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 122.131 0.967 . . . . 0.0 111.306 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.831 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 6.7 tp10 -140.96 -58.67 0.5 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 113.892 -1.503 . . . . 0.0 107.863 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 19.0 ttm -52.41 -22.78 5.05 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.328 1.051 . . . . 0.0 111.571 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.664 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 2.9 mt -87.36 -45.64 16.19 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.754 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -60.46 -31.39 70.39 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.854 0.721 . . . . 0.0 112.158 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.831 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 6.9 mm-40 -66.74 -35.65 80.61 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.11 177.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.629 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -96.57 -34.31 11.48 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.512 -178.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.664 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -60.93 127.73 33.0 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.423 -1.262 . . . . 0.0 114.174 -177.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.441 HD12 ' OE1' ' A' ' 143' ' ' GLN . 1.8 mp -89.06 -51.0 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 113.57 -1.65 . . . . 0.0 110.114 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -91.35 -25.25 19.49 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.06 49.64 4.67 Favored Glycine 0 CA--C 1.524 0.643 0 O-C-N 123.45 0.469 . . . . 0.0 113.689 178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -90.48 -19.82 23.42 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 97.22 12.11 49.98 Favored Glycine 0 CA--C 1.5 -0.888 0 CA-C-N 116.028 -0.533 . . . . 0.0 113.463 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -139.19 124.9 19.54 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.936 -1.132 . . . . 0.0 108.684 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.517 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 3.4 t -87.58 133.13 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.372 -177.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -99.48 -165.33 1.22 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.485 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.413 ' O ' HG21 ' A' ' 142' ' ' VAL . 35.7 m-85 -65.69 -56.69 10.77 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.702 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 143' ' ' GLN . 43.7 mt-10 -65.5 -20.7 66.45 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.629 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 7.3 mt-10 -86.06 -35.71 20.12 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.646 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.472 ' O ' ' HG2' ' A' ' 144' ' ' MET . 89.1 t80 -76.7 -23.87 53.14 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.212 175.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.443 ' O ' ' HG2' ' A' ' 145' ' ' MET . 14.5 t -86.13 -39.08 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 114.517 -1.22 . . . . 0.0 112.297 -177.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 147' ' ' ALA . 9.3 mt-30 -46.17 -34.03 4.01 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.617 ' HB3' ' CD2' ' B' ' 154' ' ' PHE . 19.5 ptt? -60.78 -24.34 65.7 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 118.262 0.483 . . . . 0.0 111.336 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.443 ' HG2' ' O ' ' A' ' 142' ' ' VAL . 2.4 ptp -83.39 -5.81 59.26 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 123.434 0.459 . . . . 0.0 110.41 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.7 t -130.44 -33.19 1.69 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -49.41 -31.87 10.55 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 178.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 57.4 mttp . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.515 179.946 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 19.9 p . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 120.346 0.117 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -119.69 121.77 39.98 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 123.424 0.452 . . . . 0.0 110.788 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . 0.511 ' HD2' ' OE2' ' A' ' 114' ' ' GLU . 61.2 mttp -136.43 137.3 40.31 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.671 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -133.76 -1.57 3.05 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.882 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.44 HG22 ' OE1' ' A' ' 127' ' ' GLU . 27.7 p -125.8 155.25 41.37 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.639 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' PHE . . . . . 0.705 ' CE1' ' HD2' ' B' ' 155' ' ' LYS . 0.1 OUTLIER -71.71 -28.27 63.58 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.987 178.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . 0.705 ' HD2' ' CE1' ' B' ' 154' ' ' PHE . 7.2 mptt -61.16 -38.12 85.33 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.961 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -76.89 -37.34 55.65 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.504 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' VAL . . . . . 0.587 HG23 ' O ' ' B' ' 154' ' ' PHE . 15.4 m -70.48 -29.33 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -52.41 -33.29 43.14 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -71.62 -38.23 70.81 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.581 0.229 . . . . 0.0 111.426 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.8 -39.06 45.1 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 6.5 t -108.94 -51.87 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -66.29 89.1 0.13 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.583 0.706 . . . . 0.0 111.37 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' ILE . . . . . 0.475 ' CG2' ' HG ' ' B' ' 166' ' ' SER . 2.7 tp -160.6 34.34 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.661 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 50.9 m 63.73 39.46 8.53 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.015 0.926 . . . . 0.0 111.428 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . 62.63 20.6 12.14 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.952 0.901 . . . . 0.0 112.167 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' SER . . . . . 0.475 ' HG ' ' CG2' ' B' ' 163' ' ' ILE . 5.5 m 54.66 97.56 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.107 0.963 . . . . 0.0 111.599 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.576 ' H ' ' HZ2' ' A' ' 75' ' ' LYS . 0.5 OUTLIER 43.73 75.16 0.1 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.116 0.966 . . . . 0.0 112.647 -179.596 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.63 133.59 45.09 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.499 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . 135.22 -159.02 23.89 Favored Glycine 0 C--N 1.337 0.628 0 O-C-N 123.631 0.582 . . . . 0.0 112.706 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 20.2 p . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.112 -0.947 . . . . 0.0 111.012 -179.967 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 111.357 0.132 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 63.08 126.29 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.929 0.892 . . . . 0.0 111.988 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 65' ' ' PHE . 1.3 mp0 -89.27 -69.17 0.73 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.353 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.482 HD11 ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -117.97 -117.55 0.32 Allowed 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.328 179.738 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.986 ' O ' ' HG3' ' A' ' 8' ' ' GLN . 17.2 p -101.51 -172.99 2.25 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 124.253 1.021 . . . . 0.0 110.83 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -58.19 -20.82 44.2 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.443 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 12.5 pt-20 -53.5 -37.65 62.94 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.586 0.553 . . . . 0.0 111.628 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.986 ' HG3' ' O ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -74.46 -48.32 28.18 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.082 176.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.446 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 21.2 mm -56.33 -36.48 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 113.993 -1.458 . . . . 0.0 110.999 178.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.24 -48.9 74.0 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.728 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 24.8 mt-10 -135.89 -20.24 1.51 Allowed 'General case' 0 C--N 1.358 0.959 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -176.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.513 ' CD1' HD22 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -68.79 -14.74 63.22 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 118.899 -1.121 . . . . 0.0 110.453 178.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.708 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 5.9 pttt -72.2 -42.87 65.29 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 123.775 0.83 . . . . 0.0 109.008 178.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.728 ' HG2' ' O ' ' A' ' 11' ' ' GLU . 11.5 pt-20 -67.49 -40.28 85.23 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 114.227 -1.351 . . . . 0.0 112.57 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.617 ' O ' HG13 ' A' ' 35' ' ' VAL . . . -58.62 -22.19 55.78 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.832 0.708 . . . . 0.0 110.109 176.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.472 ' CE2' ' HB3' ' A' ' 65' ' ' PHE . 23.4 m-85 -86.86 -42.76 12.98 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.469 176.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.6 t -86.78 -13.38 45.33 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -71.66 -29.4 64.58 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.999 -0.281 . . . . 0.0 111.188 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.565 ' CD1' HG23 ' A' ' 35' ' ' VAL . 1.9 m-85 -126.7 -12.14 6.05 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -101.9 74.98 1.5 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.997 0.817 . . . . 0.0 110.697 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.445 ' HD3' ' N ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -87.23 -20.58 26.71 Favored 'General case' 0 C--N 1.345 0.386 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -179.607 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.554 ' OD1' ' HB2' ' A' ' 24' ' ' ASP . 0.3 OUTLIER -70.56 -22.69 62.56 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.497 178.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.06 50.95 4.93 Favored Glycine 0 N--CA 1.467 0.7 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.554 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 0.3 OUTLIER -99.62 23.06 9.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.425 -1.388 . . . . 0.0 112.248 -176.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.56 -79.72 1.86 Allowed Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.78 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.551 HG23 ' O ' ' A' ' 63' ' ' ILE . 3.2 p -119.9 175.99 5.63 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 122.489 0.316 . . . . 0.0 111.268 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -84.39 149.45 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.31 160.59 24.19 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.722 -1.126 . . . . 0.0 113.514 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.401 ' C ' ' H ' ' A' ' 31' ' ' GLU . 0.9 OUTLIER -75.98 -55.49 5.56 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.879 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -55.8 -13.76 1.95 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.304 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.467 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 28.9 mt-10 -113.85 -16.93 12.16 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.303 -178.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.461 ' HA ' HG22 ' A' ' 35' ' ' VAL . 1.3 tm? -57.62 -40.87 80.16 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.219 0.608 . . . . 0.0 111.869 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.798 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -55.18 -39.58 71.43 Favored Glycine 0 C--N 1.338 0.683 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.8 m -74.25 -31.07 62.43 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.547 -0.827 . . . . 0.0 112.911 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.617 HG13 ' O ' ' A' ' 15' ' ' ALA . 1.1 t -74.2 -27.15 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 176.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.588 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 24.2 mtt -73.43 -41.64 63.01 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 113.152 -1.84 . . . . 0.0 111.119 176.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.798 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 10.4 mtt180 -82.0 -29.27 32.14 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 65.5 m -66.12 -7.98 21.06 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.963 0.887 . . . . 0.0 112.248 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.9 mt -93.36 -8.04 43.04 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 113.307 -1.769 . . . . 0.0 109.731 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.15 -7.61 23.18 Favored Glycine 0 CA--C 1.493 -1.309 0 N-CA-C 115.31 0.884 . . . . 0.0 115.31 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.588 ' HB2' ' O ' ' A' ' 36' ' ' MET . 46.7 mt-30 -74.82 140.41 43.92 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 112.601 -1.799 . . . . 0.0 111.991 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -126.86 63.35 55.16 Favored Pre-proline 0 CA--C 1.554 1.13 0 O-C-N 123.55 0.531 . . . . 0.0 111.312 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.414 ' HD3' ' C ' ' A' ' 41' ' ' GLN . 1.7 Cg_endo -84.73 -177.68 2.97 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.917 2.411 . . . . 0.0 111.562 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.504 ' OG1' ' N ' ' A' ' 45' ' ' GLU . 8.0 t -102.3 -175.81 2.93 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 122.245 1.021 . . . . 0.0 110.757 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.504 ' N ' ' OG1' ' A' ' 44' ' ' THR . 46.2 mt-10 -81.69 -24.7 36.06 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-N 112.797 -2.001 . . . . 0.0 108.637 177.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.426 ' H ' ' HG1' ' A' ' 44' ' ' THR . . . -68.88 -29.52 67.83 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.769 -1.56 . . . . 0.0 111.854 -177.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -87.31 -28.36 22.32 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.503 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.473 ' HB2' ' HA ' ' A' ' 45' ' ' GLU . 0.6 OUTLIER -69.55 -20.4 63.68 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 114.396 -1.275 . . . . 0.0 108.928 174.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.739 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 54.4 mt-30 -97.14 -16.53 20.42 Favored 'General case' 0 CA--C 1.483 -1.629 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.256 178.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -85.54 -33.52 21.73 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 111.978 -2.374 . . . . 0.0 109.66 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.519 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -86.66 -34.67 19.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.909 177.061 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 30.3 mt -70.96 -26.36 27.49 Favored 'Isoleucine or valine' 0 C--N 1.348 0.538 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.739 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 4.6 t-20 -68.33 -32.83 73.22 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.404 174.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -87.77 -25.4 23.4 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.347 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.63 ' C ' ' H ' ' A' ' 57' ' ' ALA . 75.2 t -84.63 -40.59 15.35 Favored 'Isoleucine or valine' 0 C--N 1.346 0.437 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -71.07 29.69 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.913 0.863 . . . . 0.0 111.167 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.63 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -87.5 -7.15 57.95 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 114.102 -1.408 . . . . 0.0 111.923 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -113.55 -41.48 3.62 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 111.689 -2.505 . . . . 0.0 110.827 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.26 37.7 10.8 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.846 -0.616 . . . . 0.0 113.307 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -110.08 -21.54 12.24 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.537 0.208 . . . . 0.0 111.512 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.27 26.96 60.6 Favored Glycine 0 N--CA 1.466 0.638 0 CA-C-N 115.885 -0.598 . . . . 0.0 114.158 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.13 170.2 16.15 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 123.103 0.561 . . . . 0.0 110.823 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.551 ' O ' HG23 ' A' ' 26' ' ' THR . 4.1 mp -113.61 79.51 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.449 ' OD2' ' HB2' ' A' ' 67' ' ' GLU . 21.8 p-10 -50.99 148.16 4.49 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.393 0.677 . . . . 0.0 111.876 176.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.492 ' CG ' ' HD3' ' A' ' 66' ' ' PRO . 16.5 p90 -81.01 -37.53 0.94 Allowed Pre-proline 0 N--CA 1.477 0.916 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.492 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 16.9 Cg_exo -68.07 -16.78 45.4 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.131 1.887 . . . . 0.0 113.288 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.449 ' HB2' ' OD2' ' A' ' 64' ' ' ASP . 23.5 mt-10 -105.51 -29.7 10.01 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 -177.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.947 ' O ' ' HG2' ' A' ' 71' ' ' MET . 4.2 t80 -85.03 -47.65 10.01 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -175.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.513 HD22 ' CD1' ' A' ' 12' ' ' PHE . 4.5 mt -61.24 -31.8 71.59 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 119.407 1.003 . . . . 0.0 110.802 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.465 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -56.72 -37.28 70.75 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 113.171 -1.832 . . . . 0.0 109.737 174.566 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.947 ' HG2' ' O ' ' A' ' 68' ' ' PHE . 23.7 ptm -76.33 -23.5 54.26 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 123.731 0.644 . . . . 0.0 109.347 176.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.506 ' O ' ' HG2' ' A' ' 76' ' ' MET . 91.9 mtp -87.57 -18.59 29.37 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.298 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.625 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -83.6 -25.76 30.58 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 70' ' ' THR . 3.9 ppt_? -90.38 -30.35 17.47 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.744 ' HD2' ' O ' ' A' ' 71' ' ' MET . 0.0 OUTLIER -74.85 -12.7 60.44 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.506 ' HG2' ' O ' ' A' ' 72' ' ' MET . 26.6 ptm -117.31 -26.21 6.8 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -177.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.625 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 29.0 mmtt -73.43 -35.73 65.84 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -91.15 -25.02 19.77 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.4 t -75.47 56.13 0.85 Allowed 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.541 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 8.5 m-20 60.2 123.78 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.026 0.93 . . . . 0.0 112.596 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.549 ' HA ' ' OE2' ' A' ' 84' ' ' GLU . 53.0 m -83.13 -13.95 54.55 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.882 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.498 ' O ' HD11 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -81.28 -43.83 18.6 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.82 0.819 . . . . 0.0 109.518 -179.696 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.621 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 37.5 mt-10 -70.17 -18.74 63.21 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 113.712 -1.585 . . . . 0.0 112.395 178.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.549 ' OE2' ' HA ' ' A' ' 81' ' ' SER . 39.7 mt-10 -63.69 -22.62 67.0 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.498 HD11 ' O ' ' A' ' 82' ' ' GLU . 3.3 mp -87.8 -49.54 14.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.134 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.83 -16.96 3.0 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.774 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.621 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 44.5 mt-10 -78.97 -20.99 47.78 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.218 0.607 . . . . 0.0 111.586 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.64 -19.71 48.5 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.482 ' HE2' ' O ' ' A' ' 98' ' ' GLY . 6.4 m-85 -84.01 -21.19 31.75 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 174.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.402 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 8.0 ttt180 -76.7 -21.41 55.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 113.868 -1.515 . . . . 0.0 106.927 174.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 87' ' ' GLU . 40.6 t -87.84 -54.21 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 CA-C-N 114.246 -1.343 . . . . 0.0 112.03 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.543 ' CE1' HG12 ' A' ' 108' ' ' VAL . 77.0 m-85 -100.51 -44.66 5.8 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -177.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.72 ' CA ' HG12 ' A' ' 100' ' ' ILE . 2.3 t70 -65.04 90.66 0.09 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.898 0.856 . . . . 0.0 111.86 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.727 ' HZ3' ' HD1' ' A' ' 107' ' ' HIS . 19.8 mttt -88.49 -45.14 10.18 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 113.957 -1.474 . . . . 0.0 114.17 -178.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -71.71 1.69 6.42 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -175.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 48.09 29.79 6.95 Favored Glycine 0 N--CA 1.474 1.175 0 CA-C-N 114.272 -1.331 . . . . 0.0 114.977 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -98.84 -3.93 34.31 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.645 0.222 . . . . 0.0 111.415 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.482 ' O ' ' HE2' ' A' ' 89' ' ' PHE . . . 101.38 -18.78 53.16 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 121.353 -0.451 . . . . 0.0 112.629 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -122.34 124.1 42.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.441 -0.879 . . . . 0.0 111.226 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.72 HG12 ' CA ' ' A' ' 93' ' ' ASP . 28.5 mt -80.27 97.46 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.7 p -72.81 162.14 29.86 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.507 ' O ' HG12 ' A' ' 121' ' ' VAL . . . -57.92 -14.98 7.23 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 -177.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.99 -29.29 19.61 Favored 'General case' 0 CA--C 1.488 -1.432 0 CA-C-O 121.873 0.844 . . . . 0.0 109.556 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.981 ' O ' HG21 ' A' ' 108' ' ' VAL . 3.4 mm-40 -79.9 -40.33 28.48 Favored 'General case' 0 CA--C 1.483 -1.597 0 CA-C-N 112.668 -2.06 . . . . 0.0 111.292 -178.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.546 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 7.6 tt -65.48 -33.0 74.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.72 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -70.67 -46.23 63.59 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.03 -1.441 . . . . 0.0 108.851 175.592 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.727 ' HD1' ' HZ3' ' A' ' 94' ' ' LYS . 3.1 t-80 -67.25 -22.03 65.69 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.386 177.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.981 HG21 ' O ' ' A' ' 104' ' ' GLU . 17.1 t -71.75 -49.84 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.905 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 176.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.759 ' SD ' HD23 ' A' ' 116' ' ' LEU . 16.1 mtt -55.89 -41.79 75.0 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 112.593 -2.094 . . . . 0.0 111.938 175.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.96 -19.15 64.16 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.537 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.92 -45.27 18.85 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.749 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.3 mt -79.23 -28.15 42.49 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.592 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 138.47 -6.45 3.29 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 117.773 -1.571 . . . . 0.0 116.74 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 109' ' ' MET . 4.9 mt-10 -101.15 152.08 21.06 Favored 'General case' 0 C--N 1.358 0.946 0 CA-C-N 120.953 2.376 . . . . 0.0 114.271 -178.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.425 ' O ' HD12 ' A' ' 116' ' ' LEU . 5.5 mttt -110.31 128.63 55.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 113.668 -1.606 . . . . 0.0 107.802 175.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.759 HD23 ' SD ' ' A' ' 109' ' ' MET . 1.3 tp -139.32 116.03 10.76 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.338 -1.301 . . . . 0.0 112.134 -176.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.803 ' O ' HG21 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -67.74 -176.31 0.63 Allowed 'General case' 0 C--N 1.347 0.473 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.153 179.721 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.507 ' N ' HG21 ' A' ' 117' ' ' THR . 16.0 t70 -73.22 -37.52 66.37 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.508 -1.224 . . . . 0.0 114.196 -177.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -86.19 -16.21 38.5 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.615 ' HG3' ' HG ' ' A' ' 116' ' ' LEU . 14.2 pt-20 -88.07 -17.19 31.63 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 123.042 0.214 . . . . 0.0 111.238 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.803 HG21 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -85.95 -30.2 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 O-C-N 123.376 0.423 . . . . 0.0 111.289 177.73 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -69.29 31.77 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.998 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.606 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 9.6 pt-20 -153.53 -11.47 0.15 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.82 -1.082 . . . . 0.0 113.005 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.561 ' SD ' ' HE1' ' A' ' 109' ' ' MET . 29.5 ttm -88.85 -37.16 15.57 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.061 0.544 . . . . 0.0 110.303 177.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.565 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 0.0 OUTLIER -86.48 -29.64 5.98 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.57 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.167 178.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.7 mtm180 -61.07 -27.32 68.27 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.955 0.883 . . . . 0.0 110.265 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.606 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 4.3 mm-40 -70.25 -27.88 64.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 113.326 -1.761 . . . . 0.0 109.808 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.554 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -102.82 -39.57 6.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.747 179.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.565 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.3 OUTLIER -61.49 126.98 29.3 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.222 179.031 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 44.9 mt -89.94 -47.56 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.868 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -72.71 -24.95 61.06 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.41 49.1 9.62 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 115.912 -0.585 . . . . 0.0 113.928 178.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -107.65 -12.76 15.19 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.731 0.301 . . . . 0.0 111.116 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.67 19.79 50.3 Favored Glycine 0 CA--C 1.504 -0.613 0 CA-C-N 115.57 -0.741 . . . . 0.0 113.487 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -137.74 113.64 9.81 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.866 -1.167 . . . . 0.0 108.137 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.58 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 1.3 t -92.15 141.07 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -175.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.6 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 2.1 t30 -107.11 -162.92 0.87 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 114.123 -1.399 . . . . 0.0 110.857 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.6 ' H ' ' ND2' ' A' ' 137' ' ' ASN . 61.3 m-85 -64.12 -64.31 0.92 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.704 -1.134 . . . . 0.0 111.244 178.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.28 -20.09 51.42 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.58 ' OE1' ' HA ' ' A' ' 136' ' ' VAL . 4.8 mt-10 -86.31 -41.28 14.68 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 123.474 0.484 . . . . 0.0 110.436 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.498 ' O ' ' HG3' ' A' ' 144' ' ' MET . 68.7 t80 -74.14 -22.59 59.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.776 175.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.53 ' O ' ' HG3' ' A' ' 145' ' ' MET . 41.8 t -85.39 -43.96 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.44 -178.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.501 ' O ' ' N ' ' A' ' 147' ' ' ALA . 0.2 OUTLIER -56.19 -35.64 67.48 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.534 0.522 . . . . 0.0 111.633 178.444 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.498 ' HG3' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -63.73 -18.64 64.24 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 179.731 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.53 ' HG3' ' O ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -89.75 -5.49 56.93 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 177.128 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.1 t -130.42 -32.46 1.75 Allowed 'General case' 0 C--N 1.351 0.671 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -45.68 -32.21 2.32 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt . . . . . 0 C--O 1.252 1.188 0 CA-C-O 118.52 -0.752 . . . . 0.0 111.312 179.877 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.468 0.175 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -106.53 150.32 26.25 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.993 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . 0.462 ' HB3' ' OE1' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -98.58 109.29 22.07 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.913 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . 0.462 ' N ' ' HE2' ' A' ' 124' ' ' MET . 10.3 tptm -146.12 -70.11 0.26 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.852 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 81.5 p -141.4 174.52 10.47 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.271 0.229 . . . . 0.0 111.569 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' PHE . . . . . 0.513 ' CE2' HD13 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -67.68 -27.07 66.53 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.771 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . 0.465 ' HG3' ' HB2' ' A' ' 144' ' ' MET . 9.4 mptt -54.86 -50.63 68.2 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.892 0.877 . . . . 0.0 112.0 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -76.38 -35.44 58.65 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' VAL . . . . . . . . . . . . . 12.3 m -72.01 -39.36 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 120.728 0.299 . . . . 0.0 111.157 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' B' ' 162' ' ' LYS . . . -74.26 -39.3 63.1 Favored 'General case' 0 C--N 1.345 0.406 0 C-N-CA 123.468 0.707 . . . . 0.0 112.039 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -59.66 -28.0 66.87 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.95 -35.96 56.89 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.642 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 7.1 p -118.98 31.78 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.277 0 O-C-N 123.415 0.447 . . . . 0.0 111.65 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 20.9 tttt -80.76 -42.5 21.69 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.343 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' ILE . . . . . 0.492 HG13 ' OG ' ' B' ' 166' ' ' SER . 1.6 tt -108.96 43.44 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 CA-C-O 121.44 0.638 . . . . 0.0 110.663 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 55.8 m -95.34 -29.88 14.22 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.609 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . -89.36 18.3 5.35 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 123.347 0.405 . . . . 0.0 111.876 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' SER . . . . . 0.492 ' OG ' HG13 ' B' ' 163' ' ' ILE . 68.4 m -89.94 -21.02 22.66 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.902 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 8.1 tp -88.6 -10.44 48.71 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 123.311 0.382 . . . . 0.0 111.296 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 64.2 mtt -98.87 130.47 45.28 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.341 0.401 . . . . 0.0 110.79 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -157.56 -151.43 6.02 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.6 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.507 -0.758 . . . . 0.0 111.087 -179.93 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 111.289 0.107 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -136.49 103.52 5.28 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.073 0.463 . . . . 0.0 111.169 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -91.58 159.17 16.03 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.873 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.491 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -105.51 -112.71 0.26 Allowed 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.765 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.539 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 17.2 p -101.29 -173.68 2.42 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 123.838 0.855 . . . . 0.0 110.359 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 10' ' ' ALA . 47.0 mt-10 -59.41 -23.87 62.99 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.539 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 12.4 pt-20 -54.43 -33.32 59.24 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.288 0.566 . . . . 0.0 111.707 178.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.759 ' HA ' ' HB2' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -77.24 -45.15 27.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.787 177.901 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.443 ' N ' ' HG3' ' A' ' 8' ' ' GLN . 9.6 mm -67.39 -32.68 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 CA-C-N 113.969 -1.469 . . . . 0.0 112.312 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 6' ' ' GLU . . . -81.47 -42.8 19.77 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -134.13 -35.77 0.93 Allowed 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 119.906 1.23 . . . . 0.0 114.021 -176.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.759 ' HB2' ' HA ' ' A' ' 8' ' ' GLN . 44.2 m-85 -62.83 -13.91 39.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.926 0.393 . . . . 0.0 110.765 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.705 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 5.0 pttt -72.83 -39.31 66.69 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.705 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 12.7 mt-10 -70.56 -47.84 58.3 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 113.613 -1.63 . . . . 0.0 110.879 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.707 ' O ' HG11 ' A' ' 35' ' ' VAL . . . -58.46 -17.85 24.05 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.858 0.837 . . . . 0.0 109.272 176.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.653 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 75.9 t80 -86.15 -52.07 5.9 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 113.777 -1.556 . . . . 0.0 109.263 176.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.487 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 53.3 m -87.89 -12.85 43.57 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -177.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.603 ' N ' ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -62.0 -31.43 71.81 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.239 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -129.5 -5.92 4.72 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.653 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -77.68 56.54 1.49 Allowed 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -177.521 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -85.09 -17.81 36.21 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 178.314 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.602 ' OD1' ' HB2' ' A' ' 24' ' ' ASP . 0.3 OUTLIER -70.91 -23.45 62.27 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.131 0.491 . . . . 0.0 111.324 178.724 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.2 45.0 32.95 Favored Glycine 0 N--CA 1.472 1.093 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.602 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 0.5 OUTLIER -111.81 23.22 14.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.23 -1.485 . . . . 0.0 112.702 -175.558 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.15 -84.8 1.54 Allowed Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -177.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -115.15 177.68 4.57 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.78 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.519 ' O ' ' HB ' ' A' ' 63' ' ' ILE . 1.0 OUTLIER -101.75 152.18 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -176.232 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.528 ' H ' ' HG1' ' A' ' 28' ' ' THR . 0.2 OUTLIER -51.97 156.61 1.48 Allowed 'General case' 0 C--N 1.344 0.334 0 C-N-CA 124.457 1.103 . . . . 0.0 113.73 -178.757 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.01 -55.06 28.94 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.859 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -57.3 -13.72 3.62 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.246 177.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.559 ' O ' HG21 ' A' ' 35' ' ' VAL . 28.7 mt-10 -103.84 -30.13 10.56 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.762 -178.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.513 HD11 ' CE1' ' A' ' 68' ' ' PHE . 14.3 tp -54.2 -38.25 65.43 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.895 0.478 . . . . 0.0 112.24 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.799 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -57.26 -40.29 91.54 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 177.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 m -74.92 -29.7 61.05 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 114.605 -0.797 . . . . 0.0 112.482 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.707 HG11 ' O ' ' A' ' 15' ' ' ALA . 2.0 t -74.99 -26.2 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 176.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.647 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 31.7 mmt -74.99 -40.53 60.64 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 113.198 -1.819 . . . . 0.0 110.935 175.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.799 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 13.8 mtt180 -85.21 -25.75 27.16 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.5 t -64.21 -8.22 11.8 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.906 0.86 . . . . 0.0 112.224 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.5 mt -93.94 -7.17 43.73 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.331 -1.759 . . . . 0.0 109.679 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.51 1.86 55.49 Favored Glycine 0 CA--C 1.491 -1.441 0 CA-C-O 122.506 1.059 . . . . 0.0 114.334 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.647 ' HB2' ' O ' ' A' ' 36' ' ' MET . 51.6 mt-30 -78.28 139.12 38.89 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 111.826 -2.187 . . . . 0.0 112.094 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -117.78 75.46 10.07 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.315 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -78.56 -177.93 4.26 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.98 2.453 . . . . 0.0 111.976 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 m -99.72 158.93 15.43 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.518 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 28.2 mt-10 -80.85 -28.14 36.18 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.452 177.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.85 -35.48 72.42 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 113.412 -1.722 . . . . 0.0 109.845 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -79.03 -30.3 44.06 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 114.041 -1.436 . . . . 0.0 108.947 176.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.664 ' O ' HD11 ' A' ' 52' ' ' ILE . 0.4 OUTLIER -68.86 -19.72 64.26 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.992 174.677 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.848 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 53.5 mt-30 -99.88 -15.56 18.33 Favored 'General case' 0 CA--C 1.48 -1.716 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.14 178.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.41 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 4.3 t70 -85.55 -32.58 22.07 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 112.025 -2.352 . . . . 0.0 109.712 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.483 ' CG ' ' HZ2' ' A' ' 75' ' ' LYS . 29.6 mmm -86.52 -35.14 19.73 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.135 177.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.664 HD11 ' O ' ' A' ' 48' ' ' LEU . 1.6 mp -71.75 -25.68 24.7 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 175.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.848 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.1 t30 -75.74 -33.9 60.29 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.721 175.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 50' ' ' ASP . 39.4 mt-10 -81.14 -42.5 20.81 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.591 ' C ' ' H ' ' A' ' 57' ' ' ALA . 78.5 t -84.65 -49.32 16.0 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -72.53 39.47 0.08 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.99 0.9 . . . . 0.0 110.132 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.591 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -84.44 -5.72 59.31 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 114.107 -1.406 . . . . 0.0 112.624 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -105.24 -31.74 8.96 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 112.21 -2.268 . . . . 0.0 110.727 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.3 49.73 4.57 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-N 115.994 -0.548 . . . . 0.0 113.458 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -110.0 -21.58 12.25 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.05 27.14 73.38 Favored Glycine 0 N--CA 1.466 0.683 0 O-C-N 123.615 0.572 . . . . 0.0 113.94 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.64 154.65 43.76 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.984 0.514 . . . . 0.0 110.977 -179.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.582 HG21 ' N ' ' A' ' 64' ' ' ASP . 43.6 mm -97.72 161.6 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.441 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.582 ' N ' HG21 ' A' ' 63' ' ' ILE . 9.3 m-20 -127.82 148.71 50.46 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.397 1.079 . . . . 0.0 108.53 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.55 ' CG ' ' HD3' ' A' ' 66' ' ' PRO . 12.0 p90 -90.36 -39.19 0.41 Allowed Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -177.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.55 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 11.4 Cg_exo -72.56 -17.82 26.22 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 121.93 1.753 . . . . 0.0 112.879 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -108.14 -29.48 8.91 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -177.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.578 ' O ' ' HB2' ' A' ' 71' ' ' MET . 0.0 OUTLIER -85.16 -20.56 30.05 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -176.465 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.506 HD22 ' CG ' ' A' ' 12' ' ' PHE . 71.2 mt -78.71 -36.62 43.14 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 122.389 1.09 . . . . 0.0 109.868 177.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -53.03 -31.47 41.51 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 111.941 -2.39 . . . . 0.0 108.433 172.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.578 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 22.4 mmt -65.98 -34.35 77.89 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 114.572 -1.194 . . . . 0.0 109.76 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.726 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -81.68 -22.22 37.61 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.458 177.13 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -73.39 -37.63 65.91 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.499 ' CD ' ' HA ' ' A' ' 71' ' ' MET . 2.8 ptm180 -77.84 -17.99 56.79 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 178.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.726 ' HD2' ' HA ' ' A' ' 72' ' ' MET . 30.5 mttt -72.44 -14.36 61.67 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 175.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 6.8 ptt? -119.72 -33.65 3.96 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 123.511 0.507 . . . . 0.0 112.018 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 34.3 mttt -76.2 -20.58 57.34 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.864 -1.062 . . . . 0.0 113.552 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -100.75 -29.74 12.1 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.7 t -81.0 48.16 1.08 Allowed 'General case' 0 CA--C 1.548 0.882 0 CA-C-O 121.132 0.492 . . . . 0.0 112.185 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 62.01 119.99 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.778 0.831 . . . . 0.0 111.97 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.546 ' HA ' ' OE1' ' A' ' 84' ' ' GLU . 13.2 t -83.2 -13.73 54.81 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.285 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -87.11 -45.81 10.36 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.77 0.795 . . . . 0.0 109.297 179.737 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.435 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 37.8 mt-10 -75.89 -18.08 59.53 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 113.63 -1.623 . . . . 0.0 113.038 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.546 ' OE1' ' HA ' ' A' ' 81' ' ' SER . 11.2 pt-20 -60.83 -22.39 64.15 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.6 mp -87.73 -50.97 13.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.607 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -56.8 -16.87 7.39 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.528 ' OE1' ' HB3' ' B' ' 164' ' ' SER . 2.6 pt-20 -79.38 -20.96 46.41 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 123.384 0.428 . . . . 0.0 110.868 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.517 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -73.95 -20.79 60.26 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.377 177.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.434 ' O ' ' HB3' ' A' ' 93' ' ' ASP . 81.8 m-85 -82.27 -20.89 36.63 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 174.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.502 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 8.2 ttt180 -76.18 -18.9 58.87 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 174.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.517 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 37.9 t -87.79 -50.51 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 CA-C-N 114.166 -1.379 . . . . 0.0 112.09 177.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.523 ' CD2' HG23 ' A' ' 108' ' ' VAL . 14.4 m-85 -100.25 -45.85 5.48 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -176.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.688 ' CA ' HG12 ' A' ' 100' ' ' ILE . 3.1 t70 -64.3 89.78 0.06 Allowed 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 121.821 0.82 . . . . 0.0 111.61 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.59 -48.71 7.37 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.141 -1.39 . . . . 0.0 114.0 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -71.22 3.51 3.54 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -175.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 47.73 29.33 5.88 Favored Glycine 0 N--CA 1.474 1.2 0 CA-C-N 114.245 -1.343 . . . . 0.0 115.247 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -98.22 -4.11 36.07 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.812 0.306 . . . . 0.0 111.165 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 99.18 -19.02 55.76 Favored Glycine 0 C--N 1.338 0.66 0 CA-C-N 116.209 -0.451 . . . . 0.0 112.482 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -114.55 118.37 33.53 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.277 -0.961 . . . . 0.0 110.385 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.688 HG12 ' CA ' ' A' ' 93' ' ' ASP . 57.7 mt -77.52 87.91 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.3 t -61.75 163.79 6.96 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.166 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.564 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -61.07 -13.35 16.34 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.603 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.4 -27.68 21.43 Favored 'General case' 0 CA--C 1.491 -1.321 0 CA-C-O 121.686 0.755 . . . . 0.0 109.483 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 1.033 ' O ' HG21 ' A' ' 108' ' ' VAL . 20.4 mt-10 -80.05 -44.34 20.25 Favored 'General case' 0 CA--C 1.483 -1.626 0 CA-C-N 112.905 -1.952 . . . . 0.0 111.688 -177.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.62 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -68.43 -26.15 65.37 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.29 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.737 HH11 ' H ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -76.73 -44.39 33.46 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 113.638 -1.619 . . . . 0.0 108.555 175.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.603 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 5.7 t60 -67.01 -21.85 65.92 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 1.033 HG21 ' O ' ' A' ' 104' ' ' GLU . 25.5 t -70.42 -51.61 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 175.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.715 ' SD ' HD22 ' A' ' 116' ' ' LEU . 16.8 mtt -56.36 -41.85 76.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 112.992 -1.913 . . . . 0.0 112.227 175.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.79 -19.1 64.29 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.405 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.01 -45.12 18.96 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.601 176.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.2 mt -79.21 -28.2 42.57 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.872 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 140.18 -7.34 2.88 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 117.704 -1.609 . . . . 0.0 116.833 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 109' ' ' MET . 5.0 mt-10 -100.69 150.96 22.21 Favored 'General case' 0 C--N 1.358 0.947 0 CA-C-N 120.955 2.378 . . . . 0.0 114.568 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -109.4 128.16 54.92 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 113.276 -1.783 . . . . 0.0 106.998 175.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.737 ' H ' HH11 ' A' ' 106' ' ' ARG . 1.8 tp -130.91 120.75 24.05 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.713 -175.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.764 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -74.51 -175.85 2.53 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.96 179.556 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.537 ' N ' HG21 ' A' ' 117' ' ' THR . 16.0 t70 -75.01 -37.25 61.87 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.51 -1.223 . . . . 0.0 114.232 -177.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -89.14 -15.88 32.76 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.598 ' HG3' ' HG ' ' A' ' 116' ' ' LEU . 14.8 pt-20 -86.73 -16.49 36.26 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 123.099 0.249 . . . . 0.0 111.051 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -83.63 -28.93 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.993 178.163 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.52 30.73 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.819 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.571 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 9.8 pt-20 -148.22 -13.93 0.35 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.796 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.529 ' O ' ' HD1' ' B' ' 154' ' ' PHE . 1.9 ttm -88.15 -35.84 17.19 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.233 0.613 . . . . 0.0 109.956 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.797 ' O ' ' N ' ' A' ' 129' ' ' ASP . 0.0 OUTLIER -80.37 -35.01 15.06 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.849 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.334 178.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -58.57 -26.9 64.1 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.894 0.854 . . . . 0.0 110.615 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.571 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 16.0 mm-40 -68.87 -31.39 70.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 113.364 -1.744 . . . . 0.0 109.861 177.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.639 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -108.43 -36.77 6.14 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.295 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.797 ' N ' ' O ' ' A' ' 125' ' ' ILE . 0.2 OUTLIER -60.93 127.73 33.01 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.131 178.71 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.9 mm -89.38 -50.75 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.553 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -81.47 -25.17 36.27 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.06 49.13 6.52 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 115.884 -0.598 . . . . 0.0 113.784 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -96.91 -12.89 22.87 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.833 0.349 . . . . 0.0 110.978 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.46 13.04 57.7 Favored Glycine 0 CA--C 1.502 -0.757 0 CA-C-N 115.397 -0.82 . . . . 0.0 113.687 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -140.51 119.35 12.56 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 124.41 1.084 . . . . 0.0 108.227 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.56 HG23 ' OD2' ' A' ' 129' ' ' ASP . 0.9 OUTLIER -90.39 129.42 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -176.601 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -84.19 -163.3 0.77 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.801 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.521 ' O ' HG21 ' A' ' 142' ' ' VAL . 50.5 m-85 -75.33 -56.25 4.9 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.479 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.96 -20.23 65.04 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.639 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 7.1 mt-10 -87.05 -39.39 15.66 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 121.276 0.56 . . . . 0.0 110.529 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -74.23 -22.93 59.13 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.611 -1.177 . . . . 0.0 108.744 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.526 ' O ' ' HG2' ' A' ' 145' ' ' MET . 24.3 t -84.17 -46.82 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.547 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.767 ' O ' ' N ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -55.54 -31.81 62.42 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 123.858 0.724 . . . . 0.0 109.689 176.532 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -26.33 61.75 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.362 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.526 ' HG2' ' O ' ' A' ' 142' ' ' VAL . 8.4 ptt? -88.35 -4.03 58.74 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 123.431 0.457 . . . . 0.0 110.479 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.7 t -137.55 -22.98 1.1 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.767 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -51.37 -34.07 32.58 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 20.1 pttp . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.123 -0.941 . . . . 0.0 111.296 179.817 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 21.1 p . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.492 0.187 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -133.03 -45.36 0.85 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.153 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . 0.472 ' O ' ' HE2' ' A' ' 124' ' ' MET . 66.2 mttm -133.0 -28.41 1.55 Allowed 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.399 0.437 . . . . 0.0 111.462 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . 0.444 ' O ' ' HG3' ' A' ' 124' ' ' MET . 84.2 mttt 64.61 139.57 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.065 0.946 . . . . 0.0 112.49 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.569 ' O ' HG21 ' B' ' 157' ' ' VAL . 55.1 p -133.09 171.19 14.32 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.952 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' PHE . . . . . 0.529 ' HD1' ' O ' ' A' ' 124' ' ' MET . 2.5 m-85 -58.16 -28.11 64.43 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 117.834 0.288 . . . . 0.0 110.856 178.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . 0.551 ' HE3' ' O ' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -72.29 -45.62 59.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.214 0.605 . . . . 0.0 111.446 178.55 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -76.61 -37.16 56.86 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' VAL . . . . . 0.569 HG21 ' O ' ' B' ' 153' ' ' THR . 29.2 m -72.02 -40.8 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 122.602 0.361 . . . . 0.0 111.613 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . 0.418 ' N ' HG23 ' B' ' 157' ' ' VAL . . . -74.05 -32.69 63.41 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.098 0.559 . . . . 0.0 112.292 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' B' ' 155' ' ' LYS . 2.9 t30 -56.81 -37.41 71.15 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.393 0.433 . . . . 0.0 111.288 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.44 -28.4 52.46 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.159 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 9.3 p -115.75 26.34 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.286 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' LYS . . . . . . . . . . . . . 19.8 mtmt -77.08 -5.7 49.92 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 120.88 0.371 . . . . 0.0 110.886 178.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' ILE . . . . . 0.58 HG12 ' N ' ' B' ' 169' ' ' GLY . 2.0 mp -115.39 110.67 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' SER . . . . . 0.528 ' HB3' ' OE1' ' A' ' 87' ' ' GLU . 12.0 t -115.77 -27.11 7.15 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' ALA . . . . . 0.673 ' HB1' ' SD ' ' B' ' 168' ' ' MET . . . -82.7 18.91 1.42 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.052 0.453 . . . . 0.0 112.179 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 66.4 m 64.06 130.05 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.342 1.057 . . . . 0.0 113.483 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.584 ' O ' ' HD3' ' A' ' 75' ' ' LYS . 25.2 mt 54.27 22.41 3.67 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 177.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' MET . . . . . 0.673 ' SD ' ' HB1' ' B' ' 165' ' ' ALA . 46.4 mtp -69.31 -26.2 64.6 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.818 0.447 . . . . 0.0 111.446 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . 0.58 ' N ' HG12 ' B' ' 163' ' ' ILE . . . 172.97 42.56 0.04 OUTLIER Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.514 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 11.8 p . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.484 -0.769 . . . . 0.0 111.117 179.942 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.44 0.162 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -128.33 108.16 10.35 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.738 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -91.38 153.08 20.13 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.582 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.57 -108.8 0.29 Allowed 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.665 ' CG2' ' H ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -102.26 -173.82 2.43 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.481 ' N ' HG21 ' A' ' 5' ' ' THR . 45.3 mt-10 -60.11 -15.35 22.7 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 122.568 0.347 . . . . 0.0 110.993 176.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.665 ' H ' ' CG2' ' A' ' 5' ' ' THR . 5.5 pt-20 -62.17 -30.01 70.76 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.741 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.501 ' O ' ' HD2' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -77.99 -45.82 22.73 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.013 -1.448 . . . . 0.0 109.147 177.894 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.8 mm -60.73 -34.87 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.371 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.57 -34.9 63.02 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.515 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 41.2 mt-10 -114.35 -18.38 11.57 Favored 'General case' 0 C--N 1.345 0.404 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.501 ' HD2' ' O ' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -73.62 -15.23 61.27 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.325 0.966 . . . . 0.0 110.344 178.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.706 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -82.31 -40.69 21.1 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.097 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.706 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 0.8 OUTLIER -86.51 -39.56 16.13 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.158 -178.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.52 ' O ' HG12 ' A' ' 35' ' ' VAL . . . -66.44 -18.67 65.49 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.431 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 48.5 t80 -86.39 -49.88 7.31 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.684 176.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.435 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 8.7 t -87.63 -12.92 44.13 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 -176.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -69.53 -28.71 66.25 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.606 0.639 . . . . 0.0 112.307 -179.373 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.57 ' CD1' HG22 ' A' ' 35' ' ' VAL . 5.5 m-85 -134.91 -2.55 2.6 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 23.5 t70 -83.44 55.2 3.09 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 119.301 0.955 . . . . 0.0 112.396 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.475 ' N ' ' HD2' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -87.04 -20.63 26.91 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 178.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.72 -22.41 61.63 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.394 0.616 . . . . 0.0 110.585 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.16 40.99 27.93 Favored Glycine 0 N--CA 1.47 0.966 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.759 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.5 23.23 10.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.03 -1.585 . . . . 0.0 112.536 -176.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.04 -81.02 1.78 Allowed Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.865 -177.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -113.76 178.31 4.33 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 122.394 0.278 . . . . 0.0 110.469 178.013 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -76.74 149.0 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -177.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.522 ' H ' ' HG1' ' A' ' 28' ' ' THR . 0.7 OUTLIER -67.47 161.8 24.6 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -179.569 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.464 ' HA ' HD11 ' A' ' 63' ' ' ILE . 1.0 OUTLIER -78.26 -55.81 4.96 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.122 -179.824 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -55.76 -13.75 1.9 Allowed 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.726 0.641 . . . . 0.0 111.137 177.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.473 ' O ' HG21 ' A' ' 35' ' ' VAL . 25.5 mt-10 -114.75 -16.65 11.75 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.234 -178.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.502 ' HA ' HG21 ' A' ' 35' ' ' VAL . 13.2 tp -53.26 -41.38 65.45 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.332 0.653 . . . . 0.0 112.465 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.756 ' O ' ' HD3' ' A' ' 37' ' ' ARG . . . -55.83 -39.37 77.3 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 177.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.5 m -75.62 -29.71 59.3 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.488 -0.856 . . . . 0.0 112.547 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.57 HG22 ' CD1' ' A' ' 19' ' ' PHE . 1.2 t -74.68 -27.48 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 176.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.635 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 42.3 mtt -73.18 -42.3 62.87 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 113.0 -1.909 . . . . 0.0 111.006 176.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.756 ' HD3' ' O ' ' A' ' 33' ' ' GLY . 12.1 mtp180 -80.97 -29.71 35.25 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 75.8 m -67.87 -8.71 38.73 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.913 0.863 . . . . 0.0 111.971 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.0 mt -92.11 -7.25 49.11 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.285 -1.78 . . . . 0.0 109.645 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.4 1.44 50.53 Favored Glycine 0 CA--C 1.491 -1.434 0 CA-C-O 122.264 0.925 . . . . 0.0 114.933 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.635 ' HB2' ' O ' ' A' ' 36' ' ' MET . 57.3 mt-30 -85.66 138.02 32.43 Favored 'General case' 0 C--N 1.278 -2.523 0 CA-C-N 112.212 -1.994 . . . . 0.0 112.048 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -117.24 76.65 9.13 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.195 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.1 178.25 5.42 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 123.035 2.49 . . . . 0.0 112.361 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.1 m -98.87 162.86 12.86 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.495 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 27.4 mt-10 -80.59 -28.78 37.02 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 121.555 0.693 . . . . 0.0 110.044 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.94 -39.49 66.18 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 113.758 -1.564 . . . . 0.0 110.261 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.582 ' HA ' ' OD2' ' A' ' 50' ' ' ASP . 0.9 OUTLIER -75.58 -28.82 59.1 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.664 176.307 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.801 ' O ' HG12 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -63.05 -23.09 67.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.094 174.334 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.659 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 20.2 mm-40 -89.68 -18.71 25.92 Favored 'General case' 0 CA--C 1.478 -1.825 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.455 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.582 ' OD2' ' HA ' ' A' ' 47' ' ' GLU . 15.2 m-20 -76.44 -30.77 57.52 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-N 112.003 -2.362 . . . . 0.0 108.837 175.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 35.1 mmt -86.6 -31.34 21.21 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.011 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.801 HG12 ' O ' ' A' ' 48' ' ' LEU . 37.2 mm -73.27 -27.23 23.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.574 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 175.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.659 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.4 t-20 -76.13 -35.03 59.44 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.457 176.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -87.32 -39.63 15.18 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.598 ' C ' ' H ' ' A' ' 57' ' ' ALA . 55.6 t -74.39 -42.79 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -72.16 34.91 0.06 Allowed 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.839 0.828 . . . . 0.0 110.734 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.598 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -86.78 -6.63 58.76 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 114.352 -1.294 . . . . 0.0 112.25 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -113.44 -35.59 5.22 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 112.027 -2.352 . . . . 0.0 110.741 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.59 45.89 5.95 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.766 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -110.19 -21.6 12.17 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.01 26.86 69.91 Favored Glycine 0 N--CA 1.466 0.661 0 CA-C-N 115.883 -0.599 . . . . 0.0 114.024 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.43 171.14 14.47 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 123.099 0.56 . . . . 0.0 110.871 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.464 HD11 ' HA ' ' A' ' 29' ' ' THR . 4.4 mp -125.16 95.63 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.477 ' O ' ' HD2' ' A' ' 68' ' ' PHE . 9.3 m-20 -53.44 149.15 8.04 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.159 175.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.505 ' HA ' ' CD2' ' A' ' 68' ' ' PHE . 25.6 p90 -82.91 -38.59 0.77 Allowed Pre-proline 0 N--CA 1.478 0.94 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -177.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.497 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 12.7 Cg_exo -70.46 -17.37 34.46 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 121.939 1.759 . . . . 0.0 112.901 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -101.52 -19.34 15.55 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.848 ' O ' ' HG2' ' A' ' 71' ' ' MET . 3.8 p90 -84.82 -42.71 14.85 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -177.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 73' ' ' ALA . 3.8 mt -63.11 -31.97 73.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.569 0.699 . . . . 0.0 110.771 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.521 ' O ' ' HD3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -57.21 -35.64 69.89 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 113.509 -1.678 . . . . 0.0 109.567 174.458 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.848 ' HG2' ' O ' ' A' ' 68' ' ' PHE . 10.3 ptt? -72.92 -27.49 61.89 Favored 'General case' 0 C--N 1.345 0.412 0 O-C-N 123.789 0.68 . . . . 0.0 109.184 176.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.568 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 68.5 mtt -85.41 -20.23 30.16 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.776 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.504 ' O ' ' HG3' ' A' ' 77' ' ' LYS . . . -76.24 -37.41 57.69 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.646 ' NE ' ' HA ' ' A' ' 71' ' ' MET . 8.7 ptt180 -77.04 -18.13 58.31 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 123.562 0.539 . . . . 0.0 112.161 178.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.679 ' HD2' ' O ' ' A' ' 71' ' ' MET . 15.0 mttm -76.95 -14.58 59.84 Favored 'General case' 0 C--N 1.348 0.519 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 176.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.572 ' O ' HG21 ' A' ' 79' ' ' THR . 14.4 ptt? -120.2 -22.97 6.4 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -177.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 73' ' ' ALA . 56.1 mttt -64.2 -13.79 51.09 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -104.19 -29.44 10.82 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.572 HG21 ' O ' ' A' ' 76' ' ' MET . 7.9 t -68.04 103.88 1.62 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.057 0.456 . . . . 0.0 111.759 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.601 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 9.1 m-20 -46.28 147.16 1.18 Allowed 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.784 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.48 ' HA ' ' OE2' ' A' ' 84' ' ' GLU . 13.2 t -71.89 -13.68 61.73 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.717 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.595 ' O ' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -80.03 -46.82 15.9 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.59 0.71 . . . . 0.0 109.819 -179.37 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.457 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 38.5 mt-10 -73.33 -18.34 61.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.941 -1.481 . . . . 0.0 112.489 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.601 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 40.7 mt-10 -66.74 -20.93 66.06 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.595 HD13 ' O ' ' A' ' 82' ' ' GLU . 1.7 mt -87.89 -55.64 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.59 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.64 ' O ' ' HD1' ' A' ' 89' ' ' PHE . 9.7 mtt180 -60.82 -16.77 44.63 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.556 ' O ' HG23 ' A' ' 91' ' ' VAL . 2.7 pt-20 -78.38 -20.13 51.91 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.52 -21.48 64.58 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.777 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.64 ' HD1' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -84.45 -20.74 31.27 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 174.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -80.41 -24.97 39.29 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.211 -1.358 . . . . 0.0 108.353 175.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 87' ' ' GLU . 97.8 t -88.75 -54.51 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.558 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.556 ' CE2' HG12 ' A' ' 108' ' ' VAL . 13.7 m-85 -100.37 -44.46 5.9 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -175.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.686 ' CA ' HG12 ' A' ' 100' ' ' ILE . 15.8 t70 -62.87 94.76 0.07 Allowed 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.591 0.71 . . . . 0.0 111.36 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -87.3 -50.2 6.74 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.483 -1.235 . . . . 0.0 113.093 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -72.14 0.81 8.72 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -175.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.47 ' HA2' ' OD2' ' A' ' 93' ' ' ASP . . . 49.51 33.26 17.23 Favored Glycine 0 N--CA 1.473 1.117 0 CA-C-N 114.34 -1.3 . . . . 0.0 114.722 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -99.87 -5.56 28.22 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.89 -19.19 50.55 Favored Glycine 0 C--N 1.337 0.609 0 C-N-CA 121.481 -0.39 . . . . 0.0 112.787 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -119.2 119.65 34.75 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.477 -0.861 . . . . 0.0 110.258 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.686 HG12 ' CA ' ' A' ' 93' ' ' ASP . 45.9 mt -77.34 87.41 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.3 t -64.51 163.56 13.24 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.131 -0.94 . . . . 0.0 112.969 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.55 -14.42 8.03 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.65 -30.92 18.81 Favored 'General case' 0 CA--C 1.488 -1.406 0 CA-C-O 121.819 0.819 . . . . 0.0 109.248 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 1.021 ' O ' HG21 ' A' ' 108' ' ' VAL . 16.1 mt-10 -77.83 -40.88 38.93 Favored 'General case' 0 CA--C 1.483 -1.634 0 CA-C-N 112.73 -2.032 . . . . 0.0 110.152 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.724 HD12 ' SD ' ' A' ' 124' ' ' MET . 6.0 tt -64.09 -35.61 81.31 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.618 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -72.39 -43.12 64.39 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.203 -1.362 . . . . 0.0 108.649 175.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.493 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 2.9 t60 -67.61 -21.85 65.38 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.277 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 1.021 HG21 ' O ' ' A' ' 104' ' ' GLU . 28.8 t -72.31 -51.42 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.878 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 176.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.535 ' SD ' HD22 ' A' ' 116' ' ' LEU . 21.2 mtt -57.3 -41.23 79.45 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 112.579 -2.1 . . . . 0.0 111.943 175.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 m -69.43 -19.26 63.79 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.366 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.13 -44.81 21.27 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.422 176.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.2 mt -80.9 -28.2 35.97 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.207 -178.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 141.67 -10.32 2.64 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-O 117.738 -1.59 . . . . 0.0 116.836 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 109' ' ' MET . 5.0 mt-10 -100.82 152.13 20.87 Favored 'General case' 0 C--N 1.357 0.903 0 CA-C-N 120.912 2.356 . . . . 0.0 114.427 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.51 ' O ' HD13 ' A' ' 116' ' ' LEU . 4.3 mptp? -110.74 128.53 55.77 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 113.703 -1.59 . . . . 0.0 107.304 175.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.639 ' HG ' ' HG3' ' A' ' 120' ' ' GLU . 1.0 OUTLIER -139.71 115.91 10.46 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.893 -176.025 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.845 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -70.43 -175.82 1.1 Allowed 'General case' 0 C--N 1.348 0.523 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.433 179.154 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.512 ' N ' HG21 ' A' ' 117' ' ' THR . 17.2 t70 -69.41 -39.48 77.9 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -88.76 -16.52 31.98 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.639 ' HG3' ' HG ' ' A' ' 116' ' ' LEU . 14.7 pt-20 -85.05 -15.72 43.13 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 123.083 0.24 . . . . 0.0 111.204 178.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 117' ' ' THR . 0.1 OUTLIER -83.02 -23.33 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.179 177.688 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -70.61 29.41 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.93 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.629 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 11.7 pt-20 -136.36 -21.2 1.37 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.208 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.724 ' SD ' HD12 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -87.61 -32.08 19.49 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 176.452 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.767 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 3.0 mt -81.71 -27.6 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.727 -178.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -73.38 -29.26 62.51 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.649 0.738 . . . . 0.0 111.194 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.629 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 15.4 mm-40 -65.06 -36.72 85.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.846 -1.525 . . . . 0.0 110.569 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.636 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -96.48 -36.12 10.9 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.361 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.767 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.5 OUTLIER -60.45 116.61 4.44 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.26 -1.336 . . . . 0.0 113.92 -178.368 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.5 mt -91.01 -52.15 10.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 113.163 -1.835 . . . . 0.0 109.605 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -87.89 -24.45 23.64 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.029 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.38 49.8 3.59 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 115.718 -0.673 . . . . 0.0 113.689 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -78.86 -22.44 46.07 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.45 24.58 56.3 Favored Glycine 0 CA--C 1.505 -0.537 0 CA-C-N 115.03 -0.986 . . . . 0.0 114.536 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.68 ' O ' ' HB ' ' A' ' 136' ' ' VAL . 40.6 mt-30 -133.7 -68.42 0.57 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.71 -0.745 . . . . 0.0 110.348 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.68 ' HB ' ' O ' ' A' ' 135' ' ' GLN . 5.2 t 115.54 118.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 125.258 1.423 . . . . 0.0 110.907 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -94.06 -163.7 1.08 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.944 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.44 ' O ' HG23 ' A' ' 142' ' ' VAL . 79.0 m-85 -69.85 -51.92 29.3 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.825 178.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -66.92 -20.63 65.94 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.636 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 8.7 mt-10 -85.47 -38.0 19.11 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.492 ' O ' ' HG3' ' A' ' 144' ' ' MET . 86.6 t80 -75.35 -23.63 57.22 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.748 176.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.572 ' O ' ' HG2' ' A' ' 145' ' ' MET . 18.3 t -85.76 -37.01 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.743 -178.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.445 ' HA ' ' OG1' ' A' ' 146' ' ' THR . 8.7 mm100 -46.73 -31.25 2.83 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 178.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.508 ' HB3' ' CD2' ' B' ' 154' ' ' PHE . 0.0 OUTLIER -63.4 -25.69 68.4 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 118.559 0.618 . . . . 0.0 110.941 178.6 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.572 ' HG2' ' O ' ' A' ' 142' ' ' VAL . 11.2 ptm -83.68 -4.2 58.4 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.739 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.445 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 59.4 p -122.4 -44.59 2.24 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.136 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -48.44 -38.75 20.62 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 20.5 pttp . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.107 -0.949 . . . . 0.0 111.115 179.895 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.526 0.203 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . 0.524 ' HA ' ' OE2' ' A' ' 123' ' ' GLU . 7.5 mpt_? -128.98 129.64 45.66 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.703 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -100.75 -58.03 1.98 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.817 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -150.1 138.92 20.89 Favored 'General case' 0 C--N 1.346 0.425 0 O-C-N 123.264 0.352 . . . . 0.0 110.656 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.447 ' O ' HG13 ' B' ' 157' ' ' VAL . 67.7 p -108.35 176.1 5.24 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.31 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' PHE . . . . . 0.586 ' CD2' ' HB3' ' A' ' 128' ' ' ALA . 0.1 OUTLIER -67.47 -27.39 66.98 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 179.561 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . 0.494 ' HD2' ' CE1' ' B' ' 154' ' ' PHE . 0.8 OUTLIER -69.55 -34.56 74.37 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 120.76 0.314 . . . . 0.0 110.624 177.653 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -76.47 -35.18 58.58 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.441 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' VAL . . . . . 0.504 HG21 ' O ' ' B' ' 154' ' ' PHE . 11.1 m -71.44 -29.49 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 122.671 0.389 . . . . 0.0 110.686 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.22 -39.06 71.89 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.706 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -68.33 -22.5 64.69 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.742 0.306 . . . . 0.0 110.938 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.69 -43.89 29.71 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.643 HG21 ' SD ' ' B' ' 168' ' ' MET . 10.7 p -126.58 -30.7 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -178.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -62.96 94.08 0.06 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.55 0.69 . . . . 0.0 111.735 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 3.5 tp -154.12 5.49 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.918 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 49.2 m 64.96 -176.97 0.17 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.073 0.949 . . . . 0.0 111.715 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' ALA . . . . . 0.413 ' HB3' ' N ' ' B' ' 170' ' ' THR . . . -75.68 58.77 1.11 Allowed 'General case' 0 C--N 1.348 0.523 0 CA-C-O 121.807 0.813 . . . . 0.0 110.78 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 8.6 t -100.31 -60.61 1.5 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.662 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.522 HD21 ' NE2' ' A' ' 41' ' ' GLN . 4.0 tp -108.47 -23.65 11.76 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.051 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' MET . . . . . 0.643 ' SD ' HG21 ' B' ' 161' ' ' VAL . 61.8 mtt -93.42 -43.96 8.5 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.579 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -105.56 -152.4 20.7 Favored Glycine 0 C--N 1.34 0.755 0 C-N-CA 121.367 -0.444 . . . . 0.0 112.615 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' THR . . . . . 0.413 ' N ' ' HB3' ' B' ' 165' ' ' ALA . 20.1 p . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.447 -0.787 . . . . 0.0 111.038 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.401 0 N-CA-C 111.433 0.16 . . . . 0.0 111.433 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -100.17 126.92 46.5 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.42 0.45 . . . . 0.0 110.874 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.657 ' HA ' ' NE2' ' A' ' 8' ' ' GLN . 49.7 mt-30 -139.45 149.52 44.11 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.679 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.481 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -110.97 -111.06 0.33 Allowed 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.518 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 15.2 p -101.26 -173.57 2.4 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 123.727 0.811 . . . . 0.0 111.236 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -56.61 -26.77 56.59 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.518 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 10.5 pt-20 -58.33 -30.07 66.41 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 121.364 0.602 . . . . 0.0 111.314 178.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.657 ' NE2' ' HA ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -79.22 -44.42 21.85 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 114.205 -1.362 . . . . 0.0 109.141 177.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.516 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . 19.8 mm -60.06 -36.96 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.392 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.89 -34.66 59.99 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -107.29 -18.07 13.97 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.516 ' CE1' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -74.16 -16.04 61.01 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.478 0.581 . . . . 0.0 110.199 178.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.695 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 1.0 OUTLIER -81.77 -41.87 20.56 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.549 179.244 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.695 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 1.5 mt-10 -81.82 -37.81 26.48 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.558 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.439 ' O ' HG12 ' A' ' 35' ' ' VAL . . . -66.14 -24.04 66.59 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.917 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 25.8 t80 -87.0 -43.44 12.34 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.22 176.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 t -86.07 -12.78 49.25 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.41 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -71.41 -29.35 64.81 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.512 179.503 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -132.7 -6.86 3.2 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.917 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 1.6 m-20 -98.48 78.98 2.45 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.69 0.677 . . . . 0.0 110.14 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.429 ' N ' ' HD2' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -75.42 -40.04 58.23 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -178.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.47 -19.2 58.26 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.206 177.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.58 51.51 5.17 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 113.734 -1.576 . . . . 0.0 109.333 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.21 22.19 3.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 113.501 -1.349 . . . . 0.0 114.138 -175.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.39 -63.1 0.26 Allowed Glycine 0 CA--C 1.527 0.811 0 CA-C-N 115.265 -0.88 . . . . 0.0 114.434 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.715 HG22 ' N ' ' A' ' 64' ' ' ASP . 12.8 p -97.75 155.86 16.83 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 123.583 0.753 . . . . 0.0 112.038 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.487 HG21 ' OD2' ' A' ' 20' ' ' ASP . 1.2 pp -115.21 149.31 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.642 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.96 150.44 10.21 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -178.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.419 ' C ' ' H ' ' A' ' 31' ' ' GLU . 1.1 p -74.12 -55.83 5.63 Favored 'General case' 0 C--N 1.347 0.464 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -54.5 -13.75 1.05 Allowed 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.732 0.645 . . . . 0.0 111.292 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.419 ' H ' ' C ' ' A' ' 29' ' ' THR . 5.4 mm-40 -111.3 -16.84 13.29 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.02 -178.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.666 ' HA ' HG21 ' A' ' 35' ' ' VAL . 8.0 tp -52.73 -41.12 63.69 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.278 0.631 . . . . 0.0 112.458 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.756 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -56.12 -39.7 81.21 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 120.516 -0.849 . . . . 0.0 111.031 177.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.4 m -72.94 -32.1 65.05 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.735 -0.732 . . . . 0.0 112.624 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.666 HG21 ' HA ' ' A' ' 32' ' ' LEU . 0.4 OUTLIER -72.9 -27.07 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.03 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.561 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 21.0 mtm -76.37 -42.56 44.21 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 112.884 -1.962 . . . . 0.0 111.763 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.756 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 8.7 mtt180 -77.69 -30.12 51.72 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.1 m -68.12 -8.24 36.63 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.953 0.882 . . . . 0.0 112.009 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 35' ' ' VAL . 88.3 mt -94.11 -6.1 45.78 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.243 -1.798 . . . . 0.0 109.837 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.48 -8.93 22.24 Favored Glycine 0 CA--C 1.494 -1.239 0 N-CA-C 115.582 0.993 . . . . 0.0 115.582 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.561 ' HB2' ' O ' ' A' ' 36' ' ' MET . 20.5 mm-40 -73.84 140.45 45.77 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 112.739 -1.731 . . . . 0.0 111.919 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -128.15 61.95 55.37 Favored Pre-proline 0 CA--C 1.555 1.171 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.199 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.409 ' HD3' ' C ' ' A' ' 41' ' ' GLN . 3.3 Cg_endo -87.96 -177.76 2.01 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.99 2.46 . . . . 0.0 112.134 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.658 ' HG1' ' H ' ' A' ' 46' ' ' ALA . 7.5 t -99.65 -175.35 2.96 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 122.156 0.979 . . . . 0.0 110.667 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.502 ' N ' ' OG1' ' A' ' 44' ' ' THR . 8.6 mm-40 -81.36 -24.89 36.77 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 112.971 -1.922 . . . . 0.0 108.38 176.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.658 ' H ' ' HG1' ' A' ' 44' ' ' THR . . . -69.18 -26.05 64.66 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 113.66 -1.609 . . . . 0.0 111.42 -177.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -87.31 -30.37 20.9 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.672 177.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.648 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 12.4 mt -69.03 -19.55 64.11 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.016 174.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.868 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 48.8 mt-30 -99.08 -15.64 18.94 Favored 'General case' 0 CA--C 1.481 -1.691 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.269 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 2.6 t70 -87.2 -36.27 18.08 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 112.146 -2.297 . . . . 0.0 110.517 177.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.543 ' HA ' ' OE1' ' A' ' 54' ' ' GLU . 0.9 OUTLIER -86.66 -32.31 20.61 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.394 178.026 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.648 ' HB ' ' O ' ' A' ' 48' ' ' LEU . 1.5 mp -73.11 -25.51 21.8 Favored 'Isoleucine or valine' 0 C--N 1.344 0.364 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 175.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.868 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.0 t30 -72.23 -34.25 68.17 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.172 175.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.543 ' OE1' ' HA ' ' A' ' 51' ' ' MET . 6.0 pt-20 -87.94 -48.9 7.43 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.588 ' C ' ' H ' ' A' ' 57' ' ' ALA . 83.1 t -72.85 -46.65 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -178.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -72.64 39.47 0.08 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.971 0.891 . . . . 0.0 110.22 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.588 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -85.37 -5.64 59.29 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 114.131 -1.395 . . . . 0.0 112.206 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -104.7 -30.89 9.64 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 112.069 -2.332 . . . . 0.0 110.621 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.38 47.96 5.24 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.863 -0.608 . . . . 0.0 113.66 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -110.11 -22.13 11.94 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.61 26.67 72.05 Favored Glycine 0 N--CA 1.468 0.827 0 CA-C-N 115.875 -0.602 . . . . 0.0 114.316 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.91 158.46 43.92 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.375 0.67 . . . . 0.0 110.609 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.448 ' C ' HG22 ' A' ' 26' ' ' THR . 3.7 mp -135.34 128.61 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.715 ' N ' HG22 ' A' ' 26' ' ' THR . 0.2 OUTLIER -74.82 159.11 32.34 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.469 176.609 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.565 ' CG ' ' HB2' ' A' ' 16' ' ' PHE . 4.8 p90 -91.29 -41.65 0.38 Allowed Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -177.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.45 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 54.3 Cg_endo -70.74 -18.82 32.11 Favored 'Trans proline' 0 C--N 1.376 2.019 0 CA-C-N 121.368 1.524 . . . . 0.0 113.357 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -96.56 -16.65 20.94 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.661 ' O ' ' HG2' ' A' ' 71' ' ' MET . 44.4 t80 -84.55 -21.52 30.44 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -177.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 mt -80.14 -32.97 38.91 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-O 121.947 0.88 . . . . 0.0 109.405 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.643 ' O ' ' HD3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -55.99 -38.66 70.73 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 112.839 -1.982 . . . . 0.0 109.499 174.861 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.664 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 24.6 ptm -73.32 -25.24 60.56 Favored 'General case' 0 C--N 1.349 0.544 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.549 ' O ' ' HG2' ' A' ' 76' ' ' MET . 93.6 mtp -83.15 -18.58 38.92 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.402 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.586 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -82.23 -32.36 29.79 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.643 ' HD3' ' O ' ' A' ' 70' ' ' THR . 6.1 ptt180 -88.46 -17.96 29.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.664 ' HD2' ' O ' ' A' ' 71' ' ' MET . 7.7 ptmt -84.45 -13.03 53.21 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 119.56 -0.856 . . . . 0.0 112.609 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.549 ' HG2' ' O ' ' A' ' 72' ' ' MET . 21.2 ptm -111.88 -31.99 6.76 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.586 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 25.6 mmtt -67.61 -11.22 57.66 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -103.76 -29.7 10.86 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -83.38 47.77 1.3 Allowed 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 121.167 0.508 . . . . 0.0 111.937 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 61.83 112.45 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.828 0.851 . . . . 0.0 111.768 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.4 p -83.26 -14.17 53.7 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.324 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.621 ' O ' HD11 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -85.76 -45.56 11.51 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.736 0.779 . . . . 0.0 109.441 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.435 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 40.7 mt-10 -74.39 -18.34 60.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.805 -1.543 . . . . 0.0 112.02 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.35 -19.43 65.44 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.017 0.527 . . . . 0.0 112.136 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.621 HD11 ' O ' ' A' ' 82' ' ' GLU . 1.8 mt -87.74 -54.16 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.439 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.591 ' O ' ' HD1' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -57.33 -21.19 33.61 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -179.539 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -72.4 -19.8 61.54 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.05 0.453 . . . . 0.0 110.397 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.554 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -68.86 -21.14 64.28 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.205 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.628 ' O ' ' HB2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -80.77 -21.98 40.53 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 174.728 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -77.95 -15.92 58.59 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 114.432 -1.258 . . . . 0.0 107.984 175.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.554 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 3.8 t -85.57 -33.04 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 114.398 -1.274 . . . . 0.0 111.298 177.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.602 ' CD2' HG12 ' A' ' 108' ' ' VAL . 33.4 m-85 -97.55 -33.21 11.44 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 -177.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.628 ' HB2' ' O ' ' A' ' 89' ' ' PHE . 1.9 t70 -60.98 93.12 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.622 0.769 . . . . 0.0 110.965 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -87.72 -50.13 6.68 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.203 -0.908 . . . . 0.0 113.261 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -72.19 1.07 8.2 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -175.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.01 31.04 24.54 Favored Glycine 0 N--CA 1.471 1.019 0 CA-C-N 114.31 -1.314 . . . . 0.0 114.646 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -97.39 -7.96 30.59 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.625 0.212 . . . . 0.0 111.548 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.12 -19.07 47.4 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 116.202 -0.453 . . . . 0.0 112.798 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -120.61 120.31 35.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.475 -0.863 . . . . 0.0 110.384 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.608 HG12 ' N ' ' A' ' 93' ' ' ASP . 15.4 mt -77.12 97.95 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.1 t -76.16 169.26 18.53 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.438 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.72 -15.04 37.23 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -89.54 -30.74 18.0 Favored 'General case' 0 CA--C 1.487 -1.458 0 CA-C-O 121.73 0.776 . . . . 0.0 109.21 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.995 ' O ' HG22 ' A' ' 108' ' ' VAL . 20.7 mt-10 -76.3 -41.75 47.59 Favored 'General case' 0 CA--C 1.485 -1.556 0 CA-C-N 112.776 -2.011 . . . . 0.0 110.729 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.557 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 2.8 tt -62.29 -38.78 90.69 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.545 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -68.7 -44.77 73.23 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 113.766 -1.561 . . . . 0.0 109.116 175.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.508 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 2.7 t60 -68.5 -21.68 64.58 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.662 178.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.995 HG22 ' O ' ' A' ' 104' ' ' GLU . 23.5 t -71.63 -50.3 40.3 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.927 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.547 ' SD ' ' HB3' ' A' ' 114' ' ' GLU . 15.6 mtt -56.6 -41.87 77.77 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 112.4 -2.182 . . . . 0.0 112.013 175.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.79 -18.97 63.51 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.339 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.82 -45.18 21.42 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.515 176.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 mt -80.55 -28.07 37.38 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.418 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 136.85 -6.33 3.76 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-O 117.78 -1.567 . . . . 0.0 116.829 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.547 ' HB3' ' SD ' ' A' ' 109' ' ' MET . 4.9 mt-10 -101.49 155.26 18.18 Favored 'General case' 0 C--N 1.356 0.882 0 CA-C-N 120.842 2.321 . . . . 0.0 114.127 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.49 ' O ' HD11 ' A' ' 116' ' ' LEU . 5.0 mptt -112.77 127.49 56.17 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.322 175.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.545 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 1.2 tp -139.87 119.52 13.23 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 113.94 -1.482 . . . . 0.0 111.057 -177.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.741 ' O ' ' HB ' ' A' ' 121' ' ' VAL . 0.6 OUTLIER -83.74 -176.55 6.34 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.911 -177.861 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.597 ' N ' HG23 ' A' ' 117' ' ' THR . 17.4 t70 -61.21 -47.54 85.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 113.827 -1.533 . . . . 0.0 113.857 -178.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.655 ' HA ' ' OD2' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -84.09 -21.73 31.4 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -179.03 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.681 ' CG ' ' H ' ' A' ' 117' ' ' THR . 10.5 pt-20 -88.61 -25.06 22.64 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.876 0.37 . . . . 0.0 110.949 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.741 ' HB ' ' O ' ' A' ' 117' ' ' THR . 0.3 OUTLIER -87.97 -26.39 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.863 178.611 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.655 ' OD2' ' HA ' ' A' ' 119' ' ' GLU . 32.1 p30 -71.7 25.63 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.75 -1.114 . . . . 0.0 113.633 -177.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.87 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 10.7 pt-20 -124.88 -43.22 2.0 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.348 177.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.522 ' SD ' HD22 ' A' ' 105' ' ' LEU . 14.1 ttm -56.35 -21.93 27.75 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.302 1.041 . . . . 0.0 111.983 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.665 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 3.0 mt -86.86 -48.64 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 O-C-N 123.528 0.517 . . . . 0.0 110.845 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -55.45 -31.2 61.74 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 124.406 1.066 . . . . 0.0 112.229 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.87 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 3.4 mm-40 -65.21 -36.75 85.14 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.962 178.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.533 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -97.56 -35.18 10.7 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.477 0.656 . . . . 0.0 110.283 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.665 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -61.56 127.28 30.71 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 113.985 -1.461 . . . . 0.0 113.488 -179.451 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.2 mt -90.14 -44.01 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.254 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -90.81 -25.35 19.97 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.34 49.81 6.57 Favored Glycine 0 CA--C 1.526 0.738 0 O-C-N 123.449 0.468 . . . . 0.0 113.989 178.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -87.27 -19.61 28.04 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.03 7.1 59.92 Favored Glycine 0 CA--C 1.5 -0.865 0 CA-C-N 115.851 -0.613 . . . . 0.0 113.611 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -139.43 107.2 5.64 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.752 -1.224 . . . . 0.0 108.124 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.564 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 2.2 t -69.18 124.85 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 114.927 -1.033 . . . . 0.0 113.448 -177.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.404 HD21 ' CD ' ' A' ' 140' ' ' GLU . 19.2 m-80 -86.75 -163.35 0.89 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 114.11 -1.404 . . . . 0.0 110.515 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.469 ' O ' HG22 ' A' ' 142' ' ' VAL . 76.5 m-85 -71.79 -55.77 6.99 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.598 0.759 . . . . 0.0 110.816 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -63.75 -20.65 65.92 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.564 ' OE1' ' HA ' ' A' ' 136' ' ' VAL . 10.9 mt-10 -86.94 -42.52 13.1 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.424 0.631 . . . . 0.0 109.703 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.407 ' O ' ' HG3' ' A' ' 144' ' ' MET . 42.3 t80 -68.76 -23.42 64.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.177 -1.374 . . . . 0.0 109.148 176.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 138' ' ' TYR . 24.6 t -85.78 -50.16 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.517 -178.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 147' ' ' ALA . 0.2 OUTLIER -56.33 -32.7 64.92 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 123.867 0.73 . . . . 0.0 111.992 179.189 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.519 ' N ' HE21 ' A' ' 143' ' ' GLN . 0.1 OUTLIER -67.01 -21.3 65.95 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 122.999 0.187 . . . . 0.0 111.197 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 50.5 mtt -87.6 -4.32 58.96 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.436 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 23.4 p -120.17 -48.78 2.31 Favored 'General case' 0 C--N 1.35 0.611 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.721 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -55.21 -40.15 70.49 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.6 mttp . . . . . 0 N--CA 1.484 1.26 0 C-N-CA 124.017 0.927 . . . . 0.0 112.462 -179.971 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 18.6 p . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.489 0.185 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -102.87 -40.73 6.42 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.277 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . 0.522 ' HD3' ' OE1' ' A' ' 114' ' ' GLU . 12.4 mptt -98.14 133.18 42.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.124 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -136.98 -6.87 1.85 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.94 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 37.8 p -139.49 158.88 43.38 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.146 0.279 . . . . 0.0 111.49 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' PHE . . . . . 0.539 ' O ' HG22 ' B' ' 157' ' ' VAL . 0.2 OUTLIER -64.24 -27.26 68.93 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 120.767 0.317 . . . . 0.0 110.384 178.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 144' ' ' MET . 0.0 OUTLIER -58.67 -44.35 90.16 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.446 0.698 . . . . 0.0 111.533 179.024 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -76.53 -35.15 58.45 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' VAL . . . . . 0.539 HG22 ' O ' ' B' ' 154' ' ' PHE . 14.5 m -71.05 -33.87 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 122.54 0.336 . . . . 0.0 111.144 -178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' B' ' 162' ' ' LYS . . . -73.63 -40.5 63.73 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.74 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -60.54 -25.98 66.54 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 123.467 0.479 . . . . 0.0 111.684 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.92 -37.88 54.51 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.633 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 9.8 p -115.32 27.62 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.264 0 O-C-N 123.298 0.374 . . . . 0.0 111.844 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 1.8 ttpm? -86.05 -37.45 18.88 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 116.865 -0.152 . . . . 0.0 111.045 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 3.3 tp -106.62 20.08 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 O-C-N 123.457 0.473 . . . . 0.0 110.759 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 52.4 m -88.56 -25.74 22.34 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.785 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . -89.33 23.56 2.48 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.018 0.437 . . . . 0.0 111.55 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 38.3 p -89.14 -36.25 15.81 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.761 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 4.8 tp -87.71 -7.17 57.73 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 123.4 0.438 . . . . 0.0 111.541 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 22.0 mmt -94.03 130.72 40.06 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.952 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -119.78 -55.44 0.25 Allowed Glycine 0 C--N 1.337 0.632 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.514 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 19.9 p . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.501 -0.761 . . . . 0.0 111.057 -179.968 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.513 0.197 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -100.19 -45.12 5.73 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.815 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -89.91 149.35 22.66 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 122.698 0.399 . . . . 0.0 111.259 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.704 ' H ' HE21 ' A' ' 8' ' ' GLN . 0.0 OUTLIER -123.65 -122.69 0.27 Allowed 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.522 ' O ' ' HG2' ' A' ' 8' ' ' GLN . 20.0 p -101.64 167.96 9.78 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 123.93 0.892 . . . . 0.0 109.89 178.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -46.04 -22.1 0.19 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.51 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 10.9 pt-20 -47.98 -32.51 6.59 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 123.708 0.63 . . . . 0.0 110.912 176.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.704 HE21 ' H ' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -66.0 -55.24 17.73 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.102 177.47 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.407 ' H ' ' HG3' ' A' ' 8' ' ' GLN . 5.1 mt -62.9 -30.96 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.682 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.37 -38.76 63.08 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -127.2 -19.24 4.36 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.576 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -71.45 -15.54 62.34 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.075 0.398 . . . . 0.0 110.161 178.742 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.707 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -80.77 -40.95 24.27 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.817 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.707 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 2.6 mt-10 -79.35 -40.47 30.16 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 114.142 -1.39 . . . . 0.0 112.108 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.521 ' O ' HG11 ' A' ' 35' ' ' VAL . . . -66.54 -20.47 66.03 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.828 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 23.9 t80 -86.99 -46.47 9.81 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.328 -1.305 . . . . 0.0 109.83 176.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.8 m -86.69 -12.98 46.78 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 -176.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -72.05 -28.82 63.59 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.654 179.81 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.574 ' CD1' HG23 ' A' ' 35' ' ' VAL . 5.4 m-85 -134.52 -6.32 2.54 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.828 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 8.1 m-20 -95.68 78.5 3.31 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 118.92 0.782 . . . . 0.0 110.944 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.472 ' N ' ' HD2' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -80.96 -40.2 24.83 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -179.607 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.21 -21.26 60.69 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.49 178.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.63 50.92 8.66 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.93 22.48 7.38 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 113.323 -1.439 . . . . 0.0 114.013 -174.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.05 -66.63 0.49 Allowed Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.296 -0.866 . . . . 0.0 113.641 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.675 ' HG1' ' N ' ' A' ' 27' ' ' ILE . 2.0 t -97.85 170.15 9.17 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 122.227 1.013 . . . . 0.0 112.271 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.675 ' N ' ' HG1' ' A' ' 26' ' ' THR . 0.1 OUTLIER -133.37 144.6 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.771 0 CA-C-N 112.838 -1.983 . . . . 0.0 109.429 179.328 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.25 155.81 4.68 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.94 -55.28 11.45 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.697 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -56.13 -13.92 2.35 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.383 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.52 ' O ' HG22 ' A' ' 35' ' ' VAL . 6.3 mm-40 -107.13 -30.28 8.87 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.509 -178.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -55.78 -33.65 64.55 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.232 0.613 . . . . 0.0 111.27 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.31 -37.31 86.92 Favored Glycine 0 C--N 1.336 0.54 0 O-C-N 123.738 0.649 . . . . 0.0 111.706 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.7 m -79.7 -29.14 40.62 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 114.65 -0.775 . . . . 0.0 111.966 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.574 HG23 ' CD1' ' A' ' 19' ' ' PHE . 1.1 t -76.76 -26.01 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 176.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.516 ' HB3' ' NH1' ' A' ' 37' ' ' ARG . 22.4 mmt -77.2 -38.77 50.82 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 112.974 -1.921 . . . . 0.0 111.691 176.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.582 ' HD3' ' N ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -83.75 -25.82 30.21 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.3 t -65.91 -8.03 20.01 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 122.096 0.95 . . . . 0.0 111.253 177.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.439 ' O ' HG22 ' B' ' 170' ' ' THR . 78.7 mt -92.83 -2.62 55.75 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 113.011 -1.904 . . . . 0.0 110.254 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.99 -11.39 17.69 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 116.296 1.278 . . . . 0.0 116.296 177.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -75.34 156.38 35.57 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 113.198 -1.501 . . . . 0.0 111.512 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.416 ' C ' ' HG3' ' A' ' 37' ' ' ARG . 4.8 t-20 -83.2 132.22 51.01 Favored Pre-proline 0 N--CA 1.475 0.78 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.574 ' N ' ' HG3' ' A' ' 37' ' ' ARG . 85.9 Cg_endo -88.75 102.4 0.4 Allowed 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.349 2.032 . . . . 0.0 116.31 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.421 ' OG1' ' N ' ' A' ' 45' ' ' GLU . 10.0 t -135.29 177.67 7.63 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.969 0.89 . . . . 0.0 108.906 173.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.435 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 45.5 mt-10 -82.79 -24.95 33.18 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 113.168 -1.833 . . . . 0.0 109.32 177.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.582 ' O ' ' HB2' ' A' ' 50' ' ' ASP . . . -71.5 -34.52 70.2 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.879 -1.51 . . . . 0.0 112.477 -176.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -87.58 -24.83 23.88 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.763 177.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.681 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.3 OUTLIER -75.81 -18.21 59.56 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 113.723 -1.58 . . . . 0.0 109.114 176.133 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 1.017 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 17.1 mm-40 -104.13 -14.13 15.99 Favored 'General case' 0 CA--C 1.478 -1.819 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.999 177.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.582 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 1.1 t70 -87.91 -40.33 14.04 Favored 'General case' 0 C--N 1.28 -2.426 0 CA-C-N 112.349 -2.205 . . . . 0.0 111.234 176.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.563 ' HA ' ' OE1' ' A' ' 54' ' ' GLU . 1.3 mpt? -87.05 -29.96 21.53 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 123.519 0.512 . . . . 0.0 110.947 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.681 ' HB ' ' O ' ' A' ' 48' ' ' LEU . 1.9 mp -78.8 -19.95 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 175.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 1.017 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.1 t30 -77.64 -33.52 53.52 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.824 174.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.563 ' OE1' ' HA ' ' A' ' 51' ' ' MET . 6.6 pt-20 -82.54 -49.6 9.71 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.606 ' C ' ' H ' ' A' ' 57' ' ' ALA . 78.5 t -89.27 -51.96 11.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.482 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 4.9 t70 -71.94 38.62 0.07 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-O 122.108 0.956 . . . . 0.0 110.143 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.606 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -85.14 -5.35 59.34 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 113.937 -1.483 . . . . 0.0 112.53 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -90.43 -32.64 16.32 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 112.31 -2.223 . . . . 0.0 111.392 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.36 50.26 4.35 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-N 116.091 -0.504 . . . . 0.0 113.489 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -109.95 -21.46 12.32 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.675 0.274 . . . . 0.0 111.401 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.68 26.1 70.44 Favored Glycine 0 N--CA 1.465 0.632 0 CA-C-N 115.587 -0.733 . . . . 0.0 114.289 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.41 -179.32 6.98 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 123.423 0.689 . . . . 0.0 110.102 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.471 ' N ' ' OG1' ' A' ' 26' ' ' THR . 22.8 mm -141.86 89.26 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -176.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -60.15 162.66 5.6 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.745 0.418 . . . . 0.0 110.605 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.583 ' HA ' ' CE2' ' A' ' 68' ' ' PHE . 19.1 p90 -81.38 -37.82 0.92 Allowed Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 -177.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.477 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 14.8 Cg_exo -69.74 -18.07 37.29 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 121.853 1.702 . . . . 0.0 112.824 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -93.82 -26.25 17.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.834 ' O ' ' HG2' ' A' ' 71' ' ' MET . 3.2 p90 -84.36 -20.01 32.68 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -177.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 73' ' ' ALA . 28.3 mt -77.85 -29.3 50.42 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 121.773 0.797 . . . . 0.0 109.043 175.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.532 ' O ' ' HD3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -53.38 -35.57 60.47 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 112.784 -2.007 . . . . 0.0 109.824 174.693 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.834 ' HG2' ' O ' ' A' ' 68' ' ' PHE . 22.7 ptt? -72.13 -26.22 62.03 Favored 'General case' 0 C--N 1.346 0.438 0 O-C-N 123.744 0.652 . . . . 0.0 110.031 176.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.63 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 58.9 mtt -88.34 -25.98 22.47 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.664 176.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.678 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -69.64 -35.85 75.59 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.607 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.665 ' NE ' ' HA ' ' A' ' 71' ' ' MET . 6.7 ptt180 -76.2 -21.83 56.0 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.925 178.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.63 ' HD3' ' HA ' ' A' ' 72' ' ' MET . 25.3 mtpt -68.72 -15.14 63.43 Favored 'General case' 0 C--N 1.346 0.423 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 175.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 11.9 ptt? -121.95 -29.45 4.27 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.184 0.516 . . . . 0.0 111.832 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.678 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 40.1 mmtt -86.77 -33.99 19.75 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.881 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 9.0 m-20 -104.45 -3.96 23.36 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 t -59.7 97.6 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 121.166 0.508 . . . . 0.0 111.878 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.453 ' OD1' ' HB3' ' A' ' 82' ' ' GLU . 2.2 t70 -67.2 144.18 56.12 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.216 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.2 p -82.94 -13.88 55.19 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.612 ' O ' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -84.78 -46.88 10.95 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.617 0.723 . . . . 0.0 109.916 -179.186 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.465 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 36.7 mt-10 -78.73 -18.27 54.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.069 -1.423 . . . . 0.0 112.201 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.566 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 3.4 mt-10 -68.45 -18.43 64.42 Favored 'General case' 0 C--N 1.345 0.392 0 C-N-CA 122.778 0.431 . . . . 0.0 111.954 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.612 HD13 ' O ' ' A' ' 82' ' ' GLU . 1.9 mt -85.18 -57.05 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.434 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -63.67 -21.76 66.55 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.021 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.584 ' O ' HG23 ' A' ' 91' ' ' VAL . 1.8 pt-20 -86.15 -20.79 28.11 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 85' ' ' ILE . . . -68.97 -22.99 64.07 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.098 178.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -81.66 -21.49 38.12 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 174.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.521 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 27.8 mmt180 -80.11 -22.64 41.93 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.2 175.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 87' ' ' GLU . 94.0 t -88.13 -56.29 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-N 114.559 -1.201 . . . . 0.0 112.002 178.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.613 ' CE1' HG11 ' A' ' 108' ' ' VAL . 2.8 m-85 -100.98 -47.1 4.88 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -176.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.678 ' CA ' HG12 ' A' ' 100' ' ' ILE . 5.2 t70 -59.64 95.17 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.714 0.769 . . . . 0.0 112.323 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -87.28 -52.22 5.52 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.781 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.459 ' HB2' ' OE2' ' A' ' 104' ' ' GLU . 5.0 t70 -72.13 0.44 9.63 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -175.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.439 ' HA2' ' OD2' ' A' ' 93' ' ' ASP . . . 49.89 31.68 17.51 Favored Glycine 0 N--CA 1.472 1.069 0 CA-C-N 114.408 -1.269 . . . . 0.0 114.656 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -97.0 -8.31 30.8 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 105.09 -19.16 41.23 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 116.252 -0.431 . . . . 0.0 112.905 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -122.63 118.2 27.61 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.65 -0.775 . . . . 0.0 110.596 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.678 HG12 ' CA ' ' A' ' 93' ' ' ASP . 14.9 mt -77.7 104.77 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.4 p -80.74 164.25 22.92 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -178.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -58.62 -14.39 8.17 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -178.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.32 -30.0 19.91 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-O 122.004 0.907 . . . . 0.0 109.535 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.969 ' O ' HG22 ' A' ' 108' ' ' VAL . 2.8 mm-40 -81.73 -38.33 25.91 Favored 'General case' 0 CA--C 1.481 -1.698 0 CA-C-N 112.476 -2.147 . . . . 0.0 110.572 -178.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.639 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 8.5 tt -67.6 -32.75 73.7 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 176.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.638 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -70.6 -44.72 66.71 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.443 175.774 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.495 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 9.2 t-80 -68.11 -21.92 64.92 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.548 177.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.969 HG22 ' O ' ' A' ' 104' ' ' GLU . 3.2 t -70.98 -52.89 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.221 0 CA-C-N 113.996 -1.456 . . . . 0.0 107.184 176.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.634 ' SD ' HG13 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -59.81 -37.6 79.6 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 111.502 -2.59 . . . . 0.0 112.03 177.426 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.6 m -71.85 -19.03 62.02 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 119.781 -0.767 . . . . 0.0 109.604 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.24 -45.26 18.27 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.47 176.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.511 HD22 ' O ' ' B' ' 169' ' ' GLY . 4.0 mt -80.18 -28.29 38.75 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.462 -178.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 142.29 -10.41 2.48 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 117.726 -1.597 . . . . 0.0 116.952 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 109' ' ' MET . 4.7 mt-10 -100.75 151.7 21.36 Favored 'General case' 0 C--N 1.357 0.921 0 CA-C-N 120.92 2.36 . . . . 0.0 114.276 -178.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -108.99 127.51 54.14 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 113.682 -1.599 . . . . 0.0 106.886 175.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.638 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 1.1 tp -134.57 115.46 13.9 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.49 -175.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.774 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -76.95 -175.81 3.68 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.717 179.502 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.482 ' N ' HG21 ' A' ' 117' ' ' THR . 16.5 t70 -71.27 -37.6 71.88 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.48 -1.236 . . . . 0.0 114.264 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -88.78 -16.21 32.69 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.626 ' CD ' ' H ' ' A' ' 117' ' ' THR . 14.8 pt-20 -87.77 -16.09 35.13 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 123.087 0.242 . . . . 0.0 110.897 178.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.774 HG22 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -83.61 -28.82 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.472 177.713 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -68.54 30.02 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.46 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.566 ' H ' ' C ' ' A' ' 121' ' ' VAL . 10.5 pt-20 -144.87 -18.86 0.51 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.65 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.746 ' HA ' ' OG1' ' B' ' 153' ' ' THR . 13.4 ttm -87.79 -21.85 24.86 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 176.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.71 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 1.8 mp -88.29 -45.33 15.81 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.557 0 CA-C-N 114.695 -1.139 . . . . 0.0 112.901 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -60.29 -33.38 72.26 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.561 ' HG3' ' OG1' ' B' ' 153' ' ' THR . 5.0 mm-40 -65.71 -36.19 82.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.938 177.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.577 ' C ' ' HB3' ' A' ' 140' ' ' GLU . . . -91.46 -42.09 10.48 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.494 -179.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.71 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -60.99 122.27 14.52 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 113.784 -1.553 . . . . 0.0 114.083 -178.011 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.0 mt -90.9 -44.0 14.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 113.106 -1.861 . . . . 0.0 110.393 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -93.61 -25.31 17.57 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.09 49.87 5.11 Favored Glycine 0 CA--C 1.526 0.77 0 O-C-N 123.459 0.474 . . . . 0.0 113.961 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -88.9 -19.79 25.39 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.95 12.72 56.24 Favored Glycine 0 CA--C 1.503 -0.702 0 CA-C-N 116.106 -0.497 . . . . 0.0 113.645 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -139.35 120.35 14.55 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.968 -1.116 . . . . 0.0 108.473 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.578 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 3.6 t -78.99 114.14 19.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.682 0.753 . . . . 0.0 112.1 -178.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -85.25 -163.19 0.8 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 113.735 -1.575 . . . . 0.0 110.838 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.435 ' O ' HG23 ' A' ' 142' ' ' VAL . 0.0 OUTLIER -69.74 -58.06 4.37 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.99 178.679 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.504 ' O ' ' HG3' ' A' ' 143' ' ' GLN . 10.6 pt-20 -60.79 -20.54 61.71 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.578 ' OE1' ' HA ' ' A' ' 136' ' ' VAL . 8.0 mt-10 -88.99 -37.2 15.37 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.183 0.516 . . . . 0.0 110.35 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.497 ' O ' ' HE2' ' A' ' 144' ' ' MET . 62.4 t80 -77.41 -23.32 50.65 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.649 -1.16 . . . . 0.0 109.058 175.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 138' ' ' TYR . 24.0 t -85.93 -40.34 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 114.898 -1.047 . . . . 0.0 112.748 -177.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 139' ' ' GLU . 9.7 mt-30 -49.91 -33.18 16.59 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.628 ' HB3' ' CD2' ' B' ' 154' ' ' PHE . 16.0 ptt? -62.64 -29.38 70.58 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 118.355 0.525 . . . . 0.0 111.08 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 50.4 mtt -81.81 -4.06 55.48 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.733 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.486 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 27.2 p -121.41 -45.73 2.31 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.684 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -55.01 -39.55 69.21 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 179.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 N--CA 1.485 1.311 0 C-N-CA 124.004 0.922 . . . . 0.0 112.416 -179.873 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 20.0 p . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.381 0.134 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -98.72 153.63 18.58 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.068 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 63.22 120.73 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.986 0.915 . . . . 0.0 111.951 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 60.8 117.01 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.994 0.918 . . . . 0.0 112.158 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.746 ' OG1' ' HA ' ' A' ' 124' ' ' MET . 76.6 p -132.72 -58.08 0.92 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.604 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 154' ' ' PHE . . . . . 0.719 ' CE1' ' HD2' ' B' ' 155' ' ' LYS . 0.1 OUTLIER -67.67 -28.24 67.52 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.231 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . 0.719 ' HD2' ' CE1' ' B' ' 154' ' ' PHE . 7.8 mptt -59.32 -33.85 71.62 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.468 177.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -77.07 -39.23 50.57 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.845 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 157' ' ' VAL . . . . . 0.641 HG21 ' O ' ' B' ' 154' ' ' PHE . 10.4 m -71.95 -29.41 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 122.754 0.422 . . . . 0.0 111.052 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . 0.619 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -60.42 -53.28 59.47 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.624 0.77 . . . . 0.0 112.755 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -65.18 -20.1 66.29 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.606 0.362 . . . . 0.0 111.633 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.14 -34.42 56.56 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.522 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 5.2 p -129.1 26.68 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 162' ' ' LYS . . . . . 0.599 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 22.1 ttpt -88.46 35.1 0.76 Allowed 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 121.198 0.523 . . . . 0.0 110.784 178.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.23 167.97 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.456 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 4.9 t -78.62 -177.07 5.17 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.25 16.62 2.91 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 166' ' ' SER . . . . . 0.563 ' O ' ' HE1' ' A' ' 51' ' ' MET . 0.3 OUTLIER -88.94 -58.75 2.43 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.406 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.621 ' HB2' ' NZ ' ' A' ' 75' ' ' LYS . 3.3 mp -137.55 106.92 6.09 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-O 121.141 0.496 . . . . 0.0 111.102 176.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -127.91 152.18 48.17 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.079 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . 0.511 ' O ' HD22 ' A' ' 112' ' ' LEU . . . 165.43 -57.94 0.25 Allowed Glycine 0 C--N 1.337 0.608 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.566 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 170' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 39' ' ' LEU . 5.1 t . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.138 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 111.362 0.134 . . . . 0.0 111.362 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -109.07 118.93 38.07 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 123.416 0.447 . . . . 0.0 110.859 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.654 ' HA ' ' OE1' ' A' ' 8' ' ' GLN . 0.4 OUTLIER -128.65 153.54 47.19 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.028 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.469 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -105.4 -108.3 0.29 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.506 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.589 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 16.5 p -101.06 -173.79 2.46 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 123.678 0.791 . . . . 0.0 110.002 178.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -60.78 -24.38 65.73 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.589 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 12.8 pt-20 -57.07 -29.28 63.32 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.374 0.607 . . . . 0.0 111.459 178.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.654 ' OE1' ' HA ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -78.13 -46.09 21.58 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 114.141 -1.391 . . . . 0.0 109.914 178.133 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.52 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . 3.9 mt -63.7 -32.33 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.569 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.94 -34.38 64.28 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -113.66 -17.98 12.0 Favored 'General case' 0 C--N 1.346 0.422 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.52 ' CE1' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -73.55 -16.16 61.27 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.754 0.707 . . . . 0.0 110.679 179.407 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.698 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 1.0 OUTLIER -83.11 -40.72 19.44 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.468 179.17 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.698 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 1.4 mt-10 -82.56 -38.48 23.63 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 114.082 -1.417 . . . . 0.0 112.604 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.519 ' O ' HG11 ' A' ' 35' ' ' VAL . . . -66.06 -22.48 66.43 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.289 0.566 . . . . 0.0 109.522 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.633 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 26.9 t80 -87.07 -46.03 10.17 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.01 176.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.4 m -87.09 -13.5 44.07 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 -176.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -69.32 -30.37 68.42 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.39 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.566 ' CD1' HG21 ' A' ' 35' ' ' VAL . 7.1 m-85 -129.01 -13.71 4.52 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.633 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -103.09 83.94 2.28 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 118.496 0.589 . . . . 0.0 110.059 178.615 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.43 ' HE2' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -86.11 -21.7 27.49 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -178.76 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.46 -21.88 44.86 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.38 177.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.44 51.85 4.74 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.802 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.15 21.98 7.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 113.848 -1.176 . . . . 0.0 113.819 -175.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.11 -64.88 0.21 Allowed Glycine 0 CA--C 1.528 0.845 0 CA-C-N 115.152 -0.931 . . . . 0.0 114.471 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.705 HG23 ' N ' ' A' ' 64' ' ' ASP . 11.0 p -97.99 155.8 16.93 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 123.559 0.744 . . . . 0.0 112.104 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.587 HG13 ' O ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -117.4 148.47 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.583 -179.581 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.37 148.4 15.11 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.418 ' C ' ' H ' ' A' ' 31' ' ' GLU . 1.1 p -74.19 -55.71 5.75 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-N 115.328 -0.851 . . . . 0.0 113.287 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -53.72 -13.89 0.79 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.469 177.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.604 ' O ' HG23 ' A' ' 35' ' ' VAL . 23.0 mt-10 -113.46 -16.76 12.37 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.744 -178.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.426 HD21 ' CZ ' ' A' ' 68' ' ' PHE . 5.2 tp -55.11 -40.59 70.65 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.222 0.609 . . . . 0.0 111.951 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.783 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -55.31 -39.81 73.66 Favored Glycine 0 C--N 1.34 0.801 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 177.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.9 m -75.22 -28.77 60.06 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 114.611 -0.794 . . . . 0.0 112.365 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 31' ' ' GLU . 1.5 t -75.46 -26.84 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 177.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.622 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 82.5 mtp -75.63 -41.95 52.88 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 112.8 -2.0 . . . . 0.0 111.273 176.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.783 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 10.5 mtt180 -80.82 -29.2 35.99 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.2 m -66.48 -8.47 26.52 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 122.009 0.909 . . . . 0.0 112.134 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 78.5 mt -92.81 -7.21 47.05 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 113.24 -1.8 . . . . 0.0 109.706 177.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.42 0.88 50.35 Favored Glycine 0 CA--C 1.492 -1.388 0 CA-C-O 122.351 0.973 . . . . 0.0 114.68 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.622 ' HB2' ' O ' ' A' ' 36' ' ' MET . 56.8 mt-30 -83.24 138.02 33.77 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 112.058 -2.071 . . . . 0.0 111.791 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -117.74 75.85 10.23 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.796 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.98 -177.8 3.24 Favored 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 123.137 2.558 . . . . 0.0 111.984 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.65 157.44 16.68 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.519 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 29.5 mt-10 -80.94 -27.71 36.01 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.697 0.761 . . . . 0.0 109.369 177.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.41 -35.07 61.08 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 113.432 -1.713 . . . . 0.0 109.667 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.534 ' HG2' ' SD ' ' A' ' 51' ' ' MET . 14.9 tt0 -78.04 -29.87 49.55 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 113.923 -1.49 . . . . 0.0 108.127 176.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.623 ' O ' HD12 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -65.17 -20.32 66.39 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.175 174.502 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.827 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 56.2 mt-30 -97.61 -15.5 20.43 Favored 'General case' 0 CA--C 1.481 -1.69 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.107 178.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -84.77 -35.85 22.13 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 111.971 -2.377 . . . . 0.0 109.936 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.534 ' SD ' ' HG2' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -86.68 -27.01 24.01 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.486 177.718 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.623 HD12 ' O ' ' A' ' 48' ' ' LEU . 1.5 mp -78.47 -25.92 13.83 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 175.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.827 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 2.9 t30 -78.24 -34.4 49.18 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.021 175.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.01 -46.76 8.61 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.596 ' C ' ' H ' ' A' ' 57' ' ' ALA . 75.5 t -83.03 -51.07 14.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.487 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 5.2 t70 -72.26 39.84 0.08 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 122.042 0.925 . . . . 0.0 110.0 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.596 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -82.46 -5.35 58.64 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 114.005 -1.452 . . . . 0.0 112.772 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -85.94 -35.31 20.55 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 112.36 -2.2 . . . . 0.0 111.229 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.14 41.78 7.87 Favored Glycine 0 C--N 1.342 0.894 0 O-C-N 123.537 0.523 . . . . 0.0 113.477 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -109.99 -21.46 12.31 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.561 0.219 . . . . 0.0 111.204 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.67 26.82 73.43 Favored Glycine 0 N--CA 1.466 0.64 0 CA-C-N 115.764 -0.653 . . . . 0.0 114.066 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.11 155.48 43.96 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.307 0.643 . . . . 0.0 110.576 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.587 ' O ' HG13 ' A' ' 27' ' ' ILE . 21.0 mm -133.47 126.85 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.705 ' N ' HG23 ' A' ' 26' ' ' THR . 0.3 OUTLIER -73.15 157.17 37.74 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.612 176.598 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.585 ' CG ' ' HD3' ' A' ' 66' ' ' PRO . 7.3 p90 -91.43 -39.99 0.38 Allowed Pre-proline 0 CA--C 1.546 0.823 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -178.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.596 ' HA ' HE22 ' A' ' 8' ' ' GLN . 14.2 Cg_exo -70.5 -18.67 33.39 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 121.903 1.736 . . . . 0.0 113.109 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -96.42 -13.79 22.9 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.453 ' O ' ' HB2' ' A' ' 71' ' ' MET . 6.5 t80 -84.38 -36.04 22.73 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -178.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 73' ' ' ALA . 1.3 mt -66.44 -32.6 74.08 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 121.688 0.756 . . . . 0.0 109.983 177.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.455 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -56.04 -33.41 64.94 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 113.195 -1.82 . . . . 0.0 108.966 174.234 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.598 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 24.2 mmt -72.59 -29.91 63.92 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.659 175.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.69 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 67.8 mtt -86.17 -19.63 29.79 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.213 0.945 . . . . 0.0 110.246 177.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . -75.2 -37.94 60.96 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.484 ' CD ' ' HA ' ' A' ' 71' ' ' MET . 3.4 ptm180 -76.19 -17.84 59.35 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 120.468 -0.493 . . . . 0.0 112.138 178.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.69 ' HD2' ' HA ' ' A' ' 72' ' ' MET . 31.8 mttt -77.89 -14.23 59.62 Favored 'General case' 0 C--N 1.348 0.506 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 176.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.59 ' O ' HG22 ' A' ' 79' ' ' THR . 18.4 ptt? -124.44 -19.58 5.41 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -177.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 73' ' ' ALA . 59.5 mttt -60.71 -13.8 17.09 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -103.02 -29.55 11.32 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.59 HG22 ' O ' ' A' ' 76' ' ' MET . 8.6 t -73.57 103.95 4.36 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.062 0.458 . . . . 0.0 111.357 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.595 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 8.6 m-20 -45.24 151.68 0.33 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.925 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.552 ' HA ' ' OE1' ' A' ' 84' ' ' GLU . 12.7 t -69.79 -13.81 62.46 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.825 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.548 ' O ' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -82.53 -44.64 15.66 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.686 0.755 . . . . 0.0 109.593 -179.641 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.442 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 40.5 mt-10 -73.87 -18.21 60.95 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 113.753 -1.567 . . . . 0.0 112.469 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.595 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 43.1 mt-10 -65.52 -20.0 66.16 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.548 HD13 ' O ' ' A' ' 82' ' ' GLU . 2.7 mp -87.88 -51.23 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.656 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.614 ' O ' ' HD1' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -58.78 -17.01 19.6 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -179.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 3.1 pt-20 -74.53 -19.59 60.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 120.872 0.368 . . . . 0.0 110.041 177.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.94 -20.06 65.83 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.647 178.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.614 ' HD1' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -84.33 -21.18 31.05 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 174.856 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 9.1 mtm180 -81.16 -23.02 38.53 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.235 -1.348 . . . . 0.0 108.498 175.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.0 t -88.64 -55.99 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.039 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.461 ' CD2' HG21 ' A' ' 108' ' ' VAL . 8.8 m-85 -100.71 -45.11 5.59 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 -176.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.707 ' CA ' HG12 ' A' ' 100' ' ' ILE . 15.5 t70 -61.93 94.69 0.05 Allowed 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.75 0.786 . . . . 0.0 111.145 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.1 mmpt? -87.25 -49.75 7.06 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 114.286 -1.325 . . . . 0.0 113.146 -178.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -72.11 0.8 8.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -175.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.426 ' HA2' ' OD2' ' A' ' 93' ' ' ASP . . . 50.29 31.73 20.6 Favored Glycine 0 N--CA 1.472 1.098 0 CA-C-N 114.396 -1.275 . . . . 0.0 114.717 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -98.83 -5.73 30.52 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.669 0.235 . . . . 0.0 111.574 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.28 -19.27 51.95 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 121.439 -0.41 . . . . 0.0 112.847 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -119.43 118.44 31.12 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.481 -0.859 . . . . 0.0 110.338 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.707 HG12 ' CA ' ' A' ' 93' ' ' ASP . 43.3 mt -77.15 94.79 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.53 ' OG ' ' HG3' ' A' ' 104' ' ' GLU . 79.9 p -71.65 170.18 14.01 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.509 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.527 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -62.75 -14.04 39.93 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 114.821 -1.081 . . . . 0.0 113.513 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.57 -28.0 21.01 Favored 'General case' 0 CA--C 1.49 -1.335 0 CA-C-O 121.717 0.77 . . . . 0.0 109.489 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 1.025 ' O ' HG22 ' A' ' 108' ' ' VAL . 20.0 mt-10 -80.7 -43.12 20.83 Favored 'General case' 0 CA--C 1.484 -1.568 0 CA-C-N 112.894 -1.957 . . . . 0.0 111.584 -178.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.614 ' O ' HD21 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -67.72 -27.75 67.07 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 177.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.633 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -74.73 -45.52 43.56 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.749 -1.569 . . . . 0.0 108.878 176.044 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.477 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 12.7 t-80 -67.18 -21.71 65.77 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.667 -1.152 . . . . 0.0 107.975 177.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 1.025 HG22 ' O ' ' A' ' 104' ' ' GLU . 29.2 t -72.46 -51.15 30.42 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.829 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 176.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.605 ' SD ' HD23 ' A' ' 116' ' ' LEU . 19.9 mtt -56.24 -40.9 74.87 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 112.579 -2.1 . . . . 0.0 112.039 175.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.19 -19.09 63.98 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.358 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.48 -45.02 20.15 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.567 176.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 mt -80.05 -28.13 39.28 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.793 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 138.86 -7.39 3.26 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-O 117.821 -1.544 . . . . 0.0 116.841 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 109' ' ' MET . 4.9 mt-10 -101.1 152.99 19.95 Favored 'General case' 0 C--N 1.357 0.892 0 CA-C-N 120.763 2.281 . . . . 0.0 114.436 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.34 128.66 56.35 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 113.642 -1.617 . . . . 0.0 107.59 175.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.633 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 1.4 tp -134.95 115.94 14.14 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.114 -176.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.617 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -76.74 -175.84 3.59 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.509 -179.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.519 ' N ' HG23 ' A' ' 117' ' ' THR . 16.0 t70 -72.94 -37.26 67.22 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.257 -1.338 . . . . 0.0 114.382 -177.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -89.36 -16.12 31.77 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.615 ' CD ' ' H ' ' A' ' 117' ' ' THR . 14.6 pt-20 -87.36 -16.24 35.56 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 123.167 0.292 . . . . 0.0 110.65 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 117' ' ' THR . 0.1 OUTLIER -84.13 -31.81 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 178.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.18 27.5 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.964 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.632 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 10.3 pt-20 -141.64 -18.29 0.77 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.064 -1.426 . . . . 0.0 110.991 177.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.408 ' O ' ' HD2' ' B' ' 154' ' ' PHE . 5.0 mmt -88.16 -26.76 22.26 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.587 1.155 . . . . 0.0 108.746 176.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.778 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 1.2 mp -86.8 -37.44 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 114.173 -1.376 . . . . 0.0 113.228 -178.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -65.07 -27.86 69.07 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.585 0.707 . . . . 0.0 111.309 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.632 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 22.3 mm-40 -63.27 -36.94 85.35 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.075 178.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.723 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -99.84 -36.52 9.4 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.052 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.778 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -61.05 125.87 25.29 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.274 -1.33 . . . . 0.0 113.685 -178.038 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.2 mt -90.22 -48.97 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 113.779 -1.555 . . . . 0.0 110.341 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -89.9 -25.27 21.05 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 81.27 49.72 5.41 Favored Glycine 0 CA--C 1.525 0.674 0 O-C-N 123.534 0.521 . . . . 0.0 113.692 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -87.15 -19.6 28.23 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 97.38 12.04 49.69 Favored Glycine 0 CA--C 1.5 -0.846 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.402 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -139.34 128.99 24.55 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.958 -1.121 . . . . 0.0 108.677 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.525 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 2.3 t -92.27 124.38 44.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.392 0.615 . . . . 0.0 112.181 -178.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -89.88 -169.5 2.47 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.219 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.484 ' HH ' ' CB ' ' A' ' 89' ' ' PHE . 37.3 m-85 -68.91 -52.06 33.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.511 177.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -65.41 -22.03 66.73 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.723 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 11.4 mt-10 -87.19 -39.93 15.04 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.779 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -70.93 -24.29 62.42 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.467 176.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.441 ' O ' ' HG3' ' A' ' 145' ' ' MET . 20.0 t -85.84 -48.07 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.498 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.446 ' HA ' ' OG1' ' A' ' 146' ' ' THR . 29.5 mt-30 -60.25 -19.31 54.09 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 123.558 0.537 . . . . 0.0 111.505 178.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.683 ' HG2' ' O ' ' A' ' 140' ' ' GLU . 7.3 mmt -71.46 -21.91 61.89 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 123.227 0.33 . . . . 0.0 110.324 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.441 ' HG3' ' O ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -88.68 -5.29 58.22 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.454 177.231 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.446 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 34.2 p -116.71 -43.31 2.91 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.771 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -42.3 -34.7 0.83 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 77.1 mttt . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.093 -0.956 . . . . 0.0 111.305 179.565 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 18.4 p . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.496 0.189 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -100.2 137.76 38.2 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.817 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -129.48 152.08 49.41 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.038 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . 0.486 ' HZ2' ' CD ' ' A' ' 114' ' ' GLU . 23.4 mmtp 61.31 113.57 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.97 0.908 . . . . 0.0 112.056 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.43 ' O ' HG11 ' B' ' 157' ' ' VAL . 64.5 p -138.51 174.76 10.2 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.183 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 154' ' ' PHE . . . . . 0.543 ' O ' HG23 ' B' ' 157' ' ' VAL . 0.2 OUTLIER -67.81 -27.19 66.52 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 117.678 0.217 . . . . 0.0 111.121 179.193 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . 0.475 ' NZ ' ' HB3' ' A' ' 127' ' ' GLU . 4.7 mptt -61.67 -42.29 98.72 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.884 0.474 . . . . 0.0 111.336 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -76.39 -35.04 58.84 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 157' ' ' VAL . . . . . 0.543 HG23 ' O ' ' B' ' 154' ' ' PHE . 11.6 m -70.09 -37.36 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 122.55 0.34 . . . . 0.0 111.109 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' B' ' 162' ' ' LYS . . . -73.77 -39.85 63.87 Favored 'General case' 0 C--N 1.345 0.413 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.636 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -64.12 -23.58 67.38 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.522 0.514 . . . . 0.0 111.64 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.66 -37.54 56.08 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.259 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 9.6 p -107.48 19.11 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.29 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 162' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 35.0 tttp -91.27 104.67 17.18 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.185 0.517 . . . . 0.0 111.097 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 5.5 tp -152.55 -20.55 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.145 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 48.7 m 53.75 95.26 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.647 1.179 . . . . 0.0 113.354 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . 35.3 73.3 0.09 Allowed 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.837 1.255 . . . . 0.0 113.647 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 166' ' ' SER . . . . . 0.442 ' O ' ' HD3' ' A' ' 75' ' ' LYS . 47.3 m -132.35 -46.03 0.91 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.384 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.444 HD21 ' NE2' ' A' ' 41' ' ' GLN . 7.3 tp -144.1 70.25 1.29 Allowed 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.246 0.546 . . . . 0.0 110.0 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 64.8 mtt -130.12 131.39 45.67 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.883 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -130.83 99.18 0.42 Allowed Glycine 0 C--N 1.337 0.585 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.462 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 19.8 p . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.06 -179.981 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.55 0.215 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -112.98 -41.89 3.66 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.179 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -135.42 149.37 49.6 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.377 0.423 . . . . 0.0 110.906 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.454 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -122.86 -123.43 0.27 Allowed 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.696 ' O ' ' HG2' ' A' ' 8' ' ' GLN . 20.2 p -101.67 170.93 7.86 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 124.052 0.941 . . . . 0.0 109.892 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -46.07 -22.03 0.19 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.437 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 12.3 pt-20 -48.31 -32.24 7.12 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 123.802 0.689 . . . . 0.0 110.761 176.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.696 ' HG2' ' O ' ' A' ' 5' ' ' THR . 1.4 pt20 -65.55 -56.02 14.56 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.689 177.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.405 ' H ' ' HG3' ' A' ' 8' ' ' GLN . 3.6 mt -58.99 -31.64 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.73 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.04 -36.36 77.63 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -126.5 -18.01 4.95 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -177.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.414 ' HD2' ' O ' ' A' ' 8' ' ' GLN . 0.1 OUTLIER -69.86 -15.6 63.12 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.037 0.835 . . . . 0.0 110.75 179.361 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.715 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 1.0 OUTLIER -80.93 -41.21 23.31 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.018 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.715 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 2.2 mt-10 -82.53 -41.35 19.78 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 114.13 -1.395 . . . . 0.0 112.353 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.522 ' O ' HG12 ' A' ' 35' ' ' VAL . . . -64.23 -19.06 65.11 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.434 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 58.5 t80 -86.54 -49.71 7.37 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.56 177.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.458 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 51.7 m -87.45 -12.77 45.1 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -177.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -69.37 -28.48 66.24 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 118.499 0.591 . . . . 0.0 112.172 -179.428 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.56 ' CD1' HG21 ' A' ' 35' ' ' VAL . 4.8 m-85 -134.5 -2.93 2.69 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 24.8 t70 -83.48 55.5 3.22 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 119.244 0.929 . . . . 0.0 112.491 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.461 ' N ' ' HD2' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -86.8 -20.79 27.06 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 178.692 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.82 -22.39 61.56 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.322 0.582 . . . . 0.0 110.558 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.9 40.79 29.73 Favored Glycine 0 N--CA 1.471 1.032 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.47 23.4 9.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 112.971 -1.614 . . . . 0.0 112.835 -176.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.51 -80.64 1.79 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.905 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.79 178.32 4.32 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 177.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -75.32 148.78 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -177.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.409 ' OG1' ' HB2' ' A' ' 31' ' ' GLU . 0.6 OUTLIER -64.11 163.67 12.09 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.399 1.079 . . . . 0.0 113.761 -179.635 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 p -80.25 -56.27 4.33 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.155 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -57.57 -13.63 4.08 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.233 177.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.46 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.4 mt-10 -111.44 -16.4 13.34 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.301 -177.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.506 ' HA ' HG23 ' A' ' 35' ' ' VAL . 9.2 tp -52.97 -41.33 64.46 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.247 0.619 . . . . 0.0 112.295 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.784 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -55.86 -39.16 76.88 Favored Glycine 0 C--N 1.34 0.801 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 177.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.0 m -75.47 -29.91 59.74 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 114.444 -0.878 . . . . 0.0 112.567 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.56 HG21 ' CD1' ' A' ' 19' ' ' PHE . 1.1 t -74.6 -27.28 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 176.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.618 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 47.1 mtt -73.72 -42.8 60.69 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 112.951 -1.932 . . . . 0.0 110.861 176.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.784 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 11.3 mtt180 -78.53 -29.76 46.67 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.6 m -67.7 -8.39 34.75 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.941 0.877 . . . . 0.0 111.997 178.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 35' ' ' VAL . 80.8 mt -94.82 -6.18 43.45 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.698 177.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.51 -0.85 46.13 Favored Glycine 0 CA--C 1.493 -1.34 0 CA-C-O 122.22 0.9 . . . . 0.0 115.236 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.618 ' HB2' ' O ' ' A' ' 36' ' ' MET . 46.6 mt-30 -82.32 140.55 33.49 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-N 112.343 -1.928 . . . . 0.0 111.752 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -120.01 73.7 19.34 Favored Pre-proline 0 CA--C 1.551 0.996 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.159 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -83.64 -179.56 4.26 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 123.216 2.611 . . . . 0.0 112.096 178.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 m -102.33 160.05 14.87 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.516 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 28.7 mt-10 -80.75 -28.29 36.52 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-O 121.584 0.707 . . . . 0.0 109.909 178.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.61 -36.79 65.53 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 113.611 -1.631 . . . . 0.0 110.043 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -77.54 -30.38 52.73 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 114.183 -1.371 . . . . 0.0 108.521 176.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.818 ' O ' HG12 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -62.73 -24.98 67.96 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.283 174.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 56.9 mt-30 -91.67 -19.45 22.65 Favored 'General case' 0 CA--C 1.478 -1.793 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.043 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -76.86 -29.08 55.68 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-N 112.031 -2.349 . . . . 0.0 107.959 176.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.63 ' SD ' ' HE1' ' A' ' 71' ' ' MET . 1.2 mtt -87.09 -30.45 21.12 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.245 177.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.818 HG12 ' O ' ' A' ' 48' ' ' LEU . 37.3 mm -73.78 -28.08 23.82 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 175.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 2.3 m120 -78.91 -37.88 38.83 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.246 -1.343 . . . . 0.0 112.023 176.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -87.59 -49.42 7.18 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.605 ' C ' ' H ' ' A' ' 57' ' ' ALA . 59.8 t -85.45 -51.12 13.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.521 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 5.9 t70 -72.48 39.26 0.08 Allowed 'General case' 0 C--O 1.239 0.516 0 CA-C-O 122.061 0.934 . . . . 0.0 110.07 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.605 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -83.28 -5.3 59.09 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 114.003 -1.453 . . . . 0.0 112.703 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -87.35 -39.56 15.22 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 112.35 -2.205 . . . . 0.0 111.182 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.09 51.11 4.08 Favored Glycine 0 C--N 1.343 0.937 0 O-C-N 123.544 0.528 . . . . 0.0 113.362 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -109.87 -21.38 12.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.663 0.268 . . . . 0.0 111.178 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.07 26.55 59.85 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.933 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.74 175.49 11.93 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.279 0.631 . . . . 0.0 110.565 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 33.7 mm -130.8 94.72 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -50.92 153.65 1.73 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.274 0.63 . . . . 0.0 110.818 177.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.687 ' HA ' ' CE2' ' A' ' 68' ' ' PHE . 37.4 p90 -78.09 -39.56 1.8 Allowed Pre-proline 0 N--CA 1.477 0.917 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -177.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.525 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 17.0 Cg_exo -67.99 -18.03 46.24 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 121.818 1.679 . . . . 0.0 113.094 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -94.66 -25.54 16.71 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.687 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 1.9 p90 -84.56 -20.01 32.2 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -177.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' A' ' 73' ' ' ALA . 14.0 mt -77.36 -34.18 55.16 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.75 0.786 . . . . 0.0 109.457 176.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.504 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 0.6 OUTLIER -54.61 -35.16 63.11 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 113.049 -1.887 . . . . 0.0 110.002 174.895 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.822 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 11.2 ptm -76.66 -25.48 53.77 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 123.695 0.622 . . . . 0.0 109.491 176.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 68.8 mtt -87.8 -18.58 29.02 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 124.09 0.869 . . . . 0.0 110.46 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . -76.7 -35.14 58.05 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.504 ' HD2' ' O ' ' A' ' 70' ' ' THR . 2.8 ptm180 -80.11 -19.0 48.39 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 178.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.822 ' HG2' ' O ' ' A' ' 71' ' ' MET . 69.2 mmtt -73.32 -14.39 61.29 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 176.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 27.1 ptm -120.34 -31.48 4.35 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -177.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.551 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 34.7 mmtt -76.8 -28.6 55.68 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -178.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -104.2 -10.74 17.69 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.4 t -72.85 -4.6 32.75 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.571 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 2.1 m-20 64.65 135.99 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.709 0.803 . . . . 0.0 111.826 -179.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 52.5 m -83.06 -13.59 55.49 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.601 ' O ' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -78.99 -51.64 9.33 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.391 0.615 . . . . 0.0 110.642 -178.42 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.536 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 10.2 pt-20 -79.37 -17.91 53.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.667 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.579 ' HA ' ' OE2' ' A' ' 87' ' ' GLU . 8.4 tt0 -64.09 -18.46 64.42 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.152 0.581 . . . . 0.0 112.348 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.601 HD13 ' O ' ' A' ' 82' ' ' GLU . 2.3 mt -86.65 -54.6 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.829 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -58.01 -25.0 60.53 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.602 179.702 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.579 ' OE2' ' HA ' ' A' ' 84' ' ' GLU . 2.3 pt-20 -81.06 -20.61 41.25 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 123.684 0.615 . . . . 0.0 110.224 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.63 -20.99 61.9 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.465 177.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.45 ' HE2' ' O ' ' A' ' 98' ' ' GLY . 3.6 m-85 -81.15 -20.97 40.16 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 173.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.424 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 10.6 tpt180 -77.34 -20.54 54.72 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 174.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 65.1 t -88.04 -53.55 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 CA-C-N 114.248 -1.342 . . . . 0.0 112.033 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.544 ' CE2' HG11 ' A' ' 108' ' ' VAL . 35.2 m-85 -100.38 -45.89 5.43 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -176.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.706 ' CA ' HG12 ' A' ' 100' ' ' ILE . 2.4 t70 -64.02 93.2 0.08 Allowed 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.843 0.83 . . . . 0.0 111.557 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.748 ' HZ1' ' HD1' ' A' ' 107' ' ' HIS . 31.8 mttm -87.93 -48.0 8.13 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 114.056 -1.429 . . . . 0.0 113.751 -179.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.417 ' HB2' ' OE2' ' A' ' 104' ' ' GLU . 5.2 t70 -71.82 1.29 7.21 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -175.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 48.74 29.27 7.76 Favored Glycine 0 N--CA 1.473 1.164 0 CA-C-N 114.289 -1.323 . . . . 0.0 114.883 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -99.67 -4.7 30.29 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.678 0.239 . . . . 0.0 111.401 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.45 ' O ' ' HE2' ' A' ' 89' ' ' PHE . . . 101.56 -18.79 52.64 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 121.287 -0.482 . . . . 0.0 112.726 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -116.03 118.37 32.71 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.458 -0.871 . . . . 0.0 110.707 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.706 HG12 ' CA ' ' A' ' 93' ' ' ASP . 31.5 mt -80.45 90.58 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.9 t -66.65 161.42 23.37 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.308 -0.86 . . . . 0.0 113.071 -177.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.2 -14.94 8.11 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.73 -29.36 19.89 Favored 'General case' 0 CA--C 1.489 -1.376 0 CA-C-O 121.994 0.902 . . . . 0.0 109.283 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.937 ' O ' HG22 ' A' ' 108' ' ' VAL . 3.4 mm-40 -79.46 -40.21 30.37 Favored 'General case' 0 CA--C 1.483 -1.627 0 CA-C-N 112.509 -2.132 . . . . 0.0 110.852 -178.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.664 HD11 ' CE2' ' B' ' 154' ' ' PHE . 5.2 tt -64.91 -34.92 79.55 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 176.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.514 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -69.21 -45.9 68.73 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.035 175.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.748 ' HD1' ' HZ1' ' A' ' 94' ' ' LYS . 9.1 t-80 -69.05 -21.58 64.08 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.715 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.937 HG22 ' O ' ' A' ' 104' ' ' GLU . 3.1 t -72.07 -49.84 41.16 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.203 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.499 ' O ' ' N ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -62.94 -37.15 85.89 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 111.57 -2.559 . . . . 0.0 112.257 177.41 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -69.9 -19.05 63.43 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 119.499 -0.881 . . . . 0.0 109.277 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.67 -45.05 19.75 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.087 175.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mt -80.28 -28.39 38.34 Favored 'General case' 0 C--N 1.35 0.608 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.169 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 109' ' ' MET . . . 139.85 -11.14 3.13 Favored Glycine 0 CA--C 1.537 1.465 0 N-CA-C 117.126 1.61 . . . . 0.0 117.126 178.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.55 ' OE1' ' HG2' ' B' ' 152' ' ' LYS . 4.3 mt-10 -101.11 153.66 19.38 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-N 120.949 2.374 . . . . 0.0 114.316 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -109.01 125.92 52.57 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 113.769 -1.56 . . . . 0.0 106.996 174.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.514 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 1.2 tp -130.25 115.5 17.07 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.191 -1.368 . . . . 0.0 112.074 -175.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.815 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -77.15 -175.69 3.73 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.664 179.476 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.529 ' N ' HG22 ' A' ' 117' ' ' THR . 16.7 t70 -72.34 -38.23 68.65 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -178.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -89.1 -16.03 32.5 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.626 ' CD ' ' H ' ' A' ' 117' ' ' THR . 14.4 pt-20 -85.63 -16.0 40.63 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 123.096 0.248 . . . . 0.0 110.816 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -82.57 -25.03 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 178.139 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -69.33 28.08 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.984 0.897 . . . . 0.0 113.126 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.57 ' H ' ' C ' ' A' ' 121' ' ' VAL . 11.7 pt-20 -137.94 -27.63 0.9 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.636 177.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.606 ' SD ' ' HA ' ' B' ' 153' ' ' THR . 1.3 mmt -81.25 -32.15 33.45 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 176.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.566 ' O ' ' HB3' ' A' ' 129' ' ' ASP . 2.6 mt -88.1 -44.38 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.303 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.506 ' HA ' ' CG ' ' A' ' 129' ' ' ASP . 63.1 mtt180 -59.31 -27.62 66.03 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 124.117 0.885 . . . . 0.0 111.732 -179.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.542 ' OE2' ' HD3' ' B' ' 155' ' ' LYS . 0.0 OUTLIER -63.43 -28.43 69.97 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.294 177.292 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.798 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -121.28 -16.41 7.92 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 123.36 0.413 . . . . 0.0 111.357 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.566 ' HB3' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -58.54 118.73 5.94 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 122.192 0.996 . . . . 0.0 112.792 -178.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 32.5 mm -90.91 -53.39 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 113.616 -1.629 . . . . 0.0 110.641 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -91.4 -25.3 19.43 Favored 'General case' 0 C--N 1.344 0.358 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.477 ' HA2' ' OD2' ' A' ' 129' ' ' ASP . . . 82.83 49.61 5.0 Favored Glycine 0 CA--C 1.523 0.558 0 O-C-N 123.476 0.485 . . . . 0.0 113.826 178.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -93.37 -19.47 21.29 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 100.69 16.32 26.77 Favored Glycine 0 CA--C 1.5 -0.892 0 CA-C-O 121.758 0.643 . . . . 0.0 112.549 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -138.02 176.57 8.58 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 113.315 -1.443 . . . . 0.0 108.144 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.619 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 2.3 t -140.65 130.52 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 121.303 0.573 . . . . 0.0 112.422 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -91.36 -168.45 2.05 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.032 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.489 ' O ' HG21 ' A' ' 142' ' ' VAL . 80.8 m-85 -66.79 -57.86 6.21 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.44 177.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -59.18 -20.84 57.33 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.798 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 4.5 mt-10 -87.08 -44.27 11.67 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.003 178.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -70.79 -22.87 62.32 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.094 176.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.489 HG21 ' O ' ' A' ' 138' ' ' TYR . 37.6 t -84.26 -45.83 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.91 -178.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.565 ' O ' ' N ' ' A' ' 147' ' ' ALA . 43.6 mt-30 -61.73 -26.02 67.8 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.312 177.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 6.3 tmm? -64.58 -24.07 67.48 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 123.814 0.696 . . . . 0.0 110.807 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.484 ' HG3' ' O ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -84.49 -7.86 59.14 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 123.206 0.316 . . . . 0.0 110.225 178.352 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.0 t -122.4 -34.89 3.2 Favored 'General case' 0 C--N 1.349 0.554 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.875 178.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -35.14 -35.24 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 94.0 mttt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.097 -0.954 . . . . 0.0 111.675 179.954 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 19.5 p . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 120.371 0.129 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -98.02 -39.96 8.68 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.525 0.515 . . . . 0.0 111.346 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -115.2 128.27 56.06 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.387 0.429 . . . . 0.0 110.793 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . 0.55 ' HG2' ' OE1' ' A' ' 114' ' ' GLU . 11.7 mptt 60.87 115.81 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.907 0.883 . . . . 0.0 111.882 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.633 ' O ' HG23 ' B' ' 157' ' ' VAL . 10.9 t -175.11 172.2 2.85 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.355 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 154' ' ' PHE . . . . . 0.664 ' CE2' HD11 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -54.88 -27.81 45.58 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.278 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . 0.542 ' HD3' ' OE2' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -72.06 -52.3 17.51 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.817 0.447 . . . . 0.0 111.102 178.61 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -77.27 -36.42 54.34 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 157' ' ' VAL . . . . . 0.633 HG23 ' O ' ' B' ' 153' ' ' THR . 20.5 m -71.89 -38.7 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' B' ' 162' ' ' LYS . . . -73.66 -33.16 64.35 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.834 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -58.95 -31.94 69.16 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.542 0.526 . . . . 0.0 111.341 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.08 -37.6 54.11 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.484 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 9.4 p -103.75 21.57 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.256 0 O-C-N 123.47 0.481 . . . . 0.0 111.575 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 162' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 5.9 ttmt -91.06 -16.22 28.24 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.256 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 3.6 tp -95.6 -8.83 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.237 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 21.7 t -88.66 84.81 6.72 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.452 0.644 . . . . 0.0 110.311 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . -130.13 -40.65 1.3 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.263 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 23.7 t -112.9 -32.09 6.5 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.798 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 9.1 tp -90.91 31.07 1.11 Allowed 'General case' 0 CA--C 1.548 0.893 0 O-C-N 123.415 0.447 . . . . 0.0 110.83 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.24 137.57 33.96 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.531 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -100.58 -148.87 22.81 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.588 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 19.8 p . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.041 -179.964 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.376 0 N-CA-C 111.315 0.117 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -128.45 121.67 29.49 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 123.453 0.471 . . . . 0.0 110.724 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.552 ' HG3' ' O ' ' A' ' 66' ' ' PRO . 20.2 mm-40 -97.06 -57.73 2.2 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.668 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.476 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -118.07 -119.83 0.31 Allowed 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.768 179.569 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.544 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 15.7 p -102.21 -173.62 2.38 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 124.024 0.93 . . . . 0.0 112.6 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.436 ' HA ' ' CG1' ' A' ' 9' ' ' ILE . 46.6 mt-10 -60.56 -25.14 65.96 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.709 0.804 . . . . 0.0 112.997 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.544 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 11.3 pt-20 -53.55 -33.55 55.1 Favored 'General case' 0 N--CA 1.479 1.025 0 O-C-N 123.791 0.682 . . . . 0.0 111.585 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.483 HE22 ' HB2' ' A' ' 3' ' ' GLN . 0.6 OUTLIER -75.86 -45.29 36.44 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.605 177.041 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.563 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . 33.5 mm -54.88 -38.15 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.643 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.63 -35.24 70.36 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -113.96 -17.96 11.86 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.563 ' CE1' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -71.82 -16.23 62.16 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.724 0.693 . . . . 0.0 110.548 179.318 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.702 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 1.0 OUTLIER -82.18 -41.83 19.84 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.576 179.269 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.702 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 1.4 mt-10 -81.75 -37.6 26.98 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 114.087 -1.415 . . . . 0.0 112.297 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.519 ' O ' HG13 ' A' ' 35' ' ' VAL . . . -66.13 -22.24 66.37 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.27 0.557 . . . . 0.0 109.507 178.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.937 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 21.7 t80 -87.04 -45.24 10.92 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.038 176.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.3 m -86.35 -12.59 48.92 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -176.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -72.43 -29.8 64.04 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.559 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.566 ' CD1' HG23 ' A' ' 35' ' ' VAL . 8.3 m-85 -131.35 -7.06 3.77 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.937 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 1.2 m-20 -99.46 79.69 2.31 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.608 0.64 . . . . 0.0 110.028 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.444 ' N ' ' HD2' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -75.77 -41.49 52.87 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -178.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.634 ' OD1' ' HB2' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -71.0 -21.96 62.22 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.248 177.305 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.05 51.57 5.31 Favored Glycine 0 N--CA 1.468 0.798 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.634 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -95.41 22.29 7.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.645 -1.278 . . . . 0.0 114.344 -175.286 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.25 -63.13 0.39 Allowed Glycine 0 CA--C 1.527 0.816 0 CA-C-N 115.405 -0.816 . . . . 0.0 114.472 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.686 HG23 ' N ' ' A' ' 64' ' ' ASP . 11.8 p -97.39 155.42 16.91 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 123.487 0.715 . . . . 0.0 112.252 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.549 HG21 ' OD2' ' A' ' 20' ' ' ASP . 0.7 OUTLIER -115.51 149.2 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.217 -179.604 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.514 ' HG1' ' CD ' ' A' ' 31' ' ' GLU . 0.6 OUTLIER -56.29 151.45 12.76 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -178.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.457 ' H ' ' HG1' ' A' ' 29' ' ' THR . 0.8 OUTLIER -72.14 -55.7 6.85 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -179.23 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -55.8 -13.41 1.74 Allowed 'General case' 0 N--CA 1.473 0.675 0 O-C-N 123.73 0.644 . . . . 0.0 111.319 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.514 ' CD ' ' HG1' ' A' ' 28' ' ' THR . 20.1 mt-10 -114.6 -16.53 11.84 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.222 -0.899 . . . . 0.0 113.049 -177.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.612 ' HA ' HG22 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -56.95 -38.02 72.36 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.638 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.735 ' O ' ' HD3' ' A' ' 37' ' ' ARG . . . -57.11 -39.02 89.13 Favored Glycine 0 C--N 1.34 0.799 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 177.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.5 m -74.03 -30.8 62.61 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 114.497 -0.851 . . . . 0.0 112.348 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.612 HG22 ' HA ' ' A' ' 32' ' ' LEU . 0.9 OUTLIER -73.22 -27.43 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 176.733 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.559 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 30.1 mmt -75.2 -41.16 58.4 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 112.912 -1.949 . . . . 0.0 111.636 176.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.735 ' HD3' ' O ' ' A' ' 33' ' ' GLY . 10.3 mtp180 -82.16 -29.53 31.5 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.5 m -67.48 -8.32 32.64 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.938 0.875 . . . . 0.0 111.965 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 35' ' ' VAL . 83.4 mt -89.42 -9.86 48.66 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 113.327 -1.76 . . . . 0.0 109.62 177.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.27 -4.81 23.52 Favored Glycine 0 CA--C 1.491 -1.409 0 CA-C-O 122.168 0.871 . . . . 0.0 114.912 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.582 ' OE1' HD22 ' B' ' 167' ' ' LEU . 47.1 mt-30 -77.32 137.72 38.93 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 112.371 -1.914 . . . . 0.0 111.902 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -126.79 66.51 65.73 Favored Pre-proline 0 CA--C 1.551 1.001 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.59 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.403 ' HD3' ' C ' ' A' ' 41' ' ' GLN . 2.1 Cg_endo -86.17 -177.8 2.58 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 123.017 2.478 . . . . 0.0 112.047 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.488 ' OG1' ' N ' ' A' ' 45' ' ' GLU . 7.5 t -98.13 -175.17 3.05 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.17 0.986 . . . . 0.0 110.527 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.488 ' N ' ' OG1' ' A' ' 44' ' ' THR . 46.2 mt-10 -81.06 -24.01 38.11 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 112.99 -1.914 . . . . 0.0 108.582 177.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.49 -30.89 68.87 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.811 -1.54 . . . . 0.0 112.033 -177.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.1 -29.21 22.03 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.369 176.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.796 ' O ' HG12 ' A' ' 52' ' ' ILE . 0.4 OUTLIER -68.06 -20.54 64.98 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.263 175.064 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.751 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 46.6 mt-30 -98.16 -17.2 19.16 Favored 'General case' 0 CA--C 1.478 -1.807 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.958 177.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -80.79 -30.23 35.97 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 111.999 -2.364 . . . . 0.0 108.871 176.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.597 ' SD ' ' HZ ' ' A' ' 68' ' ' PHE . 41.9 mtm -86.71 -32.03 20.69 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.339 177.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.796 HG12 ' O ' ' A' ' 48' ' ' LEU . 36.4 mm -73.76 -27.35 22.72 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 175.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.751 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 2.7 t30 -75.67 -35.5 60.36 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.491 176.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -86.16 -35.6 20.03 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.619 ' C ' ' H ' ' A' ' 57' ' ' ALA . 43.6 t -77.33 -43.6 30.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -70.73 31.7 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.831 0.824 . . . . 0.0 111.26 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.619 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -87.22 -7.35 58.0 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.979 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -113.94 -37.23 4.55 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 111.829 -2.441 . . . . 0.0 110.714 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.63 43.11 7.01 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.849 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -110.29 -21.79 12.05 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.44 26.87 73.52 Favored Glycine 0 N--CA 1.468 0.781 0 CA-C-N 115.861 -0.609 . . . . 0.0 114.359 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.67 156.93 43.95 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 123.329 0.652 . . . . 0.0 110.464 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.459 ' C ' HG23 ' A' ' 26' ' ' THR . 2.8 mp -133.38 127.67 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -177.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.686 ' N ' HG23 ' A' ' 26' ' ' THR . 0.2 OUTLIER -76.85 159.35 30.13 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.071 176.213 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.576 ' CG ' ' HD3' ' A' ' 66' ' ' PRO . 12.6 p90 -91.31 -39.89 0.38 Allowed Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -177.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.576 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 7.7 Cg_exo -73.46 -18.58 22.77 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 121.765 1.643 . . . . 0.0 112.814 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -98.16 -11.8 22.4 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.597 ' HZ ' ' SD ' ' A' ' 51' ' ' MET . 37.1 t80 -84.32 -40.41 17.96 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -178.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 73' ' ' ALA . 0.8 OUTLIER -64.38 -33.75 76.58 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 121.56 0.695 . . . . 0.0 110.25 177.659 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.474 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -55.92 -34.19 65.37 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 113.38 -1.736 . . . . 0.0 108.917 174.382 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.701 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 65.8 mtt -70.21 -36.43 74.58 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.23 175.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.561 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 61.6 mtm -79.47 -19.32 50.06 Favored 'General case' 0 CA--C 1.508 -0.651 0 O-C-N 124.18 0.925 . . . . 0.0 110.88 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.531 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -75.82 -40.1 55.54 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.556 ' HG2' ' O ' ' A' ' 71' ' ' MET . 2.6 ptm180 -77.15 -17.79 58.33 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.701 ' HD2' ' O ' ' A' ' 71' ' ' MET . 23.8 mttt -75.23 -14.93 60.56 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 13.1 ptt? -125.88 -28.32 3.22 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -177.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 35.0 mttm -64.87 -13.12 55.35 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -93.72 -29.64 15.29 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 9.4 t -84.07 26.42 0.74 Allowed 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.581 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 2.0 t70 64.41 149.44 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.21 1.004 . . . . 0.0 112.089 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.568 ' HA ' ' OE2' ' A' ' 84' ' ' GLU . 13.4 t -83.01 -14.1 54.61 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.954 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.493 ' HB3' ' OD1' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -84.58 -44.96 13.04 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.772 0.796 . . . . 0.0 109.247 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 79' ' ' THR . 43.3 mt-10 -68.05 -18.31 64.65 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 113.579 -1.646 . . . . 0.0 112.188 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.581 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 31.1 mt-10 -61.94 -27.48 68.86 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.7 mp -88.04 -52.77 10.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.82 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -60.9 -16.91 47.3 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.573 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 3.0 pt-20 -74.18 -20.33 60.24 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.1 0.476 . . . . 0.0 110.13 178.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.09 -20.4 64.07 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.59 177.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.489 ' HE2' ' O ' ' A' ' 98' ' ' GLY . 13.5 m-85 -82.01 -21.36 37.07 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 174.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.573 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 8.0 mtt180 -78.89 -19.2 52.46 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 114.119 -1.4 . . . . 0.0 107.532 174.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.4 t -87.85 -55.21 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.284 177.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.455 ' CE2' HG12 ' A' ' 108' ' ' VAL . 15.3 m-85 -101.05 -44.69 5.63 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -177.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.729 ' CA ' HG12 ' A' ' 100' ' ' ILE . 1.9 t70 -63.35 95.49 0.09 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.689 0.757 . . . . 0.0 112.23 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -86.81 -41.89 13.7 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 114.264 -1.334 . . . . 0.0 112.804 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -70.76 -18.88 62.76 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -176.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.17 19.99 68.7 Favored Glycine 0 C--N 1.295 -1.728 0 CA-C-N 112.774 -2.012 . . . . 0.0 114.074 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -92.13 -7.19 49.22 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.369 0.267 . . . . 0.0 111.413 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.489 ' O ' ' HE2' ' A' ' 89' ' ' PHE . . . 106.41 -18.74 38.08 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.786 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -115.18 118.39 33.2 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.611 -0.795 . . . . 0.0 111.094 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.729 HG12 ' CA ' ' A' ' 93' ' ' ASP . 53.1 mt -80.57 98.15 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.9 t -75.61 166.0 24.23 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.232 -0.895 . . . . 0.0 113.135 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.578 ' O ' HG12 ' A' ' 121' ' ' VAL . . . -62.83 -15.41 54.22 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -89.36 -31.91 17.56 Favored 'General case' 0 CA--C 1.488 -1.417 0 CA-C-O 121.969 0.89 . . . . 0.0 109.304 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 1.02 ' O ' HG21 ' A' ' 108' ' ' VAL . 2.9 mm-40 -78.6 -38.61 39.56 Favored 'General case' 0 CA--C 1.482 -1.636 0 CA-C-N 112.429 -2.169 . . . . 0.0 110.354 -178.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.556 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 5.1 tt -64.53 -36.7 85.07 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 176.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.6 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -70.9 -44.29 66.56 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.776 175.689 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.494 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 2.6 t60 -67.27 -21.83 65.69 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.542 177.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 1.02 HG21 ' O ' ' A' ' 104' ' ' GLU . 26.5 t -72.63 -51.01 30.27 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 176.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.528 ' O ' ' N ' ' A' ' 114' ' ' GLU . 17.6 mtt -55.99 -40.61 73.57 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 112.551 -2.113 . . . . 0.0 111.95 175.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.94 -19.14 64.17 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.299 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.82 -45.09 19.36 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.477 176.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.1 mt -79.18 -28.09 42.68 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.572 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 109' ' ' MET . . . 137.51 -7.28 3.64 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 117.857 -1.524 . . . . 0.0 116.671 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 109' ' ' MET . 5.0 mt-10 -101.42 153.42 19.7 Favored 'General case' 0 C--N 1.357 0.911 0 CA-C-N 120.667 2.233 . . . . 0.0 114.32 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.457 ' O ' HD11 ' A' ' 116' ' ' LEU . 5.2 mptt -111.7 128.65 56.14 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 113.827 -1.533 . . . . 0.0 107.769 175.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.6 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 1.1 tp -139.59 116.09 10.66 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.468 -1.242 . . . . 0.0 112.337 -176.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.926 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -71.57 -176.54 1.61 Allowed 'General case' 0 C--N 1.346 0.456 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.684 179.81 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.527 ' N ' HG22 ' A' ' 117' ' ' THR . 16.3 t70 -69.96 -40.79 75.22 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -177.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -83.8 -16.51 44.39 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.648 ' CD ' ' H ' ' A' ' 117' ' ' THR . 13.9 pt-20 -87.9 -15.77 35.74 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.316 0.385 . . . . 0.0 111.085 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.926 HG22 ' O ' ' A' ' 117' ' ' THR . 0.1 OUTLIER -86.15 -24.56 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.272 177.86 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -73.51 32.11 0.07 Allowed 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.72 0.771 . . . . 0.0 112.662 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.48 ' H ' ' C ' ' A' ' 121' ' ' VAL . 9.3 pt-20 -141.46 -32.99 0.52 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.269 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.506 ' HE3' ' N ' ' B' ' 153' ' ' THR . 17.8 ttm -74.2 -23.03 59.15 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.272 177.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.623 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 3.1 mt -89.16 -53.09 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.958 178.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -55.77 -28.86 58.21 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 124.204 0.94 . . . . 0.0 111.785 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.704 ' OE1' ' HD3' ' B' ' 155' ' ' LYS . 0.0 OUTLIER -63.37 -34.17 77.14 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.479 178.039 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.63 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -107.92 -30.33 8.54 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-O 121.209 0.528 . . . . 0.0 109.934 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.623 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -60.93 127.01 29.5 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.485 -1.234 . . . . 0.0 113.255 -178.753 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.9 mt -90.0 -48.28 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 113.737 -1.574 . . . . 0.0 110.525 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -84.12 -25.18 29.89 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 74.17 49.53 12.36 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 116.023 -0.535 . . . . 0.0 113.971 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -89.56 -19.49 24.93 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 98.71 13.34 40.98 Favored Glycine 0 CA--C 1.5 -0.884 0 CA-C-N 115.725 -0.67 . . . . 0.0 113.265 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -140.14 128.7 22.89 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.762 -1.219 . . . . 0.0 108.131 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.587 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 2.5 t -89.49 135.02 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -177.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -97.58 -163.24 1.03 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.399 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.417 ' CE1' HG21 ' A' ' 142' ' ' VAL . 0.0 OUTLIER -78.65 -51.22 10.18 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 123.558 0.743 . . . . 0.0 109.928 178.698 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -62.31 -20.78 64.68 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.63 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 12.4 mt-10 -87.66 -41.11 13.61 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.281 0.563 . . . . 0.0 110.216 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.589 ' O ' ' HE3' ' A' ' 144' ' ' MET . 73.3 t80 -72.13 -23.47 61.31 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.952 175.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.455 ' O ' ' HG3' ' A' ' 145' ' ' MET . 16.7 t -84.73 -47.55 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.573 -179.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.43 ' HA ' ' OG1' ' A' ' 146' ' ' THR . 31.3 mt-30 -64.85 -19.31 65.81 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.01 176.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.589 ' HE3' ' O ' ' A' ' 141' ' ' PHE . 4.5 ttp -67.55 -26.31 66.24 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.748 177.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.455 ' HG3' ' O ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -86.56 -4.4 59.17 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.71 177.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.43 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 39.6 p -119.03 -41.91 2.73 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.166 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -45.76 -34.35 3.59 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.3 pttm . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.453 -0.784 . . . . 0.0 111.38 179.813 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 111.358 0.133 . . . . 0.0 111.358 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -134.29 153.39 51.9 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.925 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 13.3 mptt 62.29 117.62 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.877 0.871 . . . . 0.0 112.237 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . 0.426 ' HB2' ' OE1' ' A' ' 123' ' ' GLU . 10.8 mptt -135.33 119.74 17.96 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.285 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.555 ' HB ' ' OE1' ' A' ' 127' ' ' GLU . 16.1 p -143.6 147.73 34.81 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 154' ' ' PHE . . . . . 0.648 ' O ' HG21 ' B' ' 157' ' ' VAL . 0.1 OUTLIER -67.28 -28.07 67.71 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.789 0.436 . . . . 0.0 110.016 178.099 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . 0.704 ' HD3' ' OE1' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -66.09 -33.49 75.9 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.61 178.224 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -76.76 -35.29 57.81 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.173 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 157' ' ' VAL . . . . . 0.648 HG21 ' O ' ' B' ' 154' ' ' PHE . 19.1 m -72.25 -29.42 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 122.763 0.425 . . . . 0.0 111.293 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.21 -46.34 72.46 Favored 'General case' 0 C--N 1.347 0.485 0 C-N-CA 123.857 0.863 . . . . 0.0 113.032 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -56.35 -25.57 49.72 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 120.743 0.306 . . . . 0.0 111.456 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.68 -43.95 29.56 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.052 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 11.5 p -142.33 57.14 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 162' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -136.88 86.22 2.19 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.303 0.573 . . . . 0.0 110.64 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 5.4 tp -149.18 -18.82 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.539 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 21.1 m 64.62 97.11 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.489 1.116 . . . . 0.0 113.483 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . 36.71 41.05 0.15 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 166' ' ' SER . . . . . 0.417 ' OG ' ' HB3' ' A' ' 72' ' ' MET . 13.9 t -95.59 -49.22 5.48 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.784 -0.189 . . . . 0.0 110.745 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.582 HD22 ' OE1' ' A' ' 41' ' ' GLN . 1.8 tp -127.56 -22.7 3.58 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 123.526 0.516 . . . . 0.0 111.007 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -95.2 145.55 24.96 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.381 0.425 . . . . 0.0 110.98 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . 100.04 -86.82 0.69 Allowed Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.505 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 19.6 p . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.048 -179.995 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.424 0 N-CA-C 111.375 0.139 . . . . 0.0 111.375 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 68.47 -62.78 0.36 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.335 1.054 . . . . 0.0 112.202 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -122.84 154.13 38.67 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 122.59 0.356 . . . . 0.0 110.621 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.512 HD13 ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -111.49 -110.7 0.34 Allowed 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.645 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.518 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 17.1 p -101.12 -173.71 2.44 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 123.794 0.838 . . . . 0.0 110.95 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -59.4 -24.58 63.58 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.518 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 12.0 pt-20 -54.98 -32.18 61.39 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.547 0.689 . . . . 0.0 111.667 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.416 ' HG3' ' N ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -77.11 -46.11 24.63 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.703 177.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.416 ' N ' ' HG3' ' A' ' 8' ' ' GLN . 11.7 mm -65.63 -34.77 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.242 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.24 -43.67 81.37 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -133.23 -31.05 1.28 Allowed 'General case' 0 C--N 1.358 0.976 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -176.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.73 -14.12 40.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.4 0.546 . . . . 0.0 111.806 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.708 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -78.59 -42.14 29.89 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.521 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.708 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 4.5 mt-10 -75.26 -43.6 50.49 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.588 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.598 ' O ' HG13 ' A' ' 35' ' ' VAL . . . -62.84 -18.85 63.46 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.554 0.692 . . . . 0.0 109.229 177.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.817 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 1.6 m-85 -86.76 -47.17 9.33 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.391 176.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.4 m -86.42 -13.24 46.84 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -177.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -70.48 -30.47 67.28 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.445 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.553 ' CD1' HG23 ' A' ' 35' ' ' VAL . 3.1 m-85 -124.52 -14.03 6.94 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.817 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 0.9 OUTLIER -101.58 82.85 2.34 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.195 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.462 ' HZ2' ' HA ' ' A' ' 19' ' ' PHE . 2.1 mppt? -75.42 -19.69 59.34 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -177.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.78 -21.62 29.9 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.51 51.92 4.69 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-N 113.851 -1.522 . . . . 0.0 109.634 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.48 15.36 18.04 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -175.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.96 -58.79 0.08 OUTLIER Glycine 0 CA--C 1.531 1.074 0 N-CA-C 115.447 0.939 . . . . 0.0 115.447 178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.517 ' H ' ' HG1' ' A' ' 26' ' ' THR . 0.5 OUTLIER -95.12 130.24 41.9 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 123.366 0.666 . . . . 0.0 112.282 -177.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.582 HG21 ' OD2' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -112.29 149.27 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.556 -179.856 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.73 148.23 43.56 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.419 ' C ' ' H ' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -70.14 -54.03 14.69 Favored 'General case' 0 C--N 1.345 0.375 0 C-N-CA 123.982 0.913 . . . . 0.0 112.751 179.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -52.76 -14.48 0.55 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.447 177.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.627 ' O ' HG22 ' A' ' 35' ' ' VAL . 27.8 mt-10 -113.02 -19.1 12.03 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.864 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -57.14 -37.56 72.2 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.69 0.796 . . . . 0.0 111.518 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.842 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -56.31 -41.02 86.58 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 177.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.5 m -75.22 -27.6 59.61 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.496 -0.852 . . . . 0.0 112.134 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 31' ' ' GLU . 1.4 t -76.37 -26.01 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 176.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.569 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 14.6 mmt -75.38 -41.64 55.87 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 113.054 -1.885 . . . . 0.0 111.546 176.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.842 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 2.9 mtt85 -82.42 -28.19 31.52 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.8 t -66.37 -7.97 22.57 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.988 0.899 . . . . 0.0 111.533 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 35' ' ' VAL . 62.7 mt -94.07 -4.15 49.91 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.205 -1.816 . . . . 0.0 110.11 178.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.33 -11.31 19.54 Favored Glycine 0 CA--C 1.495 -1.215 0 N-CA-C 115.601 1.0 . . . . 0.0 115.601 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.569 ' HB2' ' O ' ' A' ' 36' ' ' MET . 44.1 mt-30 -66.64 155.19 38.58 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 113.057 -1.572 . . . . 0.0 111.686 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -80.39 135.87 53.28 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.661 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 90.7 Cg_endo -86.78 108.65 0.79 Allowed 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 122.362 2.041 . . . . 0.0 115.292 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.38 150.08 52.29 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 176.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -80.73 -29.33 36.36 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 121.77 0.795 . . . . 0.0 109.183 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 50' ' ' ASP . . . -73.5 -31.74 63.88 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 113.304 -1.771 . . . . 0.0 109.766 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.427 ' HB3' HH21 ' A' ' 37' ' ' ARG . 25.3 tt0 -81.74 -28.22 33.47 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 113.786 -1.552 . . . . 0.0 109.197 177.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.67 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -73.43 -18.85 61.09 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.73 174.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.896 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 54.2 mt-30 -99.02 -16.03 18.84 Favored 'General case' 0 CA--C 1.482 -1.65 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.123 177.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 2.2 t70 -87.31 -37.32 17.25 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 112.166 -2.288 . . . . 0.0 110.524 176.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.602 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 0.7 OUTLIER -86.58 -32.43 20.66 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.597 178.038 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.67 ' HB ' ' O ' ' A' ' 48' ' ' LEU . 1.6 mp -74.28 -23.56 18.48 Favored 'Isoleucine or valine' 0 C--N 1.341 0.204 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 174.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.896 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.5 t-20 -69.63 -35.02 74.86 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.462 174.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.602 ' HG3' ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -86.74 -42.17 13.55 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 179.649 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.613 ' C ' ' H ' ' A' ' 57' ' ' ALA . 55.6 t -69.11 -43.14 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -71.97 34.53 0.06 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.998 0.904 . . . . 0.0 110.839 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.613 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -86.73 -5.69 59.05 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 114.108 -1.405 . . . . 0.0 112.011 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -104.89 -37.0 7.17 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 111.997 -2.365 . . . . 0.0 110.769 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.33 27.59 35.93 Favored Glycine 0 C--N 1.344 0.993 0 CA-C-N 116.053 -0.522 . . . . 0.0 114.303 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -110.28 -21.45 12.22 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.92 0.36 . . . . 0.0 111.777 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.32 26.4 70.45 Favored Glycine 0 N--CA 1.466 0.663 0 CA-C-N 115.785 -0.643 . . . . 0.0 114.177 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.447 ' CG2' ' HB ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -144.87 174.97 10.55 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 123.728 0.811 . . . . 0.0 109.916 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.532 ' HA ' ' CE2' ' A' ' 68' ' ' PHE . 5.3 mp -132.92 96.77 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.1 167.56 17.7 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.167 175.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.694 ' CD1' ' HD3' ' A' ' 66' ' ' PRO . 4.8 p90 -91.83 -39.32 0.37 Allowed Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -178.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.694 ' HD3' ' CD1' ' A' ' 65' ' ' PHE . 12.6 Cg_exo -70.71 -16.93 33.56 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.298 1.999 . . . . 0.0 112.692 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -106.14 -39.92 5.81 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -177.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.532 ' CE2' ' HA ' ' A' ' 63' ' ' ILE . 80.3 m-85 -85.69 -38.23 18.54 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -175.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.512 ' HB3' HD13 ' A' ' 4' ' ' LEU . 4.9 mt -63.8 -30.89 71.94 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.757 0.789 . . . . 0.0 110.01 177.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.602 ' O ' ' HD3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -55.73 -34.89 65.56 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 113.097 -1.865 . . . . 0.0 109.007 174.485 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.606 ' HA ' ' NE ' ' A' ' 74' ' ' ARG . 68.6 mtt -71.54 -30.4 65.86 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.51 175.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.523 ' HA ' ' CD ' ' A' ' 75' ' ' LYS . 0.9 OUTLIER -85.5 -18.37 33.69 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.702 178.29 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.673 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -80.49 -34.26 35.89 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.606 ' NE ' ' HA ' ' A' ' 71' ' ' MET . 2.5 ptt180 -81.21 -20.21 41.59 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.59 ' HD2' ' O ' ' A' ' 71' ' ' MET . 5.8 ptmt -84.45 -12.81 53.66 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.41 177.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.545 ' SD ' HD11 ' B' ' 163' ' ' ILE . 25.5 ptm -109.36 -33.51 6.81 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.159 0.504 . . . . 0.0 111.482 -178.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.673 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 26.8 mttt -75.57 -29.65 59.39 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.77 -1.105 . . . . 0.0 113.241 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -89.96 -29.46 18.46 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.8 t -66.57 101.4 0.77 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.105 0.479 . . . . 0.0 111.389 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.481 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 2.6 t70 -54.81 161.54 1.53 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.144 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.5 t -66.1 -13.78 60.66 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.571 ' O ' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -81.58 -46.03 15.02 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.597 0.713 . . . . 0.0 109.767 -179.574 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 37.6 mt-10 -77.66 -18.91 56.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.016 -1.447 . . . . 0.0 112.428 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.481 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 37.7 mt-10 -68.08 -18.02 64.55 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.781 0.432 . . . . 0.0 111.937 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.571 HD13 ' O ' ' A' ' 82' ' ' GLU . 2.1 mt -87.31 -57.72 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.8 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.694 ' O ' ' HD1' ' A' ' 89' ' ' PHE . 8.7 mpt_? -56.06 -16.6 5.24 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.777 ' O ' HG23 ' A' ' 91' ' ' VAL . 47.3 mt-10 -78.17 -20.76 51.31 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.764 -0.198 . . . . 0.0 111.076 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.17 -21.13 61.48 Favored 'General case' 0 CA--C 1.518 -0.276 0 O-C-N 123.772 0.67 . . . . 0.0 110.601 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.694 ' HD1' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -84.94 -20.95 29.86 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 175.217 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -79.89 -25.2 40.69 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.218 175.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 87' ' ' GLU . 42.4 t -88.15 -56.18 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.194 178.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.562 ' CG ' HG11 ' A' ' 108' ' ' VAL . 9.1 m-85 -100.75 -46.06 5.28 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -176.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.706 ' CA ' HG12 ' A' ' 100' ' ' ILE . 15.8 t70 -59.71 94.45 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.652 0.739 . . . . 0.0 112.316 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.633 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 15.7 mttm -88.3 -47.14 8.63 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 114.271 -1.331 . . . . 0.0 113.816 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -71.63 2.45 5.18 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -176.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 49.19 28.64 8.64 Favored Glycine 0 N--CA 1.473 1.153 0 CA-C-N 114.258 -1.337 . . . . 0.0 115.082 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -99.11 -5.84 29.44 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.754 0.277 . . . . 0.0 111.325 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.07 -19.03 53.57 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.703 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -117.4 118.18 31.53 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.507 -0.846 . . . . 0.0 110.67 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.706 HG12 ' CA ' ' A' ' 93' ' ' ASP . 18.5 mt -80.31 103.57 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 178.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.404 ' OG ' ' HG2' ' A' ' 104' ' ' GLU . 13.0 p -78.08 162.64 26.54 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.47 -14.76 13.78 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -177.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.99 -33.66 17.11 Favored 'General case' 0 CA--C 1.486 -1.483 0 CA-C-O 122.157 0.98 . . . . 0.0 109.096 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.917 ' O ' HG21 ' A' ' 108' ' ' VAL . 3.5 mm-40 -76.41 -42.26 44.92 Favored 'General case' 0 CA--C 1.481 -1.7 0 CA-C-N 112.446 -2.161 . . . . 0.0 109.691 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.543 HD23 ' O ' ' A' ' 105' ' ' LEU . 8.0 tt -60.11 -33.35 72.01 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.643 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -72.65 -45.18 60.21 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.603 -1.181 . . . . 0.0 108.475 176.401 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.522 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 2.2 t60 -69.03 -21.53 64.1 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 114.152 -1.386 . . . . 0.0 108.803 177.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.917 HG21 ' O ' ' A' ' 104' ' ' GLU . 27.3 t -73.67 -51.19 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.775 ' SD ' HD23 ' A' ' 116' ' ' LEU . 16.2 mtt -56.66 -41.21 76.86 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 112.354 -2.203 . . . . 0.0 111.717 175.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 m -70.38 -19.07 63.05 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.346 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.562 ' ND2' ' HZ2' ' A' ' 94' ' ' LYS . 0.6 OUTLIER -79.22 -44.74 21.23 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.588 176.554 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.3 mt -81.75 -28.44 33.31 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.706 -178.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 141.83 -9.99 2.58 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-O 117.616 -1.658 . . . . 0.0 117.05 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.578 ' N ' ' O ' ' A' ' 109' ' ' MET . 5.1 mt-10 -100.97 152.54 20.45 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-N 121.082 2.441 . . . . 0.0 114.476 -178.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.479 ' O ' HD11 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -109.35 129.7 55.52 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 113.796 -1.547 . . . . 0.0 107.741 175.737 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.775 HD23 ' SD ' ' A' ' 109' ' ' MET . 1.2 tp -140.14 115.53 9.96 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.62 -1.173 . . . . 0.0 112.436 -176.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.796 ' O ' HG21 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -75.31 -175.89 2.9 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.82 179.551 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.514 ' N ' HG23 ' A' ' 117' ' ' THR . 16.1 t70 -72.35 -37.47 68.82 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 -177.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.406 ' HA ' ' OD2' ' A' ' 122' ' ' ASP . 8.4 pt-20 -88.98 -15.53 33.97 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.616 ' CD ' ' H ' ' A' ' 117' ' ' THR . 14.8 pt-20 -87.69 -16.2 35.01 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.396 0.141 . . . . 0.0 110.774 178.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.796 HG21 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -83.21 -27.17 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.908 177.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.406 ' OD2' ' HA ' ' A' ' 119' ' ' GLU . 2.9 p30 -67.08 26.54 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.581 ' H ' ' C ' ' A' ' 121' ' ' VAL . 10.4 pt-20 -142.3 -14.82 0.77 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.689 -1.142 . . . . 0.0 111.933 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.471 ' SD ' ' HE1' ' A' ' 109' ' ' MET . 7.2 ttm -88.41 -22.82 23.54 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.683 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 2.3 mp -88.05 -46.89 15.78 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 CA-C-N 114.385 -1.28 . . . . 0.0 113.07 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -61.29 -31.4 71.22 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.575 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 5.0 mm-40 -69.74 -32.79 71.52 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.135 177.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.623 ' HB2' ' CD2' ' B' ' 154' ' ' PHE . . . -94.38 -40.75 9.77 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.576 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.683 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.2 OUTLIER -60.83 119.45 8.24 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.842 -1.526 . . . . 0.0 113.695 -178.355 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.3 mt -90.78 -39.25 11.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 112.964 -1.926 . . . . 0.0 110.136 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -95.91 -25.26 16.05 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.376 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.39 49.84 5.66 Favored Glycine 0 CA--C 1.526 0.727 0 O-C-N 123.464 0.478 . . . . 0.0 114.146 178.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -90.96 -19.73 22.94 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 94.18 13.62 53.82 Favored Glycine 0 CA--C 1.503 -0.692 0 CA-C-O 121.508 0.505 . . . . 0.0 113.39 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -140.03 122.46 16.1 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 113.833 -1.184 . . . . 0.0 108.32 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.527 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 3.3 t -83.86 118.4 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.531 0.681 . . . . 0.0 111.971 -178.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -84.43 -163.49 0.81 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 114.095 -1.411 . . . . 0.0 110.586 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.427 ' O ' HG23 ' A' ' 142' ' ' VAL . 37.1 m-85 -70.85 -55.62 8.1 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.786 178.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 143' ' ' GLN . 43.1 mt-10 -65.02 -20.46 66.5 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.602 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 7.8 mt-10 -87.56 -33.63 18.85 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 121.349 0.595 . . . . 0.0 109.677 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.499 ' O ' ' HE1' ' A' ' 144' ' ' MET . 78.0 t80 -78.85 -23.62 44.89 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.23 176.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 138' ' ' TYR . 38.0 t -85.88 -40.76 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 114.802 -1.09 . . . . 0.0 112.432 -177.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.554 ' HA ' ' OG1' ' A' ' 146' ' ' THR . 7.9 mt-30 -50.19 -31.64 14.32 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.66 ' HB3' ' CD2' ' B' ' 154' ' ' PHE . 19.2 ptt? -63.0 -31.4 72.52 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 118.437 0.562 . . . . 0.0 110.83 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.583 ' SD ' ' HD2' ' B' ' 162' ' ' LYS . 66.0 mtm -82.6 -3.95 56.92 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.914 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.554 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 39.6 p -119.24 -42.53 2.67 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.689 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -48.32 -33.12 8.38 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 178.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.636 ' HZ3' HD22 ' B' ' 159' ' ' ASN . 97.2 mttt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.144 -0.931 . . . . 0.0 111.223 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 120.517 0.199 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -106.3 137.23 44.62 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.595 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -99.96 156.8 16.96 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.968 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . 0.444 ' HD3' ' OE1' ' A' ' 114' ' ' GLU . 97.7 mttt -91.68 126.66 36.84 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.97 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.529 HG21 ' OE1' ' A' ' 127' ' ' GLU . 77.9 p -133.7 178.01 7.27 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.619 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 154' ' ' PHE . . . . . 0.727 ' CE1' ' HD2' ' B' ' 155' ' ' LYS . 0.1 OUTLIER -63.77 -28.36 69.82 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.506 0.139 . . . . 0.0 111.017 179.197 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . 0.727 ' HD2' ' CE1' ' B' ' 154' ' ' PHE . 7.1 mptt -65.59 -34.13 77.53 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.955 0.502 . . . . 0.0 111.687 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -76.52 -49.93 15.24 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 157' ' ' VAL . . . . . . . . . . . . . 7.8 p -72.22 -26.72 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 122.708 0.403 . . . . 0.0 111.957 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . 0.65 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -51.95 -42.82 63.16 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . 0.636 HD22 ' HZ3' ' A' ' 148' ' ' LYS . 41.2 m-80 -71.51 -20.88 62.0 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.394 0.434 . . . . 0.0 111.362 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.09 -37.67 53.91 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.288 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 2.6 m -90.53 -29.94 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 162' ' ' LYS . . . . . 0.583 ' HD2' ' SD ' ' A' ' 145' ' ' MET . 7.3 mtpt -65.4 132.4 48.89 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.444 0.298 . . . . 0.0 111.408 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 163' ' ' ILE . . . . . 0.545 HD11 ' SD ' ' A' ' 76' ' ' MET . 2.0 tp 56.44 17.12 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 124.655 1.182 . . . . 0.0 112.612 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 55.9 m -113.82 -36.19 4.91 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.452 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . -90.51 7.19 40.23 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.313 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 166' ' ' SER . . . . . 0.409 ' O ' ' HE2' ' A' ' 75' ' ' LYS . 54.4 m -86.03 16.94 3.82 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.561 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 7.3 tp -86.09 12.34 9.82 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.977 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 85.8 mmm -92.16 130.63 37.83 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.968 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -152.57 139.33 6.93 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.508 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 20.0 p . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.137 -0.935 . . . . 0.0 111.033 179.97 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.498 0.189 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -128.43 123.05 32.77 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.56 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.69 ' HA ' ' OE1' ' A' ' 8' ' ' GLN . 17.0 pt20 -85.08 150.2 25.03 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.738 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.498 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -106.03 -112.0 0.27 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.616 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.534 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 15.6 p -101.49 -173.47 2.37 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 123.757 0.823 . . . . 0.0 111.19 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -56.71 -26.11 56.07 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.534 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 11.0 pt-20 -58.19 -30.12 66.19 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 121.415 0.626 . . . . 0.0 111.307 178.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.69 ' OE1' ' HA ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -78.99 -45.76 19.61 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.141 177.51 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.4 mm -60.03 -36.46 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.473 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.22 -35.24 59.13 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -107.88 -17.82 13.97 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -177.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.517 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -73.68 -16.16 61.21 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.36 0.527 . . . . 0.0 110.257 179.105 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.676 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -82.38 -40.72 20.91 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.345 179.25 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.676 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 1.2 mt-10 -83.68 -38.49 21.4 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.834 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.568 ' O ' HG11 ' A' ' 35' ' ' VAL . . . -65.43 -22.37 66.76 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.278 0.561 . . . . 0.0 109.659 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.546 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 25.0 t80 -87.17 -45.92 10.22 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.945 176.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.7 m -87.34 -13.65 42.95 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -177.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -68.89 -30.62 69.15 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.18 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.573 ' CD1' HG21 ' A' ' 35' ' ' VAL . 7.0 m-85 -129.43 -14.91 4.15 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.546 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -103.31 82.23 2.03 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 118.551 0.614 . . . . 0.0 109.894 178.622 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.423 ' HE2' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -83.33 -28.38 29.07 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.611 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.611 ' OD1' ' HB2' ' A' ' 24' ' ' ASP . 0.3 OUTLIER -71.25 -22.84 61.93 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.702 177.414 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.43 51.9 4.72 Favored Glycine 0 N--CA 1.469 0.842 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.611 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -98.42 21.99 10.35 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -175.484 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.41 -64.24 0.16 Allowed Glycine 0 CA--C 1.529 0.916 0 CA-C-N 115.344 -0.843 . . . . 0.0 114.539 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.686 HG22 ' N ' ' A' ' 64' ' ' ASP . 6.2 p -97.5 152.94 18.49 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 123.551 0.741 . . . . 0.0 112.122 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.652 HG13 ' O ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -112.37 148.66 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.269 -179.533 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.78 154.02 5.5 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.7 p -74.33 -56.17 5.17 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -57.5 -13.45 3.69 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.387 177.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.459 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 33.6 mt-10 -111.75 -16.75 13.13 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.683 -177.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.524 HD11 ' CZ ' ' A' ' 68' ' ' PHE . 1.1 tm? -56.8 -43.33 80.82 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.044 0.538 . . . . 0.0 111.493 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.768 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -52.6 -40.66 55.68 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 177.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.5 m -72.1 -32.57 67.12 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 114.746 -0.727 . . . . 0.0 112.871 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.573 HG21 ' CD1' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -73.11 -26.74 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 176.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.573 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 32.6 mmt -76.43 -40.65 50.08 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 112.953 -1.931 . . . . 0.0 111.475 176.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.768 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 9.9 mtt180 -80.59 -28.96 36.97 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 72.4 m -67.24 -8.52 32.35 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.957 0.884 . . . . 0.0 112.094 178.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 84.2 mt -93.61 -6.65 46.02 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.234 -1.803 . . . . 0.0 109.665 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.17 -4.69 31.69 Favored Glycine 0 CA--C 1.493 -1.29 0 N-CA-C 115.424 0.93 . . . . 0.0 115.424 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.573 ' HB2' ' O ' ' A' ' 36' ' ' MET . 48.7 mt-30 -78.78 137.84 37.92 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 112.43 -1.885 . . . . 0.0 112.272 -178.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.583 ' OD1' ' HA2' ' B' ' 169' ' ' GLY . 26.3 p-10 -120.82 67.17 14.5 Favored Pre-proline 0 CA--C 1.559 1.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.336 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.44 ' HD3' ' C ' ' A' ' 41' ' ' GLN . 2.0 Cg_endo -83.27 -177.83 3.46 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 123.112 2.541 . . . . 0.0 112.786 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.717 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 2.0 m -98.27 161.7 13.57 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 14.7 mt-10 -80.53 -29.33 37.18 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.736 0.779 . . . . 0.0 109.305 177.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.63 -32.94 73.99 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 113.476 -1.693 . . . . 0.0 109.653 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -76.0 -35.85 59.42 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 113.903 -1.499 . . . . 0.0 109.188 176.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.717 ' HG ' ' O ' ' A' ' 44' ' ' THR . 40.5 mt -64.39 -20.0 65.85 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 174.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.87 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 56.5 mt-30 -97.55 -14.85 20.81 Favored 'General case' 0 CA--C 1.481 -1.688 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.265 178.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -86.19 -35.62 19.97 Favored 'General case' 0 C--N 1.279 -2.476 0 CA-C-N 112.188 -2.278 . . . . 0.0 110.271 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -86.46 -31.06 21.57 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.226 177.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.605 ' HB ' ' O ' ' A' ' 48' ' ' LEU . 1.4 mp -74.75 -25.31 18.79 Favored 'Isoleucine or valine' 0 C--N 1.343 0.297 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 175.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.87 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.0 t30 -79.9 -34.66 38.9 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.305 175.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -85.07 -49.5 8.22 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.608 ' C ' ' H ' ' A' ' 57' ' ' ALA . 46.8 t -93.1 -52.23 10.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 5.5 t70 -72.92 38.4 0.08 Allowed 'General case' 0 C--O 1.238 0.479 0 CA-C-O 122.158 0.98 . . . . 0.0 109.836 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.608 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -82.1 -5.18 58.22 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 113.865 -1.516 . . . . 0.0 112.756 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -80.7 -33.03 35.66 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 112.47 -2.15 . . . . 0.0 111.573 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.22 51.12 4.05 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-N 116.105 -0.498 . . . . 0.0 113.164 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -109.81 -21.51 12.34 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.604 0.24 . . . . 0.0 111.536 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.5 26.55 74.4 Favored Glycine 0 N--CA 1.465 0.625 0 CA-C-N 115.725 -0.67 . . . . 0.0 114.359 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.03 153.02 39.52 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 123.308 0.643 . . . . 0.0 110.479 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.652 ' O ' HG13 ' A' ' 27' ' ' ILE . 7.1 mm -132.51 125.23 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -176.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.686 ' N ' HG22 ' A' ' 26' ' ' THR . 15.5 p-10 -73.78 148.54 42.43 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.39 176.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.518 ' CG ' ' HD3' ' A' ' 66' ' ' PRO . 4.9 p90 -78.92 -37.52 1.28 Allowed Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -177.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.518 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 22.6 Cg_exo -66.25 -18.76 56.2 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 121.792 1.661 . . . . 0.0 113.33 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -88.23 -20.02 26.06 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.524 ' CZ ' HD11 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -84.03 -25.6 29.77 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -178.8 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.483 HD22 ' SD ' ' A' ' 72' ' ' MET . 1.8 mt -70.91 -29.91 66.1 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 122.022 0.915 . . . . 0.0 109.317 175.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.494 ' H ' ' HG1' ' A' ' 70' ' ' THR . 0.2 OUTLIER -56.69 -33.28 66.28 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 112.731 -2.032 . . . . 0.0 108.635 173.749 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.486 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 66.8 mtt -72.87 -24.15 60.83 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.384 175.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.483 ' SD ' HD22 ' A' ' 69' ' ' LEU . 37.0 mtt -88.81 -23.15 22.91 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.396 177.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.87 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -78.78 -23.4 45.29 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.392 178.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.483 ' HD2' ' N ' ' A' ' 75' ' ' LYS . 0.3 OUTLIER -89.65 -29.23 18.95 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.486 ' HD3' ' O ' ' A' ' 71' ' ' MET . 8.3 pttp -74.44 -11.7 60.3 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.586 ' HA ' ' OE1' ' A' ' 84' ' ' GLU . 21.6 ptp -125.07 -22.06 4.52 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 -177.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.87 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 42.4 mmtt -87.49 -35.89 17.96 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -176.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -103.96 -30.12 10.5 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -176.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.466 HG22 ' OG ' ' B' ' 164' ' ' SER . 8.8 t -84.47 19.63 1.89 Allowed 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 8.7 m-20 63.05 132.41 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.771 0.829 . . . . 0.0 112.043 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.1 m -83.34 -14.05 53.73 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.483 ' O ' HD11 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -86.98 -49.15 7.54 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.55 0.69 . . . . 0.0 110.005 -179.304 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.479 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 38.3 mt-10 -74.62 -17.85 60.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.079 -1.419 . . . . 0.0 112.28 179.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.586 ' OE1' ' HA ' ' A' ' 76' ' ' MET . 4.1 tt0 -61.11 -22.01 64.24 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.483 HD11 ' O ' ' A' ' 82' ' ' GLU . 3.1 mp -87.84 -51.85 12.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.731 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.589 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -61.39 -16.92 51.22 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -179.242 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.594 ' OE1' ' HA ' ' B' ' 164' ' ' SER . 3.2 pt-20 -77.03 -20.36 56.04 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 123.356 0.41 . . . . 0.0 110.46 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.599 ' O ' ' HD1' ' A' ' 92' ' ' PHE . . . -67.24 -27.52 67.29 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.205 178.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.655 ' CE2' HG23 ' A' ' 142' ' ' VAL . 6.3 m-85 -79.35 -21.02 46.41 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 175.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.499 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 18.8 mmm180 -82.25 -16.25 50.2 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-N 114.095 -1.411 . . . . 0.0 108.07 174.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.566 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 7.9 t -85.24 -31.41 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.091 177.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.599 ' HD1' ' O ' ' A' ' 88' ' ' ALA . 29.0 m-85 -90.54 -35.26 15.16 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.561 -177.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.632 ' CA ' HG12 ' A' ' 100' ' ' ILE . 2.7 t70 -61.98 91.61 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.156 0.982 . . . . 0.0 111.161 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.421 ' NZ ' ' HA ' ' A' ' 94' ' ' LYS . 1.6 mmpm? -88.17 -53.79 4.53 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -178.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.15 0.0 10.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.441 ' HA2' ' OD2' ' A' ' 93' ' ' ASP . . . 48.17 33.4 10.74 Favored Glycine 0 N--CA 1.473 1.137 0 CA-C-N 114.289 -1.323 . . . . 0.0 114.745 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -96.93 -5.28 38.37 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.24 -19.22 46.58 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.415 -0.422 . . . . 0.0 112.603 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -122.32 118.49 28.59 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.427 -0.887 . . . . 0.0 110.383 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.632 HG12 ' CA ' ' A' ' 93' ' ' ASP . 30.3 mt -77.01 97.24 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.4 m -74.72 164.36 26.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.627 -178.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.461 ' O ' HG13 ' A' ' 121' ' ' VAL . . . -57.41 -15.02 5.57 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -89.09 -29.85 19.09 Favored 'General case' 0 CA--C 1.486 -1.491 0 CA-C-O 121.771 0.795 . . . . 0.0 109.205 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 1.036 ' O ' HG21 ' A' ' 108' ' ' VAL . 20.3 mt-10 -77.29 -43.33 33.59 Favored 'General case' 0 CA--C 1.482 -1.672 0 CA-C-N 112.707 -2.042 . . . . 0.0 110.633 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.548 HD23 ' O ' ' A' ' 105' ' ' LEU . 7.3 tt -63.97 -33.17 75.12 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.615 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -73.66 -43.01 60.57 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.793 176.624 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.471 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 10.3 t-80 -68.54 -21.66 64.54 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.267 177.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 1.036 HG21 ' O ' ' A' ' 104' ' ' GLU . 40.0 t -72.5 -52.13 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.835 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.679 ' SD ' HD23 ' A' ' 116' ' ' LEU . 14.7 mtt -57.45 -40.46 78.51 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 112.636 -2.074 . . . . 0.0 111.983 176.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 m -70.03 -19.1 63.32 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.082 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.6 -45.04 19.88 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.487 176.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.2 mt -80.19 -28.26 38.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.871 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 141.08 -9.79 2.77 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 117.717 -1.601 . . . . 0.0 116.905 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 109' ' ' MET . 5.0 mt-10 -100.83 151.61 21.5 Favored 'General case' 0 C--N 1.359 0.98 0 CA-C-N 120.946 2.373 . . . . 0.0 114.565 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.493 ' O ' HD12 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -108.52 129.79 55.29 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 113.554 -1.657 . . . . 0.0 107.207 175.381 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.679 HD23 ' SD ' ' A' ' 109' ' ' MET . 1.0 OUTLIER -138.81 116.24 11.24 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.796 -175.771 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.839 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -73.72 -176.04 2.26 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.005 179.625 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.554 ' N ' HG22 ' A' ' 117' ' ' THR . 16.4 t70 -69.12 -39.41 78.92 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -177.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.36 -16.14 33.77 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.66 ' CD ' ' H ' ' A' ' 117' ' ' THR . 13.9 pt-20 -85.51 -15.68 42.0 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 123.208 0.317 . . . . 0.0 111.116 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.839 HG22 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -82.75 -24.44 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.305 177.719 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -72.27 31.45 0.06 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.998 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.489 ' H ' ' C ' ' A' ' 121' ' ' VAL . 11.5 pt-20 -139.89 -33.41 0.59 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.212 177.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.478 ' SD ' ' HE3' ' A' ' 109' ' ' MET . 1.9 ttm -76.44 -24.48 53.94 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.424 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.605 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 2.9 mt -88.72 -49.56 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.392 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -58.64 -29.19 66.35 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.248 0.967 . . . . 0.0 111.569 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.632 ' OE1' ' HB ' ' B' ' 153' ' ' THR . 0.0 OUTLIER -66.85 -28.9 68.72 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.368 178.142 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.79 ' HA ' ' SD ' ' A' ' 144' ' ' MET . . . -106.68 -32.82 7.84 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-O 121.377 0.608 . . . . 0.0 109.538 178.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.605 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -63.91 125.45 24.45 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.081 -1.418 . . . . 0.0 113.212 -178.583 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.7 mt -90.56 -47.25 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.183 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -88.21 -25.36 22.94 Favored 'General case' 0 C--N 1.344 0.357 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.52 49.8 5.63 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 116.131 -0.486 . . . . 0.0 113.957 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -82.72 -19.71 37.44 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.63 1.3 71.34 Favored Glycine 0 CA--C 1.498 -0.974 0 CA-C-N 115.735 -0.666 . . . . 0.0 114.169 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -140.32 92.64 2.55 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 113.974 -1.113 . . . . 0.0 108.346 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.698 HG13 ' CD1' ' A' ' 141' ' ' PHE . 2.4 t -51.2 140.15 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 114.484 -1.235 . . . . 0.0 114.13 -178.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.501 ' O ' HG11 ' A' ' 136' ' ' VAL . 1.9 m-20 -96.1 -162.84 0.99 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 113.989 -1.459 . . . . 0.0 108.319 177.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.771 ' O ' HG22 ' A' ' 142' ' ' VAL . 32.5 m-85 -80.56 -57.74 3.44 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.285 177.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -56.41 -20.48 19.84 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.716 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 10.6 mt-10 -86.61 -37.59 17.93 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.611 0.719 . . . . 0.0 109.811 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.698 ' CD1' HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -76.75 -21.84 54.66 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 113.804 -1.544 . . . . 0.0 109.53 176.271 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.771 HG22 ' O ' ' A' ' 138' ' ' TYR . 98.9 t -82.83 -48.71 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.061 -178.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.582 ' O ' ' N ' ' A' ' 147' ' ' ALA . 11.7 mm100 -56.1 -34.15 65.76 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.883 0.739 . . . . 0.0 111.86 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.79 ' SD ' ' HA ' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -66.24 -17.9 65.02 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 123.265 0.353 . . . . 0.0 111.579 179.64 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.529 ' HE2' ' CE2' ' B' ' 154' ' ' PHE . 33.3 mmt -86.21 -9.11 57.16 Favored 'General case' 0 C--N 1.348 0.531 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 176.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.1 t -121.78 -37.08 2.92 Favored 'General case' 0 C--N 1.349 0.587 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.321 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -32.09 -44.11 0.08 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 177.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.2 pttt . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.45 -0.786 . . . . 0.0 111.266 179.995 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 18.5 p . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.475 0.178 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -124.98 -43.99 1.94 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.873 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 52.3 pttt -104.52 147.47 27.56 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.367 0.417 . . . . 0.0 110.905 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . 0.405 ' HZ2' ' CD ' ' A' ' 114' ' ' GLU . 98.1 mttt -116.6 134.89 54.29 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.993 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.632 ' HB ' ' OE1' ' A' ' 127' ' ' GLU . 19.5 p -138.22 176.41 8.73 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.722 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 154' ' ' PHE . . . . . 0.543 ' CE1' ' HB2' ' B' ' 158' ' ' ALA . 54.0 t80 -67.83 -36.02 79.61 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 119.565 -0.255 . . . . 0.0 111.416 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . 0.42 ' HD2' ' OE1' ' A' ' 127' ' ' GLU . 4.5 mptt -53.85 -36.17 62.3 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 120.645 0.26 . . . . 0.0 111.166 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -77.95 -54.5 6.23 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 157' ' ' VAL . . . . . . . . . . . . . 14.1 p -72.36 -28.96 29.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . 0.543 ' HB2' ' CE1' ' B' ' 154' ' ' PHE . . . -72.23 -36.79 69.22 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -59.78 -28.7 67.63 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.431 0.457 . . . . 0.0 111.069 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' B' ' 170' ' ' THR . . . -76.98 -38.73 52.61 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.43 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 9.1 p -103.71 21.58 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 162' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 15.4 ttpt -92.95 20.09 7.04 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.049 178.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 4.4 tp -126.13 74.54 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-O 121.685 0.755 . . . . 0.0 111.784 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 164' ' ' SER . . . . . 0.594 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 8.9 t 53.62 174.49 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.389 1.076 . . . . 0.0 113.421 178.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . -95.01 12.38 28.66 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.206 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 3.9 m -89.72 -65.25 1.03 Allowed 'General case' 0 C--N 1.346 0.45 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.412 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.35 97.71 4.04 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-O 121.315 0.578 . . . . 0.0 110.05 176.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.17 116.2 28.62 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.578 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . 0.583 ' HA2' ' OD1' ' A' ' 42' ' ' ASN . . . 171.81 83.5 0.05 OUTLIER Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.57 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 170' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' B' ' 160' ' ' ALA . 10.4 p . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.44 -0.79 . . . . 0.0 111.016 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.409 0 N-CA-C 111.342 0.127 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -99.21 -41.39 7.51 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.414 0.446 . . . . 0.0 111.209 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.618 ' HA ' ' NE2' ' A' ' 8' ' ' GLN . 54.8 mt-30 -134.72 150.23 50.56 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 123.394 0.434 . . . . 0.0 110.972 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.452 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -110.81 -107.21 0.36 Allowed 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.831 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.551 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 15.2 p -100.71 -173.73 2.47 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 123.686 0.794 . . . . 0.0 110.427 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.431 ' OE1' HD12 ' A' ' 9' ' ' ILE . 3.2 tp10 -59.1 -25.96 64.27 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.551 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 11.3 pt-20 -58.42 -28.54 65.35 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.466 0.651 . . . . 0.0 111.408 178.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.618 ' NE2' ' HA ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -78.68 -44.53 23.45 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.052 -1.431 . . . . 0.0 109.81 178.119 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.456 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 4.0 mt -66.53 -33.38 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.769 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.7 -33.85 62.51 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.525 ' OE2' HD13 ' A' ' 39' ' ' LEU . 46.1 mt-10 -109.89 -18.03 13.49 Favored 'General case' 0 C--N 1.344 0.345 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -177.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.466 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 0.4 OUTLIER -72.78 -15.92 61.64 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.584 0.629 . . . . 0.0 110.63 179.152 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.707 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -82.5 -41.11 20.14 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.591 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.707 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 1.1 mt-10 -85.39 -36.9 20.41 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 114.363 -1.29 . . . . 0.0 113.349 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.436 ' HA ' ' CG1' ' A' ' 35' ' ' VAL . . . -69.52 -23.85 63.66 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.883 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 54.8 t80 -87.07 -40.88 14.28 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.094 176.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.0 m -86.09 -12.67 49.46 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -177.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.4 HD13 ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -71.99 -30.22 65.02 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.348 179.153 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.451 ' CD1' ' HG2' ' A' ' 31' ' ' GLU . 37.8 t80 -130.89 -11.77 3.77 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.883 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 1.4 m-20 -97.53 81.14 2.91 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.214 0.915 . . . . 0.0 110.254 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.436 ' N ' ' HD2' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -74.9 -42.85 57.02 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 114.771 -1.104 . . . . 0.0 113.485 -178.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.05 -17.72 56.69 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.157 178.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.42 51.73 4.8 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.332 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.2 22.08 2.58 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -174.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.87 -60.13 0.14 Allowed Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.435 -0.802 . . . . 0.0 115.034 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.694 HG22 ' N ' ' A' ' 64' ' ' ASP . 6.2 p -97.52 154.43 17.51 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 123.509 0.724 . . . . 0.0 112.403 -178.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -124.04 149.6 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.712 -179.266 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 p -54.35 153.26 5.59 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.611 1.338 . . . . 0.0 114.611 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.5 p -80.99 -55.7 4.61 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.773 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -53.64 -14.11 0.81 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.477 177.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.628 ' O ' HG21 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -113.05 -20.44 11.51 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.482 -178.765 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -51.27 -39.0 55.8 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.83 0.852 . . . . 0.0 112.217 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.766 ' O ' ' HD3' ' A' ' 37' ' ' ARG . . . -58.72 -40.28 94.69 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 177.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.8 m -75.89 -28.15 57.98 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 114.512 -0.844 . . . . 0.0 112.348 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.628 HG21 ' O ' ' A' ' 31' ' ' GLU . 1.4 t -75.56 -26.55 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 177.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.596 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 29.6 mtt -75.94 -43.13 46.42 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 112.771 -2.013 . . . . 0.0 111.401 176.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.766 ' HD3' ' O ' ' A' ' 33' ' ' GLY . 11.2 mtp180 -78.53 -28.36 46.13 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 58.0 m -66.64 -8.25 26.15 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.072 0.939 . . . . 0.0 111.708 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.525 HD13 ' OE2' ' A' ' 11' ' ' GLU . 92.4 mt -93.3 -6.67 46.93 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 113.091 -1.868 . . . . 0.0 109.65 178.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.5 0.0 53.27 Favored Glycine 0 CA--C 1.492 -1.365 0 CA-C-O 122.468 1.038 . . . . 0.0 114.452 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.596 ' HB2' ' O ' ' A' ' 36' ' ' MET . 47.2 mt-30 -80.84 138.16 36.2 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-N 111.889 -2.155 . . . . 0.0 112.093 -178.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -118.79 74.77 12.8 Favored Pre-proline 0 CA--C 1.549 0.905 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.341 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -84.11 -178.1 3.33 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 123.146 2.564 . . . . 0.0 112.374 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.5 m -101.72 160.79 14.16 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.523 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 28.9 mt-10 -80.85 -28.45 36.08 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.698 177.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.4 -36.43 71.36 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 113.584 -1.644 . . . . 0.0 109.947 -178.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -77.91 -30.05 50.43 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.766 176.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.629 ' O ' HD12 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -67.17 -20.04 65.67 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.27 174.576 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.869 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 54.5 mt-30 -99.03 -15.08 19.18 Favored 'General case' 0 CA--C 1.48 -1.723 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.01 178.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -84.87 -35.89 21.9 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 112.011 -2.359 . . . . 0.0 109.943 176.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.439 ' HE2' ' NZ ' ' A' ' 75' ' ' LYS . 13.9 mmt -86.68 -28.14 23.32 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.566 177.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.629 HD12 ' O ' ' A' ' 48' ' ' LEU . 1.5 mp -77.99 -24.99 14.18 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 175.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.869 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.7 t-20 -78.31 -34.41 48.74 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.962 175.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -88.42 -41.95 12.47 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.603 ' C ' ' H ' ' A' ' 57' ' ' ALA . 84.1 t -83.52 -48.57 17.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -178.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 5.2 t70 -72.34 39.4 0.08 Allowed 'General case' 0 C--O 1.238 0.497 0 CA-C-O 122.025 0.917 . . . . 0.0 110.099 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.603 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -84.33 -5.45 59.27 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 114.098 -1.41 . . . . 0.0 112.446 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -95.29 -34.25 12.25 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 112.159 -2.291 . . . . 0.0 110.947 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.11 45.82 6.12 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 115.992 -0.549 . . . . 0.0 113.474 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -110.0 -21.52 12.27 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.625 0.25 . . . . 0.0 111.262 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.94 26.8 73.83 Favored Glycine 0 N--CA 1.467 0.717 0 CA-C-N 115.752 -0.658 . . . . 0.0 114.198 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.68 155.45 42.44 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 123.247 0.619 . . . . 0.0 110.509 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.52 ' O ' HG13 ' A' ' 27' ' ' ILE . 8.4 mm -133.48 128.17 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -176.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.694 ' N ' HG22 ' A' ' 26' ' ' THR . 11.9 p-10 -81.77 151.76 27.3 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.273 176.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.727 ' HA ' ' CE2' ' A' ' 68' ' ' PHE . 28.7 p90 -80.14 -29.38 0.55 Allowed Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -177.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 11.5 Cg_exo -71.38 -17.54 30.54 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 121.898 1.732 . . . . 0.0 112.716 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -91.64 -31.06 16.0 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.727 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 3.5 p90 -84.67 -28.03 26.68 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 -176.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 73' ' ' ALA . 5.1 mt -69.27 -36.68 77.35 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.615 0.721 . . . . 0.0 110.004 178.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.42 -31.68 69.49 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 113.423 -1.717 . . . . 0.0 108.89 173.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.782 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 51.1 mtt -75.74 -23.92 56.08 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.004 175.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.571 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 68.5 mtt -89.05 -21.93 23.2 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.096 176.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.504 ' O ' ' HG3' ' A' ' 77' ' ' LYS . . . -74.73 -30.52 61.54 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.077 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.523 ' HD3' ' N ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -81.07 -24.49 37.76 Favored 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 123.684 0.615 . . . . 0.0 109.884 -179.536 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.782 ' HD2' ' O ' ' A' ' 71' ' ' MET . 25.7 mttt -70.52 -14.51 62.54 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.697 176.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.4 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 22.7 ptt? -121.01 -28.2 4.82 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -177.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 73' ' ' ALA . 54.6 mttt -58.24 -24.2 58.52 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -103.88 -30.56 10.26 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.4 ' CG2' ' HA ' ' A' ' 76' ' ' MET . 5.9 t -81.83 104.44 12.21 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.844 0.354 . . . . 0.0 111.499 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -14.04 134.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.803 1.641 . . . . 0.0 115.271 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.8 m -77.99 -13.52 59.85 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.166 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.563 ' O ' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -73.52 -42.04 62.28 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.879 0.847 . . . . 0.0 110.074 -179.333 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.584 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 41.8 mt-10 -73.7 -18.81 60.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.31 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.42 ' OE2' HD11 ' B' ' 163' ' ' ILE . 0.2 OUTLIER -63.89 -18.73 64.49 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.563 HD13 ' O ' ' A' ' 82' ' ' GLU . 3.4 mp -87.82 -51.3 12.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.72 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.4 mtt180 -60.29 -16.78 37.4 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.626 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.584 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 44.2 mt-10 -78.81 -20.77 48.93 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.489 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.31 -21.29 56.39 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.657 177.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.51 ' O ' ' HB3' ' A' ' 93' ' ' ASP . 6.2 m-85 -84.46 -21.04 30.81 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 174.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -76.57 -21.87 55.05 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 174.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 87' ' ' GLU . 55.6 t -88.02 -52.24 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.218 177.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.553 ' CD2' HG12 ' A' ' 108' ' ' VAL . 92.0 m-85 -100.37 -41.31 7.09 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -176.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.71 ' CA ' HG12 ' A' ' 100' ' ' ILE . 2.3 t70 -64.5 94.61 0.12 Allowed 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.662 0.744 . . . . 0.0 110.867 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.1 mmpt? -87.39 -48.9 7.6 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.385 -1.279 . . . . 0.0 113.436 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.06 0.62 9.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -175.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 49.35 30.09 11.37 Favored Glycine 0 N--CA 1.472 1.07 0 CA-C-N 114.327 -1.306 . . . . 0.0 114.715 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -96.94 -7.2 33.79 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 122.29 0.236 . . . . 0.0 111.464 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.452 ' O ' ' HE2' ' A' ' 89' ' ' PHE . . . 104.17 -18.71 45.07 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 121.396 -0.43 . . . . 0.0 112.919 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -119.72 119.68 34.37 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.61 -0.795 . . . . 0.0 110.814 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.71 HG12 ' CA ' ' A' ' 93' ' ' ASP . 50.1 mt -77.43 92.26 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.3 t -72.16 166.29 22.65 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.513 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.529 ' O ' HG12 ' A' ' 121' ' ' VAL . . . -59.35 -14.62 12.39 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.8 -29.41 19.76 Favored 'General case' 0 CA--C 1.489 -1.369 0 CA-C-O 121.775 0.798 . . . . 0.0 109.348 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.953 ' O ' HG23 ' A' ' 108' ' ' VAL . 18.4 mt-10 -79.3 -41.44 28.03 Favored 'General case' 0 CA--C 1.483 -1.621 0 CA-C-N 112.739 -2.028 . . . . 0.0 111.113 -178.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.618 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 6.4 tt -66.44 -34.31 77.65 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.584 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -70.06 -44.91 68.17 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.158 175.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.508 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 10.4 t-80 -68.79 -21.72 64.31 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.599 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.953 HG23 ' O ' ' A' ' 104' ' ' GLU . 3.5 t -70.71 -51.87 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.293 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 177.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.624 ' SD ' HG11 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -60.54 -38.56 84.85 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 111.521 -2.581 . . . . 0.0 112.383 177.635 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.25 -18.71 61.79 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.531 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.51 -45.32 19.53 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.485 176.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.6 mt -80.89 -28.45 35.94 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.292 -178.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 109' ' ' MET . . . 140.05 -6.89 2.89 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-O 117.697 -1.613 . . . . 0.0 116.922 178.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.596 ' N ' ' O ' ' A' ' 109' ' ' MET . 4.5 mt-10 -100.61 151.67 21.34 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-N 120.979 2.389 . . . . 0.0 113.994 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.75 125.7 52.22 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 113.682 -1.599 . . . . 0.0 107.442 175.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.584 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 1.3 tp -130.21 116.02 17.81 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 113.802 -1.545 . . . . 0.0 112.028 -175.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.816 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -74.52 -175.84 2.53 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.657 179.662 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.512 ' N ' HG23 ' A' ' 117' ' ' THR . 16.3 t70 -73.3 -37.86 66.06 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -177.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -87.84 -16.1 34.95 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.636 ' CD ' ' H ' ' A' ' 117' ' ' THR . 14.3 pt-20 -85.4 -15.51 42.85 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 123.107 0.254 . . . . 0.0 110.992 178.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 117' ' ' THR . 0.1 OUTLIER -83.55 -25.59 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.602 178.109 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -74.62 29.91 0.09 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.956 0.884 . . . . 0.0 112.368 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.555 ' O ' ' HB3' ' A' ' 127' ' ' GLU . 11.3 pt-20 -142.01 -28.59 0.62 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 114.187 -1.369 . . . . 0.0 109.868 177.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.698 ' HA ' ' OG1' ' B' ' 153' ' ' THR . 4.5 mmt -74.76 -29.49 61.15 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 176.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.589 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 3.0 mt -88.05 -52.48 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-N 113.919 -1.491 . . . . 0.0 112.352 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -55.96 -28.53 57.41 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 124.233 0.958 . . . . 0.0 111.681 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.668 ' OE1' ' HD2' ' B' ' 155' ' ' LYS . 0.0 OUTLIER -62.05 -33.9 75.25 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.27 178.191 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.589 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -108.39 -32.01 7.61 Favored 'General case' 0 C--N 1.349 0.559 0 CA-C-O 121.217 0.532 . . . . 0.0 110.131 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.589 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -61.29 127.38 31.21 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.429 -1.259 . . . . 0.0 113.412 -178.788 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.3 mt -89.8 -49.24 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 114.199 -1.364 . . . . 0.0 110.416 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -85.27 -25.25 27.36 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.2 49.61 9.32 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 116.133 -0.485 . . . . 0.0 113.924 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -85.05 -19.4 32.0 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 99.65 9.93 48.48 Favored Glycine 0 CA--C 1.5 -0.905 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.419 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -140.6 125.47 18.23 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 113.8 -1.2 . . . . 0.0 108.34 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.552 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 2.1 t -86.02 130.48 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -177.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -95.43 -163.54 1.06 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.171 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.447 ' O ' HG23 ' A' ' 142' ' ' VAL . 29.4 m-85 -74.89 -55.68 5.54 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.577 177.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.91 -20.43 62.04 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.589 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 13.4 mt-10 -86.35 -46.23 10.48 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.303 0.573 . . . . 0.0 109.748 178.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.58 ' O ' ' HG3' ' A' ' 144' ' ' MET . 81.8 t80 -68.09 -22.76 64.9 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.37 -1.287 . . . . 0.0 109.258 175.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.607 ' O ' ' HG3' ' A' ' 145' ' ' MET . 24.3 t -84.78 -47.09 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.921 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.601 ' O ' ' N ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -60.67 -34.09 73.8 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.439 -0.504 . . . . 0.0 111.234 177.877 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.58 ' HG3' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -63.93 -27.33 69.07 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 123.222 0.326 . . . . 0.0 110.682 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.607 ' HG3' ' O ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -82.38 -7.93 59.63 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 177.705 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.417 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 26.9 p -113.51 -46.28 3.07 Favored 'General case' 0 C--N 1.349 0.557 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.529 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.601 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -29.99 -43.77 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.787 1.235 . . . . 0.0 114.182 177.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 20.1 pttp . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.358 -179.991 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 19.4 p . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.421 0.153 . . . . 0.0 111.346 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -124.75 135.43 52.98 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.844 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -102.15 132.78 47.84 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.853 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -107.57 125.04 50.82 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.405 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.698 ' OG1' ' HA ' ' A' ' 124' ' ' MET . 1.9 p -139.54 -60.7 0.55 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.917 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 154' ' ' PHE . . . . . 0.547 ' CE2' HD11 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -66.98 -27.54 67.53 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 118.328 0.513 . . . . 0.0 110.14 178.449 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . 0.668 ' HD2' ' OE1' ' A' ' 127' ' ' GLU . 4.8 mptt -67.71 -40.94 84.23 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.607 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . 0.498 ' HA ' ' ND2' ' B' ' 159' ' ' ASN . 9.5 mm-40 -76.74 -36.15 57.3 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 157' ' ' VAL . . . . . 0.493 HG13 ' O ' ' B' ' 153' ' ' THR . 19.1 m -72.49 -29.98 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 120.871 0.367 . . . . 0.0 111.366 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' B' ' 162' ' ' LYS . . . -73.01 -44.69 60.69 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.789 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . 0.498 ' ND2' ' HA ' ' B' ' 156' ' ' GLU . 28.2 p30 -52.44 -29.65 25.55 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.66 -38.34 47.87 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.542 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 11.5 p -134.11 51.13 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 CA-C-O 121.191 0.519 . . . . 0.0 112.123 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 162' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 17.1 ttpt -90.84 -36.89 13.95 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.874 178.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 163' ' ' ILE . . . . . 0.42 HD11 ' OE2' ' A' ' 84' ' ' GLU . 3.3 tp -93.77 122.69 45.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.615 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 16.2 t -133.62 -9.56 2.81 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.443 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 165' ' ' ALA . . . . . 0.4 ' HB1' ' OE2' ' A' ' 87' ' ' GLU . . . -88.18 -10.89 48.41 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 166' ' ' SER . . . . . 0.485 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 54.0 m -87.34 -74.13 0.45 Allowed 'General case' 0 CA--C 1.536 0.439 0 O-C-N 123.096 0.248 . . . . 0.0 111.007 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 6.5 tp -107.01 96.16 6.23 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.05 0.452 . . . . 0.0 110.147 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 20.9 ptt? -129.44 149.03 51.4 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.134 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -114.8 139.33 15.51 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.5 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.092 -0.956 . . . . 0.0 110.469 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.447 0.165 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.462 ' HB2' ' NE2' ' A' ' 8' ' ' GLN . 3.1 m-20 -95.79 -49.23 5.42 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.203 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.924 ' H ' HE22 ' A' ' 8' ' ' GLN . 3.3 tt0 -138.51 -51.79 0.58 Allowed 'General case' 0 C--N 1.346 0.427 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.484 HD11 ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -113.19 -117.74 0.31 Allowed 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.509 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.538 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 17.9 p -101.66 -173.98 2.48 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 123.848 0.859 . . . . 0.0 111.093 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -67.74 -21.42 65.28 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.126 0.57 . . . . 0.0 112.064 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.538 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 13.2 pt-20 -51.49 -28.28 12.93 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.694 0.759 . . . . 0.0 111.853 178.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.924 HE22 ' H ' ' A' ' 3' ' ' GLN . 0.9 OUTLIER -76.88 -47.29 21.64 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 113.618 -1.628 . . . . 0.0 110.572 179.038 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.641 ' O ' ' HD2' ' A' ' 13' ' ' LYS . 2.9 mp -70.97 -28.27 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.319 178.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.36 -41.15 63.77 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -130.36 -33.85 1.66 Allowed 'General case' 0 C--N 1.357 0.92 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.457 ' CZ ' ' HB3' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -64.34 -14.01 53.72 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.666 179.661 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.732 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.7 OUTLIER -71.82 -40.85 68.84 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 176.461 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.732 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 6.1 mt-10 -75.0 -45.31 42.78 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-N 113.555 -1.657 . . . . 0.0 111.386 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.609 ' O ' HG11 ' A' ' 35' ' ' VAL . . . -61.36 -19.01 61.36 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.545 0.688 . . . . 0.0 109.412 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.679 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 2.1 t80 -86.83 -48.26 8.35 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.392 -1.276 . . . . 0.0 109.616 176.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.0 t -86.36 -13.25 47.03 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -177.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -69.23 -30.52 68.69 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.045 0.384 . . . . 0.0 111.097 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.554 ' CD1' HG23 ' A' ' 35' ' ' VAL . 5.1 m-85 -125.71 -15.52 5.98 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.679 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -102.9 80.8 1.92 Allowed 'General case' 0 C--O 1.239 0.55 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.136 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -76.61 -27.47 55.75 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.344 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.617 ' OD1' ' HB2' ' A' ' 24' ' ' ASP . 0.3 OUTLIER -71.53 -23.03 61.7 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.471 176.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.88 52.04 4.84 Favored Glycine 0 N--CA 1.468 0.806 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.042 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.617 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -100.73 21.59 13.26 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -175.119 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.41 -56.42 0.12 Allowed Glycine 0 CA--C 1.533 1.174 0 N-CA-C 115.809 1.083 . . . . 0.0 115.809 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 0.8 OUTLIER -96.65 139.91 32.03 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.783 0.833 . . . . 0.0 113.052 -178.286 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.41 ' H ' HG13 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -114.82 148.53 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.472 178.918 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.15 149.29 28.53 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.409 ' C ' ' H ' ' A' ' 31' ' ' GLU . 0.9 OUTLIER -73.48 -55.22 6.63 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 115.082 -0.963 . . . . 0.0 113.037 -179.787 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -53.23 -14.09 0.63 Allowed 'General case' 0 N--CA 1.474 0.772 0 O-C-N 123.807 0.692 . . . . 0.0 111.473 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.626 ' O ' HG22 ' A' ' 35' ' ' VAL . 27.6 mt-10 -113.87 -17.06 12.12 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.453 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -54.89 -43.13 72.94 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.783 0.833 . . . . 0.0 111.918 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.782 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -55.3 -39.76 73.27 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 177.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 m -74.59 -28.4 60.89 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 114.595 -0.802 . . . . 0.0 112.397 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.626 HG22 ' O ' ' A' ' 31' ' ' GLU . 1.7 t -74.77 -26.68 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.639 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 33.9 mtt -77.25 -41.11 42.37 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 112.909 -1.95 . . . . 0.0 111.729 176.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.782 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 10.6 mtt180 -83.2 -27.74 29.78 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -178.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.3 m -64.09 -8.17 11.14 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.99 0.9 . . . . 0.0 112.402 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.2 mt -93.94 -7.23 43.58 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 113.304 -1.771 . . . . 0.0 109.772 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.42 -1.38 43.06 Favored Glycine 0 CA--C 1.492 -1.401 0 CA-C-O 122.369 0.983 . . . . 0.0 114.658 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.639 ' HB2' ' O ' ' A' ' 36' ' ' MET . 46.7 mt-30 -78.63 139.82 38.5 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 112.107 -2.047 . . . . 0.0 112.081 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -121.35 73.01 28.26 Favored Pre-proline 0 CA--C 1.549 0.918 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.437 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.96 -177.82 4.09 Favored 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 123.071 2.514 . . . . 0.0 112.098 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 m -99.22 160.49 14.24 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.505 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 28.6 mt-10 -80.79 -28.36 36.33 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.668 177.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.84 -36.6 70.21 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 113.573 -1.649 . . . . 0.0 109.994 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -77.07 -29.97 55.3 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.677 176.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.505 ' HB2' ' HA ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -65.82 -20.76 66.36 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.024 174.569 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.729 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 47.9 mt-30 -95.35 -17.43 21.6 Favored 'General case' 0 CA--C 1.483 -1.61 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.168 178.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -84.07 -32.73 24.65 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 111.914 -2.403 . . . . 0.0 109.42 176.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.519 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -86.38 -35.37 19.81 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.644 176.931 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.8 mt -69.77 -27.4 33.19 Favored 'Isoleucine or valine' 0 C--N 1.351 0.638 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 175.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.729 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 4.4 t-20 -67.8 -33.33 74.6 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.431 174.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -85.1 -22.55 28.86 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.897 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.643 ' C ' ' H ' ' A' ' 57' ' ' ALA . 55.8 t -82.39 -37.82 14.79 Favored 'Isoleucine or valine' 0 C--N 1.346 0.432 0 C-N-CA 122.589 0.355 . . . . 0.0 111.786 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.99 26.94 0.04 OUTLIER 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.93 0.871 . . . . 0.0 111.094 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.643 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -87.72 -6.94 57.97 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 113.989 -1.46 . . . . 0.0 111.986 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -113.4 -29.96 7.04 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 111.72 -2.491 . . . . 0.0 110.9 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.48 18.86 61.32 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.921 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -110.24 -21.66 12.13 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.961 0.381 . . . . 0.0 111.965 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.11 27.27 73.97 Favored Glycine 0 N--CA 1.468 0.77 0 N-CA-C 114.432 0.533 . . . . 0.0 114.432 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.416 ' CG2' ' HB ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -122.65 165.98 15.62 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 122.906 0.483 . . . . 0.0 111.498 -179.06 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 26' ' ' THR . 4.9 mp -126.41 109.39 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.54 ' N ' HG22 ' A' ' 26' ' ' THR . 0.4 OUTLIER -85.19 165.5 17.35 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.601 176.032 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.448 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 31.3 p90 -91.14 -39.3 0.39 Allowed Pre-proline 0 CA--C 1.548 0.901 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 51.1 Cg_endo -69.82 -17.8 37.1 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 121.787 1.658 . . . . 0.0 113.529 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -102.91 -32.06 9.95 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -177.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.795 ' O ' ' HG2' ' A' ' 71' ' ' MET . 7.3 t80 -84.79 -27.77 26.62 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -177.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.484 ' HB3' HD11 ' A' ' 4' ' ' LEU . 4.4 mt -70.65 -32.88 70.34 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-O 121.92 0.867 . . . . 0.0 109.55 177.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.674 ' O ' ' HD3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -54.44 -41.26 69.19 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 112.785 -2.007 . . . . 0.0 109.648 175.136 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.795 ' HG2' ' O ' ' A' ' 68' ' ' PHE . 25.8 ptm -72.69 -27.13 61.89 Favored 'General case' 0 C--N 1.347 0.48 0 O-C-N 123.802 0.689 . . . . 0.0 109.351 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.584 ' O ' ' HG2' ' A' ' 76' ' ' MET . 94.4 mtp -81.78 -18.61 43.53 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.326 179.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.801 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -84.21 -31.59 24.98 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.674 ' HD3' ' O ' ' A' ' 70' ' ' THR . 4.9 ptt180 -89.6 -18.2 27.0 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 179.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.66 ' HD2' ' O ' ' A' ' 71' ' ' MET . 0.0 OUTLIER -84.61 -12.96 53.0 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.266 0.939 . . . . 0.0 113.035 179.051 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.584 ' HG2' ' O ' ' A' ' 72' ' ' MET . 7.8 ptt? -116.07 -28.97 6.44 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.801 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 34.8 mmtt -77.81 -21.89 50.9 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -178.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -103.91 -29.52 10.91 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.6 t -66.38 -62.87 1.24 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.505 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 3.2 m-20 -164.65 94.39 0.69 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.871 0.868 . . . . 0.0 110.335 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.1 m -83.99 -14.13 51.53 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.526 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.503 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -87.11 -50.06 6.89 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.352 0.596 . . . . 0.0 110.142 -179.059 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.503 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 39.5 mt-10 -74.89 -17.53 60.57 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.331 -1.304 . . . . 0.0 112.348 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.56 ' HA ' ' OE2' ' A' ' 87' ' ' GLU . 1.0 OUTLIER -58.36 -24.42 59.82 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.4 mp -87.92 -54.18 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.97 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.589 ' O ' ' HD2' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -62.67 -18.72 62.91 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.381 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.56 ' OE2' ' HA ' ' A' ' 84' ' ' GLU . 3.4 pt-20 -73.48 -19.68 60.88 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.113 0.482 . . . . 0.0 110.282 178.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.6 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -69.22 -22.73 63.85 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.437 178.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.589 ' HD2' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -81.77 -21.71 37.63 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 174.652 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.478 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 7.5 ttt180 -76.79 -15.83 59.63 Favored 'General case' 0 C--N 1.344 0.345 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.6 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 3.8 t -84.21 -33.73 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.512 177.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.543 ' CE2' HG13 ' A' ' 108' ' ' VAL . 48.6 m-85 -98.91 -36.3 9.81 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -177.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.622 ' N ' HG12 ' A' ' 100' ' ' ILE . 1.7 t70 -63.99 88.63 0.05 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.929 0.892 . . . . 0.0 111.75 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.495 ' HZ3' ' ND2' ' A' ' 111' ' ' ASN . 27.4 mttm -87.63 -41.45 13.39 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.512 -1.222 . . . . 0.0 113.641 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.448 ' HB2' HD21 ' A' ' 97' ' ' ASN . 1.7 p30 -70.72 -18.43 62.8 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -176.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.85 17.74 73.62 Favored Glycine 0 C--N 1.295 -1.746 0 CA-C-N 112.834 -1.985 . . . . 0.0 114.642 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.448 HD21 ' HB2' ' A' ' 95' ' ' ASP . 43.1 m-80 -90.29 -7.01 54.47 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.891 0.345 . . . . 0.0 111.517 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.52 -18.91 49.64 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.926 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -112.39 118.41 35.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.294 -0.953 . . . . 0.0 110.391 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.622 HG12 ' N ' ' A' ' 93' ' ' ASP . 29.1 mt -78.5 90.7 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.3 t -61.93 159.92 13.2 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.151 -0.931 . . . . 0.0 113.235 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.74 -15.97 14.53 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 115.046 1.499 . . . . 0.0 115.046 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.514 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -89.05 -26.17 21.55 Favored 'General case' 0 CA--C 1.489 -1.402 0 CA-C-O 121.769 0.795 . . . . 0.0 109.17 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.945 ' O ' HG23 ' A' ' 108' ' ' VAL . 3.3 mm-40 -79.06 -43.85 23.37 Favored 'General case' 0 CA--C 1.482 -1.638 0 CA-C-N 112.632 -2.076 . . . . 0.0 112.484 -177.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.65 HD13 ' SD ' ' A' ' 124' ' ' MET . 9.3 tt -67.17 -30.25 70.16 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.602 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -70.16 -45.3 67.04 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.8 176.286 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.514 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 3.2 t60 -68.98 -21.88 64.13 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.63 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.945 HG23 ' O ' ' A' ' 104' ' ' GLU . 3.1 t -69.73 -51.33 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.299 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.645 ' SD ' HG12 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -60.87 -39.37 88.96 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 111.568 -2.56 . . . . 0.0 112.44 177.26 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.79 -18.78 62.08 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.506 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.495 ' ND2' ' HZ3' ' A' ' 94' ' ' LYS . 0.6 OUTLIER -79.4 -45.5 19.37 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.43 175.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.6 mt -80.04 -28.35 39.29 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.027 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 140.08 -7.73 2.93 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-O 117.704 -1.609 . . . . 0.0 117.017 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.595 ' N ' ' O ' ' A' ' 109' ' ' MET . 4.2 mt-10 -100.73 151.82 21.21 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 121.051 2.425 . . . . 0.0 114.543 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.411 ' O ' HD12 ' A' ' 116' ' ' LEU . 7.0 mttt -105.32 130.01 53.54 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.431 -1.713 . . . . 0.0 106.868 174.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.602 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 1.0 OUTLIER -134.31 125.03 26.82 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.46 -1.246 . . . . 0.0 111.776 -175.696 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 1.035 ' O ' ' HB ' ' A' ' 121' ' ' VAL . 0.7 OUTLIER -96.35 -177.2 3.88 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 114.079 -1.419 . . . . 0.0 112.395 -177.458 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.481 ' N ' HG21 ' A' ' 117' ' ' THR . 17.1 t70 -63.93 -41.14 97.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.469 -1.241 . . . . 0.0 114.084 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -78.48 -42.9 28.4 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.762 ' CG ' ' H ' ' A' ' 117' ' ' THR . 13.0 pt-20 -73.24 -23.58 60.37 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.925 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 1.035 ' HB ' ' O ' ' A' ' 117' ' ' THR . 1.2 t -87.5 -23.77 6.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 114.746 -1.116 . . . . 0.0 112.472 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.12 37.34 0.85 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.906 0.86 . . . . 0.0 110.692 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -138.8 -42.54 0.48 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.246 -1.343 . . . . 0.0 109.394 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.65 ' SD ' HD13 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -63.65 -22.46 66.91 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.914 178.015 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.639 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 4.2 mt -88.96 -48.94 14.47 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.558 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -60.55 -28.01 68.1 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 123.97 0.794 . . . . 0.0 111.681 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.59 ' OE1' ' HB ' ' B' ' 153' ' ' THR . 0.0 OUTLIER -64.41 -34.31 77.88 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.941 178.311 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.605 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -102.85 -32.23 9.89 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-O 121.415 0.626 . . . . 0.0 109.504 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.639 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.2 OUTLIER -63.0 124.21 20.51 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 114.054 -1.43 . . . . 0.0 113.026 -179.46 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.8 mt -90.48 -47.79 14.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.016 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -88.59 -25.25 22.57 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.16 49.91 4.29 Favored Glycine 0 CA--C 1.524 0.646 0 O-C-N 123.501 0.501 . . . . 0.0 113.884 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -76.74 -20.05 56.96 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.72 21.88 54.8 Favored Glycine 0 CA--C 1.507 -0.448 0 CA-C-N 115.764 -0.653 . . . . 0.0 114.558 178.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.729 ' O ' ' HB ' ' A' ' 136' ' ' VAL . 42.1 mt-30 -135.72 -74.31 0.45 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.6 -0.8 . . . . 0.0 109.708 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.729 ' HB ' ' O ' ' A' ' 135' ' ' GLN . 2.5 t 124.3 121.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 125.248 1.419 . . . . 0.0 111.301 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -88.84 -163.55 1.0 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.69 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.428 ' O ' HG23 ' A' ' 142' ' ' VAL . 70.1 m-85 -72.31 -53.79 11.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.956 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.04 -20.66 66.6 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.605 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 8.9 mt-10 -86.78 -41.91 13.73 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.364 0.602 . . . . 0.0 109.739 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.626 ' CD2' ' HE3' ' A' ' 144' ' ' MET . 38.6 t80 -69.36 -24.18 63.85 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.16 176.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 138' ' ' TYR . 22.7 t -86.23 -48.33 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.996 -178.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.724 ' O ' ' N ' ' A' ' 147' ' ' ALA . 0.2 OUTLIER -54.74 -34.59 62.71 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 123.906 0.754 . . . . 0.0 111.512 179.066 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.68 ' SD ' ' HB3' ' B' ' 154' ' ' PHE . 6.4 ptt? -60.87 -26.54 67.47 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 123.238 0.336 . . . . 0.0 111.639 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 69.2 mtm -87.59 -3.87 58.97 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.52 178.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.8 t -133.55 -27.01 1.57 Allowed 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.724 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -48.11 -31.33 5.44 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 178.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 93.3 mttt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.123 -0.941 . . . . 0.0 111.632 179.936 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 19.0 p . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 120.564 0.221 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -117.4 135.45 53.87 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.781 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 62.84 124.22 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.838 0.855 . . . . 0.0 111.883 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . 0.554 ' HD2' ' OE1' ' A' ' 114' ' ' GLU . 48.0 mttp -109.36 160.25 16.32 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.403 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.59 ' HB ' ' OE1' ' A' ' 127' ' ' GLU . 12.4 p -137.86 171.38 14.51 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.783 -179.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 154' ' ' PHE . . . . . 0.68 ' HB3' ' SD ' ' A' ' 144' ' ' MET . 0.3 OUTLIER -56.07 -27.84 55.16 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 117.811 0.278 . . . . 0.0 110.879 179.094 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 144' ' ' MET . 0.3 OUTLIER -71.45 -48.89 46.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.406 0.682 . . . . 0.0 111.222 178.385 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.6 -35.44 58.11 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 157' ' ' VAL . . . . . 0.541 HG12 ' O ' ' B' ' 153' ' ' THR . 27.9 m -67.54 -29.92 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 122.774 0.43 . . . . 0.0 111.454 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . 0.566 ' O ' ' HB2' ' B' ' 162' ' ' LYS . . . -70.86 -44.49 66.28 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.881 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -61.35 -24.86 66.76 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.92 -38.59 53.18 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.655 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 9.9 p -114.12 25.86 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.253 0 O-C-N 123.401 0.438 . . . . 0.0 111.832 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 162' ' ' LYS . . . . . 0.566 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 1.5 ttpm? -87.57 -34.42 18.56 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 122.47 -0.144 . . . . 0.0 110.942 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 3.0 tp -106.25 14.02 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.91 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 19.0 t -86.46 -12.3 49.39 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.551 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 165' ' ' ALA . . . . . 0.415 ' HB1' ' OE2' ' A' ' 84' ' ' GLU . . . -94.01 8.17 42.42 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.674 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 56.5 p -84.96 -34.15 22.5 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.676 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 7.9 tp -84.32 -9.06 58.79 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 123.425 0.453 . . . . 0.0 111.106 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 65.0 mtt -96.86 130.71 44.09 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.75 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -163.44 -151.97 6.66 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.688 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 20.2 p . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.089 -0.958 . . . . 0.0 111.061 -179.956 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 111.396 0.147 . . . . 0.0 111.396 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.578 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 8.0 m-20 -117.03 -41.98 2.97 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.445 0.465 . . . . 0.0 111.2 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -141.99 157.19 45.23 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 122.848 0.459 . . . . 0.0 110.448 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.552 ' HG ' ' OE1' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -103.52 -119.43 0.2 Allowed 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.677 ' CG2' ' H ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -103.18 -173.71 2.38 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.003 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.49 ' N ' HG22 ' A' ' 5' ' ' THR . 45.5 mt-10 -63.0 -12.91 29.08 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 122.453 -0.154 . . . . 0.0 110.92 176.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.677 ' H ' ' CG2' ' A' ' 5' ' ' THR . 7.3 pt-20 -49.47 -40.19 36.26 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 123.785 0.678 . . . . 0.0 111.772 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.562 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 1.6 pt20 -72.1 -48.86 40.83 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.769 178.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.5 mt -62.18 -28.36 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-N 114.095 -1.411 . . . . 0.0 110.633 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 6' ' ' GLU . . . -68.1 -48.93 64.16 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -136.27 -29.06 1.0 Allowed 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -177.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.562 ' CD1' ' HA ' ' A' ' 8' ' ' GLN . 28.0 m-85 -63.55 -14.62 53.02 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 123.383 0.427 . . . . 0.0 110.345 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.66 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 4.3 pttt -74.19 -38.44 63.62 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.66 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 12.0 mt-10 -70.4 -43.81 69.27 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 113.607 -1.633 . . . . 0.0 110.566 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.614 ' O ' HG12 ' A' ' 35' ' ' VAL . . . -62.94 -18.26 62.93 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 115.373 -0.831 . . . . 0.0 108.927 176.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.6 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 25.9 t80 -85.84 -49.91 7.53 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.394 177.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.444 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 52.6 m -87.52 -13.03 44.13 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -177.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -66.68 -29.93 70.06 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.523 0.601 . . . . 0.0 112.256 -178.893 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.563 ' CD1' HG21 ' A' ' 35' ' ' VAL . 3.1 m-85 -126.03 -4.19 6.91 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.6 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 6.0 t70 -77.83 55.63 1.42 Allowed 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 118.479 0.581 . . . . 0.0 112.368 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.475 ' N ' ' HD2' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -86.6 -21.94 26.53 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 179.307 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.71 -22.38 61.64 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.334 0.588 . . . . 0.0 110.436 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.73 43.16 29.63 Favored Glycine 0 N--CA 1.471 0.992 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.52 23.25 12.19 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.013 -1.594 . . . . 0.0 112.78 -175.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.07 -78.81 1.87 Allowed Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.265 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.43 HG21 ' O ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -114.51 166.92 11.19 Favored 'General case' 0 N--CA 1.435 -1.223 0 O-C-N 123.649 0.264 . . . . 0.0 110.4 178.219 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -77.09 148.18 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.57 164.19 21.9 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 114.612 -1.177 . . . . 0.0 113.494 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.39 -55.2 6.25 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 123.719 0.807 . . . . 0.0 112.416 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -56.09 -14.0 2.36 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.175 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.484 ' O ' HG23 ' A' ' 35' ' ' VAL . 26.3 mt-10 -110.95 -25.85 9.6 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.813 -178.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.443 ' HA ' HG23 ' A' ' 35' ' ' VAL . 7.4 tp -56.4 -38.43 71.5 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.24 0.616 . . . . 0.0 111.637 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.641 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -56.45 -40.58 86.64 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 177.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 m -74.67 -27.95 60.63 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.772 -0.714 . . . . 0.0 112.274 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.614 HG12 ' O ' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -76.57 -26.45 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.283 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.531 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 44.7 mtt -71.59 -41.1 69.4 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 112.992 -1.913 . . . . 0.0 111.06 175.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.731 ' HD3' ' HA ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -87.29 -26.1 23.6 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.6 m -65.19 -7.86 14.61 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 122.083 0.944 . . . . 0.0 111.488 176.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.8 mt -92.59 -3.62 54.73 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.122 -1.853 . . . . 0.0 110.29 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.81 -11.43 18.19 Favored Glycine 0 CA--C 1.495 -1.202 0 N-CA-C 115.621 1.009 . . . . 0.0 115.621 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 36' ' ' MET . 9.5 mm100 -68.19 152.13 45.94 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 113.007 -1.596 . . . . 0.0 111.359 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -77.48 126.13 85.15 Favored Pre-proline 0 N--CA 1.471 0.614 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -177.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.731 ' HA ' ' HD3' ' A' ' 37' ' ' ARG . 83.6 Cg_endo -86.23 120.13 1.84 Allowed 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.498 2.132 . . . . 0.0 115.751 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -137.04 153.31 50.65 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 176.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -80.7 -29.79 36.45 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.716 0.769 . . . . 0.0 109.27 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 50' ' ' ASP . . . -71.62 -32.11 67.61 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 113.393 -1.731 . . . . 0.0 109.926 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -80.86 -28.94 35.88 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 114.052 -1.431 . . . . 0.0 109.652 177.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.586 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -73.59 -18.82 61.01 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.683 175.541 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.859 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 46.6 mt-30 -99.91 -15.73 18.24 Favored 'General case' 0 CA--C 1.482 -1.67 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.124 177.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 2.1 t70 -87.26 -36.18 18.07 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 112.289 -2.232 . . . . 0.0 110.299 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.434 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 25.3 mmt -86.61 -29.99 22.16 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.531 178.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.586 ' HB ' ' O ' ' A' ' 48' ' ' LEU . 1.6 mp -77.35 -24.14 14.72 Favored 'Isoleucine or valine' 0 C--N 1.341 0.226 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 175.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.859 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.0 t30 -78.13 -34.43 49.94 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.884 175.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.72 -45.98 8.93 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.582 ' C ' ' H ' ' A' ' 57' ' ' ALA . 34.9 t -82.1 -53.02 12.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.483 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 16.1 t70 -72.26 40.73 0.08 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 122.001 0.905 . . . . 0.0 110.008 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.582 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -78.25 -5.29 51.5 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 114.098 -1.41 . . . . 0.0 113.222 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -92.27 -42.74 9.68 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 112.672 -2.058 . . . . 0.0 111.151 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.15 51.2 4.04 Favored Glycine 0 C--N 1.344 1.017 0 O-C-N 123.486 0.492 . . . . 0.0 113.646 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -110.03 -21.41 12.32 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.507 ' C ' ' HG1' ' A' ' 62' ' ' THR . . . 78.16 25.76 61.15 Favored Glycine 0 N--CA 1.466 0.637 0 CA-C-N 115.674 -0.694 . . . . 0.0 113.585 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.512 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -160.13 172.92 16.59 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.362 1.065 . . . . 0.0 109.092 179.609 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.512 HD11 ' O ' ' A' ' 62' ' ' THR . 36.6 mm -125.1 77.2 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.505 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 8.4 m-20 -50.5 152.02 2.06 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.848 0.859 . . . . 0.0 111.25 177.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.574 ' CG ' ' HD3' ' A' ' 66' ' ' PRO . 42.5 p90 -90.49 -41.36 0.4 Allowed Pre-proline 0 CA--C 1.55 0.963 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' A' ' 2' ' ' ASP . 21.7 Cg_exo -65.51 -18.26 59.13 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 121.722 1.615 . . . . 0.0 113.169 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -107.12 -39.2 5.79 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.508 ' O ' ' HB2' ' A' ' 71' ' ' MET . 66.4 m-85 -85.09 -20.67 30.02 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -176.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 73' ' ' ALA . 15.3 mt -71.73 -41.2 68.79 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-O 122.385 1.088 . . . . 0.0 108.785 177.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.414 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 1.3 m -53.35 -31.38 44.25 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 111.967 -2.379 . . . . 0.0 109.159 173.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.508 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 23.7 mmt -72.96 -31.52 64.61 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.255 175.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.822 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 1.5 mtt -84.98 -18.37 34.7 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.193 177.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.515 ' HB3' ' NZ ' ' A' ' 77' ' ' LYS . . . -74.96 -39.43 61.33 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.475 ' CD ' ' HA ' ' A' ' 71' ' ' MET . 3.0 ptm180 -77.13 -18.15 58.11 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 112.449 0.536 . . . . 0.0 112.449 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.822 ' HD2' ' HA ' ' A' ' 72' ' ' MET . 29.9 mttt -71.89 -13.83 61.77 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 175.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.458 ' HB2' ' OE2' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -128.79 -29.46 2.35 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -177.007 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.515 ' NZ ' ' HB3' ' A' ' 73' ' ' ALA . 31.7 mttp -65.05 -48.87 72.29 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -177.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -105.4 -30.72 9.41 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.1 t -82.97 98.84 9.45 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 41.03 94.3 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 125.01 1.324 . . . . 0.0 114.108 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.525 ' HA ' ' OE1' ' A' ' 84' ' ' GLU . 51.6 m -84.14 -14.08 51.19 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.891 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.449 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -79.32 -45.41 19.71 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.634 0.773 . . . . 0.0 109.807 -179.255 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.449 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 39.9 mt-10 -66.1 -18.56 65.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 113.831 -1.531 . . . . 0.0 112.292 178.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.643 ' HG2' ' SD ' ' B' ' 168' ' ' MET . 40.3 mt-10 -61.96 -27.25 68.71 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 122.952 0.501 . . . . 0.0 112.255 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.422 HD11 ' O ' ' A' ' 82' ' ' GLU . 3.7 mp -87.94 -48.04 15.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.321 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.596 ' O ' ' HD1' ' A' ' 89' ' ' PHE . 17.7 mmt180 -57.43 -18.11 16.4 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 179.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.536 ' OE1' ' HA ' ' B' ' 164' ' ' SER . 3.4 pt-20 -73.28 -19.68 60.99 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 177.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.37 -23.44 66.34 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.04 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.596 ' HD1' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -84.36 -20.7 31.55 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 174.715 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -81.05 -24.52 37.79 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.266 -1.334 . . . . 0.0 108.418 175.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.8 t -88.67 -55.31 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 CA-C-N 114.913 -1.04 . . . . 0.0 112.126 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.472 ' CD2' HG23 ' A' ' 108' ' ' VAL . 8.5 m-85 -100.65 -44.93 5.67 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -176.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.684 ' CA ' HG12 ' A' ' 100' ' ' ILE . 17.6 t70 -63.9 92.0 0.07 Allowed 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.781 0.8 . . . . 0.0 111.412 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.733 ' HZ3' ' HD1' ' A' ' 107' ' ' HIS . 31.9 mttm -88.03 -47.11 8.77 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.225 -1.352 . . . . 0.0 113.97 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -71.43 3.06 4.11 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -175.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 49.05 29.96 9.29 Favored Glycine 0 N--CA 1.473 1.109 0 CA-C-N 114.25 -1.341 . . . . 0.0 115.035 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -100.85 -3.34 30.0 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.714 0.257 . . . . 0.0 111.239 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.13 -18.99 56.26 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-N 116.345 -0.388 . . . . 0.0 112.592 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -113.16 118.18 33.99 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.308 -0.946 . . . . 0.0 110.624 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.684 HG12 ' CA ' ' A' ' 93' ' ' ASP . 47.5 mt -79.27 89.27 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.4 m -67.08 166.0 14.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.639 -1.164 . . . . 0.0 112.571 -177.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.499 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -60.4 -14.53 19.37 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -178.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.65 -27.15 21.48 Favored 'General case' 0 CA--C 1.488 -1.433 0 CA-C-O 121.634 0.73 . . . . 0.0 109.33 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.96 ' O ' HG21 ' A' ' 108' ' ' VAL . 25.5 mt-10 -79.39 -44.3 21.74 Favored 'General case' 0 CA--C 1.486 -1.51 0 CA-C-N 112.829 -1.987 . . . . 0.0 111.948 -177.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.674 HD23 ' O ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -66.74 -30.83 71.15 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.682 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -71.48 -46.61 59.38 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 113.683 -1.599 . . . . 0.0 109.488 175.789 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.733 ' HD1' ' HZ3' ' A' ' 94' ' ' LYS . 17.4 t-80 -68.04 -21.62 65.0 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.351 178.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.96 HG21 ' O ' ' A' ' 104' ' ' GLU . 24.0 t -72.2 -49.1 45.58 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.764 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 176.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.614 ' SD ' HD21 ' A' ' 116' ' ' LEU . 19.1 mtt -57.07 -41.21 78.37 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 112.276 -2.238 . . . . 0.0 111.879 176.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.59 -19.15 64.45 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.398 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.89 -45.11 19.19 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.731 176.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 mt -79.99 -28.12 39.55 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.796 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 140.02 -7.52 2.94 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 117.798 -1.557 . . . . 0.0 116.83 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 109' ' ' MET . 5.0 mt-10 -100.94 152.36 20.65 Favored 'General case' 0 C--N 1.356 0.886 0 CA-C-N 120.813 2.306 . . . . 0.0 114.579 -178.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -111.08 129.79 55.81 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 113.505 -1.68 . . . . 0.0 107.277 175.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.682 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 1.4 tp -134.87 116.21 14.51 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.584 -1.189 . . . . 0.0 112.605 -175.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.62 ' O ' HG21 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -76.64 -175.65 3.46 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.588 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.521 ' N ' HG21 ' A' ' 117' ' ' THR . 16.1 t70 -72.5 -37.46 68.41 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.128 -1.396 . . . . 0.0 114.41 -177.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -89.57 -16.08 31.42 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.611 ' CD ' ' H ' ' A' ' 117' ' ' THR . 14.8 pt-20 -87.43 -16.01 36.1 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 123.215 0.322 . . . . 0.0 110.722 178.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.62 HG21 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -81.18 -30.5 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.011 178.035 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -68.64 30.8 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 115.003 -0.999 . . . . 0.0 113.32 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.54 ' H ' ' C ' ' A' ' 121' ' ' VAL . 10.9 pt-20 -142.7 -30.2 0.54 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.352 -1.294 . . . . 0.0 109.941 177.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.71 ' HA ' ' OG1' ' B' ' 153' ' ' THR . 2.9 mmt -71.93 -30.64 65.54 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.605 176.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.629 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 1.8 mp -87.85 -50.33 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 CA-C-N 114.088 -1.415 . . . . 0.0 113.313 -177.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -58.48 -27.24 64.25 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.007 0.817 . . . . 0.0 111.547 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.762 ' HG2' ' HG1' ' B' ' 153' ' ' THR . 0.0 OUTLIER -63.9 -33.46 75.76 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.389 177.96 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.598 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -110.47 -29.86 7.9 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-O 121.101 0.477 . . . . 0.0 110.564 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.629 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -60.97 126.82 28.75 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.716 -1.129 . . . . 0.0 113.174 -179.035 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.8 mt -90.51 -51.92 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 114.049 -1.432 . . . . 0.0 110.548 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -85.57 -25.34 26.77 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.38 49.51 6.2 Favored Glycine 0 CA--C 1.525 0.669 0 O-C-N 123.526 0.516 . . . . 0.0 113.787 178.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -84.76 -19.43 32.65 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.49 10.86 56.5 Favored Glycine 0 CA--C 1.501 -0.843 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.916 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -141.21 121.21 13.67 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.59 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 2.5 t -78.87 125.18 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -91.2 -165.31 1.33 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.784 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.543 ' OH ' ' HB3' ' A' ' 89' ' ' PHE . 2.7 m-85 -70.97 -57.25 4.74 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.18 177.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -58.95 -20.82 55.83 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -178.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.598 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 9.4 mt-10 -88.54 -39.36 14.2 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 121.379 0.609 . . . . 0.0 110.113 178.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -75.32 -23.56 57.3 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.137 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' A' ' 138' ' ' TYR . 37.4 t -85.14 -41.19 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 114.605 -1.18 . . . . 0.0 111.436 -178.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 140' ' ' GLU . 0.8 OUTLIER -56.97 -20.04 21.54 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 123.59 0.556 . . . . 0.0 111.167 177.502 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.0 -28.47 68.28 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.973 178.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -84.95 -4.39 59.11 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.788 178.478 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.426 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 58.9 p -117.44 -45.75 2.71 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.601 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -54.85 -31.16 59.24 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.453 -0.784 . . . . 0.0 111.343 179.912 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 18.3 p . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 120.571 0.224 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -129.09 -29.77 2.25 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.523 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -91.7 136.71 32.93 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.37 0.419 . . . . 0.0 111.384 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -99.08 153.35 18.95 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.815 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.762 ' HG1' ' HG2' ' A' ' 127' ' ' GLU . 10.5 p -135.5 -70.37 0.48 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 118.981 -0.533 . . . . 0.0 112.151 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 154' ' ' PHE . . . . . 0.602 ' HD2' ' O ' ' A' ' 124' ' ' MET . 0.2 OUTLIER -63.28 -27.57 69.43 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 118.885 0.766 . . . . 0.0 111.242 179.602 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . 0.473 ' HD2' ' OE2' ' A' ' 127' ' ' GLU . 8.5 mptt -67.04 -44.1 81.04 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.908 178.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -77.09 -35.83 56.19 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 157' ' ' VAL . . . . . 0.533 HG22 ' HA ' ' B' ' 154' ' ' PHE . 17.7 m -71.71 -38.61 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 122.493 0.317 . . . . 0.0 111.809 -178.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -73.6 -33.07 64.42 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.35 0.66 . . . . 0.0 112.364 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -64.63 -30.69 71.72 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 123.379 0.424 . . . . 0.0 111.374 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.02 -38.09 53.63 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.845 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 9.8 p -108.61 25.66 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 O-C-N 123.361 0.413 . . . . 0.0 111.643 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 162' ' ' LYS . . . . . . . . . . . . . 20.5 ttpt -76.5 -8.9 58.12 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 11.8 tt -89.26 153.21 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 164' ' ' SER . . . . . 0.536 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 6.4 t -88.45 171.17 10.3 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.027 0.441 . . . . 0.0 112.082 -178.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . -83.36 15.63 2.9 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.391 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 52.1 m -121.61 12.34 10.7 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.03 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.675 ' O ' ' HD3' ' A' ' 75' ' ' LYS . 56.7 mt 75.12 39.84 0.37 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.924 0.868 . . . . 0.0 111.828 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 168' ' ' MET . . . . . 0.643 ' SD ' ' HG2' ' A' ' 84' ' ' GLU . 33.7 mtt -73.13 -158.49 0.05 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.449 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -133.25 -103.81 0.85 Allowed Glycine 0 C--N 1.344 1.02 0 C-N-CA 121.419 -0.42 . . . . 0.0 112.76 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.44 -0.791 . . . . 0.0 110.709 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.402 0 N-CA-C 111.416 0.154 . . . . 0.0 111.416 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.604 ' HA ' ' OE1' ' A' ' 8' ' ' GLN . 2.7 m-20 -121.13 130.23 53.64 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 123.421 0.45 . . . . 0.0 110.853 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.498 ' H ' ' NE2' ' A' ' 8' ' ' GLN . 41.9 mt-30 -132.83 -46.61 0.86 Allowed 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 123.462 0.476 . . . . 0.0 111.947 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.712 ' HG ' HE21 ' A' ' 8' ' ' GLN . 0.0 OUTLIER -112.78 -125.18 0.28 Allowed 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.153 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.504 ' H ' ' HB2' ' A' ' 4' ' ' LEU . 16.0 p -102.25 -173.62 2.38 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 123.963 0.905 . . . . 0.0 111.777 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.48 ' HA ' HG12 ' A' ' 9' ' ' ILE . 15.4 tt0 -59.78 -21.91 61.43 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.455 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 12.5 pt-20 -49.92 -39.05 38.89 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 123.877 0.736 . . . . 0.0 111.436 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.712 HE21 ' HG ' ' A' ' 4' ' ' LEU . 1.2 pt20 -68.82 -49.82 55.31 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.626 176.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.48 HG12 ' HA ' ' A' ' 6' ' ' GLU . 15.2 mm -51.85 -43.19 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 114.231 -1.35 . . . . 0.0 111.963 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.85 -34.83 67.03 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.425 ' OE1' HD13 ' A' ' 39' ' ' LEU . 43.8 mt-10 -111.0 -19.61 12.71 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -177.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.519 ' O ' ' HB2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -74.45 -15.05 60.91 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.149 0.886 . . . . 0.0 110.009 178.736 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.709 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -81.65 -41.45 21.41 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.017 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.709 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 1.4 mt-10 -84.99 -40.04 17.37 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 114.271 -1.332 . . . . 0.0 112.716 -179.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.4 ' HA ' ' CG1' ' A' ' 35' ' ' VAL . . . -64.72 -18.75 65.3 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.554 0.693 . . . . 0.0 109.249 178.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.588 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 18.8 t80 -86.06 -49.37 7.84 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 113.975 -1.466 . . . . 0.0 109.485 177.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.2 m -87.17 -13.38 44.17 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 115.435 1.642 . . . . 0.0 115.435 -177.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -71.96 -30.47 65.32 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.538 -179.86 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.578 ' CD1' HG23 ' A' ' 35' ' ' VAL . 5.5 m-85 -133.58 -8.24 2.85 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.588 ' HB3' ' O ' ' A' ' 16' ' ' PHE . 15.3 t70 -101.33 82.67 2.36 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.601 0.637 . . . . 0.0 109.799 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.473 ' HZ3' ' HA ' ' A' ' 19' ' ' PHE . 1.5 mppt? -86.89 -34.74 19.31 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -178.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.605 ' OD1' ' HB2' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -70.74 -22.36 62.42 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.831 178.277 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.15 51.57 4.96 Favored Glycine 0 N--CA 1.468 0.797 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.605 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -98.33 22.44 9.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 113.756 -1.222 . . . . 0.0 113.557 -176.091 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.61 -67.16 0.59 Allowed Glycine 0 CA--C 1.525 0.678 0 CA-C-N 115.128 -0.942 . . . . 0.0 113.69 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.585 ' OG1' ' N ' ' A' ' 63' ' ' ILE . 1.5 t -97.6 176.01 6.0 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.749 0.785 . . . . 0.0 112.226 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.48 ' N ' ' OG1' ' A' ' 26' ' ' THR . 0.2 OUTLIER -132.93 148.71 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.147 179.726 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.82 155.3 6.12 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.407 ' C ' ' H ' ' A' ' 31' ' ' GLU . 1.3 p -74.14 -55.58 5.92 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 114.903 -1.044 . . . . 0.0 113.039 -179.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -54.47 -13.84 1.07 Allowed 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.881 0.738 . . . . 0.0 111.606 177.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.528 ' O ' HG22 ' A' ' 35' ' ' VAL . 21.7 mt-10 -111.43 -17.0 13.2 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.403 -178.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.2 tp -57.14 -40.11 76.54 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.756 0.422 . . . . 0.0 111.889 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.785 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -53.39 -41.09 62.44 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 177.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.9 m -74.72 -31.83 61.96 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.731 -0.734 . . . . 0.0 112.92 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.578 HG23 ' CD1' ' A' ' 19' ' ' PHE . 1.4 t -74.21 -26.0 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.521 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 19.4 mmt -76.1 -42.21 47.92 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 112.925 -1.943 . . . . 0.0 111.459 176.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.785 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 11.3 mtt180 -79.73 -29.62 40.65 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.1 t -67.94 -8.46 37.13 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.947 0.88 . . . . 0.0 111.756 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 35' ' ' VAL . 95.9 mt -90.9 -7.67 51.52 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.286 -1.779 . . . . 0.0 109.938 177.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.25 -7.04 23.11 Favored Glycine 0 CA--C 1.493 -1.291 0 CA-C-O 122.233 0.907 . . . . 0.0 115.142 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.521 ' HB2' ' O ' ' A' ' 36' ' ' MET . 51.9 mt-30 -76.73 138.56 40.03 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 112.376 -1.912 . . . . 0.0 111.669 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -127.43 62.5 54.6 Favored Pre-proline 0 CA--C 1.554 1.133 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.184 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.414 ' HD3' ' C ' ' A' ' 41' ' ' GLN . 4.5 Cg_endo -88.25 -178.78 2.2 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.93 2.42 . . . . 0.0 112.156 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.499 ' OG1' ' N ' ' A' ' 45' ' ' GLU . 7.1 t -99.28 -174.95 2.87 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 122.115 0.959 . . . . 0.0 110.663 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.499 ' N ' ' OG1' ' A' ' 44' ' ' THR . 46.6 mt-10 -80.96 -24.27 38.2 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-N 113.005 -1.907 . . . . 0.0 108.57 177.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.45 -30.07 66.81 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 113.699 -1.591 . . . . 0.0 111.779 -177.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.521 ' OE2' ' HA ' ' B' ' 168' ' ' MET . 44.0 mt-10 -87.32 -26.73 23.25 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.246 177.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.573 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -69.29 -20.04 63.9 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.132 174.524 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.868 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 11.7 mm100 -98.63 -16.22 19.15 Favored 'General case' 0 CA--C 1.482 -1.653 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.106 178.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.434 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 3.3 t70 -87.14 -33.97 19.24 Favored 'General case' 0 C--N 1.281 -2.391 0 CA-C-N 112.003 -2.362 . . . . 0.0 110.392 177.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.45 ' SD ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -86.51 -35.28 19.67 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.791 178.073 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.573 ' HB ' ' O ' ' A' ' 48' ' ' LEU . 1.5 mp -70.96 -27.37 29.83 Favored 'Isoleucine or valine' 0 C--N 1.345 0.399 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 175.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.868 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.8 t-20 -71.73 -34.17 69.33 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.349 175.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 50' ' ' ASP . 41.6 mt-10 -79.58 -33.42 41.73 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.591 ' C ' ' H ' ' A' ' 57' ' ' ALA . 72.1 t -82.14 -41.71 18.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -72.5 35.71 0.07 Allowed 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.894 0.854 . . . . 0.0 110.527 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.591 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -86.5 -6.32 58.93 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 114.254 -1.339 . . . . 0.0 111.907 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -113.22 -29.24 7.34 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 111.78 -2.463 . . . . 0.0 110.639 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.62 46.09 5.87 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.855 -0.612 . . . . 0.0 113.75 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -110.25 -21.75 12.08 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.23 26.42 72.55 Favored Glycine 0 N--CA 1.469 0.838 0 CA-C-N 115.851 -0.613 . . . . 0.0 114.291 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.18 -177.22 5.14 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 123.269 0.627 . . . . 0.0 110.533 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.585 ' N ' ' OG1' ' A' ' 26' ' ' THR . 5.3 mp -135.36 96.18 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -176.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.448 ' O ' ' HD2' ' A' ' 68' ' ' PHE . 10.0 m-20 -67.0 150.03 49.82 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 174.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.548 ' CG ' ' HD3' ' A' ' 66' ' ' PRO . 27.0 p90 -77.86 -39.12 1.82 Allowed Pre-proline 0 N--CA 1.477 0.919 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -177.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.548 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 9.0 Cg_exo -72.85 -17.57 25.44 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 121.838 1.692 . . . . 0.0 113.027 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.538 ' O ' ' HG3' ' A' ' 71' ' ' MET . 39.7 mt-10 -103.97 -17.43 14.99 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 -177.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.525 ' CE1' ' HG ' ' A' ' 69' ' ' LEU . 2.6 p90 -84.78 -43.56 14.12 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 -177.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.525 ' HG ' ' CE1' ' A' ' 68' ' ' PHE . 1.7 mt -62.79 -33.99 76.34 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.489 0.662 . . . . 0.0 111.091 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.61 ' O ' ' HD3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -59.75 -35.5 74.72 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 113.721 -1.581 . . . . 0.0 108.64 174.167 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.562 ' HA ' ' NE ' ' A' ' 74' ' ' ARG . 66.0 mtt -74.6 -22.66 58.84 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-N 114.887 -1.052 . . . . 0.0 109.101 176.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.531 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 72.4 mtp -88.4 -18.6 28.02 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.866 177.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.591 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -81.58 -33.57 31.53 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.61 ' HD3' ' O ' ' A' ' 70' ' ' THR . 1.4 ptt180 -84.88 -17.13 38.88 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.563 ' NZ ' ' HA ' ' B' ' 167' ' ' LEU . 0.0 OUTLIER -83.1 -13.76 55.03 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.563 0.619 . . . . 0.0 112.397 178.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 22.5 ptt? -113.47 -33.68 5.82 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 120.983 0.42 . . . . 0.0 112.091 -177.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.6 mmtp -68.15 -15.45 63.59 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.55 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -103.89 -29.72 10.79 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.6 t -75.94 76.2 2.84 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.402 0.62 . . . . 0.0 112.13 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 56.22 110.83 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.034 0.934 . . . . 0.0 112.268 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.528 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 13.9 t -83.2 -13.48 55.32 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.307 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.449 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -86.97 -45.71 10.53 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.758 0.79 . . . . 0.0 109.336 179.729 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.449 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 40.3 mt-10 -75.14 -18.18 60.26 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 113.647 -1.615 . . . . 0.0 113.199 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 81' ' ' SER . 11.2 pt-20 -58.99 -28.01 65.96 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.9 mp -88.09 -49.97 13.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.441 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.0 mtm180 -56.88 -18.19 12.27 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 3.1 pt-20 -74.17 -20.13 60.32 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.13 0.491 . . . . 0.0 110.258 178.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.506 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -70.51 -20.71 62.81 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.476 177.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.472 ' HE2' ' O ' ' A' ' 98' ' ' GLY . 4.1 m-85 -81.16 -20.79 40.51 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 174.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.456 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 4.4 tmt_? -76.23 -18.79 58.87 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 173.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.506 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 31.6 t -87.73 -53.68 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 114.249 -1.341 . . . . 0.0 111.808 177.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.513 ' CE2' HG13 ' A' ' 108' ' ' VAL . 10.4 m-85 -100.29 -45.36 5.63 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.718 ' CA ' HG12 ' A' ' 100' ' ' ILE . 2.3 t70 -63.44 93.43 0.07 Allowed 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.922 0.868 . . . . 0.0 111.246 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.685 ' HZ3' ' HD1' ' A' ' 107' ' ' HIS . 33.8 mttm -87.96 -47.35 8.61 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 113.939 -1.482 . . . . 0.0 113.977 -178.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -71.83 1.56 6.82 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 114.05 1.129 . . . . 0.0 114.05 -175.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 49.71 28.32 10.8 Favored Glycine 0 N--CA 1.472 1.085 0 CA-C-N 114.298 -1.319 . . . . 0.0 114.799 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -96.27 -8.19 33.47 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.647 0.224 . . . . 0.0 111.404 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.472 ' O ' ' HE2' ' A' ' 89' ' ' PHE . . . 104.32 -18.68 44.66 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.965 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -120.66 118.95 31.45 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.621 -0.79 . . . . 0.0 111.085 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.718 HG12 ' CA ' ' A' ' 93' ' ' ASP . 29.0 mt -77.35 100.8 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.1 p -79.12 165.18 23.62 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.582 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -59.72 -15.08 17.22 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -178.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.93 -31.69 18.06 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-O 121.885 0.85 . . . . 0.0 109.542 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 1.016 ' O ' HG23 ' A' ' 108' ' ' VAL . 3.1 mm-40 -79.95 -38.1 33.07 Favored 'General case' 0 CA--C 1.483 -1.631 0 CA-C-N 112.58 -2.1 . . . . 0.0 110.241 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.569 ' C ' HD21 ' A' ' 105' ' ' LEU . 4.1 tt -63.76 -37.71 88.37 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 176.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.626 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -70.82 -44.53 66.33 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 113.79 -1.55 . . . . 0.0 108.904 175.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.685 ' HD1' ' HZ3' ' A' ' 94' ' ' LYS . 6.1 t-80 -67.66 -21.65 65.34 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.602 177.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 1.016 HG23 ' O ' ' A' ' 104' ' ' GLU . 25.6 t -73.02 -50.71 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 176.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.765 ' SD ' HD23 ' A' ' 116' ' ' LEU . 18.0 mtt -56.32 -41.06 75.41 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 112.513 -2.131 . . . . 0.0 112.103 175.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.31 -19.06 63.89 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.238 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.5 -45.07 20.03 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.55 176.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.1 mt -80.04 -28.23 39.31 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.774 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 109' ' ' MET . . . 139.42 -7.77 3.12 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 117.79 -1.561 . . . . 0.0 116.841 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.535 ' N ' ' O ' ' A' ' 109' ' ' MET . 5.1 mt-10 -101.01 152.11 20.98 Favored 'General case' 0 C--N 1.358 0.938 0 CA-C-N 120.859 2.329 . . . . 0.0 114.506 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.429 ' O ' HD12 ' A' ' 116' ' ' LEU . 5.6 mttt -110.11 129.66 55.66 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 113.651 -1.613 . . . . 0.0 107.482 175.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.765 HD23 ' SD ' ' A' ' 109' ' ' MET . 1.2 tp -138.11 119.09 14.33 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.609 -175.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.828 ' O ' HG21 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -74.36 -176.09 2.55 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.016 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.542 ' N ' HG23 ' A' ' 117' ' ' THR . 16.0 t70 -72.2 -38.07 69.12 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -177.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -87.88 -16.11 34.84 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.642 ' CD ' ' H ' ' A' ' 117' ' ' THR . 14.3 pt-20 -85.95 -15.44 41.56 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 123.219 0.324 . . . . 0.0 110.954 178.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.828 HG21 ' O ' ' A' ' 117' ' ' THR . 0.1 OUTLIER -83.43 -25.39 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.774 178.106 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -74.09 32.33 0.08 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.738 0.78 . . . . 0.0 112.652 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.482 ' H ' ' C ' ' A' ' 121' ' ' VAL . 11.2 pt-20 -141.66 -32.32 0.54 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.166 177.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.541 ' SD ' ' HE2' ' A' ' 109' ' ' MET . 4.5 ttm -73.01 -25.61 61.03 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.498 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.572 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 3.1 mt -88.92 -52.34 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.885 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -55.66 -29.04 58.6 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 124.239 0.962 . . . . 0.0 111.773 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.448 ' HG2' ' HB ' ' B' ' 153' ' ' THR . 0.0 OUTLIER -63.73 -33.34 75.44 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.374 -1.284 . . . . 0.0 111.321 177.999 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.649 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -106.55 -32.85 7.88 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-O 121.296 0.57 . . . . 0.0 109.735 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.572 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -61.08 124.31 20.15 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 114.255 -1.338 . . . . 0.0 113.053 -178.679 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.0 mt -90.34 -44.28 14.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 113.625 -1.625 . . . . 0.0 110.398 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -87.04 -25.17 24.34 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.16 49.69 9.28 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.08 -0.509 . . . . 0.0 114.072 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -89.74 -19.47 24.72 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.43 11.85 52.85 Favored Glycine 0 CA--C 1.501 -0.796 0 CA-C-N 115.878 -0.601 . . . . 0.0 113.254 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -139.86 119.83 13.55 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 113.651 -1.275 . . . . 0.0 108.055 178.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.533 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 2.1 t -81.73 130.24 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -177.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.405 HD21 ' CD ' ' A' ' 140' ' ' GLU . 11.8 m-80 -92.27 -164.72 1.22 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.516 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.405 ' O ' HG22 ' A' ' 142' ' ' VAL . 79.8 m-85 -74.48 -56.16 5.15 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.722 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -61.07 -20.44 62.58 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -178.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.712 ' O ' ' HG2' ' A' ' 144' ' ' MET . 9.7 mt-10 -86.87 -42.4 13.26 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.17 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -71.83 -23.98 61.63 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.241 176.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.538 ' O ' ' HG2' ' A' ' 145' ' ' MET . 29.9 t -85.54 -44.86 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.883 -177.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.473 ' HA ' ' OG1' ' A' ' 146' ' ' THR . 35.9 mt-30 -61.3 -19.09 61.38 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 123.512 0.508 . . . . 0.0 111.596 178.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.712 ' HG2' ' O ' ' A' ' 140' ' ' GLU . 27.4 mmt -71.83 -23.42 61.54 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 178.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.538 ' HG2' ' O ' ' A' ' 142' ' ' VAL . 7.2 ptt? -87.61 -4.26 58.95 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.579 177.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.473 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 30.8 p -119.83 -41.4 2.67 Favored 'General case' 0 C--N 1.351 0.64 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.002 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -37.27 -34.04 0.08 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 95.5 mttt . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.109 -0.948 . . . . 0.0 111.393 179.873 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 18.9 p . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.524 0.202 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -100.17 145.71 27.7 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.832 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -100.74 147.46 26.01 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.057 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . 0.431 ' H ' ' HG3' ' B' ' 156' ' ' GLU . 97.4 mttt -131.88 177.75 7.3 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.685 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.519 ' HB ' ' HA ' ' A' ' 124' ' ' MET . 0.7 OUTLIER -83.95 -118.11 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 118.716 -0.659 . . . . 0.0 112.306 -178.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 154' ' ' PHE . . . . . 0.524 ' HA ' HG22 ' B' ' 157' ' ' VAL . 0.1 OUTLIER -60.88 -27.55 68.23 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 119.342 0.974 . . . . 0.0 111.376 -179.759 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . 0.405 ' HD2' ' SD ' ' A' ' 144' ' ' MET . 7.9 mptt -59.07 -51.1 71.52 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.114 0.565 . . . . 0.0 111.538 178.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . 0.431 ' HG3' ' H ' ' B' ' 152' ' ' LYS . 2.5 mm-40 -76.91 -38.99 52.43 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 157' ' ' VAL . . . . . 0.524 HG22 ' HA ' ' B' ' 154' ' ' PHE . 11.3 m -61.44 -33.57 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-O 120.675 0.274 . . . . 0.0 111.316 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' B' ' 162' ' ' LYS . . . -73.59 -41.48 62.83 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.985 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -64.37 -25.99 68.27 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 123.394 0.434 . . . . 0.0 111.84 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.01 -37.95 53.99 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.825 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 9.8 p -112.15 25.27 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 O-C-N 123.357 0.411 . . . . 0.0 111.743 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 162' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 11.4 ttpt -81.75 -36.6 28.36 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.755 -0.202 . . . . 0.0 110.802 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 163' ' ' ILE . . . . . 0.449 ' O ' HG22 ' B' ' 163' ' ' ILE . 0.0 OUTLIER -117.0 61.76 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 CA-C-O 122.159 0.981 . . . . 0.0 109.251 178.83 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 17.5 t -132.82 -40.99 0.94 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.618 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . -88.94 0.01 57.0 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.449 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 51.5 m -84.51 -18.68 34.99 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.71 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.563 ' HA ' ' NZ ' ' A' ' 75' ' ' LYS . 1.1 tp -86.23 -6.58 58.95 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 123.421 0.451 . . . . 0.0 111.077 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 168' ' ' MET . . . . . 0.521 ' HA ' ' OE2' ' A' ' 47' ' ' GLU . 64.8 mtt -89.0 149.53 23.22 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.263 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . 171.44 -146.86 9.8 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.49 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 19.6 p . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.142 -0.932 . . . . 0.0 111.016 -179.974 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.389 0 N-CA-C 111.345 0.128 . . . . 0.0 111.345 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -99.4 -41.35 7.45 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.422 0.451 . . . . 0.0 111.266 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.475 ' HA ' ' OE1' ' A' ' 8' ' ' GLN . 47.0 mt-30 -133.83 152.46 51.87 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 123.431 0.457 . . . . 0.0 110.853 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.496 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -109.23 -119.86 0.27 Allowed 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.692 ' CG2' ' H ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -102.82 -173.66 2.37 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.521 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.562 ' N ' HG23 ' A' ' 5' ' ' THR . 10.2 mm-40 -60.84 -13.34 14.88 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.143 0.177 . . . . 0.0 111.08 176.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.692 ' H ' ' CG2' ' A' ' 5' ' ' THR . 7.7 pt-20 -52.37 -38.75 59.62 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.906 0.754 . . . . 0.0 111.112 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.596 ' HA ' HD13 ' A' ' 69' ' ' LEU . 1.4 pt20 -70.09 -49.66 48.66 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.642 176.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.629 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . 20.1 mm -52.82 -35.1 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.947 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.36 -35.01 73.28 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -119.31 -17.72 8.77 Favored 'General case' 0 C--N 1.346 0.418 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -177.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.629 ' CE1' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -69.75 -16.33 63.29 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.743 0.701 . . . . 0.0 111.012 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.693 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 1.2 pttt -83.35 -41.51 18.12 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.693 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 1.8 mt-10 -80.94 -37.61 29.2 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 114.082 -1.417 . . . . 0.0 112.205 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.573 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -66.56 -19.19 65.72 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.52 0.676 . . . . 0.0 109.182 178.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.567 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 11.2 t80 -86.75 -48.97 7.79 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.773 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.411 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 52.3 m -87.02 -12.9 46.0 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -177.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -69.48 -28.25 65.91 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 118.54 0.609 . . . . 0.0 111.979 -179.551 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.577 ' CD1' HG22 ' A' ' 35' ' ' VAL . 4.6 m-85 -132.73 -3.07 3.29 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 -178.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.567 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 14.7 t70 -80.48 55.19 2.22 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 119.087 0.858 . . . . 0.0 112.189 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.411 ' HE3' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -87.04 -22.39 25.49 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 178.879 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.67 -22.43 61.67 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.299 0.571 . . . . 0.0 110.446 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.43 44.3 27.91 Favored Glycine 0 N--CA 1.47 0.933 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.54 23.13 13.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 113.029 -1.586 . . . . 0.0 112.458 -175.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.33 -79.96 1.77 Allowed Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.072 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.63 HG21 ' HA ' ' A' ' 64' ' ' ASP . 14.6 p -101.21 177.78 4.84 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 122.862 0.465 . . . . 0.0 110.952 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.405 ' O ' HG22 ' A' ' 62' ' ' THR . 0.8 OUTLIER -83.58 148.34 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.258 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.414 ' OG1' ' HB2' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -60.41 161.75 7.02 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -178.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.693 HG22 HD11 ' A' ' 63' ' ' ILE . 1.9 p -79.97 -56.71 4.06 Favored 'General case' 0 C--N 1.345 0.398 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -59.2 -13.34 7.17 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.332 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.476 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 28.0 mt-10 -110.14 -16.36 13.8 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.746 -177.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.564 HD21 ' CZ ' ' A' ' 68' ' ' PHE . 8.6 tp -52.57 -41.06 63.25 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.231 0.612 . . . . 0.0 112.555 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.735 ' O ' ' HD3' ' A' ' 37' ' ' ARG . . . -56.32 -39.65 83.1 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 177.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.2 m -74.28 -29.4 61.63 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.479 -0.861 . . . . 0.0 112.401 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.577 HG22 ' CD1' ' A' ' 19' ' ' PHE . 1.3 t -73.82 -27.94 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 176.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.662 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 11.4 mtm -75.03 -41.94 58.22 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 113.066 -1.879 . . . . 0.0 111.319 176.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.735 ' HD3' ' O ' ' A' ' 33' ' ' GLY . 10.3 mtp180 -79.2 -29.19 42.73 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.1 m -67.78 -8.31 34.76 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.991 0.9 . . . . 0.0 111.877 178.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 35' ' ' VAL . 80.9 mt -95.46 -5.87 42.01 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.229 -1.805 . . . . 0.0 109.535 177.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.85 -0.21 52.06 Favored Glycine 0 CA--C 1.494 -1.248 0 CA-C-O 122.206 0.892 . . . . 0.0 115.163 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.662 ' HB2' ' O ' ' A' ' 36' ' ' MET . 47.2 mt-30 -83.03 139.32 33.33 Favored 'General case' 0 C--N 1.279 -2.457 0 CA-C-N 112.293 -1.954 . . . . 0.0 112.195 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -117.87 76.52 11.12 Favored Pre-proline 0 CA--C 1.55 0.962 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.454 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.93 -179.87 4.32 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 123.063 2.509 . . . . 0.0 112.454 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.463 ' O ' HD23 ' A' ' 48' ' ' LEU . 1.5 m -100.72 160.63 14.2 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.593 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 33.5 mt-10 -80.67 -28.08 36.91 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.134 178.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.76 -36.31 67.66 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.884 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.4 ' HB3' ' HE1' ' A' ' 51' ' ' MET . 43.5 mt-10 -78.17 -29.12 48.4 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 114.088 -1.415 . . . . 0.0 108.607 176.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 45' ' ' GLU . 0.5 OUTLIER -66.06 -20.54 66.2 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.171 174.561 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.845 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 11.8 mm100 -97.48 -15.46 20.58 Favored 'General case' 0 CA--C 1.481 -1.681 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.128 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.419 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 5.9 t70 -85.58 -34.12 21.54 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 111.996 -2.365 . . . . 0.0 110.167 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.4 ' HE1' ' HB3' ' A' ' 47' ' ' GLU . 2.0 mpp? -86.46 -34.16 20.16 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.985 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.498 HD13 ' O ' ' A' ' 48' ' ' LEU . 1.2 mp -70.06 -29.17 38.93 Favored 'Isoleucine or valine' 0 C--N 1.345 0.405 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 175.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.845 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.1 t30 -71.45 -33.85 69.71 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.806 175.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 50' ' ' ASP . 41.3 mt-10 -80.25 -38.99 29.86 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.572 ' C ' ' H ' ' A' ' 57' ' ' ALA . 57.7 t -81.42 -39.36 17.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.64 34.18 0.07 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 122.015 0.912 . . . . 0.0 110.485 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.572 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -86.8 -5.99 58.95 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 114.096 -1.411 . . . . 0.0 111.929 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -110.28 -35.64 6.02 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 111.784 -2.462 . . . . 0.0 110.769 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.36 51.24 3.98 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.971 -0.559 . . . . 0.0 113.293 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -109.92 -21.53 12.3 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.568 0.223 . . . . 0.0 111.337 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.78 26.62 68.89 Favored Glycine 0 N--CA 1.466 0.638 0 CA-C-N 115.824 -0.625 . . . . 0.0 114.316 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.475 ' HB ' ' OG1' ' A' ' 26' ' ' THR . 0.1 OUTLIER -143.74 174.71 10.56 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 123.312 0.645 . . . . 0.0 110.538 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.693 HD11 HG22 ' A' ' 29' ' ' THR . 6.7 mm -136.45 110.59 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -177.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.63 ' HA ' HG21 ' A' ' 26' ' ' THR . 9.8 m-20 -55.83 143.34 31.67 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.006 173.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.527 ' CG ' ' HD3' ' A' ' 66' ' ' PRO . 7.9 p90 -91.33 -38.94 0.38 Allowed Pre-proline 0 CA--C 1.546 0.806 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -177.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.527 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 11.9 Cg_exo -71.64 -18.72 28.7 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 121.94 1.76 . . . . 0.0 113.022 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -97.51 -12.4 22.64 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.564 ' CZ ' HD21 ' A' ' 32' ' ' LEU . 7.3 t80 -84.35 -36.11 22.75 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.596 HD13 ' HA ' ' A' ' 8' ' ' GLN . 1.2 mt -66.91 -33.07 74.79 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 121.734 0.778 . . . . 0.0 110.045 177.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.543 ' O ' ' HD3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -57.28 -34.8 69.04 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 113.346 -1.752 . . . . 0.0 108.644 174.347 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.634 ' HA ' ' NE ' ' A' ' 74' ' ' ARG . 50.0 mtt -67.81 -36.62 80.72 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.712 175.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.572 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 83.4 mtp -75.33 -25.58 57.94 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.967 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -71.95 -36.81 69.98 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.634 ' NE ' ' HA ' ' A' ' 71' ' ' MET . 2.1 ptt180 -83.57 -17.79 40.51 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.611 ' HD2' ' O ' ' A' ' 71' ' ' MET . 24.2 mttt -72.84 -13.93 61.39 Favored 'General case' 0 C--N 1.346 0.451 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 176.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.692 ' SD ' HG21 ' B' ' 163' ' ' ILE . 26.0 ptt? -123.45 -34.63 3.05 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -176.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 26.7 mmtt -62.19 -40.33 95.69 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 -178.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -97.0 -29.37 13.69 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.554 HG23 ' H ' ' A' ' 80' ' ' ASP . 3.5 t -59.45 -64.86 0.79 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.554 ' H ' HG23 ' A' ' 79' ' ' THR . 7.1 m-20 -153.36 115.64 4.38 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.819 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.7 t -83.83 -14.46 51.22 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.215 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.49 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -87.12 -50.89 6.32 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.489 0.661 . . . . 0.0 109.767 -179.41 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.49 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 36.8 mt-10 -69.64 -17.76 63.54 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.295 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.566 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 9.4 tt0 -57.03 -29.85 63.72 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.36 0.664 . . . . 0.0 112.27 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.8 mp -87.97 -51.38 12.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.419 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -58.05 -19.26 30.2 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.93 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.566 ' OE1' ' HA ' ' A' ' 84' ' ' GLU . 3.4 pt-20 -75.39 -20.5 58.91 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 123.484 0.49 . . . . 0.0 110.258 178.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.25 -20.06 62.28 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.56 177.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.535 ' HE2' ' O ' ' A' ' 98' ' ' GLY . 13.9 m-85 -81.1 -21.56 39.82 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 174.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.427 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 10.7 tpt180 -77.68 -20.44 53.68 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.083 -1.417 . . . . 0.0 107.268 174.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.5 HG12 ' CD1' ' A' ' 92' ' ' PHE . 77.9 t -88.17 -56.15 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 114.201 -1.363 . . . . 0.0 112.183 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.815 ' HB3' HG21 ' A' ' 100' ' ' ILE . 29.7 m-85 -100.33 -42.98 6.41 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -176.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.731 ' CA ' HG12 ' A' ' 100' ' ' ILE . 2.9 t70 -63.57 95.83 0.11 Allowed 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.697 0.761 . . . . 0.0 113.014 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.416 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 3.2 mptp? -87.06 -48.15 8.33 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.225 -1.352 . . . . 0.0 113.423 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.419 ' HB2' ' OE2' ' A' ' 104' ' ' GLU . 5.2 t70 -71.62 0.42 8.71 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 -175.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.95 30.15 3.61 Favored Glycine 0 N--CA 1.475 1.256 0 CA-C-N 114.309 -1.314 . . . . 0.0 114.923 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -98.53 -6.55 29.96 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 122.291 0.236 . . . . 0.0 111.433 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.535 ' O ' ' HE2' ' A' ' 89' ' ' PHE . . . 105.93 -18.33 40.23 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.207 -0.52 . . . . 0.0 112.606 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -119.85 118.36 30.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.595 -0.803 . . . . 0.0 111.124 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.815 HG21 ' HB3' ' A' ' 92' ' ' PHE . 41.4 mt -78.34 89.09 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.3 t -61.74 163.56 7.2 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.892 -177.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.59 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -61.78 -14.79 35.85 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.92 -28.97 19.94 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-O 121.905 0.859 . . . . 0.0 109.422 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 1.039 ' O ' HG23 ' A' ' 108' ' ' VAL . 3.1 mm-40 -79.59 -39.9 30.62 Favored 'General case' 0 CA--C 1.484 -1.563 0 CA-C-N 112.595 -2.093 . . . . 0.0 111.253 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.551 HD23 ' O ' ' A' ' 105' ' ' LEU . 8.5 tt -67.31 -30.69 70.61 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 176.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.658 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -73.67 -43.27 59.82 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.754 176.196 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.558 ' O ' HG22 ' A' ' 110' ' ' THR . 8.5 t-80 -69.33 -21.75 63.82 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 114.086 -1.415 . . . . 0.0 108.223 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.039 HG23 ' O ' ' A' ' 104' ' ' GLU . 37.2 t -72.4 -58.48 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.297 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 175.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.641 ' SD ' HD13 ' A' ' 116' ' ' LEU . 3.4 mtt -47.82 -41.16 23.13 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 113.021 -1.9 . . . . 0.0 112.258 177.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 107' ' ' HIS . 0.8 OUTLIER -66.77 -39.18 87.76 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.522 0.677 . . . . 0.0 110.633 -178.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.47 -46.5 76.13 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.776 -1.557 . . . . 0.0 109.501 176.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.669 HD13 ' O ' ' A' ' 108' ' ' VAL . 9.2 mp -72.98 -27.92 62.09 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.131 -1.395 . . . . 0.0 112.69 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 109' ' ' MET . . . 147.92 -32.84 1.29 Allowed Glycine 0 CA--C 1.536 1.394 0 N-CA-C 116.685 1.434 . . . . 0.0 116.685 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.634 ' N ' ' O ' ' A' ' 109' ' ' MET . 5.2 mt-10 -102.14 149.88 23.83 Favored 'General case' 0 C--N 1.358 0.971 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -176.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp -105.03 131.99 51.84 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 113.87 -1.514 . . . . 0.0 107.202 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.661 ' HG ' ' HG3' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -136.26 116.03 13.06 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.726 -1.124 . . . . 0.0 113.383 -175.243 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.855 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -67.6 -175.94 0.57 Allowed 'General case' 0 C--N 1.349 0.581 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.266 179.504 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.525 ' N ' HG23 ' A' ' 117' ' ' THR . 16.4 t70 -69.8 -37.93 76.47 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -177.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.616 ' H ' HG23 ' A' ' 117' ' ' THR . 10.0 pt-20 -88.75 -16.42 32.23 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.769 ' HG2' HG22 ' A' ' 117' ' ' THR . 13.9 pt-20 -86.66 -15.88 38.3 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 123.184 0.303 . . . . 0.0 111.134 178.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.855 HG22 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -84.23 -26.78 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 123.368 0.417 . . . . 0.0 111.847 177.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -69.41 29.24 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.13 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.527 ' H ' ' C ' ' A' ' 121' ' ' VAL . 11.2 pt-20 -137.68 -34.81 0.67 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.493 177.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.49 ' HA ' ' OG1' ' B' ' 153' ' ' THR . 0.1 OUTLIER -69.77 -29.7 67.1 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.901 176.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.592 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 1.6 mp -89.11 -48.37 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.598 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -56.56 -28.47 60.22 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 124.09 0.869 . . . . 0.0 111.477 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.724 ' OE2' ' HG2' ' A' ' 144' ' ' MET . 0.2 OUTLIER -62.29 -35.08 77.9 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.146 177.722 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.721 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -106.59 -32.9 7.84 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.123 0.487 . . . . 0.0 110.113 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.592 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -59.84 126.93 29.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.47 -1.241 . . . . 0.0 113.212 -178.061 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.433 HG12 ' HG2' ' A' ' 140' ' ' GLU . 30.6 mm -89.54 -48.98 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 113.449 -1.705 . . . . 0.0 110.411 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -88.93 -25.31 22.16 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.25 49.61 5.82 Favored Glycine 0 CA--C 1.525 0.668 0 O-C-N 123.525 0.515 . . . . 0.0 113.886 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -86.48 -19.57 29.37 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.22 12.35 58.8 Favored Glycine 0 CA--C 1.501 -0.792 0 CA-C-N 115.657 -0.702 . . . . 0.0 114.04 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -140.14 105.41 5.04 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.474 HG23 HG23 ' A' ' 125' ' ' ILE . 2.4 t -64.82 125.53 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.405 HD22 ' CD ' ' A' ' 140' ' ' GLU . 11.3 m-80 -87.84 -163.16 0.9 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.267 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -53.2 7.17 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.268 0.627 . . . . 0.0 109.968 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -62.57 -20.41 64.67 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.721 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 11.2 mt-10 -88.85 -43.91 10.87 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.559 0.695 . . . . 0.0 109.769 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.44 ' HB2' ' CG1' ' A' ' 136' ' ' VAL . 11.9 t80 -67.39 -24.53 65.69 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.916 -1.493 . . . . 0.0 108.847 175.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.582 ' HA ' ' SD ' ' A' ' 145' ' ' MET . 16.1 t -86.7 -51.32 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.344 -177.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' A' ' 147' ' ' ALA . 54.1 mt-30 -56.15 -36.14 67.95 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.653 0.596 . . . . 0.0 111.837 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.724 ' HG2' ' OE2' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -66.9 -14.93 63.29 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 123.426 0.453 . . . . 0.0 111.35 179.513 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.582 ' SD ' ' HA ' ' A' ' 142' ' ' VAL . 27.1 mtp -84.72 -13.08 52.42 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 176.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.3 t -122.04 -38.18 2.75 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.048 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -31.04 -43.77 0.05 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 178.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.4 pttt . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.25 180.0 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 149' ' ' THR . . . . . 0.518 ' HB ' ' O ' ' B' ' 152' ' ' LYS . 18.7 p . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.525 0.202 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -131.47 -40.14 1.12 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.342 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 55.3 tttt -94.91 -16.61 22.71 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.455 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 152' ' ' LYS . . . . . 0.518 ' O ' ' HB ' ' B' ' 149' ' ' THR . 98.1 mttt -123.69 116.47 23.12 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 123.351 0.407 . . . . 0.0 110.56 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.49 ' OG1' ' HA ' ' A' ' 124' ' ' MET . 0.2 OUTLIER -138.34 -43.45 0.5 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 179.694 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 154' ' ' PHE . . . . . 0.692 ' HA ' HG22 ' B' ' 157' ' ' VAL . 61.1 t80 -67.95 -31.37 71.06 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 119.144 0.884 . . . . 0.0 109.48 177.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.498 ' HD2' ' OE1' ' A' ' 127' ' ' GLU . 3.6 mptt -56.79 -36.31 69.72 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.461 0.475 . . . . 0.0 110.789 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -77.41 -43.6 32.05 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.444 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 157' ' ' VAL . . . . . 0.692 HG22 ' HA ' ' B' ' 154' ' ' PHE . 17.7 m -71.78 -30.13 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 158' ' ' ALA . . . . . 0.59 ' O ' ' HB2' ' B' ' 162' ' ' LYS . . . -64.19 -40.66 96.56 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.497 0.719 . . . . 0.0 112.606 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -54.94 -36.75 65.61 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.715 0.293 . . . . 0.0 111.068 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -78.04 -47.2 18.92 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.392 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.42 HG12 HG11 ' A' ' 91' ' ' VAL . 20.8 t -131.15 66.05 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 162' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 21.2 ttmt -90.55 -26.44 19.72 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.464 176.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 163' ' ' ILE . . . . . 0.692 HG21 ' SD ' ' A' ' 76' ' ' MET . 2.1 pp -140.47 132.43 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 O-C-N 123.481 0.488 . . . . 0.0 111.459 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 164' ' ' SER . . . . . 0.627 ' O ' ' HB2' ' B' ' 168' ' ' MET . 28.2 m -128.97 -34.06 1.95 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.001 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 165' ' ' ALA . . . . . 0.432 ' HB3' ' OE2' ' A' ' 87' ' ' GLU . . . -75.25 -2.43 28.02 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.458 0.474 . . . . 0.0 112.219 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 23.5 m -75.57 -38.48 59.15 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 122.907 0.483 . . . . 0.0 110.892 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.618 HD21 ' SD ' ' A' ' 36' ' ' MET . 10.8 tp -110.81 1.43 17.72 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.82 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 168' ' ' MET . . . . . 0.627 ' HB2' ' O ' ' B' ' 164' ' ' SER . 0.0 OUTLIER -93.11 143.15 26.52 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.946 -179.877 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -143.1 101.91 0.27 Allowed Glycine 0 C--N 1.337 0.624 0 O-C-N 123.616 0.573 . . . . 0.0 112.611 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.971 179.912 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.492 0.187 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -118.31 117.35 28.86 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.085 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.422 ' HG2' HE22 ' A' ' 8' ' ' GLN . 49.1 mt-30 -97.09 151.02 20.18 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.01 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.553 ' HG ' ' OE1' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -92.65 -115.1 0.09 Allowed 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 123.183 0.593 . . . . 0.0 109.476 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.491 ' H ' ' HB2' ' A' ' 4' ' ' LEU . 19.1 p -101.38 -173.25 2.32 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 124.203 1.001 . . . . 0.0 109.685 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.496 ' HA ' HD12 ' A' ' 9' ' ' ILE . 46.2 mt-10 -69.55 -17.03 63.53 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.446 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 13.0 pt-20 -47.1 -36.3 8.1 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 123.903 0.752 . . . . 0.0 112.368 178.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.553 ' OE1' ' HG ' ' A' ' 4' ' ' LEU . 1.8 pt20 -74.49 -49.91 20.3 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.117 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 6' ' ' GLU . 5.6 mt -62.57 -28.29 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-N 113.751 -1.568 . . . . 0.0 110.404 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 6' ' ' GLU . . . -65.65 -47.38 75.74 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.768 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 22.1 mt-10 -138.1 -32.93 0.71 Allowed 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -177.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.624 ' CG ' HD21 ' A' ' 69' ' ' LEU . 74.0 m-85 -59.77 -13.12 8.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.968 0.413 . . . . 0.0 111.04 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.735 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 4.5 pttt -74.01 -41.05 62.45 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 176.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.768 ' HG2' ' O ' ' A' ' 11' ' ' GLU . 11.5 pt-20 -70.26 -43.98 69.39 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.811 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.565 ' O ' HG11 ' A' ' 35' ' ' VAL . . . -62.46 -18.09 60.98 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.779 0.8 . . . . 0.0 108.88 175.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.646 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 35.5 t80 -84.31 -49.9 8.33 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 113.886 -1.507 . . . . 0.0 109.461 177.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.458 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 9.2 t -87.35 -12.77 45.41 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -177.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.431 ' N ' ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -68.69 -29.98 68.54 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.356 0.526 . . . . 0.0 112.238 -179.236 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.549 ' CD1' HG22 ' A' ' 35' ' ' VAL . 2.5 m-85 -125.44 -4.51 7.23 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.568 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 16.8 t70 -79.36 55.78 1.98 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 118.723 0.692 . . . . 0.0 112.219 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.458 ' HE3' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -86.53 -22.5 26.32 Favored 'General case' 0 C--N 1.344 0.347 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 179.274 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.7 -22.25 61.67 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.33 0.586 . . . . 0.0 110.357 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.8 40.52 30.96 Favored Glycine 0 N--CA 1.47 0.93 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.821 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.0 23.27 9.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 112.925 -1.637 . . . . 0.0 112.753 -176.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.25 -78.46 1.97 Allowed Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.266 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.504 HG21 ' HA ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -110.96 174.76 5.71 Favored 'General case' 0 N--CA 1.436 -1.13 0 O-C-N 123.624 0.249 . . . . 0.0 110.437 178.245 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.418 ' CD1' HD23 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -78.81 148.53 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.181 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.433 ' OG1' ' HB2' ' A' ' 31' ' ' GLU . 0.6 OUTLIER -61.78 160.08 12.53 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.18 -0.918 . . . . 0.0 113.321 -179.439 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.495 HG22 HD11 ' A' ' 63' ' ' ILE . 1.2 p -76.63 -56.01 5.0 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.353 -0.839 . . . . 0.0 113.148 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.9 -13.32 6.02 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.482 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.515 ' O ' HG23 ' A' ' 35' ' ' VAL . 32.4 mt-10 -110.53 -16.84 13.57 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -176.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.445 HD22 ' O ' ' A' ' 32' ' ' LEU . 1.3 tm? -55.65 -38.86 70.11 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.915 0.486 . . . . 0.0 111.859 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.782 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -57.06 -39.55 89.91 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 110.706 -0.957 . . . . 0.0 110.706 177.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 m -73.84 -31.03 63.0 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 114.434 -0.883 . . . . 0.0 112.534 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.565 HG11 ' O ' ' A' ' 15' ' ' ALA . 1.5 t -73.84 -26.53 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 176.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.633 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 17.9 mmt -76.03 -40.87 52.5 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 113.013 -1.903 . . . . 0.0 111.429 176.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.782 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 10.8 mtt180 -82.38 -27.27 32.19 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 55.9 m -64.69 -7.95 12.71 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.996 0.903 . . . . 0.0 112.249 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.4 mt -95.66 -6.22 40.51 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 113.201 -1.818 . . . . 0.0 109.678 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.63 -0.63 52.77 Favored Glycine 0 CA--C 1.492 -1.364 0 CA-C-O 122.323 0.957 . . . . 0.0 114.719 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.633 ' HB2' ' O ' ' A' ' 36' ' ' MET . 46.2 mt-30 -79.87 139.81 37.0 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 112.11 -2.045 . . . . 0.0 111.981 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -119.44 75.34 17.17 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.821 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.71 -177.78 3.98 Favored 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 123.124 2.55 . . . . 0.0 111.754 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.69 158.3 16.05 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.967 0.413 . . . . 0.0 109.948 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.562 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 30.1 mt-10 -80.91 -28.18 35.94 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.522 177.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.43 -35.25 70.87 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 113.464 -1.698 . . . . 0.0 109.801 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -79.58 -30.3 41.53 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 113.977 -1.465 . . . . 0.0 108.776 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.562 ' HB2' ' HA ' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -67.98 -20.12 65.0 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.166 174.629 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.836 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 53.4 mt-30 -98.86 -15.74 19.1 Favored 'General case' 0 CA--C 1.482 -1.666 0 CA-C-N 114.46 -1.245 . . . . 0.0 111.07 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -85.29 -33.45 22.12 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-N 111.991 -2.368 . . . . 0.0 109.901 176.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 72.1 mtm -86.6 -33.67 20.11 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.9 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.52 HD13 ' O ' ' A' ' 48' ' ' LEU . 1.4 mp -71.23 -28.6 33.02 Favored 'Isoleucine or valine' 0 C--N 1.345 0.389 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 175.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.836 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.0 t30 -72.71 -33.97 66.82 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.882 176.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -84.03 -31.46 25.42 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.563 ' C ' ' H ' ' A' ' 57' ' ' ALA . 58.9 t -87.93 -42.23 14.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -72.55 36.79 0.07 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.979 0.895 . . . . 0.0 110.223 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.563 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -86.4 -5.71 59.1 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 114.056 -1.429 . . . . 0.0 112.056 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -108.26 -33.76 7.03 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 112.01 -2.359 . . . . 0.0 110.784 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.34 51.28 3.97 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-N 116.046 -0.525 . . . . 0.0 113.027 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -109.91 -21.43 12.35 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.53 26.76 70.93 Favored Glycine 0 N--CA 1.467 0.763 0 CA-C-N 116.001 -0.545 . . . . 0.0 114.046 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.42 165.5 30.93 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.275 0.63 . . . . 0.0 110.471 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.495 HD11 HG22 ' A' ' 29' ' ' THR . 39.9 mm -110.16 85.8 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.641 -178.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.504 ' HA ' HG21 ' A' ' 26' ' ' THR . 8.7 m-20 -50.23 151.45 2.08 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.877 0.871 . . . . 0.0 111.698 178.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.594 ' HA ' ' CD1' ' A' ' 68' ' ' PHE . 29.6 p90 -90.74 -38.5 0.4 Allowed Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.543 ' HD3' ' CD1' ' A' ' 65' ' ' PHE . 6.6 Cg_exo -74.2 -18.14 21.13 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 121.983 1.789 . . . . 0.0 113.01 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -102.26 -24.99 13.84 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -178.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.706 ' O ' ' HG2' ' A' ' 71' ' ' MET . 0.1 OUTLIER -84.91 -24.88 28.24 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -177.434 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.637 ' O ' ' N ' ' A' ' 73' ' ' ALA . 4.4 mt -74.38 -33.57 63.1 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.891 0.853 . . . . 0.0 109.38 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.49 -35.47 65.58 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 112.842 -1.981 . . . . 0.0 109.949 174.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.774 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 17.8 ptt? -78.82 -24.15 44.65 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.613 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 0.8 OUTLIER -88.98 -19.43 25.71 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.505 176.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.637 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . -77.2 -29.84 54.46 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.422 ' HD2' ' N ' ' A' ' 75' ' ' LYS . 6.7 ppt_? -82.05 -25.55 34.5 Favored 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 123.713 0.633 . . . . 0.0 110.107 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.774 ' HD2' ' O ' ' A' ' 71' ' ' MET . 24.2 mttt -68.34 -14.39 62.96 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.406 175.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.545 ' HA ' HG22 ' A' ' 79' ' ' THR . 12.5 ptt? -122.68 -23.59 5.08 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -176.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 73' ' ' ALA . 53.9 mttt -58.82 -12.75 4.73 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -103.76 -29.68 10.88 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.545 HG22 ' HA ' ' A' ' 76' ' ' MET . 9.9 t -75.59 104.45 6.15 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.053 0.454 . . . . 0.0 111.271 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.492 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 1.3 t70 -45.57 152.03 0.35 Allowed 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.219 -0.901 . . . . 0.0 112.801 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.426 ' HA ' ' OE2' ' A' ' 84' ' ' GLU . 53.0 m -71.27 -13.6 61.95 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.743 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.617 ' O ' HD12 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -74.12 -50.03 21.25 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.683 0.793 . . . . 0.0 110.597 -178.915 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.483 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 9.5 pt-20 -76.46 -18.31 58.85 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.166 -1.379 . . . . 0.0 112.835 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 39.7 mt-10 -67.79 -18.22 64.79 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 122.916 0.486 . . . . 0.0 112.289 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.617 HD12 ' O ' ' A' ' 82' ' ' GLU . 2.2 mt -86.61 -53.52 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.294 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.456 ' HD2' ' H ' ' A' ' 86' ' ' ARG . 3.0 mpt_? -56.58 -20.16 19.49 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.441 ' OE2' ' HA ' ' A' ' 84' ' ' GLU . 3.0 pt-20 -77.54 -20.38 54.26 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 123.362 0.414 . . . . 0.0 110.311 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.467 ' HB1' ' CE1' ' A' ' 141' ' ' PHE . . . -69.79 -22.87 63.29 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.774 177.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.533 ' O ' ' HB3' ' A' ' 93' ' ' ASP . 12.0 m-85 -81.84 -20.94 37.96 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 174.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.427 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 12.4 tpt180 -78.31 -21.64 49.33 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.128 -1.396 . . . . 0.0 107.491 174.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.45 HG12 ' CD1' ' A' ' 92' ' ' PHE . 53.1 t -88.25 -53.26 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.962 177.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.8 ' HB3' HG21 ' A' ' 100' ' ' ILE . 11.8 m-85 -100.3 -46.12 5.38 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -176.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.696 ' CA ' HG12 ' A' ' 100' ' ' ILE . 3.9 t70 -60.48 95.01 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.63 0.729 . . . . 0.0 111.309 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.449 ' HZ2' ' HA ' ' A' ' 94' ' ' LYS . 1.1 mmpm? -87.36 -50.33 6.64 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.424 -1.262 . . . . 0.0 113.16 -178.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -72.17 0.22 10.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -175.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 48.69 32.64 11.2 Favored Glycine 0 N--CA 1.472 1.069 0 CA-C-N 114.37 -1.286 . . . . 0.0 114.574 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -96.6 -5.73 38.43 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 122.374 0.27 . . . . 0.0 111.654 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.497 ' O ' ' HE2' ' A' ' 89' ' ' PHE . . . 104.13 -18.54 45.61 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 121.225 -0.512 . . . . 0.0 112.698 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -122.67 125.01 44.74 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.463 -0.869 . . . . 0.0 110.8 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.8 HG21 ' HB3' ' A' ' 92' ' ' PHE . 48.0 mt -80.44 88.05 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.8 t -67.54 165.38 16.97 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.893 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -60.59 -14.19 18.68 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.49 -32.45 18.23 Favored 'General case' 0 CA--C 1.49 -1.36 0 CA-C-O 121.982 0.896 . . . . 0.0 109.132 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.992 ' O ' HG23 ' A' ' 108' ' ' VAL . 16.1 mt-10 -77.12 -42.87 36.25 Favored 'General case' 0 CA--C 1.481 -1.675 0 CA-C-N 112.557 -2.111 . . . . 0.0 109.68 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.84 HD11 ' SD ' ' A' ' 124' ' ' MET . 5.3 tt -61.8 -35.57 78.58 Favored 'General case' 0 N--CA 1.441 -0.919 0 O-C-N 124.599 1.187 . . . . 0.0 108.025 177.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.438 ' HB3' ' O ' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -72.22 -43.59 64.19 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 114.253 -1.339 . . . . 0.0 108.912 176.452 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.441 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 8.5 t-80 -69.57 -21.55 63.61 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.834 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.992 HG23 ' O ' ' A' ' 104' ' ' GLU . 42.3 t -73.97 -52.34 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 176.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.718 ' SD ' ' HB2' ' A' ' 116' ' ' LEU . 18.3 mtt -56.69 -31.99 65.01 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 112.302 -2.226 . . . . 0.0 112.476 176.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -76.98 -19.06 57.78 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.516 -0.873 . . . . 0.0 110.261 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.17 -45.57 22.82 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.617 176.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.6 mt -81.49 -27.85 34.34 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.411 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 95.98 41.22 3.85 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 114.209 -1.36 . . . . 0.0 114.296 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.67 ' HB2' ' SD ' ' A' ' 109' ' ' MET . 0.1 OUTLIER -101.36 -23.46 14.37 Favored 'General case' 0 CA--C 1.479 -1.754 0 CA-C-O 123.473 1.606 . . . . 0.0 110.499 179.259 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.444 ' O ' HD12 ' A' ' 116' ' ' LEU . 5.3 mptt 34.9 122.68 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 108.902 -3.772 . . . . 0.0 112.793 -177.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.718 ' HB2' ' SD ' ' A' ' 109' ' ' MET . 0.9 OUTLIER -144.16 120.57 10.97 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 112.746 -2.025 . . . . 0.0 111.909 -175.625 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.922 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -65.74 -176.24 0.35 Allowed 'General case' 0 C--N 1.344 0.361 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.021 179.306 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.53 ' N ' HG23 ' A' ' 117' ' ' THR . 17.3 t70 -65.59 -41.05 93.28 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -177.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.584 ' H ' HG23 ' A' ' 117' ' ' THR . 10.7 pt-20 -87.27 -18.19 30.79 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.783 ' HG2' HG22 ' A' ' 117' ' ' THR . 12.7 pt-20 -85.07 -15.67 43.21 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 123.197 0.311 . . . . 0.0 111.245 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.922 HG22 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -82.47 -23.27 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 123.226 0.329 . . . . 0.0 111.005 177.1 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -70.96 31.34 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.769 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.935 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 12.0 pt-20 -132.6 -49.48 0.9 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.927 177.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.84 ' SD ' HD11 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -58.31 -29.84 66.2 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.017 0.927 . . . . 0.0 110.619 178.31 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.797 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 2.8 mt -85.02 -28.67 6.54 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.122 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -75.82 -30.21 58.92 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.369 0.604 . . . . 0.0 111.392 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.935 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 2.9 mm-40 -69.64 -28.21 65.71 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.833 177.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.574 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -99.61 -40.1 7.97 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.003 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.797 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.4 OUTLIER -61.08 122.96 16.3 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -178.123 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.7 mt -90.7 -52.74 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 113.867 -1.515 . . . . 0.0 109.676 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -87.71 -24.76 23.75 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.487 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.11 49.93 3.61 Favored Glycine 0 CA--C 1.523 0.532 0 O-C-N 123.563 0.539 . . . . 0.0 113.915 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -78.9 -20.46 49.35 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.11 26.02 49.99 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 114.766 0.667 . . . . 0.0 114.766 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.641 ' O ' ' HB ' ' A' ' 136' ' ' VAL . 38.7 mt-30 -134.03 -72.15 0.49 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.883 -0.658 . . . . 0.0 110.495 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.641 ' HB ' ' O ' ' A' ' 135' ' ' GLN . 4.1 t 120.78 116.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 125.322 1.449 . . . . 0.0 111.12 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -93.68 -163.57 1.06 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.377 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.487 ' O ' HG23 ' A' ' 142' ' ' VAL . 56.7 m-85 -66.36 -60.61 2.6 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.652 178.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -60.26 -20.51 59.26 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.574 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 9.3 mt-10 -86.58 -40.75 14.89 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 120.254 -0.578 . . . . 0.0 109.681 178.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.467 ' CE1' ' HB1' ' A' ' 88' ' ' ALA . 46.6 t80 -73.8 -24.02 59.77 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.762 176.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.539 ' O ' ' HG2' ' A' ' 145' ' ' MET . 53.5 t -86.7 -37.73 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-N 114.713 -1.13 . . . . 0.0 112.897 -177.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 140' ' ' GLU . 18.8 pt20 -50.0 -21.52 1.26 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.54 ' HB3' ' CE2' ' B' ' 154' ' ' PHE . 0.0 OUTLIER -68.58 -26.01 65.17 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 118.388 0.54 . . . . 0.0 109.912 177.712 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.539 ' HG2' ' O ' ' A' ' 142' ' ' VAL . 6.2 ptt? -82.25 -7.37 59.62 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.892 177.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 74.0 p -115.02 -48.39 2.83 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.534 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -55.23 -40.48 70.91 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 117.948 -1.025 . . . . 0.0 112.446 -179.927 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 19.5 p . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 111.303 0.112 . . . . 0.0 111.303 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -127.03 148.07 50.13 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 123.465 0.478 . . . . 0.0 110.842 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -99.96 133.31 44.52 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.893 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 152' ' ' LYS . . . . . 0.407 ' HG2' ' CD ' ' B' ' 156' ' ' GLU . 98.0 mttt -129.4 130.41 45.95 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.716 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.565 ' O ' HG12 ' B' ' 157' ' ' VAL . 11.8 t -110.85 -168.25 1.28 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.824 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 154' ' ' PHE . . . . . 0.624 ' CE1' ' HD2' ' B' ' 155' ' ' LYS . 0.1 OUTLIER -56.16 -28.17 57.07 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.507 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.624 ' HD2' ' CE1' ' B' ' 154' ' ' PHE . 9.3 mptt -60.06 -49.73 76.52 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 156' ' ' GLU . . . . . 0.407 ' CD ' ' HG2' ' B' ' 152' ' ' LYS . 42.9 mt-10 -79.67 -56.09 4.54 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 178.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 157' ' ' VAL . . . . . 0.565 HG12 ' O ' ' B' ' 153' ' ' THR . 8.9 p -73.32 -46.71 48.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -176.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 158' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' B' ' 154' ' ' PHE . . . -73.04 -34.99 66.64 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -71.6 -21.76 61.81 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.87 -41.65 43.08 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.673 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 9.4 p -92.94 7.15 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 O-C-N 123.405 0.441 . . . . 0.0 111.406 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 162' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -60.97 -38.48 86.1 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.545 0.338 . . . . 0.0 111.737 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 3.2 tp -94.39 101.39 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-O 121.14 0.495 . . . . 0.0 110.296 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 53.5 m -128.91 -15.62 4.28 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.798 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 165' ' ' ALA . . . . . 0.502 ' HB1' HG21 ' A' ' 79' ' ' THR . . . -80.83 3.11 23.64 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 166' ' ' SER . . . . . 0.509 ' O ' ' HD3' ' A' ' 75' ' ' LYS . 69.5 m -96.75 -35.11 11.09 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.56 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 4.8 tp -120.91 -39.37 2.73 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.203 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 7.3 ttt -89.33 151.87 21.84 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.32 0.388 . . . . 0.0 111.075 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . 174.06 53.84 0.05 OUTLIER Glycine 0 C--N 1.337 0.586 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.43 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 40.7 p . . . . . 0 N--CA 1.485 1.288 0 C-N-CA 124.314 1.046 . . . . 0.0 112.797 -179.92 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.569 0.223 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -97.85 165.73 11.8 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.245 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.74 162.74 4.97 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.355 0.662 . . . . 0.0 112.028 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.599 HD11 ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -107.52 -109.63 0.31 Allowed 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.557 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 16.9 p -101.04 -173.95 2.5 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 123.622 0.769 . . . . 0.0 110.194 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 10' ' ' ALA . 40.6 mt-10 -63.5 -22.61 66.99 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.557 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 12.8 pt-20 -53.07 -30.2 34.68 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.673 0.749 . . . . 0.0 111.816 178.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.776 ' HB2' HD13 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -76.74 -48.67 18.06 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 113.759 -1.564 . . . . 0.0 110.411 178.527 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.506 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 3.5 mp -68.99 -28.06 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.675 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.411 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 6' ' ' GLU . . . -68.64 -45.5 71.66 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -137.14 -37.8 0.63 Allowed 'General case' 0 C--N 1.36 1.05 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -176.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.533 ' CD2' ' HG ' ' A' ' 69' ' ' LEU . 7.6 m-85 -60.54 -13.43 14.01 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.703 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 3.1 pttt -74.21 -40.87 62.16 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.703 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 6.9 mt-10 -75.32 -42.75 53.8 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-N 113.829 -1.532 . . . . 0.0 110.525 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.755 ' O ' HG12 ' A' ' 27' ' ' ILE . . . -60.74 -18.43 54.58 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.584 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 47.8 t80 -84.11 -50.65 7.75 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.205 -1.361 . . . . 0.0 109.471 177.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.464 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 9.0 t -87.64 -12.74 44.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -177.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -66.29 -30.62 71.08 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.806 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.535 ' CD1' HG22 ' A' ' 35' ' ' VAL . 5.9 m-85 -131.94 -2.78 3.63 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 19.0 t70 -80.83 55.97 2.57 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 118.802 0.728 . . . . 0.0 112.653 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.464 ' HE3' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -86.45 -21.43 27.07 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 178.751 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.95 -22.45 61.46 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.395 0.617 . . . . 0.0 110.446 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.81 44.52 14.69 Favored Glycine 0 N--CA 1.47 0.963 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.79 23.25 13.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 113.131 -1.535 . . . . 0.0 112.831 -175.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.24 -81.47 1.75 Allowed Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.007 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.555 HG21 HG22 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -110.53 173.63 6.24 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.123 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.809 HD13 HG21 ' A' ' 35' ' ' VAL . 2.5 pp -75.51 150.12 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -177.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.18 160.41 2.16 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.306 -1.316 . . . . 0.0 113.687 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 p -80.57 -56.24 4.31 Favored 'General case' 0 C--N 1.348 0.516 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -56.31 -13.51 2.22 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.585 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.548 ' O ' HG23 ' A' ' 35' ' ' VAL . 12.5 mt-10 -111.26 -16.27 13.44 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.305 -0.862 . . . . 0.0 112.791 -177.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.458 ' HA ' HG23 ' A' ' 35' ' ' VAL . 6.3 tp -49.68 -41.41 43.05 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.541 0.736 . . . . 0.0 112.534 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.732 ' O ' ' HD3' ' A' ' 37' ' ' ARG . . . -57.75 -40.29 92.61 Favored Glycine 0 C--N 1.339 0.748 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 177.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.4 m -74.58 -29.67 61.41 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 114.452 -0.874 . . . . 0.0 112.226 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.809 HG21 HD13 ' A' ' 27' ' ' ILE . 1.7 t -73.19 -26.91 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 176.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.663 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 43.5 mtt -77.43 -42.09 37.38 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 113.055 -1.884 . . . . 0.0 111.604 176.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.732 ' HD3' ' O ' ' A' ' 33' ' ' GLY . 11.9 mtp180 -81.43 -28.0 34.45 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 56.4 m -65.12 -8.13 15.4 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 122.003 0.906 . . . . 0.0 112.237 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.5 mt -97.09 -5.39 37.52 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 113.169 -1.832 . . . . 0.0 109.588 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.52 0.98 57.85 Favored Glycine 0 CA--C 1.494 -1.275 0 CA-C-O 122.35 0.972 . . . . 0.0 114.771 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.663 ' HB2' ' O ' ' A' ' 36' ' ' MET . 47.4 mt-30 -83.27 139.74 32.91 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 112.116 -2.042 . . . . 0.0 112.036 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -116.3 78.55 8.21 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.802 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 41' ' ' GLN . 6.3 Cg_exo -80.26 -177.87 4.09 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 123.053 2.502 . . . . 0.0 111.944 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 m -101.92 159.1 15.64 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.974 0.416 . . . . 0.0 109.985 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.56 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 29.9 mt-10 -80.86 -28.16 36.16 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.728 177.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.24 -36.24 69.03 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 113.557 -1.656 . . . . 0.0 109.935 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -78.57 -28.22 45.87 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 114.03 -1.441 . . . . 0.0 108.772 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.56 ' HB2' ' HA ' ' A' ' 45' ' ' GLU . 0.5 OUTLIER -68.6 -20.26 64.49 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.097 174.711 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.92 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 47.1 mt-30 -98.71 -15.68 19.27 Favored 'General case' 0 CA--C 1.481 -1.711 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.11 178.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -86.74 -32.22 20.53 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 111.999 -2.364 . . . . 0.0 109.707 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.633 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 66.8 mtt -86.71 -35.47 19.24 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.036 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.504 HD13 ' O ' ' A' ' 48' ' ' LEU . 1.4 mp -71.83 -25.87 24.82 Favored 'Isoleucine or valine' 0 C--N 1.343 0.313 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 175.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.92 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 2.7 t30 -71.01 -36.22 72.35 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.355 175.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.633 ' HG2' ' O ' ' A' ' 51' ' ' MET . 6.8 pt-20 -79.28 -42.98 24.6 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.551 ' C ' ' H ' ' A' ' 57' ' ' ALA . 75.1 t -70.43 -41.77 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -72.82 36.19 0.07 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.924 0.869 . . . . 0.0 110.515 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.551 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -86.51 -6.21 58.95 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 114.242 -1.344 . . . . 0.0 112.351 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -112.93 -33.9 5.92 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 112.029 -2.35 . . . . 0.0 110.815 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.39 48.27 5.12 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 115.865 -0.607 . . . . 0.0 113.358 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -110.07 -21.49 12.27 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.16 26.96 62.93 Favored Glycine 0 N--CA 1.465 0.603 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.808 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.96 163.75 37.97 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.224 0.609 . . . . 0.0 110.808 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.555 HG22 HG21 ' A' ' 26' ' ' THR . 2.3 mp -94.27 162.63 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.311 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -117.14 148.39 41.61 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.992 0.917 . . . . 0.0 108.877 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.564 ' HA ' ' CE1' ' A' ' 68' ' ' PHE . 24.4 p90 -90.82 -37.25 0.39 Allowed Pre-proline 0 CA--C 1.545 0.775 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -178.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.492 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 6.5 Cg_exo -75.56 -17.75 18.11 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 121.715 1.61 . . . . 0.0 112.639 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -111.3 -7.4 14.41 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.564 ' CE1' ' HA ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -84.59 -43.18 14.7 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -177.822 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.776 HD13 ' HB2' ' A' ' 8' ' ' GLN . 1.5 mt -65.38 -31.85 73.18 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 118.827 0.74 . . . . 0.0 110.249 176.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.556 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -55.03 -34.51 63.57 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 113.563 -1.653 . . . . 0.0 108.893 175.078 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.585 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 64.7 mtt -70.46 -37.49 74.31 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.433 176.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.624 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 1.2 mpt? -78.45 -21.58 48.89 Favored 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 124.152 0.908 . . . . 0.0 110.937 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.59 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -75.5 -35.16 60.85 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.556 ' HD2' ' O ' ' A' ' 70' ' ' THR . 2.3 ptm180 -83.03 -18.02 41.23 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 120.469 -0.493 . . . . 0.0 112.276 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.624 ' HD2' ' HA ' ' A' ' 72' ' ' MET . 29.0 mttt -73.16 -13.9 61.26 Favored 'General case' 0 C--N 1.348 0.515 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 25.4 ptm -121.76 -34.88 3.31 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -177.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 16.7 mmtm -71.22 -38.34 72.01 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -178.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -104.84 -17.74 14.47 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.322 1.231 . . . . 0.0 114.322 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.627 HG23 ' H ' ' A' ' 80' ' ' ASP . 4.0 t -58.93 -68.99 0.21 Allowed 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -178.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.627 ' H ' HG23 ' A' ' 79' ' ' THR . 1.4 m-20 -167.99 125.05 1.11 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.67 0.788 . . . . 0.0 110.796 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.422 ' HA ' ' OE1' ' A' ' 84' ' ' GLU . 15.5 t -83.41 -13.63 54.43 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.415 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.616 ' O ' HD12 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -77.14 -45.8 25.57 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.775 0.83 . . . . 0.0 110.189 -179.082 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.53 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 38.9 mt-10 -74.86 -18.87 60.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.525 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.559 ' HA ' ' OG ' ' B' ' 164' ' ' SER . 37.7 mt-10 -68.65 -18.51 64.3 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 122.697 0.399 . . . . 0.0 112.008 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 82' ' ' GLU . 2.1 mt -87.87 -57.27 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.059 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.744 ' O ' ' HD1' ' A' ' 89' ' ' PHE . 9.6 mpt_? -55.5 -16.61 4.02 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.556 ' O ' HG23 ' A' ' 91' ' ' VAL . 35.3 mt-10 -79.67 -19.68 48.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.725 0.298 . . . . 0.0 111.175 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.45 -19.35 60.42 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.187 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.744 ' HD1' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -84.46 -21.51 30.65 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 175.399 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.517 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 32.3 mmt180 -78.07 -24.93 47.47 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 113.91 -1.495 . . . . 0.0 107.942 175.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 87' ' ' GLU . 85.2 t -88.38 -56.41 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.827 178.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.822 ' HB3' HG21 ' A' ' 100' ' ' ILE . 15.1 m-85 -100.54 -45.6 5.48 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -176.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.716 ' CA ' HG12 ' A' ' 100' ' ' ILE . 12.4 t70 -63.3 94.62 0.08 Allowed 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.761 0.791 . . . . 0.0 111.615 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.736 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 31.6 mttm -87.92 -48.78 7.53 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.374 -1.284 . . . . 0.0 113.892 -178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.11 0.65 9.07 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -175.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 50.02 29.3 14.27 Favored Glycine 0 N--CA 1.472 1.093 0 CA-C-N 114.357 -1.292 . . . . 0.0 114.724 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -96.23 -7.15 36.37 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.685 0.242 . . . . 0.0 111.441 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.53 -19.09 46.11 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.954 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -120.14 118.49 30.69 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.556 -0.822 . . . . 0.0 110.7 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.822 HG21 ' HB3' ' A' ' 92' ' ' PHE . 30.1 mt -77.28 93.71 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.3 p -71.94 163.37 27.97 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.334 -0.848 . . . . 0.0 113.12 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.537 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -60.13 -14.39 16.77 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -178.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.65 -33.0 17.75 Favored 'General case' 0 CA--C 1.487 -1.449 0 CA-C-O 121.943 0.878 . . . . 0.0 109.425 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 1.01 ' O ' HG23 ' A' ' 108' ' ' VAL . 3.2 mm-40 -80.02 -39.92 28.91 Favored 'General case' 0 CA--C 1.48 -1.728 0 CA-C-N 112.537 -2.12 . . . . 0.0 110.077 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.605 HD11 ' CE ' ' A' ' 124' ' ' MET . 5.9 tt -63.75 -35.74 81.58 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 177.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.712 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -71.13 -44.68 65.1 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 113.906 -1.497 . . . . 0.0 108.439 175.11 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.519 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 2.2 t60 -67.14 -21.87 65.81 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.428 177.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.01 HG23 ' O ' ' A' ' 104' ' ' GLU . 24.5 t -72.27 -50.5 35.65 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.852 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 176.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.71 ' SD ' HD22 ' A' ' 116' ' ' LEU . 20.8 mtt -56.31 -41.27 75.73 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.589 -2.096 . . . . 0.0 111.966 175.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.68 -19.21 64.38 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.412 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.95 -45.0 19.3 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.517 176.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.1 mt -79.55 -28.25 41.22 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.879 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 139.95 -8.18 3.0 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-O 117.846 -1.53 . . . . 0.0 116.765 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 109' ' ' MET . 5.0 mt-10 -100.88 151.75 21.36 Favored 'General case' 0 C--N 1.358 0.97 0 CA-C-N 120.781 2.29 . . . . 0.0 114.276 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -110.94 129.22 55.95 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 113.628 -1.624 . . . . 0.0 107.152 175.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.712 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 1.0 OUTLIER -138.67 115.87 11.05 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.968 -175.893 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.834 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -72.13 -175.7 1.57 Allowed 'General case' 0 C--N 1.347 0.494 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.784 179.372 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.513 ' N ' HG23 ' A' ' 117' ' ' THR . 17.0 t70 -70.17 -38.53 75.42 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.655 ' H ' HG23 ' A' ' 117' ' ' THR . 9.7 pt-20 -89.34 -16.99 29.77 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.765 ' HG2' HG22 ' A' ' 117' ' ' THR . 15.0 pt-20 -85.54 -16.0 40.87 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.117 0.261 . . . . 0.0 111.028 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.834 HG22 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -81.19 -26.64 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.522 177.605 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.86 30.67 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.999 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.621 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 11.6 pt-20 -141.99 -16.77 0.76 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.534 177.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.605 ' CE ' HD11 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -88.05 -27.02 22.25 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.091 0.956 . . . . 0.0 108.867 176.085 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.717 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 1.9 mp -86.88 -40.21 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 114.376 -1.284 . . . . 0.0 113.484 -177.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.1 mtt180 -61.41 -27.24 68.4 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 122.153 0.978 . . . . 0.0 110.718 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.678 ' HB3' ' CD1' ' B' ' 154' ' ' PHE . 6.5 mm-40 -56.63 -44.07 80.88 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 112.838 -1.983 . . . . 0.0 111.108 176.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.754 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -106.26 -29.57 9.72 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 114.926 -1.033 . . . . 0.0 111.7 -178.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.717 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -60.75 115.91 4.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.541 1.162 . . . . 0.0 112.902 -178.899 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.54 HD12 ' CD ' ' A' ' 140' ' ' GLU . 86.2 mt -91.09 -44.61 14.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 112.397 -2.183 . . . . 0.0 110.629 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -86.42 -25.16 25.41 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.83 49.53 6.44 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 116.04 -0.527 . . . . 0.0 113.947 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -99.52 -19.75 16.74 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.527 ' HA2' HG21 ' A' ' 125' ' ' ILE . . . 92.99 15.29 52.7 Favored Glycine 0 CA--C 1.502 -0.741 0 CA-C-O 121.5 0.5 . . . . 0.0 113.308 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -138.78 105.34 5.32 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 113.893 -1.154 . . . . 0.0 108.935 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.9 t -75.75 127.69 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.665 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.413 ' HB2' ' HG2' ' A' ' 140' ' ' GLU . 9.9 m120 -88.51 -168.15 2.11 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.949 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.465 ' O ' HG23 ' A' ' 142' ' ' VAL . 1.7 m-85 -74.06 -58.82 3.04 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.321 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -57.35 -22.95 45.81 Favored 'General case' 0 C--N 1.345 0.412 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.754 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 0.2 OUTLIER -87.68 -41.44 13.36 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.656 179.353 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -71.6 -23.37 61.7 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.679 175.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 138' ' ' TYR . 34.8 t -85.18 -48.24 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 114.633 -1.167 . . . . 0.0 112.793 -177.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' A' ' 147' ' ' ALA . 48.0 mt-30 -61.42 -23.84 66.1 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.384 0.427 . . . . 0.0 111.828 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.57 ' SD ' ' HE2' ' B' ' 154' ' ' PHE . 24.8 mmt -77.13 -14.76 59.75 Favored 'General case' 0 C--N 1.331 -0.201 0 O-C-N 123.502 0.501 . . . . 0.0 110.392 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 61.5 mtt -81.06 -19.08 44.54 Favored 'General case' 0 C--N 1.347 0.493 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 t -110.48 -48.7 3.13 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.707 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -2.54 -63.0 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 177.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.405 ' NZ ' ' HB3' ' B' ' 155' ' ' LYS . 22.8 pttm . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.48 -0.771 . . . . 0.0 111.571 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.551 0.215 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -128.38 -42.23 1.51 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.228 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt -99.7 130.0 45.88 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 123.372 0.42 . . . . 0.0 110.851 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -103.41 129.61 50.56 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.613 ' O ' HG13 ' B' ' 157' ' ' VAL . 2.4 t -138.16 -53.89 0.63 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.065 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 154' ' ' PHE . . . . . 0.808 ' H ' ' HD1' ' B' ' 154' ' ' PHE . 0.0 OUTLIER -55.56 -45.02 77.33 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.826 0.85 . . . . 0.0 112.941 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.563 ' HD2' ' CZ ' ' B' ' 154' ' ' PHE . 1.3 mppt? -71.79 -32.5 67.69 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 123.389 0.43 . . . . 0.0 109.947 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -77.37 -40.14 44.91 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.297 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 157' ' ' VAL . . . . . 0.613 HG13 ' O ' ' B' ' 153' ' ' THR . 34.6 m -66.12 -41.96 90.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.069 0.548 . . . . 0.0 110.932 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 158' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' B' ' 162' ' ' LYS . . . -73.95 -37.99 64.36 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.933 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 159' ' ' ASN . . . . . 0.563 ' HB2' ' O ' ' B' ' 155' ' ' LYS . 1.9 t30 -59.78 -30.02 68.6 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.437 0.461 . . . . 0.0 111.773 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.82 -35.86 57.28 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.577 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 8.9 p -111.07 25.5 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.402 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 162' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 1.9 ttpm? -85.66 77.15 9.87 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.586 0.707 . . . . 0.0 110.919 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 2.9 tt -143.65 107.67 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.348 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 164' ' ' SER . . . . . 0.559 ' OG ' ' HA ' ' A' ' 84' ' ' GLU . 20.2 t -128.41 122.02 30.41 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.718 -178.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . 64.18 8.93 4.39 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 18.4 t -67.46 -38.83 85.05 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.384 0.273 . . . . 0.0 111.643 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.414 HD11 ' HE1' ' A' ' 36' ' ' MET . 3.4 tp -131.58 -55.62 1.01 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.738 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 15.2 ttt 48.76 109.87 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.661 1.185 . . . . 0.0 112.68 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -97.0 -94.95 1.87 Allowed Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.559 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 19.6 p . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.442 -0.789 . . . . 0.0 111.039 179.977 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.438 0 N-CA-C 111.4 0.148 . . . . 0.0 111.4 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.517 ' OD2' HD11 ' A' ' 9' ' ' ILE . 1.4 m-20 -118.73 114.7 23.11 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 123.454 0.471 . . . . 0.0 110.735 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -108.72 -51.31 2.9 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.654 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.489 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -122.29 -112.02 0.32 Allowed 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.533 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.508 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 17.3 p -101.31 -173.77 2.45 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 123.796 0.838 . . . . 0.0 110.854 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.442 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.6 mp0 -61.94 -23.44 66.36 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.508 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 12.7 pt-20 -53.83 -30.57 45.83 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.463 0.649 . . . . 0.0 111.444 178.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.517 ' HA ' HD13 ' A' ' 69' ' ' LEU . 1.2 tp60 -75.2 -45.95 37.14 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.139 -1.391 . . . . 0.0 109.811 178.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.517 HD11 ' OD2' ' A' ' 2' ' ' ASP . 3.9 mt -65.98 -32.23 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.629 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.56 -35.47 58.18 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -114.11 -18.4 11.68 Favored 'General case' 0 C--N 1.347 0.495 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.663 ' O ' ' HB2' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -74.62 -15.28 60.83 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.939 0.79 . . . . 0.0 110.028 178.536 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.701 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 1.1 pttt -80.99 -41.6 22.5 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.701 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 2.2 mt-10 -82.17 -39.98 22.43 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 114.225 -1.352 . . . . 0.0 112.314 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.584 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -66.21 -18.85 65.6 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 178.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 1.006 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 10.3 t80 -86.27 -48.85 8.15 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.496 177.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.0 m -86.71 -12.96 46.78 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -176.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -72.74 -29.67 63.53 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.76 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.5 ' CD1' HG22 ' A' ' 35' ' ' VAL . 5.3 m-85 -134.49 -5.86 2.56 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 1.006 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 0.8 OUTLIER -97.23 79.28 2.8 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 118.833 0.742 . . . . 0.0 111.052 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.411 ' HD2' ' N ' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -81.04 -34.78 32.57 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.29 -21.57 58.39 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.37 178.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.16 51.73 6.66 Favored Glycine 0 N--CA 1.469 0.898 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.84 22.56 7.19 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 113.445 -1.377 . . . . 0.0 113.952 -175.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.29 -67.74 0.52 Allowed Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.438 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.517 ' OG1' ' N ' ' A' ' 63' ' ' ILE . 1.3 t -98.09 174.01 6.75 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.708 0.766 . . . . 0.0 111.625 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.599 HG23 ' OD2' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -132.56 148.23 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.724 0 CA-C-N 113.723 -1.58 . . . . 0.0 109.964 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.58 150.47 12.16 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.568 HG22 HD11 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -69.38 -55.18 11.12 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.909 -179.244 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -55.0 -13.92 1.3 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.599 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.553 ' O ' HG23 ' A' ' 35' ' ' VAL . 24.7 mt-10 -111.0 -18.41 13.06 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.101 -178.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.416 ' HA ' HG23 ' A' ' 35' ' ' VAL . 2.2 tm? -58.49 -36.87 74.43 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.874 0.47 . . . . 0.0 111.646 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.79 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -55.82 -39.78 78.56 Favored Glycine 0 C--N 1.34 0.769 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 177.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.7 m -76.51 -29.1 56.64 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.559 -0.82 . . . . 0.0 112.452 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 15' ' ' ALA . 1.6 t -75.71 -26.59 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 177.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.603 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 10.5 mmt -73.92 -44.1 56.19 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 112.941 -1.936 . . . . 0.0 110.982 175.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.79 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 12.1 mtt180 -77.7 -29.75 51.48 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.5 m -69.04 -8.77 48.22 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 122.002 0.906 . . . . 0.0 111.845 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 14' ' ' GLU . 83.9 mt -91.87 -6.85 50.83 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 113.255 -1.793 . . . . 0.0 109.917 177.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.95 -3.03 33.64 Favored Glycine 0 CA--C 1.492 -1.382 0 CA-C-O 122.32 0.956 . . . . 0.0 115.082 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.603 ' HB2' ' O ' ' A' ' 36' ' ' MET . 47.0 mt-30 -80.09 139.85 36.71 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 112.214 -1.993 . . . . 0.0 112.04 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -123.34 68.61 39.18 Favored Pre-proline 0 CA--C 1.55 0.97 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.295 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.43 ' HD3' ' C ' ' A' ' 41' ' ' GLN . 6.9 Cg_endo -88.37 -177.82 1.9 Allowed 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 123.157 2.571 . . . . 0.0 112.384 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.432 ' O ' HD23 ' A' ' 48' ' ' LEU . 1.4 m -100.35 160.57 14.23 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 29.7 mt-10 -80.77 -28.03 36.52 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.613 0.721 . . . . 0.0 109.835 178.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.92 -37.18 67.31 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 113.576 -1.647 . . . . 0.0 110.014 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.57 ' HA ' ' OD2' ' A' ' 50' ' ' ASP . 9.6 mm-40 -75.37 -29.14 59.78 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.724 176.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.474 ' HB2' ' HA ' ' A' ' 45' ' ' GLU . 0.5 OUTLIER -64.53 -20.79 66.43 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.644 174.538 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.789 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 53.0 mt-30 -92.33 -17.18 25.05 Favored 'General case' 0 CA--C 1.48 -1.717 0 CA-C-N 114.031 -1.44 . . . . 0.0 111.478 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.57 ' OD2' ' HA ' ' A' ' 47' ' ' GLU . 26.9 m-20 -80.9 -36.05 31.69 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 111.795 -2.457 . . . . 0.0 109.854 176.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.67 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 13.0 ttt -86.41 -30.89 21.76 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.755 177.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.3 mt -74.81 -23.48 17.68 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 174.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.789 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.0 t30 -66.42 -35.05 79.33 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.974 174.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.67 ' HG2' ' O ' ' A' ' 51' ' ' MET . 7.6 pt-20 -86.7 -40.71 14.8 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 123.475 0.484 . . . . 0.0 111.947 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.526 ' C ' ' H ' ' A' ' 57' ' ' ALA . 75.6 t -69.42 -43.52 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -72.98 38.15 0.08 Allowed 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.917 0.865 . . . . 0.0 110.376 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -86.24 -5.82 59.11 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 114.277 -1.328 . . . . 0.0 111.977 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -111.56 -33.59 6.33 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 111.982 -2.372 . . . . 0.0 110.63 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.39 48.58 5.0 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-N 115.866 -0.606 . . . . 0.0 113.43 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -110.13 -21.85 12.07 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.85 26.61 72.24 Favored Glycine 0 N--CA 1.468 0.815 0 CA-C-N 115.953 -0.567 . . . . 0.0 114.216 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.474 HG22 ' HG1' ' A' ' 26' ' ' THR . 0.0 OUTLIER -135.97 -177.51 4.72 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 123.067 0.547 . . . . 0.0 110.77 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.568 HD11 HG22 ' A' ' 29' ' ' THR . 36.6 mm -138.42 86.6 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -176.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -70.18 149.42 47.54 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.349 -0.219 . . . . 0.0 110.557 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.599 ' HA ' ' CE2' ' A' ' 68' ' ' PHE . 24.9 p90 -70.18 -36.72 6.4 Favored Pre-proline 0 N--CA 1.479 0.977 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -177.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.487 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 17.4 Cg_exo -67.63 -16.78 47.48 Favored 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 122.119 1.879 . . . . 0.0 113.194 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -104.11 -26.03 12.73 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -177.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.599 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 6.5 p90 -85.09 -45.41 12.11 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 116.409 2.004 . . . . 0.0 116.409 -176.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.517 HD13 ' HA ' ' A' ' 8' ' ' GLN . 3.0 mt -63.3 -32.41 73.82 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.694 0.759 . . . . 0.0 110.965 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.526 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -57.34 -34.75 69.1 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 113.39 -1.732 . . . . 0.0 108.878 174.278 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.644 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 23.5 mmt -70.41 -27.13 64.04 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.521 175.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.534 ' HA ' ' CD ' ' A' ' 75' ' ' LYS . 28.3 mtm -85.36 -18.53 33.51 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.351 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.513 ' O ' ' HG3' ' A' ' 77' ' ' LYS . . . -81.53 -35.29 30.52 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 176.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.526 ' HD2' ' O ' ' A' ' 70' ' ' THR . 2.3 ptm180 -82.18 -17.9 44.6 Favored 'General case' 0 C--N 1.349 0.585 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.644 ' HD2' ' O ' ' A' ' 71' ' ' MET . 0.0 OUTLIER -86.38 -12.88 48.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 119.358 -0.937 . . . . 0.0 112.398 177.369 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' A' ' 72' ' ' MET . 20.6 ptt? -111.2 -28.01 8.45 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.925 0.393 . . . . 0.0 111.969 -178.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' A' ' 73' ' ' ALA . 38.8 mttt -66.92 -13.75 62.07 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.733 0.813 . . . . 0.0 113.089 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -104.22 -23.46 13.25 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.429 HG22 ' HA ' ' A' ' 76' ' ' MET . 8.8 t -76.78 10.18 2.38 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.412 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 9.8 m-20 65.12 149.81 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.064 0.946 . . . . 0.0 112.497 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.56 ' HA ' ' OE2' ' A' ' 84' ' ' GLU . 53.8 m -83.11 -13.78 54.96 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.044 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.409 ' O ' HD12 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -77.83 -43.5 30.22 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.74 0.816 . . . . 0.0 109.947 -179.332 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -70.92 -18.42 62.65 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.847 -1.524 . . . . 0.0 112.256 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.56 ' OE2' ' HA ' ' A' ' 81' ' ' SER . 39.8 mt-10 -66.96 -19.56 65.74 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 82' ' ' GLU . 3.1 mp -87.92 -50.99 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.529 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.583 ' O ' ' HD1' ' A' ' 89' ' ' PHE . 9.4 mpt_? -63.21 -16.84 61.44 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.525 ' OE2' ' HA ' ' A' ' 84' ' ' GLU . 3.4 pt-20 -73.77 -18.78 60.93 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 177.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.524 ' HA ' ' HB ' ' A' ' 91' ' ' VAL . . . -64.67 -23.82 67.38 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.914 178.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.583 ' HD1' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -82.35 -21.0 36.15 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 175.137 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -82.01 -19.86 39.6 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.252 -1.34 . . . . 0.0 107.752 174.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.548 HG12 ' HD1' ' A' ' 92' ' ' PHE . 3.1 t -88.09 -56.12 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.181 178.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.78 ' HB3' HD13 ' A' ' 100' ' ' ILE . 1.8 m-85 -100.79 -46.28 5.19 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -177.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.704 ' CA ' HG12 ' A' ' 100' ' ' ILE . 8.3 t70 -62.33 95.56 0.07 Allowed 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.757 0.789 . . . . 0.0 112.734 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 70.1 mmtt -86.7 -41.89 13.81 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.757 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -70.68 -19.41 62.79 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 -175.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.66 20.41 75.7 Favored Glycine 0 C--N 1.295 -1.714 0 CA-C-N 112.866 -1.97 . . . . 0.0 114.159 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -94.82 -6.02 43.8 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 122.295 0.238 . . . . 0.0 111.427 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.9 -19.12 44.9 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.725 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.434 ' HB3' ' HG3' ' A' ' 135' ' ' GLN . 41.1 m-85 -112.1 121.01 43.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.486 -0.857 . . . . 0.0 110.72 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.78 HD13 ' HB3' ' A' ' 92' ' ' PHE . 16.1 mt -85.4 86.84 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-O 121.542 0.687 . . . . 0.0 109.345 178.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.1 m -61.29 162.45 7.66 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.873 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.602 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -60.72 -14.22 19.72 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.56 -30.94 18.92 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-O 122.086 0.946 . . . . 0.0 109.416 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 1.058 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.7 mm-40 -81.32 -40.81 23.04 Favored 'General case' 0 CA--C 1.481 -1.707 0 CA-C-N 112.461 -2.154 . . . . 0.0 110.392 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.727 HD21 ' SD ' ' A' ' 124' ' ' MET . 6.8 tt -65.88 -30.55 71.17 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 176.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.728 ' HA ' HD11 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -73.72 -44.65 55.76 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 113.933 -1.485 . . . . 0.0 108.855 176.043 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.516 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 10.8 t-80 -67.52 -21.53 65.48 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 114.055 -1.43 . . . . 0.0 108.041 176.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.058 HG23 ' O ' ' A' ' 104' ' ' GLU . 35.8 t -70.82 -52.84 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 176.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.839 ' SD ' HD13 ' A' ' 116' ' ' LEU . 16.7 mtt -56.85 -42.37 79.59 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 113.587 -1.642 . . . . 0.0 111.965 176.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.21 -18.7 61.22 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 119.524 -0.871 . . . . 0.0 110.256 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 107' ' ' HIS . 0.8 OUTLIER -78.92 -46.0 19.34 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.146 176.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.8 mt -79.72 -28.36 40.56 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.082 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.98 0.75 3.82 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 117.419 -1.767 . . . . 0.0 116.852 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.668 ' N ' ' O ' ' A' ' 109' ' ' MET . 4.6 mt-10 -100.94 147.54 26.04 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 121.482 2.641 . . . . 0.0 113.716 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.2 mptt -111.34 117.03 32.0 Favored 'General case' 0 CA--C 1.485 -1.558 0 CA-C-N 113.598 -1.637 . . . . 0.0 107.353 175.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.839 HD13 ' SD ' ' A' ' 109' ' ' MET . 0.5 OUTLIER -122.26 128.43 51.1 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 112.52 -2.127 . . . . 0.0 112.883 -175.505 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.935 ' H ' ' HG3' ' A' ' 120' ' ' GLU . 0.6 OUTLIER -78.17 -175.18 4.01 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.824 -1.534 . . . . 0.0 111.854 178.635 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.609 ' N ' HG23 ' A' ' 117' ' ' THR . 18.3 t70 -61.96 -44.43 96.77 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.966 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.635 ' H ' HG23 ' A' ' 117' ' ' THR . 6.9 pt-20 -78.51 -15.18 58.88 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.745 0.307 . . . . 0.0 111.112 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.935 ' HG3' ' H ' ' A' ' 117' ' ' THR . 1.4 mm-40 -74.55 -31.87 62.25 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.36 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -86.38 -34.5 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.79 -178.867 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -79.01 24.79 0.3 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.668 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.547 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 9.7 pt-20 -138.57 -19.16 1.07 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.052 -1.431 . . . . 0.0 111.134 178.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.727 ' SD ' HD21 ' A' ' 105' ' ' LEU . 8.7 ttt -88.66 -27.9 20.96 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.733 ' O ' ' N ' ' A' ' 129' ' ' ASP . 1.5 mp -87.89 -45.65 15.96 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 CA-C-N 114.662 -1.154 . . . . 0.0 112.467 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.441 ' HA ' ' CG ' ' A' ' 129' ' ' ASP . 70.9 mtt180 -60.07 -29.66 68.7 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 123.845 0.716 . . . . 0.0 112.85 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.547 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 4.6 mm-40 -74.61 -25.86 59.52 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.834 177.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.602 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -104.88 -27.8 11.51 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.074 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.733 ' N ' ' O ' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -60.03 114.13 2.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.352 -1.295 . . . . 0.0 113.489 -178.358 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 41.2 mt -91.89 -51.83 10.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 113.125 -1.852 . . . . 0.0 110.619 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -89.12 -25.35 21.92 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.612 ' HA2' ' OD2' ' A' ' 129' ' ' ASP . . . 86.5 49.76 4.04 Favored Glycine 0 CA--C 1.522 0.505 0 O-C-N 123.46 0.475 . . . . 0.0 113.783 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.653 ' HB3' ' NE2' ' A' ' 135' ' ' GLN . 6.5 m-20 -96.39 -19.64 19.05 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 100.96 -1.65 55.24 Favored Glycine 0 CA--C 1.504 -0.599 0 CA-C-O 121.688 0.604 . . . . 0.0 113.309 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.653 ' NE2' ' HB3' ' A' ' 133' ' ' ASP . 0.8 OUTLIER -119.31 175.97 5.55 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 113.496 -1.352 . . . . 0.0 109.558 178.644 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.83 HG13 ' HB2' ' A' ' 140' ' ' GLU . 15.1 t -135.02 119.33 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 121.125 0.488 . . . . 0.0 111.622 -178.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -84.67 -169.9 2.85 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.906 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.422 ' O ' HG23 ' A' ' 142' ' ' VAL . 46.5 m-85 -62.03 -48.9 78.21 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.33 177.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 143' ' ' GLN . 9.4 mm-40 -69.21 -22.18 63.89 Favored 'General case' 0 C--N 1.347 0.487 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.83 ' HB2' HG13 ' A' ' 136' ' ' VAL . 3.4 mt-10 -85.55 -34.65 21.45 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.814 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.49 ' CE2' ' HB1' ' A' ' 88' ' ' ALA . 85.8 t80 -77.56 -24.35 49.84 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.409 176.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.517 ' O ' ' HG2' ' A' ' 145' ' ' MET . 19.6 t -86.78 -38.27 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.3 -178.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 139' ' ' GLU . 10.3 mt-30 -48.76 -29.92 5.06 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.562 ' HB3' ' CD2' ' B' ' 154' ' ' PHE . 0.0 OUTLIER -63.55 -27.12 69.04 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 118.533 0.606 . . . . 0.0 110.8 178.608 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.517 ' HG2' ' O ' ' A' ' 142' ' ' VAL . 9.8 ptm -83.36 -4.37 58.4 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.881 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.444 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 44.5 p -120.23 -44.17 2.5 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.547 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -48.62 -33.5 9.96 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 94.2 mttt . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.113 -0.946 . . . . 0.0 111.302 179.732 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.531 0.205 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -100.54 -39.57 7.85 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.259 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -95.04 140.29 30.19 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.824 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -129.48 145.53 51.43 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.198 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.525 ' OG1' ' HA ' ' A' ' 124' ' ' MET . 8.7 t -137.31 -170.2 2.68 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.433 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 154' ' ' PHE . . . . . 0.57 ' HA ' HG22 ' B' ' 157' ' ' VAL . 0.1 OUTLIER -61.11 -27.89 68.7 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.452 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.505 ' HD2' ' CE1' ' B' ' 154' ' ' PHE . 1.4 mptt -71.93 -44.02 64.33 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.757 0.423 . . . . 0.0 111.319 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -76.73 -38.91 53.44 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 157' ' ' VAL . . . . . 0.57 HG22 ' HA ' ' B' ' 154' ' ' PHE . 23.4 m -71.76 -29.55 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.88 0.472 . . . . 0.0 111.622 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 158' ' ' ALA . . . . . 0.568 ' O ' ' HB2' ' B' ' 162' ' ' LYS . . . -52.57 -42.66 64.66 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.859 0.864 . . . . 0.0 113.128 -178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -58.89 -30.64 67.93 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 123.182 0.301 . . . . 0.0 111.506 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.65 -39.98 43.25 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.781 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 9.0 p -119.85 33.77 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.318 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 162' ' ' LYS . . . . . 0.568 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 0.1 OUTLIER -82.63 -45.18 14.87 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 122.252 -0.28 . . . . 0.0 110.712 178.458 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 1.7 tp -101.68 63.06 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-O 121.688 0.756 . . . . 0.0 110.241 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 16.5 t -84.74 -2.14 57.21 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.554 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . -90.39 -10.81 42.52 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.937 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 166' ' ' SER . . . . . 0.425 ' OG ' ' HB3' ' A' ' 72' ' ' MET . 22.8 t -70.36 -34.17 72.31 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.858 0.463 . . . . 0.0 111.929 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.54 HD22 ' OE1' ' A' ' 41' ' ' GLN . 4.5 tp -132.16 -39.02 1.07 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.002 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 67.2 mtt 63.62 127.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.081 0.953 . . . . 0.0 111.848 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -100.2 92.91 1.15 Allowed Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.526 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 19.7 p . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.105 -0.95 . . . . 0.0 111.061 179.994 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.568 0.223 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 62.8 122.75 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.929 0.891 . . . . 0.0 112.227 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.629 ' HA ' ' NE2' ' A' ' 8' ' ' GLN . 1.1 mp0 -89.74 160.53 16.51 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.191 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.455 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -107.27 -109.62 0.31 Allowed 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.773 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.573 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 14.0 p -101.26 -173.69 2.43 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 123.633 0.773 . . . . 0.0 111.015 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -59.39 -25.96 64.72 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.573 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 9.9 pt-20 -56.41 -32.52 64.92 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.29 0.566 . . . . 0.0 111.611 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.629 ' NE2' ' HA ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -78.3 -44.95 23.97 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.034 177.553 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.579 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . 20.8 mm -58.9 -35.97 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.557 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.03 -34.81 64.24 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -111.77 -17.96 12.84 Favored 'General case' 0 C--N 1.345 0.379 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 -177.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.579 ' CE1' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -73.3 -16.13 61.38 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.578 0.626 . . . . 0.0 110.542 179.328 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.679 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 1.2 pttt -83.35 -41.46 18.19 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.615 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.679 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 1.2 mt-10 -81.53 -37.05 28.42 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 114.241 -1.345 . . . . 0.0 112.417 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.659 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -67.28 -23.27 65.65 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.32 0.581 . . . . 0.0 109.504 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.944 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 26.1 t80 -86.91 -43.4 12.44 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.908 176.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.1 m -86.4 -12.81 48.12 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 114.814 1.412 . . . . 0.0 114.814 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -73.0 -29.4 63.0 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.348 179.364 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.572 ' CD1' HG22 ' A' ' 35' ' ' VAL . 7.4 m-85 -131.31 -7.71 3.78 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.944 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 1.4 m-20 -99.38 79.7 2.33 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.845 0.748 . . . . 0.0 110.059 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.07 -37.45 58.24 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.84 -20.33 58.21 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.243 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.5 51.55 5.97 Favored Glycine 0 C--N 1.343 0.918 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.77 22.15 4.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 113.454 -1.373 . . . . 0.0 114.338 -175.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.17 -62.82 0.23 Allowed Glycine 0 CA--C 1.528 0.858 0 CA-C-N 115.367 -0.833 . . . . 0.0 114.362 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.715 HG22 ' N ' ' A' ' 64' ' ' ASP . 10.4 p -97.65 157.77 15.86 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 123.662 0.785 . . . . 0.0 111.791 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.616 HG23 ' OD2' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -120.02 148.33 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.74 -179.463 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.48 150.24 12.21 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.24 -55.7 5.46 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.319 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -53.66 -14.07 0.81 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 123.856 0.722 . . . . 0.0 111.378 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.495 ' O ' HG23 ' A' ' 35' ' ' VAL . 18.0 mt-10 -114.07 -16.9 12.05 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.692 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.455 ' HA ' HG23 ' A' ' 35' ' ' VAL . 7.8 tp -56.0 -40.42 73.31 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.264 0.626 . . . . 0.0 111.866 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.78 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -55.82 -39.27 76.89 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 177.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.0 m -74.94 -30.85 61.35 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 114.514 -0.843 . . . . 0.0 112.565 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.659 HG12 ' HA ' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -74.48 -27.07 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 176.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.608 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 45.0 mtt -73.52 -42.56 61.61 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 113.001 -1.909 . . . . 0.0 111.064 176.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.78 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 11.8 mtt180 -80.2 -29.12 38.57 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.8 m -66.87 -8.23 27.53 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.987 0.899 . . . . 0.0 112.051 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 35' ' ' VAL . 69.0 mt -92.44 -8.27 45.2 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 113.191 -1.822 . . . . 0.0 109.63 177.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.52 -3.91 30.99 Favored Glycine 0 CA--C 1.492 -1.372 0 CA-C-O 122.25 0.917 . . . . 0.0 114.949 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.608 ' HB2' ' O ' ' A' ' 36' ' ' MET . 47.2 mt-30 -78.45 141.51 38.21 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 112.3 -1.95 . . . . 0.0 112.198 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -125.38 68.09 58.21 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.486 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -84.2 -177.83 3.19 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 123.177 2.584 . . . . 0.0 112.19 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 m -98.97 160.8 14.0 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.517 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 28.6 mt-10 -80.63 -28.32 36.99 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.686 0.755 . . . . 0.0 109.896 178.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.45 -38.23 65.54 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.087 -178.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.588 ' HA ' ' OD2' ' A' ' 50' ' ' ASP . 43.1 mt-10 -76.3 -28.68 57.07 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 114.265 -1.334 . . . . 0.0 108.562 176.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.81 ' O ' HG12 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -63.08 -24.2 67.8 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.882 174.269 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.658 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 57.0 mt-30 -87.72 -18.93 28.37 Favored 'General case' 0 CA--C 1.478 -1.791 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.553 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.588 ' OD2' ' HA ' ' A' ' 47' ' ' GLU . 10.5 m-20 -75.64 -27.96 58.6 Favored 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 112.031 -2.35 . . . . 0.0 108.332 175.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.542 ' HA ' ' OE1' ' A' ' 54' ' ' GLU . 46.9 mtt -86.61 -35.67 19.28 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.663 176.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.81 HG12 ' O ' ' A' ' 48' ' ' LEU . 30.3 mm -68.8 -27.51 36.14 Favored 'Isoleucine or valine' 0 C--N 1.352 0.711 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 175.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.658 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.7 t-20 -72.94 -34.29 66.45 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 114.006 -1.452 . . . . 0.0 111.699 176.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.542 ' OE1' ' HA ' ' A' ' 51' ' ' MET . 5.5 pt-20 -88.24 -49.53 6.93 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.592 ' C ' ' H ' ' A' ' 57' ' ' ALA . 47.8 t -83.79 -49.75 16.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -178.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 5.1 t70 -71.14 37.46 0.05 Allowed 'General case' 0 C--O 1.238 0.484 0 CA-C-O 122.089 0.947 . . . . 0.0 110.289 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.592 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -86.26 -5.77 59.11 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 113.969 -1.469 . . . . 0.0 112.154 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -101.98 -33.36 9.77 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 112.069 -2.332 . . . . 0.0 110.864 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.38 51.09 4.03 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.149 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -109.94 -21.76 12.18 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.632 0.253 . . . . 0.0 111.546 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.93 26.67 72.33 Favored Glycine 0 N--CA 1.468 0.767 0 CA-C-N 115.711 -0.677 . . . . 0.0 114.599 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.46 ' O ' HD13 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -146.67 156.17 42.99 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 123.202 0.601 . . . . 0.0 110.593 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.575 ' O ' HG13 ' A' ' 27' ' ' ILE . 10.9 mm -135.11 126.41 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.715 ' N ' HG22 ' A' ' 26' ' ' THR . 0.3 OUTLIER -73.22 156.83 38.14 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.363 176.587 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.55 ' CG ' ' HD3' ' A' ' 66' ' ' PRO . 10.6 p90 -91.61 -40.12 0.38 Allowed Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -177.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.55 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 7.4 Cg_exo -73.76 -18.17 22.31 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 121.793 1.662 . . . . 0.0 112.821 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -93.5 -19.42 21.25 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' A' ' 65' ' ' PHE . 2.7 p90 -83.62 -33.29 25.33 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 120.069 1.304 . . . . 0.0 114.283 -178.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.573 HD13 ' HA ' ' A' ' 8' ' ' GLN . 1.3 mt -65.66 -35.64 81.36 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.667 0.746 . . . . 0.0 110.417 178.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.47 -33.49 71.37 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 113.447 -1.706 . . . . 0.0 108.834 174.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.631 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 60.4 mtt -77.26 -23.32 51.23 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.992 175.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.571 ' HA ' ' CD ' ' A' ' 75' ' ' LYS . 66.0 mtt -88.75 -18.59 27.47 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.029 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.733 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -83.27 -24.99 32.01 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.846 177.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.453 ' HD2' ' N ' ' A' ' 75' ' ' LYS . 4.0 ppt_? -89.62 -28.48 19.48 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.631 ' HD2' ' O ' ' A' ' 71' ' ' MET . 8.5 ptmt -75.61 -12.9 60.3 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.552 ' HG2' ' O ' ' A' ' 72' ' ' MET . 14.7 ptm -113.27 -34.27 5.7 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.733 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 32.3 mmtt -76.39 -25.39 54.52 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.88 -1.055 . . . . 0.0 113.844 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -104.01 -22.85 13.39 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -177.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.608 HG23 ' H ' ' A' ' 80' ' ' ASP . 4.5 t -61.06 -67.6 0.39 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.608 ' H ' HG23 ' A' ' 79' ' ' THR . 4.6 m-20 -162.73 121.14 2.11 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.8 0.84 . . . . 0.0 110.327 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.3 t -83.66 -13.48 54.06 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.451 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.521 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -75.99 -52.11 10.95 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.391 0.677 . . . . 0.0 111.079 -178.049 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.55 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -72.65 -17.76 61.63 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.578 -1.192 . . . . 0.0 113.248 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -53.54 -26.63 21.96 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.225 0.61 . . . . 0.0 112.167 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.7 mp -87.77 -47.47 15.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.272 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.625 ' O ' ' HD1' ' A' ' 89' ' ' PHE . 45.7 mtt180 -51.59 -30.6 21.6 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.111 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.55 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 43.9 mt-10 -62.63 -20.39 64.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.787 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.79 -19.53 60.74 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.942 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.625 ' HD1' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -84.96 -21.35 29.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 174.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 30.9 mmt180 -78.74 -28.62 44.92 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.131 -1.395 . . . . 0.0 108.333 175.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 87' ' ' GLU . 82.5 t -88.75 -50.92 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 CA-C-N 114.4 -1.273 . . . . 0.0 113.07 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.855 ' HB3' HG21 ' A' ' 100' ' ' ILE . 30.6 m-85 -100.07 -43.05 6.48 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.688 ' CA ' HG12 ' A' ' 100' ' ' ILE . 14.1 t70 -69.02 94.96 0.68 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 122.295 1.045 . . . . 0.0 112.429 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.435 ' HD2' ' O ' ' A' ' 92' ' ' PHE . 1.2 mptm? -88.59 -48.78 7.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 113.088 -1.869 . . . . 0.0 114.075 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -71.49 2.02 5.63 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 48.19 29.15 6.62 Favored Glycine 0 N--CA 1.474 1.182 0 CA-C-N 114.302 -1.317 . . . . 0.0 115.091 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -98.56 -3.12 37.07 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.703 0.251 . . . . 0.0 111.304 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.03 -19.12 53.3 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.513 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.51 ' HB3' ' HG3' ' A' ' 135' ' ' GLN . 39.0 m-85 -115.1 129.06 56.59 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.379 -0.911 . . . . 0.0 110.852 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.855 HG21 ' HB3' ' A' ' 92' ' ' PHE . 54.9 mt -88.55 83.54 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.4 t -61.06 166.59 3.47 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 114.42 -1.263 . . . . 0.0 113.099 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.606 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -59.21 -14.8 11.94 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.612 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.46 -28.08 21.08 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 121.76 0.791 . . . . 0.0 109.473 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 1.048 ' O ' HG23 ' A' ' 108' ' ' VAL . 19.0 mt-10 -81.28 -42.18 21.04 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-N 112.639 -2.073 . . . . 0.0 111.327 -178.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.646 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 7.0 tt -67.83 -31.41 71.24 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.683 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -72.13 -44.34 63.29 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.014 -1.448 . . . . 0.0 108.724 175.244 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.612 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 16.4 t-80 -66.88 -21.95 65.99 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.033 177.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.048 HG23 ' O ' ' A' ' 104' ' ' GLU . 27.6 t -71.26 -51.47 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 176.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.649 ' SD ' HD22 ' A' ' 116' ' ' LEU . 18.6 mtt -57.42 -41.95 81.4 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 112.65 -2.068 . . . . 0.0 112.196 175.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.68 -19.07 63.6 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.221 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.91 -44.95 21.59 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.563 176.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.1 mt -80.95 -28.25 35.77 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.084 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 140.65 -8.17 2.8 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 117.691 -1.616 . . . . 0.0 116.902 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 109' ' ' MET . 4.9 mt-10 -100.7 151.55 21.52 Favored 'General case' 0 C--N 1.358 0.947 0 CA-C-N 120.988 2.394 . . . . 0.0 114.39 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -109.46 128.86 55.47 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 113.519 -1.673 . . . . 0.0 107.487 175.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.683 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 1.4 tp -135.58 119.79 17.76 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.394 -1.275 . . . . 0.0 112.425 -175.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.94 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -72.76 -175.97 1.86 Allowed 'General case' 0 C--N 1.347 0.483 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.554 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.538 ' O ' HG23 ' A' ' 121' ' ' VAL . 16.7 t70 -73.21 -38.6 66.04 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -177.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.625 ' H ' HG23 ' A' ' 117' ' ' THR . 9.5 pt-20 -88.85 -16.04 32.98 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.769 ' HG2' HG22 ' A' ' 117' ' ' THR . 14.8 pt-20 -85.11 -15.43 43.91 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 123.118 0.261 . . . . 0.0 110.887 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.94 HG22 ' O ' ' A' ' 117' ' ' THR . 0.1 OUTLIER -83.35 -24.2 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.793 178.285 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -72.87 30.54 0.06 Allowed 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.724 0.773 . . . . 0.0 112.554 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.697 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 11.3 pt-20 -141.43 -17.64 0.8 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.636 177.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.649 ' HE1' HD21 ' A' ' 116' ' ' LEU . 2.2 ttm -88.05 -22.74 24.03 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.073 0.949 . . . . 0.0 109.136 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.641 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 2.6 mt -87.82 -44.36 15.84 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.804 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -58.48 -28.47 65.4 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 122.028 0.918 . . . . 0.0 111.01 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.703 ' HB3' ' CE1' ' B' ' 154' ' ' PHE . 7.4 mm-40 -55.33 -44.19 75.63 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.111 -1.859 . . . . 0.0 111.161 176.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.842 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -106.08 -29.0 10.17 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.028 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.641 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -59.92 124.52 20.43 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 122.15 0.976 . . . . 0.0 113.109 -178.324 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.5 mm -89.8 -47.54 14.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 112.97 -1.923 . . . . 0.0 110.459 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -90.59 -25.33 20.23 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.53 49.79 5.02 Favored Glycine 0 CA--C 1.525 0.69 0 O-C-N 123.428 0.455 . . . . 0.0 113.95 178.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -87.41 -19.58 27.88 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.492 ' O ' HD13 ' A' ' 125' ' ' ILE . . . 101.39 2.52 53.77 Favored Glycine 0 CA--C 1.507 -0.453 0 CA-C-N 115.846 -0.616 . . . . 0.0 113.468 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.51 ' HG3' ' HB3' ' A' ' 99' ' ' TYR . 2.8 pt20 -133.56 135.83 44.58 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 124.63 1.172 . . . . 0.0 109.389 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.6 t -93.16 135.18 28.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.274 0.559 . . . . 0.0 112.487 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -96.07 -168.67 1.79 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.358 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.416 ' O ' ' N ' ' A' ' 142' ' ' VAL . 9.2 m-85 -73.17 -58.86 3.02 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.875 177.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -59.78 -20.5 57.1 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.842 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 11.9 mt-10 -88.79 -40.49 13.15 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 121.28 0.562 . . . . 0.0 110.192 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.447 ' CZ ' ' HB2' ' B' ' 158' ' ' ALA . 61.4 t80 -73.46 -23.38 60.07 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.363 -1.289 . . . . 0.0 109.14 175.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.632 ' O ' ' HG2' ' A' ' 145' ' ' MET . 6.8 t -85.19 -48.62 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.786 -177.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.486 ' O ' ' N ' ' A' ' 147' ' ' ALA . 57.4 mt-30 -64.78 -19.04 65.6 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.419 -0.513 . . . . 0.0 112.322 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.566 ' SD ' ' HE2' ' B' ' 154' ' ' PHE . 24.1 mmt -84.79 -21.17 30.04 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 123.292 0.37 . . . . 0.0 110.717 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.632 ' HG2' ' O ' ' A' ' 142' ' ' VAL . 14.3 ptt? -83.57 -13.78 53.64 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 175.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.429 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 31.8 p -103.7 -58.4 1.88 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.276 177.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . 7.43 -69.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 177.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 50.4 pttt . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.401 -179.908 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.498 0.189 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -128.97 129.77 45.84 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -130.6 -44.32 1.1 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.351 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 152' ' ' LYS . . . . . 0.504 ' HE2' ' HZ3' ' B' ' 155' ' ' LYS . 97.2 mttt -98.27 138.2 35.88 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.464 0.477 . . . . 0.0 110.753 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.67 ' O ' HG13 ' B' ' 157' ' ' VAL . 27.2 p -139.43 -56.04 0.58 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.993 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 154' ' ' PHE . . . . . 0.843 ' H ' ' HD1' ' B' ' 154' ' ' PHE . 0.0 OUTLIER -55.1 -43.01 73.63 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.163 0.985 . . . . 0.0 113.008 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.603 ' HD2' ' CE2' ' B' ' 154' ' ' PHE . 1.0 OUTLIER -71.87 -32.83 67.87 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.05 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -77.79 -39.23 44.61 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.564 178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 157' ' ' VAL . . . . . 0.67 HG13 ' O ' ' B' ' 153' ' ' THR . 32.0 m -62.59 -38.14 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 122.919 0.488 . . . . 0.0 111.067 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 158' ' ' ALA . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 141' ' ' PHE . . . -74.0 -43.61 57.42 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.985 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -59.77 -29.58 68.29 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.947 0.499 . . . . 0.0 112.064 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.91 -33.76 57.75 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.448 0.468 . . . . 0.0 112.112 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 7.6 p -118.77 28.82 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 O-C-N 123.374 0.421 . . . . 0.0 111.741 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 162' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -84.63 -13.72 50.73 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 3.4 tp -130.68 29.8 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-O 120.994 0.426 . . . . 0.0 111.168 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 49.8 m -92.97 -41.59 9.93 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.356 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . -92.27 20.31 6.18 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.425 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 50.3 m -86.59 -20.79 27.39 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.022 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.442 HD11 ' HE2' ' A' ' 51' ' ' MET . 12.8 tp -91.46 88.13 6.69 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.265 0.555 . . . . 0.0 110.654 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 62.8 mtt -137.76 148.49 45.62 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.742 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -177.42 71.3 0.08 OUTLIER Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.549 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.537 -0.744 . . . . 0.0 111.066 179.963 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.546 0.212 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -135.69 125.45 25.52 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.862 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -83.45 157.1 22.58 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.389 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.453 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -105.82 -114.29 0.25 Allowed 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.555 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 18.4 p -101.45 -173.59 2.4 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 123.953 0.901 . . . . 0.0 110.391 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.406 ' HA ' HD12 ' A' ' 9' ' ' ILE . 46.7 mt-10 -58.19 -23.96 57.4 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.555 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 12.9 pt-20 -55.89 -29.46 60.02 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.74 0.65 . . . . 0.0 111.078 177.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.861 ' HA ' HD13 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -75.62 -46.8 29.56 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.801 178.068 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.576 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . 3.9 mt -65.09 -32.97 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.706 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.32 -34.3 59.03 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.568 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 44.4 mt-10 -109.6 -18.29 13.52 Favored 'General case' 0 C--N 1.346 0.44 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 -177.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.576 ' CE1' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -72.12 -15.58 61.99 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.773 0.715 . . . . 0.0 110.026 178.715 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.716 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 5.3 pttt -78.4 -41.84 31.92 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 114.55 -1.205 . . . . 0.0 108.385 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.716 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 7.3 pt-20 -80.16 -44.82 19.2 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 113.605 -1.634 . . . . 0.0 113.384 -178.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.612 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -61.4 -18.49 59.05 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.459 0.647 . . . . 0.0 109.346 177.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.418 ' O ' HG23 ' A' ' 27' ' ' ILE . 82.8 t80 -86.01 -52.79 5.48 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.583 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.627 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 50.5 m -87.12 -13.0 45.42 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -176.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -65.66 -28.71 69.29 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.471 0.578 . . . . 0.0 112.216 -178.976 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.541 ' CD1' HG22 ' A' ' 35' ' ' VAL . 6.6 m-85 -135.88 -0.36 2.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 116.301 1.963 . . . . 0.0 116.301 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.627 ' OD1' ' HA ' ' A' ' 17' ' ' SER . 31.0 p-10 -78.11 54.29 1.32 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 119.348 0.976 . . . . 0.0 112.348 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.411 ' N ' ' HD2' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -87.05 -17.21 33.45 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 179.676 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.73 -22.54 61.61 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.314 0.578 . . . . 0.0 110.438 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.46 43.83 14.6 Favored Glycine 0 N--CA 1.469 0.896 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.26 23.04 14.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.107 -1.547 . . . . 0.0 112.297 -175.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.37 -82.22 1.69 Allowed Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.386 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.846 HG21 ' HA ' ' A' ' 64' ' ' ASP . 7.2 p -98.61 178.66 4.93 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 122.864 0.466 . . . . 0.0 111.302 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.418 HG23 ' O ' ' A' ' 16' ' ' PHE . 0.7 OUTLIER -78.81 148.93 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -179.13 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.01 162.58 27.86 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -78.66 -55.77 4.93 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.061 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -54.63 -14.14 1.23 Allowed 'General case' 0 N--CA 1.475 0.799 0 O-C-N 123.662 0.601 . . . . 0.0 110.85 177.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.494 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 21.5 mt-10 -113.82 -16.48 12.24 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.48 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.498 ' HA ' HG23 ' A' ' 35' ' ' VAL . 14.3 tp -53.49 -43.09 67.93 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.747 0.819 . . . . 0.0 112.326 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.788 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -55.55 -37.97 69.27 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 177.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 m -75.99 -30.48 58.57 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.451 -0.874 . . . . 0.0 112.928 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.612 HG12 ' HA ' ' A' ' 15' ' ' ALA . 0.5 OUTLIER -75.02 -27.8 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 176.342 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.645 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 44.6 mtt -70.18 -43.67 70.33 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 113.061 -1.882 . . . . 0.0 110.413 175.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.788 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 11.9 mtt180 -77.76 -28.3 50.59 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.687 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.4 m -67.47 -8.65 35.12 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.927 0.87 . . . . 0.0 112.055 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 76.8 mt -94.04 -6.08 46.02 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 113.277 -1.783 . . . . 0.0 109.701 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.65 -2.45 39.22 Favored Glycine 0 CA--C 1.493 -1.298 0 CA-C-O 122.333 0.963 . . . . 0.0 114.891 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.645 ' HB2' ' O ' ' A' ' 36' ' ' MET . 46.9 mt-30 -78.25 143.11 37.37 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 112.138 -2.031 . . . . 0.0 112.379 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -124.63 70.31 56.46 Favored Pre-proline 0 CA--C 1.55 0.973 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.92 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.4 ' HD3' ' C ' ' A' ' 41' ' ' GLN . 3.3 Cg_exo -82.66 -179.57 4.64 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 123.26 2.64 . . . . 0.0 112.784 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 46' ' ' ALA . 1.9 m -100.57 162.62 12.81 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.708 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.516 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 28.3 mt-10 -80.7 -28.72 36.59 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-O 121.63 0.728 . . . . 0.0 109.983 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.417 ' H ' HG22 ' A' ' 44' ' ' THR . . . -72.69 -38.03 67.69 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 113.638 -1.619 . . . . 0.0 110.234 -178.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -76.5 -29.25 56.75 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.598 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.793 ' O ' HG12 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -62.49 -26.32 68.47 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.09 174.581 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.625 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 57.2 mt-30 -88.76 -18.44 27.76 Favored 'General case' 0 CA--C 1.48 -1.742 0 CA-C-N 114.188 -1.369 . . . . 0.0 111.164 178.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -76.57 -28.43 56.23 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 111.957 -2.383 . . . . 0.0 107.805 175.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 23.3 mmt -86.92 -31.67 20.57 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.013 176.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.793 HG12 ' O ' ' A' ' 48' ' ' LEU . 24.4 mm -72.99 -27.17 24.12 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.625 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.1 t-20 -79.5 -35.85 39.47 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.065 -1.425 . . . . 0.0 111.765 176.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -89.99 -49.39 6.62 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.552 ' C ' ' H ' ' A' ' 57' ' ' ALA . 67.9 t -84.18 -49.81 15.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.528 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 5.0 t70 -72.43 38.78 0.08 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 122.048 0.927 . . . . 0.0 110.158 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.552 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -86.1 -5.57 59.18 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.647 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -97.33 -33.34 11.47 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 112.408 -2.178 . . . . 0.0 111.009 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.41 45.12 6.28 Favored Glycine 0 C--N 1.342 0.881 0 O-C-N 123.505 0.503 . . . . 0.0 113.702 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -110.05 -21.57 12.24 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.694 0.283 . . . . 0.0 111.432 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.76 26.41 73.83 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 115.607 -0.724 . . . . 0.0 114.181 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.425 ' HB ' ' OG1' ' A' ' 26' ' ' THR . 0.0 OUTLIER -140.43 163.82 31.79 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 123.574 0.75 . . . . 0.0 110.57 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.527 ' O ' ' HB ' ' A' ' 26' ' ' THR . 5.0 mp -133.13 111.61 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.846 ' HA ' HG21 ' A' ' 26' ' ' THR . 2.0 p30 -49.63 146.34 4.32 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.003 -0.998 . . . . 0.0 111.835 174.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.579 ' CD1' ' HD3' ' A' ' 66' ' ' PRO . 5.8 p90 -90.83 -39.91 0.4 Allowed Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -177.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.579 ' HD3' ' CD1' ' A' ' 65' ' ' PHE . 17.4 Cg_exo -67.97 -18.52 46.42 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 121.903 1.735 . . . . 0.0 112.691 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.452 ' HB2' ' OD1' ' A' ' 64' ' ' ASP . 35.1 mt-10 -107.95 5.72 26.53 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.741 ' O ' ' HG2' ' A' ' 71' ' ' MET . 57.3 t80 -84.5 -60.76 1.97 Allowed 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.861 HD13 ' HA ' ' A' ' 8' ' ' GLN . 0.8 OUTLIER -59.18 -31.46 69.03 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.673 0.749 . . . . 0.0 110.746 178.392 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.631 ' O ' ' HD3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -57.74 -39.27 76.95 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 113.362 -1.745 . . . . 0.0 109.399 174.338 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.741 ' HG2' ' O ' ' A' ' 68' ' ' PHE . 13.2 ptt? -77.43 -18.84 56.87 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 123.803 0.69 . . . . 0.0 109.195 176.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.561 ' HA ' ' HG3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -88.74 -20.38 24.86 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.193 176.642 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.559 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -80.18 -33.68 38.13 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.671 ' NE ' ' HA ' ' A' ' 71' ' ' MET . 7.7 ptt180 -83.57 -16.99 43.26 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.561 ' HG3' ' HA ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -82.8 -13.99 55.23 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 118.545 0.611 . . . . 0.0 112.495 179.181 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 22.4 ptt? -113.58 -31.5 6.49 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.114 0.483 . . . . 0.0 112.12 -177.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.559 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 30.9 mmtt -74.67 -22.64 58.77 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.853 -1.067 . . . . 0.0 113.764 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -104.12 -14.99 15.68 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.0 t -75.95 54.77 0.86 Allowed 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.501 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 8.1 m-20 58.87 121.47 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.016 0.926 . . . . 0.0 112.498 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.6 m -83.08 -14.02 54.56 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.484 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.43 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -85.13 -45.62 11.88 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.709 0.766 . . . . 0.0 109.639 -179.532 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.458 ' O ' ' HB3' ' A' ' 87' ' ' GLU . 35.3 mt-10 -73.09 -17.99 61.35 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.797 -1.547 . . . . 0.0 112.574 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.637 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 15.0 mt-10 -61.35 -22.21 64.72 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.7 mp -88.01 -52.34 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.712 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.577 ' O ' ' HD1' ' A' ' 89' ' ' PHE . 10.4 mtt180 -68.45 -16.94 64.08 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.637 ' OE1' ' HA ' ' A' ' 84' ' ' GLU . 3.5 pt-20 -75.09 -18.75 60.21 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.572 ' HA ' ' HB ' ' A' ' 91' ' ' VAL . . . -64.37 -24.39 67.62 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.13 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.577 ' HD1' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -83.02 -21.04 33.95 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 175.029 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 31.8 mmt180 -81.59 -20.14 40.45 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.757 174.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.572 ' HB ' ' HA ' ' A' ' 88' ' ' ALA . 2.6 t -88.1 -53.89 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 CA-C-N 114.285 -1.325 . . . . 0.0 112.534 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.791 ' HB3' HG21 ' A' ' 100' ' ' ILE . 1.3 m-85 -100.77 -44.44 5.79 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -176.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.715 ' CA ' HG12 ' A' ' 100' ' ' ILE . 2.7 t70 -59.8 95.11 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.455 0.645 . . . . 0.0 111.967 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.4 mmpt? -87.59 -50.85 6.24 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.785 -1.098 . . . . 0.0 113.069 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -72.31 0.84 8.92 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -175.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 50.89 32.9 27.37 Favored Glycine 0 N--CA 1.471 1.03 0 CA-C-N 114.324 -1.307 . . . . 0.0 114.554 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -98.0 -5.53 33.91 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.44 -19.25 53.44 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 121.439 -0.41 . . . . 0.0 112.811 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -121.37 118.59 29.82 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.452 -0.874 . . . . 0.0 110.302 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.791 HG21 ' HB3' ' A' ' 92' ' ' PHE . 18.9 mt -77.2 97.3 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.222 0.609 . . . . 0.0 109.429 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.426 ' H ' ' CD ' ' A' ' 104' ' ' GLU . 18.1 t -78.66 169.07 18.82 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.32 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.513 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -60.59 -14.92 23.06 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.54 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.94 -29.39 19.61 Favored 'General case' 0 CA--C 1.487 -1.458 0 CA-C-O 121.79 0.805 . . . . 0.0 109.136 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.959 ' O ' HG23 ' A' ' 108' ' ' VAL . 23.0 mt-10 -79.25 -42.92 24.8 Favored 'General case' 0 CA--C 1.482 -1.671 0 CA-C-N 112.74 -2.027 . . . . 0.0 110.883 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.546 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 7.1 tt -65.25 -34.36 78.17 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.596 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -70.87 -43.76 67.74 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.174 176.367 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.54 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 10.3 t-80 -70.06 -21.63 63.14 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.752 177.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.959 HG23 ' O ' ' A' ' 104' ' ' GLU . 4.1 t -71.18 -53.15 22.34 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.413 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.655 ' O ' ' N ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -60.07 -39.18 85.16 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 111.497 -2.592 . . . . 0.0 112.514 178.313 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.6 m -73.86 -18.73 60.89 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 119.172 -1.011 . . . . 0.0 109.831 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.25 -45.75 13.46 Favored 'General case' 0 C--N 1.347 0.467 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 176.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.48 HD23 ' O ' ' A' ' 108' ' ' VAL . 1.3 mm? -76.91 -28.09 55.18 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 114.763 -1.108 . . . . 0.0 113.466 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 140.83 -11.12 2.88 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-O 117.815 -1.547 . . . . 0.0 116.911 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.655 ' N ' ' O ' ' A' ' 109' ' ' MET . 4.8 mt-10 -101.18 152.77 20.25 Favored 'General case' 0 C--N 1.356 0.874 0 CA-C-N 120.763 2.281 . . . . 0.0 114.254 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -108.96 127.0 53.68 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.824 -1.535 . . . . 0.0 107.5 175.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.596 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 1.2 tp -135.57 116.09 13.75 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.167 -175.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.821 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -72.59 -176.01 1.81 Allowed 'General case' 0 C--N 1.346 0.42 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.675 179.4 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.509 ' N ' HG23 ' A' ' 117' ' ' THR . 16.5 t70 -73.87 -37.97 64.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.696 -1.138 . . . . 0.0 113.968 -177.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.65 ' H ' HG23 ' A' ' 117' ' ' THR . 7.2 pt-20 -86.36 -16.13 38.3 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.767 ' HG2' HG22 ' A' ' 117' ' ' THR . 13.8 pt-20 -85.64 -16.64 38.53 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 122.985 0.178 . . . . 0.0 111.308 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.821 HG22 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -85.01 -27.26 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.526 178.3 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -75.54 35.3 0.12 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 122.131 0.967 . . . . 0.0 111.306 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.857 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 6.7 tp10 -140.96 -58.67 0.5 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 113.892 -1.503 . . . . 0.0 107.863 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.546 ' SD ' HD21 ' A' ' 105' ' ' LEU . 19.0 ttm -52.41 -22.78 5.05 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.328 1.051 . . . . 0.0 111.571 178.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.642 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 2.9 mt -87.36 -45.64 16.19 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.754 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -60.46 -31.39 70.39 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.854 0.721 . . . . 0.0 112.158 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.857 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 6.9 mm-40 -66.74 -35.65 80.61 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.11 177.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.628 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -96.57 -34.31 11.48 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.512 -178.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.642 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -60.93 127.73 33.0 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.423 -1.262 . . . . 0.0 114.174 -177.822 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.807 HD13 ' HG2' ' A' ' 140' ' ' GLU . 1.8 mp -89.06 -51.0 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 113.57 -1.65 . . . . 0.0 110.114 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -91.35 -25.25 19.49 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.06 49.64 4.67 Favored Glycine 0 CA--C 1.524 0.643 0 O-C-N 123.45 0.469 . . . . 0.0 113.689 178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -90.48 -19.82 23.42 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.474 ' HA2' HG21 ' A' ' 125' ' ' ILE . . . 97.22 12.11 49.98 Favored Glycine 0 CA--C 1.5 -0.888 0 CA-C-N 116.028 -0.533 . . . . 0.0 113.463 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -139.19 124.9 19.54 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.936 -1.132 . . . . 0.0 108.684 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.554 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 3.4 t -87.58 133.13 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.372 -177.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -99.48 -165.33 1.22 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.485 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.424 ' O ' HG23 ' A' ' 142' ' ' VAL . 35.7 m-85 -65.69 -56.69 10.77 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.702 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 143' ' ' GLN . 43.7 mt-10 -65.5 -20.7 66.45 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.807 ' HG2' HD13 ' A' ' 130' ' ' ILE . 7.3 mt-10 -86.06 -35.71 20.12 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.646 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.478 ' O ' ' HG2' ' A' ' 144' ' ' MET . 89.1 t80 -76.7 -23.87 53.14 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.212 175.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.459 ' O ' ' HG2' ' A' ' 145' ' ' MET . 14.5 t -86.13 -39.08 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 114.517 -1.22 . . . . 0.0 112.297 -177.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 147' ' ' ALA . 9.3 mt-30 -46.17 -34.03 4.01 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.614 ' HB3' ' CD2' ' B' ' 154' ' ' PHE . 19.5 ptt? -60.78 -24.34 65.7 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 118.262 0.483 . . . . 0.0 111.336 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' A' ' 142' ' ' VAL . 2.4 ptp -83.39 -5.81 59.26 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 123.434 0.459 . . . . 0.0 110.41 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.7 t -130.44 -33.19 1.69 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -49.41 -31.87 10.55 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 178.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 57.4 mttp . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.515 179.946 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 19.9 p . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 120.346 0.117 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -119.69 121.77 39.98 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 123.424 0.452 . . . . 0.0 110.788 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 151' ' ' LYS . . . . . 0.517 ' HD2' ' OE2' ' A' ' 114' ' ' GLU . 61.2 mttp -136.43 137.3 40.31 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.671 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -133.76 -1.57 3.05 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.882 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.475 HG22 ' HG3' ' A' ' 127' ' ' GLU . 27.7 p -125.8 155.25 41.37 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.639 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 154' ' ' PHE . . . . . 0.714 ' CE1' ' HD2' ' B' ' 155' ' ' LYS . 0.1 OUTLIER -71.71 -28.27 63.58 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.987 178.766 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.714 ' HD2' ' CE1' ' B' ' 154' ' ' PHE . 7.2 mptt -61.16 -38.12 85.33 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.961 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -76.89 -37.34 55.65 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.504 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 157' ' ' VAL . . . . . 0.634 HG22 ' HA ' ' B' ' 154' ' ' PHE . 15.4 m -70.48 -29.33 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -52.41 -33.29 43.14 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -71.62 -38.23 70.81 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.581 0.229 . . . . 0.0 111.426 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.8 -39.06 45.1 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 6.5 t -108.94 -51.87 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 162' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -66.29 89.1 0.13 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.583 0.706 . . . . 0.0 111.37 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 2.7 tp -160.6 34.34 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.661 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 50.9 m 63.73 39.46 8.53 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.015 0.926 . . . . 0.0 111.428 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . 62.63 20.6 12.14 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.952 0.901 . . . . 0.0 112.167 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 5.5 m 54.66 97.56 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.107 0.963 . . . . 0.0 111.599 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 43.73 75.16 0.1 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.116 0.966 . . . . 0.0 112.647 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.63 133.59 45.09 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.499 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . 135.22 -159.02 23.89 Favored Glycine 0 C--N 1.337 0.628 0 O-C-N 123.631 0.582 . . . . 0.0 112.706 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 20.2 p . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.112 -0.947 . . . . 0.0 111.012 -179.967 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 111.357 0.132 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 63.08 126.29 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.929 0.892 . . . . 0.0 111.988 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.51 ' HG2' ' O ' ' A' ' 65' ' ' PHE . 1.3 mp0 -89.27 -69.17 0.73 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.353 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.67 HD11 ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -117.97 -117.55 0.32 Allowed 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.328 179.738 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 1.004 ' O ' ' HG3' ' A' ' 8' ' ' GLN . 17.2 p -101.51 -172.99 2.25 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 124.253 1.021 . . . . 0.0 110.83 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -58.19 -20.82 44.2 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.444 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 12.5 pt-20 -53.5 -37.65 62.94 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.586 0.553 . . . . 0.0 111.628 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 1.004 ' HG3' ' O ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -74.46 -48.32 28.18 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.082 176.941 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.473 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 21.2 mm -56.33 -36.48 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 113.993 -1.458 . . . . 0.0 110.999 178.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.24 -48.9 74.0 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.751 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 24.8 mt-10 -135.89 -20.24 1.51 Allowed 'General case' 0 C--N 1.358 0.959 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -176.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.452 ' HB2' HD21 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -68.79 -14.74 63.22 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 118.899 -1.121 . . . . 0.0 110.453 178.757 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.712 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 5.9 pttt -72.2 -42.87 65.29 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 123.775 0.83 . . . . 0.0 109.008 178.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.751 ' HG2' ' O ' ' A' ' 11' ' ' GLU . 11.5 pt-20 -67.49 -40.28 85.23 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 114.227 -1.351 . . . . 0.0 112.57 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.608 ' O ' HG11 ' A' ' 35' ' ' VAL . . . -58.62 -22.19 55.78 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.832 0.708 . . . . 0.0 110.109 176.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.49 ' CE2' ' HB3' ' A' ' 65' ' ' PHE . 23.4 m-85 -86.86 -42.76 12.98 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.469 176.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.6 t -86.78 -13.38 45.33 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -71.66 -29.4 64.58 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.999 -0.281 . . . . 0.0 111.188 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.581 ' CD1' HG22 ' A' ' 35' ' ' VAL . 1.9 m-85 -126.7 -12.14 6.05 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -101.9 74.98 1.5 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.997 0.817 . . . . 0.0 110.697 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.415 ' HE3' ' H ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -87.23 -20.58 26.71 Favored 'General case' 0 C--N 1.345 0.386 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -179.607 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.533 ' OD1' ' HB2' ' A' ' 24' ' ' ASP . 0.3 OUTLIER -70.56 -22.69 62.56 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.497 178.92 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.06 50.95 4.93 Favored Glycine 0 N--CA 1.467 0.7 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.533 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 0.3 OUTLIER -99.62 23.06 9.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.425 -1.388 . . . . 0.0 112.248 -176.87 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.56 -79.72 1.86 Allowed Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.78 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.698 HG21 ' HA ' ' A' ' 64' ' ' ASP . 3.2 p -119.9 175.99 5.63 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 122.489 0.316 . . . . 0.0 111.268 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -84.39 149.45 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.31 160.59 24.19 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.722 -1.126 . . . . 0.0 113.514 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.98 -55.49 5.56 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.879 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -55.8 -13.76 1.95 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.304 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.482 ' O ' HG23 ' A' ' 35' ' ' VAL . 28.9 mt-10 -113.85 -16.93 12.16 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.303 -178.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -57.62 -40.87 80.16 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.219 0.608 . . . . 0.0 111.869 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.784 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -55.18 -39.58 71.43 Favored Glycine 0 C--N 1.338 0.683 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.8 m -74.25 -31.07 62.43 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.547 -0.827 . . . . 0.0 112.911 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.608 HG11 ' O ' ' A' ' 15' ' ' ALA . 1.1 t -74.2 -27.15 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 176.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.595 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 24.2 mtt -73.43 -41.64 63.01 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 113.152 -1.84 . . . . 0.0 111.119 176.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.784 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 10.4 mtt180 -82.0 -29.27 32.14 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 65.5 m -66.12 -7.98 21.06 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.963 0.887 . . . . 0.0 112.248 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.9 mt -93.36 -8.04 43.04 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 113.307 -1.769 . . . . 0.0 109.731 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.15 -7.61 23.18 Favored Glycine 0 CA--C 1.493 -1.309 0 N-CA-C 115.31 0.884 . . . . 0.0 115.31 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.595 ' HB2' ' O ' ' A' ' 36' ' ' MET . 46.7 mt-30 -74.82 140.41 43.92 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 112.601 -1.799 . . . . 0.0 111.991 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -126.86 63.35 55.16 Favored Pre-proline 0 CA--C 1.554 1.13 0 O-C-N 123.55 0.531 . . . . 0.0 111.312 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.423 ' HD3' ' C ' ' A' ' 41' ' ' GLN . 1.7 Cg_endo -84.73 -177.68 2.97 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.917 2.411 . . . . 0.0 111.562 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.504 ' OG1' ' N ' ' A' ' 45' ' ' GLU . 8.0 t -102.3 -175.81 2.93 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 122.245 1.021 . . . . 0.0 110.757 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.504 ' N ' ' OG1' ' A' ' 44' ' ' THR . 46.2 mt-10 -81.69 -24.7 36.06 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-N 112.797 -2.001 . . . . 0.0 108.637 177.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.88 -29.52 67.83 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.769 -1.56 . . . . 0.0 111.854 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.458 ' H ' HG23 ' A' ' 44' ' ' THR . 8.5 mm-40 -87.31 -28.36 22.32 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.503 177.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 45' ' ' GLU . 0.6 OUTLIER -69.55 -20.4 63.68 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 114.396 -1.275 . . . . 0.0 108.928 174.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.756 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 54.4 mt-30 -97.14 -16.53 20.42 Favored 'General case' 0 CA--C 1.483 -1.629 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.256 178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -85.54 -33.52 21.73 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 111.978 -2.374 . . . . 0.0 109.66 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.521 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -86.66 -34.67 19.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.909 177.061 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 30.3 mt -70.96 -26.36 27.49 Favored 'Isoleucine or valine' 0 C--N 1.348 0.538 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.756 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 4.6 t-20 -68.33 -32.83 73.22 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.404 174.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -87.77 -25.4 23.4 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.347 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.594 ' C ' ' H ' ' A' ' 57' ' ' ALA . 75.2 t -84.63 -40.59 15.35 Favored 'Isoleucine or valine' 0 C--N 1.346 0.437 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -71.07 29.69 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.913 0.863 . . . . 0.0 111.167 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.594 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -87.5 -7.15 57.95 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 114.102 -1.408 . . . . 0.0 111.923 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -113.55 -41.48 3.62 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 111.689 -2.505 . . . . 0.0 110.827 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.26 37.7 10.8 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.846 -0.616 . . . . 0.0 113.307 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -110.08 -21.54 12.24 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.537 0.208 . . . . 0.0 111.512 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.27 26.96 60.6 Favored Glycine 0 N--CA 1.466 0.638 0 CA-C-N 115.885 -0.598 . . . . 0.0 114.158 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.13 170.2 16.15 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 123.103 0.561 . . . . 0.0 110.823 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.409 ' O ' HG22 ' A' ' 63' ' ' ILE . 4.1 mp -113.61 79.51 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.698 ' HA ' HG21 ' A' ' 26' ' ' THR . 21.8 p-10 -50.99 148.16 4.49 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.393 0.677 . . . . 0.0 111.876 176.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.51 ' O ' ' HG2' ' A' ' 3' ' ' GLN . 16.5 p90 -81.01 -37.53 0.94 Allowed Pre-proline 0 N--CA 1.477 0.916 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.486 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 16.9 Cg_exo -68.07 -16.78 45.4 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.131 1.887 . . . . 0.0 113.288 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.444 ' HB2' ' OD2' ' A' ' 64' ' ' ASP . 23.5 mt-10 -105.51 -29.7 10.01 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 -177.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.959 ' O ' ' HG2' ' A' ' 71' ' ' MET . 4.2 t80 -85.03 -47.65 10.01 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -175.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.67 ' HB3' HD11 ' A' ' 4' ' ' LEU . 4.5 mt -61.24 -31.8 71.59 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 119.407 1.003 . . . . 0.0 110.802 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.503 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -56.72 -37.28 70.75 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 113.171 -1.832 . . . . 0.0 109.737 174.566 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.959 ' HG2' ' O ' ' A' ' 68' ' ' PHE . 23.7 ptm -76.33 -23.5 54.26 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 123.731 0.644 . . . . 0.0 109.347 176.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.509 ' O ' ' HG2' ' A' ' 76' ' ' MET . 91.9 mtp -87.57 -18.59 29.37 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.298 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.598 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -83.6 -25.76 30.58 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.503 ' HG3' ' O ' ' A' ' 70' ' ' THR . 3.9 ppt_? -90.38 -30.35 17.47 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.738 ' HD2' ' O ' ' A' ' 71' ' ' MET . 0.0 OUTLIER -74.85 -12.7 60.44 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' A' ' 72' ' ' MET . 26.6 ptm -117.31 -26.21 6.8 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -177.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.598 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 29.0 mmtt -73.43 -35.73 65.84 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -91.15 -25.02 19.77 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.4 t -75.47 56.13 0.85 Allowed 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.549 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 8.5 m-20 60.2 123.78 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.026 0.93 . . . . 0.0 112.596 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.555 ' HA ' ' OE2' ' A' ' 84' ' ' GLU . 53.0 m -83.13 -13.95 54.55 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.882 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.405 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -81.28 -43.83 18.6 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.82 0.819 . . . . 0.0 109.518 -179.696 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.616 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 37.5 mt-10 -70.17 -18.74 63.21 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 113.712 -1.585 . . . . 0.0 112.395 178.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.555 ' OE2' ' HA ' ' A' ' 81' ' ' SER . 39.7 mt-10 -63.69 -22.62 67.0 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.3 mp -87.8 -49.54 14.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.134 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.83 -16.96 3.0 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.774 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.616 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 44.5 mt-10 -78.97 -20.99 47.78 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.218 0.607 . . . . 0.0 111.586 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.64 -19.71 48.5 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.481 ' HE2' ' O ' ' A' ' 98' ' ' GLY . 6.4 m-85 -84.01 -21.19 31.75 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 174.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.412 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 8.0 ttt180 -76.7 -21.41 55.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 113.868 -1.515 . . . . 0.0 106.927 174.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.403 HG12 ' CD2' ' A' ' 92' ' ' PHE . 40.6 t -87.84 -54.21 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 CA-C-N 114.246 -1.343 . . . . 0.0 112.03 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.841 ' HB3' HG21 ' A' ' 100' ' ' ILE . 77.0 m-85 -100.51 -44.66 5.8 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -177.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.739 ' CA ' HG12 ' A' ' 100' ' ' ILE . 2.3 t70 -65.04 90.66 0.09 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.898 0.856 . . . . 0.0 111.86 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.433 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 19.8 mttt -88.49 -45.14 10.18 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 113.957 -1.474 . . . . 0.0 114.17 -178.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -71.71 1.69 6.42 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -175.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 48.09 29.79 6.95 Favored Glycine 0 N--CA 1.474 1.175 0 CA-C-N 114.272 -1.331 . . . . 0.0 114.977 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -98.84 -3.93 34.31 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.645 0.222 . . . . 0.0 111.415 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.481 ' O ' ' HE2' ' A' ' 89' ' ' PHE . . . 101.38 -18.78 53.16 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 121.353 -0.451 . . . . 0.0 112.629 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -122.34 124.1 42.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.441 -0.879 . . . . 0.0 111.226 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.841 HG21 ' HB3' ' A' ' 92' ' ' PHE . 28.5 mt -80.27 97.46 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.7 p -72.81 162.14 29.86 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.522 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -57.92 -14.98 7.23 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 -177.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.99 -29.29 19.61 Favored 'General case' 0 CA--C 1.488 -1.432 0 CA-C-O 121.873 0.844 . . . . 0.0 109.556 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 1.012 ' O ' HG23 ' A' ' 108' ' ' VAL . 3.4 mm-40 -79.9 -40.33 28.48 Favored 'General case' 0 CA--C 1.483 -1.597 0 CA-C-N 112.668 -2.06 . . . . 0.0 111.292 -178.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.551 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 7.6 tt -65.48 -33.0 74.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.73 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -70.67 -46.23 63.59 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.03 -1.441 . . . . 0.0 108.851 175.592 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.526 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 3.1 t-80 -67.25 -22.03 65.69 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.386 177.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.012 HG23 ' O ' ' A' ' 104' ' ' GLU . 17.1 t -71.75 -49.84 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.905 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 176.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.733 ' SD ' HD22 ' A' ' 116' ' ' LEU . 16.1 mtt -55.89 -41.79 75.0 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 112.593 -2.094 . . . . 0.0 111.938 175.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.96 -19.15 64.16 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.537 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.92 -45.27 18.85 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.749 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.3 mt -79.23 -28.15 42.49 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.592 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 138.47 -6.45 3.29 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 117.773 -1.571 . . . . 0.0 116.74 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 109' ' ' MET . 4.9 mt-10 -101.15 152.08 21.06 Favored 'General case' 0 C--N 1.358 0.946 0 CA-C-N 120.953 2.376 . . . . 0.0 114.271 -178.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -110.31 128.63 55.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 113.668 -1.606 . . . . 0.0 107.802 175.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.733 HD22 ' SD ' ' A' ' 109' ' ' MET . 1.3 tp -139.32 116.03 10.76 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.338 -1.301 . . . . 0.0 112.134 -176.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.82 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -67.74 -176.31 0.63 Allowed 'General case' 0 C--N 1.347 0.473 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.153 179.721 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.508 ' N ' HG23 ' A' ' 117' ' ' THR . 16.0 t70 -73.22 -37.52 66.37 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.508 -1.224 . . . . 0.0 114.196 -177.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.656 ' H ' HG23 ' A' ' 117' ' ' THR . 7.4 pt-20 -86.19 -16.21 38.5 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.772 ' HG2' HG22 ' A' ' 117' ' ' THR . 14.2 pt-20 -88.07 -17.19 31.63 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 123.042 0.214 . . . . 0.0 111.238 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.82 HG22 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -85.95 -30.2 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 O-C-N 123.376 0.423 . . . . 0.0 111.289 177.73 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -69.29 31.77 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.998 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.655 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 9.6 pt-20 -153.53 -11.47 0.15 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.82 -1.082 . . . . 0.0 113.005 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.546 ' HE1' HD21 ' A' ' 116' ' ' LEU . 29.5 ttm -88.85 -37.16 15.57 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.061 0.544 . . . . 0.0 110.303 177.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.551 ' O ' ' N ' ' A' ' 129' ' ' ASP . 0.0 OUTLIER -86.48 -29.64 5.98 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.57 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.167 178.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.7 mtm180 -61.07 -27.32 68.27 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.955 0.883 . . . . 0.0 110.265 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.655 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 4.3 mm-40 -70.25 -27.88 64.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 113.326 -1.761 . . . . 0.0 109.808 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.587 ' HB3' HG21 ' A' ' 136' ' ' VAL . . . -102.82 -39.57 6.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.747 179.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 125' ' ' ILE . 0.3 OUTLIER -61.49 126.98 29.3 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.222 179.031 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 44.9 mt -89.94 -47.56 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.868 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -72.71 -24.95 61.06 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.41 49.1 9.62 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 115.912 -0.585 . . . . 0.0 113.928 178.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -107.65 -12.76 15.19 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.731 0.301 . . . . 0.0 111.116 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.67 19.79 50.3 Favored Glycine 0 CA--C 1.504 -0.613 0 CA-C-N 115.57 -0.741 . . . . 0.0 113.487 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -137.74 113.64 9.81 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.866 -1.167 . . . . 0.0 108.137 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.637 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 1.3 t -92.15 141.07 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -175.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.11 -162.92 0.87 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 114.123 -1.399 . . . . 0.0 110.857 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.48 ' O ' HG23 ' A' ' 142' ' ' VAL . 61.3 m-85 -64.12 -64.31 0.92 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.704 -1.134 . . . . 0.0 111.244 178.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.28 -20.09 51.42 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.637 ' OE1' ' HA ' ' A' ' 136' ' ' VAL . 4.8 mt-10 -86.31 -41.28 14.68 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 123.474 0.484 . . . . 0.0 110.436 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.508 ' O ' ' HG3' ' A' ' 144' ' ' MET . 68.7 t80 -74.14 -22.59 59.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.776 175.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.545 ' O ' ' HG3' ' A' ' 145' ' ' MET . 41.8 t -85.39 -43.96 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.44 -178.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -56.19 -35.64 67.48 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.534 0.522 . . . . 0.0 111.633 178.444 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.508 ' HG3' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -63.73 -18.64 64.24 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 179.731 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.545 ' HG3' ' O ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -89.75 -5.49 56.93 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 177.128 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.1 t -130.42 -32.46 1.75 Allowed 'General case' 0 C--N 1.351 0.671 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -45.68 -32.21 2.32 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt . . . . . 0 C--O 1.252 1.188 0 CA-C-O 118.52 -0.752 . . . . 0.0 111.312 179.877 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.468 0.175 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -106.53 150.32 26.25 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.993 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 151' ' ' LYS . . . . . 0.464 ' HB3' ' OE1' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -98.58 109.29 22.07 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.913 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 152' ' ' LYS . . . . . 0.404 ' N ' ' HE2' ' A' ' 124' ' ' MET . 10.3 tptm -146.12 -70.11 0.26 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.852 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.618 HG22 ' HG3' ' A' ' 127' ' ' GLU . 81.5 p -141.4 174.52 10.47 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.271 0.229 . . . . 0.0 111.569 -178.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 154' ' ' PHE . . . . . 0.606 ' HA ' HG22 ' B' ' 157' ' ' VAL . 0.1 OUTLIER -67.68 -27.07 66.53 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.771 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.491 ' HG3' ' HB2' ' A' ' 144' ' ' MET . 9.4 mptt -54.86 -50.63 68.2 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.892 0.877 . . . . 0.0 112.0 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -76.38 -35.44 58.65 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 157' ' ' VAL . . . . . 0.606 HG22 ' HA ' ' B' ' 154' ' ' PHE . 12.3 m -72.01 -39.36 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 120.728 0.299 . . . . 0.0 111.157 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 158' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' B' ' 162' ' ' LYS . . . -74.26 -39.3 63.1 Favored 'General case' 0 C--N 1.345 0.406 0 C-N-CA 123.468 0.707 . . . . 0.0 112.039 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -59.66 -28.0 66.87 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.95 -35.96 56.89 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.642 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 7.1 p -118.98 31.78 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.277 0 O-C-N 123.415 0.447 . . . . 0.0 111.65 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 162' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 20.9 tttt -80.76 -42.5 21.69 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.343 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 163' ' ' ILE . . . . . 0.498 HG13 ' OG ' ' B' ' 166' ' ' SER . 1.6 tt -108.96 43.44 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 CA-C-O 121.44 0.638 . . . . 0.0 110.663 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 55.8 m -95.34 -29.88 14.22 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.609 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . -89.36 18.3 5.35 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 123.347 0.405 . . . . 0.0 111.876 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 166' ' ' SER . . . . . 0.498 ' OG ' HG13 ' B' ' 163' ' ' ILE . 68.4 m -89.94 -21.02 22.66 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.902 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 8.1 tp -88.6 -10.44 48.71 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 123.311 0.382 . . . . 0.0 111.296 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 64.2 mtt -98.87 130.47 45.28 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.341 0.401 . . . . 0.0 110.79 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -157.56 -151.43 6.02 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.6 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.507 -0.758 . . . . 0.0 111.087 -179.93 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 111.289 0.107 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.423 ' H ' ' HB3' ' A' ' 66' ' ' PRO . 8.5 m-20 -136.49 103.52 5.28 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.073 0.463 . . . . 0.0 111.169 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -91.58 159.17 16.03 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.873 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.474 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -105.51 -112.71 0.26 Allowed 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.765 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.545 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 17.2 p -101.29 -173.68 2.42 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 123.838 0.855 . . . . 0.0 110.359 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 10' ' ' ALA . 47.0 mt-10 -59.41 -23.87 62.99 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.545 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 12.4 pt-20 -54.43 -33.32 59.24 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.288 0.566 . . . . 0.0 111.707 178.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.828 ' HA ' ' HB2' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -77.24 -45.15 27.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.787 177.901 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.667 HD13 ' HG3' ' A' ' 8' ' ' GLN . 9.6 mm -67.39 -32.68 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 CA-C-N 113.969 -1.469 . . . . 0.0 112.312 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 6' ' ' GLU . . . -81.47 -42.8 19.77 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -134.13 -35.77 0.93 Allowed 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 119.906 1.23 . . . . 0.0 114.021 -176.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.828 ' HB2' ' HA ' ' A' ' 8' ' ' GLN . 44.2 m-85 -62.83 -13.91 39.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.926 0.393 . . . . 0.0 110.765 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.695 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 5.0 pttt -72.83 -39.31 66.69 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.695 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 12.7 mt-10 -70.56 -47.84 58.3 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 113.613 -1.63 . . . . 0.0 110.879 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.597 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -58.46 -17.85 24.05 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.858 0.837 . . . . 0.0 109.272 176.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.648 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 75.9 t80 -86.15 -52.07 5.9 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 113.777 -1.556 . . . . 0.0 109.263 176.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.498 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 53.3 m -87.89 -12.85 43.57 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -177.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.603 ' N ' ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -62.0 -31.43 71.81 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.239 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.637 ' HB3' HG21 ' A' ' 27' ' ' ILE . 7.7 m-85 -129.5 -5.92 4.72 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.648 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -77.68 56.54 1.49 Allowed 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -177.521 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.498 ' HE3' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -85.09 -17.81 36.21 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 178.314 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.583 ' OD1' ' HB2' ' A' ' 24' ' ' ASP . 0.3 OUTLIER -70.91 -23.45 62.27 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.131 0.491 . . . . 0.0 111.324 178.724 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.2 45.0 32.95 Favored Glycine 0 N--CA 1.472 1.093 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.583 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 0.5 OUTLIER -111.81 23.22 14.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.23 -1.485 . . . . 0.0 112.702 -175.558 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.15 -84.8 1.54 Allowed Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -177.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.52 HG21 HG22 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -115.15 177.68 4.57 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.78 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.637 HG21 ' HB3' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -101.75 152.18 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -176.232 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.97 156.61 1.48 Allowed 'General case' 0 C--N 1.344 0.334 0 C-N-CA 124.457 1.103 . . . . 0.0 113.73 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.01 -55.06 28.94 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.859 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -57.3 -13.72 3.62 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.246 177.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.576 ' O ' HG23 ' A' ' 35' ' ' VAL . 28.7 mt-10 -103.84 -30.13 10.56 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.762 -178.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.503 HD11 ' CE1' ' A' ' 68' ' ' PHE . 14.3 tp -54.2 -38.25 65.43 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.895 0.478 . . . . 0.0 112.24 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.783 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -57.26 -40.29 91.54 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 177.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 m -74.92 -29.7 61.05 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 114.605 -0.797 . . . . 0.0 112.482 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.597 HG12 ' HA ' ' A' ' 15' ' ' ALA . 2.0 t -74.99 -26.2 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 176.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.656 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 31.7 mmt -74.99 -40.53 60.64 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 113.198 -1.819 . . . . 0.0 110.935 175.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.783 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 13.8 mtt180 -85.21 -25.75 27.16 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.5 t -64.21 -8.22 11.8 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.906 0.86 . . . . 0.0 112.224 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.5 mt -93.94 -7.17 43.73 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.331 -1.759 . . . . 0.0 109.679 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.51 1.86 55.49 Favored Glycine 0 CA--C 1.491 -1.441 0 CA-C-O 122.506 1.059 . . . . 0.0 114.334 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.656 ' HB2' ' O ' ' A' ' 36' ' ' MET . 46.2 mt-30 -78.28 139.12 38.89 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 111.826 -2.187 . . . . 0.0 112.094 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -117.78 75.46 10.07 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.315 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -78.56 -177.93 4.26 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.98 2.453 . . . . 0.0 111.976 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.426 HG22 ' H ' ' A' ' 46' ' ' ALA . 1.2 m -99.72 158.93 15.43 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.531 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 28.2 mt-10 -80.85 -28.14 36.18 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.452 177.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.426 ' H ' HG22 ' A' ' 44' ' ' THR . . . -70.85 -35.48 72.42 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 113.412 -1.722 . . . . 0.0 109.845 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -79.03 -30.3 44.06 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 114.041 -1.436 . . . . 0.0 108.947 176.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.628 ' O ' HD13 ' A' ' 52' ' ' ILE . 0.4 OUTLIER -68.86 -19.72 64.26 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.992 174.677 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.865 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 53.5 mt-30 -99.88 -15.56 18.33 Favored 'General case' 0 CA--C 1.48 -1.716 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.14 178.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -85.55 -32.58 22.07 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 112.025 -2.352 . . . . 0.0 109.712 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 29.6 mmm -86.52 -35.14 19.73 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.135 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.628 HD13 ' O ' ' A' ' 48' ' ' LEU . 1.6 mp -71.75 -25.68 24.7 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 175.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.865 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.1 t30 -75.74 -33.9 60.29 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.721 175.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -81.14 -42.5 20.81 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.546 ' C ' ' H ' ' A' ' 57' ' ' ALA . 78.5 t -84.65 -49.32 16.0 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -72.53 39.47 0.08 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.99 0.9 . . . . 0.0 110.132 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.546 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -84.44 -5.72 59.31 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 114.107 -1.406 . . . . 0.0 112.624 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -105.24 -31.74 8.96 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 112.21 -2.268 . . . . 0.0 110.727 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.3 49.73 4.57 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-N 115.994 -0.548 . . . . 0.0 113.458 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -110.0 -21.58 12.25 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.05 27.14 73.38 Favored Glycine 0 N--CA 1.466 0.683 0 O-C-N 123.615 0.572 . . . . 0.0 113.94 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.64 154.65 43.76 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.984 0.514 . . . . 0.0 110.977 -179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.52 HG22 HG21 ' A' ' 26' ' ' THR . 43.6 mm -97.72 161.6 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.441 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 9.3 m-20 -127.82 148.71 50.46 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.397 1.079 . . . . 0.0 108.53 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.541 ' CG ' ' HD3' ' A' ' 66' ' ' PRO . 12.0 p90 -90.36 -39.19 0.41 Allowed Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -177.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.541 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 11.4 Cg_exo -72.56 -17.82 26.22 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 121.93 1.753 . . . . 0.0 112.879 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -108.14 -29.48 8.91 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -177.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.579 ' O ' ' HB2' ' A' ' 71' ' ' MET . 0.0 OUTLIER -85.16 -20.56 30.05 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -176.465 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.566 HD22 ' CG ' ' A' ' 12' ' ' PHE . 71.2 mt -78.71 -36.62 43.14 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 122.389 1.09 . . . . 0.0 109.868 177.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -53.03 -31.47 41.51 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 111.941 -2.39 . . . . 0.0 108.433 172.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.579 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 22.4 mmt -65.98 -34.35 77.89 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 114.572 -1.194 . . . . 0.0 109.76 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.782 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -81.68 -22.22 37.61 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.458 177.13 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -73.39 -37.63 65.91 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.523 ' CD ' ' HA ' ' A' ' 71' ' ' MET . 2.8 ptm180 -77.84 -17.99 56.79 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 178.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.782 ' HD2' ' HA ' ' A' ' 72' ' ' MET . 30.5 mttt -72.44 -14.36 61.67 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 175.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 6.8 ptt? -119.72 -33.65 3.96 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 123.511 0.507 . . . . 0.0 112.018 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 34.3 mttt -76.2 -20.58 57.34 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.864 -1.062 . . . . 0.0 113.552 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -100.75 -29.74 12.1 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.7 t -81.0 48.16 1.08 Allowed 'General case' 0 CA--C 1.548 0.882 0 CA-C-O 121.132 0.492 . . . . 0.0 112.185 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 62.01 119.99 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.778 0.831 . . . . 0.0 111.97 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.551 ' HA ' ' OE1' ' A' ' 84' ' ' GLU . 13.2 t -83.2 -13.73 54.81 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.285 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.413 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -87.11 -45.81 10.36 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.77 0.795 . . . . 0.0 109.297 179.737 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.413 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 37.8 mt-10 -75.89 -18.08 59.53 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 113.63 -1.623 . . . . 0.0 113.038 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.551 ' OE1' ' HA ' ' A' ' 81' ' ' SER . 11.2 pt-20 -60.83 -22.39 64.15 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.6 mp -87.73 -50.97 13.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.607 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -56.8 -16.87 7.39 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.539 ' OE1' ' HB3' ' B' ' 164' ' ' SER . 2.6 pt-20 -79.38 -20.96 46.41 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 123.384 0.428 . . . . 0.0 110.868 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.532 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -73.95 -20.79 60.26 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.377 177.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.452 ' CZ ' ' HA ' ' A' ' 138' ' ' TYR . 81.8 m-85 -82.27 -20.89 36.63 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 174.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.512 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 8.2 ttt180 -76.18 -18.9 58.87 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 174.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.532 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 37.9 t -87.79 -50.51 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 CA-C-N 114.166 -1.379 . . . . 0.0 112.09 177.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.849 ' HB3' HG21 ' A' ' 100' ' ' ILE . 14.4 m-85 -100.25 -45.85 5.48 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -176.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.705 ' CA ' HG12 ' A' ' 100' ' ' ILE . 3.1 t70 -64.3 89.78 0.06 Allowed 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 121.821 0.82 . . . . 0.0 111.61 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.59 -48.71 7.37 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.141 -1.39 . . . . 0.0 114.0 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -71.22 3.51 3.54 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -175.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 47.73 29.33 5.88 Favored Glycine 0 N--CA 1.474 1.2 0 CA-C-N 114.245 -1.343 . . . . 0.0 115.247 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -98.22 -4.11 36.07 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.812 0.306 . . . . 0.0 111.165 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 99.18 -19.02 55.76 Favored Glycine 0 C--N 1.338 0.66 0 CA-C-N 116.209 -0.451 . . . . 0.0 112.482 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -114.55 118.37 33.53 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.277 -0.961 . . . . 0.0 110.385 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.849 HG21 ' HB3' ' A' ' 92' ' ' PHE . 57.7 mt -77.52 87.91 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.3 t -61.75 163.79 6.96 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.166 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.775 ' HA ' HD12 ' A' ' 105' ' ' LEU . . . -61.07 -13.35 16.34 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.617 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.4 -27.68 21.43 Favored 'General case' 0 CA--C 1.491 -1.321 0 CA-C-O 121.686 0.755 . . . . 0.0 109.483 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 1.023 ' O ' HG23 ' A' ' 108' ' ' VAL . 20.4 mt-10 -80.05 -44.34 20.25 Favored 'General case' 0 CA--C 1.483 -1.626 0 CA-C-N 112.905 -1.952 . . . . 0.0 111.688 -177.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.775 HD12 ' HA ' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -68.43 -26.15 65.37 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.29 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.738 HH11 ' H ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -76.73 -44.39 33.46 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 113.638 -1.619 . . . . 0.0 108.555 175.841 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.617 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 1.2 t-80 -67.01 -21.85 65.92 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.023 HG23 ' O ' ' A' ' 104' ' ' GLU . 25.5 t -70.42 -51.61 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 175.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.656 ' SD ' HD13 ' A' ' 116' ' ' LEU . 16.8 mtt -56.36 -41.85 76.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 112.992 -1.913 . . . . 0.0 112.227 175.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.421 ' H ' ' HG1' ' A' ' 110' ' ' THR . 0.2 OUTLIER -68.79 -19.1 64.29 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.405 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.01 -45.12 18.96 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.601 176.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.2 mt -79.21 -28.2 42.57 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.872 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 140.18 -7.34 2.88 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 117.704 -1.609 . . . . 0.0 116.833 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 109' ' ' MET . 5.0 mt-10 -100.69 150.96 22.21 Favored 'General case' 0 C--N 1.358 0.947 0 CA-C-N 120.955 2.378 . . . . 0.0 114.568 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -109.4 128.16 54.92 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 113.276 -1.783 . . . . 0.0 106.998 175.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.738 ' H ' HH11 ' A' ' 106' ' ' ARG . 1.8 tp -130.91 120.75 24.05 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.713 -175.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.774 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -74.51 -175.85 2.53 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.96 179.556 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.526 ' N ' HG23 ' A' ' 117' ' ' THR . 16.0 t70 -75.01 -37.25 61.87 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.51 -1.223 . . . . 0.0 114.232 -177.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.646 ' H ' HG23 ' A' ' 117' ' ' THR . 9.1 pt-20 -89.14 -15.88 32.76 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.737 ' HG2' HG22 ' A' ' 117' ' ' THR . 14.8 pt-20 -86.73 -16.49 36.26 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 123.099 0.249 . . . . 0.0 111.051 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.774 HG22 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -83.63 -28.93 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.993 178.163 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.52 30.73 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.819 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.612 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 9.8 pt-20 -148.22 -13.93 0.35 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.796 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.529 ' O ' ' HD1' ' B' ' 154' ' ' PHE . 1.9 ttm -88.15 -35.84 17.19 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.233 0.613 . . . . 0.0 109.956 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.797 ' O ' ' N ' ' A' ' 129' ' ' ASP . 0.0 OUTLIER -80.37 -35.01 15.06 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.849 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.334 178.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -58.57 -26.9 64.1 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.894 0.854 . . . . 0.0 110.615 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.612 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 16.0 mm-40 -68.87 -31.39 70.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 113.364 -1.744 . . . . 0.0 109.861 177.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.652 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -108.43 -36.77 6.14 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.295 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.797 ' N ' ' O ' ' A' ' 125' ' ' ILE . 0.2 OUTLIER -60.93 127.73 33.01 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.131 178.71 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.9 mm -89.38 -50.75 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.553 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -81.47 -25.17 36.27 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.06 49.13 6.52 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 115.884 -0.598 . . . . 0.0 113.784 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -96.91 -12.89 22.87 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.833 0.349 . . . . 0.0 110.978 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.46 13.04 57.7 Favored Glycine 0 CA--C 1.502 -0.757 0 CA-C-N 115.397 -0.82 . . . . 0.0 113.687 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -140.51 119.35 12.56 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 124.41 1.084 . . . . 0.0 108.227 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.688 HG23 HG22 ' A' ' 125' ' ' ILE . 0.9 OUTLIER -90.39 129.42 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -176.601 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -84.19 -163.3 0.77 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.801 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.48 ' O ' HG23 ' A' ' 142' ' ' VAL . 50.5 m-85 -75.33 -56.25 4.9 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.479 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.96 -20.23 65.04 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.652 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 7.1 mt-10 -87.05 -39.39 15.66 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 121.276 0.56 . . . . 0.0 110.529 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -74.23 -22.93 59.13 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.611 -1.177 . . . . 0.0 108.744 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.533 ' O ' ' HG2' ' A' ' 145' ' ' MET . 24.3 t -84.17 -46.82 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.547 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.767 ' O ' ' N ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -55.54 -31.81 62.42 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 123.858 0.724 . . . . 0.0 109.689 176.532 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -26.33 61.75 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.362 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.533 ' HG2' ' O ' ' A' ' 142' ' ' VAL . 8.4 ptt? -88.35 -4.03 58.74 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 123.431 0.457 . . . . 0.0 110.479 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.7 t -137.55 -22.98 1.1 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.767 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -51.37 -34.07 32.58 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 20.1 pttp . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.123 -0.941 . . . . 0.0 111.296 179.817 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 21.1 p . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.492 0.187 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -133.03 -45.36 0.85 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.153 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -133.0 -28.41 1.55 Allowed 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.399 0.437 . . . . 0.0 111.462 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 152' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 124' ' ' MET . 84.2 mttt 64.61 139.57 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.065 0.946 . . . . 0.0 112.49 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.544 ' O ' HG22 ' B' ' 157' ' ' VAL . 55.1 p -133.09 171.19 14.32 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.952 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 154' ' ' PHE . . . . . 0.529 ' HD1' ' O ' ' A' ' 124' ' ' MET . 2.5 m-85 -58.16 -28.11 64.43 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 117.834 0.288 . . . . 0.0 110.856 178.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.564 ' HE3' ' O ' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -72.29 -45.62 59.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.214 0.605 . . . . 0.0 111.446 178.55 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -76.61 -37.16 56.86 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 157' ' ' VAL . . . . . 0.544 HG22 ' O ' ' B' ' 153' ' ' THR . 29.2 m -72.02 -40.8 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 122.602 0.361 . . . . 0.0 111.613 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.05 -32.69 63.41 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.098 0.559 . . . . 0.0 112.292 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 159' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' B' ' 155' ' ' LYS . 2.9 t30 -56.81 -37.41 71.15 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.393 0.433 . . . . 0.0 111.288 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.44 -28.4 52.46 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.159 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 9.3 p -115.75 26.34 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.286 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 162' ' ' LYS . . . . . . . . . . . . . 19.8 mtmt -77.08 -5.7 49.92 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 120.88 0.371 . . . . 0.0 110.886 178.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 163' ' ' ILE . . . . . 0.754 HG23 ' HB2' ' B' ' 168' ' ' MET . 2.0 mp -115.39 110.67 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 164' ' ' SER . . . . . 0.539 ' HB3' ' OE1' ' A' ' 87' ' ' GLU . 12.0 t -115.77 -27.11 7.15 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 165' ' ' ALA . . . . . 0.647 ' HB3' ' SD ' ' B' ' 168' ' ' MET . . . -82.7 18.91 1.42 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.052 0.453 . . . . 0.0 112.179 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 66.4 m 64.06 130.05 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.342 1.057 . . . . 0.0 113.483 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.581 ' O ' ' HD3' ' A' ' 75' ' ' LYS . 25.2 mt 54.27 22.41 3.67 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 177.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 168' ' ' MET . . . . . 0.754 ' HB2' HG23 ' B' ' 163' ' ' ILE . 46.4 mtp -69.31 -26.2 64.6 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.818 0.447 . . . . 0.0 111.446 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 169' ' ' GLY . . . . . 0.593 ' N ' HG12 ' B' ' 163' ' ' ILE . . . 172.97 42.56 0.04 OUTLIER Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.514 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 11.8 p . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.484 -0.769 . . . . 0.0 111.117 179.942 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.44 0.162 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -128.33 108.16 10.35 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.738 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -91.38 153.08 20.13 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.582 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.443 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -105.57 -108.8 0.29 Allowed 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.613 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.696 ' CG2' ' H ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -102.26 -173.82 2.43 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.8 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.564 ' N ' HG23 ' A' ' 5' ' ' THR . 45.3 mt-10 -60.11 -15.35 22.7 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 122.568 0.347 . . . . 0.0 110.993 176.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.696 ' H ' ' CG2' ' A' ' 5' ' ' THR . 5.5 pt-20 -62.17 -30.01 70.76 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.741 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.498 ' O ' ' HD2' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -77.99 -45.82 22.73 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.013 -1.448 . . . . 0.0 109.147 177.894 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.8 mm -60.73 -34.87 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.371 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.57 -34.9 63.02 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -114.35 -18.38 11.57 Favored 'General case' 0 C--N 1.345 0.404 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.498 ' HD2' ' O ' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -73.62 -15.23 61.27 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.325 0.966 . . . . 0.0 110.344 178.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.681 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -82.31 -40.69 21.1 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.097 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.681 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 0.8 OUTLIER -86.51 -39.56 16.13 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.158 -178.794 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.637 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -66.44 -18.67 65.49 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.454 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 48.5 t80 -86.39 -49.88 7.31 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.684 176.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.441 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 8.7 t -87.63 -12.92 44.13 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 -176.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -69.53 -28.71 66.25 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.606 0.639 . . . . 0.0 112.307 -179.373 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.584 ' CD1' HG22 ' A' ' 35' ' ' VAL . 5.5 m-85 -134.91 -2.55 2.6 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 23.5 t70 -83.44 55.2 3.09 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 119.301 0.955 . . . . 0.0 112.396 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.441 ' HE3' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -87.04 -20.63 26.91 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 178.594 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.72 -22.41 61.63 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.394 0.616 . . . . 0.0 110.585 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.16 40.99 27.93 Favored Glycine 0 N--CA 1.47 0.966 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.759 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.5 23.23 10.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.03 -1.585 . . . . 0.0 112.536 -176.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.04 -81.02 1.78 Allowed Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.865 -177.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.815 HG21 ' HA ' ' A' ' 64' ' ' ASP . 0.3 OUTLIER -113.76 178.31 4.33 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 122.394 0.278 . . . . 0.0 110.469 178.013 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -76.74 149.0 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -177.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.47 161.8 24.6 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.44 ' HA ' HD11 ' A' ' 63' ' ' ILE . 1.0 OUTLIER -78.26 -55.81 4.96 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.122 -179.824 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -55.76 -13.75 1.9 Allowed 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.726 0.641 . . . . 0.0 111.137 177.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.51 ' O ' HG23 ' A' ' 35' ' ' VAL . 25.5 mt-10 -114.75 -16.65 11.75 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.234 -178.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.604 HD22 HG12 ' A' ' 63' ' ' ILE . 13.2 tp -53.26 -41.38 65.45 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.332 0.653 . . . . 0.0 112.465 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.753 ' O ' ' HD3' ' A' ' 37' ' ' ARG . . . -55.83 -39.37 77.3 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 177.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.5 m -75.62 -29.71 59.3 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.488 -0.856 . . . . 0.0 112.547 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.637 HG12 ' HA ' ' A' ' 15' ' ' ALA . 1.2 t -74.68 -27.48 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 176.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.641 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 42.3 mtt -73.18 -42.3 62.87 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 113.0 -1.909 . . . . 0.0 111.006 176.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.753 ' HD3' ' O ' ' A' ' 33' ' ' GLY . 12.1 mtp180 -80.97 -29.71 35.25 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 75.8 m -67.87 -8.71 38.73 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.913 0.863 . . . . 0.0 111.971 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.469 HD21 ' HB2' ' A' ' 14' ' ' GLU . 85.0 mt -92.11 -7.25 49.11 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.285 -1.78 . . . . 0.0 109.645 177.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.4 1.44 50.53 Favored Glycine 0 CA--C 1.491 -1.434 0 CA-C-O 122.264 0.925 . . . . 0.0 114.933 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.641 ' HB2' ' O ' ' A' ' 36' ' ' MET . 47.6 mt-30 -85.66 138.02 32.43 Favored 'General case' 0 C--N 1.278 -2.523 0 CA-C-N 112.212 -1.994 . . . . 0.0 112.048 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -117.24 76.65 9.13 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.195 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.1 178.25 5.42 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 123.035 2.49 . . . . 0.0 112.361 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 46' ' ' ALA . 2.1 m -98.87 162.86 12.86 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.508 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 27.4 mt-10 -80.59 -28.78 37.02 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 121.555 0.693 . . . . 0.0 110.044 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.415 ' H ' HG22 ' A' ' 44' ' ' THR . . . -72.94 -39.49 66.18 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 113.758 -1.564 . . . . 0.0 110.261 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.586 ' HA ' ' OD2' ' A' ' 50' ' ' ASP . 0.9 OUTLIER -75.58 -28.82 59.1 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.664 176.307 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.817 ' O ' HG12 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -63.05 -23.09 67.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.094 174.334 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.674 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 20.2 mm-40 -89.68 -18.71 25.92 Favored 'General case' 0 CA--C 1.478 -1.825 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.455 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.586 ' OD2' ' HA ' ' A' ' 47' ' ' GLU . 15.2 m-20 -76.44 -30.77 57.52 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-N 112.003 -2.362 . . . . 0.0 108.837 175.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 35.1 mmt -86.6 -31.34 21.21 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.011 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.817 HG12 ' O ' ' A' ' 48' ' ' LEU . 37.2 mm -73.27 -27.23 23.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.574 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 175.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.674 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.4 t-20 -76.13 -35.03 59.44 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.457 176.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -87.32 -39.63 15.18 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.556 ' C ' ' H ' ' A' ' 57' ' ' ALA . 55.6 t -74.39 -42.79 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -72.16 34.91 0.06 Allowed 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.839 0.828 . . . . 0.0 110.734 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.556 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -86.78 -6.63 58.76 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 114.352 -1.294 . . . . 0.0 112.25 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -113.44 -35.59 5.22 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 112.027 -2.352 . . . . 0.0 110.741 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.59 45.89 5.95 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.766 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -110.19 -21.6 12.17 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.01 26.86 69.91 Favored Glycine 0 N--CA 1.466 0.661 0 CA-C-N 115.883 -0.599 . . . . 0.0 114.024 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.43 171.14 14.47 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 123.099 0.56 . . . . 0.0 110.871 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.604 HG12 HD22 ' A' ' 32' ' ' LEU . 4.4 mp -125.16 95.63 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.815 ' HA ' HG21 ' A' ' 26' ' ' THR . 9.3 m-20 -53.44 149.15 8.04 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.159 175.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.529 ' HA ' ' CD2' ' A' ' 68' ' ' PHE . 25.6 p90 -82.91 -38.59 0.77 Allowed Pre-proline 0 N--CA 1.478 0.94 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -177.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.486 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 12.7 Cg_exo -70.46 -17.37 34.46 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 121.939 1.759 . . . . 0.0 112.901 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -101.52 -19.34 15.55 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.853 ' O ' ' HG2' ' A' ' 71' ' ' MET . 3.8 p90 -84.82 -42.71 14.85 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -177.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 73' ' ' ALA . 3.8 mt -63.11 -31.97 73.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.569 0.699 . . . . 0.0 110.771 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.51 ' O ' ' HD3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -57.21 -35.64 69.89 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 113.509 -1.678 . . . . 0.0 109.567 174.458 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.853 ' HG2' ' O ' ' A' ' 68' ' ' PHE . 10.3 ptt? -72.92 -27.49 61.89 Favored 'General case' 0 C--N 1.345 0.412 0 O-C-N 123.789 0.68 . . . . 0.0 109.184 176.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.613 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 68.5 mtt -85.41 -20.23 30.16 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.776 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.489 ' O ' ' HG3' ' A' ' 77' ' ' LYS . . . -76.24 -37.41 57.69 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.704 ' NE ' ' HA ' ' A' ' 71' ' ' MET . 8.7 ptt180 -77.04 -18.13 58.31 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 123.562 0.539 . . . . 0.0 112.161 178.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.653 ' HD2' ' O ' ' A' ' 71' ' ' MET . 15.0 mttm -76.95 -14.58 59.84 Favored 'General case' 0 C--N 1.348 0.519 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 176.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.5 ' HA ' HG22 ' A' ' 79' ' ' THR . 14.4 ptt? -120.2 -22.97 6.4 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -177.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 73' ' ' ALA . 56.1 mttt -64.2 -13.79 51.09 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -104.19 -29.44 10.82 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.5 HG22 ' HA ' ' A' ' 76' ' ' MET . 7.9 t -68.04 103.88 1.62 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.057 0.456 . . . . 0.0 111.759 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.606 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 9.1 m-20 -46.28 147.16 1.18 Allowed 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.784 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.48 ' HA ' ' OE2' ' A' ' 84' ' ' GLU . 13.2 t -71.89 -13.68 61.73 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.717 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.555 ' O ' HD12 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -80.03 -46.82 15.9 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.59 0.71 . . . . 0.0 109.819 -179.37 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.429 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 38.5 mt-10 -73.33 -18.34 61.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.941 -1.481 . . . . 0.0 112.489 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.606 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 40.7 mt-10 -66.74 -20.93 66.06 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.555 HD12 ' O ' ' A' ' 82' ' ' GLU . 1.7 mt -87.89 -55.64 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.59 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.64 ' O ' ' HD1' ' A' ' 89' ' ' PHE . 9.7 mtt180 -60.82 -16.77 44.63 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.555 ' O ' HG23 ' A' ' 91' ' ' VAL . 2.7 pt-20 -78.38 -20.13 51.91 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.438 ' HB1' ' CE2' ' A' ' 141' ' ' PHE . . . -68.52 -21.48 64.58 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.777 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.64 ' HD1' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -84.45 -20.74 31.27 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 174.908 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -80.41 -24.97 39.29 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.211 -1.358 . . . . 0.0 108.353 175.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 87' ' ' GLU . 97.8 t -88.75 -54.51 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.558 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.809 ' HB3' HG21 ' A' ' 100' ' ' ILE . 13.7 m-85 -100.37 -44.46 5.9 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -175.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.705 ' CA ' HG12 ' A' ' 100' ' ' ILE . 15.8 t70 -62.87 94.76 0.07 Allowed 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.591 0.71 . . . . 0.0 111.36 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -87.3 -50.2 6.74 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.483 -1.235 . . . . 0.0 113.093 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -72.14 0.81 8.72 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -175.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.468 ' HA2' ' OD2' ' A' ' 93' ' ' ASP . . . 49.51 33.26 17.23 Favored Glycine 0 N--CA 1.473 1.117 0 CA-C-N 114.34 -1.3 . . . . 0.0 114.722 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -99.87 -5.56 28.22 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.89 -19.19 50.55 Favored Glycine 0 C--N 1.337 0.609 0 C-N-CA 121.481 -0.39 . . . . 0.0 112.787 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -119.2 119.65 34.75 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.477 -0.861 . . . . 0.0 110.258 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.809 HG21 ' HB3' ' A' ' 92' ' ' PHE . 45.9 mt -77.34 87.41 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.3 t -64.51 163.56 13.24 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.131 -0.94 . . . . 0.0 112.969 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.554 ' HB1' HG21 ' A' ' 121' ' ' VAL . . . -58.55 -14.42 8.03 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.65 -30.92 18.81 Favored 'General case' 0 CA--C 1.488 -1.406 0 CA-C-O 121.819 0.819 . . . . 0.0 109.248 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 1.035 ' O ' HG23 ' A' ' 108' ' ' VAL . 16.1 mt-10 -77.83 -40.88 38.93 Favored 'General case' 0 CA--C 1.483 -1.634 0 CA-C-N 112.73 -2.032 . . . . 0.0 110.152 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.792 HD11 ' SD ' ' A' ' 124' ' ' MET . 6.0 tt -64.09 -35.61 81.31 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.624 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -72.39 -43.12 64.39 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.203 -1.362 . . . . 0.0 108.649 175.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.513 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 2.9 t60 -67.61 -21.85 65.38 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.277 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.035 HG23 ' O ' ' A' ' 104' ' ' GLU . 28.8 t -72.31 -51.42 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.878 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 176.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.699 ' SD ' HD22 ' A' ' 116' ' ' LEU . 21.2 mtt -57.3 -41.23 79.45 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 112.579 -2.1 . . . . 0.0 111.943 175.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 m -69.43 -19.26 63.79 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.366 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.13 -44.81 21.27 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.422 176.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.2 mt -80.9 -28.2 35.97 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.207 -178.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 141.67 -10.32 2.64 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-O 117.738 -1.59 . . . . 0.0 116.836 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 109' ' ' MET . 5.0 mt-10 -100.82 152.13 20.87 Favored 'General case' 0 C--N 1.357 0.903 0 CA-C-N 120.912 2.356 . . . . 0.0 114.427 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -110.74 128.53 55.77 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 113.703 -1.59 . . . . 0.0 107.304 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.699 HD22 ' SD ' ' A' ' 109' ' ' MET . 1.0 OUTLIER -139.71 115.91 10.46 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.893 -176.025 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.876 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -70.43 -175.82 1.1 Allowed 'General case' 0 C--N 1.348 0.523 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.433 179.154 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.538 ' N ' HG23 ' A' ' 117' ' ' THR . 17.2 t70 -69.41 -39.48 77.9 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.623 ' H ' HG23 ' A' ' 117' ' ' THR . 9.9 pt-20 -88.76 -16.52 31.98 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.796 ' HG2' HG22 ' A' ' 117' ' ' THR . 14.7 pt-20 -85.05 -15.72 43.13 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 123.083 0.24 . . . . 0.0 111.204 178.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.876 HG22 ' O ' ' A' ' 117' ' ' THR . 0.1 OUTLIER -83.02 -23.33 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.179 177.688 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -70.61 29.41 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.93 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.667 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 11.7 pt-20 -136.36 -21.2 1.37 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.208 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.792 ' SD ' HD11 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -87.61 -32.08 19.49 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 176.452 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.741 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 3.0 mt -81.71 -27.6 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.727 -178.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -73.38 -29.26 62.51 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.649 0.738 . . . . 0.0 111.194 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.667 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 15.4 mm-40 -65.06 -36.72 85.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.846 -1.525 . . . . 0.0 110.569 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.641 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -96.48 -36.12 10.9 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.361 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.741 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.5 OUTLIER -60.45 116.61 4.44 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.26 -1.336 . . . . 0.0 113.92 -178.368 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.5 mt -91.01 -52.15 10.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 113.163 -1.835 . . . . 0.0 109.605 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -87.89 -24.45 23.64 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.029 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.38 49.8 3.59 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 115.718 -0.673 . . . . 0.0 113.689 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -78.86 -22.44 46.07 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.45 24.58 56.3 Favored Glycine 0 CA--C 1.505 -0.537 0 CA-C-N 115.03 -0.986 . . . . 0.0 114.536 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.642 ' O ' ' HB ' ' A' ' 136' ' ' VAL . 40.6 mt-30 -133.7 -68.42 0.57 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.71 -0.745 . . . . 0.0 110.348 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.642 ' HB ' ' O ' ' A' ' 135' ' ' GLN . 5.2 t 115.54 118.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 125.258 1.423 . . . . 0.0 110.907 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -94.06 -163.7 1.08 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.944 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.446 ' O ' HG23 ' A' ' 142' ' ' VAL . 79.0 m-85 -69.85 -51.92 29.3 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.825 178.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -66.92 -20.63 65.94 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.641 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 8.7 mt-10 -85.47 -38.0 19.11 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.509 ' O ' ' HG3' ' A' ' 144' ' ' MET . 86.6 t80 -75.35 -23.63 57.22 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.748 176.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.574 ' O ' ' HG2' ' A' ' 145' ' ' MET . 18.3 t -85.76 -37.01 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.743 -178.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.427 ' HA ' ' OG1' ' A' ' 146' ' ' THR . 8.7 mm100 -46.73 -31.25 2.83 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 178.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.509 ' HG3' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -63.4 -25.69 68.4 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 118.559 0.618 . . . . 0.0 110.941 178.6 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.574 ' HG2' ' O ' ' A' ' 142' ' ' VAL . 11.2 ptm -83.68 -4.2 58.4 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.739 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.427 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 59.4 p -122.4 -44.59 2.24 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.136 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -48.44 -38.75 20.62 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 20.5 pttp . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.107 -0.949 . . . . 0.0 111.115 179.895 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.526 0.203 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 150' ' ' ARG . . . . . 0.534 ' HA ' ' OE2' ' A' ' 123' ' ' GLU . 7.5 mpt_? -128.98 129.64 45.66 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.703 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -100.75 -58.03 1.98 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.817 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -150.1 138.92 20.89 Favored 'General case' 0 C--N 1.346 0.425 0 O-C-N 123.264 0.352 . . . . 0.0 110.656 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.541 ' O ' HG13 ' B' ' 157' ' ' VAL . 67.7 p -108.35 176.1 5.24 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.31 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 154' ' ' PHE . . . . . 0.522 ' CE1' ' HD2' ' B' ' 155' ' ' LYS . 0.1 OUTLIER -67.47 -27.39 66.98 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 179.561 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.522 ' HD2' ' CE1' ' B' ' 154' ' ' PHE . 0.8 OUTLIER -69.55 -34.56 74.37 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 120.76 0.314 . . . . 0.0 110.624 177.653 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -76.47 -35.18 58.58 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.441 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 157' ' ' VAL . . . . . 0.541 HG13 ' O ' ' B' ' 153' ' ' THR . 11.1 m -71.44 -29.49 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 122.671 0.389 . . . . 0.0 110.686 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.22 -39.06 71.89 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.706 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -68.33 -22.5 64.69 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.742 0.306 . . . . 0.0 110.938 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.69 -43.89 29.71 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.614 HG23 ' SD ' ' B' ' 168' ' ' MET . 10.7 p -126.58 -30.7 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -178.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 162' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -62.96 94.08 0.06 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.55 0.69 . . . . 0.0 111.735 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 3.5 tp -154.12 5.49 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.918 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 49.2 m 64.96 -176.97 0.17 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.073 0.949 . . . . 0.0 111.715 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 165' ' ' ALA . . . . . 0.42 ' HB1' ' N ' ' B' ' 170' ' ' THR . . . -75.68 58.77 1.11 Allowed 'General case' 0 C--N 1.348 0.523 0 CA-C-O 121.807 0.813 . . . . 0.0 110.78 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 166' ' ' SER . . . . . 0.601 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 8.6 t -100.31 -60.61 1.5 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.662 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 4.0 tp -108.47 -23.65 11.76 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.051 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 168' ' ' MET . . . . . 0.614 ' SD ' HG23 ' B' ' 161' ' ' VAL . 61.8 mtt -93.42 -43.96 8.5 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.579 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -105.56 -152.4 20.7 Favored Glycine 0 C--N 1.34 0.755 0 C-N-CA 121.367 -0.444 . . . . 0.0 112.615 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 170' ' ' THR . . . . . 0.42 ' N ' ' HB1' ' B' ' 165' ' ' ALA . 20.1 p . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.447 -0.787 . . . . 0.0 111.038 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.401 0 N-CA-C 111.433 0.16 . . . . 0.0 111.433 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -100.17 126.92 46.5 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.42 0.45 . . . . 0.0 110.874 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.679 ' HA ' ' NE2' ' A' ' 8' ' ' GLN . 42.9 mt-30 -139.45 149.52 44.11 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.679 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.454 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -110.97 -111.06 0.33 Allowed 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.527 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 15.2 p -101.26 -173.57 2.4 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 123.727 0.811 . . . . 0.0 111.236 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -56.61 -26.77 56.59 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.527 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 10.5 pt-20 -58.33 -30.07 66.41 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 121.364 0.602 . . . . 0.0 111.314 178.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.679 ' NE2' ' HA ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -79.22 -44.42 21.85 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 114.205 -1.362 . . . . 0.0 109.141 177.57 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.541 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . 19.8 mm -60.06 -36.96 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.392 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.89 -34.66 59.99 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -107.29 -18.07 13.97 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.541 ' CE1' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -74.16 -16.04 61.01 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.478 0.581 . . . . 0.0 110.199 178.844 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.68 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 1.0 OUTLIER -81.77 -41.87 20.56 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.549 179.244 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.68 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 1.5 mt-10 -81.82 -37.81 26.48 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.558 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.7 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -66.14 -24.04 66.59 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.922 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 25.8 t80 -87.0 -43.44 12.34 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.22 176.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 t -86.07 -12.78 49.25 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -71.41 -29.35 64.81 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.512 179.503 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.446 ' CD1' HG22 ' A' ' 35' ' ' VAL . 10.8 m-85 -132.7 -6.86 3.2 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.922 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 1.6 m-20 -98.48 78.98 2.45 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.69 0.677 . . . . 0.0 110.14 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.42 -40.04 58.23 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.47 -19.2 58.26 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.206 177.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.58 51.51 5.17 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 113.734 -1.576 . . . . 0.0 109.333 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.21 22.19 3.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 113.501 -1.349 . . . . 0.0 114.138 -175.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.39 -63.1 0.26 Allowed Glycine 0 CA--C 1.527 0.811 0 CA-C-N 115.265 -0.88 . . . . 0.0 114.434 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.711 HG22 ' N ' ' A' ' 64' ' ' ASP . 12.8 p -97.75 155.86 16.83 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 123.583 0.753 . . . . 0.0 112.038 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.87 HD13 HG21 ' A' ' 35' ' ' VAL . 1.2 pp -115.21 149.31 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.642 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.96 150.44 10.21 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -178.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -74.12 -55.83 5.63 Favored 'General case' 0 C--N 1.347 0.464 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -54.5 -13.75 1.05 Allowed 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.732 0.645 . . . . 0.0 111.292 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -111.3 -16.84 13.29 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.02 -178.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.569 ' HA ' HG23 ' A' ' 35' ' ' VAL . 8.0 tp -52.73 -41.12 63.69 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.278 0.631 . . . . 0.0 112.458 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.749 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -56.12 -39.7 81.21 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 120.516 -0.849 . . . . 0.0 111.031 177.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.4 m -72.94 -32.1 65.05 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.735 -0.732 . . . . 0.0 112.624 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.87 HG21 HD13 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -72.9 -27.07 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.03 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.561 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 21.0 mtm -76.37 -42.56 44.21 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 112.884 -1.962 . . . . 0.0 111.763 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.749 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 8.7 mtt180 -77.69 -30.12 51.72 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.1 m -68.12 -8.24 36.63 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.953 0.882 . . . . 0.0 112.009 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 35' ' ' VAL . 88.3 mt -94.11 -6.1 45.78 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.243 -1.798 . . . . 0.0 109.837 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.48 -8.93 22.24 Favored Glycine 0 CA--C 1.494 -1.239 0 N-CA-C 115.582 0.993 . . . . 0.0 115.582 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.561 ' HB2' ' O ' ' A' ' 36' ' ' MET . 20.5 mm-40 -73.84 140.45 45.77 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 112.739 -1.731 . . . . 0.0 111.919 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -128.15 61.95 55.37 Favored Pre-proline 0 CA--C 1.555 1.171 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.199 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.425 ' HD2' ' HE ' ' A' ' 37' ' ' ARG . 3.3 Cg_endo -87.96 -177.76 2.01 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.99 2.46 . . . . 0.0 112.134 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.615 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 7.5 t -99.65 -175.35 2.96 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 122.156 0.979 . . . . 0.0 110.667 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.502 ' N ' ' OG1' ' A' ' 44' ' ' THR . 8.6 mm-40 -81.36 -24.89 36.77 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 112.971 -1.922 . . . . 0.0 108.38 176.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 50' ' ' ASP . . . -69.18 -26.05 64.66 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 113.66 -1.609 . . . . 0.0 111.42 -177.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.438 ' H ' HG23 ' A' ' 44' ' ' THR . 36.3 mt-10 -87.31 -30.37 20.9 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.672 177.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.646 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 12.4 mt -69.03 -19.55 64.11 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.016 174.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.882 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 48.8 mt-30 -99.08 -15.64 18.94 Favored 'General case' 0 CA--C 1.481 -1.691 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.269 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 2.6 t70 -87.2 -36.27 18.08 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 112.146 -2.297 . . . . 0.0 110.517 177.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.554 ' HA ' ' OE1' ' A' ' 54' ' ' GLU . 0.9 OUTLIER -86.66 -32.31 20.61 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.394 178.026 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.646 ' HB ' ' O ' ' A' ' 48' ' ' LEU . 1.5 mp -73.11 -25.51 21.8 Favored 'Isoleucine or valine' 0 C--N 1.344 0.364 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 175.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.882 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.0 t30 -72.23 -34.25 68.17 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.172 175.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.554 ' OE1' ' HA ' ' A' ' 51' ' ' MET . 6.0 pt-20 -87.94 -48.9 7.43 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.549 ' C ' ' H ' ' A' ' 57' ' ' ALA . 83.1 t -72.85 -46.65 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -178.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -72.64 39.47 0.08 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.971 0.891 . . . . 0.0 110.22 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.549 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -85.37 -5.64 59.29 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 114.131 -1.395 . . . . 0.0 112.206 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -104.7 -30.89 9.64 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 112.069 -2.332 . . . . 0.0 110.621 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.38 47.96 5.24 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.863 -0.608 . . . . 0.0 113.66 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -110.11 -22.13 11.94 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.61 26.67 72.05 Favored Glycine 0 N--CA 1.468 0.827 0 CA-C-N 115.875 -0.602 . . . . 0.0 114.316 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.91 158.46 43.92 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.375 0.67 . . . . 0.0 110.609 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.554 HD13 ' HB2' ' A' ' 32' ' ' LEU . 3.7 mp -135.34 128.61 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.711 ' N ' HG22 ' A' ' 26' ' ' THR . 0.2 OUTLIER -74.82 159.11 32.34 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.469 176.609 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.574 ' CG ' ' HB2' ' A' ' 16' ' ' PHE . 4.8 p90 -91.29 -41.65 0.38 Allowed Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -177.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.469 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 54.3 Cg_endo -70.74 -18.82 32.11 Favored 'Trans proline' 0 C--N 1.376 2.019 0 CA-C-N 121.368 1.524 . . . . 0.0 113.357 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -96.56 -16.65 20.94 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.683 ' O ' ' HG2' ' A' ' 71' ' ' MET . 44.4 t80 -84.55 -21.52 30.44 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -177.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.63 HD13 ' HA ' ' A' ' 8' ' ' GLN . 1.9 mt -80.14 -32.97 38.91 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-O 121.947 0.88 . . . . 0.0 109.405 176.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.635 ' O ' ' HD3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -55.99 -38.66 70.73 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 112.839 -1.982 . . . . 0.0 109.499 174.861 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.683 ' HG2' ' O ' ' A' ' 68' ' ' PHE . 24.6 ptm -73.32 -25.24 60.56 Favored 'General case' 0 C--N 1.349 0.544 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.551 ' O ' ' HG2' ' A' ' 76' ' ' MET . 93.6 mtp -83.15 -18.58 38.92 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.402 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.554 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -82.23 -32.36 29.79 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.653 ' NE ' ' HA ' ' A' ' 71' ' ' MET . 6.1 ptt180 -88.46 -17.96 29.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.661 ' HD2' ' O ' ' A' ' 71' ' ' MET . 7.7 ptmt -84.45 -13.03 53.21 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 119.56 -0.856 . . . . 0.0 112.609 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.551 ' HG2' ' O ' ' A' ' 72' ' ' MET . 21.2 ptm -111.88 -31.99 6.76 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.554 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 25.6 mmtt -67.61 -11.22 57.66 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -103.76 -29.7 10.86 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -83.38 47.77 1.3 Allowed 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 121.167 0.508 . . . . 0.0 111.937 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 61.83 112.45 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.828 0.851 . . . . 0.0 111.768 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.4 p -83.26 -14.17 53.7 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.324 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.573 ' O ' HD12 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -85.76 -45.56 11.51 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.736 0.779 . . . . 0.0 109.441 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.415 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 40.7 mt-10 -74.39 -18.34 60.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.805 -1.543 . . . . 0.0 112.02 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.35 -19.43 65.44 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.017 0.527 . . . . 0.0 112.136 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.573 HD12 ' O ' ' A' ' 82' ' ' GLU . 1.8 mt -87.74 -54.16 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.439 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.589 ' O ' ' HD1' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -57.33 -21.19 33.61 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -179.539 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 3.4 pt-20 -72.4 -19.8 61.54 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.05 0.453 . . . . 0.0 110.397 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.571 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -68.86 -21.14 64.28 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.205 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.639 ' O ' ' HB2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -80.77 -21.98 40.53 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 174.728 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 9.1 tpt180 -77.95 -15.92 58.59 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 114.432 -1.258 . . . . 0.0 107.984 175.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.571 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 3.8 t -85.57 -33.04 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 114.398 -1.274 . . . . 0.0 111.298 177.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.81 ' HB3' HG21 ' A' ' 100' ' ' ILE . 33.4 m-85 -97.55 -33.21 11.44 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 -177.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.639 ' HB2' ' O ' ' A' ' 89' ' ' PHE . 1.9 t70 -60.98 93.12 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.622 0.769 . . . . 0.0 110.965 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -87.72 -50.13 6.68 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.203 -0.908 . . . . 0.0 113.261 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -72.19 1.07 8.2 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -175.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.01 31.04 24.54 Favored Glycine 0 N--CA 1.471 1.019 0 CA-C-N 114.31 -1.314 . . . . 0.0 114.646 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -97.39 -7.96 30.59 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.625 0.212 . . . . 0.0 111.548 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.12 -19.07 47.4 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 116.202 -0.453 . . . . 0.0 112.798 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -120.61 120.31 35.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.475 -0.863 . . . . 0.0 110.384 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.81 HG21 ' HB3' ' A' ' 92' ' ' PHE . 15.4 mt -77.12 97.95 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.417 ' H ' ' CD ' ' A' ' 104' ' ' GLU . 14.1 t -76.16 169.26 18.53 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.438 -178.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.567 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -61.72 -15.04 37.23 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.525 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -89.54 -30.74 18.0 Favored 'General case' 0 CA--C 1.487 -1.458 0 CA-C-O 121.73 0.776 . . . . 0.0 109.21 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.969 ' O ' HG23 ' A' ' 108' ' ' VAL . 20.7 mt-10 -76.3 -41.75 47.59 Favored 'General case' 0 CA--C 1.485 -1.556 0 CA-C-N 112.776 -2.011 . . . . 0.0 110.729 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.561 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 2.8 tt -62.29 -38.78 90.69 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.555 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -68.7 -44.77 73.23 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 113.766 -1.561 . . . . 0.0 109.116 175.73 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.525 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 2.7 t60 -68.5 -21.68 64.58 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.662 178.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.969 HG23 ' O ' ' A' ' 104' ' ' GLU . 23.5 t -71.63 -50.3 40.3 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.927 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.806 ' SD ' HD22 ' A' ' 116' ' ' LEU . 15.6 mtt -56.6 -41.87 77.77 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 112.4 -2.182 . . . . 0.0 112.013 175.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.79 -18.97 63.51 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.339 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.82 -45.18 21.42 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.515 176.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 mt -80.55 -28.07 37.38 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.418 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 136.85 -6.33 3.76 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-O 117.78 -1.567 . . . . 0.0 116.829 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.563 ' HB3' ' SD ' ' A' ' 109' ' ' MET . 4.9 mt-10 -101.49 155.26 18.18 Favored 'General case' 0 C--N 1.356 0.882 0 CA-C-N 120.842 2.321 . . . . 0.0 114.127 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -112.77 127.49 56.17 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.322 175.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.806 HD22 ' SD ' ' A' ' 109' ' ' MET . 1.2 tp -139.87 119.52 13.23 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 113.94 -1.482 . . . . 0.0 111.057 -177.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.766 ' O ' ' HB ' ' A' ' 121' ' ' VAL . 0.6 OUTLIER -83.74 -176.55 6.34 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.911 -177.861 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.574 ' N ' HG23 ' A' ' 117' ' ' THR . 17.4 t70 -61.21 -47.54 85.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 113.827 -1.533 . . . . 0.0 113.857 -178.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.686 ' HA ' ' OD2' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -84.09 -21.73 31.4 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -179.03 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.69 ' CG ' ' H ' ' A' ' 117' ' ' THR . 10.5 pt-20 -88.61 -25.06 22.64 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.876 0.37 . . . . 0.0 110.949 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.766 ' HB ' ' O ' ' A' ' 117' ' ' THR . 0.3 OUTLIER -87.97 -26.39 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.863 178.611 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.686 ' OD2' ' HA ' ' A' ' 119' ' ' GLU . 32.1 p30 -71.7 25.63 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.75 -1.114 . . . . 0.0 113.633 -177.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.889 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 10.7 pt-20 -124.88 -43.22 2.0 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.348 177.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.469 ' SD ' HG11 ' B' ' 157' ' ' VAL . 14.1 ttm -56.35 -21.93 27.75 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.302 1.041 . . . . 0.0 111.983 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.652 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 3.0 mt -86.86 -48.64 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 O-C-N 123.528 0.517 . . . . 0.0 110.845 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -55.45 -31.2 61.74 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 124.406 1.066 . . . . 0.0 112.229 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.889 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 3.4 mm-40 -65.21 -36.75 85.14 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.962 178.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' A' ' 140' ' ' GLU . . . -97.56 -35.18 10.7 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.477 0.656 . . . . 0.0 110.283 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.652 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -61.56 127.28 30.71 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 113.985 -1.461 . . . . 0.0 113.488 -179.451 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.2 mt -90.14 -44.01 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.254 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -90.81 -25.35 19.97 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.34 49.81 6.57 Favored Glycine 0 CA--C 1.526 0.738 0 O-C-N 123.449 0.468 . . . . 0.0 113.989 178.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -87.27 -19.61 28.04 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.446 ' HA2' HG21 ' A' ' 125' ' ' ILE . . . 95.03 7.1 59.92 Favored Glycine 0 CA--C 1.5 -0.865 0 CA-C-N 115.851 -0.613 . . . . 0.0 113.611 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -139.43 107.2 5.64 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.752 -1.224 . . . . 0.0 108.124 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.595 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 2.2 t -69.18 124.85 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 114.927 -1.033 . . . . 0.0 113.448 -177.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.454 HD22 ' CD ' ' A' ' 140' ' ' GLU . 19.2 m-80 -86.75 -163.35 0.89 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 114.11 -1.404 . . . . 0.0 110.515 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.476 ' O ' HG23 ' A' ' 142' ' ' VAL . 76.5 m-85 -71.79 -55.77 6.99 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.598 0.759 . . . . 0.0 110.816 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -63.75 -20.65 65.92 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.595 ' OE1' ' HA ' ' A' ' 136' ' ' VAL . 10.9 mt-10 -86.94 -42.52 13.1 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.424 0.631 . . . . 0.0 109.703 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.42 ' O ' ' HG3' ' A' ' 144' ' ' MET . 42.3 t80 -68.76 -23.42 64.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.177 -1.374 . . . . 0.0 109.148 176.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 138' ' ' TYR . 24.6 t -85.78 -50.16 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.517 -178.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -56.33 -32.7 64.92 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 123.867 0.73 . . . . 0.0 111.992 179.189 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.458 ' O ' ' HG3' ' B' ' 155' ' ' LYS . 0.1 OUTLIER -67.01 -21.3 65.95 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 122.999 0.187 . . . . 0.0 111.197 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 50.5 mtt -87.6 -4.32 58.96 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.42 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 23.4 p -120.17 -48.78 2.31 Favored 'General case' 0 C--N 1.35 0.611 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.721 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -55.21 -40.15 70.49 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.6 mttp . . . . . 0 N--CA 1.484 1.26 0 C-N-CA 124.017 0.927 . . . . 0.0 112.462 -179.971 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 18.6 p . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.489 0.185 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -102.87 -40.73 6.42 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.277 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 151' ' ' LYS . . . . . 0.539 ' HD3' ' OE1' ' A' ' 114' ' ' GLU . 12.4 mptt -98.14 133.18 42.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.124 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -136.98 -6.87 1.85 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.94 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.651 HG22 ' HG3' ' A' ' 127' ' ' GLU . 37.8 p -139.49 158.88 43.38 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.146 0.279 . . . . 0.0 111.49 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 154' ' ' PHE . . . . . 0.586 ' HA ' HG22 ' B' ' 157' ' ' VAL . 0.2 OUTLIER -64.24 -27.26 68.93 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 120.767 0.317 . . . . 0.0 110.384 178.627 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.489 ' H ' ' HD2' ' B' ' 155' ' ' LYS . 0.0 OUTLIER -58.67 -44.35 90.16 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.446 0.698 . . . . 0.0 111.533 179.024 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -76.53 -35.15 58.45 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 157' ' ' VAL . . . . . 0.586 HG22 ' HA ' ' B' ' 154' ' ' PHE . 14.5 m -71.05 -33.87 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 122.54 0.336 . . . . 0.0 111.144 -178.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 158' ' ' ALA . . . . . 0.514 ' O ' ' HB2' ' B' ' 162' ' ' LYS . . . -73.63 -40.5 63.73 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.74 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -60.54 -25.98 66.54 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 123.467 0.479 . . . . 0.0 111.684 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.92 -37.88 54.51 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.633 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 9.8 p -115.32 27.62 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.264 0 O-C-N 123.298 0.374 . . . . 0.0 111.844 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 162' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 1.8 ttpm? -86.05 -37.45 18.88 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 116.865 -0.152 . . . . 0.0 111.045 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 3.3 tp -106.62 20.08 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 O-C-N 123.457 0.473 . . . . 0.0 110.759 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 52.4 m -88.56 -25.74 22.34 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.785 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . -89.33 23.56 2.48 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.018 0.437 . . . . 0.0 111.55 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 38.3 p -89.14 -36.25 15.81 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.761 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 4.8 tp -87.71 -7.17 57.73 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 123.4 0.438 . . . . 0.0 111.541 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 22.0 mmt -94.03 130.72 40.06 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.952 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -119.78 -55.44 0.25 Allowed Glycine 0 C--N 1.337 0.632 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.514 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 19.9 p . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.501 -0.761 . . . . 0.0 111.057 -179.968 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.513 0.197 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -100.19 -45.12 5.73 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.815 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -89.91 149.35 22.66 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 122.698 0.399 . . . . 0.0 111.259 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.576 HD11 ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -123.65 -122.69 0.27 Allowed 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.552 ' O ' ' HG2' ' A' ' 8' ' ' GLN . 20.0 p -101.64 167.96 9.78 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 123.93 0.892 . . . . 0.0 109.89 178.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -46.04 -22.1 0.19 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.513 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 10.9 pt-20 -47.98 -32.51 6.59 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 123.708 0.63 . . . . 0.0 110.912 176.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.937 HE21 HG13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -66.0 -55.24 17.73 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.102 177.47 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.937 HG13 HE21 ' A' ' 8' ' ' GLN . 5.1 mt -62.9 -30.96 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.682 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.37 -38.76 63.08 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -127.2 -19.24 4.36 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.562 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -71.45 -15.54 62.34 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.075 0.398 . . . . 0.0 110.161 178.742 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.695 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -80.77 -40.95 24.27 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.817 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.695 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 2.6 mt-10 -79.35 -40.47 30.16 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 114.142 -1.39 . . . . 0.0 112.108 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.708 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -66.54 -20.47 66.03 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.823 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 23.9 t80 -86.99 -46.47 9.81 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.328 -1.305 . . . . 0.0 109.83 176.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.8 m -86.69 -12.98 46.78 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 -176.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.44 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -72.05 -28.82 63.59 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.654 179.81 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.584 ' CD1' HG22 ' A' ' 35' ' ' VAL . 5.4 m-85 -134.52 -6.32 2.54 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.823 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 8.1 m-20 -95.68 78.5 3.31 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 118.92 0.782 . . . . 0.0 110.944 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.409 ' HD2' ' N ' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -80.96 -40.2 24.83 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -179.607 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.21 -21.26 60.69 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.49 178.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.63 50.92 8.66 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.93 22.48 7.38 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 113.323 -1.439 . . . . 0.0 114.013 -174.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.05 -66.63 0.49 Allowed Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.296 -0.866 . . . . 0.0 113.641 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.718 ' HG1' ' H ' ' A' ' 63' ' ' ILE . 2.0 t -97.85 170.15 9.17 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 122.227 1.013 . . . . 0.0 112.271 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.435 ' N ' ' OG1' ' A' ' 26' ' ' THR . 0.1 OUTLIER -133.37 144.6 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.771 0 CA-C-N 112.838 -1.983 . . . . 0.0 109.429 179.328 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.25 155.81 4.68 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.94 -55.28 11.45 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.697 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -56.13 -13.92 2.35 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.383 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.528 ' O ' HG23 ' A' ' 35' ' ' VAL . 6.3 mm-40 -107.13 -30.28 8.87 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.509 -178.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.437 ' HG ' HG13 ' A' ' 63' ' ' ILE . 1.7 tm? -55.78 -33.65 64.55 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.232 0.613 . . . . 0.0 111.27 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.589 ' HA3' HD21 ' A' ' 48' ' ' LEU . . . -58.31 -37.31 86.92 Favored Glycine 0 C--N 1.336 0.54 0 O-C-N 123.738 0.649 . . . . 0.0 111.706 177.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.7 m -79.7 -29.14 40.62 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 114.65 -0.775 . . . . 0.0 111.966 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.708 HG12 ' HA ' ' A' ' 15' ' ' ALA . 1.1 t -76.76 -26.01 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 176.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.532 ' HB3' ' NH1' ' A' ' 37' ' ' ARG . 22.4 mmt -77.2 -38.77 50.82 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 112.974 -1.921 . . . . 0.0 111.691 176.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.579 ' HD3' ' N ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -83.75 -25.82 30.21 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.3 t -65.91 -8.03 20.01 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 122.096 0.95 . . . . 0.0 111.253 177.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.448 ' O ' HG21 ' B' ' 170' ' ' THR . 78.7 mt -92.83 -2.62 55.75 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 113.011 -1.904 . . . . 0.0 110.254 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.99 -11.39 17.69 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 116.296 1.278 . . . . 0.0 116.296 177.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -75.34 156.38 35.57 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 113.198 -1.501 . . . . 0.0 111.512 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.413 ' C ' ' HG3' ' A' ' 37' ' ' ARG . 4.8 t-20 -83.2 132.22 51.01 Favored Pre-proline 0 N--CA 1.475 0.78 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.575 ' N ' ' HG3' ' A' ' 37' ' ' ARG . 85.9 Cg_endo -88.75 102.4 0.4 Allowed 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.349 2.032 . . . . 0.0 116.31 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.696 HG23 ' H ' ' A' ' 47' ' ' GLU . 10.0 t -135.29 177.67 7.63 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.969 0.89 . . . . 0.0 108.906 173.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.453 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 45.5 mt-10 -82.79 -24.95 33.18 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 113.168 -1.833 . . . . 0.0 109.32 177.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.595 ' O ' ' HB2' ' A' ' 50' ' ' ASP . . . -71.5 -34.52 70.2 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.879 -1.51 . . . . 0.0 112.477 -176.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.696 ' H ' HG23 ' A' ' 44' ' ' THR . 43.2 mt-10 -87.58 -24.83 23.88 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.763 177.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.665 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.3 OUTLIER -75.81 -18.21 59.56 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 113.723 -1.58 . . . . 0.0 109.114 176.133 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 1.034 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 17.1 mm-40 -104.13 -14.13 15.99 Favored 'General case' 0 CA--C 1.478 -1.819 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.999 177.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.595 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 1.1 t70 -87.91 -40.33 14.04 Favored 'General case' 0 C--N 1.28 -2.426 0 CA-C-N 112.349 -2.205 . . . . 0.0 111.234 176.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.587 ' HA ' ' OE1' ' A' ' 54' ' ' GLU . 1.3 mpt? -87.05 -29.96 21.53 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 123.519 0.512 . . . . 0.0 110.947 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.665 ' HB ' ' O ' ' A' ' 48' ' ' LEU . 1.9 mp -78.8 -19.95 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 175.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 1.034 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.1 t30 -77.64 -33.52 53.52 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.824 174.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.587 ' OE1' ' HA ' ' A' ' 51' ' ' MET . 6.6 pt-20 -82.54 -49.6 9.71 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.562 ' C ' ' H ' ' A' ' 57' ' ' ALA . 78.5 t -89.27 -51.96 11.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.506 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 4.9 t70 -71.94 38.62 0.07 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-O 122.108 0.956 . . . . 0.0 110.143 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.562 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -85.14 -5.35 59.34 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 113.937 -1.483 . . . . 0.0 112.53 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -90.43 -32.64 16.32 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 112.31 -2.223 . . . . 0.0 111.392 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.36 50.26 4.35 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-N 116.091 -0.504 . . . . 0.0 113.489 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -109.95 -21.46 12.32 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.675 0.274 . . . . 0.0 111.401 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.68 26.1 70.44 Favored Glycine 0 N--CA 1.465 0.632 0 CA-C-N 115.587 -0.733 . . . . 0.0 114.289 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.41 -179.32 6.98 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 123.423 0.689 . . . . 0.0 110.102 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.718 ' H ' ' HG1' ' A' ' 26' ' ' THR . 22.8 mm -141.86 89.26 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -176.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -60.15 162.66 5.6 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.745 0.418 . . . . 0.0 110.605 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.577 ' HA ' ' CE2' ' A' ' 68' ' ' PHE . 19.1 p90 -81.38 -37.82 0.92 Allowed Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 -177.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 14.8 Cg_exo -69.74 -18.07 37.29 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 121.853 1.702 . . . . 0.0 112.824 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -93.82 -26.25 17.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.854 ' O ' ' HG2' ' A' ' 71' ' ' MET . 3.2 p90 -84.36 -20.01 32.68 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -177.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.606 HD13 ' HB3' ' A' ' 8' ' ' GLN . 28.3 mt -77.85 -29.3 50.42 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 121.773 0.797 . . . . 0.0 109.043 175.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.519 ' O ' ' HD3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -53.38 -35.57 60.47 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 112.784 -2.007 . . . . 0.0 109.824 174.693 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.854 ' HG2' ' O ' ' A' ' 68' ' ' PHE . 22.7 ptt? -72.13 -26.22 62.03 Favored 'General case' 0 C--N 1.346 0.438 0 O-C-N 123.744 0.652 . . . . 0.0 110.031 176.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.641 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 58.9 mtt -88.34 -25.98 22.47 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.664 176.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.639 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -69.64 -35.85 75.59 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.607 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.72 ' NE ' ' HA ' ' A' ' 71' ' ' MET . 6.7 ptt180 -76.2 -21.83 56.0 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.925 178.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.641 ' HD3' ' HA ' ' A' ' 72' ' ' MET . 25.3 mtpt -68.72 -15.14 63.43 Favored 'General case' 0 C--N 1.346 0.423 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 175.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 11.9 ptt? -121.95 -29.45 4.27 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.184 0.516 . . . . 0.0 111.832 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.639 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 40.1 mmtt -86.77 -33.99 19.75 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.881 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 9.0 m-20 -104.45 -3.96 23.36 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 t -59.7 97.6 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 121.166 0.508 . . . . 0.0 111.878 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.422 ' OD1' ' HB3' ' A' ' 82' ' ' GLU . 2.2 t70 -67.2 144.18 56.12 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.216 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.2 p -82.94 -13.88 55.19 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.64 ' O ' HD12 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -84.78 -46.88 10.95 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.617 0.723 . . . . 0.0 109.916 -179.186 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.441 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 36.7 mt-10 -78.73 -18.27 54.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.069 -1.423 . . . . 0.0 112.201 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.589 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 3.4 mt-10 -68.45 -18.43 64.42 Favored 'General case' 0 C--N 1.345 0.392 0 C-N-CA 122.778 0.431 . . . . 0.0 111.954 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.64 HD12 ' O ' ' A' ' 82' ' ' GLU . 1.9 mt -85.18 -57.05 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.434 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -63.67 -21.76 66.55 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.021 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.589 ' OE1' ' HA ' ' A' ' 84' ' ' GLU . 1.8 pt-20 -86.15 -20.79 28.11 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.485 ' HB1' ' CE1' ' A' ' 141' ' ' PHE . . . -68.97 -22.99 64.07 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.098 178.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -81.66 -21.49 38.12 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 174.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.524 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 27.8 mmt180 -80.11 -22.64 41.93 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.2 175.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.723 HG12 ' HD1' ' A' ' 92' ' ' PHE . 94.0 t -88.13 -56.29 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-N 114.559 -1.201 . . . . 0.0 112.002 178.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.826 ' HB3' HG21 ' A' ' 100' ' ' ILE . 2.8 m-85 -100.98 -47.1 4.88 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -176.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.7 ' CA ' HG12 ' A' ' 100' ' ' ILE . 5.2 t70 -59.64 95.17 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.714 0.769 . . . . 0.0 112.323 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.404 ' HB2' ' OE2' ' A' ' 104' ' ' GLU . 71.3 mmtt -87.28 -52.22 5.52 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.781 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.464 ' HB2' ' OE2' ' A' ' 104' ' ' GLU . 5.0 t70 -72.13 0.44 9.63 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -175.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.437 ' HA2' ' OD2' ' A' ' 93' ' ' ASP . . . 49.89 31.68 17.51 Favored Glycine 0 N--CA 1.472 1.069 0 CA-C-N 114.408 -1.269 . . . . 0.0 114.656 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -97.0 -8.31 30.8 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 105.09 -19.16 41.23 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 116.252 -0.431 . . . . 0.0 112.905 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -122.63 118.2 27.61 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.65 -0.775 . . . . 0.0 110.596 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.826 HG21 ' HB3' ' A' ' 92' ' ' PHE . 14.9 mt -77.7 104.77 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.4 p -80.74 164.25 22.92 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -178.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -58.62 -14.39 8.17 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -178.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.32 -30.0 19.91 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-O 122.004 0.907 . . . . 0.0 109.535 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.985 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.8 mm-40 -81.73 -38.33 25.91 Favored 'General case' 0 CA--C 1.481 -1.698 0 CA-C-N 112.476 -2.147 . . . . 0.0 110.572 -178.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.65 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 8.5 tt -67.6 -32.75 73.7 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 176.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.648 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -70.6 -44.72 66.71 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.443 175.774 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.481 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 9.2 t-80 -68.11 -21.92 64.92 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.548 177.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.985 HG23 ' O ' ' A' ' 104' ' ' GLU . 3.2 t -70.98 -52.89 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.221 0 CA-C-N 113.996 -1.456 . . . . 0.0 107.184 176.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.601 ' O ' ' N ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -59.81 -37.6 79.6 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 111.502 -2.59 . . . . 0.0 112.03 177.426 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.6 m -71.85 -19.03 62.02 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 119.781 -0.767 . . . . 0.0 109.604 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.24 -45.26 18.27 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.47 176.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.517 HD23 ' O ' ' B' ' 169' ' ' GLY . 4.0 mt -80.18 -28.29 38.75 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.462 -178.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 142.29 -10.41 2.48 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 117.726 -1.597 . . . . 0.0 116.952 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 109' ' ' MET . 4.7 mt-10 -100.75 151.7 21.36 Favored 'General case' 0 C--N 1.357 0.921 0 CA-C-N 120.92 2.36 . . . . 0.0 114.276 -178.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -108.99 127.51 54.14 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 113.682 -1.599 . . . . 0.0 106.886 175.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.648 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 1.1 tp -134.57 115.46 13.9 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.49 -175.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.848 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -76.95 -175.81 3.68 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.717 179.502 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.521 ' N ' HG23 ' A' ' 117' ' ' THR . 16.5 t70 -71.27 -37.6 71.88 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.48 -1.236 . . . . 0.0 114.264 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.666 ' H ' HG23 ' A' ' 117' ' ' THR . 8.7 pt-20 -88.78 -16.21 32.69 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.736 ' HG2' HG22 ' A' ' 117' ' ' THR . 14.8 pt-20 -87.77 -16.09 35.13 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 123.087 0.242 . . . . 0.0 110.897 178.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.848 HG22 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -83.61 -28.82 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.472 177.713 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -68.54 30.02 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.46 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.543 ' H ' ' C ' ' A' ' 121' ' ' VAL . 10.5 pt-20 -144.87 -18.86 0.51 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.65 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.754 ' HA ' ' OG1' ' B' ' 153' ' ' THR . 13.4 ttm -87.79 -21.85 24.86 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 176.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.688 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 1.8 mp -88.29 -45.33 15.81 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.557 0 CA-C-N 114.695 -1.139 . . . . 0.0 112.901 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -60.29 -33.38 72.26 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.564 ' HG3' ' OG1' ' B' ' 153' ' ' THR . 5.0 mm-40 -65.71 -36.19 82.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.938 177.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.584 ' C ' ' HB3' ' A' ' 140' ' ' GLU . . . -91.46 -42.09 10.48 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.494 -179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.688 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -60.99 122.27 14.52 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 113.784 -1.553 . . . . 0.0 114.083 -178.011 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.0 mt -90.9 -44.0 14.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 113.106 -1.861 . . . . 0.0 110.393 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -93.61 -25.31 17.57 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.09 49.87 5.11 Favored Glycine 0 CA--C 1.526 0.77 0 O-C-N 123.459 0.474 . . . . 0.0 113.961 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -88.9 -19.79 25.39 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.95 12.72 56.24 Favored Glycine 0 CA--C 1.503 -0.702 0 CA-C-N 116.106 -0.497 . . . . 0.0 113.645 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -139.35 120.35 14.55 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.968 -1.116 . . . . 0.0 108.473 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.597 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 3.6 t -78.99 114.14 19.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.682 0.753 . . . . 0.0 112.1 -178.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -85.25 -163.19 0.8 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 113.735 -1.575 . . . . 0.0 110.838 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -69.74 -58.06 4.37 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.99 178.679 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 143' ' ' GLN . 10.6 pt-20 -60.79 -20.54 61.71 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.597 ' OE1' ' HA ' ' A' ' 136' ' ' VAL . 8.0 mt-10 -88.99 -37.2 15.37 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.183 0.516 . . . . 0.0 110.35 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.485 ' CE1' ' HB1' ' A' ' 88' ' ' ALA . 62.4 t80 -77.41 -23.32 50.65 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.649 -1.16 . . . . 0.0 109.058 175.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 138' ' ' TYR . 24.0 t -85.93 -40.34 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 114.898 -1.047 . . . . 0.0 112.748 -177.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' A' ' 139' ' ' GLU . 9.7 mt-30 -49.91 -33.18 16.59 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.662 ' SD ' ' HB2' ' B' ' 158' ' ' ALA . 16.0 ptt? -62.64 -29.38 70.58 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 118.355 0.525 . . . . 0.0 111.08 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 50.4 mtt -81.81 -4.06 55.48 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.733 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.463 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 27.2 p -121.41 -45.73 2.31 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.684 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -55.01 -39.55 69.21 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 N--CA 1.485 1.311 0 C-N-CA 124.004 0.922 . . . . 0.0 112.416 -179.873 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 20.0 p . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.381 0.134 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -98.72 153.63 18.58 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.068 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 63.22 120.73 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.986 0.915 . . . . 0.0 111.951 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 60.8 117.01 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.994 0.918 . . . . 0.0 112.158 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.754 ' OG1' ' HA ' ' A' ' 124' ' ' MET . 76.6 p -132.72 -58.08 0.92 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.604 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 154' ' ' PHE . . . . . 0.724 ' CE1' ' HD2' ' B' ' 155' ' ' LYS . 0.1 OUTLIER -67.67 -28.24 67.52 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.231 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.724 ' HD2' ' CE1' ' B' ' 154' ' ' PHE . 7.8 mptt -59.32 -33.85 71.62 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.468 177.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -77.07 -39.23 50.57 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.845 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 157' ' ' VAL . . . . . 0.601 HG22 ' HA ' ' B' ' 154' ' ' PHE . 10.4 m -71.95 -29.41 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 122.754 0.422 . . . . 0.0 111.052 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 158' ' ' ALA . . . . . 0.662 ' HB2' ' SD ' ' A' ' 144' ' ' MET . . . -60.42 -53.28 59.47 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.624 0.77 . . . . 0.0 112.755 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -65.18 -20.1 66.29 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.606 0.362 . . . . 0.0 111.633 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.14 -34.42 56.56 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.522 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 5.2 p -129.1 26.68 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 162' ' ' LYS . . . . . 0.607 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 22.1 ttpt -88.46 35.1 0.76 Allowed 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 121.198 0.523 . . . . 0.0 110.784 178.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.23 167.97 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.456 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 4.9 t -78.62 -177.07 5.17 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.25 16.62 2.91 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 166' ' ' SER . . . . . 0.49 ' O ' ' HE3' ' A' ' 51' ' ' MET . 0.3 OUTLIER -88.94 -58.75 2.43 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.406 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.631 ' HB2' ' NZ ' ' A' ' 75' ' ' LYS . 3.3 mp -137.55 106.92 6.09 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-O 121.141 0.496 . . . . 0.0 111.102 176.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -127.91 152.18 48.17 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.079 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 169' ' ' GLY . . . . . 0.517 ' O ' HD23 ' A' ' 112' ' ' LEU . . . 165.43 -57.94 0.25 Allowed Glycine 0 C--N 1.337 0.608 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.566 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 170' ' ' THR . . . . . 0.448 HG21 ' O ' ' A' ' 39' ' ' LEU . 5.1 t . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.138 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 111.362 0.134 . . . . 0.0 111.362 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -109.07 118.93 38.07 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 123.416 0.447 . . . . 0.0 110.859 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.828 ' HA ' ' NE2' ' A' ' 8' ' ' GLN . 0.4 OUTLIER -128.65 153.54 47.19 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.028 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.441 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -105.4 -108.3 0.29 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.506 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.595 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 16.5 p -101.06 -173.79 2.46 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 123.678 0.791 . . . . 0.0 110.002 178.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.415 ' HA ' HD12 ' A' ' 9' ' ' ILE . 46.1 mt-10 -60.78 -24.38 65.73 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.595 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 12.8 pt-20 -57.07 -29.28 63.32 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.374 0.607 . . . . 0.0 111.459 178.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.828 ' NE2' ' HA ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -78.13 -46.09 21.58 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 114.141 -1.391 . . . . 0.0 109.914 178.133 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.547 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . 3.9 mt -63.7 -32.33 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.569 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.94 -34.38 64.28 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -113.66 -17.98 12.0 Favored 'General case' 0 C--N 1.346 0.422 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.547 ' CE1' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -73.55 -16.16 61.27 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.754 0.707 . . . . 0.0 110.679 179.407 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.678 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 1.0 OUTLIER -83.11 -40.72 19.44 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.468 179.17 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.678 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 1.4 mt-10 -82.56 -38.48 23.63 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 114.082 -1.417 . . . . 0.0 112.604 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.65 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -66.06 -22.48 66.43 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.289 0.566 . . . . 0.0 109.522 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.655 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 26.9 t80 -87.07 -46.03 10.17 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.01 176.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.4 m -87.09 -13.5 44.07 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 -176.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -69.32 -30.37 68.42 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.39 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.593 ' CD1' HG22 ' A' ' 35' ' ' VAL . 7.1 m-85 -129.01 -13.71 4.52 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.655 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -103.09 83.94 2.28 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 118.496 0.589 . . . . 0.0 110.059 178.615 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.444 ' HE2' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -86.11 -21.7 27.49 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -178.76 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.46 -21.88 44.86 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.38 177.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.44 51.85 4.74 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.802 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.15 21.98 7.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 113.848 -1.176 . . . . 0.0 113.819 -175.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.11 -64.88 0.21 Allowed Glycine 0 CA--C 1.528 0.845 0 CA-C-N 115.152 -0.931 . . . . 0.0 114.471 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.699 HG22 ' N ' ' A' ' 64' ' ' ASP . 11.0 p -97.99 155.8 16.93 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 123.559 0.744 . . . . 0.0 112.104 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.609 HG13 ' O ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -117.4 148.47 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.583 -179.581 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.37 148.4 15.11 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -74.19 -55.71 5.75 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-N 115.328 -0.851 . . . . 0.0 113.287 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -53.72 -13.89 0.79 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.469 177.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.514 ' O ' HG23 ' A' ' 35' ' ' VAL . 23.0 mt-10 -113.46 -16.76 12.37 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.744 -178.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.492 HD21 ' CZ ' ' A' ' 68' ' ' PHE . 5.2 tp -55.11 -40.59 70.65 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.222 0.609 . . . . 0.0 111.951 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.774 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -55.31 -39.81 73.66 Favored Glycine 0 C--N 1.34 0.801 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 177.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.9 m -75.22 -28.77 60.06 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 114.611 -0.794 . . . . 0.0 112.365 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.65 HG12 ' HA ' ' A' ' 15' ' ' ALA . 1.5 t -75.46 -26.84 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 177.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.629 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 82.5 mtp -75.63 -41.95 52.88 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 112.8 -2.0 . . . . 0.0 111.273 176.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.774 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 10.5 mtt180 -80.82 -29.2 35.99 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.2 m -66.48 -8.47 26.52 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 122.009 0.909 . . . . 0.0 112.134 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.524 HD21 ' HB2' ' A' ' 14' ' ' GLU . 78.5 mt -92.81 -7.21 47.05 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 113.24 -1.8 . . . . 0.0 109.706 177.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.42 0.88 50.35 Favored Glycine 0 CA--C 1.492 -1.388 0 CA-C-O 122.351 0.973 . . . . 0.0 114.68 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.629 ' HB2' ' O ' ' A' ' 36' ' ' MET . 46.2 mt-30 -83.24 138.02 33.77 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 112.058 -2.071 . . . . 0.0 111.791 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -117.74 75.85 10.23 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.796 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.98 -177.8 3.24 Favored 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 123.137 2.558 . . . . 0.0 111.984 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.435 ' HB ' ' H ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -100.65 157.44 16.68 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.712 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.528 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 29.5 mt-10 -80.94 -27.71 36.01 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.697 0.761 . . . . 0.0 109.369 177.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.41 -35.07 61.08 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 113.432 -1.713 . . . . 0.0 109.667 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.549 ' HG2' ' SD ' ' A' ' 51' ' ' MET . 14.9 tt0 -78.04 -29.87 49.55 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 113.923 -1.49 . . . . 0.0 108.127 176.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.582 ' O ' HD13 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -65.17 -20.32 66.39 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.175 174.502 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.846 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 56.2 mt-30 -97.61 -15.5 20.43 Favored 'General case' 0 CA--C 1.481 -1.69 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.107 178.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -84.77 -35.85 22.13 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 111.971 -2.377 . . . . 0.0 109.936 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.549 ' SD ' ' HG2' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -86.68 -27.01 24.01 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.486 177.718 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.582 HD13 ' O ' ' A' ' 48' ' ' LEU . 1.5 mp -78.47 -25.92 13.83 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 175.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.846 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 2.9 t30 -78.24 -34.4 49.18 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.021 175.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.01 -46.76 8.61 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.554 ' C ' ' H ' ' A' ' 57' ' ' ALA . 75.5 t -83.03 -51.07 14.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.515 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 5.2 t70 -72.26 39.84 0.08 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 122.042 0.925 . . . . 0.0 110.0 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.554 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -82.46 -5.35 58.64 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 114.005 -1.452 . . . . 0.0 112.772 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -85.94 -35.31 20.55 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 112.36 -2.2 . . . . 0.0 111.229 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.14 41.78 7.87 Favored Glycine 0 C--N 1.342 0.894 0 O-C-N 123.537 0.523 . . . . 0.0 113.477 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -109.99 -21.46 12.31 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.561 0.219 . . . . 0.0 111.204 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.67 26.82 73.43 Favored Glycine 0 N--CA 1.466 0.64 0 CA-C-N 115.764 -0.653 . . . . 0.0 114.066 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.499 ' O ' HD13 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -144.11 155.48 43.96 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.307 0.643 . . . . 0.0 110.576 -179.367 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.609 ' O ' HG13 ' A' ' 27' ' ' ILE . 21.0 mm -133.47 126.85 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.699 ' N ' HG22 ' A' ' 26' ' ' THR . 0.3 OUTLIER -73.15 157.17 37.74 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.612 176.598 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.577 ' CG ' ' HD3' ' A' ' 66' ' ' PRO . 7.3 p90 -91.43 -39.99 0.38 Allowed Pre-proline 0 CA--C 1.546 0.823 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -178.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.577 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 14.2 Cg_exo -70.5 -18.67 33.39 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 121.903 1.736 . . . . 0.0 113.109 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -96.42 -13.79 22.9 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.492 ' CZ ' HD21 ' A' ' 32' ' ' LEU . 6.5 t80 -84.38 -36.04 22.73 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -178.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.624 HD13 ' HA ' ' A' ' 8' ' ' GLN . 1.3 mt -66.44 -32.6 74.08 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 121.688 0.756 . . . . 0.0 109.983 177.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.456 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -56.04 -33.41 64.94 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 113.195 -1.82 . . . . 0.0 108.966 174.234 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.566 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 24.2 mmt -72.59 -29.91 63.92 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.659 175.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.73 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 67.8 mtt -86.17 -19.63 29.79 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.213 0.945 . . . . 0.0 110.246 177.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . -75.2 -37.94 60.96 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.497 ' CD ' ' HA ' ' A' ' 71' ' ' MET . 3.4 ptm180 -76.19 -17.84 59.35 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 120.468 -0.493 . . . . 0.0 112.138 178.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.73 ' HD2' ' HA ' ' A' ' 72' ' ' MET . 31.8 mttt -77.89 -14.23 59.62 Favored 'General case' 0 C--N 1.348 0.506 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 176.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.537 ' HA ' HG22 ' A' ' 79' ' ' THR . 18.4 ptt? -124.44 -19.58 5.41 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -177.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 73' ' ' ALA . 59.5 mttt -60.71 -13.8 17.09 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -103.02 -29.55 11.32 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.75 HG21 ' HB3' ' B' ' 165' ' ' ALA . 8.6 t -73.57 103.95 4.36 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.062 0.458 . . . . 0.0 111.357 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.602 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 8.6 m-20 -45.24 151.68 0.33 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.925 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.552 ' HA ' ' OE1' ' A' ' 84' ' ' GLU . 12.7 t -69.79 -13.81 62.46 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.825 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -82.53 -44.64 15.66 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.686 0.755 . . . . 0.0 109.593 -179.641 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.418 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 40.5 mt-10 -73.87 -18.21 60.95 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 113.753 -1.567 . . . . 0.0 112.469 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.602 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 43.1 mt-10 -65.52 -20.0 66.16 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.7 mp -87.88 -51.23 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.656 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.612 ' O ' ' HD1' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -58.78 -17.01 19.6 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -179.585 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.505 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 3.1 pt-20 -74.53 -19.59 60.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 120.872 0.368 . . . . 0.0 110.041 177.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.94 -20.06 65.83 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.647 178.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.612 ' HD1' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -84.33 -21.18 31.05 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 174.856 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 9.1 mtm180 -81.16 -23.02 38.53 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.235 -1.348 . . . . 0.0 108.498 175.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.494 HG12 ' CD1' ' A' ' 92' ' ' PHE . 47.0 t -88.64 -55.99 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.039 178.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.809 ' HB3' HG21 ' A' ' 100' ' ' ILE . 8.8 m-85 -100.71 -45.11 5.59 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 -176.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.723 ' CA ' HG12 ' A' ' 100' ' ' ILE . 15.5 t70 -61.93 94.69 0.05 Allowed 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.75 0.786 . . . . 0.0 111.145 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.1 mmpt? -87.25 -49.75 7.06 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 114.286 -1.325 . . . . 0.0 113.146 -178.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -72.11 0.8 8.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -175.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.422 ' HA2' ' OD2' ' A' ' 93' ' ' ASP . . . 50.29 31.73 20.6 Favored Glycine 0 N--CA 1.472 1.098 0 CA-C-N 114.396 -1.275 . . . . 0.0 114.717 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -98.83 -5.73 30.52 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.669 0.235 . . . . 0.0 111.574 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.28 -19.27 51.95 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 121.439 -0.41 . . . . 0.0 112.847 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -119.43 118.44 31.12 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.481 -0.859 . . . . 0.0 110.338 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.809 HG21 ' HB3' ' A' ' 92' ' ' PHE . 43.3 mt -77.15 94.79 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.524 ' OG ' ' HG3' ' A' ' 104' ' ' GLU . 79.9 p -71.65 170.18 14.01 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.509 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.665 ' HA ' HD12 ' A' ' 105' ' ' LEU . . . -62.75 -14.04 39.93 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 114.821 -1.081 . . . . 0.0 113.513 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.57 -28.0 21.01 Favored 'General case' 0 CA--C 1.49 -1.335 0 CA-C-O 121.717 0.77 . . . . 0.0 109.489 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 1.051 ' O ' HG23 ' A' ' 108' ' ' VAL . 20.0 mt-10 -80.7 -43.12 20.83 Favored 'General case' 0 CA--C 1.484 -1.568 0 CA-C-N 112.894 -1.957 . . . . 0.0 111.584 -178.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.665 HD12 ' HA ' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -67.72 -27.75 67.07 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 177.827 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.639 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -74.73 -45.52 43.56 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.749 -1.569 . . . . 0.0 108.878 176.044 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.491 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 12.7 t-80 -67.18 -21.71 65.77 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.667 -1.152 . . . . 0.0 107.975 177.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.051 HG23 ' O ' ' A' ' 104' ' ' GLU . 29.2 t -72.46 -51.15 30.42 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.829 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 176.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.753 ' SD ' HD22 ' A' ' 116' ' ' LEU . 19.9 mtt -56.24 -40.9 74.87 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 112.579 -2.1 . . . . 0.0 112.039 175.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.19 -19.09 63.98 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.358 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.48 -45.02 20.15 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.567 176.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 mt -80.05 -28.13 39.28 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.793 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 138.86 -7.39 3.26 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-O 117.821 -1.544 . . . . 0.0 116.841 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 109' ' ' MET . 4.9 mt-10 -101.1 152.99 19.95 Favored 'General case' 0 C--N 1.357 0.892 0 CA-C-N 120.763 2.281 . . . . 0.0 114.436 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.34 128.66 56.35 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 113.642 -1.617 . . . . 0.0 107.59 175.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.753 HD22 ' SD ' ' A' ' 109' ' ' MET . 1.4 tp -134.95 115.94 14.14 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.114 -176.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.687 HG22 ' HG2' ' A' ' 120' ' ' GLU . 0.6 OUTLIER -76.74 -175.84 3.59 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.509 -179.828 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.522 ' N ' HG23 ' A' ' 117' ' ' THR . 16.0 t70 -72.94 -37.26 67.22 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.257 -1.338 . . . . 0.0 114.382 -177.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.651 ' H ' HG23 ' A' ' 117' ' ' THR . 9.4 pt-20 -89.36 -16.12 31.77 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.687 ' HG2' HG22 ' A' ' 117' ' ' THR . 14.6 pt-20 -87.36 -16.24 35.56 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 123.167 0.292 . . . . 0.0 110.65 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.679 HG22 ' O ' ' A' ' 117' ' ' THR . 0.1 OUTLIER -84.13 -31.81 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 178.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.18 27.5 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.964 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.674 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 10.3 pt-20 -141.64 -18.29 0.77 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.064 -1.426 . . . . 0.0 110.991 177.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.408 ' O ' ' HD2' ' B' ' 154' ' ' PHE . 5.0 mmt -88.16 -26.76 22.26 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.587 1.155 . . . . 0.0 108.746 176.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.761 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 1.2 mp -86.8 -37.44 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 114.173 -1.376 . . . . 0.0 113.228 -178.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -65.07 -27.86 69.07 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.585 0.707 . . . . 0.0 111.309 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.674 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 22.3 mm-40 -63.27 -36.94 85.35 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.075 178.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.731 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -99.84 -36.52 9.4 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.052 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.761 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -61.05 125.87 25.29 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.274 -1.33 . . . . 0.0 113.685 -178.038 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.2 mt -90.22 -48.97 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 113.779 -1.555 . . . . 0.0 110.341 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -89.9 -25.27 21.05 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 81.27 49.72 5.41 Favored Glycine 0 CA--C 1.525 0.674 0 O-C-N 123.534 0.521 . . . . 0.0 113.692 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -87.15 -19.6 28.23 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 97.38 12.04 49.69 Favored Glycine 0 CA--C 1.5 -0.846 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.402 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -139.34 128.99 24.55 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.958 -1.121 . . . . 0.0 108.677 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.556 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 2.3 t -92.27 124.38 44.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.392 0.615 . . . . 0.0 112.181 -178.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -89.88 -169.5 2.47 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.219 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.431 ' O ' HG23 ' A' ' 142' ' ' VAL . 37.3 m-85 -68.91 -52.06 33.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.511 177.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -65.41 -22.03 66.73 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.731 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 11.4 mt-10 -87.19 -39.93 15.04 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.779 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -70.93 -24.29 62.42 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.467 176.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.453 ' O ' ' HG3' ' A' ' 145' ' ' MET . 20.0 t -85.84 -48.07 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.498 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.432 ' HA ' ' OG1' ' A' ' 146' ' ' THR . 26.2 mt-30 -60.25 -19.31 54.09 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 123.558 0.537 . . . . 0.0 111.505 178.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.688 ' HG2' ' O ' ' A' ' 140' ' ' GLU . 7.3 mmt -71.46 -21.91 61.89 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 123.227 0.33 . . . . 0.0 110.324 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.453 ' HG3' ' O ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -88.68 -5.29 58.22 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.454 177.231 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.432 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 34.2 p -116.71 -43.31 2.91 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.771 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -42.3 -34.7 0.83 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 77.1 mttt . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.093 -0.956 . . . . 0.0 111.305 179.565 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 18.4 p . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.496 0.189 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -100.2 137.76 38.2 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.817 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -129.48 152.08 49.41 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.038 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp 61.31 113.57 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.97 0.908 . . . . 0.0 112.056 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.564 ' O ' HG13 ' B' ' 157' ' ' VAL . 64.5 p -138.51 174.76 10.2 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.183 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 154' ' ' PHE . . . . . 0.61 ' HA ' HG22 ' B' ' 157' ' ' VAL . 0.2 OUTLIER -67.81 -27.19 66.52 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 117.678 0.217 . . . . 0.0 111.121 179.193 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.489 ' NZ ' ' HB3' ' A' ' 127' ' ' GLU . 4.7 mptt -61.67 -42.29 98.72 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.884 0.474 . . . . 0.0 111.336 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -76.39 -35.04 58.84 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 157' ' ' VAL . . . . . 0.61 HG22 ' HA ' ' B' ' 154' ' ' PHE . 11.6 m -70.09 -37.36 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 122.55 0.34 . . . . 0.0 111.109 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 158' ' ' ALA . . . . . 0.575 ' O ' ' HB2' ' B' ' 162' ' ' LYS . . . -73.77 -39.85 63.87 Favored 'General case' 0 C--N 1.345 0.413 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.636 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -64.12 -23.58 67.38 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.522 0.514 . . . . 0.0 111.64 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.66 -37.54 56.08 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.259 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 9.6 p -107.48 19.11 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.29 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 162' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 35.0 tttp -91.27 104.67 17.18 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.185 0.517 . . . . 0.0 111.097 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 163' ' ' ILE . . . . . 0.421 ' H ' ' H ' ' B' ' 164' ' ' SER . 5.5 tp -152.55 -20.55 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.145 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 164' ' ' SER . . . . . 0.421 ' H ' ' H ' ' B' ' 163' ' ' ILE . 48.7 m 53.75 95.26 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.647 1.179 . . . . 0.0 113.354 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 165' ' ' ALA . . . . . 0.75 ' HB3' HG21 ' A' ' 79' ' ' THR . . . 35.3 73.3 0.09 Allowed 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.837 1.255 . . . . 0.0 113.647 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 166' ' ' SER . . . . . 0.444 ' O ' ' HD3' ' A' ' 75' ' ' LYS . 47.3 m -132.35 -46.03 0.91 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.384 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 7.3 tp -144.1 70.25 1.29 Allowed 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.246 0.546 . . . . 0.0 110.0 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 64.8 mtt -130.12 131.39 45.67 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.883 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -130.83 99.18 0.42 Allowed Glycine 0 C--N 1.337 0.585 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.462 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 19.8 p . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.06 -179.981 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.55 0.215 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -112.98 -41.89 3.66 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.179 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -135.42 149.37 49.6 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.377 0.423 . . . . 0.0 110.906 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.495 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -122.86 -123.43 0.27 Allowed 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.725 ' O ' ' HG2' ' A' ' 8' ' ' GLN . 20.2 p -101.67 170.93 7.86 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 124.052 0.941 . . . . 0.0 109.892 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -46.07 -22.03 0.19 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.431 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 12.3 pt-20 -48.31 -32.24 7.12 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 123.802 0.689 . . . . 0.0 110.761 176.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.725 ' HG2' ' O ' ' A' ' 5' ' ' THR . 1.4 pt20 -65.55 -56.02 14.56 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.689 177.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.447 HG13 HE21 ' A' ' 8' ' ' GLN . 3.6 mt -58.99 -31.64 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.73 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.04 -36.36 77.63 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -126.5 -18.01 4.95 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -177.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.584 ' HB3' HD11 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -69.86 -15.6 63.12 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.037 0.835 . . . . 0.0 110.75 179.361 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.7 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 1.0 OUTLIER -80.93 -41.21 23.31 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.018 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.7 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 2.2 mt-10 -82.53 -41.35 19.78 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 114.13 -1.395 . . . . 0.0 112.353 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.592 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -64.23 -19.06 65.11 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.458 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 58.5 t80 -86.54 -49.71 7.37 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.56 177.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.462 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 51.7 m -87.45 -12.77 45.1 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -177.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -69.37 -28.48 66.24 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 118.499 0.591 . . . . 0.0 112.172 -179.428 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.573 ' CD1' HG22 ' A' ' 35' ' ' VAL . 4.8 m-85 -134.5 -2.93 2.69 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 24.8 t70 -83.48 55.5 3.22 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 119.244 0.929 . . . . 0.0 112.491 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -86.8 -20.79 27.06 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 178.692 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.82 -22.39 61.56 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.322 0.582 . . . . 0.0 110.558 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.9 40.79 29.73 Favored Glycine 0 N--CA 1.471 1.032 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.47 23.4 9.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 112.971 -1.614 . . . . 0.0 112.835 -176.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.51 -80.64 1.79 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.905 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.403 HG21 ' N ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -113.79 178.32 4.32 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 177.789 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -75.32 148.78 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -177.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.415 ' OG1' ' HB2' ' A' ' 31' ' ' GLU . 0.6 OUTLIER -64.11 163.67 12.09 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.399 1.079 . . . . 0.0 113.761 -179.635 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.599 HG22 HD11 ' A' ' 63' ' ' ILE . 1.3 p -80.25 -56.27 4.33 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.155 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -57.57 -13.63 4.08 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.233 177.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.49 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.4 mt-10 -111.44 -16.4 13.34 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.301 -177.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.515 HD13 HG21 ' A' ' 63' ' ' ILE . 9.2 tp -52.97 -41.33 64.46 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.247 0.619 . . . . 0.0 112.295 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.774 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -55.86 -39.16 76.88 Favored Glycine 0 C--N 1.34 0.801 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 177.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.0 m -75.47 -29.91 59.74 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 114.444 -0.878 . . . . 0.0 112.567 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.592 HG12 ' HA ' ' A' ' 15' ' ' ALA . 1.1 t -74.6 -27.28 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 176.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.619 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 47.1 mtt -73.72 -42.8 60.69 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 112.951 -1.932 . . . . 0.0 110.861 176.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.774 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 11.3 mtt180 -78.53 -29.76 46.67 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.6 m -67.7 -8.39 34.75 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.941 0.877 . . . . 0.0 111.997 178.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 35' ' ' VAL . 80.8 mt -94.82 -6.18 43.45 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.698 177.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.51 -0.85 46.13 Favored Glycine 0 CA--C 1.493 -1.34 0 CA-C-O 122.22 0.9 . . . . 0.0 115.236 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.619 ' HB2' ' O ' ' A' ' 36' ' ' MET . 57.4 mt-30 -82.32 140.55 33.49 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-N 112.343 -1.928 . . . . 0.0 111.752 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -120.01 73.7 19.34 Favored Pre-proline 0 CA--C 1.551 0.996 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.159 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -83.64 -179.56 4.26 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 123.216 2.611 . . . . 0.0 112.096 178.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 m -102.33 160.05 14.87 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.54 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 28.7 mt-10 -80.75 -28.29 36.52 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-O 121.584 0.707 . . . . 0.0 109.909 178.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.61 -36.79 65.53 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 113.611 -1.631 . . . . 0.0 110.043 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -77.54 -30.38 52.73 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 114.183 -1.371 . . . . 0.0 108.521 176.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.834 ' O ' HG12 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -62.73 -24.98 67.96 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.283 174.77 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 56.9 mt-30 -91.67 -19.45 22.65 Favored 'General case' 0 CA--C 1.478 -1.793 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.043 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -76.86 -29.08 55.68 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-N 112.031 -2.349 . . . . 0.0 107.959 176.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.2 mtt -87.09 -30.45 21.12 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.245 177.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.834 HG12 ' O ' ' A' ' 48' ' ' LEU . 37.3 mm -73.78 -28.08 23.82 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 175.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 5.7 m-80 -78.91 -37.88 38.83 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.246 -1.343 . . . . 0.0 112.023 176.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -87.59 -49.42 7.18 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.554 ' C ' ' H ' ' A' ' 57' ' ' ALA . 59.8 t -85.45 -51.12 13.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.538 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 5.9 t70 -72.48 39.26 0.08 Allowed 'General case' 0 C--O 1.239 0.516 0 CA-C-O 122.061 0.934 . . . . 0.0 110.07 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.554 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -83.28 -5.3 59.09 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 114.003 -1.453 . . . . 0.0 112.703 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -87.35 -39.56 15.22 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 112.35 -2.205 . . . . 0.0 111.182 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.09 51.11 4.08 Favored Glycine 0 C--N 1.343 0.937 0 O-C-N 123.544 0.528 . . . . 0.0 113.362 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -109.87 -21.38 12.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.663 0.268 . . . . 0.0 111.178 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.07 26.55 59.85 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.933 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.74 175.49 11.93 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.279 0.631 . . . . 0.0 110.565 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.599 HD11 HG22 ' A' ' 29' ' ' THR . 33.7 mm -130.8 94.72 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -50.92 153.65 1.73 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.274 0.63 . . . . 0.0 110.818 177.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.676 ' HA ' ' CE2' ' A' ' 68' ' ' PHE . 37.4 p90 -78.09 -39.56 1.8 Allowed Pre-proline 0 N--CA 1.477 0.917 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -177.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.513 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 17.0 Cg_exo -67.99 -18.03 46.24 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 121.818 1.679 . . . . 0.0 113.094 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -94.66 -25.54 16.71 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.676 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 1.9 p90 -84.56 -20.01 32.2 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -177.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.607 HD13 ' HB3' ' A' ' 8' ' ' GLN . 14.0 mt -77.36 -34.18 55.16 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.75 0.786 . . . . 0.0 109.457 176.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.51 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 0.6 OUTLIER -54.61 -35.16 63.11 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 113.049 -1.887 . . . . 0.0 110.002 174.895 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.834 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 11.2 ptm -76.66 -25.48 53.77 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 123.695 0.622 . . . . 0.0 109.491 176.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 68.8 mtt -87.8 -18.58 29.02 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 124.09 0.869 . . . . 0.0 110.46 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . -76.7 -35.14 58.05 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.51 ' HD2' ' O ' ' A' ' 70' ' ' THR . 2.8 ptm180 -80.11 -19.0 48.39 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 178.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.834 ' HG2' ' O ' ' A' ' 71' ' ' MET . 69.2 mmtt -73.32 -14.39 61.29 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 176.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 27.1 ptm -120.34 -31.48 4.35 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -177.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 34.7 mmtt -76.8 -28.6 55.68 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -178.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -104.2 -10.74 17.69 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.4 t -72.85 -4.6 32.75 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.579 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 2.1 m-20 64.65 135.99 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.709 0.803 . . . . 0.0 111.826 -179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 52.5 m -83.06 -13.59 55.49 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.594 ' O ' HD12 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -78.99 -51.64 9.33 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.391 0.615 . . . . 0.0 110.642 -178.42 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.508 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 10.2 pt-20 -79.37 -17.91 53.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.667 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.6 ' HA ' ' OE2' ' A' ' 87' ' ' GLU . 8.4 tt0 -64.09 -18.46 64.42 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.152 0.581 . . . . 0.0 112.348 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.594 HD12 ' O ' ' A' ' 82' ' ' GLU . 2.3 mt -86.65 -54.6 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.829 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -58.01 -25.0 60.53 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.602 179.702 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.6 ' OE2' ' HA ' ' A' ' 84' ' ' GLU . 2.3 pt-20 -81.06 -20.61 41.25 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 123.684 0.615 . . . . 0.0 110.224 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.63 -20.99 61.9 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.465 177.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.448 ' HE2' ' O ' ' A' ' 98' ' ' GLY . 3.6 m-85 -81.15 -20.97 40.16 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 173.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.437 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 10.6 tpt180 -77.34 -20.54 54.72 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 174.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 65.1 t -88.04 -53.55 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 CA-C-N 114.248 -1.342 . . . . 0.0 112.033 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.835 ' HB3' HG21 ' A' ' 100' ' ' ILE . 35.2 m-85 -100.38 -45.89 5.43 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -176.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.723 ' CA ' HG12 ' A' ' 100' ' ' ILE . 2.4 t70 -64.02 93.2 0.08 Allowed 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.843 0.83 . . . . 0.0 111.557 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.506 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 31.8 mttm -87.93 -48.0 8.13 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 114.056 -1.429 . . . . 0.0 113.751 -179.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.42 ' HB2' ' OE2' ' A' ' 104' ' ' GLU . 5.2 t70 -71.82 1.29 7.21 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -175.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 48.74 29.27 7.76 Favored Glycine 0 N--CA 1.473 1.164 0 CA-C-N 114.289 -1.323 . . . . 0.0 114.883 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -99.67 -4.7 30.29 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.678 0.239 . . . . 0.0 111.401 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.448 ' O ' ' HE2' ' A' ' 89' ' ' PHE . . . 101.56 -18.79 52.64 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 121.287 -0.482 . . . . 0.0 112.726 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -116.03 118.37 32.71 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.458 -0.871 . . . . 0.0 110.707 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.835 HG21 ' HB3' ' A' ' 92' ' ' PHE . 31.5 mt -80.45 90.58 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.9 t -66.65 161.42 23.37 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.308 -0.86 . . . . 0.0 113.071 -177.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.764 ' HB1' HG21 ' A' ' 121' ' ' VAL . . . -58.2 -14.94 8.11 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -178.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.73 -29.36 19.89 Favored 'General case' 0 CA--C 1.489 -1.376 0 CA-C-O 121.994 0.902 . . . . 0.0 109.283 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.936 ' O ' HG23 ' A' ' 108' ' ' VAL . 3.4 mm-40 -79.46 -40.21 30.37 Favored 'General case' 0 CA--C 1.483 -1.627 0 CA-C-N 112.509 -2.132 . . . . 0.0 110.852 -178.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.594 HD12 ' CE2' ' B' ' 154' ' ' PHE . 5.2 tt -64.91 -34.92 79.55 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 176.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.525 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -69.21 -45.9 68.73 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.035 175.873 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.477 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 9.1 t-80 -69.05 -21.58 64.08 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.715 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.936 HG23 ' O ' ' A' ' 104' ' ' GLU . 3.1 t -72.07 -49.84 41.16 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.203 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.499 ' O ' ' N ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -62.94 -37.15 85.89 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 111.57 -2.559 . . . . 0.0 112.257 177.41 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -69.9 -19.05 63.43 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 119.499 -0.881 . . . . 0.0 109.277 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.67 -45.05 19.75 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.087 175.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mt -80.28 -28.39 38.34 Favored 'General case' 0 C--N 1.35 0.608 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.169 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 109' ' ' MET . . . 139.85 -11.14 3.13 Favored Glycine 0 CA--C 1.537 1.465 0 N-CA-C 117.126 1.61 . . . . 0.0 117.126 178.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.558 ' OE1' ' HG2' ' B' ' 152' ' ' LYS . 4.3 mt-10 -101.11 153.66 19.38 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-N 120.949 2.374 . . . . 0.0 114.316 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -109.01 125.92 52.57 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 113.769 -1.56 . . . . 0.0 106.996 174.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.525 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 1.2 tp -130.25 115.5 17.07 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.191 -1.368 . . . . 0.0 112.074 -175.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.871 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -77.15 -175.69 3.73 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.664 179.476 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.519 ' N ' HG23 ' A' ' 117' ' ' THR . 16.7 t70 -72.34 -38.23 68.65 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -178.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.646 ' H ' HG23 ' A' ' 117' ' ' THR . 9.2 pt-20 -89.1 -16.03 32.5 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.692 ' HG2' HG22 ' A' ' 117' ' ' THR . 14.4 pt-20 -85.63 -16.0 40.63 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 123.096 0.248 . . . . 0.0 110.816 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.871 HG22 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -82.57 -25.03 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 178.139 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -69.33 28.08 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.984 0.897 . . . . 0.0 113.126 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.543 ' H ' ' C ' ' A' ' 121' ' ' VAL . 11.7 pt-20 -137.94 -27.63 0.9 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.636 177.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.606 ' SD ' ' HA ' ' B' ' 153' ' ' THR . 1.3 mmt -81.25 -32.15 33.45 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 176.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.556 ' O ' ' HB3' ' A' ' 129' ' ' ASP . 2.6 mt -88.1 -44.38 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.303 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.525 ' HA ' ' CG ' ' A' ' 129' ' ' ASP . 63.1 mtt180 -59.31 -27.62 66.03 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 124.117 0.885 . . . . 0.0 111.732 -179.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.557 ' OE2' ' HD3' ' B' ' 155' ' ' LYS . 0.0 OUTLIER -63.43 -28.43 69.97 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.294 177.292 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.807 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -121.28 -16.41 7.92 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 123.36 0.413 . . . . 0.0 111.357 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.556 ' HB3' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -58.54 118.73 5.94 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 122.192 0.996 . . . . 0.0 112.792 -178.827 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 32.5 mm -90.91 -53.39 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 113.616 -1.629 . . . . 0.0 110.641 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -91.4 -25.3 19.43 Favored 'General case' 0 C--N 1.344 0.358 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.492 ' HA2' ' OD2' ' A' ' 129' ' ' ASP . . . 82.83 49.61 5.0 Favored Glycine 0 CA--C 1.523 0.558 0 O-C-N 123.476 0.485 . . . . 0.0 113.826 178.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -93.37 -19.47 21.29 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 100.69 16.32 26.77 Favored Glycine 0 CA--C 1.5 -0.892 0 CA-C-O 121.758 0.643 . . . . 0.0 112.549 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -138.02 176.57 8.58 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 113.315 -1.443 . . . . 0.0 108.144 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.643 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 2.3 t -140.65 130.52 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 121.303 0.573 . . . . 0.0 112.422 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -91.36 -168.45 2.05 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.032 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.494 ' O ' HG23 ' A' ' 142' ' ' VAL . 80.8 m-85 -66.79 -57.86 6.21 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.44 177.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -59.18 -20.84 57.33 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.807 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 4.5 mt-10 -87.08 -44.27 11.67 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.003 178.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -70.79 -22.87 62.32 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.094 176.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.499 ' O ' ' HG3' ' A' ' 145' ' ' MET . 37.6 t -84.26 -45.83 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.91 -178.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.562 ' O ' ' N ' ' A' ' 147' ' ' ALA . 43.6 mt-30 -61.73 -26.02 67.8 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.312 177.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 6.3 tmm? -64.58 -24.07 67.48 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 123.814 0.696 . . . . 0.0 110.807 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.499 ' HG3' ' O ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -84.49 -7.86 59.14 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 123.206 0.316 . . . . 0.0 110.225 178.352 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.0 t -122.4 -34.89 3.2 Favored 'General case' 0 C--N 1.349 0.554 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.875 178.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -35.14 -35.24 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 94.0 mttt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.097 -0.954 . . . . 0.0 111.675 179.954 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 19.5 p . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 120.371 0.129 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -98.02 -39.96 8.68 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.525 0.515 . . . . 0.0 111.346 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -115.2 128.27 56.06 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.387 0.429 . . . . 0.0 110.793 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 152' ' ' LYS . . . . . 0.558 ' HG2' ' OE1' ' A' ' 114' ' ' GLU . 11.7 mptt 60.87 115.81 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.907 0.883 . . . . 0.0 111.882 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.662 ' O ' HG22 ' B' ' 157' ' ' VAL . 10.9 t -175.11 172.2 2.85 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.355 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 154' ' ' PHE . . . . . 0.594 ' CE2' HD12 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -54.88 -27.81 45.58 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.278 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.557 ' HD3' ' OE2' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -72.06 -52.3 17.51 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.817 0.447 . . . . 0.0 111.102 178.61 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -77.27 -36.42 54.34 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 157' ' ' VAL . . . . . 0.662 HG22 ' O ' ' B' ' 153' ' ' THR . 20.5 m -71.89 -38.7 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 158' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' B' ' 162' ' ' LYS . . . -73.66 -33.16 64.35 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.834 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -58.95 -31.94 69.16 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.542 0.526 . . . . 0.0 111.341 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.08 -37.6 54.11 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.484 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 9.4 p -103.75 21.57 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.256 0 O-C-N 123.47 0.481 . . . . 0.0 111.575 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 162' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 5.9 ttmt -91.06 -16.22 28.24 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.256 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 3.6 tp -95.6 -8.83 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.237 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 21.7 t -88.66 84.81 6.72 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.452 0.644 . . . . 0.0 110.311 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 165' ' ' ALA . . . . . 0.401 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . . . -130.13 -40.65 1.3 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.263 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 23.7 t -112.9 -32.09 6.5 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.798 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 9.1 tp -90.91 31.07 1.11 Allowed 'General case' 0 CA--C 1.548 0.893 0 O-C-N 123.415 0.447 . . . . 0.0 110.83 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.24 137.57 33.96 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.531 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -100.58 -148.87 22.81 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.588 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 19.8 p . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.041 -179.964 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.376 0 N-CA-C 111.315 0.117 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -128.45 121.67 29.49 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 123.453 0.471 . . . . 0.0 110.724 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.558 ' HG3' ' O ' ' A' ' 66' ' ' PRO . 20.2 mm-40 -97.06 -57.73 2.2 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.668 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.507 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -118.07 -119.83 0.31 Allowed 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.768 179.569 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.552 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 15.7 p -102.21 -173.62 2.38 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 124.024 0.93 . . . . 0.0 112.6 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.486 ' HA ' HG12 ' A' ' 9' ' ' ILE . 46.6 mt-10 -60.56 -25.14 65.96 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.709 0.804 . . . . 0.0 112.997 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.552 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 11.3 pt-20 -53.55 -33.55 55.1 Favored 'General case' 0 N--CA 1.479 1.025 0 O-C-N 123.791 0.682 . . . . 0.0 111.585 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.564 ' HA ' HD13 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -75.86 -45.29 36.44 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.605 177.041 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.59 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . 33.5 mm -54.88 -38.15 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.643 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.63 -35.24 70.36 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -113.96 -17.96 11.86 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.59 ' CE1' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -71.82 -16.23 62.16 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.724 0.693 . . . . 0.0 110.548 179.318 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.689 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 1.0 OUTLIER -82.18 -41.83 19.84 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.576 179.269 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.689 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 1.4 mt-10 -81.75 -37.6 26.98 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 114.087 -1.415 . . . . 0.0 112.297 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.66 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -66.13 -22.24 66.37 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.27 0.557 . . . . 0.0 109.507 178.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.946 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 21.7 t80 -87.04 -45.24 10.92 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.038 176.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.3 m -86.35 -12.59 48.92 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -176.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -72.43 -29.8 64.04 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.559 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.581 ' CD1' HG22 ' A' ' 35' ' ' VAL . 8.3 m-85 -131.35 -7.06 3.77 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.946 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 1.2 m-20 -99.46 79.69 2.31 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.608 0.64 . . . . 0.0 110.028 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.77 -41.49 52.87 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.622 ' OD1' ' HB2' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -71.0 -21.96 62.22 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.248 177.305 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.05 51.57 5.31 Favored Glycine 0 N--CA 1.468 0.798 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.622 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -95.41 22.29 7.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.645 -1.278 . . . . 0.0 114.344 -175.286 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.25 -63.13 0.39 Allowed Glycine 0 CA--C 1.527 0.816 0 CA-C-N 115.405 -0.816 . . . . 0.0 114.472 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.7 HG22 ' N ' ' A' ' 64' ' ' ASP . 11.8 p -97.39 155.42 16.91 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 123.487 0.715 . . . . 0.0 112.252 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.769 HD13 HG21 ' A' ' 35' ' ' VAL . 0.7 OUTLIER -115.51 149.2 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.217 -179.604 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.29 151.45 12.76 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.14 -55.7 6.85 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -55.8 -13.41 1.74 Allowed 'General case' 0 N--CA 1.473 0.675 0 O-C-N 123.73 0.644 . . . . 0.0 111.319 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.428 ' O ' HG23 ' A' ' 35' ' ' VAL . 20.1 mt-10 -114.6 -16.53 11.84 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.222 -0.899 . . . . 0.0 113.049 -177.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.58 ' HA ' HG23 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -56.95 -38.02 72.36 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.638 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.73 ' O ' ' HD3' ' A' ' 37' ' ' ARG . . . -57.11 -39.02 89.13 Favored Glycine 0 C--N 1.34 0.799 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 177.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.5 m -74.03 -30.8 62.61 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 114.497 -0.851 . . . . 0.0 112.348 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.769 HG21 HD13 ' A' ' 27' ' ' ILE . 0.9 OUTLIER -73.22 -27.43 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 176.733 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.56 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 30.1 mmt -75.2 -41.16 58.4 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 112.912 -1.949 . . . . 0.0 111.636 176.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.73 ' HD3' ' O ' ' A' ' 33' ' ' GLY . 10.3 mtp180 -82.16 -29.53 31.5 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.5 m -67.48 -8.32 32.64 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.938 0.875 . . . . 0.0 111.965 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 35' ' ' VAL . 83.4 mt -89.42 -9.86 48.66 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 113.327 -1.76 . . . . 0.0 109.62 177.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.27 -4.81 23.52 Favored Glycine 0 CA--C 1.491 -1.409 0 CA-C-O 122.168 0.871 . . . . 0.0 114.912 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.59 ' OE1' HD22 ' B' ' 167' ' ' LEU . 47.1 mt-30 -77.32 137.72 38.93 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 112.371 -1.914 . . . . 0.0 111.902 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -126.79 66.51 65.73 Favored Pre-proline 0 CA--C 1.551 1.001 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.59 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.41 ' HD3' ' C ' ' A' ' 41' ' ' GLN . 2.1 Cg_endo -86.17 -177.8 2.58 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 123.017 2.478 . . . . 0.0 112.047 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.489 ' OG1' ' N ' ' A' ' 45' ' ' GLU . 7.5 t -98.13 -175.17 3.05 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.17 0.986 . . . . 0.0 110.527 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.5 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 46.2 mt-10 -81.06 -24.01 38.11 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 112.99 -1.914 . . . . 0.0 108.582 177.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.49 -30.89 68.87 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.811 -1.54 . . . . 0.0 112.033 -177.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.425 ' H ' HG23 ' A' ' 44' ' ' THR . 1.0 OUTLIER -87.1 -29.21 22.03 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.369 176.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.811 ' O ' HG12 ' A' ' 52' ' ' ILE . 0.4 OUTLIER -68.06 -20.54 64.98 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.263 175.064 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.769 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 46.6 mt-30 -98.16 -17.2 19.16 Favored 'General case' 0 CA--C 1.478 -1.807 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.958 177.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -80.79 -30.23 35.97 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 111.999 -2.364 . . . . 0.0 108.871 176.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.598 ' SD ' ' HZ ' ' A' ' 68' ' ' PHE . 41.9 mtm -86.71 -32.03 20.69 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.339 177.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.811 HG12 ' O ' ' A' ' 48' ' ' LEU . 36.4 mm -73.76 -27.35 22.72 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 175.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.769 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 2.7 t30 -75.67 -35.5 60.36 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.491 176.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -86.16 -35.6 20.03 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.588 HG11 HG13 ' A' ' 63' ' ' ILE . 43.6 t -77.33 -43.6 30.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -70.73 31.7 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.831 0.824 . . . . 0.0 111.26 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.577 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -87.22 -7.35 58.0 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.979 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -113.94 -37.23 4.55 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 111.829 -2.441 . . . . 0.0 110.714 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.63 43.11 7.01 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.849 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -110.29 -21.79 12.05 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.44 26.87 73.52 Favored Glycine 0 N--CA 1.468 0.781 0 CA-C-N 115.861 -0.609 . . . . 0.0 114.359 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.67 156.93 43.95 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 123.329 0.652 . . . . 0.0 110.464 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.588 HG13 HG11 ' A' ' 55' ' ' VAL . 2.8 mp -133.38 127.67 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -177.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.7 ' N ' HG22 ' A' ' 26' ' ' THR . 0.2 OUTLIER -76.85 159.35 30.13 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.071 176.213 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.569 ' CG ' ' HD3' ' A' ' 66' ' ' PRO . 12.6 p90 -91.31 -39.89 0.38 Allowed Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -177.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.569 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 7.7 Cg_exo -73.46 -18.58 22.77 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 121.765 1.643 . . . . 0.0 112.814 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -98.16 -11.8 22.4 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.598 ' HZ ' ' SD ' ' A' ' 51' ' ' MET . 37.1 t80 -84.32 -40.41 17.96 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -178.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.564 HD13 ' HA ' ' A' ' 8' ' ' GLN . 0.8 OUTLIER -64.38 -33.75 76.58 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 121.56 0.695 . . . . 0.0 110.25 177.659 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.473 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -55.92 -34.19 65.37 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 113.38 -1.736 . . . . 0.0 108.917 174.382 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.677 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 65.8 mtt -70.21 -36.43 74.58 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.23 175.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.611 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 61.6 mtm -79.47 -19.32 50.06 Favored 'General case' 0 CA--C 1.508 -0.651 0 O-C-N 124.18 0.925 . . . . 0.0 110.88 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . -75.82 -40.1 55.54 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 71' ' ' MET . 2.6 ptm180 -77.15 -17.79 58.33 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.677 ' HD2' ' O ' ' A' ' 71' ' ' MET . 23.8 mttt -75.23 -14.93 60.56 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 13.1 ptt? -125.88 -28.32 3.22 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -177.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 35.0 mttm -64.87 -13.12 55.35 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -93.72 -29.64 15.29 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 9.4 t -84.07 26.42 0.74 Allowed 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.588 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 2.0 t70 64.41 149.44 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.21 1.004 . . . . 0.0 112.089 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.576 ' HA ' ' OE2' ' A' ' 84' ' ' GLU . 13.4 t -83.01 -14.1 54.61 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.954 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.468 ' HB3' ' OD1' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -84.58 -44.96 13.04 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.772 0.796 . . . . 0.0 109.247 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 79' ' ' THR . 43.3 mt-10 -68.05 -18.31 64.65 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 113.579 -1.646 . . . . 0.0 112.188 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.588 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 31.1 mt-10 -61.94 -27.48 68.86 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.7 mp -88.04 -52.77 10.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.82 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -60.9 -16.91 47.3 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.583 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 3.0 pt-20 -74.18 -20.33 60.24 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.1 0.476 . . . . 0.0 110.13 178.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.09 -20.4 64.07 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.59 177.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.489 ' HE2' ' O ' ' A' ' 98' ' ' GLY . 13.5 m-85 -82.01 -21.36 37.07 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 174.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.583 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 8.0 mtt180 -78.89 -19.2 52.46 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 114.119 -1.4 . . . . 0.0 107.532 174.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.408 HG12 ' CD1' ' A' ' 92' ' ' PHE . 54.4 t -87.85 -55.21 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.284 177.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.82 ' HB3' HG21 ' A' ' 100' ' ' ILE . 15.3 m-85 -101.05 -44.69 5.63 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -177.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.743 ' CA ' HG12 ' A' ' 100' ' ' ILE . 1.9 t70 -63.35 95.49 0.09 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.689 0.757 . . . . 0.0 112.23 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.426 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 10.9 mmpt? -86.81 -41.89 13.7 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 114.264 -1.334 . . . . 0.0 112.804 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -70.76 -18.88 62.76 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -176.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.17 19.99 68.7 Favored Glycine 0 C--N 1.295 -1.728 0 CA-C-N 112.774 -2.012 . . . . 0.0 114.074 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -92.13 -7.19 49.22 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.369 0.267 . . . . 0.0 111.413 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.489 ' O ' ' HE2' ' A' ' 89' ' ' PHE . . . 106.41 -18.74 38.08 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.786 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -115.18 118.39 33.2 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.611 -0.795 . . . . 0.0 111.094 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.82 HG21 ' HB3' ' A' ' 92' ' ' PHE . 53.1 mt -80.57 98.15 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.9 t -75.61 166.0 24.23 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.232 -0.895 . . . . 0.0 113.135 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.597 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -62.83 -15.41 54.22 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -89.36 -31.91 17.56 Favored 'General case' 0 CA--C 1.488 -1.417 0 CA-C-O 121.969 0.89 . . . . 0.0 109.304 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 1.064 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.9 mm-40 -78.6 -38.61 39.56 Favored 'General case' 0 CA--C 1.482 -1.636 0 CA-C-N 112.429 -2.169 . . . . 0.0 110.354 -178.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.554 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 5.1 tt -64.53 -36.7 85.07 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 176.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.61 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -70.9 -44.29 66.56 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.776 175.689 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.49 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 2.6 t60 -67.27 -21.83 65.69 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.542 177.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.064 HG23 ' O ' ' A' ' 104' ' ' GLU . 26.5 t -72.63 -51.01 30.27 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 176.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.699 ' SD ' HD22 ' A' ' 116' ' ' LEU . 17.6 mtt -55.99 -40.61 73.57 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 112.551 -2.113 . . . . 0.0 111.95 175.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.94 -19.14 64.17 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.299 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.82 -45.09 19.36 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.477 176.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.1 mt -79.18 -28.09 42.68 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.572 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.51 -7.28 3.64 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 117.857 -1.524 . . . . 0.0 116.671 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 109' ' ' MET . 5.0 mt-10 -101.42 153.42 19.7 Favored 'General case' 0 C--N 1.357 0.911 0 CA-C-N 120.667 2.233 . . . . 0.0 114.32 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -111.7 128.65 56.14 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 113.827 -1.533 . . . . 0.0 107.769 175.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.699 HD22 ' SD ' ' A' ' 109' ' ' MET . 1.1 tp -139.59 116.09 10.66 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.468 -1.242 . . . . 0.0 112.337 -176.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.974 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -71.57 -176.54 1.61 Allowed 'General case' 0 C--N 1.346 0.456 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.684 179.81 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.547 ' O ' HG23 ' A' ' 121' ' ' VAL . 16.3 t70 -69.96 -40.79 75.22 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -177.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.594 ' H ' HG23 ' A' ' 117' ' ' THR . 8.8 pt-20 -83.8 -16.51 44.39 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.745 ' HG2' HG22 ' A' ' 117' ' ' THR . 13.9 pt-20 -87.9 -15.77 35.74 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.316 0.385 . . . . 0.0 111.085 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.974 HG22 ' O ' ' A' ' 117' ' ' THR . 0.1 OUTLIER -86.15 -24.56 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.272 177.86 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -73.51 32.11 0.07 Allowed 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.72 0.771 . . . . 0.0 112.662 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.451 ' H ' ' C ' ' A' ' 121' ' ' VAL . 9.3 pt-20 -141.46 -32.99 0.52 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.269 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.515 ' HE2' ' N ' ' B' ' 153' ' ' THR . 17.8 ttm -74.2 -23.03 59.15 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.272 177.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.617 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 3.1 mt -89.16 -53.09 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.958 178.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -55.77 -28.86 58.21 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 124.204 0.94 . . . . 0.0 111.785 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.71 ' OE1' ' HD3' ' B' ' 155' ' ' LYS . 0.0 OUTLIER -63.37 -34.17 77.14 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.479 178.039 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.631 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -107.92 -30.33 8.54 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-O 121.209 0.528 . . . . 0.0 109.934 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.617 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -60.93 127.01 29.5 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.485 -1.234 . . . . 0.0 113.255 -178.753 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.9 mt -90.0 -48.28 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 113.737 -1.574 . . . . 0.0 110.525 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -84.12 -25.18 29.89 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 74.17 49.53 12.36 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 116.023 -0.535 . . . . 0.0 113.971 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -89.56 -19.49 24.93 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 98.71 13.34 40.98 Favored Glycine 0 CA--C 1.5 -0.884 0 CA-C-N 115.725 -0.67 . . . . 0.0 113.265 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -140.14 128.7 22.89 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.762 -1.219 . . . . 0.0 108.131 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.623 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 2.5 t -89.49 135.02 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -177.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -97.58 -163.24 1.03 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.399 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.435 ' CE1' HG21 ' A' ' 142' ' ' VAL . 0.0 OUTLIER -78.65 -51.22 10.18 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 123.558 0.743 . . . . 0.0 109.928 178.698 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -62.31 -20.78 64.68 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.631 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 12.4 mt-10 -87.66 -41.11 13.61 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.281 0.563 . . . . 0.0 110.216 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.439 ' O ' ' HE2' ' A' ' 144' ' ' MET . 73.3 t80 -72.13 -23.47 61.31 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.952 175.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.467 ' O ' ' HG3' ' A' ' 145' ' ' MET . 16.7 t -84.73 -47.55 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.573 -179.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.415 ' HA ' ' OG1' ' A' ' 146' ' ' THR . 29.4 mt-30 -64.85 -19.31 65.81 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.01 176.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.498 ' SD ' ' HB3' ' B' ' 154' ' ' PHE . 4.5 ttp -67.55 -26.31 66.24 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.748 177.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.467 ' HG3' ' O ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -86.56 -4.4 59.17 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.71 177.931 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.415 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 39.6 p -119.03 -41.91 2.73 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.166 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -45.76 -34.35 3.59 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.3 pttm . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.453 -0.784 . . . . 0.0 111.38 179.813 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 111.358 0.133 . . . . 0.0 111.358 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -134.29 153.39 51.9 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.925 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 13.3 mptt 62.29 117.62 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.877 0.871 . . . . 0.0 112.237 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 152' ' ' LYS . . . . . 0.429 ' HB2' ' OE1' ' A' ' 123' ' ' GLU . 10.8 mptt -135.33 119.74 17.96 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.285 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.569 ' HB ' ' OE1' ' A' ' 127' ' ' GLU . 16.1 p -143.6 147.73 34.81 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 154' ' ' PHE . . . . . 0.513 ' O ' HG22 ' B' ' 157' ' ' VAL . 0.1 OUTLIER -67.28 -28.07 67.71 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.789 0.436 . . . . 0.0 110.016 178.099 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.71 ' HD3' ' OE1' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -66.09 -33.49 75.9 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.61 178.224 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -76.76 -35.29 57.81 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.173 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 157' ' ' VAL . . . . . 0.513 HG22 ' O ' ' B' ' 154' ' ' PHE . 19.1 m -72.25 -29.42 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 122.763 0.425 . . . . 0.0 111.293 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.21 -46.34 72.46 Favored 'General case' 0 C--N 1.347 0.485 0 C-N-CA 123.857 0.863 . . . . 0.0 113.032 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -56.35 -25.57 49.72 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 120.743 0.306 . . . . 0.0 111.456 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.68 -43.95 29.56 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.052 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 11.5 p -142.33 57.14 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 162' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -136.88 86.22 2.19 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.303 0.573 . . . . 0.0 110.64 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 5.4 tp -149.18 -18.82 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.539 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 21.1 m 64.62 97.11 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.489 1.116 . . . . 0.0 113.483 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . 36.71 41.05 0.15 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 166' ' ' SER . . . . . 0.419 ' OG ' ' HB3' ' A' ' 72' ' ' MET . 13.9 t -95.59 -49.22 5.48 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.784 -0.189 . . . . 0.0 110.745 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.59 HD22 ' OE1' ' A' ' 41' ' ' GLN . 1.8 tp -127.56 -22.7 3.58 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 123.526 0.516 . . . . 0.0 111.007 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -95.2 145.55 24.96 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.381 0.425 . . . . 0.0 110.98 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . 100.04 -86.82 0.69 Allowed Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.505 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 19.6 p . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.048 -179.995 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.424 0 N-CA-C 111.375 0.139 . . . . 0.0 111.375 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 68.47 -62.78 0.36 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.335 1.054 . . . . 0.0 112.202 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -122.84 154.13 38.67 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 122.59 0.356 . . . . 0.0 110.621 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.664 HD11 ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -111.49 -110.7 0.34 Allowed 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.645 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.521 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 17.1 p -101.12 -173.71 2.44 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 123.794 0.838 . . . . 0.0 110.95 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 10' ' ' ALA . 46.9 mt-10 -59.4 -24.58 63.58 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.521 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 12.0 pt-20 -54.98 -32.18 61.39 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.547 0.689 . . . . 0.0 111.667 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.818 ' HB2' HD13 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -77.11 -46.11 24.63 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.703 177.972 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.638 HD13 ' HG3' ' A' ' 8' ' ' GLN . 11.7 mm -65.63 -34.77 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.242 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 6' ' ' GLU . . . -67.24 -43.67 81.37 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -133.23 -31.05 1.28 Allowed 'General case' 0 C--N 1.358 0.976 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -176.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.438 ' CB ' HD11 ' A' ' 69' ' ' LEU . 0.2 OUTLIER -62.73 -14.12 40.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.4 0.546 . . . . 0.0 111.806 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.697 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -78.59 -42.14 29.89 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.521 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.697 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 4.5 mt-10 -75.26 -43.6 50.49 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.588 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.608 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -62.84 -18.85 63.46 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.554 0.692 . . . . 0.0 109.229 177.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.833 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 1.6 m-85 -86.76 -47.17 9.33 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.391 176.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.4 m -86.42 -13.24 46.84 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -177.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -70.48 -30.47 67.28 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.445 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.579 ' CD1' HG22 ' A' ' 35' ' ' VAL . 3.1 m-85 -124.52 -14.03 6.94 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.833 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 0.9 OUTLIER -101.58 82.85 2.34 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.195 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.431 ' HE2' ' H ' ' A' ' 21' ' ' LYS . 2.1 mppt? -75.42 -19.69 59.34 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -177.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.78 -21.62 29.9 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.51 51.92 4.69 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-N 113.851 -1.522 . . . . 0.0 109.634 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.48 15.36 18.04 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -175.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.96 -58.79 0.08 OUTLIER Glycine 0 CA--C 1.531 1.074 0 N-CA-C 115.447 0.939 . . . . 0.0 115.447 178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.471 ' HB ' ' CG2' ' A' ' 62' ' ' THR . 0.5 OUTLIER -95.12 130.24 41.9 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 123.366 0.666 . . . . 0.0 112.282 -177.823 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.573 HG23 ' OD2' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -112.29 149.27 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.556 -179.856 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.73 148.23 43.56 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.14 -54.03 14.69 Favored 'General case' 0 C--N 1.345 0.375 0 C-N-CA 123.982 0.913 . . . . 0.0 112.751 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -52.76 -14.48 0.55 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.447 177.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.534 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.8 mt-10 -113.02 -19.1 12.03 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.864 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.475 ' HA ' HG23 ' A' ' 35' ' ' VAL . 2.5 tm? -57.14 -37.56 72.2 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.69 0.796 . . . . 0.0 111.518 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.839 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -56.31 -41.02 86.58 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 177.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.5 m -75.22 -27.6 59.61 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.496 -0.852 . . . . 0.0 112.134 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.608 HG12 ' HA ' ' A' ' 15' ' ' ALA . 1.4 t -76.37 -26.01 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 176.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.573 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 14.6 mmt -75.38 -41.64 55.87 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 113.054 -1.885 . . . . 0.0 111.546 176.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.839 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 2.9 mtt85 -82.42 -28.19 31.52 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.8 t -66.37 -7.97 22.57 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.988 0.899 . . . . 0.0 111.533 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 35' ' ' VAL . 62.7 mt -94.07 -4.15 49.91 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.205 -1.816 . . . . 0.0 110.11 178.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.33 -11.31 19.54 Favored Glycine 0 CA--C 1.495 -1.215 0 N-CA-C 115.601 1.0 . . . . 0.0 115.601 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.573 ' HB2' ' O ' ' A' ' 36' ' ' MET . 37.8 mt-30 -66.64 155.19 38.58 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 113.057 -1.572 . . . . 0.0 111.686 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -80.39 135.87 53.28 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.681 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 90.7 Cg_endo -86.78 108.65 0.79 Allowed 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 122.362 2.041 . . . . 0.0 115.292 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.448 ' HB ' ' H ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -131.38 150.08 52.29 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 176.585 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -80.73 -29.33 36.36 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 121.77 0.795 . . . . 0.0 109.183 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 50' ' ' ASP . . . -73.5 -31.74 63.88 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 113.304 -1.771 . . . . 0.0 109.766 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.448 ' H ' ' HB ' ' A' ' 44' ' ' THR . 25.3 tt0 -81.74 -28.22 33.47 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 113.786 -1.552 . . . . 0.0 109.197 177.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.672 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -73.43 -18.85 61.09 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.73 174.946 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.905 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 54.2 mt-30 -99.02 -16.03 18.84 Favored 'General case' 0 CA--C 1.482 -1.65 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.123 177.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 2.2 t70 -87.31 -37.32 17.25 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 112.166 -2.288 . . . . 0.0 110.524 176.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.612 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 0.7 OUTLIER -86.58 -32.43 20.66 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.597 178.038 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.672 ' HB ' ' O ' ' A' ' 48' ' ' LEU . 1.6 mp -74.28 -23.56 18.48 Favored 'Isoleucine or valine' 0 C--N 1.341 0.204 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 174.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.905 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.5 t-20 -69.63 -35.02 74.86 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.462 174.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.612 ' HG3' ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -86.74 -42.17 13.55 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 179.649 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.575 ' C ' ' H ' ' A' ' 57' ' ' ALA . 55.6 t -69.11 -43.14 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -71.97 34.53 0.06 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.998 0.904 . . . . 0.0 110.839 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.575 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -86.73 -5.69 59.05 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 114.108 -1.405 . . . . 0.0 112.011 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -104.89 -37.0 7.17 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 111.997 -2.365 . . . . 0.0 110.769 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.33 27.59 35.93 Favored Glycine 0 C--N 1.344 0.993 0 CA-C-N 116.053 -0.522 . . . . 0.0 114.303 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -110.28 -21.45 12.22 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.92 0.36 . . . . 0.0 111.777 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.32 26.4 70.45 Favored Glycine 0 N--CA 1.466 0.663 0 CA-C-N 115.785 -0.643 . . . . 0.0 114.177 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.471 ' CG2' ' HB ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -144.87 174.97 10.55 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 123.728 0.811 . . . . 0.0 109.916 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.548 ' HA ' ' CE2' ' A' ' 68' ' ' PHE . 5.3 mp -132.92 96.77 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.1 167.56 17.7 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.167 175.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.695 ' CD1' ' HD3' ' A' ' 66' ' ' PRO . 4.8 p90 -91.83 -39.32 0.37 Allowed Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -178.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.695 ' HD3' ' CD1' ' A' ' 65' ' ' PHE . 12.6 Cg_exo -70.71 -16.93 33.56 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.298 1.999 . . . . 0.0 112.692 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -106.14 -39.92 5.81 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -177.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.548 ' CE2' ' HA ' ' A' ' 63' ' ' ILE . 80.3 m-85 -85.69 -38.23 18.54 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -175.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.818 HD13 ' HB2' ' A' ' 8' ' ' GLN . 4.9 mt -63.8 -30.89 71.94 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.757 0.789 . . . . 0.0 110.01 177.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.594 ' O ' ' HD3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -55.73 -34.89 65.56 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 113.097 -1.865 . . . . 0.0 109.007 174.485 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.648 ' HA ' ' NE ' ' A' ' 74' ' ' ARG . 68.6 mtt -71.54 -30.4 65.86 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.51 175.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.542 ' HA ' ' CD ' ' A' ' 75' ' ' LYS . 0.9 OUTLIER -85.5 -18.37 33.69 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.702 178.29 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.637 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -80.49 -34.26 35.89 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.648 ' NE ' ' HA ' ' A' ' 71' ' ' MET . 2.5 ptt180 -81.21 -20.21 41.59 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.591 ' HD2' ' O ' ' A' ' 71' ' ' MET . 5.8 ptmt -84.45 -12.81 53.66 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.41 177.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.556 ' SD ' HD11 ' B' ' 163' ' ' ILE . 25.5 ptm -109.36 -33.51 6.81 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.159 0.504 . . . . 0.0 111.482 -178.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.637 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 26.8 mttt -75.57 -29.65 59.39 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.77 -1.105 . . . . 0.0 113.241 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -89.96 -29.46 18.46 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.8 t -66.57 101.4 0.77 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.105 0.479 . . . . 0.0 111.389 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.481 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 2.6 t70 -54.81 161.54 1.53 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.144 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.5 t -66.1 -13.78 60.66 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.616 ' O ' HD12 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -81.58 -46.03 15.02 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.597 0.713 . . . . 0.0 109.767 -179.574 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 37.6 mt-10 -77.66 -18.91 56.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.016 -1.447 . . . . 0.0 112.428 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.481 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 37.7 mt-10 -68.08 -18.02 64.55 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.781 0.432 . . . . 0.0 111.937 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 82' ' ' GLU . 2.1 mt -87.31 -57.72 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.8 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.694 ' O ' ' HD1' ' A' ' 89' ' ' PHE . 8.7 mpt_? -56.06 -16.6 5.24 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.787 ' O ' HG23 ' A' ' 91' ' ' VAL . 47.3 mt-10 -78.17 -20.76 51.31 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.764 -0.198 . . . . 0.0 111.076 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.499 ' HB1' ' CE2' ' A' ' 141' ' ' PHE . . . -72.17 -21.13 61.48 Favored 'General case' 0 CA--C 1.518 -0.276 0 O-C-N 123.772 0.67 . . . . 0.0 110.601 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.694 ' HD1' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -84.94 -20.95 29.86 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 175.217 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -79.89 -25.2 40.69 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.218 175.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 87' ' ' GLU . 42.4 t -88.15 -56.18 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.194 178.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.871 ' HB3' HG21 ' A' ' 100' ' ' ILE . 9.1 m-85 -100.75 -46.06 5.28 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -176.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.719 ' CA ' HG12 ' A' ' 100' ' ' ILE . 15.8 t70 -59.71 94.45 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.652 0.739 . . . . 0.0 112.316 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.675 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 15.7 mttm -88.3 -47.14 8.63 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 114.271 -1.331 . . . . 0.0 113.816 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -71.63 2.45 5.18 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -176.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 49.19 28.64 8.64 Favored Glycine 0 N--CA 1.473 1.153 0 CA-C-N 114.258 -1.337 . . . . 0.0 115.082 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -99.11 -5.84 29.44 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.754 0.277 . . . . 0.0 111.325 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.07 -19.03 53.57 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.703 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -117.4 118.18 31.53 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.507 -0.846 . . . . 0.0 110.67 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.871 HG21 ' HB3' ' A' ' 92' ' ' PHE . 18.5 mt -80.31 103.57 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 178.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.421 ' OG ' ' HG2' ' A' ' 104' ' ' GLU . 13.0 p -78.08 162.64 26.54 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.47 -14.76 13.78 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -177.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.99 -33.66 17.11 Favored 'General case' 0 CA--C 1.486 -1.483 0 CA-C-O 122.157 0.98 . . . . 0.0 109.096 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.909 ' O ' HG23 ' A' ' 108' ' ' VAL . 3.5 mm-40 -76.41 -42.26 44.92 Favored 'General case' 0 CA--C 1.481 -1.7 0 CA-C-N 112.446 -2.161 . . . . 0.0 109.691 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.54 HD23 ' O ' ' A' ' 105' ' ' LEU . 8.0 tt -60.11 -33.35 72.01 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.652 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -72.65 -45.18 60.21 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.603 -1.181 . . . . 0.0 108.475 176.401 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.507 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 19.9 t-80 -69.03 -21.53 64.1 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 114.152 -1.386 . . . . 0.0 108.803 177.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.909 HG23 ' O ' ' A' ' 104' ' ' GLU . 27.3 t -73.67 -51.19 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.727 ' SD ' HD22 ' A' ' 116' ' ' LEU . 16.2 mtt -56.66 -41.21 76.86 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 112.354 -2.203 . . . . 0.0 111.717 175.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 m -70.38 -19.07 63.05 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.346 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.22 -44.74 21.23 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.588 176.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.57 HD22 HG12 ' B' ' 161' ' ' VAL . 1.3 mt -81.75 -28.44 33.31 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.706 -178.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 141.83 -9.99 2.58 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-O 117.616 -1.658 . . . . 0.0 117.05 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.578 ' N ' ' O ' ' A' ' 109' ' ' MET . 5.1 mt-10 -100.97 152.54 20.45 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-N 121.082 2.441 . . . . 0.0 114.476 -178.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.35 129.7 55.52 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 113.796 -1.547 . . . . 0.0 107.741 175.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.727 HD22 ' SD ' ' A' ' 109' ' ' MET . 1.2 tp -140.14 115.53 9.96 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.62 -1.173 . . . . 0.0 112.436 -176.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.854 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -75.31 -175.89 2.9 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.82 179.551 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.514 ' N ' HG23 ' A' ' 117' ' ' THR . 16.1 t70 -72.35 -37.47 68.82 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 -177.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.659 ' H ' HG23 ' A' ' 117' ' ' THR . 8.4 pt-20 -88.98 -15.53 33.97 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.727 ' HG2' HG22 ' A' ' 117' ' ' THR . 14.8 pt-20 -87.69 -16.2 35.01 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.396 0.141 . . . . 0.0 110.774 178.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.854 HG22 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -83.21 -27.17 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.908 177.907 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.429 ' OD2' ' HA ' ' A' ' 119' ' ' GLU . 2.9 p30 -67.08 26.54 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.575 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 10.4 pt-20 -142.3 -14.82 0.77 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.689 -1.142 . . . . 0.0 111.933 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.506 ' SD ' HD21 ' A' ' 105' ' ' LEU . 7.2 ttm -88.41 -22.82 23.54 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.662 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 2.3 mp -88.05 -46.89 15.78 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 CA-C-N 114.385 -1.28 . . . . 0.0 113.07 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -61.29 -31.4 71.22 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.575 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 5.0 mm-40 -69.74 -32.79 71.52 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.135 177.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.604 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -94.38 -40.75 9.77 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.576 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.662 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.2 OUTLIER -60.83 119.45 8.24 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.842 -1.526 . . . . 0.0 113.695 -178.355 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.3 mt -90.78 -39.25 11.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 112.964 -1.926 . . . . 0.0 110.136 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -95.91 -25.26 16.05 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.376 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.39 49.84 5.66 Favored Glycine 0 CA--C 1.526 0.727 0 O-C-N 123.464 0.478 . . . . 0.0 114.146 178.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -90.96 -19.73 22.94 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 94.18 13.62 53.82 Favored Glycine 0 CA--C 1.503 -0.692 0 CA-C-O 121.508 0.505 . . . . 0.0 113.39 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -140.03 122.46 16.1 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 113.833 -1.184 . . . . 0.0 108.32 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.552 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 3.3 t -83.86 118.4 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.531 0.681 . . . . 0.0 111.971 -178.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -84.43 -163.49 0.81 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 114.095 -1.411 . . . . 0.0 110.586 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.532 ' O ' HG23 ' A' ' 142' ' ' VAL . 37.1 m-85 -70.85 -55.62 8.1 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.786 178.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 143' ' ' GLN . 43.1 mt-10 -65.02 -20.46 66.5 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.604 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 7.8 mt-10 -87.56 -33.63 18.85 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 121.349 0.595 . . . . 0.0 109.677 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.499 ' CE2' ' HB1' ' A' ' 88' ' ' ALA . 78.0 t80 -78.85 -23.62 44.89 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.23 176.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 138' ' ' TYR . 38.0 t -85.88 -40.76 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 114.802 -1.09 . . . . 0.0 112.432 -177.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.54 ' HA ' ' OG1' ' A' ' 146' ' ' THR . 7.9 mt-30 -50.19 -31.64 14.32 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.674 ' SD ' ' HB2' ' B' ' 158' ' ' ALA . 19.2 ptt? -63.0 -31.4 72.52 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 118.437 0.562 . . . . 0.0 110.83 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.583 ' SD ' ' HD2' ' B' ' 162' ' ' LYS . 66.0 mtm -82.6 -3.95 56.92 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.914 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.54 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 39.6 p -119.24 -42.53 2.67 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.689 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -48.32 -33.12 8.38 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 178.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 97.2 mttt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.144 -0.931 . . . . 0.0 111.223 179.886 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 120.517 0.199 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -106.3 137.23 44.62 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.595 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -99.96 156.8 16.96 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.968 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 152' ' ' LYS . . . . . 0.451 ' HD3' ' OE1' ' A' ' 114' ' ' GLU . 97.7 mttt -91.68 126.66 36.84 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.97 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 77.9 p -133.7 178.01 7.27 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.619 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 154' ' ' PHE . . . . . 0.746 ' CE1' ' HD2' ' B' ' 155' ' ' LYS . 0.1 OUTLIER -63.77 -28.36 69.82 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.506 0.139 . . . . 0.0 111.017 179.197 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.746 ' HD2' ' CE1' ' B' ' 154' ' ' PHE . 7.1 mptt -65.59 -34.13 77.53 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.955 0.502 . . . . 0.0 111.687 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -76.52 -49.93 15.24 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 157' ' ' VAL . . . . . . . . . . . . . 7.8 p -72.22 -26.72 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 122.708 0.403 . . . . 0.0 111.957 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 158' ' ' ALA . . . . . 0.674 ' HB2' ' SD ' ' A' ' 144' ' ' MET . . . -51.95 -42.82 63.16 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -71.51 -20.88 62.0 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.394 0.434 . . . . 0.0 111.362 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.09 -37.67 53.91 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.288 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.661 HG11 ' HE1' ' A' ' 92' ' ' PHE . 2.6 m -90.53 -29.94 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 162' ' ' LYS . . . . . 0.583 ' HD2' ' SD ' ' A' ' 145' ' ' MET . 7.3 mtpt -65.4 132.4 48.89 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.444 0.298 . . . . 0.0 111.408 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 163' ' ' ILE . . . . . 0.556 HD11 ' SD ' ' A' ' 76' ' ' MET . 2.0 tp 56.44 17.12 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 124.655 1.182 . . . . 0.0 112.612 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 55.9 m -113.82 -36.19 4.91 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.452 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . -90.51 7.19 40.23 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.313 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 166' ' ' SER . . . . . 0.414 ' O ' ' HE2' ' A' ' 75' ' ' LYS . 54.4 m -86.03 16.94 3.82 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.561 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 7.3 tp -86.09 12.34 9.82 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.977 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 85.8 mmm -92.16 130.63 37.83 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.968 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -152.57 139.33 6.93 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.508 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 20.0 p . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.137 -0.935 . . . . 0.0 111.033 179.97 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.498 0.189 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -128.43 123.05 32.77 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.56 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.716 ' HA ' ' OE1' ' A' ' 8' ' ' GLN . 17.0 pt20 -85.08 150.2 25.03 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.738 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.518 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -106.03 -112.0 0.27 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.616 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.543 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 15.6 p -101.49 -173.47 2.37 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 123.757 0.823 . . . . 0.0 111.19 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -56.71 -26.11 56.07 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.543 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 11.0 pt-20 -58.19 -30.12 66.19 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 121.415 0.626 . . . . 0.0 111.307 178.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.716 ' OE1' ' HA ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -78.99 -45.76 19.61 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.141 177.51 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.412 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 18.4 mm -60.03 -36.46 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.473 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.22 -35.24 59.13 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -179.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -107.88 -17.82 13.97 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -177.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.506 ' CB ' HE21 ' A' ' 8' ' ' GLN . 0.2 OUTLIER -73.68 -16.16 61.21 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.36 0.527 . . . . 0.0 110.257 179.105 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.664 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -82.38 -40.72 20.91 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.345 179.25 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.664 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 1.2 mt-10 -83.68 -38.49 21.4 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.834 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.631 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -65.43 -22.37 66.76 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.278 0.561 . . . . 0.0 109.659 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.562 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 25.0 t80 -87.17 -45.92 10.22 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.945 176.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.7 m -87.34 -13.65 42.95 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -177.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -68.89 -30.62 69.15 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.18 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.605 ' CD1' HG22 ' A' ' 35' ' ' VAL . 7.0 m-85 -129.43 -14.91 4.15 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -103.31 82.23 2.03 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 118.551 0.614 . . . . 0.0 109.894 178.622 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.435 ' HE2' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -83.33 -28.38 29.07 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.611 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.6 ' OD1' ' HB2' ' A' ' 24' ' ' ASP . 0.3 OUTLIER -71.25 -22.84 61.93 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.702 177.414 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.43 51.9 4.72 Favored Glycine 0 N--CA 1.469 0.842 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.6 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -98.42 21.99 10.35 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -175.484 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.41 -64.24 0.16 Allowed Glycine 0 CA--C 1.529 0.916 0 CA-C-N 115.344 -0.843 . . . . 0.0 114.539 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.695 HG22 ' N ' ' A' ' 64' ' ' ASP . 6.2 p -97.5 152.94 18.49 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 123.551 0.741 . . . . 0.0 112.122 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.67 HG13 ' O ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -112.37 148.66 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.269 -179.533 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.78 154.02 5.5 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.593 HG22 HD11 ' A' ' 63' ' ' ILE . 1.7 p -74.33 -56.17 5.17 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -57.5 -13.45 3.69 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.387 177.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.468 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 33.6 mt-10 -111.75 -16.75 13.13 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.683 -177.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.538 HD11 ' CZ ' ' A' ' 68' ' ' PHE . 1.1 tm? -56.8 -43.33 80.82 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.044 0.538 . . . . 0.0 111.493 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.754 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -52.6 -40.66 55.68 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 177.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.5 m -72.1 -32.57 67.12 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 114.746 -0.727 . . . . 0.0 112.871 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.631 HG12 ' HA ' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -73.11 -26.74 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 176.992 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.575 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 32.6 mmt -76.43 -40.65 50.08 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 112.953 -1.931 . . . . 0.0 111.475 176.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.754 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 9.9 mtt180 -80.59 -28.96 36.97 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 72.4 m -67.24 -8.52 32.35 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.957 0.884 . . . . 0.0 112.094 178.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 84.2 mt -93.61 -6.65 46.02 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.234 -1.803 . . . . 0.0 109.665 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.17 -4.69 31.69 Favored Glycine 0 CA--C 1.493 -1.29 0 N-CA-C 115.424 0.93 . . . . 0.0 115.424 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.575 ' HB2' ' O ' ' A' ' 36' ' ' MET . 48.7 mt-30 -78.78 137.84 37.92 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 112.43 -1.885 . . . . 0.0 112.272 -178.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.597 ' OD1' ' HA2' ' B' ' 169' ' ' GLY . 26.3 p-10 -120.82 67.17 14.5 Favored Pre-proline 0 CA--C 1.559 1.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.336 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.447 ' HD3' ' C ' ' A' ' 41' ' ' GLN . 2.0 Cg_endo -83.27 -177.83 3.46 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 123.112 2.541 . . . . 0.0 112.786 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.732 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 2.0 m -98.27 161.7 13.57 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -80.53 -29.33 37.18 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.736 0.779 . . . . 0.0 109.305 177.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.476 ' H ' HG22 ' A' ' 44' ' ' THR . . . -67.63 -32.94 73.99 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 113.476 -1.693 . . . . 0.0 109.653 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -76.0 -35.85 59.42 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 113.903 -1.499 . . . . 0.0 109.188 176.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.732 ' HG ' ' O ' ' A' ' 44' ' ' THR . 40.5 mt -64.39 -20.0 65.85 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 174.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.888 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 56.5 mt-30 -97.55 -14.85 20.81 Favored 'General case' 0 CA--C 1.481 -1.688 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.265 178.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -86.19 -35.62 19.97 Favored 'General case' 0 C--N 1.279 -2.476 0 CA-C-N 112.188 -2.278 . . . . 0.0 110.271 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -86.46 -31.06 21.57 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.226 177.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.607 ' HB ' ' O ' ' A' ' 48' ' ' LEU . 1.4 mp -74.75 -25.31 18.79 Favored 'Isoleucine or valine' 0 C--N 1.343 0.297 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 175.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.888 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.0 t30 -79.9 -34.66 38.9 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.305 175.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -85.07 -49.5 8.22 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.561 ' C ' ' H ' ' A' ' 57' ' ' ALA . 46.8 t -93.1 -52.23 10.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 5.5 t70 -72.92 38.4 0.08 Allowed 'General case' 0 C--O 1.238 0.479 0 CA-C-O 122.158 0.98 . . . . 0.0 109.836 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.561 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -82.1 -5.18 58.22 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 113.865 -1.516 . . . . 0.0 112.756 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -80.7 -33.03 35.66 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 112.47 -2.15 . . . . 0.0 111.573 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.22 51.12 4.05 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-N 116.105 -0.498 . . . . 0.0 113.164 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -109.81 -21.51 12.34 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.604 0.24 . . . . 0.0 111.536 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.5 26.55 74.4 Favored Glycine 0 N--CA 1.465 0.625 0 CA-C-N 115.725 -0.67 . . . . 0.0 114.359 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.406 ' O ' HD13 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -147.03 153.02 39.52 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 123.308 0.643 . . . . 0.0 110.479 -179.698 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.67 ' O ' HG13 ' A' ' 27' ' ' ILE . 7.1 mm -132.51 125.23 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -176.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.695 ' N ' HG22 ' A' ' 26' ' ' THR . 15.5 p-10 -73.78 148.54 42.43 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.39 176.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.514 ' CG ' ' HD3' ' A' ' 66' ' ' PRO . 4.9 p90 -78.92 -37.52 1.28 Allowed Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -177.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.514 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 22.6 Cg_exo -66.25 -18.76 56.2 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 121.792 1.661 . . . . 0.0 113.33 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -88.23 -20.02 26.06 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.538 ' CZ ' HD11 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -84.03 -25.6 29.77 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -178.8 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 73' ' ' ALA . 1.8 mt -70.91 -29.91 66.1 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 122.022 0.915 . . . . 0.0 109.317 175.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.69 -33.28 66.28 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 112.731 -2.032 . . . . 0.0 108.635 173.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.489 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 66.8 mtt -72.87 -24.15 60.83 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.384 175.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.463 ' HA ' ' CE ' ' A' ' 75' ' ' LYS . 37.0 mtt -88.81 -23.15 22.91 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.396 177.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.836 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -78.78 -23.4 45.29 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.392 178.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.488 ' HD2' ' N ' ' A' ' 75' ' ' LYS . 0.3 OUTLIER -89.65 -29.23 18.95 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.488 ' N ' ' HD2' ' A' ' 74' ' ' ARG . 8.3 pttp -74.44 -11.7 60.3 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.624 ' HA ' ' OE1' ' A' ' 84' ' ' GLU . 21.6 ptp -125.07 -22.06 4.52 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 -177.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.836 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 42.4 mmtt -87.49 -35.89 17.96 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -176.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -103.96 -30.12 10.5 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -176.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.501 HG21 ' OG ' ' B' ' 164' ' ' SER . 8.8 t -84.47 19.63 1.89 Allowed 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 8.7 m-20 63.05 132.41 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.771 0.829 . . . . 0.0 112.043 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.1 m -83.34 -14.05 53.73 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -86.98 -49.15 7.54 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.55 0.69 . . . . 0.0 110.005 -179.304 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.459 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 38.3 mt-10 -74.62 -17.85 60.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.079 -1.419 . . . . 0.0 112.28 179.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.624 ' OE1' ' HA ' ' A' ' 76' ' ' MET . 4.1 tt0 -61.11 -22.01 64.24 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.1 mp -87.84 -51.85 12.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.731 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.613 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -61.39 -16.92 51.22 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -179.242 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.599 ' OE1' ' HA ' ' B' ' 164' ' ' SER . 3.2 pt-20 -77.03 -20.36 56.04 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 123.356 0.41 . . . . 0.0 110.46 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.6 ' O ' ' HD1' ' A' ' 92' ' ' PHE . . . -67.24 -27.52 67.29 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.205 178.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.657 ' CE2' HG22 ' A' ' 142' ' ' VAL . 6.3 m-85 -79.35 -21.02 46.41 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 175.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.504 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 18.8 mmm180 -82.25 -16.25 50.2 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-N 114.095 -1.411 . . . . 0.0 108.07 174.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.583 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 7.9 t -85.24 -31.41 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.091 177.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.872 ' HB3' HG21 ' A' ' 100' ' ' ILE . 29.0 m-85 -90.54 -35.26 15.16 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.561 -177.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.654 ' CA ' HG12 ' A' ' 100' ' ' ILE . 2.7 t70 -61.98 91.61 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.156 0.982 . . . . 0.0 111.161 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.444 ' NZ ' ' HA ' ' A' ' 94' ' ' LYS . 1.6 mmpm? -88.17 -53.79 4.53 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -178.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.15 0.0 10.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.444 ' HA2' ' OD2' ' A' ' 93' ' ' ASP . . . 48.17 33.4 10.74 Favored Glycine 0 N--CA 1.473 1.137 0 CA-C-N 114.289 -1.323 . . . . 0.0 114.745 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -96.93 -5.28 38.37 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.24 -19.22 46.58 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.415 -0.422 . . . . 0.0 112.603 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -122.32 118.49 28.59 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.427 -0.887 . . . . 0.0 110.383 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.872 HG21 ' HB3' ' A' ' 92' ' ' PHE . 30.3 mt -77.01 97.24 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.4 m -74.72 164.36 26.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.627 -178.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.484 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -57.41 -15.02 5.57 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -89.09 -29.85 19.09 Favored 'General case' 0 CA--C 1.486 -1.491 0 CA-C-O 121.771 0.795 . . . . 0.0 109.205 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 1.029 ' O ' HG23 ' A' ' 108' ' ' VAL . 20.3 mt-10 -77.29 -43.33 33.59 Favored 'General case' 0 CA--C 1.482 -1.672 0 CA-C-N 112.707 -2.042 . . . . 0.0 110.633 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.56 HD23 ' O ' ' A' ' 105' ' ' LEU . 7.3 tt -63.97 -33.17 75.12 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.625 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -73.66 -43.01 60.57 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.793 176.624 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.489 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 10.3 t-80 -68.54 -21.66 64.54 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.267 177.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.029 HG23 ' O ' ' A' ' 104' ' ' GLU . 40.0 t -72.5 -52.13 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.835 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.644 ' SD ' HD22 ' A' ' 116' ' ' LEU . 14.7 mtt -57.45 -40.46 78.51 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 112.636 -2.074 . . . . 0.0 111.983 176.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 m -70.03 -19.1 63.32 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.082 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.6 -45.04 19.88 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.487 176.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.2 mt -80.19 -28.26 38.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.871 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 141.08 -9.79 2.77 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 117.717 -1.601 . . . . 0.0 116.905 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 109' ' ' MET . 5.0 mt-10 -100.83 151.61 21.5 Favored 'General case' 0 C--N 1.359 0.98 0 CA-C-N 120.946 2.373 . . . . 0.0 114.565 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.52 129.79 55.29 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 113.554 -1.657 . . . . 0.0 107.207 175.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.644 HD22 ' SD ' ' A' ' 109' ' ' MET . 1.0 OUTLIER -138.81 116.24 11.24 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.796 -175.771 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.871 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -73.72 -176.04 2.26 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.005 179.625 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.534 ' O ' HG23 ' A' ' 121' ' ' VAL . 16.4 t70 -69.12 -39.41 78.92 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -177.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.576 ' H ' HG23 ' A' ' 117' ' ' THR . 0.0 OUTLIER -88.36 -16.14 33.77 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -179.659 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.752 ' HG2' HG22 ' A' ' 117' ' ' THR . 13.9 pt-20 -85.51 -15.68 42.0 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 123.208 0.317 . . . . 0.0 111.116 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.871 HG22 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -82.75 -24.44 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.305 177.719 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -72.27 31.45 0.06 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.998 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.472 ' H ' ' C ' ' A' ' 121' ' ' VAL . 11.5 pt-20 -139.89 -33.41 0.59 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.212 177.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.525 ' SD ' HD21 ' A' ' 105' ' ' LEU . 1.9 ttm -76.44 -24.48 53.94 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.424 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.601 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 2.9 mt -88.72 -49.56 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.392 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -58.64 -29.19 66.35 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.248 0.967 . . . . 0.0 111.569 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.64 ' OE1' ' HB ' ' B' ' 153' ' ' THR . 0.0 OUTLIER -66.85 -28.9 68.72 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.368 178.142 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.812 ' HA ' ' SD ' ' A' ' 144' ' ' MET . . . -106.68 -32.82 7.84 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-O 121.377 0.608 . . . . 0.0 109.538 178.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.601 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -63.91 125.45 24.45 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.081 -1.418 . . . . 0.0 113.212 -178.583 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.7 mt -90.56 -47.25 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.183 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -88.21 -25.36 22.94 Favored 'General case' 0 C--N 1.344 0.357 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.52 49.8 5.63 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 116.131 -0.486 . . . . 0.0 113.957 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -82.72 -19.71 37.44 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.63 1.3 71.34 Favored Glycine 0 CA--C 1.498 -0.974 0 CA-C-N 115.735 -0.666 . . . . 0.0 114.169 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -140.32 92.64 2.55 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 113.974 -1.113 . . . . 0.0 108.346 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.913 HG11 ' CD1' ' A' ' 141' ' ' PHE . 2.4 t -51.2 140.15 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 114.484 -1.235 . . . . 0.0 114.13 -178.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -96.1 -162.84 0.99 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 113.989 -1.459 . . . . 0.0 108.319 177.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.77 ' O ' HG23 ' A' ' 142' ' ' VAL . 32.5 m-85 -80.56 -57.74 3.44 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.285 177.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -56.41 -20.48 19.84 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.724 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 10.6 mt-10 -86.61 -37.59 17.93 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.611 0.719 . . . . 0.0 109.811 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.913 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -76.75 -21.84 54.66 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 113.804 -1.544 . . . . 0.0 109.53 176.271 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 138' ' ' TYR . 98.9 t -82.83 -48.71 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.061 -178.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.582 ' O ' ' N ' ' A' ' 147' ' ' ALA . 11.7 mm100 -56.1 -34.15 65.76 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.883 0.739 . . . . 0.0 111.86 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.812 ' SD ' ' HA ' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -66.24 -17.9 65.02 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 123.265 0.353 . . . . 0.0 111.579 179.64 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 33.3 mmt -86.21 -9.11 57.16 Favored 'General case' 0 C--N 1.348 0.531 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 176.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.1 t -121.78 -37.08 2.92 Favored 'General case' 0 C--N 1.349 0.587 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.321 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -32.09 -44.11 0.08 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 177.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.2 pttt . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.45 -0.786 . . . . 0.0 111.266 179.995 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 18.5 p . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.475 0.178 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -124.98 -43.99 1.94 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.873 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 52.3 pttt -104.52 147.47 27.56 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.367 0.417 . . . . 0.0 110.905 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -116.6 134.89 54.29 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.993 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.64 ' HB ' ' OE1' ' A' ' 127' ' ' GLU . 19.5 p -138.22 176.41 8.73 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.722 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 154' ' ' PHE . . . . . 0.582 ' CE1' ' HB2' ' B' ' 158' ' ' ALA . 54.0 t80 -67.83 -36.02 79.61 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 119.565 -0.255 . . . . 0.0 111.416 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.445 ' HD2' ' OE1' ' A' ' 127' ' ' GLU . 4.5 mptt -53.85 -36.17 62.3 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 120.645 0.26 . . . . 0.0 111.166 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -77.95 -54.5 6.23 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 157' ' ' VAL . . . . . . . . . . . . . 14.1 p -72.36 -28.96 29.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 158' ' ' ALA . . . . . 0.582 ' HB2' ' CE1' ' B' ' 154' ' ' PHE . . . -72.23 -36.79 69.22 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -59.78 -28.7 67.63 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.431 0.457 . . . . 0.0 111.069 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 160' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' B' ' 170' ' ' THR . . . -76.98 -38.73 52.61 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.43 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.463 HG21 HG11 ' A' ' 91' ' ' VAL . 9.1 p -103.71 21.58 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 162' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 15.4 ttpt -92.95 20.09 7.04 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.049 178.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 4.4 tp -126.13 74.54 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-O 121.685 0.755 . . . . 0.0 111.784 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 164' ' ' SER . . . . . 0.599 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 8.9 t 53.62 174.49 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.389 1.076 . . . . 0.0 113.421 178.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . -95.01 12.38 28.66 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.206 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 3.9 m -89.72 -65.25 1.03 Allowed 'General case' 0 C--N 1.346 0.45 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.412 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.35 97.71 4.04 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-O 121.315 0.578 . . . . 0.0 110.05 176.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.17 116.2 28.62 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.578 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 169' ' ' GLY . . . . . 0.597 ' HA2' ' OD1' ' A' ' 42' ' ' ASN . . . 171.81 83.5 0.05 OUTLIER Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.57 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 170' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' B' ' 160' ' ' ALA . 10.4 p . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.44 -0.79 . . . . 0.0 111.016 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.409 0 N-CA-C 111.342 0.127 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -99.21 -41.39 7.51 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.414 0.446 . . . . 0.0 111.209 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.643 ' HA ' ' NE2' ' A' ' 8' ' ' GLN . 46.8 mt-30 -134.72 150.23 50.56 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 123.394 0.434 . . . . 0.0 110.972 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.465 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -110.81 -107.21 0.36 Allowed 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.831 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.566 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 15.2 p -100.71 -173.73 2.47 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 123.686 0.794 . . . . 0.0 110.427 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.419 ' HA ' HD12 ' A' ' 9' ' ' ILE . 3.2 tp10 -59.1 -25.96 64.27 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.566 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 11.3 pt-20 -58.42 -28.54 65.35 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.466 0.651 . . . . 0.0 111.408 178.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.643 ' NE2' ' HA ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -78.68 -44.53 23.45 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.052 -1.431 . . . . 0.0 109.81 178.119 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.488 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 4.0 mt -66.53 -33.38 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.769 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.7 -33.85 62.51 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.472 ' OE2' HD13 ' A' ' 39' ' ' LEU . 46.1 mt-10 -109.89 -18.03 13.49 Favored 'General case' 0 C--N 1.344 0.345 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -177.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.488 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 0.4 OUTLIER -72.78 -15.92 61.64 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.584 0.629 . . . . 0.0 110.63 179.152 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.693 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -82.5 -41.11 20.14 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.591 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.693 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 1.1 mt-10 -85.39 -36.9 20.41 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 114.363 -1.29 . . . . 0.0 113.349 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.764 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -69.52 -23.85 63.66 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.901 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 54.8 t80 -87.07 -40.88 14.28 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.094 176.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.0 m -86.09 -12.67 49.46 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -177.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -71.99 -30.22 65.02 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.348 179.153 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.46 ' HB3' HG22 ' A' ' 27' ' ' ILE . 37.8 t80 -130.89 -11.77 3.77 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.901 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 1.4 m-20 -97.53 81.14 2.91 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.214 0.915 . . . . 0.0 110.254 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.9 -42.85 57.02 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 114.771 -1.104 . . . . 0.0 113.485 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.05 -17.72 56.69 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.157 178.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.42 51.73 4.8 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.332 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.2 22.08 2.58 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -174.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.87 -60.13 0.14 Allowed Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.435 -0.802 . . . . 0.0 115.034 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.702 HG22 ' N ' ' A' ' 64' ' ' ASP . 6.2 p -97.52 154.43 17.51 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 123.509 0.724 . . . . 0.0 112.403 -178.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -124.04 149.6 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.712 -179.266 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 p -54.35 153.26 5.59 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.611 1.338 . . . . 0.0 114.611 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.5 p -80.99 -55.7 4.61 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.773 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -53.64 -14.11 0.81 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.477 177.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.541 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -113.05 -20.44 11.51 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.482 -178.765 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.469 ' HA ' HG23 ' A' ' 35' ' ' VAL . 2.2 tm? -51.27 -39.0 55.8 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.83 0.852 . . . . 0.0 112.217 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.761 ' O ' ' HD3' ' A' ' 37' ' ' ARG . . . -58.72 -40.28 94.69 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 177.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.8 m -75.89 -28.15 57.98 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 114.512 -0.844 . . . . 0.0 112.348 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.764 HG12 ' HA ' ' A' ' 15' ' ' ALA . 1.4 t -75.56 -26.55 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 177.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.602 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 29.6 mtt -75.94 -43.13 46.42 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 112.771 -2.013 . . . . 0.0 111.401 176.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.761 ' HD3' ' O ' ' A' ' 33' ' ' GLY . 11.2 mtp180 -78.53 -28.36 46.13 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 58.0 m -66.64 -8.25 26.15 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.072 0.939 . . . . 0.0 111.708 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.472 HD13 ' OE2' ' A' ' 11' ' ' GLU . 92.4 mt -93.3 -6.67 46.93 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 113.091 -1.868 . . . . 0.0 109.65 178.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.5 0.0 53.27 Favored Glycine 0 CA--C 1.492 -1.365 0 CA-C-O 122.468 1.038 . . . . 0.0 114.452 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.602 ' HB2' ' O ' ' A' ' 36' ' ' MET . 47.2 mt-30 -80.84 138.16 36.2 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-N 111.889 -2.155 . . . . 0.0 112.093 -178.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -118.79 74.77 12.8 Favored Pre-proline 0 CA--C 1.549 0.905 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.341 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -84.11 -178.1 3.33 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 123.146 2.564 . . . . 0.0 112.374 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.421 HG22 ' H ' ' A' ' 46' ' ' ALA . 1.5 m -101.72 160.79 14.16 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.544 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 28.9 mt-10 -80.85 -28.45 36.08 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.698 177.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.421 ' H ' HG22 ' A' ' 44' ' ' THR . . . -71.4 -36.43 71.36 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 113.584 -1.644 . . . . 0.0 109.947 -178.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -77.91 -30.05 50.43 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.766 176.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.591 ' O ' HD13 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -67.17 -20.04 65.67 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.27 174.576 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.884 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 54.5 mt-30 -99.03 -15.08 19.18 Favored 'General case' 0 CA--C 1.48 -1.723 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.01 178.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -84.87 -35.89 21.9 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 112.011 -2.359 . . . . 0.0 109.943 176.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 13.9 mmt -86.68 -28.14 23.32 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.566 177.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.591 HD13 ' O ' ' A' ' 48' ' ' LEU . 1.5 mp -77.99 -24.99 14.18 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 175.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.884 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.7 t-20 -78.31 -34.41 48.74 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.962 175.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -88.42 -41.95 12.47 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.559 ' C ' ' H ' ' A' ' 57' ' ' ALA . 84.1 t -83.52 -48.57 17.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -178.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 5.2 t70 -72.34 39.4 0.08 Allowed 'General case' 0 C--O 1.238 0.497 0 CA-C-O 122.025 0.917 . . . . 0.0 110.099 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.559 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -84.33 -5.45 59.27 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 114.098 -1.41 . . . . 0.0 112.446 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -95.29 -34.25 12.25 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 112.159 -2.291 . . . . 0.0 110.947 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.11 45.82 6.12 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 115.992 -0.549 . . . . 0.0 113.474 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -110.0 -21.52 12.27 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.625 0.25 . . . . 0.0 111.262 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.94 26.8 73.83 Favored Glycine 0 N--CA 1.467 0.717 0 CA-C-N 115.752 -0.658 . . . . 0.0 114.198 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.421 ' O ' HD13 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -146.68 155.45 42.44 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 123.247 0.619 . . . . 0.0 110.509 -179.425 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.542 ' O ' HG13 ' A' ' 27' ' ' ILE . 8.4 mm -133.48 128.17 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -176.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.702 ' N ' HG22 ' A' ' 26' ' ' THR . 11.9 p-10 -81.77 151.76 27.3 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.273 176.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.729 ' HA ' ' CE2' ' A' ' 68' ' ' PHE . 28.7 p90 -80.14 -29.38 0.55 Allowed Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -177.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 11.5 Cg_exo -71.38 -17.54 30.54 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 121.898 1.732 . . . . 0.0 112.716 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -91.64 -31.06 16.0 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.729 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 3.5 p90 -84.67 -28.03 26.68 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 -176.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 73' ' ' ALA . 5.1 mt -69.27 -36.68 77.35 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.615 0.721 . . . . 0.0 110.004 178.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.42 -31.68 69.49 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 113.423 -1.717 . . . . 0.0 108.89 173.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.766 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 51.1 mtt -75.74 -23.92 56.08 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.004 175.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.612 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 68.5 mtt -89.05 -21.93 23.2 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.096 176.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.49 ' O ' ' HG3' ' A' ' 77' ' ' LYS . . . -74.73 -30.52 61.54 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.077 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.519 ' HD3' ' N ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -81.07 -24.49 37.76 Favored 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 123.684 0.615 . . . . 0.0 109.884 -179.536 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.766 ' HD2' ' O ' ' A' ' 71' ' ' MET . 25.7 mttt -70.52 -14.51 62.54 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.697 176.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.442 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 22.7 ptt? -121.01 -28.2 4.82 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -177.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 73' ' ' ALA . 54.6 mttt -58.24 -24.2 58.52 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -103.88 -30.56 10.26 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.442 ' CG2' ' HA ' ' A' ' 76' ' ' MET . 5.9 t -81.83 104.44 12.21 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.844 0.354 . . . . 0.0 111.499 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -14.04 134.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.803 1.641 . . . . 0.0 115.271 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.8 m -77.99 -13.52 59.85 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.166 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.52 -42.04 62.28 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.879 0.847 . . . . 0.0 110.074 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.579 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 41.8 mt-10 -73.7 -18.81 60.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.31 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.428 ' OE2' HD12 ' B' ' 163' ' ' ILE . 0.2 OUTLIER -63.89 -18.73 64.49 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.4 mp -87.82 -51.3 12.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.72 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.4 mtt180 -60.29 -16.78 37.4 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.626 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.579 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 44.2 mt-10 -78.81 -20.77 48.93 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.489 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.31 -21.29 56.39 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.657 177.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.526 ' O ' ' HB3' ' A' ' 93' ' ' ASP . 6.2 m-85 -84.46 -21.04 30.81 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 174.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -76.57 -21.87 55.05 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 174.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 87' ' ' GLU . 55.6 t -88.02 -52.24 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.218 177.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.781 ' HB2' HD13 ' A' ' 100' ' ' ILE . 92.0 m-85 -100.37 -41.31 7.09 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -176.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.727 ' CA ' HG12 ' A' ' 100' ' ' ILE . 2.3 t70 -64.5 94.61 0.12 Allowed 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.662 0.744 . . . . 0.0 110.867 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.1 mmpt? -87.39 -48.9 7.6 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.385 -1.279 . . . . 0.0 113.436 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.06 0.62 9.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -175.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 49.35 30.09 11.37 Favored Glycine 0 N--CA 1.472 1.07 0 CA-C-N 114.327 -1.306 . . . . 0.0 114.715 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -96.94 -7.2 33.79 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 122.29 0.236 . . . . 0.0 111.464 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.452 ' O ' ' HE2' ' A' ' 89' ' ' PHE . . . 104.17 -18.71 45.07 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 121.396 -0.43 . . . . 0.0 112.919 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -119.72 119.68 34.37 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.61 -0.795 . . . . 0.0 110.814 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.781 HD13 ' HB2' ' A' ' 92' ' ' PHE . 50.1 mt -77.43 92.26 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.3 t -72.16 166.29 22.65 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.513 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.542 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -59.35 -14.62 12.39 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.528 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.8 -29.41 19.76 Favored 'General case' 0 CA--C 1.489 -1.369 0 CA-C-O 121.775 0.798 . . . . 0.0 109.348 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.968 ' O ' HG23 ' A' ' 108' ' ' VAL . 18.4 mt-10 -79.3 -41.44 28.03 Favored 'General case' 0 CA--C 1.483 -1.621 0 CA-C-N 112.739 -2.028 . . . . 0.0 111.113 -178.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.625 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 6.4 tt -66.44 -34.31 77.65 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.597 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -70.06 -44.91 68.17 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.158 175.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.528 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 10.4 t-80 -68.79 -21.72 64.31 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.599 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.968 HG23 ' O ' ' A' ' 104' ' ' GLU . 3.5 t -70.71 -51.87 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.293 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 177.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.596 ' O ' ' N ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -60.54 -38.56 84.85 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 111.521 -2.581 . . . . 0.0 112.383 177.635 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.25 -18.71 61.79 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.531 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.51 -45.32 19.53 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.485 176.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.6 mt -80.89 -28.45 35.94 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.292 -178.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 140.05 -6.89 2.89 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-O 117.697 -1.613 . . . . 0.0 116.922 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.596 ' N ' ' O ' ' A' ' 109' ' ' MET . 4.5 mt-10 -100.61 151.67 21.34 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-N 120.979 2.389 . . . . 0.0 113.994 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.75 125.7 52.22 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 113.682 -1.599 . . . . 0.0 107.442 175.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.597 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 1.3 tp -130.21 116.02 17.81 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 113.802 -1.545 . . . . 0.0 112.028 -175.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.848 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -74.52 -175.84 2.53 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.657 179.662 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.527 ' O ' HG23 ' A' ' 121' ' ' VAL . 16.3 t70 -73.3 -37.86 66.06 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -177.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.648 ' H ' HG23 ' A' ' 117' ' ' THR . 8.2 pt-20 -87.84 -16.1 34.95 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.72 ' HG2' HG22 ' A' ' 117' ' ' THR . 14.3 pt-20 -85.4 -15.51 42.85 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 123.107 0.254 . . . . 0.0 110.992 178.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.848 HG22 ' O ' ' A' ' 117' ' ' THR . 0.1 OUTLIER -83.55 -25.59 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.602 178.109 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -74.62 29.91 0.09 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.956 0.884 . . . . 0.0 112.368 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.557 ' O ' ' HB3' ' A' ' 127' ' ' GLU . 11.3 pt-20 -142.01 -28.59 0.62 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 114.187 -1.369 . . . . 0.0 109.868 177.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.705 ' HA ' ' OG1' ' B' ' 153' ' ' THR . 4.5 mmt -74.76 -29.49 61.15 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 176.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.583 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 3.0 mt -88.05 -52.48 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-N 113.919 -1.491 . . . . 0.0 112.352 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -55.96 -28.53 57.41 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 124.233 0.958 . . . . 0.0 111.681 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.686 ' OE1' ' HD2' ' B' ' 155' ' ' LYS . 0.0 OUTLIER -62.05 -33.9 75.25 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.27 178.191 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.59 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -108.39 -32.01 7.61 Favored 'General case' 0 C--N 1.349 0.559 0 CA-C-O 121.217 0.532 . . . . 0.0 110.131 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.583 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -61.29 127.38 31.21 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.429 -1.259 . . . . 0.0 113.412 -178.788 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.3 mt -89.8 -49.24 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 114.199 -1.364 . . . . 0.0 110.416 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -85.27 -25.25 27.36 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.2 49.61 9.32 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 116.133 -0.485 . . . . 0.0 113.924 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -85.05 -19.4 32.0 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 99.65 9.93 48.48 Favored Glycine 0 CA--C 1.5 -0.905 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.419 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -140.6 125.47 18.23 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 113.8 -1.2 . . . . 0.0 108.34 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.586 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 2.1 t -86.02 130.48 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -177.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -95.43 -163.54 1.06 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.171 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.453 ' O ' HG23 ' A' ' 142' ' ' VAL . 29.4 m-85 -74.89 -55.68 5.54 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.577 177.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.91 -20.43 62.04 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.59 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 13.4 mt-10 -86.35 -46.23 10.48 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.303 0.573 . . . . 0.0 109.748 178.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.594 ' O ' ' HG3' ' A' ' 144' ' ' MET . 81.8 t80 -68.09 -22.76 64.9 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.37 -1.287 . . . . 0.0 109.258 175.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.621 ' O ' ' HG3' ' A' ' 145' ' ' MET . 24.3 t -84.78 -47.09 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.921 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -60.67 -34.09 73.8 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.439 -0.504 . . . . 0.0 111.234 177.877 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.594 ' HG3' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -63.93 -27.33 69.07 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 123.222 0.326 . . . . 0.0 110.682 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.621 ' HG3' ' O ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -82.38 -7.93 59.63 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 177.705 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.9 p -113.51 -46.28 3.07 Favored 'General case' 0 C--N 1.349 0.557 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.529 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -29.99 -43.77 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.787 1.235 . . . . 0.0 114.182 177.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 20.1 pttp . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.358 -179.991 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 19.4 p . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.421 0.153 . . . . 0.0 111.346 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -124.75 135.43 52.98 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.844 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -102.15 132.78 47.84 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.853 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -107.57 125.04 50.82 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.405 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.705 ' OG1' ' HA ' ' A' ' 124' ' ' MET . 1.9 p -139.54 -60.7 0.55 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.917 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 154' ' ' PHE . . . . . 0.632 ' HA ' HG22 ' B' ' 157' ' ' VAL . 0.1 OUTLIER -66.98 -27.54 67.53 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 118.328 0.513 . . . . 0.0 110.14 178.449 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.686 ' HD2' ' OE1' ' A' ' 127' ' ' GLU . 4.8 mptt -67.71 -40.94 84.23 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.607 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 156' ' ' GLU . . . . . 0.515 ' HA ' ' ND2' ' B' ' 159' ' ' ASN . 9.5 mm-40 -76.74 -36.15 57.3 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 157' ' ' VAL . . . . . 0.632 HG22 ' HA ' ' B' ' 154' ' ' PHE . 19.1 m -72.49 -29.98 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 120.871 0.367 . . . . 0.0 111.366 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 158' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' B' ' 162' ' ' LYS . . . -73.01 -44.69 60.69 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.789 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 159' ' ' ASN . . . . . 0.515 ' ND2' ' HA ' ' B' ' 156' ' ' GLU . 28.2 p30 -52.44 -29.65 25.55 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.66 -38.34 47.87 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.542 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 11.5 p -134.11 51.13 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 CA-C-O 121.191 0.519 . . . . 0.0 112.123 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 162' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 17.1 ttpt -90.84 -36.89 13.95 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.874 178.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 163' ' ' ILE . . . . . 0.428 HD12 ' OE2' ' A' ' 84' ' ' GLU . 3.3 tp -93.77 122.69 45.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.615 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 16.2 t -133.62 -9.56 2.81 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.443 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 165' ' ' ALA . . . . . 0.455 ' HB2' ' OE2' ' A' ' 87' ' ' GLU . . . -88.18 -10.89 48.41 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 166' ' ' SER . . . . . 0.497 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 54.0 m -87.34 -74.13 0.45 Allowed 'General case' 0 CA--C 1.536 0.439 0 O-C-N 123.096 0.248 . . . . 0.0 111.007 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 6.5 tp -107.01 96.16 6.23 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.05 0.452 . . . . 0.0 110.147 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 20.9 ptt? -129.44 149.03 51.4 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.134 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -114.8 139.33 15.51 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.5 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.092 -0.956 . . . . 0.0 110.469 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.447 0.165 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.79 -49.23 5.42 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.203 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.551 ' CB ' HE22 ' A' ' 8' ' ' GLN . 3.3 tt0 -138.51 -51.79 0.58 Allowed 'General case' 0 C--N 1.346 0.427 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.492 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -113.19 -117.74 0.31 Allowed 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.509 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.537 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 17.9 p -101.66 -173.98 2.48 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 123.848 0.859 . . . . 0.0 111.093 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -67.74 -21.42 65.28 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.126 0.57 . . . . 0.0 112.064 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.537 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 13.2 pt-20 -51.49 -28.28 12.93 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.694 0.759 . . . . 0.0 111.853 178.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.72 ' HB2' HD13 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -76.88 -47.29 21.64 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 113.618 -1.628 . . . . 0.0 110.572 179.038 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.641 ' O ' ' HD2' ' A' ' 13' ' ' LYS . 2.9 mp -70.97 -28.27 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.319 178.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.36 -41.15 63.77 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -130.36 -33.85 1.66 Allowed 'General case' 0 C--N 1.357 0.92 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.465 ' CB ' HD11 ' A' ' 69' ' ' LEU . 0.2 OUTLIER -64.34 -14.01 53.72 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.666 179.661 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.728 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.7 OUTLIER -71.82 -40.85 68.84 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 176.461 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.728 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 6.1 mt-10 -75.0 -45.31 42.78 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-N 113.555 -1.657 . . . . 0.0 111.386 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.593 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -61.36 -19.01 61.36 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.545 0.688 . . . . 0.0 109.412 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.695 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 2.1 t80 -86.83 -48.26 8.35 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.392 -1.276 . . . . 0.0 109.616 176.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.0 t -86.36 -13.25 47.03 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -177.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -69.23 -30.52 68.69 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.045 0.384 . . . . 0.0 111.097 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.58 ' CD1' HG22 ' A' ' 35' ' ' VAL . 5.1 m-85 -125.71 -15.52 5.98 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.695 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -102.9 80.8 1.92 Allowed 'General case' 0 C--O 1.239 0.55 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.136 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.446 ' HE2' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -76.61 -27.47 55.75 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.344 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.607 ' OD1' ' HB2' ' A' ' 24' ' ' ASP . 0.3 OUTLIER -71.53 -23.03 61.7 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.471 176.937 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.88 52.04 4.84 Favored Glycine 0 N--CA 1.468 0.806 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.042 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.607 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -100.73 21.59 13.26 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -175.119 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.478 ' H ' ' HE1' ' A' ' 16' ' ' PHE . . . 65.41 -56.42 0.12 Allowed Glycine 0 CA--C 1.533 1.174 0 N-CA-C 115.809 1.083 . . . . 0.0 115.809 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 0.8 OUTLIER -96.65 139.91 32.03 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.783 0.833 . . . . 0.0 113.052 -178.286 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.477 ' H ' HG13 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -114.82 148.53 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.472 178.918 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.15 149.29 28.53 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.48 -55.22 6.63 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 115.082 -0.963 . . . . 0.0 113.037 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -53.23 -14.09 0.63 Allowed 'General case' 0 N--CA 1.474 0.772 0 O-C-N 123.807 0.692 . . . . 0.0 111.473 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.535 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.6 mt-10 -113.87 -17.06 12.12 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.453 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.475 ' HA ' HG23 ' A' ' 35' ' ' VAL . 2.2 tm? -54.89 -43.13 72.94 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.783 0.833 . . . . 0.0 111.918 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.775 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -55.3 -39.76 73.27 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 177.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 m -74.59 -28.4 60.89 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 114.595 -0.802 . . . . 0.0 112.397 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' ' 15' ' ' ALA . 1.7 t -74.77 -26.68 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.062 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.647 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 33.9 mtt -77.25 -41.11 42.37 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 112.909 -1.95 . . . . 0.0 111.729 176.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.775 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 10.6 mtt180 -83.2 -27.74 29.78 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -178.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.3 m -64.09 -8.17 11.14 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.99 0.9 . . . . 0.0 112.402 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.2 mt -93.94 -7.23 43.58 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 113.304 -1.771 . . . . 0.0 109.772 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.42 -1.38 43.06 Favored Glycine 0 CA--C 1.492 -1.401 0 CA-C-O 122.369 0.983 . . . . 0.0 114.658 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.647 ' HB2' ' O ' ' A' ' 36' ' ' MET . 46.7 mt-30 -78.63 139.82 38.5 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 112.107 -2.047 . . . . 0.0 112.081 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -121.35 73.01 28.26 Favored Pre-proline 0 CA--C 1.549 0.918 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.437 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.96 -177.82 4.09 Favored 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 123.071 2.514 . . . . 0.0 112.098 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 46' ' ' ALA . 1.4 m -99.22 160.49 14.24 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.522 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 28.6 mt-10 -80.79 -28.36 36.33 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.668 177.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.417 ' H ' HG22 ' A' ' 44' ' ' THR . . . -71.84 -36.6 70.21 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 113.573 -1.649 . . . . 0.0 109.994 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -77.07 -29.97 55.3 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.677 176.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -65.82 -20.76 66.36 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.024 174.569 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.741 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 47.9 mt-30 -95.35 -17.43 21.6 Favored 'General case' 0 CA--C 1.483 -1.61 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.168 178.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -84.07 -32.73 24.65 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 111.914 -2.403 . . . . 0.0 109.42 176.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.522 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -86.38 -35.37 19.81 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.644 176.931 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.8 mt -69.77 -27.4 33.19 Favored 'Isoleucine or valine' 0 C--N 1.351 0.638 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 175.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.741 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 4.4 t-20 -67.8 -33.33 74.6 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.431 174.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -85.1 -22.55 28.86 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.897 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.603 ' C ' ' H ' ' A' ' 57' ' ' ALA . 55.8 t -82.39 -37.82 14.79 Favored 'Isoleucine or valine' 0 C--N 1.346 0.432 0 C-N-CA 122.589 0.355 . . . . 0.0 111.786 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.99 26.94 0.04 OUTLIER 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.93 0.871 . . . . 0.0 111.094 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.603 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -87.72 -6.94 57.97 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 113.989 -1.46 . . . . 0.0 111.986 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -113.4 -29.96 7.04 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 111.72 -2.491 . . . . 0.0 110.9 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.48 18.86 61.32 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.921 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -110.24 -21.66 12.13 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.961 0.381 . . . . 0.0 111.965 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.11 27.27 73.97 Favored Glycine 0 N--CA 1.468 0.77 0 N-CA-C 114.432 0.533 . . . . 0.0 114.432 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.435 ' CG2' ' HB ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -122.65 165.98 15.62 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 122.906 0.483 . . . . 0.0 111.498 -179.06 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 26' ' ' THR . 4.9 mp -126.41 109.39 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.522 ' N ' HG22 ' A' ' 26' ' ' THR . 0.4 OUTLIER -85.19 165.5 17.35 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.601 176.032 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.528 ' O ' HD12 ' A' ' 69' ' ' LEU . 31.3 p90 -91.14 -39.3 0.39 Allowed Pre-proline 0 CA--C 1.548 0.901 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 51.1 Cg_endo -69.82 -17.8 37.1 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 121.787 1.658 . . . . 0.0 113.529 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -102.91 -32.06 9.95 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -177.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.816 ' O ' ' HG2' ' A' ' 71' ' ' MET . 7.3 t80 -84.79 -27.77 26.62 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -177.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.72 HD13 ' HB2' ' A' ' 8' ' ' GLN . 4.4 mt -70.65 -32.88 70.34 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-O 121.92 0.867 . . . . 0.0 109.55 177.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.666 ' O ' ' HD3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -54.44 -41.26 69.19 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 112.785 -2.007 . . . . 0.0 109.648 175.136 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.816 ' HG2' ' O ' ' A' ' 68' ' ' PHE . 25.8 ptm -72.69 -27.13 61.89 Favored 'General case' 0 C--N 1.347 0.48 0 O-C-N 123.802 0.689 . . . . 0.0 109.351 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.593 ' O ' ' HG2' ' A' ' 76' ' ' MET . 94.4 mtp -81.78 -18.61 43.53 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.326 179.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.778 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -84.21 -31.59 24.98 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.666 ' HD3' ' O ' ' A' ' 70' ' ' THR . 4.9 ptt180 -89.6 -18.2 27.0 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 179.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.656 ' HD2' ' O ' ' A' ' 71' ' ' MET . 0.0 OUTLIER -84.61 -12.96 53.0 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.266 0.939 . . . . 0.0 113.035 179.051 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.593 ' HG2' ' O ' ' A' ' 72' ' ' MET . 7.8 ptt? -116.07 -28.97 6.44 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.778 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 34.8 mmtt -77.81 -21.89 50.9 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -178.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -103.91 -29.52 10.91 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.52 HG23 ' H ' ' A' ' 80' ' ' ASP . 5.6 t -66.38 -62.87 1.24 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.52 ' H ' HG23 ' A' ' 79' ' ' THR . 3.2 m-20 -164.65 94.39 0.69 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.871 0.868 . . . . 0.0 110.335 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.1 m -83.99 -14.13 51.53 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.526 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.472 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -87.11 -50.06 6.89 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.352 0.596 . . . . 0.0 110.142 -179.059 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.472 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 39.5 mt-10 -74.89 -17.53 60.57 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.331 -1.304 . . . . 0.0 112.348 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.588 ' HA ' ' OE2' ' A' ' 87' ' ' GLU . 1.0 OUTLIER -58.36 -24.42 59.82 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.4 mp -87.92 -54.18 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.97 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.588 ' O ' ' HD2' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -62.67 -18.72 62.91 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.381 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.588 ' OE2' ' HA ' ' A' ' 84' ' ' GLU . 3.4 pt-20 -73.48 -19.68 60.88 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.113 0.482 . . . . 0.0 110.282 178.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.614 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -69.22 -22.73 63.85 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.437 178.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.604 ' O ' ' HB2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -81.77 -21.71 37.63 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 174.652 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 7.5 ttt180 -76.79 -15.83 59.63 Favored 'General case' 0 C--N 1.344 0.345 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.614 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 3.8 t -84.21 -33.73 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.512 177.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.83 ' HB3' HG21 ' A' ' 100' ' ' ILE . 48.6 m-85 -98.91 -36.3 9.81 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -177.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.622 ' N ' HG12 ' A' ' 100' ' ' ILE . 1.7 t70 -63.99 88.63 0.05 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.929 0.892 . . . . 0.0 111.75 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 27.4 mttm -87.63 -41.45 13.39 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.512 -1.222 . . . . 0.0 113.641 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -70.72 -18.43 62.8 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -176.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.85 17.74 73.62 Favored Glycine 0 C--N 1.295 -1.746 0 CA-C-N 112.834 -1.985 . . . . 0.0 114.642 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -90.29 -7.01 54.47 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.891 0.345 . . . . 0.0 111.517 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.52 -18.91 49.64 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.926 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -112.39 118.41 35.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.294 -0.953 . . . . 0.0 110.391 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.83 HG21 ' HB3' ' A' ' 92' ' ' PHE . 29.1 mt -78.5 90.7 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.3 t -61.93 159.92 13.2 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.151 -0.931 . . . . 0.0 113.235 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.508 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -58.74 -15.97 14.53 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 115.046 1.499 . . . . 0.0 115.046 -178.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -89.05 -26.17 21.55 Favored 'General case' 0 CA--C 1.489 -1.402 0 CA-C-O 121.769 0.795 . . . . 0.0 109.17 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.942 ' O ' HG23 ' A' ' 108' ' ' VAL . 3.3 mm-40 -79.06 -43.85 23.37 Favored 'General case' 0 CA--C 1.482 -1.638 0 CA-C-N 112.632 -2.076 . . . . 0.0 112.484 -177.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.733 HD13 ' SD ' ' A' ' 124' ' ' MET . 9.3 tt -67.17 -30.25 70.16 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.618 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -70.16 -45.3 67.04 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.8 176.286 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.533 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 32.3 t-80 -68.98 -21.88 64.13 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.63 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.942 HG23 ' O ' ' A' ' 104' ' ' GLU . 3.1 t -69.73 -51.33 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.299 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.595 ' O ' ' N ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -60.87 -39.37 88.96 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 111.568 -2.56 . . . . 0.0 112.44 177.26 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.79 -18.78 62.08 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.506 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.4 -45.5 19.37 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.43 175.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.6 mt -80.04 -28.35 39.29 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.027 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 140.08 -7.73 2.93 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-O 117.704 -1.609 . . . . 0.0 117.017 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.595 ' N ' ' O ' ' A' ' 109' ' ' MET . 4.2 mt-10 -100.73 151.82 21.21 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 121.051 2.425 . . . . 0.0 114.543 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -105.32 130.01 53.54 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.431 -1.713 . . . . 0.0 106.868 174.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.618 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 1.0 OUTLIER -134.31 125.03 26.82 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.46 -1.246 . . . . 0.0 111.776 -175.696 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . 1.008 ' O ' ' HB ' ' A' ' 121' ' ' VAL . 0.7 OUTLIER -96.35 -177.2 3.88 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 114.079 -1.419 . . . . 0.0 112.395 -177.458 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.517 ' N ' HG23 ' A' ' 117' ' ' THR . 17.1 t70 -63.93 -41.14 97.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.469 -1.241 . . . . 0.0 114.084 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.681 ' H ' HG23 ' A' ' 117' ' ' THR . 4.0 mt-10 -78.48 -42.9 28.4 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.788 ' CG ' ' H ' ' A' ' 117' ' ' THR . 13.0 pt-20 -73.24 -23.58 60.37 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.925 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 1.008 ' HB ' ' O ' ' A' ' 117' ' ' THR . 1.2 t -87.5 -23.77 6.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 114.746 -1.116 . . . . 0.0 112.472 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.12 37.34 0.85 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.906 0.86 . . . . 0.0 110.692 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -138.8 -42.54 0.48 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.246 -1.343 . . . . 0.0 109.394 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.801 ' HE3' HG13 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -63.65 -22.46 66.91 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.914 178.015 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.634 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 4.2 mt -88.96 -48.94 14.47 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.558 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -60.55 -28.01 68.1 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 123.97 0.794 . . . . 0.0 111.681 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.585 ' OE1' ' HB ' ' B' ' 153' ' ' THR . 0.0 OUTLIER -64.41 -34.31 77.88 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.941 178.311 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.609 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -102.85 -32.23 9.89 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-O 121.415 0.626 . . . . 0.0 109.504 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.634 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.2 OUTLIER -63.0 124.21 20.51 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 114.054 -1.43 . . . . 0.0 113.026 -179.46 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.8 mt -90.48 -47.79 14.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.016 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -88.59 -25.25 22.57 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.16 49.91 4.29 Favored Glycine 0 CA--C 1.524 0.646 0 O-C-N 123.501 0.501 . . . . 0.0 113.884 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -76.74 -20.05 56.96 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.409 ' HA2' HG21 ' A' ' 125' ' ' ILE . . . 84.72 21.88 54.8 Favored Glycine 0 CA--C 1.507 -0.448 0 CA-C-N 115.764 -0.653 . . . . 0.0 114.558 178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.698 ' O ' ' HB ' ' A' ' 136' ' ' VAL . 42.1 mt-30 -135.72 -74.31 0.45 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.6 -0.8 . . . . 0.0 109.708 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.698 ' HB ' ' O ' ' A' ' 135' ' ' GLN . 2.5 t 124.3 121.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 125.248 1.419 . . . . 0.0 111.301 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.444 HD22 ' CD ' ' A' ' 140' ' ' GLU . 20.0 m-80 -88.84 -163.55 1.0 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.69 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.431 ' O ' HG23 ' A' ' 142' ' ' VAL . 70.1 m-85 -72.31 -53.79 11.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.956 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.04 -20.66 66.6 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.609 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 8.9 mt-10 -86.78 -41.91 13.73 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.364 0.602 . . . . 0.0 109.739 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.625 ' HA ' ' SD ' ' A' ' 144' ' ' MET . 38.6 t80 -69.36 -24.18 63.85 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.16 176.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 138' ' ' TYR . 22.7 t -86.23 -48.33 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.996 -178.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.724 ' O ' ' N ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -54.74 -34.59 62.71 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 123.906 0.754 . . . . 0.0 111.512 179.066 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.669 ' SD ' ' HB3' ' B' ' 154' ' ' PHE . 6.4 ptt? -60.87 -26.54 67.47 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 123.238 0.336 . . . . 0.0 111.639 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 69.2 mtm -87.59 -3.87 58.97 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.52 178.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.8 t -133.55 -27.01 1.57 Allowed 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.724 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -48.11 -31.33 5.44 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 178.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 93.3 mttt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.123 -0.941 . . . . 0.0 111.632 179.936 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 19.0 p . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 120.564 0.221 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -117.4 135.45 53.87 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.781 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 62.84 124.22 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.838 0.855 . . . . 0.0 111.883 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 152' ' ' LYS . . . . . 0.557 ' HD2' ' OE1' ' A' ' 114' ' ' GLU . 48.0 mttp -109.36 160.25 16.32 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.403 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.585 ' HB ' ' OE1' ' A' ' 127' ' ' GLU . 12.4 p -137.86 171.38 14.51 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.783 -179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 154' ' ' PHE . . . . . 0.669 ' HB3' ' SD ' ' A' ' 144' ' ' MET . 0.3 OUTLIER -56.07 -27.84 55.16 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 117.811 0.278 . . . . 0.0 110.879 179.094 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 144' ' ' MET . 0.3 OUTLIER -71.45 -48.89 46.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.406 0.682 . . . . 0.0 111.222 178.385 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.6 -35.44 58.11 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 157' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' B' ' 154' ' ' PHE . 27.9 m -67.54 -29.92 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 122.774 0.43 . . . . 0.0 111.454 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 158' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' B' ' 162' ' ' LYS . . . -70.86 -44.49 66.28 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.881 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -61.35 -24.86 66.76 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.92 -38.59 53.18 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.655 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 9.9 p -114.12 25.86 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.253 0 O-C-N 123.401 0.438 . . . . 0.0 111.832 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 162' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 1.5 ttpm? -87.57 -34.42 18.56 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 122.47 -0.144 . . . . 0.0 110.942 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 3.0 tp -106.25 14.02 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.91 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 19.0 t -86.46 -12.3 49.39 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.551 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 165' ' ' ALA . . . . . 0.414 ' HB3' ' OE2' ' A' ' 84' ' ' GLU . . . -94.01 8.17 42.42 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.674 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 56.5 p -84.96 -34.15 22.5 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.676 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 7.9 tp -84.32 -9.06 58.79 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 123.425 0.453 . . . . 0.0 111.106 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 65.0 mtt -96.86 130.71 44.09 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.75 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -163.44 -151.97 6.66 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.688 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 20.2 p . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.089 -0.958 . . . . 0.0 111.061 -179.956 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 111.396 0.147 . . . . 0.0 111.396 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.543 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 8.0 m-20 -117.03 -41.98 2.97 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.445 0.465 . . . . 0.0 111.2 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -141.99 157.19 45.23 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 122.848 0.459 . . . . 0.0 110.448 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.564 ' HG ' ' OE1' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -103.52 -119.43 0.2 Allowed 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.695 ' CG2' ' H ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -103.18 -173.71 2.38 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.003 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.539 ' N ' HG23 ' A' ' 5' ' ' THR . 45.5 mt-10 -63.0 -12.91 29.08 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 122.453 -0.154 . . . . 0.0 110.92 176.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.695 ' H ' ' CG2' ' A' ' 5' ' ' THR . 7.3 pt-20 -49.47 -40.19 36.26 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 123.785 0.678 . . . . 0.0 111.772 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.583 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 1.6 pt20 -72.1 -48.86 40.83 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.769 178.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.405 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 4.5 mt -62.18 -28.36 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-N 114.095 -1.411 . . . . 0.0 110.633 178.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 6' ' ' GLU . . . -68.1 -48.93 64.16 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -136.27 -29.06 1.0 Allowed 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -177.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.583 ' CD1' ' HA ' ' A' ' 8' ' ' GLN . 28.0 m-85 -63.55 -14.62 53.02 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 123.383 0.427 . . . . 0.0 110.345 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.666 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 4.3 pttt -74.19 -38.44 63.62 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.666 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 12.0 mt-10 -70.4 -43.81 69.27 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 113.607 -1.633 . . . . 0.0 110.566 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.532 ' O ' HG11 ' A' ' 35' ' ' VAL . . . -62.94 -18.26 62.93 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 115.373 -0.831 . . . . 0.0 108.927 176.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.62 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 25.9 t80 -85.84 -49.91 7.53 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.394 177.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.457 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 52.6 m -87.52 -13.03 44.13 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -177.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -66.68 -29.93 70.06 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.523 0.601 . . . . 0.0 112.256 -178.893 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.577 ' CD1' HG22 ' A' ' 35' ' ' VAL . 3.1 m-85 -126.03 -4.19 6.91 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.62 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 6.0 t70 -77.83 55.63 1.42 Allowed 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 118.479 0.581 . . . . 0.0 112.368 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.457 ' HE3' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -86.6 -21.94 26.53 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 179.307 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.71 -22.38 61.64 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.334 0.588 . . . . 0.0 110.436 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.73 43.16 29.63 Favored Glycine 0 N--CA 1.471 0.992 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.52 23.25 12.19 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.013 -1.594 . . . . 0.0 112.78 -175.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.07 -78.81 1.87 Allowed Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.265 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.583 HG21 ' HA ' ' A' ' 64' ' ' ASP . 0.4 OUTLIER -114.51 166.92 11.19 Favored 'General case' 0 N--CA 1.435 -1.223 0 O-C-N 123.649 0.264 . . . . 0.0 110.4 178.219 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -77.09 148.18 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.403 ' OG1' ' HB2' ' A' ' 31' ' ' GLU . 0.6 OUTLIER -68.57 164.19 21.9 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 114.612 -1.177 . . . . 0.0 113.494 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.39 -55.2 6.25 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 123.719 0.807 . . . . 0.0 112.416 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -56.09 -14.0 2.36 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.175 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.507 ' O ' HG23 ' A' ' 35' ' ' VAL . 26.3 mt-10 -110.95 -25.85 9.6 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.813 -178.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.595 HD22 HG13 ' A' ' 63' ' ' ILE . 7.4 tp -56.4 -38.43 71.5 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.24 0.616 . . . . 0.0 111.637 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.617 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -56.45 -40.58 86.64 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 177.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 m -74.67 -27.95 60.63 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.772 -0.714 . . . . 0.0 112.274 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.577 HG22 ' CD1' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -76.57 -26.45 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.283 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.537 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 44.7 mtt -71.59 -41.1 69.4 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 112.992 -1.913 . . . . 0.0 111.06 175.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.698 ' HD3' ' HA ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -87.29 -26.1 23.6 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.6 m -65.19 -7.86 14.61 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 122.083 0.944 . . . . 0.0 111.488 176.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.8 mt -92.59 -3.62 54.73 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.122 -1.853 . . . . 0.0 110.29 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.81 -11.43 18.19 Favored Glycine 0 CA--C 1.495 -1.202 0 N-CA-C 115.621 1.009 . . . . 0.0 115.621 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 36' ' ' MET . 9.5 mm100 -68.19 152.13 45.94 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 113.007 -1.596 . . . . 0.0 111.359 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -77.48 126.13 85.15 Favored Pre-proline 0 N--CA 1.471 0.614 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -177.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.698 ' HA ' ' HD3' ' A' ' 37' ' ' ARG . 83.6 Cg_endo -86.23 120.13 1.84 Allowed 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.498 2.132 . . . . 0.0 115.751 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -137.04 153.31 50.65 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 176.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -80.7 -29.79 36.45 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.716 0.769 . . . . 0.0 109.27 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 50' ' ' ASP . . . -71.62 -32.11 67.61 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 113.393 -1.731 . . . . 0.0 109.926 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -80.86 -28.94 35.88 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 114.052 -1.431 . . . . 0.0 109.652 177.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.588 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -73.59 -18.82 61.01 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.683 175.541 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.877 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 46.6 mt-30 -99.91 -15.73 18.24 Favored 'General case' 0 CA--C 1.482 -1.67 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.124 177.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.505 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 2.1 t70 -87.26 -36.18 18.07 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 112.289 -2.232 . . . . 0.0 110.299 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.441 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 25.3 mmt -86.61 -29.99 22.16 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.531 178.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.588 ' HB ' ' O ' ' A' ' 48' ' ' LEU . 1.6 mp -77.35 -24.14 14.72 Favored 'Isoleucine or valine' 0 C--N 1.341 0.226 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 175.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.877 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.0 t30 -78.13 -34.43 49.94 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.884 175.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.72 -45.98 8.93 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.534 ' C ' ' H ' ' A' ' 57' ' ' ALA . 34.9 t -82.1 -53.02 12.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.509 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 16.1 t70 -72.26 40.73 0.08 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 122.001 0.905 . . . . 0.0 110.008 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.534 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -78.25 -5.29 51.5 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 114.098 -1.41 . . . . 0.0 113.222 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -92.27 -42.74 9.68 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 112.672 -2.058 . . . . 0.0 111.151 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.15 51.2 4.04 Favored Glycine 0 C--N 1.344 1.017 0 O-C-N 123.486 0.492 . . . . 0.0 113.646 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -110.03 -21.41 12.32 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.16 25.76 61.15 Favored Glycine 0 N--CA 1.466 0.637 0 CA-C-N 115.674 -0.694 . . . . 0.0 113.585 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.534 ' O ' HD13 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -160.13 172.92 16.59 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.362 1.065 . . . . 0.0 109.092 179.609 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.595 HG13 HD22 ' A' ' 32' ' ' LEU . 36.6 mm -125.1 77.2 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.583 ' HA ' HG21 ' A' ' 26' ' ' THR . 8.4 m-20 -50.5 152.02 2.06 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.848 0.859 . . . . 0.0 111.25 177.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.576 ' CD1' ' HD3' ' A' ' 66' ' ' PRO . 42.5 p90 -90.49 -41.36 0.4 Allowed Pre-proline 0 CA--C 1.55 0.963 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.576 ' HD3' ' CD1' ' A' ' 65' ' ' PHE . 21.7 Cg_exo -65.51 -18.26 59.13 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 121.722 1.615 . . . . 0.0 113.169 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -107.12 -39.2 5.79 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -178.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.514 ' O ' ' HB2' ' A' ' 71' ' ' MET . 66.4 m-85 -85.09 -20.67 30.02 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -176.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.516 ' HB2' HD21 ' A' ' 4' ' ' LEU . 15.3 mt -71.73 -41.2 68.79 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-O 122.385 1.088 . . . . 0.0 108.785 177.078 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.417 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 1.3 m -53.35 -31.38 44.25 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 111.967 -2.379 . . . . 0.0 109.159 173.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.514 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 23.7 mmt -72.96 -31.52 64.61 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.255 175.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.875 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 1.5 mtt -84.98 -18.37 34.7 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.193 177.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.501 ' HB1' ' NZ ' ' A' ' 77' ' ' LYS . . . -74.96 -39.43 61.33 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.494 ' CD ' ' HA ' ' A' ' 71' ' ' MET . 3.0 ptm180 -77.13 -18.15 58.11 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 112.449 0.536 . . . . 0.0 112.449 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.875 ' HD2' ' HA ' ' A' ' 72' ' ' MET . 29.9 mttt -71.89 -13.83 61.77 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 175.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.472 ' HB2' ' OE2' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -128.79 -29.46 2.35 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -177.007 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.501 ' NZ ' ' HB1' ' A' ' 73' ' ' ALA . 31.7 mttp -65.05 -48.87 72.29 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -177.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -105.4 -30.72 9.41 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.1 t -82.97 98.84 9.45 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 41.03 94.3 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 125.01 1.324 . . . . 0.0 114.108 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.533 ' HA ' ' OE1' ' A' ' 84' ' ' GLU . 51.6 m -84.14 -14.08 51.19 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.891 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.423 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -79.32 -45.41 19.71 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.634 0.773 . . . . 0.0 109.807 -179.255 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.423 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 39.9 mt-10 -66.1 -18.56 65.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 113.831 -1.531 . . . . 0.0 112.292 178.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.653 ' HG2' ' SD ' ' B' ' 168' ' ' MET . 40.3 mt-10 -61.96 -27.25 68.71 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 122.952 0.501 . . . . 0.0 112.255 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.7 mp -87.94 -48.04 15.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.321 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.595 ' O ' ' HD1' ' A' ' 89' ' ' PHE . 17.7 mmt180 -57.43 -18.11 16.4 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.529 ' OE1' ' HA ' ' B' ' 164' ' ' SER . 3.4 pt-20 -73.28 -19.68 60.99 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 177.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.37 -23.44 66.34 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.04 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.595 ' HD1' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -84.36 -20.7 31.55 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 174.715 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -81.05 -24.52 37.79 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.266 -1.334 . . . . 0.0 108.418 175.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.471 HG12 ' CD1' ' A' ' 92' ' ' PHE . 43.8 t -88.67 -55.31 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 CA-C-N 114.913 -1.04 . . . . 0.0 112.126 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.793 ' HB3' HG21 ' A' ' 100' ' ' ILE . 8.5 m-85 -100.65 -44.93 5.67 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -176.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.705 ' CA ' HG12 ' A' ' 100' ' ' ILE . 17.6 t70 -63.9 92.0 0.07 Allowed 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.781 0.8 . . . . 0.0 111.412 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.421 ' HE3' ' C ' ' A' ' 107' ' ' HIS . 31.9 mttm -88.03 -47.11 8.77 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.225 -1.352 . . . . 0.0 113.97 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -71.43 3.06 4.11 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -175.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 49.05 29.96 9.29 Favored Glycine 0 N--CA 1.473 1.109 0 CA-C-N 114.25 -1.341 . . . . 0.0 115.035 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -100.85 -3.34 30.0 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.714 0.257 . . . . 0.0 111.239 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.13 -18.99 56.26 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-N 116.345 -0.388 . . . . 0.0 112.592 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -113.16 118.18 33.99 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.308 -0.946 . . . . 0.0 110.624 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.793 HG21 ' HB3' ' A' ' 92' ' ' PHE . 47.5 mt -79.27 89.27 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.4 m -67.08 166.0 14.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.639 -1.164 . . . . 0.0 112.571 -177.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.528 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -60.4 -14.53 19.37 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -178.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.534 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.65 -27.15 21.48 Favored 'General case' 0 CA--C 1.488 -1.433 0 CA-C-O 121.634 0.73 . . . . 0.0 109.33 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 1.01 ' O ' HG23 ' A' ' 108' ' ' VAL . 25.5 mt-10 -79.39 -44.3 21.74 Favored 'General case' 0 CA--C 1.486 -1.51 0 CA-C-N 112.829 -1.987 . . . . 0.0 111.948 -177.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.636 HD22 ' O ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -66.74 -30.83 71.15 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.981 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.692 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -71.48 -46.61 59.38 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 113.683 -1.599 . . . . 0.0 109.488 175.789 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.534 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 17.4 t-80 -68.04 -21.62 65.0 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.351 178.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.01 HG23 ' O ' ' A' ' 104' ' ' GLU . 24.0 t -72.2 -49.1 45.58 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.764 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 176.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.713 ' SD ' HD22 ' A' ' 116' ' ' LEU . 19.1 mtt -57.07 -41.21 78.37 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 112.276 -2.238 . . . . 0.0 111.879 176.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.59 -19.15 64.45 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.398 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.89 -45.11 19.19 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.731 176.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 mt -79.99 -28.12 39.55 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.796 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 140.02 -7.52 2.94 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 117.798 -1.557 . . . . 0.0 116.83 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 109' ' ' MET . 5.0 mt-10 -100.94 152.36 20.65 Favored 'General case' 0 C--N 1.356 0.886 0 CA-C-N 120.813 2.306 . . . . 0.0 114.579 -178.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -111.08 129.79 55.81 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 113.505 -1.68 . . . . 0.0 107.277 175.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.713 HD22 ' SD ' ' A' ' 109' ' ' MET . 1.4 tp -134.87 116.21 14.51 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.584 -1.189 . . . . 0.0 112.605 -175.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.684 HG22 ' HG2' ' A' ' 120' ' ' GLU . 0.6 OUTLIER -76.64 -175.65 3.46 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.588 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.518 ' N ' HG23 ' A' ' 117' ' ' THR . 16.1 t70 -72.5 -37.46 68.41 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.128 -1.396 . . . . 0.0 114.41 -177.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.645 ' H ' HG23 ' A' ' 117' ' ' THR . 9.7 pt-20 -89.57 -16.08 31.42 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 179.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.684 ' HG2' HG22 ' A' ' 117' ' ' THR . 14.8 pt-20 -87.43 -16.01 36.1 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 123.215 0.322 . . . . 0.0 110.722 178.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -81.18 -30.5 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.011 178.035 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -68.64 30.8 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 115.003 -0.999 . . . . 0.0 113.32 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.532 ' H ' ' C ' ' A' ' 121' ' ' VAL . 10.9 pt-20 -142.7 -30.2 0.54 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.352 -1.294 . . . . 0.0 109.941 177.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.729 ' HA ' ' OG1' ' B' ' 153' ' ' THR . 2.9 mmt -71.93 -30.64 65.54 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.605 176.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.625 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 1.8 mp -87.85 -50.33 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 CA-C-N 114.088 -1.415 . . . . 0.0 113.313 -177.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -58.48 -27.24 64.25 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.007 0.817 . . . . 0.0 111.547 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.561 ' HG2' ' OG1' ' B' ' 153' ' ' THR . 0.0 OUTLIER -63.9 -33.46 75.76 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.389 177.96 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.598 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -110.47 -29.86 7.9 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-O 121.101 0.477 . . . . 0.0 110.564 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.625 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -60.97 126.82 28.75 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.716 -1.129 . . . . 0.0 113.174 -179.035 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.8 mt -90.51 -51.92 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 114.049 -1.432 . . . . 0.0 110.548 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -85.57 -25.34 26.77 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.38 49.51 6.2 Favored Glycine 0 CA--C 1.525 0.669 0 O-C-N 123.526 0.516 . . . . 0.0 113.787 178.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -84.76 -19.43 32.65 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.49 10.86 56.5 Favored Glycine 0 CA--C 1.501 -0.843 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.916 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -141.21 121.21 13.67 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.613 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 2.5 t -78.87 125.18 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -91.2 -165.31 1.33 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.784 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.556 ' OH ' ' HB3' ' A' ' 89' ' ' PHE . 2.7 m-85 -70.97 -57.25 4.74 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.18 177.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -58.95 -20.82 55.83 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -178.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.613 ' OE1' ' HA ' ' A' ' 136' ' ' VAL . 9.4 mt-10 -88.54 -39.36 14.2 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 121.379 0.609 . . . . 0.0 110.113 178.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -75.32 -23.56 57.3 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.137 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' A' ' 138' ' ' TYR . 37.4 t -85.14 -41.19 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 114.605 -1.18 . . . . 0.0 111.436 -178.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -56.97 -20.04 21.54 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 123.59 0.556 . . . . 0.0 111.167 177.502 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.0 -28.47 68.28 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.973 178.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.414 ' HG3' ' O ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -84.95 -4.39 59.11 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.788 178.478 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.411 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 58.9 p -117.44 -45.75 2.71 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.601 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -54.85 -31.16 59.24 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.453 -0.784 . . . . 0.0 111.343 179.912 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 18.3 p . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 120.571 0.224 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -129.09 -29.77 2.25 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.523 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -91.7 136.71 32.93 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.37 0.419 . . . . 0.0 111.384 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -99.08 153.35 18.95 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.815 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.729 ' OG1' ' HA ' ' A' ' 124' ' ' MET . 10.5 p -135.5 -70.37 0.48 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 118.981 -0.533 . . . . 0.0 112.151 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 154' ' ' PHE . . . . . 0.689 ' HA ' HG22 ' B' ' 157' ' ' VAL . 0.2 OUTLIER -63.28 -27.57 69.43 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 118.885 0.766 . . . . 0.0 111.242 179.602 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.486 ' HD2' ' OE2' ' A' ' 127' ' ' GLU . 8.5 mptt -67.04 -44.1 81.04 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.908 178.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -77.09 -35.83 56.19 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 157' ' ' VAL . . . . . 0.689 HG22 ' HA ' ' B' ' 154' ' ' PHE . 17.7 m -71.71 -38.61 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 122.493 0.317 . . . . 0.0 111.809 -178.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -73.6 -33.07 64.42 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.35 0.66 . . . . 0.0 112.364 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -64.63 -30.69 71.72 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 123.379 0.424 . . . . 0.0 111.374 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.02 -38.09 53.63 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.845 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 9.8 p -108.61 25.66 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 O-C-N 123.361 0.413 . . . . 0.0 111.643 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 162' ' ' LYS . . . . . . . . . . . . . 20.5 ttpt -76.5 -8.9 58.12 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 163' ' ' ILE . . . . . 0.433 HD11 ' O ' ' B' ' 168' ' ' MET . 11.8 tt -89.26 153.21 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 164' ' ' SER . . . . . 0.529 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 6.4 t -88.45 171.17 10.3 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.027 0.441 . . . . 0.0 112.082 -178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . -83.36 15.63 2.9 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.391 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 52.1 m -121.61 12.34 10.7 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.03 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.667 ' O ' ' HD3' ' A' ' 75' ' ' LYS . 56.7 mt 75.12 39.84 0.37 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.924 0.868 . . . . 0.0 111.828 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 168' ' ' MET . . . . . 0.653 ' SD ' ' HG2' ' A' ' 84' ' ' GLU . 33.7 mtt -73.13 -158.49 0.05 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.449 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -133.25 -103.81 0.85 Allowed Glycine 0 C--N 1.344 1.02 0 C-N-CA 121.419 -0.42 . . . . 0.0 112.76 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.44 -0.791 . . . . 0.0 110.709 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.402 0 N-CA-C 111.416 0.154 . . . . 0.0 111.416 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.845 ' HA ' HE22 ' A' ' 8' ' ' GLN . 2.7 m-20 -121.13 130.23 53.64 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 123.421 0.45 . . . . 0.0 110.853 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -132.83 -46.61 0.86 Allowed 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 123.462 0.476 . . . . 0.0 111.947 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.454 ' H ' ' HG ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -112.78 -125.18 0.28 Allowed 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.153 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.452 ' H ' ' HB2' ' A' ' 4' ' ' LEU . 16.0 p -102.25 -173.62 2.38 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 123.963 0.905 . . . . 0.0 111.777 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.54 ' HA ' HG12 ' A' ' 9' ' ' ILE . 15.4 tt0 -59.78 -21.91 61.43 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.452 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 12.5 pt-20 -49.92 -39.05 38.89 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 123.877 0.736 . . . . 0.0 111.436 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.845 HE22 ' HA ' ' A' ' 2' ' ' ASP . 2.2 pt20 -68.82 -49.82 55.31 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.626 176.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.805 HD13 HE21 ' A' ' 8' ' ' GLN . 15.2 mm -51.85 -43.19 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 114.231 -1.35 . . . . 0.0 111.963 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.85 -34.83 67.03 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -111.0 -19.61 12.71 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -177.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.542 ' O ' ' HB2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -74.45 -15.05 60.91 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.149 0.886 . . . . 0.0 110.009 178.736 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.694 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -81.65 -41.45 21.41 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.017 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.694 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 1.4 mt-10 -84.99 -40.04 17.37 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 114.271 -1.332 . . . . 0.0 112.716 -179.032 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.641 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -64.72 -18.75 65.3 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.554 0.693 . . . . 0.0 109.249 178.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.611 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 18.8 t80 -86.06 -49.37 7.84 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 113.975 -1.466 . . . . 0.0 109.485 177.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.2 m -87.17 -13.38 44.17 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 115.435 1.642 . . . . 0.0 115.435 -177.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -71.96 -30.47 65.32 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.538 -179.86 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.587 ' CD1' HG22 ' A' ' 35' ' ' VAL . 5.5 m-85 -133.58 -8.24 2.85 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.611 ' HB3' ' O ' ' A' ' 16' ' ' PHE . 15.3 t70 -101.33 82.67 2.36 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.601 0.637 . . . . 0.0 109.799 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.456 ' HZ2' ' HA ' ' A' ' 19' ' ' PHE . 1.5 mppt? -86.89 -34.74 19.31 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -178.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.596 ' OD1' ' HB2' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -70.74 -22.36 62.42 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.831 178.277 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.15 51.57 4.96 Favored Glycine 0 N--CA 1.468 0.797 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.596 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -98.33 22.44 9.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 113.756 -1.222 . . . . 0.0 113.557 -176.091 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.61 -67.16 0.59 Allowed Glycine 0 CA--C 1.525 0.678 0 CA-C-N 115.128 -0.942 . . . . 0.0 113.69 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.585 ' OG1' ' N ' ' A' ' 63' ' ' ILE . 1.5 t -97.6 176.01 6.0 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.749 0.785 . . . . 0.0 112.226 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.525 ' N ' ' HG1' ' A' ' 26' ' ' THR . 0.2 OUTLIER -132.93 148.71 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.147 179.726 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.82 155.3 6.12 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 p -74.14 -55.58 5.92 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 114.903 -1.044 . . . . 0.0 113.039 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -54.47 -13.84 1.07 Allowed 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.881 0.738 . . . . 0.0 111.606 177.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.536 ' O ' HG23 ' A' ' 35' ' ' VAL . 21.7 mt-10 -111.43 -17.0 13.2 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.403 -178.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.525 HD22 HG12 ' A' ' 63' ' ' ILE . 12.2 tp -57.14 -40.11 76.54 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.756 0.422 . . . . 0.0 111.889 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.773 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -53.39 -41.09 62.44 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 177.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.9 m -74.72 -31.83 61.96 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.731 -0.734 . . . . 0.0 112.92 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.641 HG12 ' HA ' ' A' ' 15' ' ' ALA . 1.4 t -74.21 -26.0 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.52 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 19.4 mmt -76.1 -42.21 47.92 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 112.925 -1.943 . . . . 0.0 111.459 176.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.773 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 11.3 mtt180 -79.73 -29.62 40.65 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.1 t -67.94 -8.46 37.13 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.947 0.88 . . . . 0.0 111.756 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.557 HD21 ' HB2' ' A' ' 14' ' ' GLU . 95.9 mt -90.9 -7.67 51.52 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.286 -1.779 . . . . 0.0 109.938 177.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.25 -7.04 23.11 Favored Glycine 0 CA--C 1.493 -1.291 0 CA-C-O 122.233 0.907 . . . . 0.0 115.142 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.52 ' HB2' ' O ' ' A' ' 36' ' ' MET . 43.0 mt-30 -76.73 138.56 40.03 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 112.376 -1.912 . . . . 0.0 111.669 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -127.43 62.5 54.6 Favored Pre-proline 0 CA--C 1.554 1.133 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.184 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.422 ' HD3' ' C ' ' A' ' 41' ' ' GLN . 4.5 Cg_endo -88.25 -178.78 2.2 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.93 2.42 . . . . 0.0 112.156 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.504 ' OG1' ' N ' ' A' ' 45' ' ' GLU . 7.1 t -99.28 -174.95 2.87 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 122.115 0.959 . . . . 0.0 110.663 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.521 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 46.6 mt-10 -80.96 -24.27 38.2 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-N 113.005 -1.907 . . . . 0.0 108.57 177.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.45 -30.07 66.81 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 113.699 -1.591 . . . . 0.0 111.779 -177.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.535 ' OE2' ' HA ' ' B' ' 168' ' ' MET . 44.0 mt-10 -87.32 -26.73 23.25 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.246 177.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.572 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -69.29 -20.04 63.9 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.132 174.524 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.884 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 11.7 mm100 -98.63 -16.22 19.15 Favored 'General case' 0 CA--C 1.482 -1.653 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.106 178.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.426 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 3.3 t70 -87.14 -33.97 19.24 Favored 'General case' 0 C--N 1.281 -2.391 0 CA-C-N 112.003 -2.362 . . . . 0.0 110.392 177.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.453 ' SD ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -86.51 -35.28 19.67 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.791 178.073 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.572 ' HB ' ' O ' ' A' ' 48' ' ' LEU . 1.5 mp -70.96 -27.37 29.83 Favored 'Isoleucine or valine' 0 C--N 1.345 0.399 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 175.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.884 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.8 t-20 -71.73 -34.17 69.33 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.349 175.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 50' ' ' ASP . 41.6 mt-10 -79.58 -33.42 41.73 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.546 ' C ' ' H ' ' A' ' 57' ' ' ALA . 72.1 t -82.14 -41.71 18.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -72.5 35.71 0.07 Allowed 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.894 0.854 . . . . 0.0 110.527 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.546 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -86.5 -6.32 58.93 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 114.254 -1.339 . . . . 0.0 111.907 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -113.22 -29.24 7.34 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 111.78 -2.463 . . . . 0.0 110.639 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.62 46.09 5.87 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.855 -0.612 . . . . 0.0 113.75 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -110.25 -21.75 12.08 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.23 26.42 72.55 Favored Glycine 0 N--CA 1.469 0.838 0 CA-C-N 115.851 -0.613 . . . . 0.0 114.291 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.492 HG22 ' HG1' ' A' ' 26' ' ' THR . 0.0 OUTLIER -142.18 -177.22 5.14 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 123.269 0.627 . . . . 0.0 110.533 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.585 ' N ' ' OG1' ' A' ' 26' ' ' THR . 5.3 mp -135.36 96.18 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -176.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.447 ' O ' ' HD2' ' A' ' 68' ' ' PHE . 10.0 m-20 -67.0 150.03 49.82 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 174.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.539 ' CG ' ' HD3' ' A' ' 66' ' ' PRO . 27.0 p90 -77.86 -39.12 1.82 Allowed Pre-proline 0 N--CA 1.477 0.919 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -177.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.539 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 9.0 Cg_exo -72.85 -17.57 25.44 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 121.838 1.692 . . . . 0.0 113.027 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.539 ' O ' ' HG3' ' A' ' 71' ' ' MET . 39.7 mt-10 -103.97 -17.43 14.99 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 -177.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.532 ' CE1' ' HG ' ' A' ' 69' ' ' LEU . 2.6 p90 -84.78 -43.56 14.12 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 -177.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.532 ' HG ' ' CE1' ' A' ' 68' ' ' PHE . 1.7 mt -62.79 -33.99 76.34 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.489 0.662 . . . . 0.0 111.091 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.603 ' O ' ' HD3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -59.75 -35.5 74.72 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 113.721 -1.581 . . . . 0.0 108.64 174.167 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.606 ' HA ' ' NE ' ' A' ' 74' ' ' ARG . 66.0 mtt -74.6 -22.66 58.84 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-N 114.887 -1.052 . . . . 0.0 109.101 176.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.537 ' HA ' ' HG3' ' A' ' 75' ' ' LYS . 72.4 mtp -88.4 -18.6 28.02 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.866 177.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.559 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -81.58 -33.57 31.53 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.606 ' NE ' ' HA ' ' A' ' 71' ' ' MET . 1.4 ptt180 -84.88 -17.13 38.88 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.762 ' HZ2' ' HA ' ' B' ' 167' ' ' LEU . 0.0 OUTLIER -83.1 -13.76 55.03 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.563 0.619 . . . . 0.0 112.397 178.842 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.457 ' HA ' HG22 ' A' ' 79' ' ' THR . 22.5 ptt? -113.47 -33.68 5.82 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 120.983 0.42 . . . . 0.0 112.091 -177.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.559 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.6 mmtp -68.15 -15.45 63.59 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.55 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -103.89 -29.72 10.79 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.457 HG22 ' HA ' ' A' ' 76' ' ' MET . 8.6 t -75.94 76.2 2.84 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.402 0.62 . . . . 0.0 112.13 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 56.22 110.83 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.034 0.934 . . . . 0.0 112.268 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.543 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 13.9 t -83.2 -13.48 55.32 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.307 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.419 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -86.97 -45.71 10.53 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.758 0.79 . . . . 0.0 109.336 179.729 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.419 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 40.3 mt-10 -75.14 -18.18 60.26 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 113.647 -1.615 . . . . 0.0 113.199 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 81' ' ' SER . 11.2 pt-20 -58.99 -28.01 65.96 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.9 mp -88.09 -49.97 13.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.441 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.0 mtm180 -56.88 -18.19 12.27 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 3.1 pt-20 -74.17 -20.13 60.32 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.13 0.491 . . . . 0.0 110.258 178.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.524 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -70.51 -20.71 62.81 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.476 177.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.472 ' HE2' ' O ' ' A' ' 98' ' ' GLY . 4.1 m-85 -81.16 -20.79 40.51 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 174.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.472 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 4.4 tmt_? -76.23 -18.79 58.87 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 173.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.524 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 31.6 t -87.73 -53.68 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 114.249 -1.341 . . . . 0.0 111.808 177.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.809 ' HB3' HG21 ' A' ' 100' ' ' ILE . 10.4 m-85 -100.29 -45.36 5.63 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.734 ' CA ' HG12 ' A' ' 100' ' ' ILE . 2.3 t70 -63.44 93.43 0.07 Allowed 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.922 0.868 . . . . 0.0 111.246 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.643 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 33.8 mttm -87.96 -47.35 8.61 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 113.939 -1.482 . . . . 0.0 113.977 -178.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -71.83 1.56 6.82 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 114.05 1.129 . . . . 0.0 114.05 -175.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 49.71 28.32 10.8 Favored Glycine 0 N--CA 1.472 1.085 0 CA-C-N 114.298 -1.319 . . . . 0.0 114.799 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -96.27 -8.19 33.47 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.647 0.224 . . . . 0.0 111.404 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.472 ' O ' ' HE2' ' A' ' 89' ' ' PHE . . . 104.32 -18.68 44.66 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.965 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -120.66 118.95 31.45 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.621 -0.79 . . . . 0.0 111.085 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.809 HG21 ' HB3' ' A' ' 92' ' ' PHE . 29.0 mt -77.35 100.8 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.1 p -79.12 165.18 23.62 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.593 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -59.72 -15.08 17.22 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -178.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.93 -31.69 18.06 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-O 121.885 0.85 . . . . 0.0 109.542 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 1.027 ' O ' HG23 ' A' ' 108' ' ' VAL . 3.1 mm-40 -79.95 -38.1 33.07 Favored 'General case' 0 CA--C 1.483 -1.631 0 CA-C-N 112.58 -2.1 . . . . 0.0 110.241 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.516 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 4.1 tt -63.76 -37.71 88.37 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 176.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.634 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -70.82 -44.53 66.33 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 113.79 -1.55 . . . . 0.0 108.904 175.964 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.503 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 6.1 t-80 -67.66 -21.65 65.34 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.602 177.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.027 HG23 ' O ' ' A' ' 104' ' ' GLU . 25.6 t -73.02 -50.71 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 176.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.686 ' SD ' HD22 ' A' ' 116' ' ' LEU . 18.0 mtt -56.32 -41.06 75.41 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 112.513 -2.131 . . . . 0.0 112.103 175.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.31 -19.06 63.89 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.238 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.5 -45.07 20.03 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.55 176.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.1 mt -80.04 -28.23 39.31 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.774 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 139.42 -7.77 3.12 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 117.79 -1.561 . . . . 0.0 116.841 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.535 ' N ' ' O ' ' A' ' 109' ' ' MET . 5.1 mt-10 -101.01 152.11 20.98 Favored 'General case' 0 C--N 1.358 0.938 0 CA-C-N 120.859 2.329 . . . . 0.0 114.506 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -110.11 129.66 55.66 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 113.651 -1.613 . . . . 0.0 107.482 175.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.686 HD22 ' SD ' ' A' ' 109' ' ' MET . 1.2 tp -138.11 119.09 14.33 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.609 -175.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.914 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -74.36 -176.09 2.55 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.016 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.554 ' O ' HG23 ' A' ' 121' ' ' VAL . 16.0 t70 -72.2 -38.07 69.12 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -177.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.631 ' H ' HG23 ' A' ' 117' ' ' THR . 9.5 pt-20 -87.88 -16.11 34.84 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.751 ' HG2' HG22 ' A' ' 117' ' ' THR . 14.3 pt-20 -85.95 -15.44 41.56 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 123.219 0.324 . . . . 0.0 110.954 178.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.914 HG22 ' O ' ' A' ' 117' ' ' THR . 0.1 OUTLIER -83.43 -25.39 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.774 178.106 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -74.09 32.33 0.08 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.738 0.78 . . . . 0.0 112.652 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.463 ' H ' ' C ' ' A' ' 121' ' ' VAL . 11.2 pt-20 -141.66 -32.32 0.54 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.166 177.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.546 ' HA ' ' HB ' ' B' ' 153' ' ' THR . 4.5 ttm -73.01 -25.61 61.03 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.498 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.562 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 3.1 mt -88.92 -52.34 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.885 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -55.66 -29.04 58.6 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 124.239 0.962 . . . . 0.0 111.773 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.465 ' HG2' ' HB ' ' B' ' 153' ' ' THR . 0.0 OUTLIER -63.73 -33.34 75.44 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.374 -1.284 . . . . 0.0 111.321 177.999 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.653 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -106.55 -32.85 7.88 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-O 121.296 0.57 . . . . 0.0 109.735 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -61.08 124.31 20.15 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 114.255 -1.338 . . . . 0.0 113.053 -178.679 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.422 HD11 ' OE1' ' A' ' 143' ' ' GLN . 14.0 mt -90.34 -44.28 14.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 113.625 -1.625 . . . . 0.0 110.398 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -87.04 -25.17 24.34 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.16 49.69 9.28 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.08 -0.509 . . . . 0.0 114.072 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -89.74 -19.47 24.72 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.43 11.85 52.85 Favored Glycine 0 CA--C 1.501 -0.796 0 CA-C-N 115.878 -0.601 . . . . 0.0 113.254 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -139.86 119.83 13.55 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 113.651 -1.275 . . . . 0.0 108.055 178.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.564 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 2.1 t -81.73 130.24 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -177.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.451 HD22 ' CD ' ' A' ' 140' ' ' GLU . 11.8 m-80 -92.27 -164.72 1.22 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.516 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.409 ' O ' HG23 ' A' ' 142' ' ' VAL . 79.8 m-85 -74.48 -56.16 5.15 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.722 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -61.07 -20.44 62.58 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -178.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.723 ' O ' ' HG2' ' A' ' 144' ' ' MET . 9.7 mt-10 -86.87 -42.4 13.26 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.17 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -71.83 -23.98 61.63 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.241 176.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.54 ' O ' ' HG2' ' A' ' 145' ' ' MET . 29.9 t -85.54 -44.86 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.883 -177.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.458 ' HA ' ' OG1' ' A' ' 146' ' ' THR . 35.9 mt-30 -61.3 -19.09 61.38 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 123.512 0.508 . . . . 0.0 111.596 178.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.723 ' HG2' ' O ' ' A' ' 140' ' ' GLU . 27.4 mmt -71.83 -23.42 61.54 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 178.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.54 ' HG2' ' O ' ' A' ' 142' ' ' VAL . 7.2 ptt? -87.61 -4.26 58.95 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.579 177.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.458 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 30.8 p -119.83 -41.4 2.67 Favored 'General case' 0 C--N 1.351 0.64 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.002 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -37.27 -34.04 0.08 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 95.5 mttt . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.109 -0.948 . . . . 0.0 111.393 179.873 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 18.9 p . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.524 0.202 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -100.17 145.71 27.7 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.832 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -100.74 147.46 26.01 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.057 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 152' ' ' LYS . . . . . 0.451 ' H ' ' HG3' ' B' ' 156' ' ' GLU . 97.4 mttt -131.88 177.75 7.3 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.685 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.553 ' O ' HG13 ' B' ' 157' ' ' VAL . 0.7 OUTLIER -83.95 -118.11 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 118.716 -0.659 . . . . 0.0 112.306 -178.949 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 154' ' ' PHE . . . . . 0.667 ' HA ' HG22 ' B' ' 157' ' ' VAL . 0.1 OUTLIER -60.88 -27.55 68.23 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 119.342 0.974 . . . . 0.0 111.376 -179.759 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -59.07 -51.1 71.52 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.114 0.565 . . . . 0.0 111.538 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 156' ' ' GLU . . . . . 0.451 ' HG3' ' H ' ' B' ' 152' ' ' LYS . 2.5 mm-40 -76.91 -38.99 52.43 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 157' ' ' VAL . . . . . 0.667 HG22 ' HA ' ' B' ' 154' ' ' PHE . 11.3 m -61.44 -33.57 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-O 120.675 0.274 . . . . 0.0 111.316 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 158' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' B' ' 162' ' ' LYS . . . -73.59 -41.48 62.83 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.985 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -64.37 -25.99 68.27 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 123.394 0.434 . . . . 0.0 111.84 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.01 -37.95 53.99 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.825 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 9.8 p -112.15 25.27 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 O-C-N 123.357 0.411 . . . . 0.0 111.743 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 162' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 11.4 ttpt -81.75 -36.6 28.36 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.755 -0.202 . . . . 0.0 110.802 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 163' ' ' ILE . . . . . 0.454 HG23 ' O ' ' B' ' 163' ' ' ILE . 0.0 OUTLIER -117.0 61.76 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 CA-C-O 122.159 0.981 . . . . 0.0 109.251 178.83 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 17.5 t -132.82 -40.99 0.94 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.618 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . -88.94 0.01 57.0 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.449 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 51.5 m -84.51 -18.68 34.99 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.71 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.762 ' HA ' ' HZ2' ' A' ' 75' ' ' LYS . 1.1 tp -86.23 -6.58 58.95 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 123.421 0.451 . . . . 0.0 111.077 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 168' ' ' MET . . . . . 0.535 ' HA ' ' OE2' ' A' ' 47' ' ' GLU . 64.8 mtt -89.0 149.53 23.22 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.263 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . 171.44 -146.86 9.8 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.49 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 19.6 p . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.142 -0.932 . . . . 0.0 111.016 -179.974 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.389 0 N-CA-C 111.345 0.128 . . . . 0.0 111.345 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -99.4 -41.35 7.45 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.422 0.451 . . . . 0.0 111.266 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.673 HE21 HE22 ' A' ' 8' ' ' GLN . 54.5 mt-30 -133.83 152.46 51.87 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 123.431 0.457 . . . . 0.0 110.853 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.496 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -109.23 -119.86 0.27 Allowed 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.692 ' CG2' ' H ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -102.82 -173.66 2.37 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.562 ' N ' HG23 ' A' ' 5' ' ' THR . 10.2 mm-40 -60.84 -13.34 14.88 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.143 0.177 . . . . 0.0 111.08 176.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.692 ' H ' ' CG2' ' A' ' 5' ' ' THR . 7.7 pt-20 -52.37 -38.75 59.62 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.906 0.754 . . . . 0.0 111.112 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.673 HE22 HE21 ' A' ' 3' ' ' GLN . 1.4 pt20 -70.09 -49.66 48.66 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.642 176.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.629 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . 20.1 mm -52.82 -35.1 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.947 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.36 -35.01 73.28 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -119.31 -17.72 8.77 Favored 'General case' 0 C--N 1.346 0.418 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -177.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.629 ' CE1' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -69.75 -16.33 63.29 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.743 0.701 . . . . 0.0 111.012 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.693 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 1.2 pttt -83.35 -41.51 18.12 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.693 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 1.8 mt-10 -80.94 -37.61 29.2 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 114.082 -1.417 . . . . 0.0 112.205 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.573 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -66.56 -19.19 65.72 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.52 0.676 . . . . 0.0 109.182 178.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.567 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 11.2 t80 -86.75 -48.97 7.79 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.773 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.411 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 52.3 m -87.02 -12.9 46.0 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -177.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -69.48 -28.25 65.91 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 118.54 0.609 . . . . 0.0 111.979 -179.551 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.577 ' CD1' HG22 ' A' ' 35' ' ' VAL . 4.6 m-85 -132.73 -3.07 3.29 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 -178.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.567 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 14.7 t70 -80.48 55.19 2.22 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 119.087 0.858 . . . . 0.0 112.189 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.411 ' HE3' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -87.04 -22.39 25.49 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 178.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.67 -22.43 61.67 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.299 0.571 . . . . 0.0 110.446 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.43 44.3 27.91 Favored Glycine 0 N--CA 1.47 0.933 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.54 23.13 13.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 113.029 -1.586 . . . . 0.0 112.458 -175.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.33 -79.96 1.77 Allowed Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.072 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.63 HG21 ' HA ' ' A' ' 64' ' ' ASP . 14.6 p -101.21 177.78 4.84 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 122.862 0.465 . . . . 0.0 110.952 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.405 ' O ' HG22 ' A' ' 62' ' ' THR . 0.8 OUTLIER -83.58 148.34 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.258 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.414 ' OG1' ' HB2' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -60.41 161.75 7.02 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -178.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.693 HG22 HD11 ' A' ' 63' ' ' ILE . 1.9 p -79.97 -56.71 4.06 Favored 'General case' 0 C--N 1.345 0.398 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -59.2 -13.34 7.17 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.332 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.476 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 28.0 mt-10 -110.14 -16.36 13.8 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.746 -177.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.564 HD21 ' CZ ' ' A' ' 68' ' ' PHE . 8.6 tp -52.57 -41.06 63.25 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.231 0.612 . . . . 0.0 112.555 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.735 ' O ' ' HD3' ' A' ' 37' ' ' ARG . . . -56.32 -39.65 83.1 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 177.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.2 m -74.28 -29.4 61.63 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.479 -0.861 . . . . 0.0 112.401 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.577 HG22 ' CD1' ' A' ' 19' ' ' PHE . 1.3 t -73.82 -27.94 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 176.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.662 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 11.4 mtm -75.03 -41.94 58.22 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 113.066 -1.879 . . . . 0.0 111.319 176.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.735 ' HD3' ' O ' ' A' ' 33' ' ' GLY . 10.3 mtp180 -79.2 -29.19 42.73 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.1 m -67.78 -8.31 34.76 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.991 0.9 . . . . 0.0 111.877 178.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 35' ' ' VAL . 80.9 mt -95.46 -5.87 42.01 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.229 -1.805 . . . . 0.0 109.535 177.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.85 -0.21 52.06 Favored Glycine 0 CA--C 1.494 -1.248 0 CA-C-O 122.206 0.892 . . . . 0.0 115.163 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.662 ' HB2' ' O ' ' A' ' 36' ' ' MET . 47.2 mt-30 -83.03 139.32 33.33 Favored 'General case' 0 C--N 1.279 -2.457 0 CA-C-N 112.293 -1.954 . . . . 0.0 112.195 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -117.87 76.52 11.12 Favored Pre-proline 0 CA--C 1.55 0.962 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.454 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.93 -179.87 4.32 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 123.063 2.509 . . . . 0.0 112.454 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.463 ' O ' HD23 ' A' ' 48' ' ' LEU . 1.5 m -100.72 160.63 14.2 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.593 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 33.5 mt-10 -80.67 -28.08 36.91 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.134 178.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.76 -36.31 67.66 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.884 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.4 ' HB3' ' HE1' ' A' ' 51' ' ' MET . 43.5 mt-10 -78.17 -29.12 48.4 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 114.088 -1.415 . . . . 0.0 108.607 176.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 45' ' ' GLU . 0.5 OUTLIER -66.06 -20.54 66.2 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.171 174.561 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.845 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 11.8 mm100 -97.48 -15.46 20.58 Favored 'General case' 0 CA--C 1.481 -1.681 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.128 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.419 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 5.9 t70 -85.58 -34.12 21.54 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 111.996 -2.365 . . . . 0.0 110.167 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.4 ' HE1' ' HB3' ' A' ' 47' ' ' GLU . 2.0 mpp? -86.46 -34.16 20.16 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.985 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.498 HD13 ' O ' ' A' ' 48' ' ' LEU . 1.2 mp -70.06 -29.17 38.93 Favored 'Isoleucine or valine' 0 C--N 1.345 0.405 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 175.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.845 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.1 t30 -71.45 -33.85 69.71 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.806 175.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 50' ' ' ASP . 41.3 mt-10 -80.25 -38.99 29.86 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.572 ' C ' ' H ' ' A' ' 57' ' ' ALA . 57.7 t -81.42 -39.36 17.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.64 34.18 0.07 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 122.015 0.912 . . . . 0.0 110.485 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.572 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -86.8 -5.99 58.95 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 114.096 -1.411 . . . . 0.0 111.929 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -110.28 -35.64 6.02 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 111.784 -2.462 . . . . 0.0 110.769 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.36 51.24 3.98 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.971 -0.559 . . . . 0.0 113.293 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -109.92 -21.53 12.3 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.568 0.223 . . . . 0.0 111.337 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.78 26.62 68.89 Favored Glycine 0 N--CA 1.466 0.638 0 CA-C-N 115.824 -0.625 . . . . 0.0 114.316 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.475 ' HB ' ' OG1' ' A' ' 26' ' ' THR . 0.1 OUTLIER -143.74 174.71 10.56 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 123.312 0.645 . . . . 0.0 110.538 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.693 HD11 HG22 ' A' ' 29' ' ' THR . 6.7 mm -136.45 110.59 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -177.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.63 ' HA ' HG21 ' A' ' 26' ' ' THR . 9.8 m-20 -55.83 143.34 31.67 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.006 173.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.527 ' CG ' ' HD3' ' A' ' 66' ' ' PRO . 7.9 p90 -91.33 -38.94 0.38 Allowed Pre-proline 0 CA--C 1.546 0.806 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -177.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.527 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 11.9 Cg_exo -71.64 -18.72 28.7 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 121.94 1.76 . . . . 0.0 113.022 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -97.51 -12.4 22.64 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.564 ' CZ ' HD21 ' A' ' 32' ' ' LEU . 7.3 t80 -84.35 -36.11 22.75 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.596 HD13 ' HA ' ' A' ' 8' ' ' GLN . 1.2 mt -66.91 -33.07 74.79 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 121.734 0.778 . . . . 0.0 110.045 177.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.543 ' O ' ' HD3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -57.28 -34.8 69.04 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 113.346 -1.752 . . . . 0.0 108.644 174.347 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.634 ' HA ' ' NE ' ' A' ' 74' ' ' ARG . 50.0 mtt -67.81 -36.62 80.72 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.712 175.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.572 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 83.4 mtp -75.33 -25.58 57.94 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.967 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -71.95 -36.81 69.98 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.634 ' NE ' ' HA ' ' A' ' 71' ' ' MET . 2.1 ptt180 -83.57 -17.79 40.51 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.611 ' HD2' ' O ' ' A' ' 71' ' ' MET . 24.2 mttt -72.84 -13.93 61.39 Favored 'General case' 0 C--N 1.346 0.451 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 176.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.692 ' SD ' HG21 ' B' ' 163' ' ' ILE . 26.0 ptt? -123.45 -34.63 3.05 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -176.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 26.7 mmtt -62.19 -40.33 95.69 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 -178.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -97.0 -29.37 13.69 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.554 HG23 ' H ' ' A' ' 80' ' ' ASP . 3.5 t -59.45 -64.86 0.79 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.554 ' H ' HG23 ' A' ' 79' ' ' THR . 7.1 m-20 -153.36 115.64 4.38 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.819 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.7 t -83.83 -14.46 51.22 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.215 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.49 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -87.12 -50.89 6.32 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.489 0.661 . . . . 0.0 109.767 -179.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.49 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 36.8 mt-10 -69.64 -17.76 63.54 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.295 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.566 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 9.4 tt0 -57.03 -29.85 63.72 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.36 0.664 . . . . 0.0 112.27 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.8 mp -87.97 -51.38 12.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.419 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -58.05 -19.26 30.2 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.93 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.566 ' OE1' ' HA ' ' A' ' 84' ' ' GLU . 3.4 pt-20 -75.39 -20.5 58.91 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 123.484 0.49 . . . . 0.0 110.258 178.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.25 -20.06 62.28 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.56 177.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.535 ' HE2' ' O ' ' A' ' 98' ' ' GLY . 13.9 m-85 -81.1 -21.56 39.82 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 174.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.427 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 10.7 tpt180 -77.68 -20.44 53.68 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.083 -1.417 . . . . 0.0 107.268 174.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.5 HG12 ' CD1' ' A' ' 92' ' ' PHE . 77.9 t -88.17 -56.15 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 114.201 -1.363 . . . . 0.0 112.183 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.815 ' HB3' HG21 ' A' ' 100' ' ' ILE . 29.7 m-85 -100.33 -42.98 6.41 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -176.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.731 ' CA ' HG12 ' A' ' 100' ' ' ILE . 2.9 t70 -63.57 95.83 0.11 Allowed 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.697 0.761 . . . . 0.0 113.014 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.416 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 3.2 mptp? -87.06 -48.15 8.33 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.225 -1.352 . . . . 0.0 113.423 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.419 ' HB2' ' OE2' ' A' ' 104' ' ' GLU . 5.2 t70 -71.62 0.42 8.71 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 -175.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.95 30.15 3.61 Favored Glycine 0 N--CA 1.475 1.256 0 CA-C-N 114.309 -1.314 . . . . 0.0 114.923 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -98.53 -6.55 29.96 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 122.291 0.236 . . . . 0.0 111.433 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.535 ' O ' ' HE2' ' A' ' 89' ' ' PHE . . . 105.93 -18.33 40.23 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.207 -0.52 . . . . 0.0 112.606 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -119.85 118.36 30.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.595 -0.803 . . . . 0.0 111.124 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.815 HG21 ' HB3' ' A' ' 92' ' ' PHE . 41.4 mt -78.34 89.09 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.3 t -61.74 163.56 7.2 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.892 -177.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.59 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -61.78 -14.79 35.85 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.92 -28.97 19.94 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-O 121.905 0.859 . . . . 0.0 109.422 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 1.039 ' O ' HG23 ' A' ' 108' ' ' VAL . 3.1 mm-40 -79.59 -39.9 30.62 Favored 'General case' 0 CA--C 1.484 -1.563 0 CA-C-N 112.595 -2.093 . . . . 0.0 111.253 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.551 HD23 ' O ' ' A' ' 105' ' ' LEU . 8.5 tt -67.31 -30.69 70.61 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 176.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.658 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -73.67 -43.27 59.82 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.754 176.196 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.558 ' O ' HG22 ' A' ' 110' ' ' THR . 8.5 t-80 -69.33 -21.75 63.82 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 114.086 -1.415 . . . . 0.0 108.223 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.039 HG23 ' O ' ' A' ' 104' ' ' GLU . 37.2 t -72.4 -58.48 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.297 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 175.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.641 ' SD ' HD13 ' A' ' 116' ' ' LEU . 3.4 mtt -47.82 -41.16 23.13 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 113.021 -1.9 . . . . 0.0 112.258 177.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 107' ' ' HIS . 0.8 OUTLIER -66.77 -39.18 87.76 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.522 0.677 . . . . 0.0 110.633 -178.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.47 -46.5 76.13 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.776 -1.557 . . . . 0.0 109.501 176.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.669 HD13 ' O ' ' A' ' 108' ' ' VAL . 9.2 mp -72.98 -27.92 62.09 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.131 -1.395 . . . . 0.0 112.69 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 109' ' ' MET . . . 147.92 -32.84 1.29 Allowed Glycine 0 CA--C 1.536 1.394 0 N-CA-C 116.685 1.434 . . . . 0.0 116.685 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.634 ' N ' ' O ' ' A' ' 109' ' ' MET . 5.2 mt-10 -102.14 149.88 23.83 Favored 'General case' 0 C--N 1.358 0.971 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -176.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp -105.03 131.99 51.84 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 113.87 -1.514 . . . . 0.0 107.202 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.661 ' HG ' ' HG3' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -136.26 116.03 13.06 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.726 -1.124 . . . . 0.0 113.383 -175.243 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.855 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -67.6 -175.94 0.57 Allowed 'General case' 0 C--N 1.349 0.581 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.266 179.504 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.525 ' N ' HG23 ' A' ' 117' ' ' THR . 16.4 t70 -69.8 -37.93 76.47 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -177.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.616 ' H ' HG23 ' A' ' 117' ' ' THR . 10.0 pt-20 -88.75 -16.42 32.23 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.769 ' HG2' HG22 ' A' ' 117' ' ' THR . 13.9 pt-20 -86.66 -15.88 38.3 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 123.184 0.303 . . . . 0.0 111.134 178.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.855 HG22 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -84.23 -26.78 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 123.368 0.417 . . . . 0.0 111.847 177.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -69.41 29.24 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.13 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.527 ' H ' ' C ' ' A' ' 121' ' ' VAL . 11.2 pt-20 -137.68 -34.81 0.67 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.493 177.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.49 ' HA ' ' OG1' ' B' ' 153' ' ' THR . 0.1 OUTLIER -69.77 -29.7 67.1 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.901 176.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.592 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 1.6 mp -89.11 -48.37 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.598 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -56.56 -28.47 60.22 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 124.09 0.869 . . . . 0.0 111.477 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.724 ' OE2' ' HG2' ' A' ' 144' ' ' MET . 0.2 OUTLIER -62.29 -35.08 77.9 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.146 177.722 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.721 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -106.59 -32.9 7.84 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.123 0.487 . . . . 0.0 110.113 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.592 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -59.84 126.93 29.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.47 -1.241 . . . . 0.0 113.212 -178.061 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.433 HG12 ' HG2' ' A' ' 140' ' ' GLU . 30.6 mm -89.54 -48.98 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 113.449 -1.705 . . . . 0.0 110.411 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -88.93 -25.31 22.16 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.25 49.61 5.82 Favored Glycine 0 CA--C 1.525 0.668 0 O-C-N 123.525 0.515 . . . . 0.0 113.886 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -86.48 -19.57 29.37 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.22 12.35 58.8 Favored Glycine 0 CA--C 1.501 -0.792 0 CA-C-N 115.657 -0.702 . . . . 0.0 114.04 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -140.14 105.41 5.04 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.474 HG23 HG23 ' A' ' 125' ' ' ILE . 2.4 t -64.82 125.53 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.405 HD22 ' CD ' ' A' ' 140' ' ' GLU . 11.3 m-80 -87.84 -163.16 0.9 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.267 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -53.2 7.17 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.268 0.627 . . . . 0.0 109.968 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -62.57 -20.41 64.67 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.721 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 11.2 mt-10 -88.85 -43.91 10.87 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.559 0.695 . . . . 0.0 109.769 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.44 ' HB2' ' CG1' ' A' ' 136' ' ' VAL . 11.9 t80 -67.39 -24.53 65.69 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.916 -1.493 . . . . 0.0 108.847 175.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.582 ' HA ' ' SD ' ' A' ' 145' ' ' MET . 16.1 t -86.7 -51.32 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.344 -177.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' A' ' 147' ' ' ALA . 54.1 mt-30 -56.15 -36.14 67.95 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.653 0.596 . . . . 0.0 111.837 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.724 ' HG2' ' OE2' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -66.9 -14.93 63.29 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 123.426 0.453 . . . . 0.0 111.35 179.513 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.582 ' SD ' ' HA ' ' A' ' 142' ' ' VAL . 27.1 mtp -84.72 -13.08 52.42 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 176.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.3 t -122.04 -38.18 2.75 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.048 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -31.04 -43.77 0.05 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 178.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.4 pttt . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.25 180.0 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . 0.518 ' HB ' ' O ' ' B' ' 152' ' ' LYS . 18.7 p . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.525 0.202 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -131.47 -40.14 1.12 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.342 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 55.3 tttt -94.91 -16.61 22.71 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.455 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . 0.518 ' O ' ' HB ' ' B' ' 149' ' ' THR . 98.1 mttt -123.69 116.47 23.12 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 123.351 0.407 . . . . 0.0 110.56 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.49 ' OG1' ' HA ' ' A' ' 124' ' ' MET . 0.2 OUTLIER -138.34 -43.45 0.5 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 179.694 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' PHE . . . . . 0.692 ' HA ' HG22 ' B' ' 157' ' ' VAL . 61.1 t80 -67.95 -31.37 71.06 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 119.144 0.884 . . . . 0.0 109.48 177.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.498 ' HD2' ' OE1' ' A' ' 127' ' ' GLU . 3.6 mptt -56.79 -36.31 69.72 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.461 0.475 . . . . 0.0 110.789 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -77.41 -43.6 32.05 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.444 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' VAL . . . . . 0.692 HG22 ' HA ' ' B' ' 154' ' ' PHE . 17.7 m -71.78 -30.13 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . 0.59 ' O ' ' HB2' ' B' ' 162' ' ' LYS . . . -64.19 -40.66 96.56 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.497 0.719 . . . . 0.0 112.606 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -54.94 -36.75 65.61 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.715 0.293 . . . . 0.0 111.068 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -78.04 -47.2 18.92 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.392 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.42 HG12 HG11 ' A' ' 91' ' ' VAL . 20.8 t -131.15 66.05 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 21.2 ttmt -90.55 -26.44 19.72 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.464 176.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' ILE . . . . . 0.692 HG21 ' SD ' ' A' ' 76' ' ' MET . 2.1 pp -140.47 132.43 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 O-C-N 123.481 0.488 . . . . 0.0 111.459 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . 0.627 ' O ' ' HB2' ' B' ' 168' ' ' MET . 28.2 m -128.97 -34.06 1.95 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.001 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' ALA . . . . . 0.432 ' HB3' ' OE2' ' A' ' 87' ' ' GLU . . . -75.25 -2.43 28.02 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.458 0.474 . . . . 0.0 112.219 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 23.5 m -75.57 -38.48 59.15 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 122.907 0.483 . . . . 0.0 110.892 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.618 HD21 ' SD ' ' A' ' 36' ' ' MET . 10.8 tp -110.81 1.43 17.72 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.82 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . 0.627 ' HB2' ' O ' ' B' ' 164' ' ' SER . 0.0 OUTLIER -93.11 143.15 26.52 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.946 -179.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -143.1 101.91 0.27 Allowed Glycine 0 C--N 1.337 0.624 0 O-C-N 123.616 0.573 . . . . 0.0 112.611 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.971 179.912 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.492 0.187 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -118.31 117.35 28.86 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.085 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.422 ' HG2' HE22 ' A' ' 8' ' ' GLN . 49.1 mt-30 -97.09 151.02 20.18 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.01 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.553 ' HG ' ' OE1' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -92.65 -115.1 0.09 Allowed 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 123.183 0.593 . . . . 0.0 109.476 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.491 ' H ' ' HB2' ' A' ' 4' ' ' LEU . 19.1 p -101.38 -173.25 2.32 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 124.203 1.001 . . . . 0.0 109.685 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.496 ' HA ' HD12 ' A' ' 9' ' ' ILE . 46.2 mt-10 -69.55 -17.03 63.53 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.446 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 13.0 pt-20 -47.1 -36.3 8.1 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 123.903 0.752 . . . . 0.0 112.368 178.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.553 ' OE1' ' HG ' ' A' ' 4' ' ' LEU . 1.8 pt20 -74.49 -49.91 20.3 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.117 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 6' ' ' GLU . 5.6 mt -62.57 -28.29 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-N 113.751 -1.568 . . . . 0.0 110.404 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 6' ' ' GLU . . . -65.65 -47.38 75.74 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.768 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 22.1 mt-10 -138.1 -32.93 0.71 Allowed 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -177.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.624 ' CG ' HD21 ' A' ' 69' ' ' LEU . 74.0 m-85 -59.77 -13.12 8.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.968 0.413 . . . . 0.0 111.04 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.735 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 4.5 pttt -74.01 -41.05 62.45 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 176.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.768 ' HG2' ' O ' ' A' ' 11' ' ' GLU . 11.5 pt-20 -70.26 -43.98 69.39 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.811 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.565 ' O ' HG11 ' A' ' 35' ' ' VAL . . . -62.46 -18.09 60.98 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.779 0.8 . . . . 0.0 108.88 175.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.646 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 35.5 t80 -84.31 -49.9 8.33 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 113.886 -1.507 . . . . 0.0 109.461 177.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.458 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 9.2 t -87.35 -12.77 45.41 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -177.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.431 ' N ' ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -68.69 -29.98 68.54 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.356 0.526 . . . . 0.0 112.238 -179.236 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.549 ' CD1' HG22 ' A' ' 35' ' ' VAL . 2.5 m-85 -125.44 -4.51 7.23 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.568 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 16.8 t70 -79.36 55.78 1.98 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 118.723 0.692 . . . . 0.0 112.219 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.458 ' HE3' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -86.53 -22.5 26.32 Favored 'General case' 0 C--N 1.344 0.347 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 179.274 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.7 -22.25 61.67 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.33 0.586 . . . . 0.0 110.357 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.8 40.52 30.96 Favored Glycine 0 N--CA 1.47 0.93 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.821 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.0 23.27 9.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 112.925 -1.637 . . . . 0.0 112.753 -176.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.25 -78.46 1.97 Allowed Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.266 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.504 HG21 ' HA ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -110.96 174.76 5.71 Favored 'General case' 0 N--CA 1.436 -1.13 0 O-C-N 123.624 0.249 . . . . 0.0 110.437 178.245 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.418 ' CD1' HD23 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -78.81 148.53 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.181 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.433 ' OG1' ' HB2' ' A' ' 31' ' ' GLU . 0.6 OUTLIER -61.78 160.08 12.53 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.18 -0.918 . . . . 0.0 113.321 -179.439 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.495 HG22 HD11 ' A' ' 63' ' ' ILE . 1.2 p -76.63 -56.01 5.0 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.353 -0.839 . . . . 0.0 113.148 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.9 -13.32 6.02 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.482 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.515 ' O ' HG23 ' A' ' 35' ' ' VAL . 32.4 mt-10 -110.53 -16.84 13.57 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -176.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.445 HD22 ' O ' ' A' ' 32' ' ' LEU . 1.3 tm? -55.65 -38.86 70.11 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.915 0.486 . . . . 0.0 111.859 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.782 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -57.06 -39.55 89.91 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 110.706 -0.957 . . . . 0.0 110.706 177.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 m -73.84 -31.03 63.0 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 114.434 -0.883 . . . . 0.0 112.534 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.565 HG11 ' O ' ' A' ' 15' ' ' ALA . 1.5 t -73.84 -26.53 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 176.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.633 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 17.9 mmt -76.03 -40.87 52.5 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 113.013 -1.903 . . . . 0.0 111.429 176.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.782 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 10.8 mtt180 -82.38 -27.27 32.19 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 55.9 m -64.69 -7.95 12.71 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.996 0.903 . . . . 0.0 112.249 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.4 mt -95.66 -6.22 40.51 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 113.201 -1.818 . . . . 0.0 109.678 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.63 -0.63 52.77 Favored Glycine 0 CA--C 1.492 -1.364 0 CA-C-O 122.323 0.957 . . . . 0.0 114.719 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.633 ' HB2' ' O ' ' A' ' 36' ' ' MET . 54.3 mt-30 -79.87 139.81 37.0 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 112.11 -2.045 . . . . 0.0 111.981 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -119.44 75.34 17.17 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.821 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.71 -177.78 3.98 Favored 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 123.124 2.55 . . . . 0.0 111.754 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.69 158.3 16.05 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.967 0.413 . . . . 0.0 109.948 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.562 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 30.1 mt-10 -80.91 -28.18 35.94 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.522 177.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.43 -35.25 70.87 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 113.464 -1.698 . . . . 0.0 109.801 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -79.58 -30.3 41.53 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 113.977 -1.465 . . . . 0.0 108.776 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.562 ' HB2' ' HA ' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -67.98 -20.12 65.0 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.166 174.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.836 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 53.4 mt-30 -98.86 -15.74 19.1 Favored 'General case' 0 CA--C 1.482 -1.666 0 CA-C-N 114.46 -1.245 . . . . 0.0 111.07 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -85.29 -33.45 22.12 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-N 111.991 -2.368 . . . . 0.0 109.901 176.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 72.1 mtm -86.6 -33.67 20.11 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.9 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.52 HD13 ' O ' ' A' ' 48' ' ' LEU . 1.4 mp -71.23 -28.6 33.02 Favored 'Isoleucine or valine' 0 C--N 1.345 0.389 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 175.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.836 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.0 t30 -72.71 -33.97 66.82 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.882 176.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -84.03 -31.46 25.42 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.563 ' C ' ' H ' ' A' ' 57' ' ' ALA . 58.9 t -87.93 -42.23 14.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -72.55 36.79 0.07 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.979 0.895 . . . . 0.0 110.223 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.563 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -86.4 -5.71 59.1 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 114.056 -1.429 . . . . 0.0 112.056 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -108.26 -33.76 7.03 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 112.01 -2.359 . . . . 0.0 110.784 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.34 51.28 3.97 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-N 116.046 -0.525 . . . . 0.0 113.027 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -109.91 -21.43 12.35 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.53 26.76 70.93 Favored Glycine 0 N--CA 1.467 0.763 0 CA-C-N 116.001 -0.545 . . . . 0.0 114.046 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.42 165.5 30.93 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.275 0.63 . . . . 0.0 110.471 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.495 HD11 HG22 ' A' ' 29' ' ' THR . 39.9 mm -110.16 85.8 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.641 -178.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.504 ' HA ' HG21 ' A' ' 26' ' ' THR . 8.7 m-20 -50.23 151.45 2.08 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.877 0.871 . . . . 0.0 111.698 178.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.594 ' HA ' ' CD1' ' A' ' 68' ' ' PHE . 29.6 p90 -90.74 -38.5 0.4 Allowed Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.543 ' HD3' ' CD1' ' A' ' 65' ' ' PHE . 6.6 Cg_exo -74.2 -18.14 21.13 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 121.983 1.789 . . . . 0.0 113.01 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -102.26 -24.99 13.84 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -178.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.706 ' O ' ' HG2' ' A' ' 71' ' ' MET . 0.1 OUTLIER -84.91 -24.88 28.24 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -177.434 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.637 ' O ' ' N ' ' A' ' 73' ' ' ALA . 4.4 mt -74.38 -33.57 63.1 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.891 0.853 . . . . 0.0 109.38 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.49 -35.47 65.58 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 112.842 -1.981 . . . . 0.0 109.949 174.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.774 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 17.8 ptt? -78.82 -24.15 44.65 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.613 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 0.8 OUTLIER -88.98 -19.43 25.71 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.505 176.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.637 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . -77.2 -29.84 54.46 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.422 ' HD2' ' N ' ' A' ' 75' ' ' LYS . 6.7 ppt_? -82.05 -25.55 34.5 Favored 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 123.713 0.633 . . . . 0.0 110.107 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.774 ' HD2' ' O ' ' A' ' 71' ' ' MET . 24.2 mttt -68.34 -14.39 62.96 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.406 175.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.545 ' HA ' HG22 ' A' ' 79' ' ' THR . 12.5 ptt? -122.68 -23.59 5.08 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -176.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 73' ' ' ALA . 53.9 mttt -58.82 -12.75 4.73 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -103.76 -29.68 10.88 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.545 HG22 ' HA ' ' A' ' 76' ' ' MET . 9.9 t -75.59 104.45 6.15 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.053 0.454 . . . . 0.0 111.271 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.492 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 1.3 t70 -45.57 152.03 0.35 Allowed 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.219 -0.901 . . . . 0.0 112.801 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.426 ' HA ' ' OE2' ' A' ' 84' ' ' GLU . 53.0 m -71.27 -13.6 61.95 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.743 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.617 ' O ' HD12 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -74.12 -50.03 21.25 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.683 0.793 . . . . 0.0 110.597 -178.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.483 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 9.5 pt-20 -76.46 -18.31 58.85 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.166 -1.379 . . . . 0.0 112.835 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 39.7 mt-10 -67.79 -18.22 64.79 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 122.916 0.486 . . . . 0.0 112.289 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.617 HD12 ' O ' ' A' ' 82' ' ' GLU . 2.2 mt -86.61 -53.52 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.294 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.456 ' HD2' ' H ' ' A' ' 86' ' ' ARG . 3.0 mpt_? -56.58 -20.16 19.49 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.441 ' OE2' ' HA ' ' A' ' 84' ' ' GLU . 3.0 pt-20 -77.54 -20.38 54.26 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 123.362 0.414 . . . . 0.0 110.311 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.467 ' HB1' ' CE1' ' A' ' 141' ' ' PHE . . . -69.79 -22.87 63.29 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.774 177.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.533 ' O ' ' HB3' ' A' ' 93' ' ' ASP . 12.0 m-85 -81.84 -20.94 37.96 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 174.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.427 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 12.4 tpt180 -78.31 -21.64 49.33 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.128 -1.396 . . . . 0.0 107.491 174.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.45 HG12 ' CD1' ' A' ' 92' ' ' PHE . 53.1 t -88.25 -53.26 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.962 177.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.8 ' HB3' HG21 ' A' ' 100' ' ' ILE . 11.8 m-85 -100.3 -46.12 5.38 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -176.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.696 ' CA ' HG12 ' A' ' 100' ' ' ILE . 3.9 t70 -60.48 95.01 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.63 0.729 . . . . 0.0 111.309 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.449 ' HZ2' ' HA ' ' A' ' 94' ' ' LYS . 1.1 mmpm? -87.36 -50.33 6.64 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.424 -1.262 . . . . 0.0 113.16 -178.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -72.17 0.22 10.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -175.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 48.69 32.64 11.2 Favored Glycine 0 N--CA 1.472 1.069 0 CA-C-N 114.37 -1.286 . . . . 0.0 114.574 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -96.6 -5.73 38.43 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 122.374 0.27 . . . . 0.0 111.654 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.497 ' O ' ' HE2' ' A' ' 89' ' ' PHE . . . 104.13 -18.54 45.61 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 121.225 -0.512 . . . . 0.0 112.698 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -122.67 125.01 44.74 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.463 -0.869 . . . . 0.0 110.8 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.8 HG21 ' HB3' ' A' ' 92' ' ' PHE . 48.0 mt -80.44 88.05 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.8 t -67.54 165.38 16.97 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.893 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -60.59 -14.19 18.68 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.49 -32.45 18.23 Favored 'General case' 0 CA--C 1.49 -1.36 0 CA-C-O 121.982 0.896 . . . . 0.0 109.132 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.992 ' O ' HG23 ' A' ' 108' ' ' VAL . 16.1 mt-10 -77.12 -42.87 36.25 Favored 'General case' 0 CA--C 1.481 -1.675 0 CA-C-N 112.557 -2.111 . . . . 0.0 109.68 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.84 HD11 ' SD ' ' A' ' 124' ' ' MET . 5.3 tt -61.8 -35.57 78.58 Favored 'General case' 0 N--CA 1.441 -0.919 0 O-C-N 124.599 1.187 . . . . 0.0 108.025 177.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.438 ' HB3' ' O ' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -72.22 -43.59 64.19 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 114.253 -1.339 . . . . 0.0 108.912 176.452 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.441 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 8.5 t-80 -69.57 -21.55 63.61 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.834 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.992 HG23 ' O ' ' A' ' 104' ' ' GLU . 42.3 t -73.97 -52.34 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 176.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.718 ' SD ' ' HB2' ' A' ' 116' ' ' LEU . 18.3 mtt -56.69 -31.99 65.01 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 112.302 -2.226 . . . . 0.0 112.476 176.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -76.98 -19.06 57.78 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.516 -0.873 . . . . 0.0 110.261 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.17 -45.57 22.82 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.617 176.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.6 mt -81.49 -27.85 34.34 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.411 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 95.98 41.22 3.85 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 114.209 -1.36 . . . . 0.0 114.296 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.67 ' HB2' ' SD ' ' A' ' 109' ' ' MET . 0.1 OUTLIER -101.36 -23.46 14.37 Favored 'General case' 0 CA--C 1.479 -1.754 0 CA-C-O 123.473 1.606 . . . . 0.0 110.499 179.259 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.444 ' O ' HD12 ' A' ' 116' ' ' LEU . 5.3 mptt 34.9 122.68 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 108.902 -3.772 . . . . 0.0 112.793 -177.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.718 ' HB2' ' SD ' ' A' ' 109' ' ' MET . 0.9 OUTLIER -144.16 120.57 10.97 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 112.746 -2.025 . . . . 0.0 111.909 -175.625 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.922 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -65.74 -176.24 0.35 Allowed 'General case' 0 C--N 1.344 0.361 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.021 179.306 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.53 ' N ' HG23 ' A' ' 117' ' ' THR . 17.3 t70 -65.59 -41.05 93.28 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -177.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.584 ' H ' HG23 ' A' ' 117' ' ' THR . 10.7 pt-20 -87.27 -18.19 30.79 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.783 ' HG2' HG22 ' A' ' 117' ' ' THR . 12.7 pt-20 -85.07 -15.67 43.21 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 123.197 0.311 . . . . 0.0 111.245 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.922 HG22 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -82.47 -23.27 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 123.226 0.329 . . . . 0.0 111.005 177.1 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -70.96 31.34 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.769 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.935 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 12.0 pt-20 -132.6 -49.48 0.9 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.927 177.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.84 ' SD ' HD11 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -58.31 -29.84 66.2 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.017 0.927 . . . . 0.0 110.619 178.31 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.797 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 2.8 mt -85.02 -28.67 6.54 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.122 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -75.82 -30.21 58.92 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.369 0.604 . . . . 0.0 111.392 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.935 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 2.9 mm-40 -69.64 -28.21 65.71 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.833 177.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.574 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -99.61 -40.1 7.97 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.003 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.797 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.4 OUTLIER -61.08 122.96 16.3 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -178.123 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.7 mt -90.7 -52.74 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 113.867 -1.515 . . . . 0.0 109.676 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -87.71 -24.76 23.75 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.487 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.11 49.93 3.61 Favored Glycine 0 CA--C 1.523 0.532 0 O-C-N 123.563 0.539 . . . . 0.0 113.915 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -78.9 -20.46 49.35 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.11 26.02 49.99 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 114.766 0.667 . . . . 0.0 114.766 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.641 ' O ' ' HB ' ' A' ' 136' ' ' VAL . 38.7 mt-30 -134.03 -72.15 0.49 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.883 -0.658 . . . . 0.0 110.495 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.641 ' HB ' ' O ' ' A' ' 135' ' ' GLN . 4.1 t 120.78 116.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 125.322 1.449 . . . . 0.0 111.12 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -93.68 -163.57 1.06 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.377 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.487 ' O ' HG23 ' A' ' 142' ' ' VAL . 56.7 m-85 -66.36 -60.61 2.6 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.652 178.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -60.26 -20.51 59.26 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.574 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 9.3 mt-10 -86.58 -40.75 14.89 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 120.254 -0.578 . . . . 0.0 109.681 178.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.467 ' CE1' ' HB1' ' A' ' 88' ' ' ALA . 46.6 t80 -73.8 -24.02 59.77 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.762 176.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.539 ' O ' ' HG2' ' A' ' 145' ' ' MET . 53.5 t -86.7 -37.73 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-N 114.713 -1.13 . . . . 0.0 112.897 -177.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 140' ' ' GLU . 18.8 pt20 -50.0 -21.52 1.26 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.54 ' HB3' ' CE2' ' B' ' 154' ' ' PHE . 0.0 OUTLIER -68.58 -26.01 65.17 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 118.388 0.54 . . . . 0.0 109.912 177.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.539 ' HG2' ' O ' ' A' ' 142' ' ' VAL . 6.2 ptt? -82.25 -7.37 59.62 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.892 177.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 74.0 p -115.02 -48.39 2.83 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.534 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -55.23 -40.48 70.91 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 117.948 -1.025 . . . . 0.0 112.446 -179.927 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 19.5 p . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 111.303 0.112 . . . . 0.0 111.303 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -127.03 148.07 50.13 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 123.465 0.478 . . . . 0.0 110.842 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -99.96 133.31 44.52 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.893 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . 0.407 ' HG2' ' CD ' ' B' ' 156' ' ' GLU . 98.0 mttt -129.4 130.41 45.95 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.716 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.565 ' O ' HG12 ' B' ' 157' ' ' VAL . 11.8 t -110.85 -168.25 1.28 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.824 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' PHE . . . . . 0.624 ' CE1' ' HD2' ' B' ' 155' ' ' LYS . 0.1 OUTLIER -56.16 -28.17 57.07 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.624 ' HD2' ' CE1' ' B' ' 154' ' ' PHE . 9.3 mptt -60.06 -49.73 76.52 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . 0.407 ' CD ' ' HG2' ' B' ' 152' ' ' LYS . 42.9 mt-10 -79.67 -56.09 4.54 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 178.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' VAL . . . . . 0.565 HG12 ' O ' ' B' ' 153' ' ' THR . 8.9 p -73.32 -46.71 48.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -176.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' B' ' 154' ' ' PHE . . . -73.04 -34.99 66.64 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -71.6 -21.76 61.81 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.87 -41.65 43.08 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.673 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 9.4 p -92.94 7.15 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 O-C-N 123.405 0.441 . . . . 0.0 111.406 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -60.97 -38.48 86.1 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.545 0.338 . . . . 0.0 111.737 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 3.2 tp -94.39 101.39 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-O 121.14 0.495 . . . . 0.0 110.296 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 53.5 m -128.91 -15.62 4.28 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.798 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' ALA . . . . . 0.502 ' HB1' HG21 ' A' ' 79' ' ' THR . . . -80.83 3.11 23.64 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . 0.509 ' O ' ' HD3' ' A' ' 75' ' ' LYS . 69.5 m -96.75 -35.11 11.09 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.56 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 4.8 tp -120.91 -39.37 2.73 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.203 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 7.3 ttt -89.33 151.87 21.84 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.32 0.388 . . . . 0.0 111.075 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . 174.06 53.84 0.05 OUTLIER Glycine 0 C--N 1.337 0.586 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.43 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 40.7 p . . . . . 0 N--CA 1.485 1.288 0 C-N-CA 124.314 1.046 . . . . 0.0 112.797 -179.92 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.569 0.223 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.419 ' HB3' HE21 ' A' ' 3' ' ' GLN . 7.9 m-20 -97.85 165.73 11.8 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.245 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.635 ' NE2' ' H ' ' A' ' 3' ' ' GLN . 0.4 OUTLIER -59.74 162.74 4.97 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.355 0.662 . . . . 0.0 112.028 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.599 HD11 ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -107.52 -109.63 0.31 Allowed 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.557 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 16.9 p -101.04 -173.95 2.5 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 123.622 0.769 . . . . 0.0 110.194 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 10' ' ' ALA . 40.6 mt-10 -63.5 -22.61 66.99 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.557 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 12.8 pt-20 -53.07 -30.2 34.68 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.673 0.749 . . . . 0.0 111.816 178.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.776 ' HB2' HD13 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -76.74 -48.67 18.06 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 113.759 -1.564 . . . . 0.0 110.411 178.527 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.506 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 3.5 mp -68.99 -28.06 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.675 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.411 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 6' ' ' GLU . . . -68.64 -45.5 71.66 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -137.14 -37.8 0.63 Allowed 'General case' 0 C--N 1.36 1.05 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -176.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.533 ' CD2' ' HG ' ' A' ' 69' ' ' LEU . 7.6 m-85 -60.54 -13.43 14.01 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.703 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 3.1 pttt -74.21 -40.87 62.16 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.703 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 6.9 mt-10 -75.32 -42.75 53.8 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-N 113.829 -1.532 . . . . 0.0 110.525 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.755 ' O ' HG12 ' A' ' 27' ' ' ILE . . . -60.74 -18.43 54.58 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.584 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 47.8 t80 -84.11 -50.65 7.75 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.205 -1.361 . . . . 0.0 109.471 177.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.464 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 9.0 t -87.64 -12.74 44.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -177.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -66.29 -30.62 71.08 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.535 ' CD1' HG22 ' A' ' 35' ' ' VAL . 5.9 m-85 -131.94 -2.78 3.63 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 19.0 t70 -80.83 55.97 2.57 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 118.802 0.728 . . . . 0.0 112.653 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.464 ' HE3' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -86.45 -21.43 27.07 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 178.751 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.95 -22.45 61.46 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.395 0.617 . . . . 0.0 110.446 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.81 44.52 14.69 Favored Glycine 0 N--CA 1.47 0.963 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.79 23.25 13.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 113.131 -1.535 . . . . 0.0 112.831 -175.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.24 -81.47 1.75 Allowed Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.007 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.555 HG21 HG22 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -110.53 173.63 6.24 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.123 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.809 HD13 HG21 ' A' ' 35' ' ' VAL . 2.5 pp -75.51 150.12 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -177.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.18 160.41 2.16 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.306 -1.316 . . . . 0.0 113.687 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 p -80.57 -56.24 4.31 Favored 'General case' 0 C--N 1.348 0.516 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -56.31 -13.51 2.22 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.585 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.548 ' O ' HG23 ' A' ' 35' ' ' VAL . 12.5 mt-10 -111.26 -16.27 13.44 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.305 -0.862 . . . . 0.0 112.791 -177.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.458 ' HA ' HG23 ' A' ' 35' ' ' VAL . 6.3 tp -49.68 -41.41 43.05 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.541 0.736 . . . . 0.0 112.534 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.732 ' O ' ' HD3' ' A' ' 37' ' ' ARG . . . -57.75 -40.29 92.61 Favored Glycine 0 C--N 1.339 0.748 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 177.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.4 m -74.58 -29.67 61.41 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 114.452 -0.874 . . . . 0.0 112.226 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.809 HG21 HD13 ' A' ' 27' ' ' ILE . 1.7 t -73.19 -26.91 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 176.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.663 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 43.5 mtt -77.43 -42.09 37.38 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 113.055 -1.884 . . . . 0.0 111.604 176.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.732 ' HD3' ' O ' ' A' ' 33' ' ' GLY . 11.9 mtp180 -81.43 -28.0 34.45 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 56.4 m -65.12 -8.13 15.4 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 122.003 0.906 . . . . 0.0 112.237 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.5 mt -97.09 -5.39 37.52 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 113.169 -1.832 . . . . 0.0 109.588 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.52 0.98 57.85 Favored Glycine 0 CA--C 1.494 -1.275 0 CA-C-O 122.35 0.972 . . . . 0.0 114.771 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.663 ' HB2' ' O ' ' A' ' 36' ' ' MET . 55.9 mt-30 -83.27 139.74 32.91 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 112.116 -2.042 . . . . 0.0 112.036 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -116.3 78.55 8.21 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.802 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 41' ' ' GLN . 6.3 Cg_exo -80.26 -177.87 4.09 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 123.053 2.502 . . . . 0.0 111.944 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 m -101.92 159.1 15.64 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.974 0.416 . . . . 0.0 109.985 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.56 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 29.9 mt-10 -80.86 -28.16 36.16 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.728 177.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.24 -36.24 69.03 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 113.557 -1.656 . . . . 0.0 109.935 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -78.57 -28.22 45.87 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 114.03 -1.441 . . . . 0.0 108.772 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.56 ' HB2' ' HA ' ' A' ' 45' ' ' GLU . 0.5 OUTLIER -68.6 -20.26 64.49 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.097 174.711 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.92 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 47.1 mt-30 -98.71 -15.68 19.27 Favored 'General case' 0 CA--C 1.481 -1.711 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.11 178.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -86.74 -32.22 20.53 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 111.999 -2.364 . . . . 0.0 109.707 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.633 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 66.8 mtt -86.71 -35.47 19.24 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.036 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.504 HD13 ' O ' ' A' ' 48' ' ' LEU . 1.4 mp -71.83 -25.87 24.82 Favored 'Isoleucine or valine' 0 C--N 1.343 0.313 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 175.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.92 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 2.7 t30 -71.01 -36.22 72.35 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.355 175.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.633 ' HG2' ' O ' ' A' ' 51' ' ' MET . 6.8 pt-20 -79.28 -42.98 24.6 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.551 ' C ' ' H ' ' A' ' 57' ' ' ALA . 75.1 t -70.43 -41.77 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -72.82 36.19 0.07 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.924 0.869 . . . . 0.0 110.515 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.551 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -86.51 -6.21 58.95 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 114.242 -1.344 . . . . 0.0 112.351 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -112.93 -33.9 5.92 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 112.029 -2.35 . . . . 0.0 110.815 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.39 48.27 5.12 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 115.865 -0.607 . . . . 0.0 113.358 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -110.07 -21.49 12.27 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.16 26.96 62.93 Favored Glycine 0 N--CA 1.465 0.603 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.808 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.96 163.75 37.97 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.224 0.609 . . . . 0.0 110.808 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.555 HG22 HG21 ' A' ' 26' ' ' THR . 2.3 mp -94.27 162.63 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.311 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -117.14 148.39 41.61 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.992 0.917 . . . . 0.0 108.877 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.564 ' HA ' ' CE1' ' A' ' 68' ' ' PHE . 24.4 p90 -90.82 -37.25 0.39 Allowed Pre-proline 0 CA--C 1.545 0.775 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -178.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.492 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 6.5 Cg_exo -75.56 -17.75 18.11 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 121.715 1.61 . . . . 0.0 112.639 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -111.3 -7.4 14.41 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.564 ' CE1' ' HA ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -84.59 -43.18 14.7 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -177.822 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.776 HD13 ' HB2' ' A' ' 8' ' ' GLN . 1.5 mt -65.38 -31.85 73.18 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 118.827 0.74 . . . . 0.0 110.249 176.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.556 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -55.03 -34.51 63.57 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 113.563 -1.653 . . . . 0.0 108.893 175.078 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.585 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 64.7 mtt -70.46 -37.49 74.31 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.433 176.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.624 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 1.2 mpt? -78.45 -21.58 48.89 Favored 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 124.152 0.908 . . . . 0.0 110.937 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.59 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -75.5 -35.16 60.85 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.556 ' HD2' ' O ' ' A' ' 70' ' ' THR . 2.3 ptm180 -83.03 -18.02 41.23 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 120.469 -0.493 . . . . 0.0 112.276 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.624 ' HD2' ' HA ' ' A' ' 72' ' ' MET . 29.0 mttt -73.16 -13.9 61.26 Favored 'General case' 0 C--N 1.348 0.515 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 25.4 ptm -121.76 -34.88 3.31 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -177.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 16.7 mmtm -71.22 -38.34 72.01 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -178.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -104.84 -17.74 14.47 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.322 1.231 . . . . 0.0 114.322 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.627 HG23 ' H ' ' A' ' 80' ' ' ASP . 4.0 t -58.93 -68.99 0.21 Allowed 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -178.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.627 ' H ' HG23 ' A' ' 79' ' ' THR . 1.4 m-20 -167.99 125.05 1.11 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.67 0.788 . . . . 0.0 110.796 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.422 ' HA ' ' OE1' ' A' ' 84' ' ' GLU . 15.5 t -83.41 -13.63 54.43 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.415 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.616 ' O ' HD12 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -77.14 -45.8 25.57 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.775 0.83 . . . . 0.0 110.189 -179.082 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.53 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 38.9 mt-10 -74.86 -18.87 60.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.525 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.559 ' HA ' ' OG ' ' B' ' 164' ' ' SER . 37.7 mt-10 -68.65 -18.51 64.3 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 122.697 0.399 . . . . 0.0 112.008 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 82' ' ' GLU . 2.1 mt -87.87 -57.27 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.059 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.744 ' O ' ' HD1' ' A' ' 89' ' ' PHE . 9.6 mpt_? -55.5 -16.61 4.02 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.556 ' O ' HG23 ' A' ' 91' ' ' VAL . 35.3 mt-10 -79.67 -19.68 48.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.725 0.298 . . . . 0.0 111.175 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.45 -19.35 60.42 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.187 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.744 ' HD1' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -84.46 -21.51 30.65 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 175.399 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.517 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 32.3 mmt180 -78.07 -24.93 47.47 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 113.91 -1.495 . . . . 0.0 107.942 175.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 87' ' ' GLU . 85.2 t -88.38 -56.41 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.827 178.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.822 ' HB3' HG21 ' A' ' 100' ' ' ILE . 15.1 m-85 -100.54 -45.6 5.48 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -176.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.716 ' CA ' HG12 ' A' ' 100' ' ' ILE . 12.4 t70 -63.3 94.62 0.08 Allowed 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.761 0.791 . . . . 0.0 111.615 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.736 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 31.6 mttm -87.92 -48.78 7.53 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.374 -1.284 . . . . 0.0 113.892 -178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.11 0.65 9.07 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -175.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 50.02 29.3 14.27 Favored Glycine 0 N--CA 1.472 1.093 0 CA-C-N 114.357 -1.292 . . . . 0.0 114.724 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -96.23 -7.15 36.37 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.685 0.242 . . . . 0.0 111.441 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.53 -19.09 46.11 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.954 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -120.14 118.49 30.69 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.556 -0.822 . . . . 0.0 110.7 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.822 HG21 ' HB3' ' A' ' 92' ' ' PHE . 30.1 mt -77.28 93.71 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.3 p -71.94 163.37 27.97 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.334 -0.848 . . . . 0.0 113.12 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.537 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -60.13 -14.39 16.77 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -178.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.65 -33.0 17.75 Favored 'General case' 0 CA--C 1.487 -1.449 0 CA-C-O 121.943 0.878 . . . . 0.0 109.425 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 1.01 ' O ' HG23 ' A' ' 108' ' ' VAL . 3.2 mm-40 -80.02 -39.92 28.91 Favored 'General case' 0 CA--C 1.48 -1.728 0 CA-C-N 112.537 -2.12 . . . . 0.0 110.077 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.605 HD11 ' CE ' ' A' ' 124' ' ' MET . 5.9 tt -63.75 -35.74 81.58 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 177.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.712 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -71.13 -44.68 65.1 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 113.906 -1.497 . . . . 0.0 108.439 175.11 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.519 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 2.2 t60 -67.14 -21.87 65.81 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.428 177.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.01 HG23 ' O ' ' A' ' 104' ' ' GLU . 24.5 t -72.27 -50.5 35.65 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.852 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 176.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.71 ' SD ' HD22 ' A' ' 116' ' ' LEU . 20.8 mtt -56.31 -41.27 75.73 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.589 -2.096 . . . . 0.0 111.966 175.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.68 -19.21 64.38 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.412 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.95 -45.0 19.3 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.517 176.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.1 mt -79.55 -28.25 41.22 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.879 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 139.95 -8.18 3.0 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-O 117.846 -1.53 . . . . 0.0 116.765 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 109' ' ' MET . 5.0 mt-10 -100.88 151.75 21.36 Favored 'General case' 0 C--N 1.358 0.97 0 CA-C-N 120.781 2.29 . . . . 0.0 114.276 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -110.94 129.22 55.95 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 113.628 -1.624 . . . . 0.0 107.152 175.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.712 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 1.0 OUTLIER -138.67 115.87 11.05 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.968 -175.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.834 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -72.13 -175.7 1.57 Allowed 'General case' 0 C--N 1.347 0.494 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.784 179.372 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.513 ' N ' HG23 ' A' ' 117' ' ' THR . 17.0 t70 -70.17 -38.53 75.42 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.655 ' H ' HG23 ' A' ' 117' ' ' THR . 9.7 pt-20 -89.34 -16.99 29.77 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.765 ' HG2' HG22 ' A' ' 117' ' ' THR . 15.0 pt-20 -85.54 -16.0 40.87 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.117 0.261 . . . . 0.0 111.028 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.834 HG22 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -81.19 -26.64 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.522 177.605 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.86 30.67 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.999 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.621 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 11.6 pt-20 -141.99 -16.77 0.76 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.534 177.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.605 ' CE ' HD11 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -88.05 -27.02 22.25 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.091 0.956 . . . . 0.0 108.867 176.085 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.717 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 1.9 mp -86.88 -40.21 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 114.376 -1.284 . . . . 0.0 113.484 -177.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.1 mtt180 -61.41 -27.24 68.4 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 122.153 0.978 . . . . 0.0 110.718 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.678 ' HB3' ' CD1' ' B' ' 154' ' ' PHE . 6.5 mm-40 -56.63 -44.07 80.88 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 112.838 -1.983 . . . . 0.0 111.108 176.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.754 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -106.26 -29.57 9.72 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 114.926 -1.033 . . . . 0.0 111.7 -178.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.717 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -60.75 115.91 4.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.541 1.162 . . . . 0.0 112.902 -178.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.54 HD12 ' CD ' ' A' ' 140' ' ' GLU . 86.2 mt -91.09 -44.61 14.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 112.397 -2.183 . . . . 0.0 110.629 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -86.42 -25.16 25.41 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.83 49.53 6.44 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 116.04 -0.527 . . . . 0.0 113.947 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -99.52 -19.75 16.74 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.527 ' HA2' HG21 ' A' ' 125' ' ' ILE . . . 92.99 15.29 52.7 Favored Glycine 0 CA--C 1.502 -0.741 0 CA-C-O 121.5 0.5 . . . . 0.0 113.308 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -138.78 105.34 5.32 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 113.893 -1.154 . . . . 0.0 108.935 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.9 t -75.75 127.69 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.665 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.413 ' HB2' ' HG2' ' A' ' 140' ' ' GLU . 9.9 m120 -88.51 -168.15 2.11 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.949 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.465 ' O ' HG23 ' A' ' 142' ' ' VAL . 1.7 m-85 -74.06 -58.82 3.04 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.321 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -57.35 -22.95 45.81 Favored 'General case' 0 C--N 1.345 0.412 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.754 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 0.2 OUTLIER -87.68 -41.44 13.36 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.656 179.353 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -71.6 -23.37 61.7 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.679 175.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 138' ' ' TYR . 34.8 t -85.18 -48.24 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 114.633 -1.167 . . . . 0.0 112.793 -177.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' A' ' 147' ' ' ALA . 48.0 mt-30 -61.42 -23.84 66.1 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.384 0.427 . . . . 0.0 111.828 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.57 ' SD ' ' HE2' ' B' ' 154' ' ' PHE . 24.8 mmt -77.13 -14.76 59.75 Favored 'General case' 0 C--N 1.331 -0.201 0 O-C-N 123.502 0.501 . . . . 0.0 110.392 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 61.5 mtt -81.06 -19.08 44.54 Favored 'General case' 0 C--N 1.347 0.493 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 t -110.48 -48.7 3.13 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.707 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -2.54 -63.0 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 177.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.405 ' NZ ' ' HB3' ' B' ' 155' ' ' LYS . 22.8 pttm . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.48 -0.771 . . . . 0.0 111.571 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.551 0.215 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -128.38 -42.23 1.51 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.228 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt -99.7 130.0 45.88 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 123.372 0.42 . . . . 0.0 110.851 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -103.41 129.61 50.56 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.613 ' O ' HG13 ' B' ' 157' ' ' VAL . 2.4 t -138.16 -53.89 0.63 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.065 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' PHE . . . . . 0.808 ' H ' ' HD1' ' B' ' 154' ' ' PHE . 0.0 OUTLIER -55.56 -45.02 77.33 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.826 0.85 . . . . 0.0 112.941 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.563 ' HD2' ' CZ ' ' B' ' 154' ' ' PHE . 1.3 mppt? -71.79 -32.5 67.69 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 123.389 0.43 . . . . 0.0 109.947 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -77.37 -40.14 44.91 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.297 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' VAL . . . . . 0.613 HG13 ' O ' ' B' ' 153' ' ' THR . 34.6 m -66.12 -41.96 90.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.069 0.548 . . . . 0.0 110.932 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' B' ' 162' ' ' LYS . . . -73.95 -37.99 64.36 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.933 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . 0.563 ' HB2' ' O ' ' B' ' 155' ' ' LYS . 1.9 t30 -59.78 -30.02 68.6 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.437 0.461 . . . . 0.0 111.773 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.82 -35.86 57.28 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.577 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 8.9 p -111.07 25.5 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.402 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 1.9 ttpm? -85.66 77.15 9.87 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.586 0.707 . . . . 0.0 110.919 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 2.9 tt -143.65 107.67 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.348 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . 0.559 ' OG ' ' HA ' ' A' ' 84' ' ' GLU . 20.2 t -128.41 122.02 30.41 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.718 -178.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . 64.18 8.93 4.39 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 18.4 t -67.46 -38.83 85.05 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.384 0.273 . . . . 0.0 111.643 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.414 HD11 ' HE1' ' A' ' 36' ' ' MET . 3.4 tp -131.58 -55.62 1.01 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.738 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 15.2 ttt 48.76 109.87 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.661 1.185 . . . . 0.0 112.68 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -97.0 -94.95 1.87 Allowed Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.559 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 19.6 p . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.442 -0.789 . . . . 0.0 111.039 179.977 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.438 0 N-CA-C 111.4 0.148 . . . . 0.0 111.4 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.517 ' OD2' HD11 ' A' ' 9' ' ' ILE . 1.4 m-20 -118.73 114.7 23.11 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 123.454 0.471 . . . . 0.0 110.735 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -108.72 -51.31 2.9 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.654 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.489 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -122.29 -112.02 0.32 Allowed 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.533 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.508 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 17.3 p -101.31 -173.77 2.45 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 123.796 0.838 . . . . 0.0 110.854 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.442 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.6 mp0 -61.94 -23.44 66.36 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.508 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 12.7 pt-20 -53.83 -30.57 45.83 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.463 0.649 . . . . 0.0 111.444 178.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.517 ' HA ' HD13 ' A' ' 69' ' ' LEU . 1.2 tp60 -75.2 -45.95 37.14 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.139 -1.391 . . . . 0.0 109.811 178.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.517 HD11 ' OD2' ' A' ' 2' ' ' ASP . 3.9 mt -65.98 -32.23 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.629 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.56 -35.47 58.18 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -114.11 -18.4 11.68 Favored 'General case' 0 C--N 1.347 0.495 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.663 ' O ' ' HB2' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -74.62 -15.28 60.83 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.939 0.79 . . . . 0.0 110.028 178.536 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.701 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 1.1 pttt -80.99 -41.6 22.5 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.701 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 2.2 mt-10 -82.17 -39.98 22.43 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 114.225 -1.352 . . . . 0.0 112.314 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.584 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -66.21 -18.85 65.6 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 178.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 1.006 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 10.3 t80 -86.27 -48.85 8.15 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.496 177.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.0 m -86.71 -12.96 46.78 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -176.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -72.74 -29.67 63.53 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.76 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.5 ' CD1' HG22 ' A' ' 35' ' ' VAL . 5.3 m-85 -134.49 -5.86 2.56 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 1.006 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 0.8 OUTLIER -97.23 79.28 2.8 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 118.833 0.742 . . . . 0.0 111.052 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.411 ' HD2' ' N ' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -81.04 -34.78 32.57 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.29 -21.57 58.39 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.37 178.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.16 51.73 6.66 Favored Glycine 0 N--CA 1.469 0.898 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.84 22.56 7.19 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 113.445 -1.377 . . . . 0.0 113.952 -175.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.29 -67.74 0.52 Allowed Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.438 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.517 ' OG1' ' N ' ' A' ' 63' ' ' ILE . 1.3 t -98.09 174.01 6.75 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.708 0.766 . . . . 0.0 111.625 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.599 HG23 ' OD2' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -132.56 148.23 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.724 0 CA-C-N 113.723 -1.58 . . . . 0.0 109.964 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.58 150.47 12.16 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.568 HG22 HD11 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -69.38 -55.18 11.12 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.909 -179.244 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -55.0 -13.92 1.3 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.599 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.553 ' O ' HG23 ' A' ' 35' ' ' VAL . 24.7 mt-10 -111.0 -18.41 13.06 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.101 -178.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.416 ' HA ' HG23 ' A' ' 35' ' ' VAL . 2.2 tm? -58.49 -36.87 74.43 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.874 0.47 . . . . 0.0 111.646 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.79 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -55.82 -39.78 78.56 Favored Glycine 0 C--N 1.34 0.769 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 177.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.7 m -76.51 -29.1 56.64 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.559 -0.82 . . . . 0.0 112.452 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 15' ' ' ALA . 1.6 t -75.71 -26.59 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 177.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.603 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 10.5 mmt -73.92 -44.1 56.19 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 112.941 -1.936 . . . . 0.0 110.982 175.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.79 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 12.1 mtt180 -77.7 -29.75 51.48 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.5 m -69.04 -8.77 48.22 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 122.002 0.906 . . . . 0.0 111.845 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 14' ' ' GLU . 83.9 mt -91.87 -6.85 50.83 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 113.255 -1.793 . . . . 0.0 109.917 177.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.95 -3.03 33.64 Favored Glycine 0 CA--C 1.492 -1.382 0 CA-C-O 122.32 0.956 . . . . 0.0 115.082 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.603 ' HB2' ' O ' ' A' ' 36' ' ' MET . 47.0 mt-30 -80.09 139.85 36.71 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 112.214 -1.993 . . . . 0.0 112.04 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -123.34 68.61 39.18 Favored Pre-proline 0 CA--C 1.55 0.97 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.295 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.43 ' HD3' ' C ' ' A' ' 41' ' ' GLN . 6.9 Cg_endo -88.37 -177.82 1.9 Allowed 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 123.157 2.571 . . . . 0.0 112.384 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.432 ' O ' HD23 ' A' ' 48' ' ' LEU . 1.4 m -100.35 160.57 14.23 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 29.7 mt-10 -80.77 -28.03 36.52 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.613 0.721 . . . . 0.0 109.835 178.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.422 ' HA ' HE21 ' A' ' 49' ' ' GLN . . . -72.92 -37.18 67.31 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 113.576 -1.647 . . . . 0.0 110.014 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.57 ' HA ' ' OD2' ' A' ' 50' ' ' ASP . 9.6 mm-40 -75.37 -29.14 59.78 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.724 176.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.474 ' HB2' ' HA ' ' A' ' 45' ' ' GLU . 0.5 OUTLIER -64.53 -20.79 66.43 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.644 174.538 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.789 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 49.1 mt-30 -92.33 -17.18 25.05 Favored 'General case' 0 CA--C 1.48 -1.717 0 CA-C-N 114.031 -1.44 . . . . 0.0 111.478 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.57 ' OD2' ' HA ' ' A' ' 47' ' ' GLU . 26.9 m-20 -80.9 -36.05 31.69 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 111.795 -2.457 . . . . 0.0 109.854 176.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.67 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 13.0 ttt -86.41 -30.89 21.76 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.755 177.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.3 mt -74.81 -23.48 17.68 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 174.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.789 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.0 t30 -66.42 -35.05 79.33 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.974 174.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.67 ' HG2' ' O ' ' A' ' 51' ' ' MET . 7.6 pt-20 -86.7 -40.71 14.8 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 123.475 0.484 . . . . 0.0 111.947 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.526 ' C ' ' H ' ' A' ' 57' ' ' ALA . 75.6 t -69.42 -43.52 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -72.98 38.15 0.08 Allowed 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.917 0.865 . . . . 0.0 110.376 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -86.24 -5.82 59.11 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 114.277 -1.328 . . . . 0.0 111.977 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -111.56 -33.59 6.33 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 111.982 -2.372 . . . . 0.0 110.63 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.39 48.58 5.0 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-N 115.866 -0.606 . . . . 0.0 113.43 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -110.13 -21.85 12.07 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.85 26.61 72.24 Favored Glycine 0 N--CA 1.468 0.815 0 CA-C-N 115.953 -0.567 . . . . 0.0 114.216 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.474 HG22 ' HG1' ' A' ' 26' ' ' THR . 0.0 OUTLIER -135.97 -177.51 4.72 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 123.067 0.547 . . . . 0.0 110.77 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.568 HD11 HG22 ' A' ' 29' ' ' THR . 36.6 mm -138.42 86.6 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -176.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -70.18 149.42 47.54 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.349 -0.219 . . . . 0.0 110.557 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.599 ' HA ' ' CE2' ' A' ' 68' ' ' PHE . 24.9 p90 -70.18 -36.72 6.4 Favored Pre-proline 0 N--CA 1.479 0.977 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -177.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.487 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 17.4 Cg_exo -67.63 -16.78 47.48 Favored 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 122.119 1.879 . . . . 0.0 113.194 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -104.11 -26.03 12.73 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -177.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.599 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 6.5 p90 -85.09 -45.41 12.11 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 116.409 2.004 . . . . 0.0 116.409 -176.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.517 HD13 ' HA ' ' A' ' 8' ' ' GLN . 3.0 mt -63.3 -32.41 73.82 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.694 0.759 . . . . 0.0 110.965 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.526 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -57.34 -34.75 69.1 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 113.39 -1.732 . . . . 0.0 108.878 174.278 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.644 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 23.5 mmt -70.41 -27.13 64.04 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.521 175.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.534 ' HA ' ' CD ' ' A' ' 75' ' ' LYS . 28.3 mtm -85.36 -18.53 33.51 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.351 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.513 ' O ' ' HG3' ' A' ' 77' ' ' LYS . . . -81.53 -35.29 30.52 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 176.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.526 ' HD2' ' O ' ' A' ' 70' ' ' THR . 2.3 ptm180 -82.18 -17.9 44.6 Favored 'General case' 0 C--N 1.349 0.585 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.644 ' HD2' ' O ' ' A' ' 71' ' ' MET . 0.0 OUTLIER -86.38 -12.88 48.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 119.358 -0.937 . . . . 0.0 112.398 177.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' A' ' 72' ' ' MET . 20.6 ptt? -111.2 -28.01 8.45 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.925 0.393 . . . . 0.0 111.969 -178.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' A' ' 73' ' ' ALA . 38.8 mttt -66.92 -13.75 62.07 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.733 0.813 . . . . 0.0 113.089 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -104.22 -23.46 13.25 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.429 HG22 ' HA ' ' A' ' 76' ' ' MET . 8.8 t -76.78 10.18 2.38 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.412 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 9.8 m-20 65.12 149.81 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.064 0.946 . . . . 0.0 112.497 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.56 ' HA ' ' OE2' ' A' ' 84' ' ' GLU . 53.8 m -83.11 -13.78 54.96 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.044 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.409 ' O ' HD12 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -77.83 -43.5 30.22 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.74 0.816 . . . . 0.0 109.947 -179.332 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -70.92 -18.42 62.65 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.847 -1.524 . . . . 0.0 112.256 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.56 ' OE2' ' HA ' ' A' ' 81' ' ' SER . 39.8 mt-10 -66.96 -19.56 65.74 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 82' ' ' GLU . 3.1 mp -87.92 -50.99 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.529 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.583 ' O ' ' HD1' ' A' ' 89' ' ' PHE . 9.4 mpt_? -63.21 -16.84 61.44 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.525 ' OE2' ' HA ' ' A' ' 84' ' ' GLU . 3.4 pt-20 -73.77 -18.78 60.93 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 177.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.524 ' HA ' ' HB ' ' A' ' 91' ' ' VAL . . . -64.67 -23.82 67.38 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.914 178.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.583 ' HD1' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -82.35 -21.0 36.15 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 175.137 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -82.01 -19.86 39.6 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.252 -1.34 . . . . 0.0 107.752 174.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.548 HG12 ' HD1' ' A' ' 92' ' ' PHE . 3.1 t -88.09 -56.12 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.181 178.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.78 ' HB3' HD13 ' A' ' 100' ' ' ILE . 1.8 m-85 -100.79 -46.28 5.19 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -177.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.704 ' CA ' HG12 ' A' ' 100' ' ' ILE . 8.3 t70 -62.33 95.56 0.07 Allowed 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.757 0.789 . . . . 0.0 112.734 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 70.1 mmtt -86.7 -41.89 13.81 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.757 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -70.68 -19.41 62.79 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 -175.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.66 20.41 75.7 Favored Glycine 0 C--N 1.295 -1.714 0 CA-C-N 112.866 -1.97 . . . . 0.0 114.159 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -94.82 -6.02 43.8 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 122.295 0.238 . . . . 0.0 111.427 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.9 -19.12 44.9 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.725 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.577 ' CB ' HE21 ' A' ' 135' ' ' GLN . 41.1 m-85 -112.1 121.01 43.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.486 -0.857 . . . . 0.0 110.72 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.78 HD13 ' HB3' ' A' ' 92' ' ' PHE . 16.1 mt -85.4 86.84 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-O 121.542 0.687 . . . . 0.0 109.345 178.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.1 m -61.29 162.45 7.66 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.873 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.602 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -60.72 -14.22 19.72 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.56 -30.94 18.92 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-O 122.086 0.946 . . . . 0.0 109.416 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 1.058 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.7 mm-40 -81.32 -40.81 23.04 Favored 'General case' 0 CA--C 1.481 -1.707 0 CA-C-N 112.461 -2.154 . . . . 0.0 110.392 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.727 HD21 ' SD ' ' A' ' 124' ' ' MET . 6.8 tt -65.88 -30.55 71.17 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 176.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.728 ' HA ' HD11 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -73.72 -44.65 55.76 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 113.933 -1.485 . . . . 0.0 108.855 176.043 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.516 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 10.8 t-80 -67.52 -21.53 65.48 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 114.055 -1.43 . . . . 0.0 108.041 176.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.058 HG23 ' O ' ' A' ' 104' ' ' GLU . 35.8 t -70.82 -52.84 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 176.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.839 ' SD ' HD13 ' A' ' 116' ' ' LEU . 16.7 mtt -56.85 -42.37 79.59 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 113.587 -1.642 . . . . 0.0 111.965 176.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.21 -18.7 61.22 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 119.524 -0.871 . . . . 0.0 110.256 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 107' ' ' HIS . 0.8 OUTLIER -78.92 -46.0 19.34 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.146 176.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.8 mt -79.72 -28.36 40.56 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.082 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.98 0.75 3.82 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 117.419 -1.767 . . . . 0.0 116.852 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.668 ' N ' ' O ' ' A' ' 109' ' ' MET . 4.6 mt-10 -100.94 147.54 26.04 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 121.482 2.641 . . . . 0.0 113.716 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.2 mptt -111.34 117.03 32.0 Favored 'General case' 0 CA--C 1.485 -1.558 0 CA-C-N 113.598 -1.637 . . . . 0.0 107.353 175.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.839 HD13 ' SD ' ' A' ' 109' ' ' MET . 0.5 OUTLIER -122.26 128.43 51.1 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 112.52 -2.127 . . . . 0.0 112.883 -175.505 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.935 ' H ' ' HG3' ' A' ' 120' ' ' GLU . 0.6 OUTLIER -78.17 -175.18 4.01 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.824 -1.534 . . . . 0.0 111.854 178.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.609 ' N ' HG23 ' A' ' 117' ' ' THR . 18.3 t70 -61.96 -44.43 96.77 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.966 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.635 ' H ' HG23 ' A' ' 117' ' ' THR . 6.9 pt-20 -78.51 -15.18 58.88 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.745 0.307 . . . . 0.0 111.112 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.935 ' HG3' ' H ' ' A' ' 117' ' ' THR . 1.4 mm-40 -74.55 -31.87 62.25 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.36 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -86.38 -34.5 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.79 -178.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -79.01 24.79 0.3 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.668 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.547 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 9.7 pt-20 -138.57 -19.16 1.07 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.052 -1.431 . . . . 0.0 111.134 178.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.727 ' SD ' HD21 ' A' ' 105' ' ' LEU . 8.7 ttt -88.66 -27.9 20.96 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.733 ' O ' ' N ' ' A' ' 129' ' ' ASP . 1.5 mp -87.89 -45.65 15.96 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 CA-C-N 114.662 -1.154 . . . . 0.0 112.467 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.441 ' HA ' ' CG ' ' A' ' 129' ' ' ASP . 70.9 mtt180 -60.07 -29.66 68.7 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 123.845 0.716 . . . . 0.0 112.85 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.547 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 4.6 mm-40 -74.61 -25.86 59.52 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.834 177.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.602 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -104.88 -27.8 11.51 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.074 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.733 ' N ' ' O ' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -60.03 114.13 2.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.352 -1.295 . . . . 0.0 113.489 -178.358 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 41.2 mt -91.89 -51.83 10.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 113.125 -1.852 . . . . 0.0 110.619 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -89.12 -25.35 21.92 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.612 ' HA2' ' OD2' ' A' ' 129' ' ' ASP . . . 86.5 49.76 4.04 Favored Glycine 0 CA--C 1.522 0.505 0 O-C-N 123.46 0.475 . . . . 0.0 113.783 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.508 ' HB3' ' OE1' ' A' ' 135' ' ' GLN . 6.5 m-20 -96.39 -19.64 19.05 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 100.96 -1.65 55.24 Favored Glycine 0 CA--C 1.504 -0.599 0 CA-C-O 121.688 0.604 . . . . 0.0 113.309 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.577 HE21 ' CB ' ' A' ' 99' ' ' TYR . 1.7 pt20 -119.31 175.97 5.55 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 113.496 -1.352 . . . . 0.0 109.558 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.83 HG13 ' HB2' ' A' ' 140' ' ' GLU . 15.1 t -135.02 119.33 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 121.125 0.488 . . . . 0.0 111.622 -178.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -84.67 -169.9 2.85 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.906 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.422 ' O ' HG23 ' A' ' 142' ' ' VAL . 46.5 m-85 -62.03 -48.9 78.21 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.33 177.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 143' ' ' GLN . 9.4 mm-40 -69.21 -22.18 63.89 Favored 'General case' 0 C--N 1.347 0.487 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.83 ' HB2' HG13 ' A' ' 136' ' ' VAL . 3.4 mt-10 -85.55 -34.65 21.45 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.814 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.49 ' CE2' ' HB1' ' A' ' 88' ' ' ALA . 85.8 t80 -77.56 -24.35 49.84 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.409 176.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.517 ' O ' ' HG2' ' A' ' 145' ' ' MET . 19.6 t -86.78 -38.27 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.3 -178.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 139' ' ' GLU . 10.3 mt-30 -48.76 -29.92 5.06 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.562 ' HB3' ' CD2' ' B' ' 154' ' ' PHE . 0.0 OUTLIER -63.55 -27.12 69.04 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 118.533 0.606 . . . . 0.0 110.8 178.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.517 ' HG2' ' O ' ' A' ' 142' ' ' VAL . 9.8 ptm -83.36 -4.37 58.4 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.881 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.444 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 44.5 p -120.23 -44.17 2.5 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.547 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -48.62 -33.5 9.96 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 94.2 mttt . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.113 -0.946 . . . . 0.0 111.302 179.732 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.531 0.205 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -100.54 -39.57 7.85 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.259 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -95.04 140.29 30.19 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.824 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -129.48 145.53 51.43 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.198 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.525 ' OG1' ' HA ' ' A' ' 124' ' ' MET . 8.7 t -137.31 -170.2 2.68 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.433 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' PHE . . . . . 0.57 ' HA ' HG22 ' B' ' 157' ' ' VAL . 0.1 OUTLIER -61.11 -27.89 68.7 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.452 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.505 ' HD2' ' CE1' ' B' ' 154' ' ' PHE . 1.4 mptt -71.93 -44.02 64.33 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.757 0.423 . . . . 0.0 111.319 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -76.73 -38.91 53.44 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' VAL . . . . . 0.57 HG22 ' HA ' ' B' ' 154' ' ' PHE . 23.4 m -71.76 -29.55 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.88 0.472 . . . . 0.0 111.622 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . 0.568 ' O ' ' HB2' ' B' ' 162' ' ' LYS . . . -52.57 -42.66 64.66 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.859 0.864 . . . . 0.0 113.128 -178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -58.89 -30.64 67.93 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 123.182 0.301 . . . . 0.0 111.506 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.65 -39.98 43.25 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.781 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 9.0 p -119.85 33.77 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.318 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' LYS . . . . . 0.568 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 0.1 OUTLIER -82.63 -45.18 14.87 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 122.252 -0.28 . . . . 0.0 110.712 178.458 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 1.7 tp -101.68 63.06 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-O 121.688 0.756 . . . . 0.0 110.241 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 16.5 t -84.74 -2.14 57.21 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.554 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . -90.39 -10.81 42.52 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.937 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . 0.425 ' OG ' ' HB3' ' A' ' 72' ' ' MET . 22.8 t -70.36 -34.17 72.31 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.858 0.463 . . . . 0.0 111.929 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.54 HD22 ' OE1' ' A' ' 41' ' ' GLN . 4.5 tp -132.16 -39.02 1.07 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.002 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 67.2 mtt 63.62 127.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.081 0.953 . . . . 0.0 111.848 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -100.2 92.91 1.15 Allowed Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.526 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 19.7 p . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.105 -0.95 . . . . 0.0 111.061 179.994 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.568 0.223 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 62.8 122.75 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.929 0.891 . . . . 0.0 112.227 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.629 ' HA ' ' NE2' ' A' ' 8' ' ' GLN . 1.1 mp0 -89.74 160.53 16.51 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.191 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.455 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -107.27 -109.62 0.31 Allowed 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.773 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.573 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 14.0 p -101.26 -173.69 2.43 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 123.633 0.773 . . . . 0.0 111.015 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -59.39 -25.96 64.72 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.573 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 9.9 pt-20 -56.41 -32.52 64.92 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.29 0.566 . . . . 0.0 111.611 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.629 ' NE2' ' HA ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -78.3 -44.95 23.97 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.034 177.553 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.579 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . 20.8 mm -58.9 -35.97 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.557 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.03 -34.81 64.24 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -111.77 -17.96 12.84 Favored 'General case' 0 C--N 1.345 0.379 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 -177.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.579 ' CE1' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -73.3 -16.13 61.38 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.578 0.626 . . . . 0.0 110.542 179.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.679 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 1.2 pttt -83.35 -41.46 18.19 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.615 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.679 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 1.2 mt-10 -81.53 -37.05 28.42 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 114.241 -1.345 . . . . 0.0 112.417 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.659 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -67.28 -23.27 65.65 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.32 0.581 . . . . 0.0 109.504 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.944 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 26.1 t80 -86.91 -43.4 12.44 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.908 176.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.1 m -86.4 -12.81 48.12 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 114.814 1.412 . . . . 0.0 114.814 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -73.0 -29.4 63.0 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.348 179.364 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.572 ' CD1' HG22 ' A' ' 35' ' ' VAL . 7.4 m-85 -131.31 -7.71 3.78 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.944 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 1.4 m-20 -99.38 79.7 2.33 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.845 0.748 . . . . 0.0 110.059 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.07 -37.45 58.24 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.84 -20.33 58.21 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.243 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.5 51.55 5.97 Favored Glycine 0 C--N 1.343 0.918 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.77 22.15 4.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 113.454 -1.373 . . . . 0.0 114.338 -175.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.17 -62.82 0.23 Allowed Glycine 0 CA--C 1.528 0.858 0 CA-C-N 115.367 -0.833 . . . . 0.0 114.362 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.715 HG22 ' N ' ' A' ' 64' ' ' ASP . 10.4 p -97.65 157.77 15.86 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 123.662 0.785 . . . . 0.0 111.791 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.616 HG23 ' OD2' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -120.02 148.33 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.74 -179.463 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.48 150.24 12.21 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.24 -55.7 5.46 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.319 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -53.66 -14.07 0.81 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 123.856 0.722 . . . . 0.0 111.378 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.495 ' O ' HG23 ' A' ' 35' ' ' VAL . 18.0 mt-10 -114.07 -16.9 12.05 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.692 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.455 ' HA ' HG23 ' A' ' 35' ' ' VAL . 7.8 tp -56.0 -40.42 73.31 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.264 0.626 . . . . 0.0 111.866 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.78 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -55.82 -39.27 76.89 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 177.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.0 m -74.94 -30.85 61.35 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 114.514 -0.843 . . . . 0.0 112.565 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.659 HG12 ' HA ' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -74.48 -27.07 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 176.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.608 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 45.0 mtt -73.52 -42.56 61.61 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 113.001 -1.909 . . . . 0.0 111.064 176.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.78 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 11.8 mtt180 -80.2 -29.12 38.57 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.8 m -66.87 -8.23 27.53 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.987 0.899 . . . . 0.0 112.051 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 35' ' ' VAL . 69.0 mt -92.44 -8.27 45.2 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 113.191 -1.822 . . . . 0.0 109.63 177.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.52 -3.91 30.99 Favored Glycine 0 CA--C 1.492 -1.372 0 CA-C-O 122.25 0.917 . . . . 0.0 114.949 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.608 ' HB2' ' O ' ' A' ' 36' ' ' MET . 55.7 mt-30 -78.45 141.51 38.21 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 112.3 -1.95 . . . . 0.0 112.198 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -125.38 68.09 58.21 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.486 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -84.2 -177.83 3.19 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 123.177 2.584 . . . . 0.0 112.19 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 m -98.97 160.8 14.0 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.517 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 28.6 mt-10 -80.63 -28.32 36.99 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.686 0.755 . . . . 0.0 109.896 178.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.45 -38.23 65.54 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.087 -178.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.588 ' HA ' ' OD2' ' A' ' 50' ' ' ASP . 43.1 mt-10 -76.3 -28.68 57.07 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 114.265 -1.334 . . . . 0.0 108.562 176.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.81 ' O ' HG12 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -63.08 -24.2 67.8 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.882 174.269 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.658 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 57.0 mt-30 -87.72 -18.93 28.37 Favored 'General case' 0 CA--C 1.478 -1.791 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.553 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.588 ' OD2' ' HA ' ' A' ' 47' ' ' GLU . 10.5 m-20 -75.64 -27.96 58.6 Favored 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 112.031 -2.35 . . . . 0.0 108.332 175.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.542 ' HA ' ' OE1' ' A' ' 54' ' ' GLU . 46.9 mtt -86.61 -35.67 19.28 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.663 176.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.81 HG12 ' O ' ' A' ' 48' ' ' LEU . 30.3 mm -68.8 -27.51 36.14 Favored 'Isoleucine or valine' 0 C--N 1.352 0.711 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 175.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.658 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.7 t-20 -72.94 -34.29 66.45 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 114.006 -1.452 . . . . 0.0 111.699 176.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.542 ' OE1' ' HA ' ' A' ' 51' ' ' MET . 5.5 pt-20 -88.24 -49.53 6.93 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.592 ' C ' ' H ' ' A' ' 57' ' ' ALA . 47.8 t -83.79 -49.75 16.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -178.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 5.1 t70 -71.14 37.46 0.05 Allowed 'General case' 0 C--O 1.238 0.484 0 CA-C-O 122.089 0.947 . . . . 0.0 110.289 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.592 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -86.26 -5.77 59.11 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 113.969 -1.469 . . . . 0.0 112.154 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -101.98 -33.36 9.77 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 112.069 -2.332 . . . . 0.0 110.864 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.38 51.09 4.03 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.149 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -109.94 -21.76 12.18 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.632 0.253 . . . . 0.0 111.546 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.93 26.67 72.33 Favored Glycine 0 N--CA 1.468 0.767 0 CA-C-N 115.711 -0.677 . . . . 0.0 114.599 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.46 ' O ' HD13 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -146.67 156.17 42.99 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 123.202 0.601 . . . . 0.0 110.593 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.575 ' O ' HG13 ' A' ' 27' ' ' ILE . 10.9 mm -135.11 126.41 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.715 ' N ' HG22 ' A' ' 26' ' ' THR . 0.3 OUTLIER -73.22 156.83 38.14 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.363 176.587 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.55 ' CG ' ' HD3' ' A' ' 66' ' ' PRO . 10.6 p90 -91.61 -40.12 0.38 Allowed Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -177.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.55 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 7.4 Cg_exo -73.76 -18.17 22.31 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 121.793 1.662 . . . . 0.0 112.821 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -93.5 -19.42 21.25 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' A' ' 65' ' ' PHE . 2.7 p90 -83.62 -33.29 25.33 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 120.069 1.304 . . . . 0.0 114.283 -178.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.573 HD13 ' HA ' ' A' ' 8' ' ' GLN . 1.3 mt -65.66 -35.64 81.36 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.667 0.746 . . . . 0.0 110.417 178.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.47 -33.49 71.37 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 113.447 -1.706 . . . . 0.0 108.834 174.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.631 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 60.4 mtt -77.26 -23.32 51.23 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.992 175.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.571 ' HA ' ' CD ' ' A' ' 75' ' ' LYS . 66.0 mtt -88.75 -18.59 27.47 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.029 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.733 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -83.27 -24.99 32.01 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.846 177.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.453 ' HD2' ' N ' ' A' ' 75' ' ' LYS . 4.0 ppt_? -89.62 -28.48 19.48 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.631 ' HD2' ' O ' ' A' ' 71' ' ' MET . 8.5 ptmt -75.61 -12.9 60.3 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.552 ' HG2' ' O ' ' A' ' 72' ' ' MET . 14.7 ptm -113.27 -34.27 5.7 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.733 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 32.3 mmtt -76.39 -25.39 54.52 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.88 -1.055 . . . . 0.0 113.844 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -104.01 -22.85 13.39 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -177.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.608 HG23 ' H ' ' A' ' 80' ' ' ASP . 4.5 t -61.06 -67.6 0.39 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.608 ' H ' HG23 ' A' ' 79' ' ' THR . 4.6 m-20 -162.73 121.14 2.11 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.8 0.84 . . . . 0.0 110.327 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.3 t -83.66 -13.48 54.06 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.451 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.521 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -75.99 -52.11 10.95 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.391 0.677 . . . . 0.0 111.079 -178.049 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.55 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -72.65 -17.76 61.63 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.578 -1.192 . . . . 0.0 113.248 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -53.54 -26.63 21.96 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.225 0.61 . . . . 0.0 112.167 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.7 mp -87.77 -47.47 15.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.272 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.625 ' O ' ' HD1' ' A' ' 89' ' ' PHE . 45.7 mtt180 -51.59 -30.6 21.6 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.111 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.55 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 43.9 mt-10 -62.63 -20.39 64.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.787 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.79 -19.53 60.74 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.942 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.625 ' HD1' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -84.96 -21.35 29.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 174.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 30.9 mmt180 -78.74 -28.62 44.92 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.131 -1.395 . . . . 0.0 108.333 175.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 87' ' ' GLU . 82.5 t -88.75 -50.92 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 CA-C-N 114.4 -1.273 . . . . 0.0 113.07 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.855 ' HB3' HG21 ' A' ' 100' ' ' ILE . 30.6 m-85 -100.07 -43.05 6.48 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.688 ' CA ' HG12 ' A' ' 100' ' ' ILE . 14.1 t70 -69.02 94.96 0.68 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 122.295 1.045 . . . . 0.0 112.429 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.435 ' HD2' ' O ' ' A' ' 92' ' ' PHE . 1.2 mptm? -88.59 -48.78 7.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 113.088 -1.869 . . . . 0.0 114.075 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -71.49 2.02 5.63 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 48.19 29.15 6.62 Favored Glycine 0 N--CA 1.474 1.182 0 CA-C-N 114.302 -1.317 . . . . 0.0 115.091 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -98.56 -3.12 37.07 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.703 0.251 . . . . 0.0 111.304 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.03 -19.12 53.3 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.513 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.51 ' HB3' ' HG3' ' A' ' 135' ' ' GLN . 39.0 m-85 -115.1 129.06 56.59 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.379 -0.911 . . . . 0.0 110.852 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.855 HG21 ' HB3' ' A' ' 92' ' ' PHE . 54.9 mt -88.55 83.54 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.4 t -61.06 166.59 3.47 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 114.42 -1.263 . . . . 0.0 113.099 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.606 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -59.21 -14.8 11.94 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.612 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.46 -28.08 21.08 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 121.76 0.791 . . . . 0.0 109.473 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 1.048 ' O ' HG23 ' A' ' 108' ' ' VAL . 19.0 mt-10 -81.28 -42.18 21.04 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-N 112.639 -2.073 . . . . 0.0 111.327 -178.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.646 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 7.0 tt -67.83 -31.41 71.24 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.683 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -72.13 -44.34 63.29 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.014 -1.448 . . . . 0.0 108.724 175.244 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.612 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 2.2 t60 -66.88 -21.95 65.99 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.033 177.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.048 HG23 ' O ' ' A' ' 104' ' ' GLU . 27.6 t -71.26 -51.47 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 176.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.649 ' SD ' HD22 ' A' ' 116' ' ' LEU . 18.6 mtt -57.42 -41.95 81.4 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 112.65 -2.068 . . . . 0.0 112.196 175.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.68 -19.07 63.6 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.221 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.91 -44.95 21.59 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.563 176.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.1 mt -80.95 -28.25 35.77 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.084 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 140.65 -8.17 2.8 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 117.691 -1.616 . . . . 0.0 116.902 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 109' ' ' MET . 4.9 mt-10 -100.7 151.55 21.52 Favored 'General case' 0 C--N 1.358 0.947 0 CA-C-N 120.988 2.394 . . . . 0.0 114.39 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -109.46 128.86 55.47 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 113.519 -1.673 . . . . 0.0 107.487 175.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.683 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 1.4 tp -135.58 119.79 17.76 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.394 -1.275 . . . . 0.0 112.425 -175.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.94 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -72.76 -175.97 1.86 Allowed 'General case' 0 C--N 1.347 0.483 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.554 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.538 ' O ' HG23 ' A' ' 121' ' ' VAL . 16.7 t70 -73.21 -38.6 66.04 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -177.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.625 ' H ' HG23 ' A' ' 117' ' ' THR . 9.5 pt-20 -88.85 -16.04 32.98 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.769 ' HG2' HG22 ' A' ' 117' ' ' THR . 14.8 pt-20 -85.11 -15.43 43.91 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 123.118 0.261 . . . . 0.0 110.887 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.94 HG22 ' O ' ' A' ' 117' ' ' THR . 0.1 OUTLIER -83.35 -24.2 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.793 178.285 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -72.87 30.54 0.06 Allowed 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.724 0.773 . . . . 0.0 112.554 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.697 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 11.3 pt-20 -141.43 -17.64 0.8 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.636 177.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.649 ' HE1' HD21 ' A' ' 116' ' ' LEU . 2.2 ttm -88.05 -22.74 24.03 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.073 0.949 . . . . 0.0 109.136 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.641 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 2.6 mt -87.82 -44.36 15.84 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.804 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -58.48 -28.47 65.4 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 122.028 0.918 . . . . 0.0 111.01 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.703 ' HB3' ' CE1' ' B' ' 154' ' ' PHE . 7.4 mm-40 -55.33 -44.19 75.63 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.111 -1.859 . . . . 0.0 111.161 176.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.842 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -106.08 -29.0 10.17 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.028 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.641 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -59.92 124.52 20.43 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 122.15 0.976 . . . . 0.0 113.109 -178.324 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.5 mm -89.8 -47.54 14.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 112.97 -1.923 . . . . 0.0 110.459 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -90.59 -25.33 20.23 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.53 49.79 5.02 Favored Glycine 0 CA--C 1.525 0.69 0 O-C-N 123.428 0.455 . . . . 0.0 113.95 178.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -87.41 -19.58 27.88 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.492 ' O ' HD13 ' A' ' 125' ' ' ILE . . . 101.39 2.52 53.77 Favored Glycine 0 CA--C 1.507 -0.453 0 CA-C-N 115.846 -0.616 . . . . 0.0 113.468 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.51 ' HG3' ' HB3' ' A' ' 99' ' ' TYR . 5.1 pt20 -133.56 135.83 44.58 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 124.63 1.172 . . . . 0.0 109.389 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.6 t -93.16 135.18 28.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.274 0.559 . . . . 0.0 112.487 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -96.07 -168.67 1.79 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.358 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.416 ' O ' ' N ' ' A' ' 142' ' ' VAL . 9.2 m-85 -73.17 -58.86 3.02 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.875 177.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -59.78 -20.5 57.1 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.842 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 11.9 mt-10 -88.79 -40.49 13.15 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 121.28 0.562 . . . . 0.0 110.192 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.447 ' CZ ' ' HB2' ' B' ' 158' ' ' ALA . 61.4 t80 -73.46 -23.38 60.07 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.363 -1.289 . . . . 0.0 109.14 175.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.632 ' O ' ' HG2' ' A' ' 145' ' ' MET . 6.8 t -85.19 -48.62 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.786 -177.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.486 ' O ' ' N ' ' A' ' 147' ' ' ALA . 57.4 mt-30 -64.78 -19.04 65.6 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.419 -0.513 . . . . 0.0 112.322 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.566 ' SD ' ' HE2' ' B' ' 154' ' ' PHE . 24.1 mmt -84.79 -21.17 30.04 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 123.292 0.37 . . . . 0.0 110.717 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.632 ' HG2' ' O ' ' A' ' 142' ' ' VAL . 14.3 ptt? -83.57 -13.78 53.64 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 175.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.429 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 31.8 p -103.7 -58.4 1.88 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.276 177.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . 7.43 -69.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 177.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 50.4 pttt . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.401 -179.908 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.498 0.189 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -128.97 129.77 45.84 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -130.6 -44.32 1.1 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.351 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . 0.504 ' HE2' ' HZ3' ' B' ' 155' ' ' LYS . 97.2 mttt -98.27 138.2 35.88 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.464 0.477 . . . . 0.0 110.753 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.67 ' O ' HG13 ' B' ' 157' ' ' VAL . 27.2 p -139.43 -56.04 0.58 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.993 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' PHE . . . . . 0.843 ' H ' ' HD1' ' B' ' 154' ' ' PHE . 0.0 OUTLIER -55.1 -43.01 73.63 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.163 0.985 . . . . 0.0 113.008 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.603 ' HD2' ' CE2' ' B' ' 154' ' ' PHE . 1.0 OUTLIER -71.87 -32.83 67.87 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.05 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -77.79 -39.23 44.61 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.564 178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' VAL . . . . . 0.67 HG13 ' O ' ' B' ' 153' ' ' THR . 32.0 m -62.59 -38.14 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 122.919 0.488 . . . . 0.0 111.067 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 141' ' ' PHE . . . -74.0 -43.61 57.42 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.985 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -59.77 -29.58 68.29 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.947 0.499 . . . . 0.0 112.064 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.91 -33.76 57.75 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.448 0.468 . . . . 0.0 112.112 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 7.6 p -118.77 28.82 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 O-C-N 123.374 0.421 . . . . 0.0 111.741 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -84.63 -13.72 50.73 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 3.4 tp -130.68 29.8 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-O 120.994 0.426 . . . . 0.0 111.168 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 49.8 m -92.97 -41.59 9.93 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.356 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . -92.27 20.31 6.18 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.425 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 50.3 m -86.59 -20.79 27.39 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.022 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.442 HD11 ' HE2' ' A' ' 51' ' ' MET . 12.8 tp -91.46 88.13 6.69 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.265 0.555 . . . . 0.0 110.654 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 62.8 mtt -137.76 148.49 45.62 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.742 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -177.42 71.3 0.08 OUTLIER Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.549 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.537 -0.744 . . . . 0.0 111.066 179.963 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.546 0.212 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -135.69 125.45 25.52 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.862 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -83.45 157.1 22.58 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.389 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.453 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -105.82 -114.29 0.25 Allowed 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.555 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 18.4 p -101.45 -173.59 2.4 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 123.953 0.901 . . . . 0.0 110.391 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.406 ' HA ' HD12 ' A' ' 9' ' ' ILE . 46.7 mt-10 -58.19 -23.96 57.4 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.555 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 12.9 pt-20 -55.89 -29.46 60.02 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.74 0.65 . . . . 0.0 111.078 177.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.861 ' HA ' HD13 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -75.62 -46.8 29.56 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.801 178.068 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.576 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . 3.9 mt -65.09 -32.97 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.706 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.32 -34.3 59.03 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.568 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 44.4 mt-10 -109.6 -18.29 13.52 Favored 'General case' 0 C--N 1.346 0.44 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 -177.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.576 ' CE1' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -72.12 -15.58 61.99 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.773 0.715 . . . . 0.0 110.026 178.715 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.716 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 5.3 pttt -78.4 -41.84 31.92 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 114.55 -1.205 . . . . 0.0 108.385 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.716 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 7.3 pt-20 -80.16 -44.82 19.2 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 113.605 -1.634 . . . . 0.0 113.384 -178.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.612 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -61.4 -18.49 59.05 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.459 0.647 . . . . 0.0 109.346 177.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.418 ' O ' HG23 ' A' ' 27' ' ' ILE . 82.8 t80 -86.01 -52.79 5.48 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.583 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.627 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 50.5 m -87.12 -13.0 45.42 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -176.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -65.66 -28.71 69.29 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.471 0.578 . . . . 0.0 112.216 -178.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.541 ' CD1' HG22 ' A' ' 35' ' ' VAL . 6.6 m-85 -135.88 -0.36 2.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 116.301 1.963 . . . . 0.0 116.301 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.627 ' OD1' ' HA ' ' A' ' 17' ' ' SER . 31.0 p-10 -78.11 54.29 1.32 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 119.348 0.976 . . . . 0.0 112.348 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.411 ' N ' ' HD2' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -87.05 -17.21 33.45 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 179.676 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.73 -22.54 61.61 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.314 0.578 . . . . 0.0 110.438 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.46 43.83 14.6 Favored Glycine 0 N--CA 1.469 0.896 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.26 23.04 14.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.107 -1.547 . . . . 0.0 112.297 -175.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.37 -82.22 1.69 Allowed Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.386 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.846 HG21 ' HA ' ' A' ' 64' ' ' ASP . 7.2 p -98.61 178.66 4.93 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 122.864 0.466 . . . . 0.0 111.302 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.418 HG23 ' O ' ' A' ' 16' ' ' PHE . 0.7 OUTLIER -78.81 148.93 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -179.13 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.01 162.58 27.86 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -78.66 -55.77 4.93 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.061 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -54.63 -14.14 1.23 Allowed 'General case' 0 N--CA 1.475 0.799 0 O-C-N 123.662 0.601 . . . . 0.0 110.85 177.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.494 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 21.5 mt-10 -113.82 -16.48 12.24 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.48 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.498 ' HA ' HG23 ' A' ' 35' ' ' VAL . 14.3 tp -53.49 -43.09 67.93 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.747 0.819 . . . . 0.0 112.326 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.788 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -55.55 -37.97 69.27 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 177.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 m -75.99 -30.48 58.57 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.451 -0.874 . . . . 0.0 112.928 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.612 HG12 ' HA ' ' A' ' 15' ' ' ALA . 0.5 OUTLIER -75.02 -27.8 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 176.342 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.645 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 44.6 mtt -70.18 -43.67 70.33 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 113.061 -1.882 . . . . 0.0 110.413 175.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.788 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 11.9 mtt180 -77.76 -28.3 50.59 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.687 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.4 m -67.47 -8.65 35.12 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.927 0.87 . . . . 0.0 112.055 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 76.8 mt -94.04 -6.08 46.02 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 113.277 -1.783 . . . . 0.0 109.701 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.65 -2.45 39.22 Favored Glycine 0 CA--C 1.493 -1.298 0 CA-C-O 122.333 0.963 . . . . 0.0 114.891 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.645 ' HB2' ' O ' ' A' ' 36' ' ' MET . 46.9 mt-30 -78.25 143.11 37.37 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 112.138 -2.031 . . . . 0.0 112.379 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -124.63 70.31 56.46 Favored Pre-proline 0 CA--C 1.55 0.973 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.92 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.4 ' HD3' ' C ' ' A' ' 41' ' ' GLN . 3.3 Cg_exo -82.66 -179.57 4.64 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 123.26 2.64 . . . . 0.0 112.784 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 46' ' ' ALA . 1.9 m -100.57 162.62 12.81 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.708 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.516 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 28.3 mt-10 -80.7 -28.72 36.59 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-O 121.63 0.728 . . . . 0.0 109.983 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.417 ' H ' HG22 ' A' ' 44' ' ' THR . . . -72.69 -38.03 67.69 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 113.638 -1.619 . . . . 0.0 110.234 -178.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -76.5 -29.25 56.75 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.598 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.793 ' O ' HG12 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -62.49 -26.32 68.47 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.09 174.581 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.625 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 57.2 mt-30 -88.76 -18.44 27.76 Favored 'General case' 0 CA--C 1.48 -1.742 0 CA-C-N 114.188 -1.369 . . . . 0.0 111.164 178.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -76.57 -28.43 56.23 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 111.957 -2.383 . . . . 0.0 107.805 175.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 23.3 mmt -86.92 -31.67 20.57 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.013 176.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.793 HG12 ' O ' ' A' ' 48' ' ' LEU . 24.4 mm -72.99 -27.17 24.12 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.625 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.1 t-20 -79.5 -35.85 39.47 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.065 -1.425 . . . . 0.0 111.765 176.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -89.99 -49.39 6.62 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.552 ' C ' ' H ' ' A' ' 57' ' ' ALA . 67.9 t -84.18 -49.81 15.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.528 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 5.0 t70 -72.43 38.78 0.08 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 122.048 0.927 . . . . 0.0 110.158 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.552 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -86.1 -5.57 59.18 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.647 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -97.33 -33.34 11.47 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 112.408 -2.178 . . . . 0.0 111.009 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.41 45.12 6.28 Favored Glycine 0 C--N 1.342 0.881 0 O-C-N 123.505 0.503 . . . . 0.0 113.702 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -110.05 -21.57 12.24 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.694 0.283 . . . . 0.0 111.432 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.76 26.41 73.83 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 115.607 -0.724 . . . . 0.0 114.181 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.425 ' HB ' ' OG1' ' A' ' 26' ' ' THR . 0.0 OUTLIER -140.43 163.82 31.79 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 123.574 0.75 . . . . 0.0 110.57 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.527 ' O ' ' HB ' ' A' ' 26' ' ' THR . 5.0 mp -133.13 111.61 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.846 ' HA ' HG21 ' A' ' 26' ' ' THR . 2.0 p30 -49.63 146.34 4.32 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.003 -0.998 . . . . 0.0 111.835 174.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.579 ' CD1' ' HD3' ' A' ' 66' ' ' PRO . 5.8 p90 -90.83 -39.91 0.4 Allowed Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -177.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.579 ' HD3' ' CD1' ' A' ' 65' ' ' PHE . 17.4 Cg_exo -67.97 -18.52 46.42 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 121.903 1.735 . . . . 0.0 112.691 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.452 ' HB2' ' OD1' ' A' ' 64' ' ' ASP . 35.1 mt-10 -107.95 5.72 26.53 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.741 ' O ' ' HG2' ' A' ' 71' ' ' MET . 57.3 t80 -84.5 -60.76 1.97 Allowed 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.861 HD13 ' HA ' ' A' ' 8' ' ' GLN . 0.8 OUTLIER -59.18 -31.46 69.03 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.673 0.749 . . . . 0.0 110.746 178.392 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.631 ' O ' ' HD3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -57.74 -39.27 76.95 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 113.362 -1.745 . . . . 0.0 109.399 174.338 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.741 ' HG2' ' O ' ' A' ' 68' ' ' PHE . 13.2 ptt? -77.43 -18.84 56.87 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 123.803 0.69 . . . . 0.0 109.195 176.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.561 ' HA ' ' HG3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -88.74 -20.38 24.86 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.193 176.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.559 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -80.18 -33.68 38.13 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.671 ' NE ' ' HA ' ' A' ' 71' ' ' MET . 7.7 ptt180 -83.57 -16.99 43.26 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.561 ' HG3' ' HA ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -82.8 -13.99 55.23 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 118.545 0.611 . . . . 0.0 112.495 179.181 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 22.4 ptt? -113.58 -31.5 6.49 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.114 0.483 . . . . 0.0 112.12 -177.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.559 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 30.9 mmtt -74.67 -22.64 58.77 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.853 -1.067 . . . . 0.0 113.764 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -104.12 -14.99 15.68 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.0 t -75.95 54.77 0.86 Allowed 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.501 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 8.1 m-20 58.87 121.47 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.016 0.926 . . . . 0.0 112.498 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.6 m -83.08 -14.02 54.56 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.484 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.43 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -85.13 -45.62 11.88 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.709 0.766 . . . . 0.0 109.639 -179.532 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.458 ' O ' ' HB3' ' A' ' 87' ' ' GLU . 35.3 mt-10 -73.09 -17.99 61.35 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.797 -1.547 . . . . 0.0 112.574 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.637 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 15.0 mt-10 -61.35 -22.21 64.72 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.7 mp -88.01 -52.34 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.712 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.577 ' O ' ' HD1' ' A' ' 89' ' ' PHE . 10.4 mtt180 -68.45 -16.94 64.08 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.637 ' OE1' ' HA ' ' A' ' 84' ' ' GLU . 3.5 pt-20 -75.09 -18.75 60.21 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.572 ' HA ' ' HB ' ' A' ' 91' ' ' VAL . . . -64.37 -24.39 67.62 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.13 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.577 ' HD1' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -83.02 -21.04 33.95 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 175.029 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 31.8 mmt180 -81.59 -20.14 40.45 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.757 174.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.572 ' HB ' ' HA ' ' A' ' 88' ' ' ALA . 2.6 t -88.1 -53.89 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 CA-C-N 114.285 -1.325 . . . . 0.0 112.534 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.791 ' HB3' HG21 ' A' ' 100' ' ' ILE . 1.3 m-85 -100.77 -44.44 5.79 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -176.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.715 ' CA ' HG12 ' A' ' 100' ' ' ILE . 2.7 t70 -59.8 95.11 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.455 0.645 . . . . 0.0 111.967 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.4 mmpt? -87.59 -50.85 6.24 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.785 -1.098 . . . . 0.0 113.069 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -72.31 0.84 8.92 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -175.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 50.89 32.9 27.37 Favored Glycine 0 N--CA 1.471 1.03 0 CA-C-N 114.324 -1.307 . . . . 0.0 114.554 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -98.0 -5.53 33.91 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.44 -19.25 53.44 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 121.439 -0.41 . . . . 0.0 112.811 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -121.37 118.59 29.82 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.452 -0.874 . . . . 0.0 110.302 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.791 HG21 ' HB3' ' A' ' 92' ' ' PHE . 18.9 mt -77.2 97.3 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.222 0.609 . . . . 0.0 109.429 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.426 ' H ' ' CD ' ' A' ' 104' ' ' GLU . 18.1 t -78.66 169.07 18.82 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.32 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.513 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -60.59 -14.92 23.06 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.54 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.94 -29.39 19.61 Favored 'General case' 0 CA--C 1.487 -1.458 0 CA-C-O 121.79 0.805 . . . . 0.0 109.136 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.959 ' O ' HG23 ' A' ' 108' ' ' VAL . 23.0 mt-10 -79.25 -42.92 24.8 Favored 'General case' 0 CA--C 1.482 -1.671 0 CA-C-N 112.74 -2.027 . . . . 0.0 110.883 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.546 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 7.1 tt -65.25 -34.36 78.17 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.596 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -70.87 -43.76 67.74 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.174 176.367 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.54 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 10.3 t-80 -70.06 -21.63 63.14 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.752 177.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.959 HG23 ' O ' ' A' ' 104' ' ' GLU . 4.1 t -71.18 -53.15 22.34 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.413 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.655 ' O ' ' N ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -60.07 -39.18 85.16 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 111.497 -2.592 . . . . 0.0 112.514 178.313 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.6 m -73.86 -18.73 60.89 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 119.172 -1.011 . . . . 0.0 109.831 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.25 -45.75 13.46 Favored 'General case' 0 C--N 1.347 0.467 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 176.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.48 HD23 ' O ' ' A' ' 108' ' ' VAL . 1.3 mm? -76.91 -28.09 55.18 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 114.763 -1.108 . . . . 0.0 113.466 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 140.83 -11.12 2.88 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-O 117.815 -1.547 . . . . 0.0 116.911 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.655 ' N ' ' O ' ' A' ' 109' ' ' MET . 4.8 mt-10 -101.18 152.77 20.25 Favored 'General case' 0 C--N 1.356 0.874 0 CA-C-N 120.763 2.281 . . . . 0.0 114.254 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -108.96 127.0 53.68 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.824 -1.535 . . . . 0.0 107.5 175.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.596 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 1.2 tp -135.57 116.09 13.75 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.167 -175.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.821 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -72.59 -176.01 1.81 Allowed 'General case' 0 C--N 1.346 0.42 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.675 179.4 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.509 ' N ' HG23 ' A' ' 117' ' ' THR . 16.5 t70 -73.87 -37.97 64.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.696 -1.138 . . . . 0.0 113.968 -177.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.65 ' H ' HG23 ' A' ' 117' ' ' THR . 7.2 pt-20 -86.36 -16.13 38.3 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.767 ' HG2' HG22 ' A' ' 117' ' ' THR . 13.8 pt-20 -85.64 -16.64 38.53 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 122.985 0.178 . . . . 0.0 111.308 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.821 HG22 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -85.01 -27.26 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.526 178.3 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -75.54 35.3 0.12 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 122.131 0.967 . . . . 0.0 111.306 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.857 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 6.7 tp10 -140.96 -58.67 0.5 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 113.892 -1.503 . . . . 0.0 107.863 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.546 ' SD ' HD21 ' A' ' 105' ' ' LEU . 19.0 ttm -52.41 -22.78 5.05 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.328 1.051 . . . . 0.0 111.571 178.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.642 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 2.9 mt -87.36 -45.64 16.19 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.754 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -60.46 -31.39 70.39 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.854 0.721 . . . . 0.0 112.158 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.857 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 6.9 mm-40 -66.74 -35.65 80.61 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.11 177.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.628 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -96.57 -34.31 11.48 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.512 -178.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.642 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -60.93 127.73 33.0 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.423 -1.262 . . . . 0.0 114.174 -177.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.807 HD13 ' HG2' ' A' ' 140' ' ' GLU . 1.8 mp -89.06 -51.0 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 113.57 -1.65 . . . . 0.0 110.114 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -91.35 -25.25 19.49 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.06 49.64 4.67 Favored Glycine 0 CA--C 1.524 0.643 0 O-C-N 123.45 0.469 . . . . 0.0 113.689 178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -90.48 -19.82 23.42 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.474 ' HA2' HG21 ' A' ' 125' ' ' ILE . . . 97.22 12.11 49.98 Favored Glycine 0 CA--C 1.5 -0.888 0 CA-C-N 116.028 -0.533 . . . . 0.0 113.463 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -139.19 124.9 19.54 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.936 -1.132 . . . . 0.0 108.684 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.554 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 3.4 t -87.58 133.13 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.372 -177.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -99.48 -165.33 1.22 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.485 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.424 ' O ' HG23 ' A' ' 142' ' ' VAL . 35.7 m-85 -65.69 -56.69 10.77 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.702 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 143' ' ' GLN . 43.7 mt-10 -65.5 -20.7 66.45 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.807 ' HG2' HD13 ' A' ' 130' ' ' ILE . 7.3 mt-10 -86.06 -35.71 20.12 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.646 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.478 ' O ' ' HG2' ' A' ' 144' ' ' MET . 89.1 t80 -76.7 -23.87 53.14 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.212 175.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.459 ' O ' ' HG2' ' A' ' 145' ' ' MET . 14.5 t -86.13 -39.08 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 114.517 -1.22 . . . . 0.0 112.297 -177.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 147' ' ' ALA . 9.3 mt-30 -46.17 -34.03 4.01 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.614 ' HB3' ' CD2' ' B' ' 154' ' ' PHE . 19.5 ptt? -60.78 -24.34 65.7 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 118.262 0.483 . . . . 0.0 111.336 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' A' ' 142' ' ' VAL . 2.4 ptp -83.39 -5.81 59.26 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 123.434 0.459 . . . . 0.0 110.41 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.7 t -130.44 -33.19 1.69 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -49.41 -31.87 10.55 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 178.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 57.4 mttp . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.515 179.946 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 19.9 p . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 120.346 0.117 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -119.69 121.77 39.98 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 123.424 0.452 . . . . 0.0 110.788 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . 0.517 ' HD2' ' OE2' ' A' ' 114' ' ' GLU . 61.2 mttp -136.43 137.3 40.31 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.671 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -133.76 -1.57 3.05 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.882 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.475 HG22 ' HG3' ' A' ' 127' ' ' GLU . 27.7 p -125.8 155.25 41.37 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.639 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' PHE . . . . . 0.714 ' CE1' ' HD2' ' B' ' 155' ' ' LYS . 0.1 OUTLIER -71.71 -28.27 63.58 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.987 178.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.714 ' HD2' ' CE1' ' B' ' 154' ' ' PHE . 7.2 mptt -61.16 -38.12 85.33 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.961 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -76.89 -37.34 55.65 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.504 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' VAL . . . . . 0.634 HG22 ' HA ' ' B' ' 154' ' ' PHE . 15.4 m -70.48 -29.33 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -52.41 -33.29 43.14 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -71.62 -38.23 70.81 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.581 0.229 . . . . 0.0 111.426 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.8 -39.06 45.1 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 6.5 t -108.94 -51.87 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -66.29 89.1 0.13 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.583 0.706 . . . . 0.0 111.37 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 2.7 tp -160.6 34.34 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.661 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 50.9 m 63.73 39.46 8.53 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.015 0.926 . . . . 0.0 111.428 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . 62.63 20.6 12.14 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.952 0.901 . . . . 0.0 112.167 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 5.5 m 54.66 97.56 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.107 0.963 . . . . 0.0 111.599 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 43.73 75.16 0.1 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.116 0.966 . . . . 0.0 112.647 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.63 133.59 45.09 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.499 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . 135.22 -159.02 23.89 Favored Glycine 0 C--N 1.337 0.628 0 O-C-N 123.631 0.582 . . . . 0.0 112.706 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 20.2 p . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.112 -0.947 . . . . 0.0 111.012 -179.967 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 111.357 0.132 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 63.08 126.29 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.929 0.892 . . . . 0.0 111.988 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.51 ' HG2' ' O ' ' A' ' 65' ' ' PHE . 1.3 mp0 -89.27 -69.17 0.73 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.353 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.67 HD11 ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -117.97 -117.55 0.32 Allowed 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.328 179.738 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 1.004 ' O ' ' HG3' ' A' ' 8' ' ' GLN . 17.2 p -101.51 -172.99 2.25 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 124.253 1.021 . . . . 0.0 110.83 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -58.19 -20.82 44.2 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.444 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 12.5 pt-20 -53.5 -37.65 62.94 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.586 0.553 . . . . 0.0 111.628 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 1.004 ' HG3' ' O ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -74.46 -48.32 28.18 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.082 176.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.473 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 21.2 mm -56.33 -36.48 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 113.993 -1.458 . . . . 0.0 110.999 178.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.24 -48.9 74.0 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.751 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 24.8 mt-10 -135.89 -20.24 1.51 Allowed 'General case' 0 C--N 1.358 0.959 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -176.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.452 ' HB2' HD21 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -68.79 -14.74 63.22 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 118.899 -1.121 . . . . 0.0 110.453 178.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.712 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 5.9 pttt -72.2 -42.87 65.29 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 123.775 0.83 . . . . 0.0 109.008 178.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.751 ' HG2' ' O ' ' A' ' 11' ' ' GLU . 11.5 pt-20 -67.49 -40.28 85.23 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 114.227 -1.351 . . . . 0.0 112.57 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.608 ' O ' HG11 ' A' ' 35' ' ' VAL . . . -58.62 -22.19 55.78 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.832 0.708 . . . . 0.0 110.109 176.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.49 ' CE2' ' HB3' ' A' ' 65' ' ' PHE . 23.4 m-85 -86.86 -42.76 12.98 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.469 176.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.6 t -86.78 -13.38 45.33 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -71.66 -29.4 64.58 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.999 -0.281 . . . . 0.0 111.188 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.581 ' CD1' HG22 ' A' ' 35' ' ' VAL . 1.9 m-85 -126.7 -12.14 6.05 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -101.9 74.98 1.5 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.997 0.817 . . . . 0.0 110.697 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.415 ' HE3' ' H ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -87.23 -20.58 26.71 Favored 'General case' 0 C--N 1.345 0.386 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -179.607 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.533 ' OD1' ' HB2' ' A' ' 24' ' ' ASP . 0.3 OUTLIER -70.56 -22.69 62.56 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.497 178.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.06 50.95 4.93 Favored Glycine 0 N--CA 1.467 0.7 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.533 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 0.3 OUTLIER -99.62 23.06 9.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.425 -1.388 . . . . 0.0 112.248 -176.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.56 -79.72 1.86 Allowed Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.78 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.698 HG21 ' HA ' ' A' ' 64' ' ' ASP . 3.2 p -119.9 175.99 5.63 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 122.489 0.316 . . . . 0.0 111.268 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -84.39 149.45 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.31 160.59 24.19 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.722 -1.126 . . . . 0.0 113.514 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.98 -55.49 5.56 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.879 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -55.8 -13.76 1.95 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.304 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.482 ' O ' HG23 ' A' ' 35' ' ' VAL . 28.9 mt-10 -113.85 -16.93 12.16 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.303 -178.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -57.62 -40.87 80.16 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.219 0.608 . . . . 0.0 111.869 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.784 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -55.18 -39.58 71.43 Favored Glycine 0 C--N 1.338 0.683 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.8 m -74.25 -31.07 62.43 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.547 -0.827 . . . . 0.0 112.911 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.608 HG11 ' O ' ' A' ' 15' ' ' ALA . 1.1 t -74.2 -27.15 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 176.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.595 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 24.2 mtt -73.43 -41.64 63.01 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 113.152 -1.84 . . . . 0.0 111.119 176.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.784 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 10.4 mtt180 -82.0 -29.27 32.14 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 65.5 m -66.12 -7.98 21.06 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.963 0.887 . . . . 0.0 112.248 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.9 mt -93.36 -8.04 43.04 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 113.307 -1.769 . . . . 0.0 109.731 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.15 -7.61 23.18 Favored Glycine 0 CA--C 1.493 -1.309 0 N-CA-C 115.31 0.884 . . . . 0.0 115.31 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.595 ' HB2' ' O ' ' A' ' 36' ' ' MET . 46.7 mt-30 -74.82 140.41 43.92 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 112.601 -1.799 . . . . 0.0 111.991 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -126.86 63.35 55.16 Favored Pre-proline 0 CA--C 1.554 1.13 0 O-C-N 123.55 0.531 . . . . 0.0 111.312 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.423 ' HD3' ' C ' ' A' ' 41' ' ' GLN . 1.7 Cg_endo -84.73 -177.68 2.97 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.917 2.411 . . . . 0.0 111.562 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.504 ' OG1' ' N ' ' A' ' 45' ' ' GLU . 8.0 t -102.3 -175.81 2.93 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 122.245 1.021 . . . . 0.0 110.757 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.504 ' N ' ' OG1' ' A' ' 44' ' ' THR . 46.2 mt-10 -81.69 -24.7 36.06 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-N 112.797 -2.001 . . . . 0.0 108.637 177.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.88 -29.52 67.83 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.769 -1.56 . . . . 0.0 111.854 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.458 ' H ' HG23 ' A' ' 44' ' ' THR . 8.5 mm-40 -87.31 -28.36 22.32 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.503 177.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 45' ' ' GLU . 0.6 OUTLIER -69.55 -20.4 63.68 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 114.396 -1.275 . . . . 0.0 108.928 174.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.756 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 54.4 mt-30 -97.14 -16.53 20.42 Favored 'General case' 0 CA--C 1.483 -1.629 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.256 178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -85.54 -33.52 21.73 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 111.978 -2.374 . . . . 0.0 109.66 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.521 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -86.66 -34.67 19.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.909 177.061 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 30.3 mt -70.96 -26.36 27.49 Favored 'Isoleucine or valine' 0 C--N 1.348 0.538 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.756 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 4.6 t-20 -68.33 -32.83 73.22 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.404 174.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -87.77 -25.4 23.4 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.347 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.594 ' C ' ' H ' ' A' ' 57' ' ' ALA . 75.2 t -84.63 -40.59 15.35 Favored 'Isoleucine or valine' 0 C--N 1.346 0.437 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -71.07 29.69 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.913 0.863 . . . . 0.0 111.167 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.594 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -87.5 -7.15 57.95 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 114.102 -1.408 . . . . 0.0 111.923 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -113.55 -41.48 3.62 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 111.689 -2.505 . . . . 0.0 110.827 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.26 37.7 10.8 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.846 -0.616 . . . . 0.0 113.307 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -110.08 -21.54 12.24 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.537 0.208 . . . . 0.0 111.512 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.27 26.96 60.6 Favored Glycine 0 N--CA 1.466 0.638 0 CA-C-N 115.885 -0.598 . . . . 0.0 114.158 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.13 170.2 16.15 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 123.103 0.561 . . . . 0.0 110.823 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.409 ' O ' HG22 ' A' ' 63' ' ' ILE . 4.1 mp -113.61 79.51 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.698 ' HA ' HG21 ' A' ' 26' ' ' THR . 21.8 p-10 -50.99 148.16 4.49 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.393 0.677 . . . . 0.0 111.876 176.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.51 ' O ' ' HG2' ' A' ' 3' ' ' GLN . 16.5 p90 -81.01 -37.53 0.94 Allowed Pre-proline 0 N--CA 1.477 0.916 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.486 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 16.9 Cg_exo -68.07 -16.78 45.4 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.131 1.887 . . . . 0.0 113.288 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.444 ' HB2' ' OD2' ' A' ' 64' ' ' ASP . 23.5 mt-10 -105.51 -29.7 10.01 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 -177.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.959 ' O ' ' HG2' ' A' ' 71' ' ' MET . 4.2 t80 -85.03 -47.65 10.01 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -175.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.67 ' HB3' HD11 ' A' ' 4' ' ' LEU . 4.5 mt -61.24 -31.8 71.59 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 119.407 1.003 . . . . 0.0 110.802 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.503 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -56.72 -37.28 70.75 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 113.171 -1.832 . . . . 0.0 109.737 174.566 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.959 ' HG2' ' O ' ' A' ' 68' ' ' PHE . 23.7 ptm -76.33 -23.5 54.26 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 123.731 0.644 . . . . 0.0 109.347 176.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.509 ' O ' ' HG2' ' A' ' 76' ' ' MET . 91.9 mtp -87.57 -18.59 29.37 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.298 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.598 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -83.6 -25.76 30.58 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.503 ' HG3' ' O ' ' A' ' 70' ' ' THR . 3.9 ppt_? -90.38 -30.35 17.47 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.738 ' HD2' ' O ' ' A' ' 71' ' ' MET . 0.0 OUTLIER -74.85 -12.7 60.44 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' A' ' 72' ' ' MET . 26.6 ptm -117.31 -26.21 6.8 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -177.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.598 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 29.0 mmtt -73.43 -35.73 65.84 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -91.15 -25.02 19.77 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.4 t -75.47 56.13 0.85 Allowed 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.549 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 8.5 m-20 60.2 123.78 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.026 0.93 . . . . 0.0 112.596 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.555 ' HA ' ' OE2' ' A' ' 84' ' ' GLU . 53.0 m -83.13 -13.95 54.55 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.882 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.405 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -81.28 -43.83 18.6 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.82 0.819 . . . . 0.0 109.518 -179.696 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.616 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 37.5 mt-10 -70.17 -18.74 63.21 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 113.712 -1.585 . . . . 0.0 112.395 178.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.555 ' OE2' ' HA ' ' A' ' 81' ' ' SER . 39.7 mt-10 -63.69 -22.62 67.0 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.3 mp -87.8 -49.54 14.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.134 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.83 -16.96 3.0 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.774 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.616 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 44.5 mt-10 -78.97 -20.99 47.78 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.218 0.607 . . . . 0.0 111.586 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.64 -19.71 48.5 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.481 ' HE2' ' O ' ' A' ' 98' ' ' GLY . 6.4 m-85 -84.01 -21.19 31.75 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 174.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.412 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 8.0 ttt180 -76.7 -21.41 55.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 113.868 -1.515 . . . . 0.0 106.927 174.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.403 HG12 ' CD2' ' A' ' 92' ' ' PHE . 40.6 t -87.84 -54.21 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 CA-C-N 114.246 -1.343 . . . . 0.0 112.03 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.841 ' HB3' HG21 ' A' ' 100' ' ' ILE . 77.0 m-85 -100.51 -44.66 5.8 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -177.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.739 ' CA ' HG12 ' A' ' 100' ' ' ILE . 2.3 t70 -65.04 90.66 0.09 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.898 0.856 . . . . 0.0 111.86 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.433 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 19.8 mttt -88.49 -45.14 10.18 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 113.957 -1.474 . . . . 0.0 114.17 -178.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -71.71 1.69 6.42 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -175.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 48.09 29.79 6.95 Favored Glycine 0 N--CA 1.474 1.175 0 CA-C-N 114.272 -1.331 . . . . 0.0 114.977 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -98.84 -3.93 34.31 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.645 0.222 . . . . 0.0 111.415 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.481 ' O ' ' HE2' ' A' ' 89' ' ' PHE . . . 101.38 -18.78 53.16 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 121.353 -0.451 . . . . 0.0 112.629 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -122.34 124.1 42.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.441 -0.879 . . . . 0.0 111.226 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.841 HG21 ' HB3' ' A' ' 92' ' ' PHE . 28.5 mt -80.27 97.46 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.7 p -72.81 162.14 29.86 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.522 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -57.92 -14.98 7.23 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 -177.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.99 -29.29 19.61 Favored 'General case' 0 CA--C 1.488 -1.432 0 CA-C-O 121.873 0.844 . . . . 0.0 109.556 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 1.012 ' O ' HG23 ' A' ' 108' ' ' VAL . 3.4 mm-40 -79.9 -40.33 28.48 Favored 'General case' 0 CA--C 1.483 -1.597 0 CA-C-N 112.668 -2.06 . . . . 0.0 111.292 -178.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.551 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 7.6 tt -65.48 -33.0 74.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.73 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -70.67 -46.23 63.59 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.03 -1.441 . . . . 0.0 108.851 175.592 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.526 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 3.1 t-80 -67.25 -22.03 65.69 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.386 177.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.012 HG23 ' O ' ' A' ' 104' ' ' GLU . 17.1 t -71.75 -49.84 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.905 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 176.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.733 ' SD ' HD22 ' A' ' 116' ' ' LEU . 16.1 mtt -55.89 -41.79 75.0 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 112.593 -2.094 . . . . 0.0 111.938 175.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.96 -19.15 64.16 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.537 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.92 -45.27 18.85 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.749 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.3 mt -79.23 -28.15 42.49 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.592 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 138.47 -6.45 3.29 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 117.773 -1.571 . . . . 0.0 116.74 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 109' ' ' MET . 4.9 mt-10 -101.15 152.08 21.06 Favored 'General case' 0 C--N 1.358 0.946 0 CA-C-N 120.953 2.376 . . . . 0.0 114.271 -178.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -110.31 128.63 55.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 113.668 -1.606 . . . . 0.0 107.802 175.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.733 HD22 ' SD ' ' A' ' 109' ' ' MET . 1.3 tp -139.32 116.03 10.76 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.338 -1.301 . . . . 0.0 112.134 -176.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.82 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -67.74 -176.31 0.63 Allowed 'General case' 0 C--N 1.347 0.473 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.153 179.721 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.508 ' N ' HG23 ' A' ' 117' ' ' THR . 16.0 t70 -73.22 -37.52 66.37 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.508 -1.224 . . . . 0.0 114.196 -177.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.656 ' H ' HG23 ' A' ' 117' ' ' THR . 7.4 pt-20 -86.19 -16.21 38.5 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.772 ' HG2' HG22 ' A' ' 117' ' ' THR . 14.2 pt-20 -88.07 -17.19 31.63 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 123.042 0.214 . . . . 0.0 111.238 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.82 HG22 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -85.95 -30.2 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 O-C-N 123.376 0.423 . . . . 0.0 111.289 177.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -69.29 31.77 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.998 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.655 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 9.6 pt-20 -153.53 -11.47 0.15 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.82 -1.082 . . . . 0.0 113.005 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.546 ' HE1' HD21 ' A' ' 116' ' ' LEU . 29.5 ttm -88.85 -37.16 15.57 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.061 0.544 . . . . 0.0 110.303 177.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.551 ' O ' ' N ' ' A' ' 129' ' ' ASP . 0.0 OUTLIER -86.48 -29.64 5.98 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.57 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.167 178.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.7 mtm180 -61.07 -27.32 68.27 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.955 0.883 . . . . 0.0 110.265 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.655 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 4.3 mm-40 -70.25 -27.88 64.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 113.326 -1.761 . . . . 0.0 109.808 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.587 ' HB3' HG21 ' A' ' 136' ' ' VAL . . . -102.82 -39.57 6.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.747 179.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 125' ' ' ILE . 0.3 OUTLIER -61.49 126.98 29.3 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.222 179.031 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 44.9 mt -89.94 -47.56 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.868 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -72.71 -24.95 61.06 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.41 49.1 9.62 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 115.912 -0.585 . . . . 0.0 113.928 178.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -107.65 -12.76 15.19 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.731 0.301 . . . . 0.0 111.116 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.67 19.79 50.3 Favored Glycine 0 CA--C 1.504 -0.613 0 CA-C-N 115.57 -0.741 . . . . 0.0 113.487 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -137.74 113.64 9.81 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.866 -1.167 . . . . 0.0 108.137 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.637 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 1.3 t -92.15 141.07 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -175.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.632 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 2.1 t30 -107.11 -162.92 0.87 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 114.123 -1.399 . . . . 0.0 110.857 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.632 ' H ' ' ND2' ' A' ' 137' ' ' ASN . 61.3 m-85 -64.12 -64.31 0.92 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.704 -1.134 . . . . 0.0 111.244 178.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.28 -20.09 51.42 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.637 ' OE1' ' HA ' ' A' ' 136' ' ' VAL . 4.8 mt-10 -86.31 -41.28 14.68 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 123.474 0.484 . . . . 0.0 110.436 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.508 ' O ' ' HG3' ' A' ' 144' ' ' MET . 68.7 t80 -74.14 -22.59 59.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.776 175.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.545 ' O ' ' HG3' ' A' ' 145' ' ' MET . 41.8 t -85.39 -43.96 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.44 -178.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.518 HE21 ' N ' ' A' ' 144' ' ' MET . 0.2 OUTLIER -56.19 -35.64 67.48 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.534 0.522 . . . . 0.0 111.633 178.444 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.518 ' N ' HE21 ' A' ' 143' ' ' GLN . 0.0 OUTLIER -63.73 -18.64 64.24 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 179.731 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.545 ' HG3' ' O ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -89.75 -5.49 56.93 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 177.128 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.1 t -130.42 -32.46 1.75 Allowed 'General case' 0 C--N 1.351 0.671 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -45.68 -32.21 2.32 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt . . . . . 0 C--O 1.252 1.188 0 CA-C-O 118.52 -0.752 . . . . 0.0 111.312 179.877 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.468 0.175 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -106.53 150.32 26.25 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.993 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . 0.464 ' HB3' ' OE1' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -98.58 109.29 22.07 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.913 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . 0.404 ' N ' ' HE2' ' A' ' 124' ' ' MET . 10.3 tptm -146.12 -70.11 0.26 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.852 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.618 HG22 ' HG3' ' A' ' 127' ' ' GLU . 81.5 p -141.4 174.52 10.47 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.271 0.229 . . . . 0.0 111.569 -178.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' PHE . . . . . 0.606 ' HA ' HG22 ' B' ' 157' ' ' VAL . 0.1 OUTLIER -67.68 -27.07 66.53 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.771 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.491 ' HG3' ' HB2' ' A' ' 144' ' ' MET . 9.4 mptt -54.86 -50.63 68.2 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.892 0.877 . . . . 0.0 112.0 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -76.38 -35.44 58.65 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' VAL . . . . . 0.606 HG22 ' HA ' ' B' ' 154' ' ' PHE . 12.3 m -72.01 -39.36 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 120.728 0.299 . . . . 0.0 111.157 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' B' ' 162' ' ' LYS . . . -74.26 -39.3 63.1 Favored 'General case' 0 C--N 1.345 0.406 0 C-N-CA 123.468 0.707 . . . . 0.0 112.039 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -59.66 -28.0 66.87 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.95 -35.96 56.89 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.642 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 7.1 p -118.98 31.78 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.277 0 O-C-N 123.415 0.447 . . . . 0.0 111.65 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 20.9 tttt -80.76 -42.5 21.69 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.343 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' ILE . . . . . 0.498 HG13 ' OG ' ' B' ' 166' ' ' SER . 1.6 tt -108.96 43.44 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 CA-C-O 121.44 0.638 . . . . 0.0 110.663 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 55.8 m -95.34 -29.88 14.22 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.609 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . -89.36 18.3 5.35 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 123.347 0.405 . . . . 0.0 111.876 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . 0.498 ' OG ' HG13 ' B' ' 163' ' ' ILE . 68.4 m -89.94 -21.02 22.66 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.902 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 8.1 tp -88.6 -10.44 48.71 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 123.311 0.382 . . . . 0.0 111.296 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 64.2 mtt -98.87 130.47 45.28 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.341 0.401 . . . . 0.0 110.79 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -157.56 -151.43 6.02 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.6 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.507 -0.758 . . . . 0.0 111.087 -179.93 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 111.289 0.107 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.423 ' H ' ' HB3' ' A' ' 66' ' ' PRO . 8.5 m-20 -136.49 103.52 5.28 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.073 0.463 . . . . 0.0 111.169 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -91.58 159.17 16.03 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.873 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.474 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -105.51 -112.71 0.26 Allowed 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.765 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.545 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 17.2 p -101.29 -173.68 2.42 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 123.838 0.855 . . . . 0.0 110.359 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 10' ' ' ALA . 47.0 mt-10 -59.41 -23.87 62.99 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.545 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 12.4 pt-20 -54.43 -33.32 59.24 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.288 0.566 . . . . 0.0 111.707 178.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.828 ' HA ' ' HB2' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -77.24 -45.15 27.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.787 177.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.667 HD13 ' HG3' ' A' ' 8' ' ' GLN . 9.6 mm -67.39 -32.68 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 CA-C-N 113.969 -1.469 . . . . 0.0 112.312 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 6' ' ' GLU . . . -81.47 -42.8 19.77 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -134.13 -35.77 0.93 Allowed 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 119.906 1.23 . . . . 0.0 114.021 -176.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.828 ' HB2' ' HA ' ' A' ' 8' ' ' GLN . 44.2 m-85 -62.83 -13.91 39.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.926 0.393 . . . . 0.0 110.765 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.695 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 5.0 pttt -72.83 -39.31 66.69 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.695 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 12.7 mt-10 -70.56 -47.84 58.3 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 113.613 -1.63 . . . . 0.0 110.879 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.597 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -58.46 -17.85 24.05 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.858 0.837 . . . . 0.0 109.272 176.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.648 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 75.9 t80 -86.15 -52.07 5.9 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 113.777 -1.556 . . . . 0.0 109.263 176.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.498 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 53.3 m -87.89 -12.85 43.57 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -177.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.603 ' N ' ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -62.0 -31.43 71.81 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.239 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.637 ' HB3' HG21 ' A' ' 27' ' ' ILE . 7.7 m-85 -129.5 -5.92 4.72 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.648 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -77.68 56.54 1.49 Allowed 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -177.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.498 ' HE3' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -85.09 -17.81 36.21 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 178.314 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.583 ' OD1' ' HB2' ' A' ' 24' ' ' ASP . 0.3 OUTLIER -70.91 -23.45 62.27 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.131 0.491 . . . . 0.0 111.324 178.724 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.2 45.0 32.95 Favored Glycine 0 N--CA 1.472 1.093 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.583 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 0.5 OUTLIER -111.81 23.22 14.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.23 -1.485 . . . . 0.0 112.702 -175.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.15 -84.8 1.54 Allowed Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -177.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.52 HG21 HG22 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -115.15 177.68 4.57 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.637 HG21 ' HB3' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -101.75 152.18 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -176.232 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.97 156.61 1.48 Allowed 'General case' 0 C--N 1.344 0.334 0 C-N-CA 124.457 1.103 . . . . 0.0 113.73 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.01 -55.06 28.94 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.859 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -57.3 -13.72 3.62 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.246 177.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.576 ' O ' HG23 ' A' ' 35' ' ' VAL . 28.7 mt-10 -103.84 -30.13 10.56 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.762 -178.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.503 HD11 ' CE1' ' A' ' 68' ' ' PHE . 14.3 tp -54.2 -38.25 65.43 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.895 0.478 . . . . 0.0 112.24 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.783 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -57.26 -40.29 91.54 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 177.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 m -74.92 -29.7 61.05 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 114.605 -0.797 . . . . 0.0 112.482 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.597 HG12 ' HA ' ' A' ' 15' ' ' ALA . 2.0 t -74.99 -26.2 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 176.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.656 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 31.7 mmt -74.99 -40.53 60.64 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 113.198 -1.819 . . . . 0.0 110.935 175.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.783 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 13.8 mtt180 -85.21 -25.75 27.16 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.5 t -64.21 -8.22 11.8 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.906 0.86 . . . . 0.0 112.224 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.5 mt -93.94 -7.17 43.73 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.331 -1.759 . . . . 0.0 109.679 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.51 1.86 55.49 Favored Glycine 0 CA--C 1.491 -1.441 0 CA-C-O 122.506 1.059 . . . . 0.0 114.334 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.656 ' HB2' ' O ' ' A' ' 36' ' ' MET . 51.6 mt-30 -78.28 139.12 38.89 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 111.826 -2.187 . . . . 0.0 112.094 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -117.78 75.46 10.07 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.315 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -78.56 -177.93 4.26 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.98 2.453 . . . . 0.0 111.976 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.426 HG22 ' H ' ' A' ' 46' ' ' ALA . 1.2 m -99.72 158.93 15.43 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.531 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 28.2 mt-10 -80.85 -28.14 36.18 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.452 177.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.426 ' H ' HG22 ' A' ' 44' ' ' THR . . . -70.85 -35.48 72.42 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 113.412 -1.722 . . . . 0.0 109.845 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -79.03 -30.3 44.06 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 114.041 -1.436 . . . . 0.0 108.947 176.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.628 ' O ' HD13 ' A' ' 52' ' ' ILE . 0.4 OUTLIER -68.86 -19.72 64.26 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.992 174.677 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.865 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 53.5 mt-30 -99.88 -15.56 18.33 Favored 'General case' 0 CA--C 1.48 -1.716 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.14 178.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -85.55 -32.58 22.07 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 112.025 -2.352 . . . . 0.0 109.712 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 29.6 mmm -86.52 -35.14 19.73 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.135 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.628 HD13 ' O ' ' A' ' 48' ' ' LEU . 1.6 mp -71.75 -25.68 24.7 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 175.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.865 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.1 t30 -75.74 -33.9 60.29 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.721 175.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -81.14 -42.5 20.81 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.546 ' C ' ' H ' ' A' ' 57' ' ' ALA . 78.5 t -84.65 -49.32 16.0 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -72.53 39.47 0.08 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.99 0.9 . . . . 0.0 110.132 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.546 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -84.44 -5.72 59.31 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 114.107 -1.406 . . . . 0.0 112.624 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.437 ' HB3' HD22 ' A' ' 60' ' ' ASN . 6.6 t70 -105.24 -31.74 8.96 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 112.21 -2.268 . . . . 0.0 110.727 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.3 49.73 4.57 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-N 115.994 -0.548 . . . . 0.0 113.458 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.437 HD22 ' HB3' ' A' ' 58' ' ' ASP . 40.5 m-80 -110.0 -21.58 12.25 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.05 27.14 73.38 Favored Glycine 0 N--CA 1.466 0.683 0 O-C-N 123.615 0.572 . . . . 0.0 113.94 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.64 154.65 43.76 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.984 0.514 . . . . 0.0 110.977 -179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.52 HG22 HG21 ' A' ' 26' ' ' THR . 43.6 mm -97.72 161.6 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.441 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 9.3 m-20 -127.82 148.71 50.46 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.397 1.079 . . . . 0.0 108.53 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.541 ' CG ' ' HD3' ' A' ' 66' ' ' PRO . 12.0 p90 -90.36 -39.19 0.41 Allowed Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -177.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.541 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 11.4 Cg_exo -72.56 -17.82 26.22 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 121.93 1.753 . . . . 0.0 112.879 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -108.14 -29.48 8.91 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -177.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.579 ' O ' ' HB2' ' A' ' 71' ' ' MET . 0.0 OUTLIER -85.16 -20.56 30.05 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -176.465 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.566 HD22 ' CG ' ' A' ' 12' ' ' PHE . 71.2 mt -78.71 -36.62 43.14 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 122.389 1.09 . . . . 0.0 109.868 177.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -53.03 -31.47 41.51 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 111.941 -2.39 . . . . 0.0 108.433 172.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.579 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 22.4 mmt -65.98 -34.35 77.89 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 114.572 -1.194 . . . . 0.0 109.76 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.782 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -81.68 -22.22 37.61 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.458 177.13 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -73.39 -37.63 65.91 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.523 ' CD ' ' HA ' ' A' ' 71' ' ' MET . 2.8 ptm180 -77.84 -17.99 56.79 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 178.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.782 ' HD2' ' HA ' ' A' ' 72' ' ' MET . 30.5 mttt -72.44 -14.36 61.67 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 175.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 6.8 ptt? -119.72 -33.65 3.96 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 123.511 0.507 . . . . 0.0 112.018 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 34.3 mttt -76.2 -20.58 57.34 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.864 -1.062 . . . . 0.0 113.552 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -100.75 -29.74 12.1 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.7 t -81.0 48.16 1.08 Allowed 'General case' 0 CA--C 1.548 0.882 0 CA-C-O 121.132 0.492 . . . . 0.0 112.185 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 62.01 119.99 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.778 0.831 . . . . 0.0 111.97 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.551 ' HA ' ' OE1' ' A' ' 84' ' ' GLU . 13.2 t -83.2 -13.73 54.81 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.285 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.413 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -87.11 -45.81 10.36 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.77 0.795 . . . . 0.0 109.297 179.737 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.413 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 37.8 mt-10 -75.89 -18.08 59.53 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 113.63 -1.623 . . . . 0.0 113.038 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.551 ' OE1' ' HA ' ' A' ' 81' ' ' SER . 11.2 pt-20 -60.83 -22.39 64.15 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.6 mp -87.73 -50.97 13.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.607 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -56.8 -16.87 7.39 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.539 ' OE1' ' HB3' ' B' ' 164' ' ' SER . 2.6 pt-20 -79.38 -20.96 46.41 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 123.384 0.428 . . . . 0.0 110.868 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.532 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -73.95 -20.79 60.26 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.377 177.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.452 ' CZ ' ' HA ' ' A' ' 138' ' ' TYR . 81.8 m-85 -82.27 -20.89 36.63 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 174.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.512 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 8.2 ttt180 -76.18 -18.9 58.87 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 174.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.532 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 37.9 t -87.79 -50.51 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 CA-C-N 114.166 -1.379 . . . . 0.0 112.09 177.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.849 ' HB3' HG21 ' A' ' 100' ' ' ILE . 14.4 m-85 -100.25 -45.85 5.48 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -176.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.705 ' CA ' HG12 ' A' ' 100' ' ' ILE . 3.1 t70 -64.3 89.78 0.06 Allowed 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 121.821 0.82 . . . . 0.0 111.61 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.59 -48.71 7.37 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.141 -1.39 . . . . 0.0 114.0 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -71.22 3.51 3.54 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -175.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 47.73 29.33 5.88 Favored Glycine 0 N--CA 1.474 1.2 0 CA-C-N 114.245 -1.343 . . . . 0.0 115.247 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -98.22 -4.11 36.07 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.812 0.306 . . . . 0.0 111.165 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 99.18 -19.02 55.76 Favored Glycine 0 C--N 1.338 0.66 0 CA-C-N 116.209 -0.451 . . . . 0.0 112.482 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -114.55 118.37 33.53 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.277 -0.961 . . . . 0.0 110.385 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.849 HG21 ' HB3' ' A' ' 92' ' ' PHE . 57.7 mt -77.52 87.91 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.3 t -61.75 163.79 6.96 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.166 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.775 ' HA ' HD12 ' A' ' 105' ' ' LEU . . . -61.07 -13.35 16.34 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.617 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.4 -27.68 21.43 Favored 'General case' 0 CA--C 1.491 -1.321 0 CA-C-O 121.686 0.755 . . . . 0.0 109.483 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 1.023 ' O ' HG23 ' A' ' 108' ' ' VAL . 20.4 mt-10 -80.05 -44.34 20.25 Favored 'General case' 0 CA--C 1.483 -1.626 0 CA-C-N 112.905 -1.952 . . . . 0.0 111.688 -177.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.775 HD12 ' HA ' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -68.43 -26.15 65.37 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.29 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.738 HH11 ' H ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -76.73 -44.39 33.46 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 113.638 -1.619 . . . . 0.0 108.555 175.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.617 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 5.7 t60 -67.01 -21.85 65.92 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.023 HG23 ' O ' ' A' ' 104' ' ' GLU . 25.5 t -70.42 -51.61 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 175.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.656 ' SD ' HD13 ' A' ' 116' ' ' LEU . 16.8 mtt -56.36 -41.85 76.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 112.992 -1.913 . . . . 0.0 112.227 175.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.421 ' H ' ' HG1' ' A' ' 110' ' ' THR . 0.2 OUTLIER -68.79 -19.1 64.29 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.405 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.01 -45.12 18.96 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.601 176.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.2 mt -79.21 -28.2 42.57 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.872 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 140.18 -7.34 2.88 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 117.704 -1.609 . . . . 0.0 116.833 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 109' ' ' MET . 5.0 mt-10 -100.69 150.96 22.21 Favored 'General case' 0 C--N 1.358 0.947 0 CA-C-N 120.955 2.378 . . . . 0.0 114.568 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -109.4 128.16 54.92 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 113.276 -1.783 . . . . 0.0 106.998 175.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.738 ' H ' HH11 ' A' ' 106' ' ' ARG . 1.8 tp -130.91 120.75 24.05 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.713 -175.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.774 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -74.51 -175.85 2.53 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.96 179.556 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.526 ' N ' HG23 ' A' ' 117' ' ' THR . 16.0 t70 -75.01 -37.25 61.87 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.51 -1.223 . . . . 0.0 114.232 -177.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.646 ' H ' HG23 ' A' ' 117' ' ' THR . 9.1 pt-20 -89.14 -15.88 32.76 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.737 ' HG2' HG22 ' A' ' 117' ' ' THR . 14.8 pt-20 -86.73 -16.49 36.26 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 123.099 0.249 . . . . 0.0 111.051 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.774 HG22 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -83.63 -28.93 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.993 178.163 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.52 30.73 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.819 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.612 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 9.8 pt-20 -148.22 -13.93 0.35 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.796 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.529 ' O ' ' HD1' ' B' ' 154' ' ' PHE . 1.9 ttm -88.15 -35.84 17.19 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.233 0.613 . . . . 0.0 109.956 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.797 ' O ' ' N ' ' A' ' 129' ' ' ASP . 0.0 OUTLIER -80.37 -35.01 15.06 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.849 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.334 178.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -58.57 -26.9 64.1 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.894 0.854 . . . . 0.0 110.615 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.612 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 16.0 mm-40 -68.87 -31.39 70.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 113.364 -1.744 . . . . 0.0 109.861 177.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.652 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -108.43 -36.77 6.14 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.295 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.797 ' N ' ' O ' ' A' ' 125' ' ' ILE . 0.2 OUTLIER -60.93 127.73 33.01 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.131 178.71 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.9 mm -89.38 -50.75 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.553 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -81.47 -25.17 36.27 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.06 49.13 6.52 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 115.884 -0.598 . . . . 0.0 113.784 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -96.91 -12.89 22.87 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.833 0.349 . . . . 0.0 110.978 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.46 13.04 57.7 Favored Glycine 0 CA--C 1.502 -0.757 0 CA-C-N 115.397 -0.82 . . . . 0.0 113.687 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -140.51 119.35 12.56 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 124.41 1.084 . . . . 0.0 108.227 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.688 HG23 HG22 ' A' ' 125' ' ' ILE . 0.9 OUTLIER -90.39 129.42 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -176.601 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -84.19 -163.3 0.77 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.801 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.48 ' O ' HG23 ' A' ' 142' ' ' VAL . 50.5 m-85 -75.33 -56.25 4.9 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.479 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.96 -20.23 65.04 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.652 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 7.1 mt-10 -87.05 -39.39 15.66 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 121.276 0.56 . . . . 0.0 110.529 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -74.23 -22.93 59.13 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.611 -1.177 . . . . 0.0 108.744 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.533 ' O ' ' HG2' ' A' ' 145' ' ' MET . 24.3 t -84.17 -46.82 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.547 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.767 ' O ' ' N ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -55.54 -31.81 62.42 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 123.858 0.724 . . . . 0.0 109.689 176.532 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -26.33 61.75 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.362 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.533 ' HG2' ' O ' ' A' ' 142' ' ' VAL . 8.4 ptt? -88.35 -4.03 58.74 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 123.431 0.457 . . . . 0.0 110.479 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.7 t -137.55 -22.98 1.1 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.767 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -51.37 -34.07 32.58 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 20.1 pttp . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.123 -0.941 . . . . 0.0 111.296 179.817 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 21.1 p . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.492 0.187 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -133.03 -45.36 0.85 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.153 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -133.0 -28.41 1.55 Allowed 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.399 0.437 . . . . 0.0 111.462 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 124' ' ' MET . 84.2 mttt 64.61 139.57 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.065 0.946 . . . . 0.0 112.49 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.544 ' O ' HG22 ' B' ' 157' ' ' VAL . 55.1 p -133.09 171.19 14.32 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.952 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' PHE . . . . . 0.529 ' HD1' ' O ' ' A' ' 124' ' ' MET . 2.5 m-85 -58.16 -28.11 64.43 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 117.834 0.288 . . . . 0.0 110.856 178.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.564 ' HE3' ' O ' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -72.29 -45.62 59.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.214 0.605 . . . . 0.0 111.446 178.55 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -76.61 -37.16 56.86 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' VAL . . . . . 0.544 HG22 ' O ' ' B' ' 153' ' ' THR . 29.2 m -72.02 -40.8 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 122.602 0.361 . . . . 0.0 111.613 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.05 -32.69 63.41 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.098 0.559 . . . . 0.0 112.292 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' B' ' 155' ' ' LYS . 2.9 t30 -56.81 -37.41 71.15 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.393 0.433 . . . . 0.0 111.288 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.44 -28.4 52.46 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.159 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 9.3 p -115.75 26.34 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.286 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' LYS . . . . . . . . . . . . . 19.8 mtmt -77.08 -5.7 49.92 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 120.88 0.371 . . . . 0.0 110.886 178.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' ILE . . . . . 0.754 HG23 ' HB2' ' B' ' 168' ' ' MET . 2.0 mp -115.39 110.67 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . 0.539 ' HB3' ' OE1' ' A' ' 87' ' ' GLU . 12.0 t -115.77 -27.11 7.15 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' ALA . . . . . 0.647 ' HB3' ' SD ' ' B' ' 168' ' ' MET . . . -82.7 18.91 1.42 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.052 0.453 . . . . 0.0 112.179 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 66.4 m 64.06 130.05 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.342 1.057 . . . . 0.0 113.483 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.581 ' O ' ' HD3' ' A' ' 75' ' ' LYS . 25.2 mt 54.27 22.41 3.67 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 177.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . 0.754 ' HB2' HG23 ' B' ' 163' ' ' ILE . 46.4 mtp -69.31 -26.2 64.6 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.818 0.447 . . . . 0.0 111.446 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . 0.593 ' N ' HG12 ' B' ' 163' ' ' ILE . . . 172.97 42.56 0.04 OUTLIER Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.514 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 11.8 p . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.484 -0.769 . . . . 0.0 111.117 179.942 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.44 0.162 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -128.33 108.16 10.35 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.738 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -91.38 153.08 20.13 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.582 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.443 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -105.57 -108.8 0.29 Allowed 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.613 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.696 ' CG2' ' H ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -102.26 -173.82 2.43 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.564 ' N ' HG23 ' A' ' 5' ' ' THR . 45.3 mt-10 -60.11 -15.35 22.7 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 122.568 0.347 . . . . 0.0 110.993 176.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.696 ' H ' ' CG2' ' A' ' 5' ' ' THR . 5.5 pt-20 -62.17 -30.01 70.76 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.741 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.498 ' O ' ' HD2' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -77.99 -45.82 22.73 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.013 -1.448 . . . . 0.0 109.147 177.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.8 mm -60.73 -34.87 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.371 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.57 -34.9 63.02 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -114.35 -18.38 11.57 Favored 'General case' 0 C--N 1.345 0.404 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.498 ' HD2' ' O ' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -73.62 -15.23 61.27 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.325 0.966 . . . . 0.0 110.344 178.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.681 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -82.31 -40.69 21.1 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.097 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.681 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 0.8 OUTLIER -86.51 -39.56 16.13 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.158 -178.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.637 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -66.44 -18.67 65.49 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.454 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 48.5 t80 -86.39 -49.88 7.31 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.684 176.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.441 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 8.7 t -87.63 -12.92 44.13 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 -176.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -69.53 -28.71 66.25 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.606 0.639 . . . . 0.0 112.307 -179.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.584 ' CD1' HG22 ' A' ' 35' ' ' VAL . 5.5 m-85 -134.91 -2.55 2.6 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 23.5 t70 -83.44 55.2 3.09 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 119.301 0.955 . . . . 0.0 112.396 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.441 ' HE3' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -87.04 -20.63 26.91 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 178.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.72 -22.41 61.63 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.394 0.616 . . . . 0.0 110.585 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.16 40.99 27.93 Favored Glycine 0 N--CA 1.47 0.966 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.759 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.5 23.23 10.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.03 -1.585 . . . . 0.0 112.536 -176.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.04 -81.02 1.78 Allowed Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.865 -177.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.815 HG21 ' HA ' ' A' ' 64' ' ' ASP . 0.3 OUTLIER -113.76 178.31 4.33 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 122.394 0.278 . . . . 0.0 110.469 178.013 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -76.74 149.0 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -177.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.47 161.8 24.6 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.44 ' HA ' HD11 ' A' ' 63' ' ' ILE . 1.0 OUTLIER -78.26 -55.81 4.96 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.122 -179.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -55.76 -13.75 1.9 Allowed 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.726 0.641 . . . . 0.0 111.137 177.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.51 ' O ' HG23 ' A' ' 35' ' ' VAL . 25.5 mt-10 -114.75 -16.65 11.75 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.234 -178.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.604 HD22 HG12 ' A' ' 63' ' ' ILE . 13.2 tp -53.26 -41.38 65.45 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.332 0.653 . . . . 0.0 112.465 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.753 ' O ' ' HD3' ' A' ' 37' ' ' ARG . . . -55.83 -39.37 77.3 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 177.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.5 m -75.62 -29.71 59.3 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.488 -0.856 . . . . 0.0 112.547 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.637 HG12 ' HA ' ' A' ' 15' ' ' ALA . 1.2 t -74.68 -27.48 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 176.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.641 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 42.3 mtt -73.18 -42.3 62.87 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 113.0 -1.909 . . . . 0.0 111.006 176.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.753 ' HD3' ' O ' ' A' ' 33' ' ' GLY . 12.1 mtp180 -80.97 -29.71 35.25 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 75.8 m -67.87 -8.71 38.73 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.913 0.863 . . . . 0.0 111.971 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.469 HD21 ' HB2' ' A' ' 14' ' ' GLU . 85.0 mt -92.11 -7.25 49.11 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.285 -1.78 . . . . 0.0 109.645 177.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.4 1.44 50.53 Favored Glycine 0 CA--C 1.491 -1.434 0 CA-C-O 122.264 0.925 . . . . 0.0 114.933 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.641 ' HB2' ' O ' ' A' ' 36' ' ' MET . 57.3 mt-30 -85.66 138.02 32.43 Favored 'General case' 0 C--N 1.278 -2.523 0 CA-C-N 112.212 -1.994 . . . . 0.0 112.048 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -117.24 76.65 9.13 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.195 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.1 178.25 5.42 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 123.035 2.49 . . . . 0.0 112.361 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 46' ' ' ALA . 2.1 m -98.87 162.86 12.86 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.508 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 27.4 mt-10 -80.59 -28.78 37.02 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 121.555 0.693 . . . . 0.0 110.044 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.415 ' H ' HG22 ' A' ' 44' ' ' THR . . . -72.94 -39.49 66.18 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 113.758 -1.564 . . . . 0.0 110.261 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.586 ' HA ' ' OD2' ' A' ' 50' ' ' ASP . 0.9 OUTLIER -75.58 -28.82 59.1 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.664 176.307 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.817 ' O ' HG12 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -63.05 -23.09 67.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.094 174.334 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.674 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 20.2 mm-40 -89.68 -18.71 25.92 Favored 'General case' 0 CA--C 1.478 -1.825 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.455 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.586 ' OD2' ' HA ' ' A' ' 47' ' ' GLU . 15.2 m-20 -76.44 -30.77 57.52 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-N 112.003 -2.362 . . . . 0.0 108.837 175.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 35.1 mmt -86.6 -31.34 21.21 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.011 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.817 HG12 ' O ' ' A' ' 48' ' ' LEU . 37.2 mm -73.27 -27.23 23.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.574 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 175.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.674 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.4 t-20 -76.13 -35.03 59.44 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.457 176.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -87.32 -39.63 15.18 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.556 ' C ' ' H ' ' A' ' 57' ' ' ALA . 55.6 t -74.39 -42.79 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -72.16 34.91 0.06 Allowed 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.839 0.828 . . . . 0.0 110.734 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.556 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -86.78 -6.63 58.76 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 114.352 -1.294 . . . . 0.0 112.25 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -113.44 -35.59 5.22 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 112.027 -2.352 . . . . 0.0 110.741 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.59 45.89 5.95 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.766 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -110.19 -21.6 12.17 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.01 26.86 69.91 Favored Glycine 0 N--CA 1.466 0.661 0 CA-C-N 115.883 -0.599 . . . . 0.0 114.024 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.43 171.14 14.47 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 123.099 0.56 . . . . 0.0 110.871 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.604 HG12 HD22 ' A' ' 32' ' ' LEU . 4.4 mp -125.16 95.63 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.815 ' HA ' HG21 ' A' ' 26' ' ' THR . 9.3 m-20 -53.44 149.15 8.04 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.159 175.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.529 ' HA ' ' CD2' ' A' ' 68' ' ' PHE . 25.6 p90 -82.91 -38.59 0.77 Allowed Pre-proline 0 N--CA 1.478 0.94 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -177.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.486 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 12.7 Cg_exo -70.46 -17.37 34.46 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 121.939 1.759 . . . . 0.0 112.901 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -101.52 -19.34 15.55 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.853 ' O ' ' HG2' ' A' ' 71' ' ' MET . 3.8 p90 -84.82 -42.71 14.85 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -177.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 73' ' ' ALA . 3.8 mt -63.11 -31.97 73.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.569 0.699 . . . . 0.0 110.771 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.51 ' O ' ' HD3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -57.21 -35.64 69.89 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 113.509 -1.678 . . . . 0.0 109.567 174.458 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.853 ' HG2' ' O ' ' A' ' 68' ' ' PHE . 10.3 ptt? -72.92 -27.49 61.89 Favored 'General case' 0 C--N 1.345 0.412 0 O-C-N 123.789 0.68 . . . . 0.0 109.184 176.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.613 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 68.5 mtt -85.41 -20.23 30.16 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.776 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.489 ' O ' ' HG3' ' A' ' 77' ' ' LYS . . . -76.24 -37.41 57.69 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.704 ' NE ' ' HA ' ' A' ' 71' ' ' MET . 8.7 ptt180 -77.04 -18.13 58.31 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 123.562 0.539 . . . . 0.0 112.161 178.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.653 ' HD2' ' O ' ' A' ' 71' ' ' MET . 15.0 mttm -76.95 -14.58 59.84 Favored 'General case' 0 C--N 1.348 0.519 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 176.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.5 ' HA ' HG22 ' A' ' 79' ' ' THR . 14.4 ptt? -120.2 -22.97 6.4 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -177.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 73' ' ' ALA . 56.1 mttt -64.2 -13.79 51.09 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -104.19 -29.44 10.82 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.5 HG22 ' HA ' ' A' ' 76' ' ' MET . 7.9 t -68.04 103.88 1.62 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.057 0.456 . . . . 0.0 111.759 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.606 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 9.1 m-20 -46.28 147.16 1.18 Allowed 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.784 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.48 ' HA ' ' OE2' ' A' ' 84' ' ' GLU . 13.2 t -71.89 -13.68 61.73 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.717 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.555 ' O ' HD12 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -80.03 -46.82 15.9 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.59 0.71 . . . . 0.0 109.819 -179.37 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.429 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 38.5 mt-10 -73.33 -18.34 61.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.941 -1.481 . . . . 0.0 112.489 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.606 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 40.7 mt-10 -66.74 -20.93 66.06 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.555 HD12 ' O ' ' A' ' 82' ' ' GLU . 1.7 mt -87.89 -55.64 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.59 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.64 ' O ' ' HD1' ' A' ' 89' ' ' PHE . 9.7 mtt180 -60.82 -16.77 44.63 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.555 ' O ' HG23 ' A' ' 91' ' ' VAL . 2.7 pt-20 -78.38 -20.13 51.91 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.438 ' HB1' ' CE2' ' A' ' 141' ' ' PHE . . . -68.52 -21.48 64.58 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.777 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.64 ' HD1' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -84.45 -20.74 31.27 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 174.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -80.41 -24.97 39.29 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.211 -1.358 . . . . 0.0 108.353 175.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 87' ' ' GLU . 97.8 t -88.75 -54.51 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.558 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.809 ' HB3' HG21 ' A' ' 100' ' ' ILE . 13.7 m-85 -100.37 -44.46 5.9 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -175.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.705 ' CA ' HG12 ' A' ' 100' ' ' ILE . 15.8 t70 -62.87 94.76 0.07 Allowed 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.591 0.71 . . . . 0.0 111.36 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -87.3 -50.2 6.74 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.483 -1.235 . . . . 0.0 113.093 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -72.14 0.81 8.72 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -175.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.468 ' HA2' ' OD2' ' A' ' 93' ' ' ASP . . . 49.51 33.26 17.23 Favored Glycine 0 N--CA 1.473 1.117 0 CA-C-N 114.34 -1.3 . . . . 0.0 114.722 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -99.87 -5.56 28.22 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.89 -19.19 50.55 Favored Glycine 0 C--N 1.337 0.609 0 C-N-CA 121.481 -0.39 . . . . 0.0 112.787 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -119.2 119.65 34.75 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.477 -0.861 . . . . 0.0 110.258 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.809 HG21 ' HB3' ' A' ' 92' ' ' PHE . 45.9 mt -77.34 87.41 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.3 t -64.51 163.56 13.24 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.131 -0.94 . . . . 0.0 112.969 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.554 ' HB1' HG21 ' A' ' 121' ' ' VAL . . . -58.55 -14.42 8.03 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.65 -30.92 18.81 Favored 'General case' 0 CA--C 1.488 -1.406 0 CA-C-O 121.819 0.819 . . . . 0.0 109.248 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 1.035 ' O ' HG23 ' A' ' 108' ' ' VAL . 16.1 mt-10 -77.83 -40.88 38.93 Favored 'General case' 0 CA--C 1.483 -1.634 0 CA-C-N 112.73 -2.032 . . . . 0.0 110.152 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.792 HD11 ' SD ' ' A' ' 124' ' ' MET . 6.0 tt -64.09 -35.61 81.31 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.624 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -72.39 -43.12 64.39 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.203 -1.362 . . . . 0.0 108.649 175.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.513 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 2.9 t60 -67.61 -21.85 65.38 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.277 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.035 HG23 ' O ' ' A' ' 104' ' ' GLU . 28.8 t -72.31 -51.42 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.878 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 176.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.699 ' SD ' HD22 ' A' ' 116' ' ' LEU . 21.2 mtt -57.3 -41.23 79.45 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 112.579 -2.1 . . . . 0.0 111.943 175.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 m -69.43 -19.26 63.79 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.366 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.13 -44.81 21.27 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.422 176.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.2 mt -80.9 -28.2 35.97 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.207 -178.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 141.67 -10.32 2.64 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-O 117.738 -1.59 . . . . 0.0 116.836 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 109' ' ' MET . 5.0 mt-10 -100.82 152.13 20.87 Favored 'General case' 0 C--N 1.357 0.903 0 CA-C-N 120.912 2.356 . . . . 0.0 114.427 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -110.74 128.53 55.77 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 113.703 -1.59 . . . . 0.0 107.304 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.699 HD22 ' SD ' ' A' ' 109' ' ' MET . 1.0 OUTLIER -139.71 115.91 10.46 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.893 -176.025 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.876 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -70.43 -175.82 1.1 Allowed 'General case' 0 C--N 1.348 0.523 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.433 179.154 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.538 ' N ' HG23 ' A' ' 117' ' ' THR . 17.2 t70 -69.41 -39.48 77.9 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.623 ' H ' HG23 ' A' ' 117' ' ' THR . 9.9 pt-20 -88.76 -16.52 31.98 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.796 ' HG2' HG22 ' A' ' 117' ' ' THR . 14.7 pt-20 -85.05 -15.72 43.13 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 123.083 0.24 . . . . 0.0 111.204 178.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.876 HG22 ' O ' ' A' ' 117' ' ' THR . 0.1 OUTLIER -83.02 -23.33 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.179 177.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -70.61 29.41 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.93 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.667 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 11.7 pt-20 -136.36 -21.2 1.37 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.208 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.792 ' SD ' HD11 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -87.61 -32.08 19.49 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 176.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.741 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 3.0 mt -81.71 -27.6 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.727 -178.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -73.38 -29.26 62.51 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.649 0.738 . . . . 0.0 111.194 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.667 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 15.4 mm-40 -65.06 -36.72 85.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.846 -1.525 . . . . 0.0 110.569 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.641 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -96.48 -36.12 10.9 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.361 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.741 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.5 OUTLIER -60.45 116.61 4.44 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.26 -1.336 . . . . 0.0 113.92 -178.368 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.5 mt -91.01 -52.15 10.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 113.163 -1.835 . . . . 0.0 109.605 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -87.89 -24.45 23.64 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.029 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.38 49.8 3.59 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 115.718 -0.673 . . . . 0.0 113.689 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -78.86 -22.44 46.07 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.45 24.58 56.3 Favored Glycine 0 CA--C 1.505 -0.537 0 CA-C-N 115.03 -0.986 . . . . 0.0 114.536 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.642 ' O ' ' HB ' ' A' ' 136' ' ' VAL . 40.6 mt-30 -133.7 -68.42 0.57 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.71 -0.745 . . . . 0.0 110.348 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.642 ' HB ' ' O ' ' A' ' 135' ' ' GLN . 5.2 t 115.54 118.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 125.258 1.423 . . . . 0.0 110.907 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -94.06 -163.7 1.08 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.944 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.446 ' O ' HG23 ' A' ' 142' ' ' VAL . 79.0 m-85 -69.85 -51.92 29.3 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.825 178.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -66.92 -20.63 65.94 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.641 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 8.7 mt-10 -85.47 -38.0 19.11 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.509 ' O ' ' HG3' ' A' ' 144' ' ' MET . 86.6 t80 -75.35 -23.63 57.22 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.748 176.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.574 ' O ' ' HG2' ' A' ' 145' ' ' MET . 18.3 t -85.76 -37.01 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.743 -178.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.427 ' HA ' ' OG1' ' A' ' 146' ' ' THR . 8.7 mm100 -46.73 -31.25 2.83 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 178.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.509 ' HG3' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -63.4 -25.69 68.4 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 118.559 0.618 . . . . 0.0 110.941 178.6 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.574 ' HG2' ' O ' ' A' ' 142' ' ' VAL . 11.2 ptm -83.68 -4.2 58.4 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.739 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.427 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 59.4 p -122.4 -44.59 2.24 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.136 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -48.44 -38.75 20.62 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 20.5 pttp . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.107 -0.949 . . . . 0.0 111.115 179.895 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.526 0.203 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . 0.534 ' HA ' ' OE2' ' A' ' 123' ' ' GLU . 7.5 mpt_? -128.98 129.64 45.66 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.703 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -100.75 -58.03 1.98 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.817 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -150.1 138.92 20.89 Favored 'General case' 0 C--N 1.346 0.425 0 O-C-N 123.264 0.352 . . . . 0.0 110.656 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.541 ' O ' HG13 ' B' ' 157' ' ' VAL . 67.7 p -108.35 176.1 5.24 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.31 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' PHE . . . . . 0.522 ' CE1' ' HD2' ' B' ' 155' ' ' LYS . 0.1 OUTLIER -67.47 -27.39 66.98 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 179.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.522 ' HD2' ' CE1' ' B' ' 154' ' ' PHE . 0.8 OUTLIER -69.55 -34.56 74.37 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 120.76 0.314 . . . . 0.0 110.624 177.653 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -76.47 -35.18 58.58 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.441 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' VAL . . . . . 0.541 HG13 ' O ' ' B' ' 153' ' ' THR . 11.1 m -71.44 -29.49 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 122.671 0.389 . . . . 0.0 110.686 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.22 -39.06 71.89 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.706 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -68.33 -22.5 64.69 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.742 0.306 . . . . 0.0 110.938 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.69 -43.89 29.71 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.614 HG23 ' SD ' ' B' ' 168' ' ' MET . 10.7 p -126.58 -30.7 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -178.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -62.96 94.08 0.06 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.55 0.69 . . . . 0.0 111.735 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 3.5 tp -154.12 5.49 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.918 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 49.2 m 64.96 -176.97 0.17 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.073 0.949 . . . . 0.0 111.715 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' ALA . . . . . 0.42 ' HB1' ' N ' ' B' ' 170' ' ' THR . . . -75.68 58.77 1.11 Allowed 'General case' 0 C--N 1.348 0.523 0 CA-C-O 121.807 0.813 . . . . 0.0 110.78 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . 0.601 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 8.6 t -100.31 -60.61 1.5 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.662 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.529 HD22 ' NE2' ' A' ' 41' ' ' GLN . 4.0 tp -108.47 -23.65 11.76 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.051 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . 0.614 ' SD ' HG23 ' B' ' 161' ' ' VAL . 61.8 mtt -93.42 -43.96 8.5 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.579 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -105.56 -152.4 20.7 Favored Glycine 0 C--N 1.34 0.755 0 C-N-CA 121.367 -0.444 . . . . 0.0 112.615 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . 0.42 ' N ' ' HB1' ' B' ' 165' ' ' ALA . 20.1 p . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.447 -0.787 . . . . 0.0 111.038 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.401 0 N-CA-C 111.433 0.16 . . . . 0.0 111.433 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -100.17 126.92 46.5 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.42 0.45 . . . . 0.0 110.874 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.679 ' HA ' ' NE2' ' A' ' 8' ' ' GLN . 49.7 mt-30 -139.45 149.52 44.11 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.679 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.454 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -110.97 -111.06 0.33 Allowed 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.527 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 15.2 p -101.26 -173.57 2.4 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 123.727 0.811 . . . . 0.0 111.236 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -56.61 -26.77 56.59 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.527 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 10.5 pt-20 -58.33 -30.07 66.41 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 121.364 0.602 . . . . 0.0 111.314 178.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.679 ' NE2' ' HA ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -79.22 -44.42 21.85 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 114.205 -1.362 . . . . 0.0 109.141 177.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.541 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . 19.8 mm -60.06 -36.96 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.392 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.89 -34.66 59.99 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -107.29 -18.07 13.97 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.541 ' CE1' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -74.16 -16.04 61.01 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.478 0.581 . . . . 0.0 110.199 178.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.68 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 1.0 OUTLIER -81.77 -41.87 20.56 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.549 179.244 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.68 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 1.5 mt-10 -81.82 -37.81 26.48 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.558 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.7 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -66.14 -24.04 66.59 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.922 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 25.8 t80 -87.0 -43.44 12.34 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.22 176.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 t -86.07 -12.78 49.25 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -71.41 -29.35 64.81 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.512 179.503 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.446 ' CD1' HG22 ' A' ' 35' ' ' VAL . 10.8 m-85 -132.7 -6.86 3.2 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.922 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 1.6 m-20 -98.48 78.98 2.45 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.69 0.677 . . . . 0.0 110.14 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.42 -40.04 58.23 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.47 -19.2 58.26 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.206 177.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.58 51.51 5.17 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 113.734 -1.576 . . . . 0.0 109.333 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.21 22.19 3.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 113.501 -1.349 . . . . 0.0 114.138 -175.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.39 -63.1 0.26 Allowed Glycine 0 CA--C 1.527 0.811 0 CA-C-N 115.265 -0.88 . . . . 0.0 114.434 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.711 HG22 ' N ' ' A' ' 64' ' ' ASP . 12.8 p -97.75 155.86 16.83 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 123.583 0.753 . . . . 0.0 112.038 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.87 HD13 HG21 ' A' ' 35' ' ' VAL . 1.2 pp -115.21 149.31 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.642 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.96 150.44 10.21 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -178.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -74.12 -55.83 5.63 Favored 'General case' 0 C--N 1.347 0.464 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -54.5 -13.75 1.05 Allowed 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.732 0.645 . . . . 0.0 111.292 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -111.3 -16.84 13.29 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.02 -178.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.569 ' HA ' HG23 ' A' ' 35' ' ' VAL . 8.0 tp -52.73 -41.12 63.69 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.278 0.631 . . . . 0.0 112.458 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.749 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -56.12 -39.7 81.21 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 120.516 -0.849 . . . . 0.0 111.031 177.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.4 m -72.94 -32.1 65.05 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.735 -0.732 . . . . 0.0 112.624 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.87 HG21 HD13 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -72.9 -27.07 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.03 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.561 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 21.0 mtm -76.37 -42.56 44.21 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 112.884 -1.962 . . . . 0.0 111.763 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.749 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 8.7 mtt180 -77.69 -30.12 51.72 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.1 m -68.12 -8.24 36.63 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.953 0.882 . . . . 0.0 112.009 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 35' ' ' VAL . 88.3 mt -94.11 -6.1 45.78 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.243 -1.798 . . . . 0.0 109.837 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.48 -8.93 22.24 Favored Glycine 0 CA--C 1.494 -1.239 0 N-CA-C 115.582 0.993 . . . . 0.0 115.582 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.561 ' HB2' ' O ' ' A' ' 36' ' ' MET . 20.5 mm-40 -73.84 140.45 45.77 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 112.739 -1.731 . . . . 0.0 111.919 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -128.15 61.95 55.37 Favored Pre-proline 0 CA--C 1.555 1.171 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.199 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.425 ' HD2' ' HE ' ' A' ' 37' ' ' ARG . 3.3 Cg_endo -87.96 -177.76 2.01 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.99 2.46 . . . . 0.0 112.134 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.615 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 7.5 t -99.65 -175.35 2.96 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 122.156 0.979 . . . . 0.0 110.667 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.502 ' N ' ' OG1' ' A' ' 44' ' ' THR . 8.6 mm-40 -81.36 -24.89 36.77 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 112.971 -1.922 . . . . 0.0 108.38 176.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 50' ' ' ASP . . . -69.18 -26.05 64.66 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 113.66 -1.609 . . . . 0.0 111.42 -177.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.438 ' H ' HG23 ' A' ' 44' ' ' THR . 36.3 mt-10 -87.31 -30.37 20.9 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.672 177.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.646 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 12.4 mt -69.03 -19.55 64.11 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.016 174.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.882 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 48.8 mt-30 -99.08 -15.64 18.94 Favored 'General case' 0 CA--C 1.481 -1.691 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.269 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 2.6 t70 -87.2 -36.27 18.08 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 112.146 -2.297 . . . . 0.0 110.517 177.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.554 ' HA ' ' OE1' ' A' ' 54' ' ' GLU . 0.9 OUTLIER -86.66 -32.31 20.61 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.394 178.026 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.646 ' HB ' ' O ' ' A' ' 48' ' ' LEU . 1.5 mp -73.11 -25.51 21.8 Favored 'Isoleucine or valine' 0 C--N 1.344 0.364 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 175.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.882 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.0 t30 -72.23 -34.25 68.17 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.172 175.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.554 ' OE1' ' HA ' ' A' ' 51' ' ' MET . 6.0 pt-20 -87.94 -48.9 7.43 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.549 ' C ' ' H ' ' A' ' 57' ' ' ALA . 83.1 t -72.85 -46.65 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -178.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -72.64 39.47 0.08 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.971 0.891 . . . . 0.0 110.22 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.549 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -85.37 -5.64 59.29 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 114.131 -1.395 . . . . 0.0 112.206 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.436 ' HB3' HD22 ' A' ' 60' ' ' ASN . 6.6 t70 -104.7 -30.89 9.64 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 112.069 -2.332 . . . . 0.0 110.621 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.38 47.96 5.24 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.863 -0.608 . . . . 0.0 113.66 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.436 HD22 ' HB3' ' A' ' 58' ' ' ASP . 42.6 m-80 -110.11 -22.13 11.94 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.61 26.67 72.05 Favored Glycine 0 N--CA 1.468 0.827 0 CA-C-N 115.875 -0.602 . . . . 0.0 114.316 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.91 158.46 43.92 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.375 0.67 . . . . 0.0 110.609 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.554 HD13 ' HB2' ' A' ' 32' ' ' LEU . 3.7 mp -135.34 128.61 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.711 ' N ' HG22 ' A' ' 26' ' ' THR . 0.2 OUTLIER -74.82 159.11 32.34 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.469 176.609 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.574 ' CG ' ' HB2' ' A' ' 16' ' ' PHE . 4.8 p90 -91.29 -41.65 0.38 Allowed Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -177.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.469 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 54.3 Cg_endo -70.74 -18.82 32.11 Favored 'Trans proline' 0 C--N 1.376 2.019 0 CA-C-N 121.368 1.524 . . . . 0.0 113.357 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -96.56 -16.65 20.94 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.683 ' O ' ' HG2' ' A' ' 71' ' ' MET . 44.4 t80 -84.55 -21.52 30.44 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -177.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.63 HD13 ' HA ' ' A' ' 8' ' ' GLN . 1.9 mt -80.14 -32.97 38.91 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-O 121.947 0.88 . . . . 0.0 109.405 176.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.635 ' O ' ' HD3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -55.99 -38.66 70.73 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 112.839 -1.982 . . . . 0.0 109.499 174.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.683 ' HG2' ' O ' ' A' ' 68' ' ' PHE . 24.6 ptm -73.32 -25.24 60.56 Favored 'General case' 0 C--N 1.349 0.544 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.551 ' O ' ' HG2' ' A' ' 76' ' ' MET . 93.6 mtp -83.15 -18.58 38.92 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.402 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.554 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -82.23 -32.36 29.79 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.653 ' NE ' ' HA ' ' A' ' 71' ' ' MET . 6.1 ptt180 -88.46 -17.96 29.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.661 ' HD2' ' O ' ' A' ' 71' ' ' MET . 7.7 ptmt -84.45 -13.03 53.21 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 119.56 -0.856 . . . . 0.0 112.609 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.551 ' HG2' ' O ' ' A' ' 72' ' ' MET . 21.2 ptm -111.88 -31.99 6.76 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.554 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 25.6 mmtt -67.61 -11.22 57.66 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -103.76 -29.7 10.86 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -83.38 47.77 1.3 Allowed 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 121.167 0.508 . . . . 0.0 111.937 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 61.83 112.45 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.828 0.851 . . . . 0.0 111.768 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.4 p -83.26 -14.17 53.7 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.324 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.573 ' O ' HD12 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -85.76 -45.56 11.51 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.736 0.779 . . . . 0.0 109.441 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.415 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 40.7 mt-10 -74.39 -18.34 60.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.805 -1.543 . . . . 0.0 112.02 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.35 -19.43 65.44 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.017 0.527 . . . . 0.0 112.136 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.573 HD12 ' O ' ' A' ' 82' ' ' GLU . 1.8 mt -87.74 -54.16 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.439 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.589 ' O ' ' HD1' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -57.33 -21.19 33.61 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -179.539 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 3.4 pt-20 -72.4 -19.8 61.54 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.05 0.453 . . . . 0.0 110.397 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.571 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -68.86 -21.14 64.28 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.205 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.639 ' O ' ' HB2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -80.77 -21.98 40.53 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 174.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 9.1 tpt180 -77.95 -15.92 58.59 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 114.432 -1.258 . . . . 0.0 107.984 175.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.571 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 3.8 t -85.57 -33.04 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 114.398 -1.274 . . . . 0.0 111.298 177.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.81 ' HB3' HG21 ' A' ' 100' ' ' ILE . 33.4 m-85 -97.55 -33.21 11.44 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 -177.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.639 ' HB2' ' O ' ' A' ' 89' ' ' PHE . 1.9 t70 -60.98 93.12 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.622 0.769 . . . . 0.0 110.965 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -87.72 -50.13 6.68 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.203 -0.908 . . . . 0.0 113.261 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -72.19 1.07 8.2 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -175.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.01 31.04 24.54 Favored Glycine 0 N--CA 1.471 1.019 0 CA-C-N 114.31 -1.314 . . . . 0.0 114.646 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -97.39 -7.96 30.59 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.625 0.212 . . . . 0.0 111.548 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.12 -19.07 47.4 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 116.202 -0.453 . . . . 0.0 112.798 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -120.61 120.31 35.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.475 -0.863 . . . . 0.0 110.384 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.81 HG21 ' HB3' ' A' ' 92' ' ' PHE . 15.4 mt -77.12 97.95 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.417 ' H ' ' CD ' ' A' ' 104' ' ' GLU . 14.1 t -76.16 169.26 18.53 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.438 -178.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.567 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -61.72 -15.04 37.23 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.525 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -89.54 -30.74 18.0 Favored 'General case' 0 CA--C 1.487 -1.458 0 CA-C-O 121.73 0.776 . . . . 0.0 109.21 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.969 ' O ' HG23 ' A' ' 108' ' ' VAL . 20.7 mt-10 -76.3 -41.75 47.59 Favored 'General case' 0 CA--C 1.485 -1.556 0 CA-C-N 112.776 -2.011 . . . . 0.0 110.729 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.561 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 2.8 tt -62.29 -38.78 90.69 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.555 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -68.7 -44.77 73.23 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 113.766 -1.561 . . . . 0.0 109.116 175.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.525 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 2.7 t60 -68.5 -21.68 64.58 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.662 178.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.969 HG23 ' O ' ' A' ' 104' ' ' GLU . 23.5 t -71.63 -50.3 40.3 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.927 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.806 ' SD ' HD22 ' A' ' 116' ' ' LEU . 15.6 mtt -56.6 -41.87 77.77 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 112.4 -2.182 . . . . 0.0 112.013 175.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.79 -18.97 63.51 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.339 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.82 -45.18 21.42 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.515 176.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 mt -80.55 -28.07 37.38 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.418 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 136.85 -6.33 3.76 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-O 117.78 -1.567 . . . . 0.0 116.829 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.563 ' HB3' ' SD ' ' A' ' 109' ' ' MET . 4.9 mt-10 -101.49 155.26 18.18 Favored 'General case' 0 C--N 1.356 0.882 0 CA-C-N 120.842 2.321 . . . . 0.0 114.127 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -112.77 127.49 56.17 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.322 175.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.806 HD22 ' SD ' ' A' ' 109' ' ' MET . 1.2 tp -139.87 119.52 13.23 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 113.94 -1.482 . . . . 0.0 111.057 -177.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.766 ' O ' ' HB ' ' A' ' 121' ' ' VAL . 0.6 OUTLIER -83.74 -176.55 6.34 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.911 -177.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.574 ' N ' HG23 ' A' ' 117' ' ' THR . 17.4 t70 -61.21 -47.54 85.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 113.827 -1.533 . . . . 0.0 113.857 -178.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.686 ' HA ' ' OD2' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -84.09 -21.73 31.4 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -179.03 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.69 ' CG ' ' H ' ' A' ' 117' ' ' THR . 10.5 pt-20 -88.61 -25.06 22.64 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.876 0.37 . . . . 0.0 110.949 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.766 ' HB ' ' O ' ' A' ' 117' ' ' THR . 0.3 OUTLIER -87.97 -26.39 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.863 178.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.686 ' OD2' ' HA ' ' A' ' 119' ' ' GLU . 32.1 p30 -71.7 25.63 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.75 -1.114 . . . . 0.0 113.633 -177.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.889 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 10.7 pt-20 -124.88 -43.22 2.0 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.348 177.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.469 ' SD ' HG11 ' B' ' 157' ' ' VAL . 14.1 ttm -56.35 -21.93 27.75 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.302 1.041 . . . . 0.0 111.983 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.652 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 3.0 mt -86.86 -48.64 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 O-C-N 123.528 0.517 . . . . 0.0 110.845 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -55.45 -31.2 61.74 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 124.406 1.066 . . . . 0.0 112.229 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.889 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 3.4 mm-40 -65.21 -36.75 85.14 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.962 178.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' A' ' 140' ' ' GLU . . . -97.56 -35.18 10.7 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.477 0.656 . . . . 0.0 110.283 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.652 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -61.56 127.28 30.71 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 113.985 -1.461 . . . . 0.0 113.488 -179.451 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.2 mt -90.14 -44.01 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.254 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -90.81 -25.35 19.97 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.34 49.81 6.57 Favored Glycine 0 CA--C 1.526 0.738 0 O-C-N 123.449 0.468 . . . . 0.0 113.989 178.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -87.27 -19.61 28.04 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.446 ' HA2' HG21 ' A' ' 125' ' ' ILE . . . 95.03 7.1 59.92 Favored Glycine 0 CA--C 1.5 -0.865 0 CA-C-N 115.851 -0.613 . . . . 0.0 113.611 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -139.43 107.2 5.64 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.752 -1.224 . . . . 0.0 108.124 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.595 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 2.2 t -69.18 124.85 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 114.927 -1.033 . . . . 0.0 113.448 -177.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.454 HD22 ' CD ' ' A' ' 140' ' ' GLU . 19.2 m-80 -86.75 -163.35 0.89 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 114.11 -1.404 . . . . 0.0 110.515 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.476 ' O ' HG23 ' A' ' 142' ' ' VAL . 76.5 m-85 -71.79 -55.77 6.99 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.598 0.759 . . . . 0.0 110.816 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -63.75 -20.65 65.92 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.595 ' OE1' ' HA ' ' A' ' 136' ' ' VAL . 10.9 mt-10 -86.94 -42.52 13.1 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.424 0.631 . . . . 0.0 109.703 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.42 ' O ' ' HG3' ' A' ' 144' ' ' MET . 42.3 t80 -68.76 -23.42 64.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.177 -1.374 . . . . 0.0 109.148 176.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 138' ' ' TYR . 24.6 t -85.78 -50.16 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.517 -178.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.545 HE21 ' N ' ' A' ' 144' ' ' MET . 0.2 OUTLIER -56.33 -32.7 64.92 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 123.867 0.73 . . . . 0.0 111.992 179.189 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.545 ' N ' HE21 ' A' ' 143' ' ' GLN . 0.1 OUTLIER -67.01 -21.3 65.95 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 122.999 0.187 . . . . 0.0 111.197 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 50.5 mtt -87.6 -4.32 58.96 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.42 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 23.4 p -120.17 -48.78 2.31 Favored 'General case' 0 C--N 1.35 0.611 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.721 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -55.21 -40.15 70.49 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.6 mttp . . . . . 0 N--CA 1.484 1.26 0 C-N-CA 124.017 0.927 . . . . 0.0 112.462 -179.971 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 18.6 p . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.489 0.185 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -102.87 -40.73 6.42 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.277 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . 0.539 ' HD3' ' OE1' ' A' ' 114' ' ' GLU . 12.4 mptt -98.14 133.18 42.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.124 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -136.98 -6.87 1.85 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.94 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.651 HG22 ' HG3' ' A' ' 127' ' ' GLU . 37.8 p -139.49 158.88 43.38 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.146 0.279 . . . . 0.0 111.49 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' PHE . . . . . 0.586 ' HA ' HG22 ' B' ' 157' ' ' VAL . 0.2 OUTLIER -64.24 -27.26 68.93 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 120.767 0.317 . . . . 0.0 110.384 178.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.489 ' H ' ' HD2' ' B' ' 155' ' ' LYS . 0.0 OUTLIER -58.67 -44.35 90.16 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.446 0.698 . . . . 0.0 111.533 179.024 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -76.53 -35.15 58.45 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' VAL . . . . . 0.586 HG22 ' HA ' ' B' ' 154' ' ' PHE . 14.5 m -71.05 -33.87 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 122.54 0.336 . . . . 0.0 111.144 -178.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . 0.514 ' O ' ' HB2' ' B' ' 162' ' ' LYS . . . -73.63 -40.5 63.73 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.74 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -60.54 -25.98 66.54 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 123.467 0.479 . . . . 0.0 111.684 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.92 -37.88 54.51 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.633 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 9.8 p -115.32 27.62 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.264 0 O-C-N 123.298 0.374 . . . . 0.0 111.844 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 1.8 ttpm? -86.05 -37.45 18.88 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 116.865 -0.152 . . . . 0.0 111.045 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 3.3 tp -106.62 20.08 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 O-C-N 123.457 0.473 . . . . 0.0 110.759 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 52.4 m -88.56 -25.74 22.34 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.785 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . -89.33 23.56 2.48 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.018 0.437 . . . . 0.0 111.55 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 38.3 p -89.14 -36.25 15.81 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.761 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 4.8 tp -87.71 -7.17 57.73 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 123.4 0.438 . . . . 0.0 111.541 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 22.0 mmt -94.03 130.72 40.06 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.952 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -119.78 -55.44 0.25 Allowed Glycine 0 C--N 1.337 0.632 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.514 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 19.9 p . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.501 -0.761 . . . . 0.0 111.057 -179.968 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.513 0.197 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -100.19 -45.12 5.73 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.815 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.408 ' HG2' HE22 ' A' ' 8' ' ' GLN . 48.5 mt-30 -89.91 149.35 22.66 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 122.698 0.399 . . . . 0.0 111.259 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.734 ' H ' HE21 ' A' ' 8' ' ' GLN . 0.0 OUTLIER -123.65 -122.69 0.27 Allowed 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.552 ' O ' ' HG2' ' A' ' 8' ' ' GLN . 20.0 p -101.64 167.96 9.78 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 123.93 0.892 . . . . 0.0 109.89 178.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -46.04 -22.1 0.19 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.513 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 10.9 pt-20 -47.98 -32.51 6.59 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 123.708 0.63 . . . . 0.0 110.912 176.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.734 HE21 ' H ' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -66.0 -55.24 17.73 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.102 177.47 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.1 mt -62.9 -30.96 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.682 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.37 -38.76 63.08 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -127.2 -19.24 4.36 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.562 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -71.45 -15.54 62.34 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.075 0.398 . . . . 0.0 110.161 178.742 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.695 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -80.77 -40.95 24.27 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.817 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.695 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 2.6 mt-10 -79.35 -40.47 30.16 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 114.142 -1.39 . . . . 0.0 112.108 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.708 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -66.54 -20.47 66.03 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.823 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 23.9 t80 -86.99 -46.47 9.81 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.328 -1.305 . . . . 0.0 109.83 176.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.8 m -86.69 -12.98 46.78 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 -176.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.44 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -72.05 -28.82 63.59 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.654 179.81 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.584 ' CD1' HG22 ' A' ' 35' ' ' VAL . 5.4 m-85 -134.52 -6.32 2.54 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.823 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 8.1 m-20 -95.68 78.5 3.31 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 118.92 0.782 . . . . 0.0 110.944 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.409 ' HD2' ' N ' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -80.96 -40.2 24.83 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -179.607 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.21 -21.26 60.69 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.49 178.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.63 50.92 8.66 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.93 22.48 7.38 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 113.323 -1.439 . . . . 0.0 114.013 -174.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.05 -66.63 0.49 Allowed Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.296 -0.866 . . . . 0.0 113.641 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.718 ' HG1' ' H ' ' A' ' 63' ' ' ILE . 2.0 t -97.85 170.15 9.17 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 122.227 1.013 . . . . 0.0 112.271 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.435 ' N ' ' OG1' ' A' ' 26' ' ' THR . 0.1 OUTLIER -133.37 144.6 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.771 0 CA-C-N 112.838 -1.983 . . . . 0.0 109.429 179.328 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.25 155.81 4.68 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.94 -55.28 11.45 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.697 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -56.13 -13.92 2.35 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.383 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.528 ' O ' HG23 ' A' ' 35' ' ' VAL . 6.3 mm-40 -107.13 -30.28 8.87 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.509 -178.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.437 ' HG ' HG13 ' A' ' 63' ' ' ILE . 1.7 tm? -55.78 -33.65 64.55 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.232 0.613 . . . . 0.0 111.27 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.589 ' HA3' HD21 ' A' ' 48' ' ' LEU . . . -58.31 -37.31 86.92 Favored Glycine 0 C--N 1.336 0.54 0 O-C-N 123.738 0.649 . . . . 0.0 111.706 177.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.7 m -79.7 -29.14 40.62 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 114.65 -0.775 . . . . 0.0 111.966 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.708 HG12 ' HA ' ' A' ' 15' ' ' ALA . 1.1 t -76.76 -26.01 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 176.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.532 ' HB3' ' NH1' ' A' ' 37' ' ' ARG . 22.4 mmt -77.2 -38.77 50.82 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 112.974 -1.921 . . . . 0.0 111.691 176.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.579 ' HD3' ' N ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -83.75 -25.82 30.21 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.3 t -65.91 -8.03 20.01 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 122.096 0.95 . . . . 0.0 111.253 177.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.448 ' O ' HG21 ' B' ' 170' ' ' THR . 78.7 mt -92.83 -2.62 55.75 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 113.011 -1.904 . . . . 0.0 110.254 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.99 -11.39 17.69 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 116.296 1.278 . . . . 0.0 116.296 177.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.414 HE22 HD23 ' B' ' 167' ' ' LEU . 54.8 mt-30 -75.34 156.38 35.57 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 113.198 -1.501 . . . . 0.0 111.512 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.413 ' C ' ' HG3' ' A' ' 37' ' ' ARG . 4.8 t-20 -83.2 132.22 51.01 Favored Pre-proline 0 N--CA 1.475 0.78 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.575 ' N ' ' HG3' ' A' ' 37' ' ' ARG . 85.9 Cg_endo -88.75 102.4 0.4 Allowed 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.349 2.032 . . . . 0.0 116.31 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.696 HG23 ' H ' ' A' ' 47' ' ' GLU . 10.0 t -135.29 177.67 7.63 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.969 0.89 . . . . 0.0 108.906 173.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.453 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 45.5 mt-10 -82.79 -24.95 33.18 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 113.168 -1.833 . . . . 0.0 109.32 177.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.595 ' O ' ' HB2' ' A' ' 50' ' ' ASP . . . -71.5 -34.52 70.2 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.879 -1.51 . . . . 0.0 112.477 -176.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.696 ' H ' HG23 ' A' ' 44' ' ' THR . 43.2 mt-10 -87.58 -24.83 23.88 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.763 177.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.665 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.3 OUTLIER -75.81 -18.21 59.56 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 113.723 -1.58 . . . . 0.0 109.114 176.133 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 1.034 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 17.1 mm-40 -104.13 -14.13 15.99 Favored 'General case' 0 CA--C 1.478 -1.819 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.999 177.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.595 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 1.1 t70 -87.91 -40.33 14.04 Favored 'General case' 0 C--N 1.28 -2.426 0 CA-C-N 112.349 -2.205 . . . . 0.0 111.234 176.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.587 ' HA ' ' OE1' ' A' ' 54' ' ' GLU . 1.3 mpt? -87.05 -29.96 21.53 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 123.519 0.512 . . . . 0.0 110.947 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.665 ' HB ' ' O ' ' A' ' 48' ' ' LEU . 1.9 mp -78.8 -19.95 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 175.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 1.034 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.1 t30 -77.64 -33.52 53.52 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.824 174.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.587 ' OE1' ' HA ' ' A' ' 51' ' ' MET . 6.6 pt-20 -82.54 -49.6 9.71 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.562 ' C ' ' H ' ' A' ' 57' ' ' ALA . 78.5 t -89.27 -51.96 11.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.506 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 4.9 t70 -71.94 38.62 0.07 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-O 122.108 0.956 . . . . 0.0 110.143 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.562 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -85.14 -5.35 59.34 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 113.937 -1.483 . . . . 0.0 112.53 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.449 ' HB3' HD22 ' A' ' 60' ' ' ASN . 5.9 t70 -90.43 -32.64 16.32 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 112.31 -2.223 . . . . 0.0 111.392 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.36 50.26 4.35 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-N 116.091 -0.504 . . . . 0.0 113.489 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.449 HD22 ' HB3' ' A' ' 58' ' ' ASP . 40.7 m-80 -109.95 -21.46 12.32 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.675 0.274 . . . . 0.0 111.401 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.68 26.1 70.44 Favored Glycine 0 N--CA 1.465 0.632 0 CA-C-N 115.587 -0.733 . . . . 0.0 114.289 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.41 -179.32 6.98 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 123.423 0.689 . . . . 0.0 110.102 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.718 ' H ' ' HG1' ' A' ' 26' ' ' THR . 22.8 mm -141.86 89.26 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -176.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -60.15 162.66 5.6 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.745 0.418 . . . . 0.0 110.605 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.577 ' HA ' ' CE2' ' A' ' 68' ' ' PHE . 19.1 p90 -81.38 -37.82 0.92 Allowed Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 -177.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 14.8 Cg_exo -69.74 -18.07 37.29 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 121.853 1.702 . . . . 0.0 112.824 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -93.82 -26.25 17.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.854 ' O ' ' HG2' ' A' ' 71' ' ' MET . 3.2 p90 -84.36 -20.01 32.68 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -177.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.606 HD13 ' HB3' ' A' ' 8' ' ' GLN . 28.3 mt -77.85 -29.3 50.42 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 121.773 0.797 . . . . 0.0 109.043 175.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.519 ' O ' ' HD3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -53.38 -35.57 60.47 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 112.784 -2.007 . . . . 0.0 109.824 174.693 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.854 ' HG2' ' O ' ' A' ' 68' ' ' PHE . 22.7 ptt? -72.13 -26.22 62.03 Favored 'General case' 0 C--N 1.346 0.438 0 O-C-N 123.744 0.652 . . . . 0.0 110.031 176.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.641 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 58.9 mtt -88.34 -25.98 22.47 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.664 176.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.639 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -69.64 -35.85 75.59 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.607 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.72 ' NE ' ' HA ' ' A' ' 71' ' ' MET . 6.7 ptt180 -76.2 -21.83 56.0 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.925 178.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.641 ' HD3' ' HA ' ' A' ' 72' ' ' MET . 25.3 mtpt -68.72 -15.14 63.43 Favored 'General case' 0 C--N 1.346 0.423 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 175.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 11.9 ptt? -121.95 -29.45 4.27 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.184 0.516 . . . . 0.0 111.832 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.639 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 40.1 mmtt -86.77 -33.99 19.75 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.881 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 9.0 m-20 -104.45 -3.96 23.36 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 t -59.7 97.6 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 121.166 0.508 . . . . 0.0 111.878 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.422 ' OD1' ' HB3' ' A' ' 82' ' ' GLU . 2.2 t70 -67.2 144.18 56.12 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.216 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.2 p -82.94 -13.88 55.19 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.64 ' O ' HD12 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -84.78 -46.88 10.95 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.617 0.723 . . . . 0.0 109.916 -179.186 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.441 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 36.7 mt-10 -78.73 -18.27 54.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.069 -1.423 . . . . 0.0 112.201 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.589 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 3.4 mt-10 -68.45 -18.43 64.42 Favored 'General case' 0 C--N 1.345 0.392 0 C-N-CA 122.778 0.431 . . . . 0.0 111.954 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.64 HD12 ' O ' ' A' ' 82' ' ' GLU . 1.9 mt -85.18 -57.05 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.434 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -63.67 -21.76 66.55 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.021 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.589 ' OE1' ' HA ' ' A' ' 84' ' ' GLU . 1.8 pt-20 -86.15 -20.79 28.11 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.485 ' HB1' ' CE1' ' A' ' 141' ' ' PHE . . . -68.97 -22.99 64.07 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.098 178.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -81.66 -21.49 38.12 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 174.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.524 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 27.8 mmt180 -80.11 -22.64 41.93 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.2 175.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.723 HG12 ' HD1' ' A' ' 92' ' ' PHE . 94.0 t -88.13 -56.29 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-N 114.559 -1.201 . . . . 0.0 112.002 178.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.826 ' HB3' HG21 ' A' ' 100' ' ' ILE . 2.8 m-85 -100.98 -47.1 4.88 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -176.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.7 ' CA ' HG12 ' A' ' 100' ' ' ILE . 5.2 t70 -59.64 95.17 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.714 0.769 . . . . 0.0 112.323 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.404 ' HB2' ' OE2' ' A' ' 104' ' ' GLU . 71.3 mmtt -87.28 -52.22 5.52 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.781 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.464 ' HB2' ' OE2' ' A' ' 104' ' ' GLU . 5.0 t70 -72.13 0.44 9.63 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -175.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.437 ' HA2' ' OD2' ' A' ' 93' ' ' ASP . . . 49.89 31.68 17.51 Favored Glycine 0 N--CA 1.472 1.069 0 CA-C-N 114.408 -1.269 . . . . 0.0 114.656 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -97.0 -8.31 30.8 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 105.09 -19.16 41.23 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 116.252 -0.431 . . . . 0.0 112.905 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -122.63 118.2 27.61 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.65 -0.775 . . . . 0.0 110.596 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.826 HG21 ' HB3' ' A' ' 92' ' ' PHE . 14.9 mt -77.7 104.77 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.4 p -80.74 164.25 22.92 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -178.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -58.62 -14.39 8.17 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -178.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.32 -30.0 19.91 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-O 122.004 0.907 . . . . 0.0 109.535 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.985 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.8 mm-40 -81.73 -38.33 25.91 Favored 'General case' 0 CA--C 1.481 -1.698 0 CA-C-N 112.476 -2.147 . . . . 0.0 110.572 -178.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.65 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 8.5 tt -67.6 -32.75 73.7 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 176.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.648 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -70.6 -44.72 66.71 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.443 175.774 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.481 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 9.2 t-80 -68.11 -21.92 64.92 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.548 177.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.985 HG23 ' O ' ' A' ' 104' ' ' GLU . 3.2 t -70.98 -52.89 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.221 0 CA-C-N 113.996 -1.456 . . . . 0.0 107.184 176.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.601 ' O ' ' N ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -59.81 -37.6 79.6 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 111.502 -2.59 . . . . 0.0 112.03 177.426 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.6 m -71.85 -19.03 62.02 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 119.781 -0.767 . . . . 0.0 109.604 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.24 -45.26 18.27 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.47 176.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.517 HD23 ' O ' ' B' ' 169' ' ' GLY . 4.0 mt -80.18 -28.29 38.75 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.462 -178.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 142.29 -10.41 2.48 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 117.726 -1.597 . . . . 0.0 116.952 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 109' ' ' MET . 4.7 mt-10 -100.75 151.7 21.36 Favored 'General case' 0 C--N 1.357 0.921 0 CA-C-N 120.92 2.36 . . . . 0.0 114.276 -178.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -108.99 127.51 54.14 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 113.682 -1.599 . . . . 0.0 106.886 175.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.648 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 1.1 tp -134.57 115.46 13.9 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.49 -175.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.848 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -76.95 -175.81 3.68 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.717 179.502 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.521 ' N ' HG23 ' A' ' 117' ' ' THR . 16.5 t70 -71.27 -37.6 71.88 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.48 -1.236 . . . . 0.0 114.264 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.666 ' H ' HG23 ' A' ' 117' ' ' THR . 8.7 pt-20 -88.78 -16.21 32.69 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.736 ' HG2' HG22 ' A' ' 117' ' ' THR . 14.8 pt-20 -87.77 -16.09 35.13 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 123.087 0.242 . . . . 0.0 110.897 178.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.848 HG22 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -83.61 -28.82 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.472 177.713 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -68.54 30.02 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.46 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.543 ' H ' ' C ' ' A' ' 121' ' ' VAL . 10.5 pt-20 -144.87 -18.86 0.51 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.65 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.754 ' HA ' ' OG1' ' B' ' 153' ' ' THR . 13.4 ttm -87.79 -21.85 24.86 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 176.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.688 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 1.8 mp -88.29 -45.33 15.81 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.557 0 CA-C-N 114.695 -1.139 . . . . 0.0 112.901 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -60.29 -33.38 72.26 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.564 ' HG3' ' OG1' ' B' ' 153' ' ' THR . 5.0 mm-40 -65.71 -36.19 82.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.938 177.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.584 ' C ' ' HB3' ' A' ' 140' ' ' GLU . . . -91.46 -42.09 10.48 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.494 -179.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.688 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -60.99 122.27 14.52 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 113.784 -1.553 . . . . 0.0 114.083 -178.011 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.0 mt -90.9 -44.0 14.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 113.106 -1.861 . . . . 0.0 110.393 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -93.61 -25.31 17.57 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.09 49.87 5.11 Favored Glycine 0 CA--C 1.526 0.77 0 O-C-N 123.459 0.474 . . . . 0.0 113.961 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -88.9 -19.79 25.39 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.95 12.72 56.24 Favored Glycine 0 CA--C 1.503 -0.702 0 CA-C-N 116.106 -0.497 . . . . 0.0 113.645 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -139.35 120.35 14.55 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.968 -1.116 . . . . 0.0 108.473 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.597 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 3.6 t -78.99 114.14 19.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.682 0.753 . . . . 0.0 112.1 -178.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -85.25 -163.19 0.8 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 113.735 -1.575 . . . . 0.0 110.838 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -69.74 -58.06 4.37 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.99 178.679 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 143' ' ' GLN . 10.6 pt-20 -60.79 -20.54 61.71 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.597 ' OE1' ' HA ' ' A' ' 136' ' ' VAL . 8.0 mt-10 -88.99 -37.2 15.37 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.183 0.516 . . . . 0.0 110.35 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.485 ' CE1' ' HB1' ' A' ' 88' ' ' ALA . 62.4 t80 -77.41 -23.32 50.65 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.649 -1.16 . . . . 0.0 109.058 175.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 138' ' ' TYR . 24.0 t -85.93 -40.34 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 114.898 -1.047 . . . . 0.0 112.748 -177.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' A' ' 139' ' ' GLU . 9.7 mt-30 -49.91 -33.18 16.59 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.662 ' SD ' ' HB2' ' B' ' 158' ' ' ALA . 16.0 ptt? -62.64 -29.38 70.58 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 118.355 0.525 . . . . 0.0 111.08 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 50.4 mtt -81.81 -4.06 55.48 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.733 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.463 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 27.2 p -121.41 -45.73 2.31 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.684 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -55.01 -39.55 69.21 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 N--CA 1.485 1.311 0 C-N-CA 124.004 0.922 . . . . 0.0 112.416 -179.873 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 20.0 p . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.381 0.134 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -98.72 153.63 18.58 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.068 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 63.22 120.73 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.986 0.915 . . . . 0.0 111.951 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 60.8 117.01 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.994 0.918 . . . . 0.0 112.158 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.754 ' OG1' ' HA ' ' A' ' 124' ' ' MET . 76.6 p -132.72 -58.08 0.92 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.604 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 154' ' ' PHE . . . . . 0.724 ' CE1' ' HD2' ' B' ' 155' ' ' LYS . 0.1 OUTLIER -67.67 -28.24 67.52 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.231 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.724 ' HD2' ' CE1' ' B' ' 154' ' ' PHE . 7.8 mptt -59.32 -33.85 71.62 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.468 177.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -77.07 -39.23 50.57 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.845 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 157' ' ' VAL . . . . . 0.601 HG22 ' HA ' ' B' ' 154' ' ' PHE . 10.4 m -71.95 -29.41 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 122.754 0.422 . . . . 0.0 111.052 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . 0.662 ' HB2' ' SD ' ' A' ' 144' ' ' MET . . . -60.42 -53.28 59.47 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.624 0.77 . . . . 0.0 112.755 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -65.18 -20.1 66.29 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.606 0.362 . . . . 0.0 111.633 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.14 -34.42 56.56 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.522 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 5.2 p -129.1 26.68 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 162' ' ' LYS . . . . . 0.607 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 22.1 ttpt -88.46 35.1 0.76 Allowed 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 121.198 0.523 . . . . 0.0 110.784 178.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.23 167.97 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.456 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 4.9 t -78.62 -177.07 5.17 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.25 16.62 2.91 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . 0.49 ' O ' ' HE3' ' A' ' 51' ' ' MET . 0.3 OUTLIER -88.94 -58.75 2.43 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.406 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.631 ' HB2' ' NZ ' ' A' ' 75' ' ' LYS . 3.3 mp -137.55 106.92 6.09 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-O 121.141 0.496 . . . . 0.0 111.102 176.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -127.91 152.18 48.17 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.079 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . 0.517 ' O ' HD23 ' A' ' 112' ' ' LEU . . . 165.43 -57.94 0.25 Allowed Glycine 0 C--N 1.337 0.608 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.566 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . 0.448 HG21 ' O ' ' A' ' 39' ' ' LEU . 5.1 t . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.138 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 111.362 0.134 . . . . 0.0 111.362 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -109.07 118.93 38.07 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 123.416 0.447 . . . . 0.0 110.859 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.678 ' HA ' ' OE1' ' A' ' 8' ' ' GLN . 0.4 OUTLIER -128.65 153.54 47.19 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.028 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.441 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -105.4 -108.3 0.29 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.506 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.595 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 16.5 p -101.06 -173.79 2.46 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 123.678 0.791 . . . . 0.0 110.002 178.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.415 ' HA ' HD12 ' A' ' 9' ' ' ILE . 46.1 mt-10 -60.78 -24.38 65.73 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.595 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 12.8 pt-20 -57.07 -29.28 63.32 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.374 0.607 . . . . 0.0 111.459 178.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.678 ' OE1' ' HA ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -78.13 -46.09 21.58 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 114.141 -1.391 . . . . 0.0 109.914 178.133 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.547 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . 3.9 mt -63.7 -32.33 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.569 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.94 -34.38 64.28 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -113.66 -17.98 12.0 Favored 'General case' 0 C--N 1.346 0.422 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.547 ' CE1' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -73.55 -16.16 61.27 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.754 0.707 . . . . 0.0 110.679 179.407 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.678 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 1.0 OUTLIER -83.11 -40.72 19.44 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.468 179.17 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.678 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 1.4 mt-10 -82.56 -38.48 23.63 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 114.082 -1.417 . . . . 0.0 112.604 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.65 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -66.06 -22.48 66.43 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.289 0.566 . . . . 0.0 109.522 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.655 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 26.9 t80 -87.07 -46.03 10.17 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.01 176.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.4 m -87.09 -13.5 44.07 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 -176.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -69.32 -30.37 68.42 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.39 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.593 ' CD1' HG22 ' A' ' 35' ' ' VAL . 7.1 m-85 -129.01 -13.71 4.52 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.655 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -103.09 83.94 2.28 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 118.496 0.589 . . . . 0.0 110.059 178.615 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.444 ' HE2' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -86.11 -21.7 27.49 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -178.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.46 -21.88 44.86 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.38 177.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.44 51.85 4.74 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.802 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.15 21.98 7.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 113.848 -1.176 . . . . 0.0 113.819 -175.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.11 -64.88 0.21 Allowed Glycine 0 CA--C 1.528 0.845 0 CA-C-N 115.152 -0.931 . . . . 0.0 114.471 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.699 HG22 ' N ' ' A' ' 64' ' ' ASP . 11.0 p -97.99 155.8 16.93 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 123.559 0.744 . . . . 0.0 112.104 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.609 HG13 ' O ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -117.4 148.47 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.583 -179.581 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.37 148.4 15.11 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -74.19 -55.71 5.75 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-N 115.328 -0.851 . . . . 0.0 113.287 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -53.72 -13.89 0.79 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.469 177.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.514 ' O ' HG23 ' A' ' 35' ' ' VAL . 23.0 mt-10 -113.46 -16.76 12.37 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.744 -178.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.492 HD21 ' CZ ' ' A' ' 68' ' ' PHE . 5.2 tp -55.11 -40.59 70.65 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.222 0.609 . . . . 0.0 111.951 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.774 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -55.31 -39.81 73.66 Favored Glycine 0 C--N 1.34 0.801 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 177.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.9 m -75.22 -28.77 60.06 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 114.611 -0.794 . . . . 0.0 112.365 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.65 HG12 ' HA ' ' A' ' 15' ' ' ALA . 1.5 t -75.46 -26.84 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 177.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.629 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 82.5 mtp -75.63 -41.95 52.88 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 112.8 -2.0 . . . . 0.0 111.273 176.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.774 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 10.5 mtt180 -80.82 -29.2 35.99 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.2 m -66.48 -8.47 26.52 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 122.009 0.909 . . . . 0.0 112.134 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.524 HD21 ' HB2' ' A' ' 14' ' ' GLU . 78.5 mt -92.81 -7.21 47.05 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 113.24 -1.8 . . . . 0.0 109.706 177.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.42 0.88 50.35 Favored Glycine 0 CA--C 1.492 -1.388 0 CA-C-O 122.351 0.973 . . . . 0.0 114.68 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.629 ' HB2' ' O ' ' A' ' 36' ' ' MET . 56.8 mt-30 -83.24 138.02 33.77 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 112.058 -2.071 . . . . 0.0 111.791 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -117.74 75.85 10.23 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.796 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.98 -177.8 3.24 Favored 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 123.137 2.558 . . . . 0.0 111.984 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.435 ' HB ' ' H ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -100.65 157.44 16.68 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.712 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.528 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 29.5 mt-10 -80.94 -27.71 36.01 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.697 0.761 . . . . 0.0 109.369 177.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.41 -35.07 61.08 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 113.432 -1.713 . . . . 0.0 109.667 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.549 ' HG2' ' SD ' ' A' ' 51' ' ' MET . 14.9 tt0 -78.04 -29.87 49.55 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 113.923 -1.49 . . . . 0.0 108.127 176.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.582 ' O ' HD13 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -65.17 -20.32 66.39 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.175 174.502 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.846 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 56.2 mt-30 -97.61 -15.5 20.43 Favored 'General case' 0 CA--C 1.481 -1.69 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.107 178.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -84.77 -35.85 22.13 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 111.971 -2.377 . . . . 0.0 109.936 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.549 ' SD ' ' HG2' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -86.68 -27.01 24.01 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.486 177.718 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.582 HD13 ' O ' ' A' ' 48' ' ' LEU . 1.5 mp -78.47 -25.92 13.83 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 175.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.846 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 2.9 t30 -78.24 -34.4 49.18 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.021 175.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.01 -46.76 8.61 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.554 ' C ' ' H ' ' A' ' 57' ' ' ALA . 75.5 t -83.03 -51.07 14.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.515 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 5.2 t70 -72.26 39.84 0.08 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 122.042 0.925 . . . . 0.0 110.0 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.554 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -82.46 -5.35 58.64 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 114.005 -1.452 . . . . 0.0 112.772 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -85.94 -35.31 20.55 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 112.36 -2.2 . . . . 0.0 111.229 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.14 41.78 7.87 Favored Glycine 0 C--N 1.342 0.894 0 O-C-N 123.537 0.523 . . . . 0.0 113.477 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -109.99 -21.46 12.31 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.561 0.219 . . . . 0.0 111.204 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.67 26.82 73.43 Favored Glycine 0 N--CA 1.466 0.64 0 CA-C-N 115.764 -0.653 . . . . 0.0 114.066 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.499 ' O ' HD13 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -144.11 155.48 43.96 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.307 0.643 . . . . 0.0 110.576 -179.367 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.609 ' O ' HG13 ' A' ' 27' ' ' ILE . 21.0 mm -133.47 126.85 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.699 ' N ' HG22 ' A' ' 26' ' ' THR . 0.3 OUTLIER -73.15 157.17 37.74 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.612 176.598 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.577 ' CG ' ' HD3' ' A' ' 66' ' ' PRO . 7.3 p90 -91.43 -39.99 0.38 Allowed Pre-proline 0 CA--C 1.546 0.823 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -178.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.674 ' HA ' HE22 ' A' ' 8' ' ' GLN . 14.2 Cg_exo -70.5 -18.67 33.39 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 121.903 1.736 . . . . 0.0 113.109 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -96.42 -13.79 22.9 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.492 ' CZ ' HD21 ' A' ' 32' ' ' LEU . 6.5 t80 -84.38 -36.04 22.73 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -178.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.624 HD13 ' HA ' ' A' ' 8' ' ' GLN . 1.3 mt -66.44 -32.6 74.08 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 121.688 0.756 . . . . 0.0 109.983 177.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.456 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -56.04 -33.41 64.94 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 113.195 -1.82 . . . . 0.0 108.966 174.234 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.566 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 24.2 mmt -72.59 -29.91 63.92 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.659 175.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.73 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 67.8 mtt -86.17 -19.63 29.79 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.213 0.945 . . . . 0.0 110.246 177.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . -75.2 -37.94 60.96 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.497 ' CD ' ' HA ' ' A' ' 71' ' ' MET . 3.4 ptm180 -76.19 -17.84 59.35 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 120.468 -0.493 . . . . 0.0 112.138 178.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.73 ' HD2' ' HA ' ' A' ' 72' ' ' MET . 31.8 mttt -77.89 -14.23 59.62 Favored 'General case' 0 C--N 1.348 0.506 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 176.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.537 ' HA ' HG22 ' A' ' 79' ' ' THR . 18.4 ptt? -124.44 -19.58 5.41 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -177.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 73' ' ' ALA . 59.5 mttt -60.71 -13.8 17.09 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -103.02 -29.55 11.32 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.75 HG21 ' HB3' ' B' ' 165' ' ' ALA . 8.6 t -73.57 103.95 4.36 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.062 0.458 . . . . 0.0 111.357 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.602 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 8.6 m-20 -45.24 151.68 0.33 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.925 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.552 ' HA ' ' OE1' ' A' ' 84' ' ' GLU . 12.7 t -69.79 -13.81 62.46 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.825 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -82.53 -44.64 15.66 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.686 0.755 . . . . 0.0 109.593 -179.641 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.418 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 40.5 mt-10 -73.87 -18.21 60.95 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 113.753 -1.567 . . . . 0.0 112.469 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.602 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 43.1 mt-10 -65.52 -20.0 66.16 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.7 mp -87.88 -51.23 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.656 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.612 ' O ' ' HD1' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -58.78 -17.01 19.6 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -179.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.505 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 3.1 pt-20 -74.53 -19.59 60.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 120.872 0.368 . . . . 0.0 110.041 177.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.94 -20.06 65.83 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.647 178.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.612 ' HD1' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -84.33 -21.18 31.05 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 174.856 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 9.1 mtm180 -81.16 -23.02 38.53 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.235 -1.348 . . . . 0.0 108.498 175.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.494 HG12 ' CD1' ' A' ' 92' ' ' PHE . 47.0 t -88.64 -55.99 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.039 178.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.809 ' HB3' HG21 ' A' ' 100' ' ' ILE . 8.8 m-85 -100.71 -45.11 5.59 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 -176.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.723 ' CA ' HG12 ' A' ' 100' ' ' ILE . 15.5 t70 -61.93 94.69 0.05 Allowed 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.75 0.786 . . . . 0.0 111.145 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.1 mmpt? -87.25 -49.75 7.06 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 114.286 -1.325 . . . . 0.0 113.146 -178.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -72.11 0.8 8.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -175.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.422 ' HA2' ' OD2' ' A' ' 93' ' ' ASP . . . 50.29 31.73 20.6 Favored Glycine 0 N--CA 1.472 1.098 0 CA-C-N 114.396 -1.275 . . . . 0.0 114.717 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -98.83 -5.73 30.52 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.669 0.235 . . . . 0.0 111.574 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.28 -19.27 51.95 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 121.439 -0.41 . . . . 0.0 112.847 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -119.43 118.44 31.12 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.481 -0.859 . . . . 0.0 110.338 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.809 HG21 ' HB3' ' A' ' 92' ' ' PHE . 43.3 mt -77.15 94.79 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.524 ' OG ' ' HG3' ' A' ' 104' ' ' GLU . 79.9 p -71.65 170.18 14.01 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.509 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.665 ' HA ' HD12 ' A' ' 105' ' ' LEU . . . -62.75 -14.04 39.93 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 114.821 -1.081 . . . . 0.0 113.513 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.57 -28.0 21.01 Favored 'General case' 0 CA--C 1.49 -1.335 0 CA-C-O 121.717 0.77 . . . . 0.0 109.489 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 1.051 ' O ' HG23 ' A' ' 108' ' ' VAL . 20.0 mt-10 -80.7 -43.12 20.83 Favored 'General case' 0 CA--C 1.484 -1.568 0 CA-C-N 112.894 -1.957 . . . . 0.0 111.584 -178.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.665 HD12 ' HA ' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -67.72 -27.75 67.07 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 177.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.639 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -74.73 -45.52 43.56 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.749 -1.569 . . . . 0.0 108.878 176.044 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.491 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 12.7 t-80 -67.18 -21.71 65.77 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.667 -1.152 . . . . 0.0 107.975 177.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.051 HG23 ' O ' ' A' ' 104' ' ' GLU . 29.2 t -72.46 -51.15 30.42 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.829 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 176.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.753 ' SD ' HD22 ' A' ' 116' ' ' LEU . 19.9 mtt -56.24 -40.9 74.87 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 112.579 -2.1 . . . . 0.0 112.039 175.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.19 -19.09 63.98 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.358 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.48 -45.02 20.15 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.567 176.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 mt -80.05 -28.13 39.28 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.793 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 138.86 -7.39 3.26 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-O 117.821 -1.544 . . . . 0.0 116.841 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 109' ' ' MET . 4.9 mt-10 -101.1 152.99 19.95 Favored 'General case' 0 C--N 1.357 0.892 0 CA-C-N 120.763 2.281 . . . . 0.0 114.436 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.34 128.66 56.35 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 113.642 -1.617 . . . . 0.0 107.59 175.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.753 HD22 ' SD ' ' A' ' 109' ' ' MET . 1.4 tp -134.95 115.94 14.14 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.114 -176.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.687 HG22 ' HG2' ' A' ' 120' ' ' GLU . 0.6 OUTLIER -76.74 -175.84 3.59 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.509 -179.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.522 ' N ' HG23 ' A' ' 117' ' ' THR . 16.0 t70 -72.94 -37.26 67.22 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.257 -1.338 . . . . 0.0 114.382 -177.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.651 ' H ' HG23 ' A' ' 117' ' ' THR . 9.4 pt-20 -89.36 -16.12 31.77 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.687 ' HG2' HG22 ' A' ' 117' ' ' THR . 14.6 pt-20 -87.36 -16.24 35.56 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 123.167 0.292 . . . . 0.0 110.65 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.679 HG22 ' O ' ' A' ' 117' ' ' THR . 0.1 OUTLIER -84.13 -31.81 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 178.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.18 27.5 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.964 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.674 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 10.3 pt-20 -141.64 -18.29 0.77 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.064 -1.426 . . . . 0.0 110.991 177.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.408 ' O ' ' HD2' ' B' ' 154' ' ' PHE . 5.0 mmt -88.16 -26.76 22.26 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.587 1.155 . . . . 0.0 108.746 176.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.761 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 1.2 mp -86.8 -37.44 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 114.173 -1.376 . . . . 0.0 113.228 -178.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -65.07 -27.86 69.07 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.585 0.707 . . . . 0.0 111.309 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.674 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 22.3 mm-40 -63.27 -36.94 85.35 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.075 178.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.731 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -99.84 -36.52 9.4 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.052 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.761 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -61.05 125.87 25.29 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.274 -1.33 . . . . 0.0 113.685 -178.038 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.581 HD11 HE21 ' A' ' 143' ' ' GLN . 22.2 mt -90.22 -48.97 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 113.779 -1.555 . . . . 0.0 110.341 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -89.9 -25.27 21.05 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 81.27 49.72 5.41 Favored Glycine 0 CA--C 1.525 0.674 0 O-C-N 123.534 0.521 . . . . 0.0 113.692 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -87.15 -19.6 28.23 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 97.38 12.04 49.69 Favored Glycine 0 CA--C 1.5 -0.846 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.402 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -139.34 128.99 24.55 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.958 -1.121 . . . . 0.0 108.677 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.556 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 2.3 t -92.27 124.38 44.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.392 0.615 . . . . 0.0 112.181 -178.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -89.88 -169.5 2.47 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.219 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.431 ' O ' HG23 ' A' ' 142' ' ' VAL . 37.3 m-85 -68.91 -52.06 33.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.511 177.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -65.41 -22.03 66.73 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.731 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 11.4 mt-10 -87.19 -39.93 15.04 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.779 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -70.93 -24.29 62.42 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.467 176.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.453 ' O ' ' HG3' ' A' ' 145' ' ' MET . 20.0 t -85.84 -48.07 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.498 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.581 HE21 HD11 ' A' ' 130' ' ' ILE . 29.5 mt-30 -60.25 -19.31 54.09 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 123.558 0.537 . . . . 0.0 111.505 178.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.688 ' HG2' ' O ' ' A' ' 140' ' ' GLU . 7.3 mmt -71.46 -21.91 61.89 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 123.227 0.33 . . . . 0.0 110.324 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.453 ' HG3' ' O ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -88.68 -5.29 58.22 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.454 177.231 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.432 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 34.2 p -116.71 -43.31 2.91 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.771 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -42.3 -34.7 0.83 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 77.1 mttt . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.093 -0.956 . . . . 0.0 111.305 179.565 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 18.4 p . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.496 0.189 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -100.2 137.76 38.2 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.817 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -129.48 152.08 49.41 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.038 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp 61.31 113.57 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.97 0.908 . . . . 0.0 112.056 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.564 ' O ' HG13 ' B' ' 157' ' ' VAL . 64.5 p -138.51 174.76 10.2 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.183 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 154' ' ' PHE . . . . . 0.61 ' HA ' HG22 ' B' ' 157' ' ' VAL . 0.2 OUTLIER -67.81 -27.19 66.52 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 117.678 0.217 . . . . 0.0 111.121 179.193 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.489 ' NZ ' ' HB3' ' A' ' 127' ' ' GLU . 4.7 mptt -61.67 -42.29 98.72 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.884 0.474 . . . . 0.0 111.336 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -76.39 -35.04 58.84 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 157' ' ' VAL . . . . . 0.61 HG22 ' HA ' ' B' ' 154' ' ' PHE . 11.6 m -70.09 -37.36 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 122.55 0.34 . . . . 0.0 111.109 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . 0.575 ' O ' ' HB2' ' B' ' 162' ' ' LYS . . . -73.77 -39.85 63.87 Favored 'General case' 0 C--N 1.345 0.413 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.636 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -64.12 -23.58 67.38 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.522 0.514 . . . . 0.0 111.64 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.66 -37.54 56.08 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.259 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 9.6 p -107.48 19.11 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.29 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 162' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 35.0 tttp -91.27 104.67 17.18 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.185 0.517 . . . . 0.0 111.097 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 163' ' ' ILE . . . . . 0.421 ' H ' ' H ' ' B' ' 164' ' ' SER . 5.5 tp -152.55 -20.55 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.145 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . 0.421 ' H ' ' H ' ' B' ' 163' ' ' ILE . 48.7 m 53.75 95.26 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.647 1.179 . . . . 0.0 113.354 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 165' ' ' ALA . . . . . 0.75 ' HB3' HG21 ' A' ' 79' ' ' THR . . . 35.3 73.3 0.09 Allowed 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.837 1.255 . . . . 0.0 113.647 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . 0.444 ' O ' ' HD3' ' A' ' 75' ' ' LYS . 47.3 m -132.35 -46.03 0.91 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.384 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 7.3 tp -144.1 70.25 1.29 Allowed 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.246 0.546 . . . . 0.0 110.0 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 64.8 mtt -130.12 131.39 45.67 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.883 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -130.83 99.18 0.42 Allowed Glycine 0 C--N 1.337 0.585 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.462 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 19.8 p . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.06 -179.981 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.55 0.215 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -112.98 -41.89 3.66 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.179 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.423 HE21 HE22 ' A' ' 8' ' ' GLN . 55.6 mt-30 -135.42 149.37 49.6 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.377 0.423 . . . . 0.0 110.906 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.495 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -122.86 -123.43 0.27 Allowed 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.725 ' O ' ' HG2' ' A' ' 8' ' ' GLN . 20.2 p -101.67 170.93 7.86 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 124.052 0.941 . . . . 0.0 109.892 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -46.07 -22.03 0.19 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.431 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 12.3 pt-20 -48.31 -32.24 7.12 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 123.802 0.689 . . . . 0.0 110.761 176.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.725 ' HG2' ' O ' ' A' ' 5' ' ' THR . 1.4 pt20 -65.55 -56.02 14.56 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.689 177.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.447 HG13 HE21 ' A' ' 8' ' ' GLN . 3.6 mt -58.99 -31.64 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.73 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.04 -36.36 77.63 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -126.5 -18.01 4.95 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -177.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.584 ' HB3' HD11 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -69.86 -15.6 63.12 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.037 0.835 . . . . 0.0 110.75 179.361 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.7 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 1.0 OUTLIER -80.93 -41.21 23.31 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.018 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.7 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 2.2 mt-10 -82.53 -41.35 19.78 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 114.13 -1.395 . . . . 0.0 112.353 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.592 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -64.23 -19.06 65.11 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.458 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 58.5 t80 -86.54 -49.71 7.37 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.56 177.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.462 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 51.7 m -87.45 -12.77 45.1 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -177.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -69.37 -28.48 66.24 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 118.499 0.591 . . . . 0.0 112.172 -179.428 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.573 ' CD1' HG22 ' A' ' 35' ' ' VAL . 4.8 m-85 -134.5 -2.93 2.69 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 24.8 t70 -83.48 55.5 3.22 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 119.244 0.929 . . . . 0.0 112.491 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -86.8 -20.79 27.06 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 178.692 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.82 -22.39 61.56 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.322 0.582 . . . . 0.0 110.558 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.9 40.79 29.73 Favored Glycine 0 N--CA 1.471 1.032 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.47 23.4 9.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 112.971 -1.614 . . . . 0.0 112.835 -176.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.51 -80.64 1.79 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.905 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.403 HG21 ' N ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -113.79 178.32 4.32 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 177.789 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -75.32 148.78 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -177.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.415 ' OG1' ' HB2' ' A' ' 31' ' ' GLU . 0.6 OUTLIER -64.11 163.67 12.09 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.399 1.079 . . . . 0.0 113.761 -179.635 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.599 HG22 HD11 ' A' ' 63' ' ' ILE . 1.3 p -80.25 -56.27 4.33 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.155 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -57.57 -13.63 4.08 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.233 177.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.49 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.4 mt-10 -111.44 -16.4 13.34 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.301 -177.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.515 HD13 HG21 ' A' ' 63' ' ' ILE . 9.2 tp -52.97 -41.33 64.46 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.247 0.619 . . . . 0.0 112.295 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.774 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -55.86 -39.16 76.88 Favored Glycine 0 C--N 1.34 0.801 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 177.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.0 m -75.47 -29.91 59.74 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 114.444 -0.878 . . . . 0.0 112.567 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.592 HG12 ' HA ' ' A' ' 15' ' ' ALA . 1.1 t -74.6 -27.28 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 176.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.619 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 47.1 mtt -73.72 -42.8 60.69 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 112.951 -1.932 . . . . 0.0 110.861 176.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.774 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 11.3 mtt180 -78.53 -29.76 46.67 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.6 m -67.7 -8.39 34.75 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.941 0.877 . . . . 0.0 111.997 178.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.445 ' HB2' HE21 ' A' ' 41' ' ' GLN . 80.8 mt -94.82 -6.18 43.45 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.698 177.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.51 -0.85 46.13 Favored Glycine 0 CA--C 1.493 -1.34 0 CA-C-O 122.22 0.9 . . . . 0.0 115.236 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.619 ' HB2' ' O ' ' A' ' 36' ' ' MET . 46.6 mt-30 -82.32 140.55 33.49 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-N 112.343 -1.928 . . . . 0.0 111.752 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -120.01 73.7 19.34 Favored Pre-proline 0 CA--C 1.551 0.996 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.159 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -83.64 -179.56 4.26 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 123.216 2.611 . . . . 0.0 112.096 178.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 m -102.33 160.05 14.87 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.54 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 28.7 mt-10 -80.75 -28.29 36.52 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-O 121.584 0.707 . . . . 0.0 109.909 178.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.61 -36.79 65.53 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 113.611 -1.631 . . . . 0.0 110.043 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -77.54 -30.38 52.73 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 114.183 -1.371 . . . . 0.0 108.521 176.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.834 ' O ' HG12 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -62.73 -24.98 67.96 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.283 174.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 56.9 mt-30 -91.67 -19.45 22.65 Favored 'General case' 0 CA--C 1.478 -1.793 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.043 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -76.86 -29.08 55.68 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-N 112.031 -2.349 . . . . 0.0 107.959 176.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.2 mtt -87.09 -30.45 21.12 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.245 177.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.834 HG12 ' O ' ' A' ' 48' ' ' LEU . 37.3 mm -73.78 -28.08 23.82 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 175.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 2.3 m120 -78.91 -37.88 38.83 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.246 -1.343 . . . . 0.0 112.023 176.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -87.59 -49.42 7.18 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.554 ' C ' ' H ' ' A' ' 57' ' ' ALA . 59.8 t -85.45 -51.12 13.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.538 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 5.9 t70 -72.48 39.26 0.08 Allowed 'General case' 0 C--O 1.239 0.516 0 CA-C-O 122.061 0.934 . . . . 0.0 110.07 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.554 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -83.28 -5.3 59.09 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 114.003 -1.453 . . . . 0.0 112.703 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -87.35 -39.56 15.22 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 112.35 -2.205 . . . . 0.0 111.182 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.09 51.11 4.08 Favored Glycine 0 C--N 1.343 0.937 0 O-C-N 123.544 0.528 . . . . 0.0 113.362 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -109.87 -21.38 12.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.663 0.268 . . . . 0.0 111.178 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.07 26.55 59.85 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.933 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.74 175.49 11.93 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.279 0.631 . . . . 0.0 110.565 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.599 HD11 HG22 ' A' ' 29' ' ' THR . 33.7 mm -130.8 94.72 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -50.92 153.65 1.73 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.274 0.63 . . . . 0.0 110.818 177.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.676 ' HA ' ' CE2' ' A' ' 68' ' ' PHE . 37.4 p90 -78.09 -39.56 1.8 Allowed Pre-proline 0 N--CA 1.477 0.917 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -177.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.513 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 17.0 Cg_exo -67.99 -18.03 46.24 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 121.818 1.679 . . . . 0.0 113.094 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -94.66 -25.54 16.71 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.676 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 1.9 p90 -84.56 -20.01 32.2 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -177.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.607 HD13 ' HB3' ' A' ' 8' ' ' GLN . 14.0 mt -77.36 -34.18 55.16 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.75 0.786 . . . . 0.0 109.457 176.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.51 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 0.6 OUTLIER -54.61 -35.16 63.11 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 113.049 -1.887 . . . . 0.0 110.002 174.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.834 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 11.2 ptm -76.66 -25.48 53.77 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 123.695 0.622 . . . . 0.0 109.491 176.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 68.8 mtt -87.8 -18.58 29.02 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 124.09 0.869 . . . . 0.0 110.46 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . -76.7 -35.14 58.05 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.51 ' HD2' ' O ' ' A' ' 70' ' ' THR . 2.8 ptm180 -80.11 -19.0 48.39 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 178.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.834 ' HG2' ' O ' ' A' ' 71' ' ' MET . 69.2 mmtt -73.32 -14.39 61.29 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 176.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 27.1 ptm -120.34 -31.48 4.35 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -177.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 34.7 mmtt -76.8 -28.6 55.68 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -178.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -104.2 -10.74 17.69 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.4 t -72.85 -4.6 32.75 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.579 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 2.1 m-20 64.65 135.99 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.709 0.803 . . . . 0.0 111.826 -179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 52.5 m -83.06 -13.59 55.49 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.594 ' O ' HD12 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -78.99 -51.64 9.33 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.391 0.615 . . . . 0.0 110.642 -178.42 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.508 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 10.2 pt-20 -79.37 -17.91 53.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.667 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.6 ' HA ' ' OE2' ' A' ' 87' ' ' GLU . 8.4 tt0 -64.09 -18.46 64.42 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.152 0.581 . . . . 0.0 112.348 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.594 HD12 ' O ' ' A' ' 82' ' ' GLU . 2.3 mt -86.65 -54.6 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.829 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -58.01 -25.0 60.53 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.602 179.702 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.6 ' OE2' ' HA ' ' A' ' 84' ' ' GLU . 2.3 pt-20 -81.06 -20.61 41.25 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 123.684 0.615 . . . . 0.0 110.224 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.63 -20.99 61.9 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.465 177.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.448 ' HE2' ' O ' ' A' ' 98' ' ' GLY . 3.6 m-85 -81.15 -20.97 40.16 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 173.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.437 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 10.6 tpt180 -77.34 -20.54 54.72 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 174.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 65.1 t -88.04 -53.55 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 CA-C-N 114.248 -1.342 . . . . 0.0 112.033 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.835 ' HB3' HG21 ' A' ' 100' ' ' ILE . 35.2 m-85 -100.38 -45.89 5.43 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -176.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.723 ' CA ' HG12 ' A' ' 100' ' ' ILE . 2.4 t70 -64.02 93.2 0.08 Allowed 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.843 0.83 . . . . 0.0 111.557 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.506 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 31.8 mttm -87.93 -48.0 8.13 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 114.056 -1.429 . . . . 0.0 113.751 -179.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.42 ' HB2' ' OE2' ' A' ' 104' ' ' GLU . 5.2 t70 -71.82 1.29 7.21 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -175.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 48.74 29.27 7.76 Favored Glycine 0 N--CA 1.473 1.164 0 CA-C-N 114.289 -1.323 . . . . 0.0 114.883 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -99.67 -4.7 30.29 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.678 0.239 . . . . 0.0 111.401 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.448 ' O ' ' HE2' ' A' ' 89' ' ' PHE . . . 101.56 -18.79 52.64 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 121.287 -0.482 . . . . 0.0 112.726 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -116.03 118.37 32.71 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.458 -0.871 . . . . 0.0 110.707 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.835 HG21 ' HB3' ' A' ' 92' ' ' PHE . 31.5 mt -80.45 90.58 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.9 t -66.65 161.42 23.37 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.308 -0.86 . . . . 0.0 113.071 -177.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.764 ' HB1' HG21 ' A' ' 121' ' ' VAL . . . -58.2 -14.94 8.11 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -178.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.73 -29.36 19.89 Favored 'General case' 0 CA--C 1.489 -1.376 0 CA-C-O 121.994 0.902 . . . . 0.0 109.283 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.936 ' O ' HG23 ' A' ' 108' ' ' VAL . 3.4 mm-40 -79.46 -40.21 30.37 Favored 'General case' 0 CA--C 1.483 -1.627 0 CA-C-N 112.509 -2.132 . . . . 0.0 110.852 -178.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.594 HD12 ' CE2' ' B' ' 154' ' ' PHE . 5.2 tt -64.91 -34.92 79.55 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 176.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.525 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -69.21 -45.9 68.73 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.035 175.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.477 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 9.1 t-80 -69.05 -21.58 64.08 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.715 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.936 HG23 ' O ' ' A' ' 104' ' ' GLU . 3.1 t -72.07 -49.84 41.16 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.203 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.499 ' O ' ' N ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -62.94 -37.15 85.89 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 111.57 -2.559 . . . . 0.0 112.257 177.41 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -69.9 -19.05 63.43 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 119.499 -0.881 . . . . 0.0 109.277 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.67 -45.05 19.75 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.087 175.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mt -80.28 -28.39 38.34 Favored 'General case' 0 C--N 1.35 0.608 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.169 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 109' ' ' MET . . . 139.85 -11.14 3.13 Favored Glycine 0 CA--C 1.537 1.465 0 N-CA-C 117.126 1.61 . . . . 0.0 117.126 178.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.558 ' OE1' ' HG2' ' B' ' 152' ' ' LYS . 4.3 mt-10 -101.11 153.66 19.38 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-N 120.949 2.374 . . . . 0.0 114.316 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -109.01 125.92 52.57 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 113.769 -1.56 . . . . 0.0 106.996 174.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.525 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 1.2 tp -130.25 115.5 17.07 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.191 -1.368 . . . . 0.0 112.074 -175.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.871 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -77.15 -175.69 3.73 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.664 179.476 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.519 ' N ' HG23 ' A' ' 117' ' ' THR . 16.7 t70 -72.34 -38.23 68.65 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -178.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.646 ' H ' HG23 ' A' ' 117' ' ' THR . 9.2 pt-20 -89.1 -16.03 32.5 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.692 ' HG2' HG22 ' A' ' 117' ' ' THR . 14.4 pt-20 -85.63 -16.0 40.63 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 123.096 0.248 . . . . 0.0 110.816 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.871 HG22 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -82.57 -25.03 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 178.139 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -69.33 28.08 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.984 0.897 . . . . 0.0 113.126 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.543 ' H ' ' C ' ' A' ' 121' ' ' VAL . 11.7 pt-20 -137.94 -27.63 0.9 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.636 177.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.606 ' SD ' ' HA ' ' B' ' 153' ' ' THR . 1.3 mmt -81.25 -32.15 33.45 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 176.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.556 ' O ' ' HB3' ' A' ' 129' ' ' ASP . 2.6 mt -88.1 -44.38 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.303 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.525 ' HA ' ' CG ' ' A' ' 129' ' ' ASP . 63.1 mtt180 -59.31 -27.62 66.03 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 124.117 0.885 . . . . 0.0 111.732 -179.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.557 ' OE2' ' HD3' ' B' ' 155' ' ' LYS . 0.0 OUTLIER -63.43 -28.43 69.97 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.294 177.292 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.807 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -121.28 -16.41 7.92 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 123.36 0.413 . . . . 0.0 111.357 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.556 ' HB3' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -58.54 118.73 5.94 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 122.192 0.996 . . . . 0.0 112.792 -178.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 32.5 mm -90.91 -53.39 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 113.616 -1.629 . . . . 0.0 110.641 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -91.4 -25.3 19.43 Favored 'General case' 0 C--N 1.344 0.358 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.492 ' HA2' ' OD2' ' A' ' 129' ' ' ASP . . . 82.83 49.61 5.0 Favored Glycine 0 CA--C 1.523 0.558 0 O-C-N 123.476 0.485 . . . . 0.0 113.826 178.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -93.37 -19.47 21.29 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 100.69 16.32 26.77 Favored Glycine 0 CA--C 1.5 -0.892 0 CA-C-O 121.758 0.643 . . . . 0.0 112.549 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -138.02 176.57 8.58 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 113.315 -1.443 . . . . 0.0 108.144 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.643 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 2.3 t -140.65 130.52 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 121.303 0.573 . . . . 0.0 112.422 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -91.36 -168.45 2.05 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.032 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.494 ' O ' HG23 ' A' ' 142' ' ' VAL . 80.8 m-85 -66.79 -57.86 6.21 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.44 177.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -59.18 -20.84 57.33 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.807 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 4.5 mt-10 -87.08 -44.27 11.67 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.003 178.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -70.79 -22.87 62.32 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.094 176.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.499 ' O ' ' HG3' ' A' ' 145' ' ' MET . 37.6 t -84.26 -45.83 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.91 -178.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.562 ' O ' ' N ' ' A' ' 147' ' ' ALA . 43.6 mt-30 -61.73 -26.02 67.8 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.312 177.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 6.3 tmm? -64.58 -24.07 67.48 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 123.814 0.696 . . . . 0.0 110.807 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.499 ' HG3' ' O ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -84.49 -7.86 59.14 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 123.206 0.316 . . . . 0.0 110.225 178.352 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.0 t -122.4 -34.89 3.2 Favored 'General case' 0 C--N 1.349 0.554 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.875 178.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -35.14 -35.24 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 94.0 mttt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.097 -0.954 . . . . 0.0 111.675 179.954 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 19.5 p . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 120.371 0.129 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -98.02 -39.96 8.68 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.525 0.515 . . . . 0.0 111.346 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -115.2 128.27 56.06 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.387 0.429 . . . . 0.0 110.793 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . 0.558 ' HG2' ' OE1' ' A' ' 114' ' ' GLU . 11.7 mptt 60.87 115.81 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.907 0.883 . . . . 0.0 111.882 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.662 ' O ' HG22 ' B' ' 157' ' ' VAL . 10.9 t -175.11 172.2 2.85 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.355 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 154' ' ' PHE . . . . . 0.594 ' CE2' HD12 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -54.88 -27.81 45.58 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.278 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.557 ' HD3' ' OE2' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -72.06 -52.3 17.51 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.817 0.447 . . . . 0.0 111.102 178.61 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -77.27 -36.42 54.34 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 157' ' ' VAL . . . . . 0.662 HG22 ' O ' ' B' ' 153' ' ' THR . 20.5 m -71.89 -38.7 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' B' ' 162' ' ' LYS . . . -73.66 -33.16 64.35 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.834 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -58.95 -31.94 69.16 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.542 0.526 . . . . 0.0 111.341 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.08 -37.6 54.11 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.484 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 9.4 p -103.75 21.57 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.256 0 O-C-N 123.47 0.481 . . . . 0.0 111.575 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 162' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 5.9 ttmt -91.06 -16.22 28.24 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.256 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 3.6 tp -95.6 -8.83 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.237 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 21.7 t -88.66 84.81 6.72 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.452 0.644 . . . . 0.0 110.311 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 165' ' ' ALA . . . . . 0.401 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . . . -130.13 -40.65 1.3 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.263 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 23.7 t -112.9 -32.09 6.5 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.798 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 9.1 tp -90.91 31.07 1.11 Allowed 'General case' 0 CA--C 1.548 0.893 0 O-C-N 123.415 0.447 . . . . 0.0 110.83 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.24 137.57 33.96 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.531 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -100.58 -148.87 22.81 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.588 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 19.8 p . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.041 -179.964 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.376 0 N-CA-C 111.315 0.117 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -128.45 121.67 29.49 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 123.453 0.471 . . . . 0.0 110.724 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.558 ' HG3' ' O ' ' A' ' 66' ' ' PRO . 20.2 mm-40 -97.06 -57.73 2.2 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.668 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.507 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -118.07 -119.83 0.31 Allowed 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.768 179.569 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.552 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 15.7 p -102.21 -173.62 2.38 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 124.024 0.93 . . . . 0.0 112.6 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.486 ' HA ' HG12 ' A' ' 9' ' ' ILE . 46.6 mt-10 -60.56 -25.14 65.96 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.709 0.804 . . . . 0.0 112.997 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.552 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 11.3 pt-20 -53.55 -33.55 55.1 Favored 'General case' 0 N--CA 1.479 1.025 0 O-C-N 123.791 0.682 . . . . 0.0 111.585 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.564 ' HA ' HD13 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -75.86 -45.29 36.44 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.605 177.041 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.59 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . 33.5 mm -54.88 -38.15 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.643 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.63 -35.24 70.36 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -113.96 -17.96 11.86 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.59 ' CE1' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -71.82 -16.23 62.16 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.724 0.693 . . . . 0.0 110.548 179.318 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.689 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 1.0 OUTLIER -82.18 -41.83 19.84 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.576 179.269 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.689 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 1.4 mt-10 -81.75 -37.6 26.98 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 114.087 -1.415 . . . . 0.0 112.297 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.66 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -66.13 -22.24 66.37 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.27 0.557 . . . . 0.0 109.507 178.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.946 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 21.7 t80 -87.04 -45.24 10.92 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.038 176.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.3 m -86.35 -12.59 48.92 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -176.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -72.43 -29.8 64.04 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.559 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.581 ' CD1' HG22 ' A' ' 35' ' ' VAL . 8.3 m-85 -131.35 -7.06 3.77 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.946 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 1.2 m-20 -99.46 79.69 2.31 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.608 0.64 . . . . 0.0 110.028 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.77 -41.49 52.87 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.622 ' OD1' ' HB2' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -71.0 -21.96 62.22 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.248 177.305 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.05 51.57 5.31 Favored Glycine 0 N--CA 1.468 0.798 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.622 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -95.41 22.29 7.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.645 -1.278 . . . . 0.0 114.344 -175.286 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.25 -63.13 0.39 Allowed Glycine 0 CA--C 1.527 0.816 0 CA-C-N 115.405 -0.816 . . . . 0.0 114.472 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.7 HG22 ' N ' ' A' ' 64' ' ' ASP . 11.8 p -97.39 155.42 16.91 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 123.487 0.715 . . . . 0.0 112.252 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.769 HD13 HG21 ' A' ' 35' ' ' VAL . 0.7 OUTLIER -115.51 149.2 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.217 -179.604 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.29 151.45 12.76 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.14 -55.7 6.85 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -55.8 -13.41 1.74 Allowed 'General case' 0 N--CA 1.473 0.675 0 O-C-N 123.73 0.644 . . . . 0.0 111.319 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.428 ' O ' HG23 ' A' ' 35' ' ' VAL . 20.1 mt-10 -114.6 -16.53 11.84 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.222 -0.899 . . . . 0.0 113.049 -177.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.58 ' HA ' HG23 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -56.95 -38.02 72.36 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.638 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.73 ' O ' ' HD3' ' A' ' 37' ' ' ARG . . . -57.11 -39.02 89.13 Favored Glycine 0 C--N 1.34 0.799 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 177.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.5 m -74.03 -30.8 62.61 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 114.497 -0.851 . . . . 0.0 112.348 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.769 HG21 HD13 ' A' ' 27' ' ' ILE . 0.9 OUTLIER -73.22 -27.43 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 176.733 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.56 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 30.1 mmt -75.2 -41.16 58.4 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 112.912 -1.949 . . . . 0.0 111.636 176.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.73 ' HD3' ' O ' ' A' ' 33' ' ' GLY . 10.3 mtp180 -82.16 -29.53 31.5 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.5 m -67.48 -8.32 32.64 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.938 0.875 . . . . 0.0 111.965 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 35' ' ' VAL . 83.4 mt -89.42 -9.86 48.66 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 113.327 -1.76 . . . . 0.0 109.62 177.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.27 -4.81 23.52 Favored Glycine 0 CA--C 1.491 -1.409 0 CA-C-O 122.168 0.871 . . . . 0.0 114.912 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.59 ' OE1' HD22 ' B' ' 167' ' ' LEU . 47.1 mt-30 -77.32 137.72 38.93 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 112.371 -1.914 . . . . 0.0 111.902 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -126.79 66.51 65.73 Favored Pre-proline 0 CA--C 1.551 1.001 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.59 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.41 ' HD3' ' C ' ' A' ' 41' ' ' GLN . 2.1 Cg_endo -86.17 -177.8 2.58 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 123.017 2.478 . . . . 0.0 112.047 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.489 ' OG1' ' N ' ' A' ' 45' ' ' GLU . 7.5 t -98.13 -175.17 3.05 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.17 0.986 . . . . 0.0 110.527 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.5 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 46.2 mt-10 -81.06 -24.01 38.11 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 112.99 -1.914 . . . . 0.0 108.582 177.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.49 -30.89 68.87 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.811 -1.54 . . . . 0.0 112.033 -177.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.425 ' H ' HG23 ' A' ' 44' ' ' THR . 1.0 OUTLIER -87.1 -29.21 22.03 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.369 176.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.811 ' O ' HG12 ' A' ' 52' ' ' ILE . 0.4 OUTLIER -68.06 -20.54 64.98 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.263 175.064 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.769 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 46.6 mt-30 -98.16 -17.2 19.16 Favored 'General case' 0 CA--C 1.478 -1.807 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.958 177.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -80.79 -30.23 35.97 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 111.999 -2.364 . . . . 0.0 108.871 176.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.598 ' SD ' ' HZ ' ' A' ' 68' ' ' PHE . 41.9 mtm -86.71 -32.03 20.69 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.339 177.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.811 HG12 ' O ' ' A' ' 48' ' ' LEU . 36.4 mm -73.76 -27.35 22.72 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 175.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.769 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 2.7 t30 -75.67 -35.5 60.36 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.491 176.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -86.16 -35.6 20.03 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.588 HG11 HG13 ' A' ' 63' ' ' ILE . 43.6 t -77.33 -43.6 30.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -70.73 31.7 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.831 0.824 . . . . 0.0 111.26 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.577 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -87.22 -7.35 58.0 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.979 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -113.94 -37.23 4.55 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 111.829 -2.441 . . . . 0.0 110.714 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.63 43.11 7.01 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.849 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -110.29 -21.79 12.05 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.44 26.87 73.52 Favored Glycine 0 N--CA 1.468 0.781 0 CA-C-N 115.861 -0.609 . . . . 0.0 114.359 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.67 156.93 43.95 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 123.329 0.652 . . . . 0.0 110.464 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.588 HG13 HG11 ' A' ' 55' ' ' VAL . 2.8 mp -133.38 127.67 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -177.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.7 ' N ' HG22 ' A' ' 26' ' ' THR . 0.2 OUTLIER -76.85 159.35 30.13 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.071 176.213 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.569 ' CG ' ' HD3' ' A' ' 66' ' ' PRO . 12.6 p90 -91.31 -39.89 0.38 Allowed Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -177.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.569 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 7.7 Cg_exo -73.46 -18.58 22.77 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 121.765 1.643 . . . . 0.0 112.814 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -98.16 -11.8 22.4 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.598 ' HZ ' ' SD ' ' A' ' 51' ' ' MET . 37.1 t80 -84.32 -40.41 17.96 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -178.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.564 HD13 ' HA ' ' A' ' 8' ' ' GLN . 0.8 OUTLIER -64.38 -33.75 76.58 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 121.56 0.695 . . . . 0.0 110.25 177.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.473 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -55.92 -34.19 65.37 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 113.38 -1.736 . . . . 0.0 108.917 174.382 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.677 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 65.8 mtt -70.21 -36.43 74.58 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.23 175.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.611 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 61.6 mtm -79.47 -19.32 50.06 Favored 'General case' 0 CA--C 1.508 -0.651 0 O-C-N 124.18 0.925 . . . . 0.0 110.88 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . -75.82 -40.1 55.54 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 71' ' ' MET . 2.6 ptm180 -77.15 -17.79 58.33 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.677 ' HD2' ' O ' ' A' ' 71' ' ' MET . 23.8 mttt -75.23 -14.93 60.56 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 13.1 ptt? -125.88 -28.32 3.22 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -177.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 35.0 mttm -64.87 -13.12 55.35 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -93.72 -29.64 15.29 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 9.4 t -84.07 26.42 0.74 Allowed 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.588 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 2.0 t70 64.41 149.44 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.21 1.004 . . . . 0.0 112.089 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.576 ' HA ' ' OE2' ' A' ' 84' ' ' GLU . 13.4 t -83.01 -14.1 54.61 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.954 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.468 ' HB3' ' OD1' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -84.58 -44.96 13.04 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.772 0.796 . . . . 0.0 109.247 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 79' ' ' THR . 43.3 mt-10 -68.05 -18.31 64.65 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 113.579 -1.646 . . . . 0.0 112.188 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.588 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 31.1 mt-10 -61.94 -27.48 68.86 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.7 mp -88.04 -52.77 10.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.82 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -60.9 -16.91 47.3 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.583 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 3.0 pt-20 -74.18 -20.33 60.24 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.1 0.476 . . . . 0.0 110.13 178.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.09 -20.4 64.07 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.59 177.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.489 ' HE2' ' O ' ' A' ' 98' ' ' GLY . 13.5 m-85 -82.01 -21.36 37.07 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 174.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.583 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 8.0 mtt180 -78.89 -19.2 52.46 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 114.119 -1.4 . . . . 0.0 107.532 174.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.408 HG12 ' CD1' ' A' ' 92' ' ' PHE . 54.4 t -87.85 -55.21 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.284 177.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.82 ' HB3' HG21 ' A' ' 100' ' ' ILE . 15.3 m-85 -101.05 -44.69 5.63 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -177.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.743 ' CA ' HG12 ' A' ' 100' ' ' ILE . 1.9 t70 -63.35 95.49 0.09 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.689 0.757 . . . . 0.0 112.23 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.426 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 10.9 mmpt? -86.81 -41.89 13.7 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 114.264 -1.334 . . . . 0.0 112.804 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -70.76 -18.88 62.76 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -176.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.17 19.99 68.7 Favored Glycine 0 C--N 1.295 -1.728 0 CA-C-N 112.774 -2.012 . . . . 0.0 114.074 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -92.13 -7.19 49.22 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.369 0.267 . . . . 0.0 111.413 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.489 ' O ' ' HE2' ' A' ' 89' ' ' PHE . . . 106.41 -18.74 38.08 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.786 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -115.18 118.39 33.2 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.611 -0.795 . . . . 0.0 111.094 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.82 HG21 ' HB3' ' A' ' 92' ' ' PHE . 53.1 mt -80.57 98.15 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.9 t -75.61 166.0 24.23 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.232 -0.895 . . . . 0.0 113.135 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.597 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -62.83 -15.41 54.22 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -89.36 -31.91 17.56 Favored 'General case' 0 CA--C 1.488 -1.417 0 CA-C-O 121.969 0.89 . . . . 0.0 109.304 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 1.064 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.9 mm-40 -78.6 -38.61 39.56 Favored 'General case' 0 CA--C 1.482 -1.636 0 CA-C-N 112.429 -2.169 . . . . 0.0 110.354 -178.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.554 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 5.1 tt -64.53 -36.7 85.07 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 176.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.61 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -70.9 -44.29 66.56 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.776 175.689 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.49 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 2.6 t60 -67.27 -21.83 65.69 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.542 177.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.064 HG23 ' O ' ' A' ' 104' ' ' GLU . 26.5 t -72.63 -51.01 30.27 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 176.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.699 ' SD ' HD22 ' A' ' 116' ' ' LEU . 17.6 mtt -55.99 -40.61 73.57 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 112.551 -2.113 . . . . 0.0 111.95 175.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.94 -19.14 64.17 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.299 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.82 -45.09 19.36 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.477 176.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.1 mt -79.18 -28.09 42.68 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.572 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.51 -7.28 3.64 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 117.857 -1.524 . . . . 0.0 116.671 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 109' ' ' MET . 5.0 mt-10 -101.42 153.42 19.7 Favored 'General case' 0 C--N 1.357 0.911 0 CA-C-N 120.667 2.233 . . . . 0.0 114.32 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -111.7 128.65 56.14 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 113.827 -1.533 . . . . 0.0 107.769 175.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.699 HD22 ' SD ' ' A' ' 109' ' ' MET . 1.1 tp -139.59 116.09 10.66 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.468 -1.242 . . . . 0.0 112.337 -176.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.974 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -71.57 -176.54 1.61 Allowed 'General case' 0 C--N 1.346 0.456 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.684 179.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.547 ' O ' HG23 ' A' ' 121' ' ' VAL . 16.3 t70 -69.96 -40.79 75.22 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -177.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.594 ' H ' HG23 ' A' ' 117' ' ' THR . 8.8 pt-20 -83.8 -16.51 44.39 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.745 ' HG2' HG22 ' A' ' 117' ' ' THR . 13.9 pt-20 -87.9 -15.77 35.74 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.316 0.385 . . . . 0.0 111.085 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.974 HG22 ' O ' ' A' ' 117' ' ' THR . 0.1 OUTLIER -86.15 -24.56 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.272 177.86 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -73.51 32.11 0.07 Allowed 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.72 0.771 . . . . 0.0 112.662 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.451 ' H ' ' C ' ' A' ' 121' ' ' VAL . 9.3 pt-20 -141.46 -32.99 0.52 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.269 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.515 ' HE2' ' N ' ' B' ' 153' ' ' THR . 17.8 ttm -74.2 -23.03 59.15 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.272 177.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.617 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 3.1 mt -89.16 -53.09 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.958 178.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -55.77 -28.86 58.21 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 124.204 0.94 . . . . 0.0 111.785 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.71 ' OE1' ' HD3' ' B' ' 155' ' ' LYS . 0.0 OUTLIER -63.37 -34.17 77.14 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.479 178.039 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.631 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -107.92 -30.33 8.54 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-O 121.209 0.528 . . . . 0.0 109.934 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.617 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -60.93 127.01 29.5 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.485 -1.234 . . . . 0.0 113.255 -178.753 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.576 HD11 HE21 ' A' ' 143' ' ' GLN . 13.9 mt -90.0 -48.28 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 113.737 -1.574 . . . . 0.0 110.525 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -84.12 -25.18 29.89 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 74.17 49.53 12.36 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 116.023 -0.535 . . . . 0.0 113.971 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -89.56 -19.49 24.93 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 98.71 13.34 40.98 Favored Glycine 0 CA--C 1.5 -0.884 0 CA-C-N 115.725 -0.67 . . . . 0.0 113.265 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -140.14 128.7 22.89 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.762 -1.219 . . . . 0.0 108.131 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.623 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 2.5 t -89.49 135.02 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -177.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -97.58 -163.24 1.03 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.399 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.435 ' CE1' HG21 ' A' ' 142' ' ' VAL . 0.0 OUTLIER -78.65 -51.22 10.18 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 123.558 0.743 . . . . 0.0 109.928 178.698 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -62.31 -20.78 64.68 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.631 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 12.4 mt-10 -87.66 -41.11 13.61 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.281 0.563 . . . . 0.0 110.216 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.439 ' O ' ' HE2' ' A' ' 144' ' ' MET . 73.3 t80 -72.13 -23.47 61.31 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.952 175.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.467 ' O ' ' HG3' ' A' ' 145' ' ' MET . 16.7 t -84.73 -47.55 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.573 -179.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.576 HE21 HD11 ' A' ' 130' ' ' ILE . 31.3 mt-30 -64.85 -19.31 65.81 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.01 176.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.498 ' SD ' ' HB3' ' B' ' 154' ' ' PHE . 4.5 ttp -67.55 -26.31 66.24 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.748 177.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.467 ' HG3' ' O ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -86.56 -4.4 59.17 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.71 177.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.415 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 39.6 p -119.03 -41.91 2.73 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.166 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -45.76 -34.35 3.59 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.3 pttm . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.453 -0.784 . . . . 0.0 111.38 179.813 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 111.358 0.133 . . . . 0.0 111.358 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -134.29 153.39 51.9 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.925 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 13.3 mptt 62.29 117.62 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.877 0.871 . . . . 0.0 112.237 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . 0.429 ' HB2' ' OE1' ' A' ' 123' ' ' GLU . 10.8 mptt -135.33 119.74 17.96 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.285 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.569 ' HB ' ' OE1' ' A' ' 127' ' ' GLU . 16.1 p -143.6 147.73 34.81 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 154' ' ' PHE . . . . . 0.513 ' O ' HG22 ' B' ' 157' ' ' VAL . 0.1 OUTLIER -67.28 -28.07 67.71 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.789 0.436 . . . . 0.0 110.016 178.099 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.71 ' HD3' ' OE1' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -66.09 -33.49 75.9 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.61 178.224 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -76.76 -35.29 57.81 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.173 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 157' ' ' VAL . . . . . 0.513 HG22 ' O ' ' B' ' 154' ' ' PHE . 19.1 m -72.25 -29.42 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 122.763 0.425 . . . . 0.0 111.293 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.21 -46.34 72.46 Favored 'General case' 0 C--N 1.347 0.485 0 C-N-CA 123.857 0.863 . . . . 0.0 113.032 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -56.35 -25.57 49.72 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 120.743 0.306 . . . . 0.0 111.456 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.68 -43.95 29.56 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.052 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 11.5 p -142.33 57.14 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 162' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -136.88 86.22 2.19 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.303 0.573 . . . . 0.0 110.64 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 5.4 tp -149.18 -18.82 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.539 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 21.1 m 64.62 97.11 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.489 1.116 . . . . 0.0 113.483 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . 36.71 41.05 0.15 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . 0.419 ' OG ' ' HB3' ' A' ' 72' ' ' MET . 13.9 t -95.59 -49.22 5.48 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.784 -0.189 . . . . 0.0 110.745 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.59 HD22 ' OE1' ' A' ' 41' ' ' GLN . 1.8 tp -127.56 -22.7 3.58 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 123.526 0.516 . . . . 0.0 111.007 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -95.2 145.55 24.96 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.381 0.425 . . . . 0.0 110.98 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . 100.04 -86.82 0.69 Allowed Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.505 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 19.6 p . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.048 -179.995 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.424 0 N-CA-C 111.375 0.139 . . . . 0.0 111.375 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 68.47 -62.78 0.36 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.335 1.054 . . . . 0.0 112.202 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -122.84 154.13 38.67 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 122.59 0.356 . . . . 0.0 110.621 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.664 HD11 ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -111.49 -110.7 0.34 Allowed 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.645 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.521 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 17.1 p -101.12 -173.71 2.44 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 123.794 0.838 . . . . 0.0 110.95 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 10' ' ' ALA . 46.9 mt-10 -59.4 -24.58 63.58 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.521 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 12.0 pt-20 -54.98 -32.18 61.39 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.547 0.689 . . . . 0.0 111.667 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.818 ' HB2' HD13 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -77.11 -46.11 24.63 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.703 177.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.638 HD13 ' HG3' ' A' ' 8' ' ' GLN . 11.7 mm -65.63 -34.77 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.242 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 6' ' ' GLU . . . -67.24 -43.67 81.37 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -133.23 -31.05 1.28 Allowed 'General case' 0 C--N 1.358 0.976 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -176.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.438 ' CB ' HD11 ' A' ' 69' ' ' LEU . 0.2 OUTLIER -62.73 -14.12 40.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.4 0.546 . . . . 0.0 111.806 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.697 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -78.59 -42.14 29.89 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.521 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.697 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 4.5 mt-10 -75.26 -43.6 50.49 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.588 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.608 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -62.84 -18.85 63.46 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.554 0.692 . . . . 0.0 109.229 177.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.833 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 1.6 m-85 -86.76 -47.17 9.33 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.391 176.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.4 m -86.42 -13.24 46.84 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -177.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -70.48 -30.47 67.28 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.445 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.579 ' CD1' HG22 ' A' ' 35' ' ' VAL . 3.1 m-85 -124.52 -14.03 6.94 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.833 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 0.9 OUTLIER -101.58 82.85 2.34 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.195 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.431 ' HE2' ' H ' ' A' ' 21' ' ' LYS . 2.1 mppt? -75.42 -19.69 59.34 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -177.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.78 -21.62 29.9 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.51 51.92 4.69 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-N 113.851 -1.522 . . . . 0.0 109.634 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.48 15.36 18.04 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -175.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.96 -58.79 0.08 OUTLIER Glycine 0 CA--C 1.531 1.074 0 N-CA-C 115.447 0.939 . . . . 0.0 115.447 178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.471 ' HB ' ' CG2' ' A' ' 62' ' ' THR . 0.5 OUTLIER -95.12 130.24 41.9 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 123.366 0.666 . . . . 0.0 112.282 -177.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.573 HG23 ' OD2' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -112.29 149.27 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.556 -179.856 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.73 148.23 43.56 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.14 -54.03 14.69 Favored 'General case' 0 C--N 1.345 0.375 0 C-N-CA 123.982 0.913 . . . . 0.0 112.751 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -52.76 -14.48 0.55 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.447 177.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.534 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.8 mt-10 -113.02 -19.1 12.03 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.864 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.475 ' HA ' HG23 ' A' ' 35' ' ' VAL . 2.5 tm? -57.14 -37.56 72.2 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.69 0.796 . . . . 0.0 111.518 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.839 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -56.31 -41.02 86.58 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 177.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.5 m -75.22 -27.6 59.61 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.496 -0.852 . . . . 0.0 112.134 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.608 HG12 ' HA ' ' A' ' 15' ' ' ALA . 1.4 t -76.37 -26.01 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 176.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.573 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 14.6 mmt -75.38 -41.64 55.87 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 113.054 -1.885 . . . . 0.0 111.546 176.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.839 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 2.9 mtt85 -82.42 -28.19 31.52 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.8 t -66.37 -7.97 22.57 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.988 0.899 . . . . 0.0 111.533 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 35' ' ' VAL . 62.7 mt -94.07 -4.15 49.91 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.205 -1.816 . . . . 0.0 110.11 178.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.33 -11.31 19.54 Favored Glycine 0 CA--C 1.495 -1.215 0 N-CA-C 115.601 1.0 . . . . 0.0 115.601 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.573 ' HB2' ' O ' ' A' ' 36' ' ' MET . 44.1 mt-30 -66.64 155.19 38.58 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 113.057 -1.572 . . . . 0.0 111.686 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -80.39 135.87 53.28 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.681 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 90.7 Cg_endo -86.78 108.65 0.79 Allowed 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 122.362 2.041 . . . . 0.0 115.292 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.448 ' HB ' ' H ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -131.38 150.08 52.29 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 176.585 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -80.73 -29.33 36.36 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 121.77 0.795 . . . . 0.0 109.183 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 50' ' ' ASP . . . -73.5 -31.74 63.88 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 113.304 -1.771 . . . . 0.0 109.766 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.448 ' H ' ' HB ' ' A' ' 44' ' ' THR . 25.3 tt0 -81.74 -28.22 33.47 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 113.786 -1.552 . . . . 0.0 109.197 177.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.672 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -73.43 -18.85 61.09 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.73 174.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.905 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 54.2 mt-30 -99.02 -16.03 18.84 Favored 'General case' 0 CA--C 1.482 -1.65 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.123 177.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 2.2 t70 -87.31 -37.32 17.25 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 112.166 -2.288 . . . . 0.0 110.524 176.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.612 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 0.7 OUTLIER -86.58 -32.43 20.66 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.597 178.038 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.672 ' HB ' ' O ' ' A' ' 48' ' ' LEU . 1.6 mp -74.28 -23.56 18.48 Favored 'Isoleucine or valine' 0 C--N 1.341 0.204 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 174.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.905 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.5 t-20 -69.63 -35.02 74.86 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.462 174.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.612 ' HG3' ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -86.74 -42.17 13.55 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 179.649 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.575 ' C ' ' H ' ' A' ' 57' ' ' ALA . 55.6 t -69.11 -43.14 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -71.97 34.53 0.06 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.998 0.904 . . . . 0.0 110.839 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.575 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -86.73 -5.69 59.05 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 114.108 -1.405 . . . . 0.0 112.011 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -104.89 -37.0 7.17 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 111.997 -2.365 . . . . 0.0 110.769 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.33 27.59 35.93 Favored Glycine 0 C--N 1.344 0.993 0 CA-C-N 116.053 -0.522 . . . . 0.0 114.303 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -110.28 -21.45 12.22 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.92 0.36 . . . . 0.0 111.777 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.32 26.4 70.45 Favored Glycine 0 N--CA 1.466 0.663 0 CA-C-N 115.785 -0.643 . . . . 0.0 114.177 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.471 ' CG2' ' HB ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -144.87 174.97 10.55 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 123.728 0.811 . . . . 0.0 109.916 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.548 ' HA ' ' CE2' ' A' ' 68' ' ' PHE . 5.3 mp -132.92 96.77 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.1 167.56 17.7 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.167 175.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.695 ' CD1' ' HD3' ' A' ' 66' ' ' PRO . 4.8 p90 -91.83 -39.32 0.37 Allowed Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -178.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.695 ' HD3' ' CD1' ' A' ' 65' ' ' PHE . 12.6 Cg_exo -70.71 -16.93 33.56 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.298 1.999 . . . . 0.0 112.692 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -106.14 -39.92 5.81 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -177.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.548 ' CE2' ' HA ' ' A' ' 63' ' ' ILE . 80.3 m-85 -85.69 -38.23 18.54 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -175.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.818 HD13 ' HB2' ' A' ' 8' ' ' GLN . 4.9 mt -63.8 -30.89 71.94 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.757 0.789 . . . . 0.0 110.01 177.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.594 ' O ' ' HD3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -55.73 -34.89 65.56 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 113.097 -1.865 . . . . 0.0 109.007 174.485 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.648 ' HA ' ' NE ' ' A' ' 74' ' ' ARG . 68.6 mtt -71.54 -30.4 65.86 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.51 175.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.542 ' HA ' ' CD ' ' A' ' 75' ' ' LYS . 0.9 OUTLIER -85.5 -18.37 33.69 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.702 178.29 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.637 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -80.49 -34.26 35.89 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.648 ' NE ' ' HA ' ' A' ' 71' ' ' MET . 2.5 ptt180 -81.21 -20.21 41.59 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.591 ' HD2' ' O ' ' A' ' 71' ' ' MET . 5.8 ptmt -84.45 -12.81 53.66 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.41 177.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.556 ' SD ' HD11 ' B' ' 163' ' ' ILE . 25.5 ptm -109.36 -33.51 6.81 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.159 0.504 . . . . 0.0 111.482 -178.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.637 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 26.8 mttt -75.57 -29.65 59.39 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.77 -1.105 . . . . 0.0 113.241 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -89.96 -29.46 18.46 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.8 t -66.57 101.4 0.77 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.105 0.479 . . . . 0.0 111.389 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.481 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 2.6 t70 -54.81 161.54 1.53 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.144 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.5 t -66.1 -13.78 60.66 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.616 ' O ' HD12 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -81.58 -46.03 15.02 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.597 0.713 . . . . 0.0 109.767 -179.574 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 37.6 mt-10 -77.66 -18.91 56.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.016 -1.447 . . . . 0.0 112.428 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.481 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 37.7 mt-10 -68.08 -18.02 64.55 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.781 0.432 . . . . 0.0 111.937 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 82' ' ' GLU . 2.1 mt -87.31 -57.72 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.8 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.694 ' O ' ' HD1' ' A' ' 89' ' ' PHE . 8.7 mpt_? -56.06 -16.6 5.24 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.787 ' O ' HG23 ' A' ' 91' ' ' VAL . 47.3 mt-10 -78.17 -20.76 51.31 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.764 -0.198 . . . . 0.0 111.076 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.499 ' HB1' ' CE2' ' A' ' 141' ' ' PHE . . . -72.17 -21.13 61.48 Favored 'General case' 0 CA--C 1.518 -0.276 0 O-C-N 123.772 0.67 . . . . 0.0 110.601 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.694 ' HD1' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -84.94 -20.95 29.86 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 175.217 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -79.89 -25.2 40.69 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.218 175.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 87' ' ' GLU . 42.4 t -88.15 -56.18 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.194 178.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.871 ' HB3' HG21 ' A' ' 100' ' ' ILE . 9.1 m-85 -100.75 -46.06 5.28 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -176.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.719 ' CA ' HG12 ' A' ' 100' ' ' ILE . 15.8 t70 -59.71 94.45 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.652 0.739 . . . . 0.0 112.316 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.675 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 15.7 mttm -88.3 -47.14 8.63 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 114.271 -1.331 . . . . 0.0 113.816 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -71.63 2.45 5.18 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -176.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 49.19 28.64 8.64 Favored Glycine 0 N--CA 1.473 1.153 0 CA-C-N 114.258 -1.337 . . . . 0.0 115.082 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -99.11 -5.84 29.44 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.754 0.277 . . . . 0.0 111.325 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.07 -19.03 53.57 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.703 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -117.4 118.18 31.53 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.507 -0.846 . . . . 0.0 110.67 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.871 HG21 ' HB3' ' A' ' 92' ' ' PHE . 18.5 mt -80.31 103.57 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 178.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.421 ' OG ' ' HG2' ' A' ' 104' ' ' GLU . 13.0 p -78.08 162.64 26.54 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.47 -14.76 13.78 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -177.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.99 -33.66 17.11 Favored 'General case' 0 CA--C 1.486 -1.483 0 CA-C-O 122.157 0.98 . . . . 0.0 109.096 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.909 ' O ' HG23 ' A' ' 108' ' ' VAL . 3.5 mm-40 -76.41 -42.26 44.92 Favored 'General case' 0 CA--C 1.481 -1.7 0 CA-C-N 112.446 -2.161 . . . . 0.0 109.691 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.54 HD23 ' O ' ' A' ' 105' ' ' LEU . 8.0 tt -60.11 -33.35 72.01 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.652 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -72.65 -45.18 60.21 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.603 -1.181 . . . . 0.0 108.475 176.401 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.507 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 2.2 t60 -69.03 -21.53 64.1 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 114.152 -1.386 . . . . 0.0 108.803 177.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.909 HG23 ' O ' ' A' ' 104' ' ' GLU . 27.3 t -73.67 -51.19 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.727 ' SD ' HD22 ' A' ' 116' ' ' LEU . 16.2 mtt -56.66 -41.21 76.86 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 112.354 -2.203 . . . . 0.0 111.717 175.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 m -70.38 -19.07 63.05 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.346 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.22 -44.74 21.23 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.588 176.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.57 HD22 HG12 ' B' ' 161' ' ' VAL . 1.3 mt -81.75 -28.44 33.31 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.706 -178.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 141.83 -9.99 2.58 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-O 117.616 -1.658 . . . . 0.0 117.05 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.578 ' N ' ' O ' ' A' ' 109' ' ' MET . 5.1 mt-10 -100.97 152.54 20.45 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-N 121.082 2.441 . . . . 0.0 114.476 -178.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.35 129.7 55.52 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 113.796 -1.547 . . . . 0.0 107.741 175.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.727 HD22 ' SD ' ' A' ' 109' ' ' MET . 1.2 tp -140.14 115.53 9.96 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.62 -1.173 . . . . 0.0 112.436 -176.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.854 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -75.31 -175.89 2.9 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.82 179.551 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.514 ' N ' HG23 ' A' ' 117' ' ' THR . 16.1 t70 -72.35 -37.47 68.82 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 -177.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.659 ' H ' HG23 ' A' ' 117' ' ' THR . 8.4 pt-20 -88.98 -15.53 33.97 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.727 ' HG2' HG22 ' A' ' 117' ' ' THR . 14.8 pt-20 -87.69 -16.2 35.01 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.396 0.141 . . . . 0.0 110.774 178.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.854 HG22 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -83.21 -27.17 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.908 177.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.429 ' OD2' ' HA ' ' A' ' 119' ' ' GLU . 2.9 p30 -67.08 26.54 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.575 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 10.4 pt-20 -142.3 -14.82 0.77 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.689 -1.142 . . . . 0.0 111.933 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.506 ' SD ' HD21 ' A' ' 105' ' ' LEU . 7.2 ttm -88.41 -22.82 23.54 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.662 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 2.3 mp -88.05 -46.89 15.78 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 CA-C-N 114.385 -1.28 . . . . 0.0 113.07 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -61.29 -31.4 71.22 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.575 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 5.0 mm-40 -69.74 -32.79 71.52 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.135 177.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.604 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -94.38 -40.75 9.77 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.576 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.662 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.2 OUTLIER -60.83 119.45 8.24 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.842 -1.526 . . . . 0.0 113.695 -178.355 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.3 mt -90.78 -39.25 11.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 112.964 -1.926 . . . . 0.0 110.136 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -95.91 -25.26 16.05 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.376 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.39 49.84 5.66 Favored Glycine 0 CA--C 1.526 0.727 0 O-C-N 123.464 0.478 . . . . 0.0 114.146 178.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -90.96 -19.73 22.94 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 94.18 13.62 53.82 Favored Glycine 0 CA--C 1.503 -0.692 0 CA-C-O 121.508 0.505 . . . . 0.0 113.39 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -140.03 122.46 16.1 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 113.833 -1.184 . . . . 0.0 108.32 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.552 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 3.3 t -83.86 118.4 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.531 0.681 . . . . 0.0 111.971 -178.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -84.43 -163.49 0.81 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 114.095 -1.411 . . . . 0.0 110.586 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.532 ' O ' HG23 ' A' ' 142' ' ' VAL . 37.1 m-85 -70.85 -55.62 8.1 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.786 178.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 143' ' ' GLN . 43.1 mt-10 -65.02 -20.46 66.5 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.604 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 7.8 mt-10 -87.56 -33.63 18.85 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 121.349 0.595 . . . . 0.0 109.677 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.499 ' CE2' ' HB1' ' A' ' 88' ' ' ALA . 78.0 t80 -78.85 -23.62 44.89 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.23 176.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 138' ' ' TYR . 38.0 t -85.88 -40.76 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 114.802 -1.09 . . . . 0.0 112.432 -177.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.54 ' HA ' ' OG1' ' A' ' 146' ' ' THR . 7.9 mt-30 -50.19 -31.64 14.32 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.674 ' SD ' ' HB2' ' B' ' 158' ' ' ALA . 19.2 ptt? -63.0 -31.4 72.52 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 118.437 0.562 . . . . 0.0 110.83 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.583 ' SD ' ' HD2' ' B' ' 162' ' ' LYS . 66.0 mtm -82.6 -3.95 56.92 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.914 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.54 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 39.6 p -119.24 -42.53 2.67 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.689 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -48.32 -33.12 8.38 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 178.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 97.2 mttt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.144 -0.931 . . . . 0.0 111.223 179.886 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 120.517 0.199 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -106.3 137.23 44.62 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.595 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -99.96 156.8 16.96 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.968 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . 0.451 ' HD3' ' OE1' ' A' ' 114' ' ' GLU . 97.7 mttt -91.68 126.66 36.84 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.97 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 77.9 p -133.7 178.01 7.27 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.619 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 154' ' ' PHE . . . . . 0.746 ' CE1' ' HD2' ' B' ' 155' ' ' LYS . 0.1 OUTLIER -63.77 -28.36 69.82 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.506 0.139 . . . . 0.0 111.017 179.197 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.746 ' HD2' ' CE1' ' B' ' 154' ' ' PHE . 7.1 mptt -65.59 -34.13 77.53 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.955 0.502 . . . . 0.0 111.687 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -76.52 -49.93 15.24 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 157' ' ' VAL . . . . . . . . . . . . . 7.8 p -72.22 -26.72 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 122.708 0.403 . . . . 0.0 111.957 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . 0.674 ' HB2' ' SD ' ' A' ' 144' ' ' MET . . . -51.95 -42.82 63.16 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -71.51 -20.88 62.0 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.394 0.434 . . . . 0.0 111.362 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.09 -37.67 53.91 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.288 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.661 HG11 ' HE1' ' A' ' 92' ' ' PHE . 2.6 m -90.53 -29.94 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 162' ' ' LYS . . . . . 0.583 ' HD2' ' SD ' ' A' ' 145' ' ' MET . 7.3 mtpt -65.4 132.4 48.89 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.444 0.298 . . . . 0.0 111.408 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 163' ' ' ILE . . . . . 0.556 HD11 ' SD ' ' A' ' 76' ' ' MET . 2.0 tp 56.44 17.12 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 124.655 1.182 . . . . 0.0 112.612 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 55.9 m -113.82 -36.19 4.91 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.452 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . -90.51 7.19 40.23 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.313 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . 0.414 ' O ' ' HE2' ' A' ' 75' ' ' LYS . 54.4 m -86.03 16.94 3.82 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.561 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 7.3 tp -86.09 12.34 9.82 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.977 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 85.8 mmm -92.16 130.63 37.83 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.968 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -152.57 139.33 6.93 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.508 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 20.0 p . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.137 -0.935 . . . . 0.0 111.033 179.97 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.498 0.189 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -128.43 123.05 32.77 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.56 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.716 ' HA ' ' OE1' ' A' ' 8' ' ' GLN . 17.0 pt20 -85.08 150.2 25.03 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.738 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.518 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -106.03 -112.0 0.27 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.616 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.543 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 15.6 p -101.49 -173.47 2.37 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 123.757 0.823 . . . . 0.0 111.19 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -56.71 -26.11 56.07 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.543 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 11.0 pt-20 -58.19 -30.12 66.19 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 121.415 0.626 . . . . 0.0 111.307 178.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.716 ' OE1' ' HA ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -78.99 -45.76 19.61 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.141 177.51 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.412 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 18.4 mm -60.03 -36.46 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.473 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.22 -35.24 59.13 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -179.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -107.88 -17.82 13.97 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -177.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.506 ' CB ' HE21 ' A' ' 8' ' ' GLN . 0.2 OUTLIER -73.68 -16.16 61.21 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.36 0.527 . . . . 0.0 110.257 179.105 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.664 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -82.38 -40.72 20.91 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.345 179.25 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.664 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 1.2 mt-10 -83.68 -38.49 21.4 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.834 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.631 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -65.43 -22.37 66.76 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.278 0.561 . . . . 0.0 109.659 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.562 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 25.0 t80 -87.17 -45.92 10.22 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.945 176.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.7 m -87.34 -13.65 42.95 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -177.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -68.89 -30.62 69.15 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.18 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.605 ' CD1' HG22 ' A' ' 35' ' ' VAL . 7.0 m-85 -129.43 -14.91 4.15 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -103.31 82.23 2.03 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 118.551 0.614 . . . . 0.0 109.894 178.622 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.435 ' HE2' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -83.33 -28.38 29.07 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.611 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.6 ' OD1' ' HB2' ' A' ' 24' ' ' ASP . 0.3 OUTLIER -71.25 -22.84 61.93 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.702 177.414 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.43 51.9 4.72 Favored Glycine 0 N--CA 1.469 0.842 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.6 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -98.42 21.99 10.35 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -175.484 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.41 -64.24 0.16 Allowed Glycine 0 CA--C 1.529 0.916 0 CA-C-N 115.344 -0.843 . . . . 0.0 114.539 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.695 HG22 ' N ' ' A' ' 64' ' ' ASP . 6.2 p -97.5 152.94 18.49 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 123.551 0.741 . . . . 0.0 112.122 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.67 HG13 ' O ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -112.37 148.66 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.269 -179.533 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.78 154.02 5.5 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.593 HG22 HD11 ' A' ' 63' ' ' ILE . 1.7 p -74.33 -56.17 5.17 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -57.5 -13.45 3.69 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.387 177.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.468 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 33.6 mt-10 -111.75 -16.75 13.13 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.683 -177.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.538 HD11 ' CZ ' ' A' ' 68' ' ' PHE . 1.1 tm? -56.8 -43.33 80.82 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.044 0.538 . . . . 0.0 111.493 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.754 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -52.6 -40.66 55.68 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 177.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.5 m -72.1 -32.57 67.12 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 114.746 -0.727 . . . . 0.0 112.871 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.631 HG12 ' HA ' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -73.11 -26.74 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 176.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.575 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 32.6 mmt -76.43 -40.65 50.08 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 112.953 -1.931 . . . . 0.0 111.475 176.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.754 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 9.9 mtt180 -80.59 -28.96 36.97 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 72.4 m -67.24 -8.52 32.35 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.957 0.884 . . . . 0.0 112.094 178.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 84.2 mt -93.61 -6.65 46.02 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.234 -1.803 . . . . 0.0 109.665 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.17 -4.69 31.69 Favored Glycine 0 CA--C 1.493 -1.29 0 N-CA-C 115.424 0.93 . . . . 0.0 115.424 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.575 ' HB2' ' O ' ' A' ' 36' ' ' MET . 48.7 mt-30 -78.78 137.84 37.92 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 112.43 -1.885 . . . . 0.0 112.272 -178.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.597 ' OD1' ' HA2' ' B' ' 169' ' ' GLY . 26.3 p-10 -120.82 67.17 14.5 Favored Pre-proline 0 CA--C 1.559 1.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.336 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.447 ' HD3' ' C ' ' A' ' 41' ' ' GLN . 2.0 Cg_endo -83.27 -177.83 3.46 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 123.112 2.541 . . . . 0.0 112.786 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.732 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 2.0 m -98.27 161.7 13.57 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -80.53 -29.33 37.18 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.736 0.779 . . . . 0.0 109.305 177.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.476 ' H ' HG22 ' A' ' 44' ' ' THR . . . -67.63 -32.94 73.99 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 113.476 -1.693 . . . . 0.0 109.653 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -76.0 -35.85 59.42 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 113.903 -1.499 . . . . 0.0 109.188 176.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.732 ' HG ' ' O ' ' A' ' 44' ' ' THR . 40.5 mt -64.39 -20.0 65.85 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 174.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.888 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 56.5 mt-30 -97.55 -14.85 20.81 Favored 'General case' 0 CA--C 1.481 -1.688 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.265 178.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -86.19 -35.62 19.97 Favored 'General case' 0 C--N 1.279 -2.476 0 CA-C-N 112.188 -2.278 . . . . 0.0 110.271 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -86.46 -31.06 21.57 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.226 177.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.607 ' HB ' ' O ' ' A' ' 48' ' ' LEU . 1.4 mp -74.75 -25.31 18.79 Favored 'Isoleucine or valine' 0 C--N 1.343 0.297 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 175.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.888 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.0 t30 -79.9 -34.66 38.9 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.305 175.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -85.07 -49.5 8.22 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.561 ' C ' ' H ' ' A' ' 57' ' ' ALA . 46.8 t -93.1 -52.23 10.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 5.5 t70 -72.92 38.4 0.08 Allowed 'General case' 0 C--O 1.238 0.479 0 CA-C-O 122.158 0.98 . . . . 0.0 109.836 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.561 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -82.1 -5.18 58.22 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 113.865 -1.516 . . . . 0.0 112.756 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -80.7 -33.03 35.66 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 112.47 -2.15 . . . . 0.0 111.573 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.22 51.12 4.05 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-N 116.105 -0.498 . . . . 0.0 113.164 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -109.81 -21.51 12.34 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.604 0.24 . . . . 0.0 111.536 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.5 26.55 74.4 Favored Glycine 0 N--CA 1.465 0.625 0 CA-C-N 115.725 -0.67 . . . . 0.0 114.359 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.406 ' O ' HD13 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -147.03 153.02 39.52 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 123.308 0.643 . . . . 0.0 110.479 -179.698 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.67 ' O ' HG13 ' A' ' 27' ' ' ILE . 7.1 mm -132.51 125.23 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -176.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.695 ' N ' HG22 ' A' ' 26' ' ' THR . 15.5 p-10 -73.78 148.54 42.43 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.39 176.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.514 ' CG ' ' HD3' ' A' ' 66' ' ' PRO . 4.9 p90 -78.92 -37.52 1.28 Allowed Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -177.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.514 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 22.6 Cg_exo -66.25 -18.76 56.2 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 121.792 1.661 . . . . 0.0 113.33 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -88.23 -20.02 26.06 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.538 ' CZ ' HD11 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -84.03 -25.6 29.77 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -178.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 73' ' ' ALA . 1.8 mt -70.91 -29.91 66.1 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 122.022 0.915 . . . . 0.0 109.317 175.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.69 -33.28 66.28 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 112.731 -2.032 . . . . 0.0 108.635 173.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.489 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 66.8 mtt -72.87 -24.15 60.83 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.384 175.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.463 ' HA ' ' CE ' ' A' ' 75' ' ' LYS . 37.0 mtt -88.81 -23.15 22.91 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.396 177.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.836 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -78.78 -23.4 45.29 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.392 178.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.488 ' HD2' ' N ' ' A' ' 75' ' ' LYS . 0.3 OUTLIER -89.65 -29.23 18.95 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.488 ' N ' ' HD2' ' A' ' 74' ' ' ARG . 8.3 pttp -74.44 -11.7 60.3 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.624 ' HA ' ' OE1' ' A' ' 84' ' ' GLU . 21.6 ptp -125.07 -22.06 4.52 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 -177.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.836 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 42.4 mmtt -87.49 -35.89 17.96 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -176.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -103.96 -30.12 10.5 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -176.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.501 HG21 ' OG ' ' B' ' 164' ' ' SER . 8.8 t -84.47 19.63 1.89 Allowed 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 8.7 m-20 63.05 132.41 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.771 0.829 . . . . 0.0 112.043 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.1 m -83.34 -14.05 53.73 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -86.98 -49.15 7.54 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.55 0.69 . . . . 0.0 110.005 -179.304 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.459 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 38.3 mt-10 -74.62 -17.85 60.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.079 -1.419 . . . . 0.0 112.28 179.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.624 ' OE1' ' HA ' ' A' ' 76' ' ' MET . 4.1 tt0 -61.11 -22.01 64.24 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.1 mp -87.84 -51.85 12.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.731 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.613 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -61.39 -16.92 51.22 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -179.242 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.599 ' OE1' ' HA ' ' B' ' 164' ' ' SER . 3.2 pt-20 -77.03 -20.36 56.04 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 123.356 0.41 . . . . 0.0 110.46 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.6 ' O ' ' HD1' ' A' ' 92' ' ' PHE . . . -67.24 -27.52 67.29 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.205 178.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.657 ' CE2' HG22 ' A' ' 142' ' ' VAL . 6.3 m-85 -79.35 -21.02 46.41 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 175.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.504 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 18.8 mmm180 -82.25 -16.25 50.2 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-N 114.095 -1.411 . . . . 0.0 108.07 174.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.583 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 7.9 t -85.24 -31.41 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.091 177.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.872 ' HB3' HG21 ' A' ' 100' ' ' ILE . 29.0 m-85 -90.54 -35.26 15.16 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.561 -177.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.654 ' CA ' HG12 ' A' ' 100' ' ' ILE . 2.7 t70 -61.98 91.61 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.156 0.982 . . . . 0.0 111.161 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.444 ' NZ ' ' HA ' ' A' ' 94' ' ' LYS . 1.6 mmpm? -88.17 -53.79 4.53 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -178.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.15 0.0 10.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.444 ' HA2' ' OD2' ' A' ' 93' ' ' ASP . . . 48.17 33.4 10.74 Favored Glycine 0 N--CA 1.473 1.137 0 CA-C-N 114.289 -1.323 . . . . 0.0 114.745 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -96.93 -5.28 38.37 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.24 -19.22 46.58 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.415 -0.422 . . . . 0.0 112.603 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -122.32 118.49 28.59 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.427 -0.887 . . . . 0.0 110.383 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.872 HG21 ' HB3' ' A' ' 92' ' ' PHE . 30.3 mt -77.01 97.24 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.4 m -74.72 164.36 26.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.627 -178.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.484 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -57.41 -15.02 5.57 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -89.09 -29.85 19.09 Favored 'General case' 0 CA--C 1.486 -1.491 0 CA-C-O 121.771 0.795 . . . . 0.0 109.205 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 1.029 ' O ' HG23 ' A' ' 108' ' ' VAL . 20.3 mt-10 -77.29 -43.33 33.59 Favored 'General case' 0 CA--C 1.482 -1.672 0 CA-C-N 112.707 -2.042 . . . . 0.0 110.633 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.56 HD23 ' O ' ' A' ' 105' ' ' LEU . 7.3 tt -63.97 -33.17 75.12 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.625 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -73.66 -43.01 60.57 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.793 176.624 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.489 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 10.3 t-80 -68.54 -21.66 64.54 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.267 177.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.029 HG23 ' O ' ' A' ' 104' ' ' GLU . 40.0 t -72.5 -52.13 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.835 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.644 ' SD ' HD22 ' A' ' 116' ' ' LEU . 14.7 mtt -57.45 -40.46 78.51 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 112.636 -2.074 . . . . 0.0 111.983 176.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 m -70.03 -19.1 63.32 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.082 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.6 -45.04 19.88 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.487 176.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.2 mt -80.19 -28.26 38.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.871 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 141.08 -9.79 2.77 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 117.717 -1.601 . . . . 0.0 116.905 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 109' ' ' MET . 5.0 mt-10 -100.83 151.61 21.5 Favored 'General case' 0 C--N 1.359 0.98 0 CA-C-N 120.946 2.373 . . . . 0.0 114.565 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.52 129.79 55.29 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 113.554 -1.657 . . . . 0.0 107.207 175.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.644 HD22 ' SD ' ' A' ' 109' ' ' MET . 1.0 OUTLIER -138.81 116.24 11.24 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.796 -175.771 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.871 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -73.72 -176.04 2.26 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.005 179.625 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.534 ' O ' HG23 ' A' ' 121' ' ' VAL . 16.4 t70 -69.12 -39.41 78.92 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -177.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.576 ' H ' HG23 ' A' ' 117' ' ' THR . 0.0 OUTLIER -88.36 -16.14 33.77 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -179.659 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.752 ' HG2' HG22 ' A' ' 117' ' ' THR . 13.9 pt-20 -85.51 -15.68 42.0 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 123.208 0.317 . . . . 0.0 111.116 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.871 HG22 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -82.75 -24.44 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.305 177.719 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -72.27 31.45 0.06 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.998 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.472 ' H ' ' C ' ' A' ' 121' ' ' VAL . 11.5 pt-20 -139.89 -33.41 0.59 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.212 177.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.525 ' SD ' HD21 ' A' ' 105' ' ' LEU . 1.9 ttm -76.44 -24.48 53.94 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.424 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.601 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 2.9 mt -88.72 -49.56 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.392 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -58.64 -29.19 66.35 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.248 0.967 . . . . 0.0 111.569 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.64 ' OE1' ' HB ' ' B' ' 153' ' ' THR . 0.0 OUTLIER -66.85 -28.9 68.72 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.368 178.142 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.812 ' HA ' ' SD ' ' A' ' 144' ' ' MET . . . -106.68 -32.82 7.84 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-O 121.377 0.608 . . . . 0.0 109.538 178.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.601 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -63.91 125.45 24.45 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.081 -1.418 . . . . 0.0 113.212 -178.583 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.7 mt -90.56 -47.25 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.183 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -88.21 -25.36 22.94 Favored 'General case' 0 C--N 1.344 0.357 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.52 49.8 5.63 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 116.131 -0.486 . . . . 0.0 113.957 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -82.72 -19.71 37.44 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.63 1.3 71.34 Favored Glycine 0 CA--C 1.498 -0.974 0 CA-C-N 115.735 -0.666 . . . . 0.0 114.169 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -140.32 92.64 2.55 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 113.974 -1.113 . . . . 0.0 108.346 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.913 HG11 ' CD1' ' A' ' 141' ' ' PHE . 2.4 t -51.2 140.15 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 114.484 -1.235 . . . . 0.0 114.13 -178.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -96.1 -162.84 0.99 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 113.989 -1.459 . . . . 0.0 108.319 177.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.77 ' O ' HG23 ' A' ' 142' ' ' VAL . 32.5 m-85 -80.56 -57.74 3.44 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.285 177.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -56.41 -20.48 19.84 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.724 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 10.6 mt-10 -86.61 -37.59 17.93 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.611 0.719 . . . . 0.0 109.811 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.913 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -76.75 -21.84 54.66 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 113.804 -1.544 . . . . 0.0 109.53 176.271 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 138' ' ' TYR . 98.9 t -82.83 -48.71 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.061 -178.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.582 ' O ' ' N ' ' A' ' 147' ' ' ALA . 11.7 mm100 -56.1 -34.15 65.76 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.883 0.739 . . . . 0.0 111.86 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.812 ' SD ' ' HA ' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -66.24 -17.9 65.02 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 123.265 0.353 . . . . 0.0 111.579 179.64 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 33.3 mmt -86.21 -9.11 57.16 Favored 'General case' 0 C--N 1.348 0.531 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 176.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.1 t -121.78 -37.08 2.92 Favored 'General case' 0 C--N 1.349 0.587 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.321 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -32.09 -44.11 0.08 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 177.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.2 pttt . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.45 -0.786 . . . . 0.0 111.266 179.995 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 18.5 p . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.475 0.178 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -124.98 -43.99 1.94 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.873 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 52.3 pttt -104.52 147.47 27.56 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.367 0.417 . . . . 0.0 110.905 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -116.6 134.89 54.29 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.993 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.64 ' HB ' ' OE1' ' A' ' 127' ' ' GLU . 19.5 p -138.22 176.41 8.73 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.722 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 154' ' ' PHE . . . . . 0.582 ' CE1' ' HB2' ' B' ' 158' ' ' ALA . 54.0 t80 -67.83 -36.02 79.61 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 119.565 -0.255 . . . . 0.0 111.416 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.445 ' HD2' ' OE1' ' A' ' 127' ' ' GLU . 4.5 mptt -53.85 -36.17 62.3 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 120.645 0.26 . . . . 0.0 111.166 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -77.95 -54.5 6.23 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 157' ' ' VAL . . . . . . . . . . . . . 14.1 p -72.36 -28.96 29.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . 0.582 ' HB2' ' CE1' ' B' ' 154' ' ' PHE . . . -72.23 -36.79 69.22 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -59.78 -28.7 67.63 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.431 0.457 . . . . 0.0 111.069 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' B' ' 170' ' ' THR . . . -76.98 -38.73 52.61 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.43 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.463 HG21 HG11 ' A' ' 91' ' ' VAL . 9.1 p -103.71 21.58 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 162' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 15.4 ttpt -92.95 20.09 7.04 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.049 178.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 4.4 tp -126.13 74.54 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-O 121.685 0.755 . . . . 0.0 111.784 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . 0.599 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 8.9 t 53.62 174.49 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.389 1.076 . . . . 0.0 113.421 178.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . -95.01 12.38 28.66 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.206 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 3.9 m -89.72 -65.25 1.03 Allowed 'General case' 0 C--N 1.346 0.45 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.412 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.35 97.71 4.04 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-O 121.315 0.578 . . . . 0.0 110.05 176.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.17 116.2 28.62 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.578 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . 0.597 ' HA2' ' OD1' ' A' ' 42' ' ' ASN . . . 171.81 83.5 0.05 OUTLIER Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.57 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' B' ' 160' ' ' ALA . 10.4 p . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.44 -0.79 . . . . 0.0 111.016 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.409 0 N-CA-C 111.342 0.127 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -99.21 -41.39 7.51 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.414 0.446 . . . . 0.0 111.209 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.643 ' HA ' ' NE2' ' A' ' 8' ' ' GLN . 54.8 mt-30 -134.72 150.23 50.56 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 123.394 0.434 . . . . 0.0 110.972 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.465 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -110.81 -107.21 0.36 Allowed 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.566 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 15.2 p -100.71 -173.73 2.47 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 123.686 0.794 . . . . 0.0 110.427 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.419 ' HA ' HD12 ' A' ' 9' ' ' ILE . 3.2 tp10 -59.1 -25.96 64.27 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.566 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 11.3 pt-20 -58.42 -28.54 65.35 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.466 0.651 . . . . 0.0 111.408 178.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.643 ' NE2' ' HA ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -78.68 -44.53 23.45 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.052 -1.431 . . . . 0.0 109.81 178.119 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.488 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 4.0 mt -66.53 -33.38 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.769 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.7 -33.85 62.51 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.472 ' OE2' HD13 ' A' ' 39' ' ' LEU . 46.1 mt-10 -109.89 -18.03 13.49 Favored 'General case' 0 C--N 1.344 0.345 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -177.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.488 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 0.4 OUTLIER -72.78 -15.92 61.64 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.584 0.629 . . . . 0.0 110.63 179.152 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.693 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -82.5 -41.11 20.14 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.591 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.693 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 1.1 mt-10 -85.39 -36.9 20.41 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 114.363 -1.29 . . . . 0.0 113.349 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.764 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -69.52 -23.85 63.66 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.901 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 54.8 t80 -87.07 -40.88 14.28 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.094 176.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.0 m -86.09 -12.67 49.46 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -177.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -71.99 -30.22 65.02 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.348 179.153 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.46 ' HB3' HG22 ' A' ' 27' ' ' ILE . 37.8 t80 -130.89 -11.77 3.77 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.901 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 1.4 m-20 -97.53 81.14 2.91 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.214 0.915 . . . . 0.0 110.254 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.9 -42.85 57.02 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 114.771 -1.104 . . . . 0.0 113.485 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.05 -17.72 56.69 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.157 178.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.42 51.73 4.8 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.332 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.2 22.08 2.58 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -174.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.87 -60.13 0.14 Allowed Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.435 -0.802 . . . . 0.0 115.034 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.702 HG22 ' N ' ' A' ' 64' ' ' ASP . 6.2 p -97.52 154.43 17.51 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 123.509 0.724 . . . . 0.0 112.403 -178.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -124.04 149.6 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.712 -179.266 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 p -54.35 153.26 5.59 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.611 1.338 . . . . 0.0 114.611 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.5 p -80.99 -55.7 4.61 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.773 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -53.64 -14.11 0.81 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.477 177.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.541 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -113.05 -20.44 11.51 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.482 -178.765 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.469 ' HA ' HG23 ' A' ' 35' ' ' VAL . 2.2 tm? -51.27 -39.0 55.8 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.83 0.852 . . . . 0.0 112.217 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.761 ' O ' ' HD3' ' A' ' 37' ' ' ARG . . . -58.72 -40.28 94.69 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 177.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.8 m -75.89 -28.15 57.98 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 114.512 -0.844 . . . . 0.0 112.348 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.764 HG12 ' HA ' ' A' ' 15' ' ' ALA . 1.4 t -75.56 -26.55 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 177.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.602 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 29.6 mtt -75.94 -43.13 46.42 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 112.771 -2.013 . . . . 0.0 111.401 176.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.761 ' HD3' ' O ' ' A' ' 33' ' ' GLY . 11.2 mtp180 -78.53 -28.36 46.13 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 58.0 m -66.64 -8.25 26.15 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.072 0.939 . . . . 0.0 111.708 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.472 HD13 ' OE2' ' A' ' 11' ' ' GLU . 92.4 mt -93.3 -6.67 46.93 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 113.091 -1.868 . . . . 0.0 109.65 178.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.5 0.0 53.27 Favored Glycine 0 CA--C 1.492 -1.365 0 CA-C-O 122.468 1.038 . . . . 0.0 114.452 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.602 ' HB2' ' O ' ' A' ' 36' ' ' MET . 47.2 mt-30 -80.84 138.16 36.2 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-N 111.889 -2.155 . . . . 0.0 112.093 -178.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -118.79 74.77 12.8 Favored Pre-proline 0 CA--C 1.549 0.905 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.341 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -84.11 -178.1 3.33 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 123.146 2.564 . . . . 0.0 112.374 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.421 HG22 ' H ' ' A' ' 46' ' ' ALA . 1.5 m -101.72 160.79 14.16 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.544 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 28.9 mt-10 -80.85 -28.45 36.08 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.698 177.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.421 ' H ' HG22 ' A' ' 44' ' ' THR . . . -71.4 -36.43 71.36 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 113.584 -1.644 . . . . 0.0 109.947 -178.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -77.91 -30.05 50.43 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.766 176.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.591 ' O ' HD13 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -67.17 -20.04 65.67 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.27 174.576 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.884 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 54.5 mt-30 -99.03 -15.08 19.18 Favored 'General case' 0 CA--C 1.48 -1.723 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.01 178.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -84.87 -35.89 21.9 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 112.011 -2.359 . . . . 0.0 109.943 176.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 13.9 mmt -86.68 -28.14 23.32 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.566 177.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.591 HD13 ' O ' ' A' ' 48' ' ' LEU . 1.5 mp -77.99 -24.99 14.18 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 175.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.884 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.7 t-20 -78.31 -34.41 48.74 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.962 175.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -88.42 -41.95 12.47 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.559 ' C ' ' H ' ' A' ' 57' ' ' ALA . 84.1 t -83.52 -48.57 17.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -178.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 5.2 t70 -72.34 39.4 0.08 Allowed 'General case' 0 C--O 1.238 0.497 0 CA-C-O 122.025 0.917 . . . . 0.0 110.099 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.559 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -84.33 -5.45 59.27 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 114.098 -1.41 . . . . 0.0 112.446 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -95.29 -34.25 12.25 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 112.159 -2.291 . . . . 0.0 110.947 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.11 45.82 6.12 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 115.992 -0.549 . . . . 0.0 113.474 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -110.0 -21.52 12.27 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.625 0.25 . . . . 0.0 111.262 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.94 26.8 73.83 Favored Glycine 0 N--CA 1.467 0.717 0 CA-C-N 115.752 -0.658 . . . . 0.0 114.198 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.421 ' O ' HD13 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -146.68 155.45 42.44 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 123.247 0.619 . . . . 0.0 110.509 -179.425 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.542 ' O ' HG13 ' A' ' 27' ' ' ILE . 8.4 mm -133.48 128.17 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -176.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.702 ' N ' HG22 ' A' ' 26' ' ' THR . 11.9 p-10 -81.77 151.76 27.3 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.273 176.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.729 ' HA ' ' CE2' ' A' ' 68' ' ' PHE . 28.7 p90 -80.14 -29.38 0.55 Allowed Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -177.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 11.5 Cg_exo -71.38 -17.54 30.54 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 121.898 1.732 . . . . 0.0 112.716 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -91.64 -31.06 16.0 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.729 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 3.5 p90 -84.67 -28.03 26.68 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 -176.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 73' ' ' ALA . 5.1 mt -69.27 -36.68 77.35 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.615 0.721 . . . . 0.0 110.004 178.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.42 -31.68 69.49 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 113.423 -1.717 . . . . 0.0 108.89 173.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.766 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 51.1 mtt -75.74 -23.92 56.08 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.004 175.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.612 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 68.5 mtt -89.05 -21.93 23.2 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.096 176.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.49 ' O ' ' HG3' ' A' ' 77' ' ' LYS . . . -74.73 -30.52 61.54 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.077 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.519 ' HD3' ' N ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -81.07 -24.49 37.76 Favored 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 123.684 0.615 . . . . 0.0 109.884 -179.536 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.766 ' HD2' ' O ' ' A' ' 71' ' ' MET . 25.7 mttt -70.52 -14.51 62.54 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.697 176.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.442 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 22.7 ptt? -121.01 -28.2 4.82 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -177.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 73' ' ' ALA . 54.6 mttt -58.24 -24.2 58.52 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -103.88 -30.56 10.26 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.442 ' CG2' ' HA ' ' A' ' 76' ' ' MET . 5.9 t -81.83 104.44 12.21 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.844 0.354 . . . . 0.0 111.499 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -14.04 134.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.803 1.641 . . . . 0.0 115.271 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.8 m -77.99 -13.52 59.85 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.166 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.52 -42.04 62.28 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.879 0.847 . . . . 0.0 110.074 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.579 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 41.8 mt-10 -73.7 -18.81 60.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.31 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.428 ' OE2' HD12 ' B' ' 163' ' ' ILE . 0.2 OUTLIER -63.89 -18.73 64.49 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.4 mp -87.82 -51.3 12.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.72 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.4 mtt180 -60.29 -16.78 37.4 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.626 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.579 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 44.2 mt-10 -78.81 -20.77 48.93 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.489 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.31 -21.29 56.39 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.657 177.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.526 ' O ' ' HB3' ' A' ' 93' ' ' ASP . 6.2 m-85 -84.46 -21.04 30.81 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 174.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -76.57 -21.87 55.05 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 174.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 87' ' ' GLU . 55.6 t -88.02 -52.24 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.218 177.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.781 ' HB2' HD13 ' A' ' 100' ' ' ILE . 92.0 m-85 -100.37 -41.31 7.09 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -176.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.727 ' CA ' HG12 ' A' ' 100' ' ' ILE . 2.3 t70 -64.5 94.61 0.12 Allowed 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.662 0.744 . . . . 0.0 110.867 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.1 mmpt? -87.39 -48.9 7.6 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.385 -1.279 . . . . 0.0 113.436 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.06 0.62 9.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -175.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 49.35 30.09 11.37 Favored Glycine 0 N--CA 1.472 1.07 0 CA-C-N 114.327 -1.306 . . . . 0.0 114.715 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -96.94 -7.2 33.79 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 122.29 0.236 . . . . 0.0 111.464 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.452 ' O ' ' HE2' ' A' ' 89' ' ' PHE . . . 104.17 -18.71 45.07 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 121.396 -0.43 . . . . 0.0 112.919 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -119.72 119.68 34.37 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.61 -0.795 . . . . 0.0 110.814 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.781 HD13 ' HB2' ' A' ' 92' ' ' PHE . 50.1 mt -77.43 92.26 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.3 t -72.16 166.29 22.65 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.513 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.542 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -59.35 -14.62 12.39 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.528 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.8 -29.41 19.76 Favored 'General case' 0 CA--C 1.489 -1.369 0 CA-C-O 121.775 0.798 . . . . 0.0 109.348 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.968 ' O ' HG23 ' A' ' 108' ' ' VAL . 18.4 mt-10 -79.3 -41.44 28.03 Favored 'General case' 0 CA--C 1.483 -1.621 0 CA-C-N 112.739 -2.028 . . . . 0.0 111.113 -178.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.625 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 6.4 tt -66.44 -34.31 77.65 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.597 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -70.06 -44.91 68.17 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.158 175.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.528 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 10.4 t-80 -68.79 -21.72 64.31 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.599 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.968 HG23 ' O ' ' A' ' 104' ' ' GLU . 3.5 t -70.71 -51.87 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.293 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 177.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.596 ' O ' ' N ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -60.54 -38.56 84.85 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 111.521 -2.581 . . . . 0.0 112.383 177.635 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.25 -18.71 61.79 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.531 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.51 -45.32 19.53 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.485 176.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.6 mt -80.89 -28.45 35.94 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.292 -178.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 140.05 -6.89 2.89 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-O 117.697 -1.613 . . . . 0.0 116.922 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.596 ' N ' ' O ' ' A' ' 109' ' ' MET . 4.5 mt-10 -100.61 151.67 21.34 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-N 120.979 2.389 . . . . 0.0 113.994 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.75 125.7 52.22 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 113.682 -1.599 . . . . 0.0 107.442 175.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.597 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 1.3 tp -130.21 116.02 17.81 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 113.802 -1.545 . . . . 0.0 112.028 -175.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.848 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -74.52 -175.84 2.53 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.657 179.662 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.527 ' O ' HG23 ' A' ' 121' ' ' VAL . 16.3 t70 -73.3 -37.86 66.06 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -177.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.648 ' H ' HG23 ' A' ' 117' ' ' THR . 8.2 pt-20 -87.84 -16.1 34.95 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.72 ' HG2' HG22 ' A' ' 117' ' ' THR . 14.3 pt-20 -85.4 -15.51 42.85 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 123.107 0.254 . . . . 0.0 110.992 178.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.848 HG22 ' O ' ' A' ' 117' ' ' THR . 0.1 OUTLIER -83.55 -25.59 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.602 178.109 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -74.62 29.91 0.09 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.956 0.884 . . . . 0.0 112.368 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.557 ' O ' ' HB3' ' A' ' 127' ' ' GLU . 11.3 pt-20 -142.01 -28.59 0.62 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 114.187 -1.369 . . . . 0.0 109.868 177.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.705 ' HA ' ' OG1' ' B' ' 153' ' ' THR . 4.5 mmt -74.76 -29.49 61.15 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 176.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.583 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 3.0 mt -88.05 -52.48 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-N 113.919 -1.491 . . . . 0.0 112.352 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -55.96 -28.53 57.41 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 124.233 0.958 . . . . 0.0 111.681 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.686 ' OE1' ' HD2' ' B' ' 155' ' ' LYS . 0.0 OUTLIER -62.05 -33.9 75.25 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.27 178.191 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.59 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -108.39 -32.01 7.61 Favored 'General case' 0 C--N 1.349 0.559 0 CA-C-O 121.217 0.532 . . . . 0.0 110.131 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.583 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -61.29 127.38 31.21 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.429 -1.259 . . . . 0.0 113.412 -178.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.3 mt -89.8 -49.24 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 114.199 -1.364 . . . . 0.0 110.416 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -85.27 -25.25 27.36 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.2 49.61 9.32 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 116.133 -0.485 . . . . 0.0 113.924 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -85.05 -19.4 32.0 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 99.65 9.93 48.48 Favored Glycine 0 CA--C 1.5 -0.905 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.419 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -140.6 125.47 18.23 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 113.8 -1.2 . . . . 0.0 108.34 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.586 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 2.1 t -86.02 130.48 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -177.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -95.43 -163.54 1.06 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.171 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.453 ' O ' HG23 ' A' ' 142' ' ' VAL . 29.4 m-85 -74.89 -55.68 5.54 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.577 177.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.91 -20.43 62.04 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.59 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 13.4 mt-10 -86.35 -46.23 10.48 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.303 0.573 . . . . 0.0 109.748 178.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.594 ' O ' ' HG3' ' A' ' 144' ' ' MET . 81.8 t80 -68.09 -22.76 64.9 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.37 -1.287 . . . . 0.0 109.258 175.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.621 ' O ' ' HG3' ' A' ' 145' ' ' MET . 24.3 t -84.78 -47.09 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.921 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -60.67 -34.09 73.8 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.439 -0.504 . . . . 0.0 111.234 177.877 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.594 ' HG3' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -63.93 -27.33 69.07 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 123.222 0.326 . . . . 0.0 110.682 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.621 ' HG3' ' O ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -82.38 -7.93 59.63 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 177.705 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.9 p -113.51 -46.28 3.07 Favored 'General case' 0 C--N 1.349 0.557 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.529 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -29.99 -43.77 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.787 1.235 . . . . 0.0 114.182 177.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 20.1 pttp . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.358 -179.991 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 19.4 p . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.421 0.153 . . . . 0.0 111.346 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -124.75 135.43 52.98 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.844 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -102.15 132.78 47.84 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.853 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -107.57 125.04 50.82 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.405 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.705 ' OG1' ' HA ' ' A' ' 124' ' ' MET . 1.9 p -139.54 -60.7 0.55 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.917 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 154' ' ' PHE . . . . . 0.632 ' HA ' HG22 ' B' ' 157' ' ' VAL . 0.1 OUTLIER -66.98 -27.54 67.53 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 118.328 0.513 . . . . 0.0 110.14 178.449 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.686 ' HD2' ' OE1' ' A' ' 127' ' ' GLU . 4.8 mptt -67.71 -40.94 84.23 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.607 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . 0.515 ' HA ' ' ND2' ' B' ' 159' ' ' ASN . 9.5 mm-40 -76.74 -36.15 57.3 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 157' ' ' VAL . . . . . 0.632 HG22 ' HA ' ' B' ' 154' ' ' PHE . 19.1 m -72.49 -29.98 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 120.871 0.367 . . . . 0.0 111.366 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' B' ' 162' ' ' LYS . . . -73.01 -44.69 60.69 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.789 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . 0.515 ' ND2' ' HA ' ' B' ' 156' ' ' GLU . 28.2 p30 -52.44 -29.65 25.55 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.66 -38.34 47.87 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.542 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 11.5 p -134.11 51.13 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 CA-C-O 121.191 0.519 . . . . 0.0 112.123 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 162' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 17.1 ttpt -90.84 -36.89 13.95 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.874 178.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 163' ' ' ILE . . . . . 0.428 HD12 ' OE2' ' A' ' 84' ' ' GLU . 3.3 tp -93.77 122.69 45.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.615 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 16.2 t -133.62 -9.56 2.81 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.443 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 165' ' ' ALA . . . . . 0.455 ' HB2' ' OE2' ' A' ' 87' ' ' GLU . . . -88.18 -10.89 48.41 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . 0.497 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 54.0 m -87.34 -74.13 0.45 Allowed 'General case' 0 CA--C 1.536 0.439 0 O-C-N 123.096 0.248 . . . . 0.0 111.007 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 6.5 tp -107.01 96.16 6.23 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.05 0.452 . . . . 0.0 110.147 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 20.9 ptt? -129.44 149.03 51.4 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.134 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -114.8 139.33 15.51 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.5 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.092 -0.956 . . . . 0.0 110.469 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.447 0.165 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.468 ' HB2' ' NE2' ' A' ' 8' ' ' GLN . 3.1 m-20 -95.79 -49.23 5.42 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.203 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.935 ' H ' HE22 ' A' ' 8' ' ' GLN . 3.3 tt0 -138.51 -51.79 0.58 Allowed 'General case' 0 C--N 1.346 0.427 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.492 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -113.19 -117.74 0.31 Allowed 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.509 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.537 ' OG1' ' HG2' ' A' ' 7' ' ' GLU . 17.9 p -101.66 -173.98 2.48 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 123.848 0.859 . . . . 0.0 111.093 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -67.74 -21.42 65.28 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.126 0.57 . . . . 0.0 112.064 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.537 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 13.2 pt-20 -51.49 -28.28 12.93 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.694 0.759 . . . . 0.0 111.853 178.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.935 HE22 ' H ' ' A' ' 3' ' ' GLN . 0.9 OUTLIER -76.88 -47.29 21.64 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 113.618 -1.628 . . . . 0.0 110.572 179.038 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.641 ' O ' ' HD2' ' A' ' 13' ' ' LYS . 2.9 mp -70.97 -28.27 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.319 178.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.36 -41.15 63.77 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -130.36 -33.85 1.66 Allowed 'General case' 0 C--N 1.357 0.92 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.465 ' CB ' HD11 ' A' ' 69' ' ' LEU . 0.2 OUTLIER -64.34 -14.01 53.72 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.666 179.661 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.728 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.7 OUTLIER -71.82 -40.85 68.84 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 176.461 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.728 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 6.1 mt-10 -75.0 -45.31 42.78 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-N 113.555 -1.657 . . . . 0.0 111.386 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.593 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -61.36 -19.01 61.36 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.545 0.688 . . . . 0.0 109.412 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.695 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 2.1 t80 -86.83 -48.26 8.35 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.392 -1.276 . . . . 0.0 109.616 176.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.0 t -86.36 -13.25 47.03 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -177.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -69.23 -30.52 68.69 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.045 0.384 . . . . 0.0 111.097 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.58 ' CD1' HG22 ' A' ' 35' ' ' VAL . 5.1 m-85 -125.71 -15.52 5.98 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.695 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -102.9 80.8 1.92 Allowed 'General case' 0 C--O 1.239 0.55 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.136 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.446 ' HE2' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -76.61 -27.47 55.75 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.344 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.607 ' OD1' ' HB2' ' A' ' 24' ' ' ASP . 0.3 OUTLIER -71.53 -23.03 61.7 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.471 176.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.88 52.04 4.84 Favored Glycine 0 N--CA 1.468 0.806 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.042 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.607 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -100.73 21.59 13.26 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -175.119 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.478 ' H ' ' HE1' ' A' ' 16' ' ' PHE . . . 65.41 -56.42 0.12 Allowed Glycine 0 CA--C 1.533 1.174 0 N-CA-C 115.809 1.083 . . . . 0.0 115.809 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 0.8 OUTLIER -96.65 139.91 32.03 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.783 0.833 . . . . 0.0 113.052 -178.286 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.477 ' H ' HG13 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -114.82 148.53 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.472 178.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.15 149.29 28.53 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.48 -55.22 6.63 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 115.082 -0.963 . . . . 0.0 113.037 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -53.23 -14.09 0.63 Allowed 'General case' 0 N--CA 1.474 0.772 0 O-C-N 123.807 0.692 . . . . 0.0 111.473 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.535 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.6 mt-10 -113.87 -17.06 12.12 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.453 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.475 ' HA ' HG23 ' A' ' 35' ' ' VAL . 2.2 tm? -54.89 -43.13 72.94 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.783 0.833 . . . . 0.0 111.918 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.775 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -55.3 -39.76 73.27 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 177.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 m -74.59 -28.4 60.89 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 114.595 -0.802 . . . . 0.0 112.397 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' ' 15' ' ' ALA . 1.7 t -74.77 -26.68 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.647 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 33.9 mtt -77.25 -41.11 42.37 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 112.909 -1.95 . . . . 0.0 111.729 176.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.775 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 10.6 mtt180 -83.2 -27.74 29.78 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -178.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.3 m -64.09 -8.17 11.14 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.99 0.9 . . . . 0.0 112.402 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.2 mt -93.94 -7.23 43.58 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 113.304 -1.771 . . . . 0.0 109.772 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.42 -1.38 43.06 Favored Glycine 0 CA--C 1.492 -1.401 0 CA-C-O 122.369 0.983 . . . . 0.0 114.658 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.647 ' HB2' ' O ' ' A' ' 36' ' ' MET . 46.7 mt-30 -78.63 139.82 38.5 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 112.107 -2.047 . . . . 0.0 112.081 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -121.35 73.01 28.26 Favored Pre-proline 0 CA--C 1.549 0.918 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.437 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.96 -177.82 4.09 Favored 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 123.071 2.514 . . . . 0.0 112.098 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 46' ' ' ALA . 1.4 m -99.22 160.49 14.24 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.522 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 28.6 mt-10 -80.79 -28.36 36.33 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.668 177.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.417 ' H ' HG22 ' A' ' 44' ' ' THR . . . -71.84 -36.6 70.21 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 113.573 -1.649 . . . . 0.0 109.994 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -77.07 -29.97 55.3 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.677 176.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -65.82 -20.76 66.36 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.024 174.569 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.741 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 47.9 mt-30 -95.35 -17.43 21.6 Favored 'General case' 0 CA--C 1.483 -1.61 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.168 178.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -84.07 -32.73 24.65 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 111.914 -2.403 . . . . 0.0 109.42 176.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.522 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -86.38 -35.37 19.81 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.644 176.931 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.8 mt -69.77 -27.4 33.19 Favored 'Isoleucine or valine' 0 C--N 1.351 0.638 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 175.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.741 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 4.4 t-20 -67.8 -33.33 74.6 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.431 174.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -85.1 -22.55 28.86 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.897 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.603 ' C ' ' H ' ' A' ' 57' ' ' ALA . 55.8 t -82.39 -37.82 14.79 Favored 'Isoleucine or valine' 0 C--N 1.346 0.432 0 C-N-CA 122.589 0.355 . . . . 0.0 111.786 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.99 26.94 0.04 OUTLIER 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.93 0.871 . . . . 0.0 111.094 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.603 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -87.72 -6.94 57.97 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 113.989 -1.46 . . . . 0.0 111.986 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -113.4 -29.96 7.04 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 111.72 -2.491 . . . . 0.0 110.9 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.48 18.86 61.32 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.921 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -110.24 -21.66 12.13 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.961 0.381 . . . . 0.0 111.965 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.11 27.27 73.97 Favored Glycine 0 N--CA 1.468 0.77 0 N-CA-C 114.432 0.533 . . . . 0.0 114.432 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.435 ' CG2' ' HB ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -122.65 165.98 15.62 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 122.906 0.483 . . . . 0.0 111.498 -179.06 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 26' ' ' THR . 4.9 mp -126.41 109.39 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.522 ' N ' HG22 ' A' ' 26' ' ' THR . 0.4 OUTLIER -85.19 165.5 17.35 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.601 176.032 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.528 ' O ' HD12 ' A' ' 69' ' ' LEU . 31.3 p90 -91.14 -39.3 0.39 Allowed Pre-proline 0 CA--C 1.548 0.901 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 51.1 Cg_endo -69.82 -17.8 37.1 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 121.787 1.658 . . . . 0.0 113.529 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -102.91 -32.06 9.95 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -177.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.816 ' O ' ' HG2' ' A' ' 71' ' ' MET . 7.3 t80 -84.79 -27.77 26.62 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -177.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.72 HD13 ' HB2' ' A' ' 8' ' ' GLN . 4.4 mt -70.65 -32.88 70.34 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-O 121.92 0.867 . . . . 0.0 109.55 177.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.666 ' O ' ' HD3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -54.44 -41.26 69.19 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 112.785 -2.007 . . . . 0.0 109.648 175.136 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.816 ' HG2' ' O ' ' A' ' 68' ' ' PHE . 25.8 ptm -72.69 -27.13 61.89 Favored 'General case' 0 C--N 1.347 0.48 0 O-C-N 123.802 0.689 . . . . 0.0 109.351 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.593 ' O ' ' HG2' ' A' ' 76' ' ' MET . 94.4 mtp -81.78 -18.61 43.53 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.326 179.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.778 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -84.21 -31.59 24.98 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.666 ' HD3' ' O ' ' A' ' 70' ' ' THR . 4.9 ptt180 -89.6 -18.2 27.0 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 179.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.656 ' HD2' ' O ' ' A' ' 71' ' ' MET . 0.0 OUTLIER -84.61 -12.96 53.0 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.266 0.939 . . . . 0.0 113.035 179.051 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.593 ' HG2' ' O ' ' A' ' 72' ' ' MET . 7.8 ptt? -116.07 -28.97 6.44 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.778 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 34.8 mmtt -77.81 -21.89 50.9 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -178.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -103.91 -29.52 10.91 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.52 HG23 ' H ' ' A' ' 80' ' ' ASP . 5.6 t -66.38 -62.87 1.24 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.52 ' H ' HG23 ' A' ' 79' ' ' THR . 3.2 m-20 -164.65 94.39 0.69 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.871 0.868 . . . . 0.0 110.335 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.1 m -83.99 -14.13 51.53 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.526 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.472 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -87.11 -50.06 6.89 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.352 0.596 . . . . 0.0 110.142 -179.059 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.472 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 39.5 mt-10 -74.89 -17.53 60.57 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.331 -1.304 . . . . 0.0 112.348 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.588 ' HA ' ' OE2' ' A' ' 87' ' ' GLU . 1.0 OUTLIER -58.36 -24.42 59.82 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.4 mp -87.92 -54.18 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.97 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.588 ' O ' ' HD2' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -62.67 -18.72 62.91 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.381 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.588 ' OE2' ' HA ' ' A' ' 84' ' ' GLU . 3.4 pt-20 -73.48 -19.68 60.88 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.113 0.482 . . . . 0.0 110.282 178.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.614 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -69.22 -22.73 63.85 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.437 178.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.604 ' O ' ' HB2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -81.77 -21.71 37.63 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 174.652 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 7.5 ttt180 -76.79 -15.83 59.63 Favored 'General case' 0 C--N 1.344 0.345 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.614 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 3.8 t -84.21 -33.73 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.512 177.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.83 ' HB3' HG21 ' A' ' 100' ' ' ILE . 48.6 m-85 -98.91 -36.3 9.81 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -177.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.622 ' N ' HG12 ' A' ' 100' ' ' ILE . 1.7 t70 -63.99 88.63 0.05 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.929 0.892 . . . . 0.0 111.75 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 27.4 mttm -87.63 -41.45 13.39 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.512 -1.222 . . . . 0.0 113.641 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.476 ' HB2' HD22 ' A' ' 97' ' ' ASN . 1.7 p30 -70.72 -18.43 62.8 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -176.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.85 17.74 73.62 Favored Glycine 0 C--N 1.295 -1.746 0 CA-C-N 112.834 -1.985 . . . . 0.0 114.642 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.476 HD22 ' HB2' ' A' ' 95' ' ' ASP . 43.1 m-80 -90.29 -7.01 54.47 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.891 0.345 . . . . 0.0 111.517 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.52 -18.91 49.64 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.926 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -112.39 118.41 35.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.294 -0.953 . . . . 0.0 110.391 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.83 HG21 ' HB3' ' A' ' 92' ' ' PHE . 29.1 mt -78.5 90.7 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.3 t -61.93 159.92 13.2 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.151 -0.931 . . . . 0.0 113.235 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.508 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -58.74 -15.97 14.53 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 115.046 1.499 . . . . 0.0 115.046 -178.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -89.05 -26.17 21.55 Favored 'General case' 0 CA--C 1.489 -1.402 0 CA-C-O 121.769 0.795 . . . . 0.0 109.17 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.942 ' O ' HG23 ' A' ' 108' ' ' VAL . 3.3 mm-40 -79.06 -43.85 23.37 Favored 'General case' 0 CA--C 1.482 -1.638 0 CA-C-N 112.632 -2.076 . . . . 0.0 112.484 -177.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.733 HD13 ' SD ' ' A' ' 124' ' ' MET . 9.3 tt -67.17 -30.25 70.16 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.618 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -70.16 -45.3 67.04 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.8 176.286 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.533 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 3.2 t60 -68.98 -21.88 64.13 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.63 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.942 HG23 ' O ' ' A' ' 104' ' ' GLU . 3.1 t -69.73 -51.33 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.299 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.595 ' O ' ' N ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -60.87 -39.37 88.96 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 111.568 -2.56 . . . . 0.0 112.44 177.26 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.79 -18.78 62.08 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.506 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.4 -45.5 19.37 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.43 175.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.6 mt -80.04 -28.35 39.29 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.027 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 140.08 -7.73 2.93 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-O 117.704 -1.609 . . . . 0.0 117.017 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.595 ' N ' ' O ' ' A' ' 109' ' ' MET . 4.2 mt-10 -100.73 151.82 21.21 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 121.051 2.425 . . . . 0.0 114.543 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -105.32 130.01 53.54 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.431 -1.713 . . . . 0.0 106.868 174.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.618 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 1.0 OUTLIER -134.31 125.03 26.82 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.46 -1.246 . . . . 0.0 111.776 -175.696 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 1.008 ' O ' ' HB ' ' A' ' 121' ' ' VAL . 0.7 OUTLIER -96.35 -177.2 3.88 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 114.079 -1.419 . . . . 0.0 112.395 -177.458 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.517 ' N ' HG23 ' A' ' 117' ' ' THR . 17.1 t70 -63.93 -41.14 97.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.469 -1.241 . . . . 0.0 114.084 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.681 ' H ' HG23 ' A' ' 117' ' ' THR . 4.0 mt-10 -78.48 -42.9 28.4 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.788 ' CG ' ' H ' ' A' ' 117' ' ' THR . 13.0 pt-20 -73.24 -23.58 60.37 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.925 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 1.008 ' HB ' ' O ' ' A' ' 117' ' ' THR . 1.2 t -87.5 -23.77 6.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 114.746 -1.116 . . . . 0.0 112.472 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.12 37.34 0.85 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.906 0.86 . . . . 0.0 110.692 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -138.8 -42.54 0.48 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.246 -1.343 . . . . 0.0 109.394 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.801 ' HE3' HG13 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -63.65 -22.46 66.91 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.914 178.015 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.634 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 4.2 mt -88.96 -48.94 14.47 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.558 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -60.55 -28.01 68.1 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 123.97 0.794 . . . . 0.0 111.681 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.585 ' OE1' ' HB ' ' B' ' 153' ' ' THR . 0.0 OUTLIER -64.41 -34.31 77.88 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.941 178.311 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.609 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -102.85 -32.23 9.89 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-O 121.415 0.626 . . . . 0.0 109.504 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.634 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.2 OUTLIER -63.0 124.21 20.51 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 114.054 -1.43 . . . . 0.0 113.026 -179.46 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.8 mt -90.48 -47.79 14.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.016 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -88.59 -25.25 22.57 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.16 49.91 4.29 Favored Glycine 0 CA--C 1.524 0.646 0 O-C-N 123.501 0.501 . . . . 0.0 113.884 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -76.74 -20.05 56.96 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.409 ' HA2' HG21 ' A' ' 125' ' ' ILE . . . 84.72 21.88 54.8 Favored Glycine 0 CA--C 1.507 -0.448 0 CA-C-N 115.764 -0.653 . . . . 0.0 114.558 178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.698 ' O ' ' HB ' ' A' ' 136' ' ' VAL . 42.1 mt-30 -135.72 -74.31 0.45 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.6 -0.8 . . . . 0.0 109.708 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.698 ' HB ' ' O ' ' A' ' 135' ' ' GLN . 2.5 t 124.3 121.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 125.248 1.419 . . . . 0.0 111.301 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.444 HD22 ' CD ' ' A' ' 140' ' ' GLU . 20.0 m-80 -88.84 -163.55 1.0 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.69 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.431 ' O ' HG23 ' A' ' 142' ' ' VAL . 70.1 m-85 -72.31 -53.79 11.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.956 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.04 -20.66 66.6 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.609 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 8.9 mt-10 -86.78 -41.91 13.73 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.364 0.602 . . . . 0.0 109.739 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.625 ' HA ' ' SD ' ' A' ' 144' ' ' MET . 38.6 t80 -69.36 -24.18 63.85 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.16 176.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 138' ' ' TYR . 22.7 t -86.23 -48.33 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.996 -178.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.724 ' O ' ' N ' ' A' ' 147' ' ' ALA . 0.2 OUTLIER -54.74 -34.59 62.71 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 123.906 0.754 . . . . 0.0 111.512 179.066 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.669 ' SD ' ' HB3' ' B' ' 154' ' ' PHE . 6.4 ptt? -60.87 -26.54 67.47 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 123.238 0.336 . . . . 0.0 111.639 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 69.2 mtm -87.59 -3.87 58.97 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.52 178.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.8 t -133.55 -27.01 1.57 Allowed 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.724 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -48.11 -31.33 5.44 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 178.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 93.3 mttt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.123 -0.941 . . . . 0.0 111.632 179.936 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 19.0 p . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 120.564 0.221 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -117.4 135.45 53.87 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.781 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 62.84 124.22 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.838 0.855 . . . . 0.0 111.883 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . 0.557 ' HD2' ' OE1' ' A' ' 114' ' ' GLU . 48.0 mttp -109.36 160.25 16.32 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.403 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.585 ' HB ' ' OE1' ' A' ' 127' ' ' GLU . 12.4 p -137.86 171.38 14.51 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.783 -179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 154' ' ' PHE . . . . . 0.669 ' HB3' ' SD ' ' A' ' 144' ' ' MET . 0.3 OUTLIER -56.07 -27.84 55.16 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 117.811 0.278 . . . . 0.0 110.879 179.094 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 144' ' ' MET . 0.3 OUTLIER -71.45 -48.89 46.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.406 0.682 . . . . 0.0 111.222 178.385 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.6 -35.44 58.11 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 157' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' B' ' 154' ' ' PHE . 27.9 m -67.54 -29.92 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 122.774 0.43 . . . . 0.0 111.454 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' B' ' 162' ' ' LYS . . . -70.86 -44.49 66.28 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.881 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -61.35 -24.86 66.76 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.92 -38.59 53.18 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.655 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 9.9 p -114.12 25.86 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.253 0 O-C-N 123.401 0.438 . . . . 0.0 111.832 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 162' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 1.5 ttpm? -87.57 -34.42 18.56 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 122.47 -0.144 . . . . 0.0 110.942 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 163' ' ' ILE . . . . . . . . . . . . . 3.0 tp -106.25 14.02 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.91 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 19.0 t -86.46 -12.3 49.39 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.551 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 165' ' ' ALA . . . . . 0.414 ' HB3' ' OE2' ' A' ' 84' ' ' GLU . . . -94.01 8.17 42.42 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.674 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 56.5 p -84.96 -34.15 22.5 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.676 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 7.9 tp -84.32 -9.06 58.79 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 123.425 0.453 . . . . 0.0 111.106 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 65.0 mtt -96.86 130.71 44.09 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.75 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -163.44 -151.97 6.66 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.688 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 20.2 p . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.089 -0.958 . . . . 0.0 111.061 -179.956 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 111.396 0.147 . . . . 0.0 111.396 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.543 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 8.0 m-20 -117.03 -41.98 2.97 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.445 0.465 . . . . 0.0 111.2 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -141.99 157.19 45.23 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 122.848 0.459 . . . . 0.0 110.448 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.564 ' HG ' ' OE1' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -103.52 -119.43 0.2 Allowed 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.695 ' CG2' ' H ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -103.18 -173.71 2.38 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.003 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.539 ' N ' HG23 ' A' ' 5' ' ' THR . 45.5 mt-10 -63.0 -12.91 29.08 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 122.453 -0.154 . . . . 0.0 110.92 176.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.695 ' H ' ' CG2' ' A' ' 5' ' ' THR . 7.3 pt-20 -49.47 -40.19 36.26 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 123.785 0.678 . . . . 0.0 111.772 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.583 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 1.6 pt20 -72.1 -48.86 40.83 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.769 178.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.405 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 4.5 mt -62.18 -28.36 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-N 114.095 -1.411 . . . . 0.0 110.633 178.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 6' ' ' GLU . . . -68.1 -48.93 64.16 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -136.27 -29.06 1.0 Allowed 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -177.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.583 ' CD1' ' HA ' ' A' ' 8' ' ' GLN . 28.0 m-85 -63.55 -14.62 53.02 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 123.383 0.427 . . . . 0.0 110.345 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.666 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 4.3 pttt -74.19 -38.44 63.62 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.666 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 12.0 mt-10 -70.4 -43.81 69.27 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 113.607 -1.633 . . . . 0.0 110.566 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.532 ' O ' HG11 ' A' ' 35' ' ' VAL . . . -62.94 -18.26 62.93 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 115.373 -0.831 . . . . 0.0 108.927 176.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.62 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 25.9 t80 -85.84 -49.91 7.53 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.394 177.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.457 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 52.6 m -87.52 -13.03 44.13 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -177.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -66.68 -29.93 70.06 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.523 0.601 . . . . 0.0 112.256 -178.893 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.577 ' CD1' HG22 ' A' ' 35' ' ' VAL . 3.1 m-85 -126.03 -4.19 6.91 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.62 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 6.0 t70 -77.83 55.63 1.42 Allowed 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 118.479 0.581 . . . . 0.0 112.368 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.457 ' HE3' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -86.6 -21.94 26.53 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 179.307 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.71 -22.38 61.64 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.334 0.588 . . . . 0.0 110.436 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.73 43.16 29.63 Favored Glycine 0 N--CA 1.471 0.992 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.52 23.25 12.19 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.013 -1.594 . . . . 0.0 112.78 -175.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.07 -78.81 1.87 Allowed Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.265 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.583 HG21 ' HA ' ' A' ' 64' ' ' ASP . 0.4 OUTLIER -114.51 166.92 11.19 Favored 'General case' 0 N--CA 1.435 -1.223 0 O-C-N 123.649 0.264 . . . . 0.0 110.4 178.219 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -77.09 148.18 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.403 ' OG1' ' HB2' ' A' ' 31' ' ' GLU . 0.6 OUTLIER -68.57 164.19 21.9 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 114.612 -1.177 . . . . 0.0 113.494 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.39 -55.2 6.25 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 123.719 0.807 . . . . 0.0 112.416 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -56.09 -14.0 2.36 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.175 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.507 ' O ' HG23 ' A' ' 35' ' ' VAL . 26.3 mt-10 -110.95 -25.85 9.6 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.813 -178.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.595 HD22 HG13 ' A' ' 63' ' ' ILE . 7.4 tp -56.4 -38.43 71.5 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.24 0.616 . . . . 0.0 111.637 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.617 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -56.45 -40.58 86.64 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 177.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 m -74.67 -27.95 60.63 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.772 -0.714 . . . . 0.0 112.274 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.577 HG22 ' CD1' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -76.57 -26.45 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.283 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.537 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 44.7 mtt -71.59 -41.1 69.4 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 112.992 -1.913 . . . . 0.0 111.06 175.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.698 ' HD3' ' HA ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -87.29 -26.1 23.6 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.6 m -65.19 -7.86 14.61 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 122.083 0.944 . . . . 0.0 111.488 176.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.8 mt -92.59 -3.62 54.73 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.122 -1.853 . . . . 0.0 110.29 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.81 -11.43 18.19 Favored Glycine 0 CA--C 1.495 -1.202 0 N-CA-C 115.621 1.009 . . . . 0.0 115.621 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 36' ' ' MET . 9.5 mm100 -68.19 152.13 45.94 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 113.007 -1.596 . . . . 0.0 111.359 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -77.48 126.13 85.15 Favored Pre-proline 0 N--CA 1.471 0.614 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -177.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.698 ' HA ' ' HD3' ' A' ' 37' ' ' ARG . 83.6 Cg_endo -86.23 120.13 1.84 Allowed 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.498 2.132 . . . . 0.0 115.751 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -137.04 153.31 50.65 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 176.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -80.7 -29.79 36.45 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.716 0.769 . . . . 0.0 109.27 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 50' ' ' ASP . . . -71.62 -32.11 67.61 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 113.393 -1.731 . . . . 0.0 109.926 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -80.86 -28.94 35.88 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 114.052 -1.431 . . . . 0.0 109.652 177.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.588 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -73.59 -18.82 61.01 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.683 175.541 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.877 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 46.6 mt-30 -99.91 -15.73 18.24 Favored 'General case' 0 CA--C 1.482 -1.67 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.124 177.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.505 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 2.1 t70 -87.26 -36.18 18.07 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 112.289 -2.232 . . . . 0.0 110.299 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.441 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 25.3 mmt -86.61 -29.99 22.16 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.531 178.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.588 ' HB ' ' O ' ' A' ' 48' ' ' LEU . 1.6 mp -77.35 -24.14 14.72 Favored 'Isoleucine or valine' 0 C--N 1.341 0.226 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 175.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.877 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.0 t30 -78.13 -34.43 49.94 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.884 175.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.72 -45.98 8.93 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.534 ' C ' ' H ' ' A' ' 57' ' ' ALA . 34.9 t -82.1 -53.02 12.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.509 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 16.1 t70 -72.26 40.73 0.08 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 122.001 0.905 . . . . 0.0 110.008 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.534 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -78.25 -5.29 51.5 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 114.098 -1.41 . . . . 0.0 113.222 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -92.27 -42.74 9.68 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 112.672 -2.058 . . . . 0.0 111.151 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.15 51.2 4.04 Favored Glycine 0 C--N 1.344 1.017 0 O-C-N 123.486 0.492 . . . . 0.0 113.646 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -110.03 -21.41 12.32 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.16 25.76 61.15 Favored Glycine 0 N--CA 1.466 0.637 0 CA-C-N 115.674 -0.694 . . . . 0.0 113.585 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.534 ' O ' HD13 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -160.13 172.92 16.59 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.362 1.065 . . . . 0.0 109.092 179.609 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.595 HG13 HD22 ' A' ' 32' ' ' LEU . 36.6 mm -125.1 77.2 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.583 ' HA ' HG21 ' A' ' 26' ' ' THR . 8.4 m-20 -50.5 152.02 2.06 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.848 0.859 . . . . 0.0 111.25 177.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.576 ' CD1' ' HD3' ' A' ' 66' ' ' PRO . 42.5 p90 -90.49 -41.36 0.4 Allowed Pre-proline 0 CA--C 1.55 0.963 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.576 ' HD3' ' CD1' ' A' ' 65' ' ' PHE . 21.7 Cg_exo -65.51 -18.26 59.13 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 121.722 1.615 . . . . 0.0 113.169 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -107.12 -39.2 5.79 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -178.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.514 ' O ' ' HB2' ' A' ' 71' ' ' MET . 66.4 m-85 -85.09 -20.67 30.02 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -176.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.516 ' HB2' HD21 ' A' ' 4' ' ' LEU . 15.3 mt -71.73 -41.2 68.79 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-O 122.385 1.088 . . . . 0.0 108.785 177.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.417 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 1.3 m -53.35 -31.38 44.25 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 111.967 -2.379 . . . . 0.0 109.159 173.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.514 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 23.7 mmt -72.96 -31.52 64.61 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.255 175.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.875 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 1.5 mtt -84.98 -18.37 34.7 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.193 177.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.501 ' HB1' ' NZ ' ' A' ' 77' ' ' LYS . . . -74.96 -39.43 61.33 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.494 ' CD ' ' HA ' ' A' ' 71' ' ' MET . 3.0 ptm180 -77.13 -18.15 58.11 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 112.449 0.536 . . . . 0.0 112.449 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.875 ' HD2' ' HA ' ' A' ' 72' ' ' MET . 29.9 mttt -71.89 -13.83 61.77 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 175.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.472 ' HB2' ' OE2' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -128.79 -29.46 2.35 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -177.007 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.501 ' NZ ' ' HB1' ' A' ' 73' ' ' ALA . 31.7 mttp -65.05 -48.87 72.29 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -177.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -105.4 -30.72 9.41 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.1 t -82.97 98.84 9.45 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 41.03 94.3 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 125.01 1.324 . . . . 0.0 114.108 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.533 ' HA ' ' OE1' ' A' ' 84' ' ' GLU . 51.6 m -84.14 -14.08 51.19 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.891 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.423 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -79.32 -45.41 19.71 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.634 0.773 . . . . 0.0 109.807 -179.255 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.423 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 39.9 mt-10 -66.1 -18.56 65.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 113.831 -1.531 . . . . 0.0 112.292 178.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.653 ' HG2' ' SD ' ' B' ' 168' ' ' MET . 40.3 mt-10 -61.96 -27.25 68.71 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 122.952 0.501 . . . . 0.0 112.255 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.7 mp -87.94 -48.04 15.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.321 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.595 ' O ' ' HD1' ' A' ' 89' ' ' PHE . 17.7 mmt180 -57.43 -18.11 16.4 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.529 ' OE1' ' HA ' ' B' ' 164' ' ' SER . 3.4 pt-20 -73.28 -19.68 60.99 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 177.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.37 -23.44 66.34 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.04 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.595 ' HD1' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -84.36 -20.7 31.55 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 174.715 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -81.05 -24.52 37.79 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.266 -1.334 . . . . 0.0 108.418 175.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.471 HG12 ' CD1' ' A' ' 92' ' ' PHE . 43.8 t -88.67 -55.31 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 CA-C-N 114.913 -1.04 . . . . 0.0 112.126 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.793 ' HB3' HG21 ' A' ' 100' ' ' ILE . 8.5 m-85 -100.65 -44.93 5.67 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -176.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.705 ' CA ' HG12 ' A' ' 100' ' ' ILE . 17.6 t70 -63.9 92.0 0.07 Allowed 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.781 0.8 . . . . 0.0 111.412 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.421 ' HE3' ' C ' ' A' ' 107' ' ' HIS . 31.9 mttm -88.03 -47.11 8.77 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.225 -1.352 . . . . 0.0 113.97 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -71.43 3.06 4.11 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -175.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 49.05 29.96 9.29 Favored Glycine 0 N--CA 1.473 1.109 0 CA-C-N 114.25 -1.341 . . . . 0.0 115.035 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -100.85 -3.34 30.0 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.714 0.257 . . . . 0.0 111.239 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.13 -18.99 56.26 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-N 116.345 -0.388 . . . . 0.0 112.592 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -113.16 118.18 33.99 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.308 -0.946 . . . . 0.0 110.624 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.793 HG21 ' HB3' ' A' ' 92' ' ' PHE . 47.5 mt -79.27 89.27 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.4 m -67.08 166.0 14.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.639 -1.164 . . . . 0.0 112.571 -177.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.528 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -60.4 -14.53 19.37 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -178.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.534 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.65 -27.15 21.48 Favored 'General case' 0 CA--C 1.488 -1.433 0 CA-C-O 121.634 0.73 . . . . 0.0 109.33 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 1.01 ' O ' HG23 ' A' ' 108' ' ' VAL . 25.5 mt-10 -79.39 -44.3 21.74 Favored 'General case' 0 CA--C 1.486 -1.51 0 CA-C-N 112.829 -1.987 . . . . 0.0 111.948 -177.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.636 HD22 ' O ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -66.74 -30.83 71.15 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.692 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -71.48 -46.61 59.38 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 113.683 -1.599 . . . . 0.0 109.488 175.789 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.534 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 17.4 t-80 -68.04 -21.62 65.0 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.351 178.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.01 HG23 ' O ' ' A' ' 104' ' ' GLU . 24.0 t -72.2 -49.1 45.58 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.764 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 176.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.713 ' SD ' HD22 ' A' ' 116' ' ' LEU . 19.1 mtt -57.07 -41.21 78.37 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 112.276 -2.238 . . . . 0.0 111.879 176.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.59 -19.15 64.45 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.398 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.89 -45.11 19.19 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.731 176.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 mt -79.99 -28.12 39.55 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.796 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 140.02 -7.52 2.94 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 117.798 -1.557 . . . . 0.0 116.83 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 109' ' ' MET . 5.0 mt-10 -100.94 152.36 20.65 Favored 'General case' 0 C--N 1.356 0.886 0 CA-C-N 120.813 2.306 . . . . 0.0 114.579 -178.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -111.08 129.79 55.81 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 113.505 -1.68 . . . . 0.0 107.277 175.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.713 HD22 ' SD ' ' A' ' 109' ' ' MET . 1.4 tp -134.87 116.21 14.51 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.584 -1.189 . . . . 0.0 112.605 -175.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.684 HG22 ' HG2' ' A' ' 120' ' ' GLU . 0.6 OUTLIER -76.64 -175.65 3.46 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.588 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.518 ' N ' HG23 ' A' ' 117' ' ' THR . 16.1 t70 -72.5 -37.46 68.41 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.128 -1.396 . . . . 0.0 114.41 -177.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.645 ' H ' HG23 ' A' ' 117' ' ' THR . 9.7 pt-20 -89.57 -16.08 31.42 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 179.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.684 ' HG2' HG22 ' A' ' 117' ' ' THR . 14.8 pt-20 -87.43 -16.01 36.1 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 123.215 0.322 . . . . 0.0 110.722 178.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -81.18 -30.5 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.011 178.035 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -68.64 30.8 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 115.003 -0.999 . . . . 0.0 113.32 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.532 ' H ' ' C ' ' A' ' 121' ' ' VAL . 10.9 pt-20 -142.7 -30.2 0.54 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.352 -1.294 . . . . 0.0 109.941 177.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.729 ' HA ' ' OG1' ' B' ' 153' ' ' THR . 2.9 mmt -71.93 -30.64 65.54 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.605 176.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.625 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 1.8 mp -87.85 -50.33 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 CA-C-N 114.088 -1.415 . . . . 0.0 113.313 -177.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -58.48 -27.24 64.25 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.007 0.817 . . . . 0.0 111.547 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.561 ' HG2' ' OG1' ' B' ' 153' ' ' THR . 0.0 OUTLIER -63.9 -33.46 75.76 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.389 177.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.598 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -110.47 -29.86 7.9 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-O 121.101 0.477 . . . . 0.0 110.564 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.625 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -60.97 126.82 28.75 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.716 -1.129 . . . . 0.0 113.174 -179.035 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.8 mt -90.51 -51.92 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 114.049 -1.432 . . . . 0.0 110.548 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -85.57 -25.34 26.77 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.38 49.51 6.2 Favored Glycine 0 CA--C 1.525 0.669 0 O-C-N 123.526 0.516 . . . . 0.0 113.787 178.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -84.76 -19.43 32.65 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.49 10.86 56.5 Favored Glycine 0 CA--C 1.501 -0.843 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.916 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -141.21 121.21 13.67 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.613 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 2.5 t -78.87 125.18 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -91.2 -165.31 1.33 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.784 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.556 ' OH ' ' HB3' ' A' ' 89' ' ' PHE . 2.7 m-85 -70.97 -57.25 4.74 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.18 177.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -58.95 -20.82 55.83 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -178.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.613 ' OE1' ' HA ' ' A' ' 136' ' ' VAL . 9.4 mt-10 -88.54 -39.36 14.2 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 121.379 0.609 . . . . 0.0 110.113 178.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -75.32 -23.56 57.3 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.137 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' A' ' 138' ' ' TYR . 37.4 t -85.14 -41.19 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 114.605 -1.18 . . . . 0.0 111.436 -178.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 140' ' ' GLU . 0.8 OUTLIER -56.97 -20.04 21.54 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 123.59 0.556 . . . . 0.0 111.167 177.502 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.402 ' N ' HE21 ' A' ' 143' ' ' GLN . 0.0 OUTLIER -67.0 -28.47 68.28 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.973 178.489 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.414 ' HG3' ' O ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -84.95 -4.39 59.11 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.788 178.478 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.411 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 58.9 p -117.44 -45.75 2.71 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.601 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -54.85 -31.16 59.24 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.453 -0.784 . . . . 0.0 111.343 179.912 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 18.3 p . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 120.571 0.224 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -129.09 -29.77 2.25 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.523 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -91.7 136.71 32.93 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.37 0.419 . . . . 0.0 111.384 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -99.08 153.35 18.95 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.815 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.729 ' OG1' ' HA ' ' A' ' 124' ' ' MET . 10.5 p -135.5 -70.37 0.48 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 118.981 -0.533 . . . . 0.0 112.151 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 154' ' ' PHE . . . . . 0.689 ' HA ' HG22 ' B' ' 157' ' ' VAL . 0.2 OUTLIER -63.28 -27.57 69.43 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 118.885 0.766 . . . . 0.0 111.242 179.602 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.486 ' HD2' ' OE2' ' A' ' 127' ' ' GLU . 8.5 mptt -67.04 -44.1 81.04 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.908 178.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -77.09 -35.83 56.19 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 157' ' ' VAL . . . . . 0.689 HG22 ' HA ' ' B' ' 154' ' ' PHE . 17.7 m -71.71 -38.61 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 122.493 0.317 . . . . 0.0 111.809 -178.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -73.6 -33.07 64.42 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.35 0.66 . . . . 0.0 112.364 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -64.63 -30.69 71.72 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 123.379 0.424 . . . . 0.0 111.374 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.02 -38.09 53.63 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.845 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 9.8 p -108.61 25.66 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 O-C-N 123.361 0.413 . . . . 0.0 111.643 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 162' ' ' LYS . . . . . . . . . . . . . 20.5 ttpt -76.5 -8.9 58.12 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 163' ' ' ILE . . . . . 0.433 HD11 ' O ' ' B' ' 168' ' ' MET . 11.8 tt -89.26 153.21 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . 0.529 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 6.4 t -88.45 171.17 10.3 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.027 0.441 . . . . 0.0 112.082 -178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . -83.36 15.63 2.9 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.391 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 52.1 m -121.61 12.34 10.7 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.03 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.667 ' O ' ' HD3' ' A' ' 75' ' ' LYS . 56.7 mt 75.12 39.84 0.37 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.924 0.868 . . . . 0.0 111.828 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . 0.653 ' SD ' ' HG2' ' A' ' 84' ' ' GLU . 33.7 mtt -73.13 -158.49 0.05 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.449 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -133.25 -103.81 0.85 Allowed Glycine 0 C--N 1.344 1.02 0 C-N-CA 121.419 -0.42 . . . . 0.0 112.76 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.44 -0.791 . . . . 0.0 110.709 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.402 0 N-CA-C 111.416 0.154 . . . . 0.0 111.416 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.614 ' HA ' ' OE1' ' A' ' 8' ' ' GLN . 2.7 m-20 -121.13 130.23 53.64 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 123.421 0.45 . . . . 0.0 110.853 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.56 ' H ' ' NE2' ' A' ' 8' ' ' GLN . 41.9 mt-30 -132.83 -46.61 0.86 Allowed 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 123.462 0.476 . . . . 0.0 111.947 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.757 ' HG ' HE21 ' A' ' 8' ' ' GLN . 0.0 OUTLIER -112.78 -125.18 0.28 Allowed 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.153 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.452 ' H ' ' HB2' ' A' ' 4' ' ' LEU . 16.0 p -102.25 -173.62 2.38 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 123.963 0.905 . . . . 0.0 111.777 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.54 ' HA ' HG12 ' A' ' 9' ' ' ILE . 15.4 tt0 -59.78 -21.91 61.43 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.452 ' HG2' ' OG1' ' A' ' 5' ' ' THR . 12.5 pt-20 -49.92 -39.05 38.89 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 123.877 0.736 . . . . 0.0 111.436 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.757 HE21 ' HG ' ' A' ' 4' ' ' LEU . 1.2 pt20 -68.82 -49.82 55.31 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.626 176.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.54 HG12 ' HA ' ' A' ' 6' ' ' GLU . 15.2 mm -51.85 -43.19 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 114.231 -1.35 . . . . 0.0 111.963 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.85 -34.83 67.03 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -111.0 -19.61 12.71 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -177.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.542 ' O ' ' HB2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -74.45 -15.05 60.91 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.149 0.886 . . . . 0.0 110.009 178.736 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.694 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -81.65 -41.45 21.41 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.017 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.694 ' N ' ' HG2' ' A' ' 13' ' ' LYS . 1.4 mt-10 -84.99 -40.04 17.37 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 114.271 -1.332 . . . . 0.0 112.716 -179.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.641 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -64.72 -18.75 65.3 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.554 0.693 . . . . 0.0 109.249 178.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.611 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 18.8 t80 -86.06 -49.37 7.84 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 113.975 -1.466 . . . . 0.0 109.485 177.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.2 m -87.17 -13.38 44.17 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 115.435 1.642 . . . . 0.0 115.435 -177.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -71.96 -30.47 65.32 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.538 -179.86 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.587 ' CD1' HG22 ' A' ' 35' ' ' VAL . 5.5 m-85 -133.58 -8.24 2.85 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.611 ' HB3' ' O ' ' A' ' 16' ' ' PHE . 15.3 t70 -101.33 82.67 2.36 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.601 0.637 . . . . 0.0 109.799 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.456 ' HZ2' ' HA ' ' A' ' 19' ' ' PHE . 1.5 mppt? -86.89 -34.74 19.31 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -178.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.596 ' OD1' ' HB2' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -70.74 -22.36 62.42 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.831 178.277 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.15 51.57 4.96 Favored Glycine 0 N--CA 1.468 0.797 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.596 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -98.33 22.44 9.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 113.756 -1.222 . . . . 0.0 113.557 -176.091 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.61 -67.16 0.59 Allowed Glycine 0 CA--C 1.525 0.678 0 CA-C-N 115.128 -0.942 . . . . 0.0 113.69 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.585 ' OG1' ' N ' ' A' ' 63' ' ' ILE . 1.5 t -97.6 176.01 6.0 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.749 0.785 . . . . 0.0 112.226 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.525 ' N ' ' HG1' ' A' ' 26' ' ' THR . 0.2 OUTLIER -132.93 148.71 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.147 179.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.82 155.3 6.12 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 p -74.14 -55.58 5.92 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 114.903 -1.044 . . . . 0.0 113.039 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -54.47 -13.84 1.07 Allowed 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.881 0.738 . . . . 0.0 111.606 177.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.536 ' O ' HG23 ' A' ' 35' ' ' VAL . 21.7 mt-10 -111.43 -17.0 13.2 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.403 -178.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.525 HD22 HG12 ' A' ' 63' ' ' ILE . 12.2 tp -57.14 -40.11 76.54 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.756 0.422 . . . . 0.0 111.889 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.773 ' O ' ' HD2' ' A' ' 37' ' ' ARG . . . -53.39 -41.09 62.44 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 177.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.9 m -74.72 -31.83 61.96 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.731 -0.734 . . . . 0.0 112.92 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.641 HG12 ' HA ' ' A' ' 15' ' ' ALA . 1.4 t -74.21 -26.0 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.52 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 19.4 mmt -76.1 -42.21 47.92 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 112.925 -1.943 . . . . 0.0 111.459 176.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.773 ' HD2' ' O ' ' A' ' 33' ' ' GLY . 11.3 mtt180 -79.73 -29.62 40.65 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.1 t -67.94 -8.46 37.13 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.947 0.88 . . . . 0.0 111.756 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.557 HD21 ' HB2' ' A' ' 14' ' ' GLU . 95.9 mt -90.9 -7.67 51.52 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.286 -1.779 . . . . 0.0 109.938 177.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.25 -7.04 23.11 Favored Glycine 0 CA--C 1.493 -1.291 0 CA-C-O 122.233 0.907 . . . . 0.0 115.142 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.52 ' HB2' ' O ' ' A' ' 36' ' ' MET . 51.9 mt-30 -76.73 138.56 40.03 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 112.376 -1.912 . . . . 0.0 111.669 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -127.43 62.5 54.6 Favored Pre-proline 0 CA--C 1.554 1.133 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.184 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.422 ' HD3' ' C ' ' A' ' 41' ' ' GLN . 4.5 Cg_endo -88.25 -178.78 2.2 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.93 2.42 . . . . 0.0 112.156 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.504 ' OG1' ' N ' ' A' ' 45' ' ' GLU . 7.1 t -99.28 -174.95 2.87 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 122.115 0.959 . . . . 0.0 110.663 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.521 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 46.6 mt-10 -80.96 -24.27 38.2 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-N 113.005 -1.907 . . . . 0.0 108.57 177.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.45 -30.07 66.81 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 113.699 -1.591 . . . . 0.0 111.779 -177.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.535 ' OE2' ' HA ' ' B' ' 168' ' ' MET . 44.0 mt-10 -87.32 -26.73 23.25 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.246 177.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.572 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -69.29 -20.04 63.9 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.132 174.524 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.884 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 11.7 mm100 -98.63 -16.22 19.15 Favored 'General case' 0 CA--C 1.482 -1.653 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.106 178.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.426 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 3.3 t70 -87.14 -33.97 19.24 Favored 'General case' 0 C--N 1.281 -2.391 0 CA-C-N 112.003 -2.362 . . . . 0.0 110.392 177.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.453 ' SD ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -86.51 -35.28 19.67 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.791 178.073 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.572 ' HB ' ' O ' ' A' ' 48' ' ' LEU . 1.5 mp -70.96 -27.37 29.83 Favored 'Isoleucine or valine' 0 C--N 1.345 0.399 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 175.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.884 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 3.8 t-20 -71.73 -34.17 69.33 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.349 175.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 50' ' ' ASP . 41.6 mt-10 -79.58 -33.42 41.73 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.546 ' C ' ' H ' ' A' ' 57' ' ' ALA . 72.1 t -82.14 -41.71 18.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -72.5 35.71 0.07 Allowed 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.894 0.854 . . . . 0.0 110.527 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.546 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -86.5 -6.32 58.93 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 114.254 -1.339 . . . . 0.0 111.907 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.449 ' HB3' HD22 ' A' ' 60' ' ' ASN . 6.5 t70 -113.22 -29.24 7.34 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 111.78 -2.463 . . . . 0.0 110.639 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.62 46.09 5.87 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.855 -0.612 . . . . 0.0 113.75 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.449 HD22 ' HB3' ' A' ' 58' ' ' ASP . 45.7 m-80 -110.25 -21.75 12.08 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.23 26.42 72.55 Favored Glycine 0 N--CA 1.469 0.838 0 CA-C-N 115.851 -0.613 . . . . 0.0 114.291 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.492 HG22 ' HG1' ' A' ' 26' ' ' THR . 0.0 OUTLIER -142.18 -177.22 5.14 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 123.269 0.627 . . . . 0.0 110.533 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.585 ' N ' ' OG1' ' A' ' 26' ' ' THR . 5.3 mp -135.36 96.18 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -176.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.447 ' O ' ' HD2' ' A' ' 68' ' ' PHE . 10.0 m-20 -67.0 150.03 49.82 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 174.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.539 ' CG ' ' HD3' ' A' ' 66' ' ' PRO . 27.0 p90 -77.86 -39.12 1.82 Allowed Pre-proline 0 N--CA 1.477 0.919 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -177.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.539 ' HD3' ' CG ' ' A' ' 65' ' ' PHE . 9.0 Cg_exo -72.85 -17.57 25.44 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 121.838 1.692 . . . . 0.0 113.027 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.539 ' O ' ' HG3' ' A' ' 71' ' ' MET . 39.7 mt-10 -103.97 -17.43 14.99 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 -177.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.532 ' CE1' ' HG ' ' A' ' 69' ' ' LEU . 2.6 p90 -84.78 -43.56 14.12 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 -177.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.532 ' HG ' ' CE1' ' A' ' 68' ' ' PHE . 1.7 mt -62.79 -33.99 76.34 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.489 0.662 . . . . 0.0 111.091 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.603 ' O ' ' HD3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -59.75 -35.5 74.72 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 113.721 -1.581 . . . . 0.0 108.64 174.167 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.606 ' HA ' ' NE ' ' A' ' 74' ' ' ARG . 66.0 mtt -74.6 -22.66 58.84 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-N 114.887 -1.052 . . . . 0.0 109.101 176.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.537 ' HA ' ' HG3' ' A' ' 75' ' ' LYS . 72.4 mtp -88.4 -18.6 28.02 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.866 177.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.559 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -81.58 -33.57 31.53 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.606 ' NE ' ' HA ' ' A' ' 71' ' ' MET . 1.4 ptt180 -84.88 -17.13 38.88 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.762 ' HZ2' ' HA ' ' B' ' 167' ' ' LEU . 0.0 OUTLIER -83.1 -13.76 55.03 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.563 0.619 . . . . 0.0 112.397 178.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.457 ' HA ' HG22 ' A' ' 79' ' ' THR . 22.5 ptt? -113.47 -33.68 5.82 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 120.983 0.42 . . . . 0.0 112.091 -177.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.559 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.6 mmtp -68.15 -15.45 63.59 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.55 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -103.89 -29.72 10.79 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.457 HG22 ' HA ' ' A' ' 76' ' ' MET . 8.6 t -75.94 76.2 2.84 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.402 0.62 . . . . 0.0 112.13 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 56.22 110.83 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.034 0.934 . . . . 0.0 112.268 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.543 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 13.9 t -83.2 -13.48 55.32 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.307 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.419 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -86.97 -45.71 10.53 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.758 0.79 . . . . 0.0 109.336 179.729 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.419 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 40.3 mt-10 -75.14 -18.18 60.26 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 113.647 -1.615 . . . . 0.0 113.199 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 81' ' ' SER . 11.2 pt-20 -58.99 -28.01 65.96 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.9 mp -88.09 -49.97 13.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.441 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.0 mtm180 -56.88 -18.19 12.27 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 3.1 pt-20 -74.17 -20.13 60.32 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.13 0.491 . . . . 0.0 110.258 178.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.524 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -70.51 -20.71 62.81 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.476 177.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.472 ' HE2' ' O ' ' A' ' 98' ' ' GLY . 4.1 m-85 -81.16 -20.79 40.51 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 174.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.472 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 4.4 tmt_? -76.23 -18.79 58.87 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 173.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.524 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 31.6 t -87.73 -53.68 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 114.249 -1.341 . . . . 0.0 111.808 177.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.809 ' HB3' HG21 ' A' ' 100' ' ' ILE . 10.4 m-85 -100.29 -45.36 5.63 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.734 ' CA ' HG12 ' A' ' 100' ' ' ILE . 2.3 t70 -63.44 93.43 0.07 Allowed 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.922 0.868 . . . . 0.0 111.246 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.643 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 33.8 mttm -87.96 -47.35 8.61 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 113.939 -1.482 . . . . 0.0 113.977 -178.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -71.83 1.56 6.82 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 114.05 1.129 . . . . 0.0 114.05 -175.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 49.71 28.32 10.8 Favored Glycine 0 N--CA 1.472 1.085 0 CA-C-N 114.298 -1.319 . . . . 0.0 114.799 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -96.27 -8.19 33.47 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.647 0.224 . . . . 0.0 111.404 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.472 ' O ' ' HE2' ' A' ' 89' ' ' PHE . . . 104.32 -18.68 44.66 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.965 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -120.66 118.95 31.45 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.621 -0.79 . . . . 0.0 111.085 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.809 HG21 ' HB3' ' A' ' 92' ' ' PHE . 29.0 mt -77.35 100.8 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.1 p -79.12 165.18 23.62 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.593 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -59.72 -15.08 17.22 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -178.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 107' ' ' HIS . . . -88.93 -31.69 18.06 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-O 121.885 0.85 . . . . 0.0 109.542 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 1.027 ' O ' HG23 ' A' ' 108' ' ' VAL . 3.1 mm-40 -79.95 -38.1 33.07 Favored 'General case' 0 CA--C 1.483 -1.631 0 CA-C-N 112.58 -2.1 . . . . 0.0 110.241 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.516 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 4.1 tt -63.76 -37.71 88.37 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 176.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.634 ' HD3' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -70.82 -44.53 66.33 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 113.79 -1.55 . . . . 0.0 108.904 175.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.503 ' HB2' ' O ' ' A' ' 103' ' ' ALA . 6.1 t-80 -67.66 -21.65 65.34 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.602 177.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.027 HG23 ' O ' ' A' ' 104' ' ' GLU . 25.6 t -73.02 -50.71 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 176.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.686 ' SD ' HD22 ' A' ' 116' ' ' LEU . 18.0 mtt -56.32 -41.06 75.41 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 112.513 -2.131 . . . . 0.0 112.103 175.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.31 -19.06 63.89 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.238 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.5 -45.07 20.03 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.55 176.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.1 mt -80.04 -28.23 39.31 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.774 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 139.42 -7.77 3.12 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 117.79 -1.561 . . . . 0.0 116.841 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.535 ' N ' ' O ' ' A' ' 109' ' ' MET . 5.1 mt-10 -101.01 152.11 20.98 Favored 'General case' 0 C--N 1.358 0.938 0 CA-C-N 120.859 2.329 . . . . 0.0 114.506 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -110.11 129.66 55.66 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 113.651 -1.613 . . . . 0.0 107.482 175.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.686 HD22 ' SD ' ' A' ' 109' ' ' MET . 1.2 tp -138.11 119.09 14.33 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.609 -175.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.914 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -74.36 -176.09 2.55 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.016 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.554 ' O ' HG23 ' A' ' 121' ' ' VAL . 16.0 t70 -72.2 -38.07 69.12 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -177.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.631 ' H ' HG23 ' A' ' 117' ' ' THR . 9.5 pt-20 -87.88 -16.11 34.84 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.751 ' HG2' HG22 ' A' ' 117' ' ' THR . 14.3 pt-20 -85.95 -15.44 41.56 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 123.219 0.324 . . . . 0.0 110.954 178.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.914 HG22 ' O ' ' A' ' 117' ' ' THR . 0.1 OUTLIER -83.43 -25.39 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.774 178.106 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -74.09 32.33 0.08 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.738 0.78 . . . . 0.0 112.652 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.463 ' H ' ' C ' ' A' ' 121' ' ' VAL . 11.2 pt-20 -141.66 -32.32 0.54 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.166 177.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.546 ' HA ' ' HB ' ' B' ' 153' ' ' THR . 4.5 ttm -73.01 -25.61 61.03 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.498 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.562 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 3.1 mt -88.92 -52.34 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.885 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -55.66 -29.04 58.6 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 124.239 0.962 . . . . 0.0 111.773 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.465 ' HG2' ' HB ' ' B' ' 153' ' ' THR . 0.0 OUTLIER -63.73 -33.34 75.44 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.374 -1.284 . . . . 0.0 111.321 177.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.653 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -106.55 -32.85 7.88 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-O 121.296 0.57 . . . . 0.0 109.735 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -61.08 124.31 20.15 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 114.255 -1.338 . . . . 0.0 113.053 -178.679 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.422 HD11 ' OE1' ' A' ' 143' ' ' GLN . 14.0 mt -90.34 -44.28 14.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 113.625 -1.625 . . . . 0.0 110.398 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -87.04 -25.17 24.34 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.16 49.69 9.28 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.08 -0.509 . . . . 0.0 114.072 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -89.74 -19.47 24.72 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.43 11.85 52.85 Favored Glycine 0 CA--C 1.501 -0.796 0 CA-C-N 115.878 -0.601 . . . . 0.0 113.254 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -139.86 119.83 13.55 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 113.651 -1.275 . . . . 0.0 108.055 178.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.564 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 2.1 t -81.73 130.24 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -177.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.451 HD22 ' CD ' ' A' ' 140' ' ' GLU . 11.8 m-80 -92.27 -164.72 1.22 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.516 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.409 ' O ' HG23 ' A' ' 142' ' ' VAL . 79.8 m-85 -74.48 -56.16 5.15 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.722 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -61.07 -20.44 62.58 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -178.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.723 ' O ' ' HG2' ' A' ' 144' ' ' MET . 9.7 mt-10 -86.87 -42.4 13.26 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.17 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -71.83 -23.98 61.63 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.241 176.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.54 ' O ' ' HG2' ' A' ' 145' ' ' MET . 29.9 t -85.54 -44.86 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.883 -177.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.458 ' HA ' ' OG1' ' A' ' 146' ' ' THR . 35.9 mt-30 -61.3 -19.09 61.38 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 123.512 0.508 . . . . 0.0 111.596 178.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.723 ' HG2' ' O ' ' A' ' 140' ' ' GLU . 27.4 mmt -71.83 -23.42 61.54 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 178.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.54 ' HG2' ' O ' ' A' ' 142' ' ' VAL . 7.2 ptt? -87.61 -4.26 58.95 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.579 177.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.458 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 30.8 p -119.83 -41.4 2.67 Favored 'General case' 0 C--N 1.351 0.64 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.002 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -37.27 -34.04 0.08 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 95.5 mttt . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.109 -0.948 . . . . 0.0 111.393 179.873 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 18.9 p . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.524 0.202 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -100.17 145.71 27.7 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.832 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -100.74 147.46 26.01 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.057 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . 0.451 ' H ' ' HG3' ' B' ' 156' ' ' GLU . 97.4 mttt -131.88 177.75 7.3 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.685 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.553 ' O ' HG13 ' B' ' 157' ' ' VAL . 0.7 OUTLIER -83.95 -118.11 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 118.716 -0.659 . . . . 0.0 112.306 -178.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 154' ' ' PHE . . . . . 0.667 ' HA ' HG22 ' B' ' 157' ' ' VAL . 0.1 OUTLIER -60.88 -27.55 68.23 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 119.342 0.974 . . . . 0.0 111.376 -179.759 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -59.07 -51.1 71.52 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.114 0.565 . . . . 0.0 111.538 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . 0.451 ' HG3' ' H ' ' B' ' 152' ' ' LYS . 2.5 mm-40 -76.91 -38.99 52.43 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 157' ' ' VAL . . . . . 0.667 HG22 ' HA ' ' B' ' 154' ' ' PHE . 11.3 m -61.44 -33.57 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-O 120.675 0.274 . . . . 0.0 111.316 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' B' ' 162' ' ' LYS . . . -73.59 -41.48 62.83 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.985 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -64.37 -25.99 68.27 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 123.394 0.434 . . . . 0.0 111.84 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.01 -37.95 53.99 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.825 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 9.8 p -112.15 25.27 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 O-C-N 123.357 0.411 . . . . 0.0 111.743 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 162' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' B' ' 158' ' ' ALA . 11.4 ttpt -81.75 -36.6 28.36 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.755 -0.202 . . . . 0.0 110.802 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 163' ' ' ILE . . . . . 0.454 HG23 ' O ' ' B' ' 163' ' ' ILE . 0.0 OUTLIER -117.0 61.76 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 CA-C-O 122.159 0.981 . . . . 0.0 109.251 178.83 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 17.5 t -132.82 -40.99 0.94 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.618 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 165' ' ' ALA . . . . . . . . . . . . . . . -88.94 0.01 57.0 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.449 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 51.5 m -84.51 -18.68 34.99 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.71 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.762 ' HA ' ' HZ2' ' A' ' 75' ' ' LYS . 1.1 tp -86.23 -6.58 58.95 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 123.421 0.451 . . . . 0.0 111.077 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . 0.535 ' HA ' ' OE2' ' A' ' 47' ' ' GLU . 64.8 mtt -89.0 149.53 23.22 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.263 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . 171.44 -146.86 9.8 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.49 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 19.6 p . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.142 -0.932 . . . . 0.0 111.016 -179.974 . . . . . . . . 0 0 . 1 stop_ save_